Citrus Sinensis ID: 041565
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 862 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SR05 | 850 | Receptor-like protein kin | yes | no | 0.979 | 0.992 | 0.594 | 0.0 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.982 | 0.987 | 0.595 | 0.0 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.967 | 0.931 | 0.553 | 0.0 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.958 | 0.946 | 0.454 | 0.0 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.936 | 0.972 | 0.428 | 0.0 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.952 | 0.960 | 0.437 | 0.0 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.888 | 0.902 | 0.446 | 0.0 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.959 | 0.939 | 0.435 | 0.0 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.901 | 0.937 | 0.420 | 1e-177 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.910 | 0.932 | 0.427 | 1e-176 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1040 bits (2690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/868 (59%), Positives = 650/868 (74%), Gaps = 24/868 (2%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
M+ T+ILF L+ ++ +L T+S+ L+CG S D + +KW D+KF
Sbjct: 1 MSGKTRILF-------FLTCLSFLLVFPTRSNGQDLALSCGTSEASADQDKKKWEPDTKF 53
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
L +GNSI ATA QD SL ST+PYMTARIF + ++Y+ + R LRL+FYP++Y
Sbjct: 54 L-KTGNSIHATATYQDPSLLSTVPYMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTG 112
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ SN+YF+V AN TLL+NFSA+IT +ALTQAY+V+E+SL P L I FTPS ++
Sbjct: 113 LNISNSYFTVEANDVTLLSNFSAAITCQALTQAYLVKEYSLAPTDKDVLSIKFTPSDKYR 172
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-L 239
D++AF+NGIEVI MP++F +A LVGF+DQ+++ ++ LQ+M+RLNVGG+ IP + DSG L
Sbjct: 173 DAFAFINGIEVIQMPELFDTAALVGFTDQTMDAKTANLQSMFRLNVGGQDIPGSQDSGGL 232
Query: 240 TRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299
TRTWY+D+PY+F A GV QA N +I Y N+ IAP +Y+TARS GP+ ++N
Sbjct: 233 TRTWYNDAPYIFSAGLGVTLQASNNFRINY-QNMPVSIAPADIYKTARSQGPNGDINLKS 291
Query: 300 NLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEG---ADVIGWAGEQGV 356
NLTW+FQID NFTYI+R HFCE L+KINQ+VF+I+INN+TAQ AD+IGW GE+G+
Sbjct: 292 NLTWMFQIDKNFTYILRLHFCEFQLSKINQKVFNIYINNRTAQADTTPADIIGWTGEKGI 351
Query: 357 PVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVP 416
P+YKDYAIY + G +E+ + + PS PEYYD+ LNGLEIFK DTM NLAGPNP P
Sbjct: 352 PMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLNGLEIFKM-DTMKNLAGPNPEP 410
Query: 417 SAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRC 476
S M AE KK + R ++ G AGGV + + A+ F KK+ G
Sbjct: 411 SPM--QAEEEVKKEFKNEKRHAFII----GSAGGVLAVLIG-ALCFTAYKKKQGYQGGDS 463
Query: 477 STSSWLPLYGTSHTTG-KSTGTGKSTS-SHLTNLAAGLCRHFSLAEIKHGTRNFSESHVI 534
TSSWLP+YG S T+G KST +GKS + SHL+NLAAGLCR FSL EIKHGT+NF +S+VI
Sbjct: 464 HTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVI 523
Query: 535 GVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594
GVGGFGKVY+G IDG TKVA+K+SNP+SEQG++EF+TEIE+LS+LRHKHLVSLIG+C+E
Sbjct: 524 GVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEG 583
Query: 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654
GEM LVYDYMA GTLREHLY KP L WK+RLEI IGAARGLHYLHTGA+YTIIHRDVK
Sbjct: 584 GEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVK 643
Query: 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYS 714
TTNIL+DE W AKVSDFGLSKTGPN+N HV+T+VKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 644 TTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYS 703
Query: 715 FGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFT 774
FGVVLFE+LCARPALN +LPKEQVSL DWA++C+R G +EDIIDPNLKG I +CL+KF
Sbjct: 704 FGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFA 763
Query: 775 ETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAMLNI 834
+TAEKCL+D G++RP+MGDVLWNLEFALQLQ+ DG + + +++ +N+
Sbjct: 764 DTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTPNNGGSSEDLGRGGMAVNV 823
Query: 835 DEESVLSDEIDTSNTTDIFSQIVNPKGR 862
+SD + + + T+IFSQIVNPKGR
Sbjct: 824 AGRDDVSD-LSSEDNTEIFSQIVNPKGR 850
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1033 bits (2671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/873 (59%), Positives = 640/873 (73%), Gaps = 26/873 (2%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
MN +ILFS F L L +QS+ L+CGAS D + +KW D+KF
Sbjct: 1 MNEKLRILFSFLCFFYVL------LVSPSQSNGQDISLSCGASEPAVDQDKKKWEPDTKF 54
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
L + N++ A A QD SL ST+PYMT+RIF + ++Y+ V R LRLHFYP++Y
Sbjct: 55 L-KTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTG 113
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ ++YFSV AN TLL+NFSA+IT +ALTQAY+VRE+SL P++ L I FTPS H
Sbjct: 114 LNILDSYFSVAANDLTLLSNFSAAITCQALTQAYLVREYSLAPSEKDVLSIIFTPSDKHP 173
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-L 239
++AF+NGIEVIPMP++F +A LVGFSDQ+ + ++ LQTM+RLNVGG+ IP + DSG L
Sbjct: 174 KAFAFINGIEVIPMPELFDTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGL 233
Query: 240 TRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299
TRTWY+D+PY+F A GV QA N +I+Y + AP VY+TARS GP+ ++N
Sbjct: 234 TRTWYNDAPYIFSAGLGVTLQASNNFRIDY-QKMPVSTAPADVYKTARSQGPNGDINMKS 292
Query: 300 NLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQ---EGADVIGWAGEQGV 356
NLTW+FQ+D NFTYI+R HFCE L KINQ+VF+IFINN+TAQ AD++GW G +G+
Sbjct: 293 NLTWMFQVDTNFTYIMRLHFCEFQLAKINQKVFNIFINNRTAQGDTNPADILGWTGGKGI 352
Query: 357 PVYKDYAIY--AEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNP 414
P YKDYAIY A G +E+ + + PS PEYYD+ LNGLEIFK DTM NLAGPNP
Sbjct: 353 PTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKI-DTMKNLAGPNP 411
Query: 415 VPSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGS 474
PS M + E KK F + V+ GGVA +F A+ F + +K+ GS
Sbjct: 412 KPSPMQAN-EDVKKDFQGDKRITAFVIGSAGGVAAVLF-----CALCFTMYQRKRKFSGS 465
Query: 475 RCSTSSWLPLYGTSHTTG-KSTGTGKSTS-SHLTNLAAGLCRHFSLAEIKHGTRNFSESH 532
TSSWLP+YG SHT+ KST +GKS + SHL+NLAAGLCR FSL+EIKHGT NF ES+
Sbjct: 466 DSHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESN 525
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
VIGVGGFGKVY+G IDG TKVAIK+SNP+SEQG++EF+TEIE+LS+LRHKHLVSLIG+C+
Sbjct: 526 VIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCD 585
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
E GEM L+YDYM+ GTLREHLY +P L WK+RLEI IGAARGLHYLHTGA+YTIIHRD
Sbjct: 586 EGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRD 645
Query: 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDV 712
VKTTNILLDE W AKVSDFGLSKTGPN+N HV+T+VKGSFGYLDPEYFRRQQLTEKSDV
Sbjct: 646 VKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDV 705
Query: 713 YSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRK 772
YSFGVVLFEVLCARPALN +L KEQVSL DWA++C+R GT+EDIIDPNLKG I +CL+K
Sbjct: 706 YSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKK 765
Query: 773 FTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAML 832
F +TAEKCLSD G+DRP+MGDVLWNLEFALQLQ+ DG + + + +
Sbjct: 766 FADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHRTPSNGGGSVDLGGGGGGV 825
Query: 833 NID---EESVLSDEIDTSNTTDIFSQIVNPKGR 862
++ ES L D++ + + IFSQIVNPKGR
Sbjct: 826 TVNISAGESDLGDDLSSEENSGIFSQIVNPKGR 858
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 926 bits (2394), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/881 (55%), Positives = 615/881 (69%), Gaps = 47/881 (5%)
Query: 22 ACVLSQGTQSDSNSYVLACGA-SSDGTDSNDRKWTSD--SKFLTNSGNSITAT-AQSQDS 77
A ++S S + +L CG +S+ TD+++R W SD SKFL++S + A +QD
Sbjct: 22 ATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDP 81
Query: 78 SLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTL 137
S+P +PYMTAR+F+S +Y F V+S +F +RL+FYP SY L+ +N+ FSV+ +TL
Sbjct: 82 SVPE-VPYMTARVFRSPFTYTFPVASGRKF-VRLYFYPNSYDGLNATNSLFSVSFGPYTL 139
Query: 138 LNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDI 197
L NFSAS TA+ALT A+I++EF +V + G L +TFTP S ++YAFVNGIEV MPD+
Sbjct: 140 LKNFSASQTAEALTYAFIIKEF-VVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDM 198
Query: 198 F----GSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGA 253
+ G+ +VG S NS+ L+ +YRLNVGG I + D+GL R+WYDD PY+FGA
Sbjct: 199 YSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGA 258
Query: 254 AFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTY 313
G+ AD I+YP+ +AP+ VY TARSMGP +N NYNLTWIF ID+ FTY
Sbjct: 259 GLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTY 318
Query: 314 IVRFHFCEIL--LTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPG 371
+VR HFCE+ +TKINQRVF I++NNQTA+ ADVI W GVP +KDY + + G
Sbjct: 319 LVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGNG 378
Query: 372 DDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFA 431
+LW+ALHP+ PEYYD++LNG+EIFK N + GNLAG NP+P + + K
Sbjct: 379 QQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPS--KVLR 436
Query: 432 PSSSRSKTVVHVIGGVAGGVFGIAVATAI-IFYVSNKKKNNDGSRCS--TSSWLPL--YG 486
P++ +SK+ +I G A G +A+ +F ++K D S TS WLPL YG
Sbjct: 437 PTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYG 496
Query: 487 TSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGY 546
SH+ G + +T S+ ++L + LCRHFS AEIK T+NF ES V+GVGGFGKVY G
Sbjct: 497 NSHSAG--SAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGE 554
Query: 547 IDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605
IDG TKVAIKR NP SEQGVHEFQTEIEMLSKLRH+HLVSLIG+CEE+ EMILVYDYMA
Sbjct: 555 IDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA 614
Query: 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665
+GT+REHLYK P LPWKQRLEICIGAARGLHYLHTGA++TIIHRDVKTTNILLDEKW
Sbjct: 615 HGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV 674
Query: 666 AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 725
AKVSDFGLSKTGP L+ THVST+VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCA
Sbjct: 675 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCA 734
Query: 726 RPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQG 785
RPALN L KEQVSLA+WA +C + G ++ I+DP LKG IT +C +KF ETA KC+ DQG
Sbjct: 735 RPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQG 794
Query: 786 IDRPSMGDVLWNLEFALQLQDNP-----------DGDKL------ISIQTDKANDTYAMH 828
I+RPSMGDVLWNLEFALQLQ++ D D++ + DK++D Y +
Sbjct: 795 IERPSMGDVLWNLEFALQLQESAEENGKGVCGDMDMDEIKYDDGNCKGKNDKSSDVYEGN 854
Query: 829 KA-------MLNIDEESVLSDEIDTSNTTDIFSQIVNPKGR 862
++I S+ S++ D + +FSQI+NPKGR
Sbjct: 855 VTDSRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 694 bits (1791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/904 (45%), Positives = 550/904 (60%), Gaps = 78/904 (8%)
Query: 6 QILFSIFFFSLTLSN-IACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKFLTNS 64
I ++ FS+ +S I + T ++ ++ CG +S+ D + R WT++++ + +S
Sbjct: 1 MIRHALLIFSILVSTPIVGEGATSTYEPTDVFLFNCGDTSNNVDVSGRNWTAENQKILSS 60
Query: 65 G---NSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN- 120
S TA A Q+S + S IPYMTARIF+S +Y F V+ F LRL+FYP YG+
Sbjct: 61 NLVNASFTAQASYQESGV-SQIPYMTARIFRSEFTYSFPVTPGSNF-LRLYFYPTRYGSQ 118
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALT--QAYIVREFSLVPAQSGDLIITFTPSSD 178
+ ++FSV NGFTLLNNFSA +T KA +I++EF + Q+ L +TFTPS
Sbjct: 119 FNAVKSFFSVKVNGFTLLNNFSADLTVKASKPQTEFIIKEFIIPVYQT--LNLTFTPS-- 174
Query: 179 HKDSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEV---------NSSTLQTMYRLNVGGK 229
DS AFVNGIE++ +P+ F S GF D V NS+ +T+YRLNVGGK
Sbjct: 175 -LDSLAFVNGIEIVSIPNRFYSKG--GFDDVITNVGSSVDFHIENSTAFETVYRLNVGGK 231
Query: 230 FIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSM 289
+ DSG+ R W D + + G++ + KI Y +AP VY T+RSM
Sbjct: 232 ---TVGDSGMFRRWVSDDEIILSESSGISPIVPD-IKINYTEKTPSYVAPDDVYATSRSM 287
Query: 290 G--PDPNVNRNYNLTWIFQIDANFTYIVRFHFCEIL--LTKINQRVFDIFINNQTAQEGA 345
G P N N+NLTW+F +DA F+Y+VR HFCE L + K QRVF IFI NQTA
Sbjct: 288 GNADHPEQNLNFNLTWLFTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEM 347
Query: 346 DVIGWAGEQGVPVYKDYAIYAEDLPGD-DELWVALHPSVSMHPEYYDAILNGLEIFKQND 404
DV +G +P+Y DY + A G +L + LHP VS++P+YYDAILNG+EI K ND
Sbjct: 348 DVFRMSGGSWIPMYLDYTVIAGSGSGRRHDLRLDLHPLVSINPKYYDAILNGVEILKMND 407
Query: 405 TMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKT-VVHVIGGVAGGVFGIAVATAIIFY 463
GNLAGPNP P L+ + + P ++K+ ++ + V G + +A+ +
Sbjct: 408 PDGNLAGPNPDP---LVSPDLIPNRATPRIRKNKSHILPITLAVVGSLVVLAMFVVGVLV 464
Query: 464 VSNKKKNNDGSRCSTSSWLPL-YGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIK 522
+ KKK + + SSW PL +GT T K + L A LCR FS+ EIK
Sbjct: 465 IMKKKKKS--KPSTNSSWCPLPHGTDSTNTKPAKS----------LPADLCRRFSIFEIK 512
Query: 523 HGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH 581
T +F + +IGVGGFG VY+G IDG T VA+KR +S QG EF+TE+EMLSKLRH
Sbjct: 513 SATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRH 572
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK---PGLPWKQRLEICIGAARGLH 638
HLVSLIG+C+ED EM+LVY+YM +GTL++HL++ DK P L WK+RLEICIGAARGL
Sbjct: 573 VHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQ 632
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFGYLD 697
YLHTGA+YTIIHRD+KTTNILLDE + KVSDFGLS+ GP + +QTHVST+VKG+FGYLD
Sbjct: 633 YLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLD 692
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
PEY+RRQ LTEKSDVYSFGVVL EVLC RP ++P EQ L W R GT++ II
Sbjct: 693 PEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQII 752
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN---------- 807
D +L +IT L KF E A +C+ D+G++RP M DV+W LEFALQL +
Sbjct: 753 DSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVES 812
Query: 808 ----PDGDKLISIQTDKANDTYA-----MHKAMLNIDEESVLSDEIDTSNTTDIFSQIVN 858
P G+ + TD +D ++ + K+ D V+ DE + ++ +FS+I
Sbjct: 813 LDLMPSGE--VGTTTDGEDDLFSRTTGHVGKSTTTDDSVLVVGDE-RSGSSWGVFSEINE 869
Query: 859 PKGR 862
PK R
Sbjct: 870 PKAR 873
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 652 bits (1683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/872 (42%), Positives = 520/872 (59%), Gaps = 65/872 (7%)
Query: 9 FSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSD---SKFLTNSG 65
F F T+S + C+ T D+ Y++ CG+ ++GT R + SD SK LT+S
Sbjct: 6 FETFILISTISILLCICHGFTPVDN--YLINCGSPTNGTLMG-RIFLSDKLSSKLLTSSK 62
Query: 66 NSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSN 125
+ + + S + Y TAR+F SSYKF+V+ + R W+RL+F P Y N +
Sbjct: 63 EILASVGGNSGSDI-----YHTARVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGS 116
Query: 126 AYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAF 185
A F+V++ LL++F+ +T + +V+E+SL + DL++TFTPSS S+AF
Sbjct: 117 AKFAVSSQSHVLLSDFT-------VTSSKVVKEYSL-NVTTNDLVLTFTPSSG---SFAF 165
Query: 186 VNGIEVIPMPD--IFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTW 243
VN IEVI +PD I GS VG Q +++ L+T++R+N+GG + S ND+ LTRTW
Sbjct: 166 VNAIEVISIPDTLITGSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDT-LTRTW 224
Query: 244 YDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTW 303
DS +L S + T P +++ AP +VY + M N N +N+TW
Sbjct: 225 VPDSEFLLEKNLA-KSMSKFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTW 283
Query: 304 IFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYK-DY 362
F +D F Y RFHFC+I+ +NQ F++++++ A D+ Y D+
Sbjct: 284 EFDVDPGFQYYFRFHFCDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDF 343
Query: 363 AIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLH 422
+ G +++ V++ PS ++H +Y +AI+NGLEI K N++ G L+ VP +
Sbjct: 344 V--TQTPKGSNKVRVSIGPS-TVHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGS---- 396
Query: 423 AEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTSSWL 482
SSS + ++G G + + + +K+ DG + +W+
Sbjct: 397 ----------SSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKRGQDGH---SKTWM 443
Query: 483 PLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKV 542
P G S G+ S + LT++ A +K T NF ES IGVGGFGKV
Sbjct: 444 PF----SINGTSMGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKV 499
Query: 543 YEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602
Y+G ++ TKVA+KR NP S+QG+ EF+TEIEMLS+ RH+HLVSLIG+C+E+ EMIL+Y+
Sbjct: 500 YKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYE 559
Query: 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE 662
YM NGT++ HLY P L WKQRLEICIGAARGLHYLHTG +IHRDVK+ NILLDE
Sbjct: 560 YMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDE 619
Query: 663 KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
+ AKV+DFGLSKTGP L+QTHVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEV
Sbjct: 620 NFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 679
Query: 723 LCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLS 782
LCARP ++ LP+E V+LA+WA+ Q+ G ++ IID +L+GNI LRKF ET EKCL+
Sbjct: 680 LCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLA 739
Query: 783 DQGIDRPSMGDVLWNLEFALQLQD------------NPDGDKLISIQTDKANDTYAMHKA 830
D G+DRPSMGDVLWNLE+ALQLQ+ N G+ I DT
Sbjct: 740 DYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINNFSQGDTSVNVPG 799
Query: 831 MLNIDEESVLSDEIDTSNTTDIFSQIVNPKGR 862
EES + D++ + + +FSQ+V +GR
Sbjct: 800 TAGRFEESSI-DDLSGVSMSKVFSQLVKSEGR 830
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 648 bits (1672), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/889 (43%), Positives = 534/889 (60%), Gaps = 68/889 (7%)
Query: 5 TQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDS---KFL 61
T+ L + +F LS S + ++Y+++CG+S + T N R + DS +
Sbjct: 4 TKSLLVLLWF---LSCYTTTTSSALFNPPDNYLISCGSSQNITFQN-RIFVPDSLHSSLV 59
Query: 62 TNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNL 121
GNS + A S S+ + Y TAR+F S +SY+F ++S R W+RLHF P +
Sbjct: 60 LKIGNS--SVATSTTSNNSTNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTW 117
Query: 122 DPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKD 181
+ ++A +V F LL + + +YI +E++ V S L ++F PS++
Sbjct: 118 NLTSASITVVTEDFVLL----NNFSFNNFNGSYIFKEYT-VNVTSEFLTLSFIPSNN--- 169
Query: 182 SYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSST---------LQTMYRLNVGGKFIP 232
S FVN IEV+ +PD DQ++ +N ST +T+YRLN+GG +
Sbjct: 170 SVVFVNAIEVVSVPDNL-------IPDQALALNPSTPFSGLSLLAFETVYRLNMGGPLLT 222
Query: 233 STNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPD 292
S ND+ L R W +D+ YL + + A N + I+Y +++QE AP VY TA +MG D
Sbjct: 223 SQNDT-LGRQWDNDAEYLHVNSSVLVVTA-NPSSIKYSPSVTQETAPNMVYATADTMG-D 279
Query: 293 PNV-NRNYNLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWA 351
NV + ++N+TW+ +D +F Y VR HFC+I+ +N VF++++N+ A D+
Sbjct: 280 ANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQALNTLVFNLYVNDDLALGSLDLSTLT 339
Query: 352 GEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAG 411
VP +KD+ I + L V++ P + +A +NGLE+ K ++ +L+G
Sbjct: 340 NGLKVPYFKDF-ISNGSVESSGVLTVSVGPD--SQADITNATMNGLEVLKISNEAKSLSG 396
Query: 412 PNPVPSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGV---FGIAVATAIIFYVSNKK 468
+ V S + + + KK A +IG + G V IAV S K+
Sbjct: 397 VSSVKSLLPGGSGSKSKKKAV----------IIGSLVGAVTLILLIAVCCYCCLVASRKQ 446
Query: 469 KN---NDGSRCSTSSWLPLYGTSHTTGKSTGTGKSTSSHLTNLAAG-LCRHFSLAEIKHG 524
++ +G LPLYG S T KST + KS ++ +LA+ L R F EI
Sbjct: 447 RSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFMFQEIMDA 506
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
T F ES ++GVGGFG+VY+G ++ TKVA+KR NP SEQG+ EF+TEIEMLSKLRH+HL
Sbjct: 507 TNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHL 566
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
VSLIG+C+E EMILVY+YMANG LR HLY D P L WKQRLEICIGAARGLHYLHTGA
Sbjct: 567 VSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGA 626
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
+IIHRDVKTTNILLDE AKV+DFGLSKTGP+L+QTHVST VKGSFGYLDPEYFRRQ
Sbjct: 627 SQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQ 686
Query: 705 QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764
QLTEKSDVYSFGVVL EVLC RPALN LP+EQV++A+WA+ Q+ G ++ I+D NL G
Sbjct: 687 QLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGK 746
Query: 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN------PDGDKLISIQT 818
+ L+KF ETAEKCL++ G+DRPSMGDVLWNLE+ALQL++ PD + I
Sbjct: 747 VNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSALMEPDDNSTNHIPG 806
Query: 819 DKANDTYAMHKAMLNIDEESVLS-----DEIDTSNTTDIFSQIVNPKGR 862
+M ID V S D+ + + T+ +FSQ+V+P+GR
Sbjct: 807 IPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAVFSQLVHPRGR 855
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/813 (44%), Positives = 507/813 (62%), Gaps = 47/813 (5%)
Query: 18 LSNIACVLSQGT------QSDSNSYVLACGASSDGTDSNDRKWTSD---SKFLTNSGNSI 68
L ++ CVL T ++ S S+++ CG+++ T+ + R W D +K +T G
Sbjct: 9 LEHLLCVLIFFTYVIGYGEAQSKSFLVDCGSNAT-TEVDGRTWVGDLSPNKSVTLQGFDA 67
Query: 69 TATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYF 128
+ S+ SS+ + I Y TAR+F + +Y F ++ +++RLHF P + N + + + F
Sbjct: 68 ITASTSKGSSVYAEI-YKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSF 126
Query: 129 SVNANGFTLL--NNFSASITAKAL---------TQAYIVREFSLVPAQSGDLIITFTPSS 177
SV A+G L+ N + I K L T + +V+EF L+P G L+++F P
Sbjct: 127 SVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEF-LLPTGPGKLVLSFIP-- 183
Query: 178 DHKDSYAFVNGIEVIPMPD-IFG-SAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTN 235
K S+ FVN IE++ + D +F S VG S+ + + ++TMYRLNVGG + +
Sbjct: 184 -EKGSFGFVNAIEIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSK 242
Query: 236 DSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNV 295
D L RTW D Y+ GV + N + I Y +APL VYETAR M +
Sbjct: 243 DLKLYRTWETDLSYMVIENAGV--EVKNSSNITYALADDSPVAPLLVYETARMMSNTEVL 300
Query: 296 NRNYNLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQG 355
+ +N++W F++D NF Y+VR HFCE+L+ K NQR+F I+INNQTA D+ AG +
Sbjct: 301 EKRFNISWKFEVDPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKN 360
Query: 356 VPVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPV 415
+Y+DY +D LW+ L P S+ DA+L+GLEIFK + GNLA
Sbjct: 361 KGIYQDYLDPVSS--KNDVLWIQLGPDSSVGASG-DALLSGLEIFKLSKN-GNLA----- 411
Query: 416 PSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSR 475
L+ ++T + S R + V G+A +F + + ++ ++ +D S+
Sbjct: 412 ---HLIRFDSTGHSVSDSKMRI-IWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESK 467
Query: 476 CSTSSWLPLY-GTSHTTGKSTGTGKSTSSHLTNLAAG-LCRHFSLAEIKHGTRNFSESHV 533
+ W PL+ +++T + TG S L LAA + R F+LAEI+ T+NF +
Sbjct: 468 NNPPGWRPLFLHVNNSTANAKATGGSL--RLNTLAASTMGRKFTLAEIRAATKNFDDGLA 525
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
IGVGGFGKVY G ++ T +AIKR+ P S+QG+ EF+TEI MLS+LRH+HLVSLIGFC+E
Sbjct: 526 IGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDE 585
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
EMILVY+YMANGTLR HL+ + P L WKQRLE CIG+ARGLHYLHTG+ IIHRDV
Sbjct: 586 HNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDV 645
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
KTTNILLDE + AK+SDFGLSK GP+++ THVST VKGSFGYLDPEYFRRQQLTEKSDVY
Sbjct: 646 KTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 705
Query: 714 SFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKF 773
SFGVVLFE +CAR +N LPK+Q++LA+WAL Q+ +E IID NL+GN + + L K+
Sbjct: 706 SFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKY 765
Query: 774 TETAEKCLSDQGIDRPSMGDVLWNLEFALQLQD 806
E AEKCL+D+G +RP MG+VLW+LE+ LQ+ +
Sbjct: 766 GEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHE 798
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/908 (43%), Positives = 535/908 (58%), Gaps = 81/908 (8%)
Query: 7 ILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDS-KFLTNSG 65
I + F++ +S A V + + ++ +++ CG +S+ D + R WT+++ KF++++
Sbjct: 2 ICHVLVIFTILVS--AVVDATASYEPTDVFLINCGDTSNNMDYSGRNWTTENPKFMSSNA 59
Query: 66 ---NSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYG-NL 121
S T++A Q+S +P +PY+ ARIF+ +Y F VS +F LRL+FYP YG +
Sbjct: 60 VDDASFTSSASYQESGIPQ-VPYLKARIFRYDFTYSFPVSPGWKF-LRLYFYPTRYGSDF 117
Query: 122 DPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKD 181
D ++FSVN N FTLL+NFS + A + +++EF + Q+ DL TFTPS +
Sbjct: 118 DAVKSFFSVNVNRFTLLHNFS--VKASIPESSSLIKEFIVPVNQTLDL--TFTPS---PN 170
Query: 182 SYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEV---------NSSTLQTMYRLNVGGKFIP 232
S AFVNGIE+I MPD F S GF D V NS+ +T+YR+NVGGK +
Sbjct: 171 SLAFVNGIEIISMPDRFYSKG--GFDDVVRNVGRDVDFEIDNSTAFETVYRVNVGGKVVG 228
Query: 233 STNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMG-- 290
DSG+ R W D +L G G KI Y +AP VY T R MG
Sbjct: 229 DVGDSGMFRRWLSDEGFLLGINSGAIPNI-TGVKINYTDKTPAYVAPEDVYTTCRLMGNK 287
Query: 291 PDPNVNRNYNLTWIFQIDANFTYIVRFHFCEIL--LTKINQRVFDIFINNQTAQEGADVI 348
P +N N+NLTW+F++DA F YIVR HFCE + K RVF IF Q A DV
Sbjct: 288 DSPELNLNFNLTWLFEVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVF 347
Query: 349 GWAGEQGVPVYKDYAIY--AEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTM 406
+G +P+Y D+ + A+ L V L P +P YYDAIL+G+EI K +++
Sbjct: 348 RLSGGFRLPMYLDFKVLVDADGTSQRPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSD 407
Query: 407 GNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFY--V 464
GNLAG NP+P T K +S V+ +I V G +A ++ +
Sbjct: 408 GNLAGLNPIPQLSPPPQSITPLK---GKGKSSHVLPIIIAVVGSAVALAFFVLVVVLVVM 464
Query: 465 SNKKKNNDGSRCST------SSWLPLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSL 518
KKK+N+ S +T SSW PL GTG + + ++L + LCR FS+
Sbjct: 465 KRKKKSNESSVDTTNKPSTNSSWGPLLH---------GTGSTNTKSASSLPSDLCRRFSI 515
Query: 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLS 577
EIK T +F E +IGVGGFG VY+G IDG T VA+KR +S QG EF TE+EMLS
Sbjct: 516 YEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLS 575
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK---PGLPWKQRLEICIGAA 634
KLRH HLVSLIG+C++D EM+LVY+YM +GTL++HL++ DK P L WK+RLEICIGAA
Sbjct: 576 KLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAA 635
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSF 693
RGL YLHTGA+YTIIHRD+KTTNILLDE + AKVSDFGLS+ GP + +QTHVST+VKG+F
Sbjct: 636 RGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTSASQTHVSTVVKGTF 695
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753
GYLDPEY+RRQ LTEKSDVYSFGVVL EVLC RP ++P EQ L W T+
Sbjct: 696 GYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNFNKRTV 755
Query: 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN------ 807
+ IID +L +IT + KF E A +C+ D+G++RP M DV+W LEFALQL +
Sbjct: 756 DQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHETAKKKND 815
Query: 808 --------PDGDKLISIQTDKANDTYA-----MHKAMLNIDEESVLSDEIDTSNTTDIFS 854
P G+ + TD +D ++ + K+ D V+ DE + ++ +FS
Sbjct: 816 NVESLDLMPSGE--VGTTTDGEDDLFSRTTGHVGKSTTTDDSVLVVGDE-RSGSSWGVFS 872
Query: 855 QIVNPKGR 862
+I PK R
Sbjct: 873 EINEPKAR 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 621 bits (1601), Expect = e-177, Method: Compositional matrix adjust.
Identities = 359/853 (42%), Positives = 506/853 (59%), Gaps = 76/853 (8%)
Query: 34 NSYVLACGASSDGTDSNDRKWTSD---SKFLTNSGNSITATAQSQDSSLPSTIPYMTARI 90
++Y++ CG+S++ T ++ R + SD S FLT+ + A+ ++ +S + Y TARI
Sbjct: 29 DNYLINCGSSTNVTVTS-RVFISDNLASNFLTSPNEILAASNRNSNSDI-----YQTARI 82
Query: 91 FKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKAL 150
F S Y+F+V+ + R W+RLHF P Y N +A FSV++ LL++F+ S
Sbjct: 83 FTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVS------ 135
Query: 151 TQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIF--GSAPLVGFSD 208
+ +++E+SL A + L +TFTPS D S+AF+N +EV+ +PD G G
Sbjct: 136 --SRVMKEYSLNVA-TDHLELTFTPSGD---SFAFLNALEVVSVPDTLFSGDPSFAGSPG 189
Query: 209 QSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIE 268
+ ++ L+T+YR+N+GG + +ND+ L+R W DS +L + ++
Sbjct: 190 KFQGLSWQALETVYRVNMGGPRVTPSNDT-LSRIWEPDSEFLVEK--NLVKSVSKIASVD 246
Query: 269 Y-PSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILLTKI 327
Y P ++E AP +VY T M N + N+N+TW F +D F Y +RFHFC+I+ +
Sbjct: 247 YVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKAL 306
Query: 328 NQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAED-LPGDDELWVALHPSV--- 383
NQ F++++++ E D+ + YA D + G +L + S+
Sbjct: 307 NQLYFNLYVDSMDVVENLDLSSYLSNTLS------GAYAMDFVTGSAKLTKRIRVSIGRS 360
Query: 384 SMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTVVHV 443
S+H +Y AILNGLEI K N++ L+ +PS SS+ K V +
Sbjct: 361 SVHTDYPTAILNGLEIMKMNNSKSQLSIGTFLPSG-------------SSSTTKKNVGMI 407
Query: 444 IGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTSSWLPLYGTSHTTGKSTGTGKSTSS 503
IG G + + V + ++ DG+ + +W+PL T+ S +
Sbjct: 408 IGLTIGSLLALVVLGGFFVLYKKRGRDQDGN---SKTWIPLSSNGTTS-------SSNGT 457
Query: 504 HLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE 563
L ++A+ L +K T +F E+ IGVGGFGKVY+G + TKVA+KR+NP S+
Sbjct: 458 TLASIASNSSYRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQ 517
Query: 564 QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW 623
QG+ EF+TEIEMLS+ RH+HLVSLIG+C+E+ EMILVY+YM NGTL+ HLY L W
Sbjct: 518 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSW 577
Query: 624 KQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683
KQRLEICIG+ARGLHYLHTG +IHRDVK+ NILLDE AKV+DFGLSKTGP ++QT
Sbjct: 578 KQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQT 637
Query: 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW 743
HVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVV+FEVLCARP ++ L +E V+LA+W
Sbjct: 638 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEW 697
Query: 744 ALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803
A+ Q+ G +E IIDP+L+G I LRKF ET EKCL+D G+DRPSMGDVLWNLE+ALQ
Sbjct: 698 AMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQ 757
Query: 804 LQ------DNPDGDKLISIQTDKANDTYAMHKAMLN--------IDEESVLSDEIDTSNT 849
LQ D D +I + ND Y +N DEE D+ +
Sbjct: 758 LQEAVVDGDPEDSTNMIGELPLRFND-YNHGDTSVNFSVAKEGRFDEEESSVDDSSGVSM 816
Query: 850 TDIFSQIVNPKGR 862
+ +FSQ++ +GR
Sbjct: 817 SKVFSQLIKSEGR 829
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 618 bits (1593), Expect = e-176, Method: Compositional matrix adjust.
Identities = 365/853 (42%), Positives = 506/853 (59%), Gaps = 68/853 (7%)
Query: 24 VLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSK---FL-TNSGNSITATAQSQDSSL 79
V S + + +++Y++ CG+S + S+ R + SD + FL T+ + + S
Sbjct: 22 VKSSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSN 81
Query: 80 PSTIP-YMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLL 138
ST+P Y+TARIF S+Y F +S R W+RLHFYP ++ + +N+ FSV + LL
Sbjct: 82 ASTLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLL 141
Query: 139 NNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPD-- 196
++FSA T+ + + Y++ + L + F P HK S AF+N +E++ +PD
Sbjct: 142 HDFSAGDTSSIVFKEYLIYA-------AEKLSLYFKP---HKGSTAFINAVEIVSVPDEL 191
Query: 197 IFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAF- 255
+ SA V + ++S +L+ ++R+N+GG I D L+RTW D PY F
Sbjct: 192 VPDSASSVPQAPDFKGLSSFSLEILHRINIGGDLISPKIDP-LSRTWLSDKPY---NTFP 247
Query: 256 -GVASQADNKTKIEYP-SNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTY 313
G + + + I YP + IAP VY TA M N+NL+W +D Y
Sbjct: 248 EGSRNVTVDPSTITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDY 307
Query: 314 IVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDD 373
+R HFC+I+ +N +F++FIN +A D+ G Y D+ + A + +
Sbjct: 308 FIRLHFCDIVSKSLNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTIT-NG 366
Query: 374 ELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPS 433
+ V + P+ ++ +AILNGLEI K N+ G+L G L + K
Sbjct: 367 SILVQVGPTPNLQSGKPNAILNGLEIMKLNNAAGSLDG--------LFGVDGKYKGPIGG 418
Query: 434 SSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTSSWLPLYGTSHTT-- 491
S K + IG V + V ++ + ++ + + S SSWL SH++
Sbjct: 419 MSSKKLAIAGIGFVMALTAFLGVVVLLVRW--QRRPKDWQKQNSFSSWLLPLHASHSSYI 476
Query: 492 ---GKST-------GTGKSTSSHLTNLAA--GLCRHFSLAEIKHGTRNFSESHVIGVGGF 539
G ST G+ KS S+ ++ + GL R+F E++ T+NF E+ V GVGGF
Sbjct: 477 SSKGGSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGF 536
Query: 540 GKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599
GKVY G IDG T+VAIKR + SSEQG++EFQTEI+MLSKLRH+HLVSLIGFC+E+ EMIL
Sbjct: 537 GKVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMIL 596
Query: 600 VYDYMANGTLREHLYKGDK------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
VY+YM+NG LR+HLY + P L WKQRLEICIG+ARGLHYLHTGA IIHRDV
Sbjct: 597 VYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 656
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
KTTNILLDE AKVSDFGLSK P +++ HVST VKGSFGYLDPEYFRRQQLT+KSDVY
Sbjct: 657 KTTNILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVY 715
Query: 714 SFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKF 773
SFGVVLFEVLCARP +N LP+EQV+LA++A++ R G +E IIDP + G I+ LRKF
Sbjct: 716 SFGVVLFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKF 775
Query: 774 TETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAMLN 833
E AEKCL++ G+DRP MGDVLWNLE+ALQLQ+ S Q D + D K +N
Sbjct: 776 VEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQE-------ASAQVDLSED-----KTTMN 823
Query: 834 IDEESVLSDEIDT 846
I+ + + +E+ +
Sbjct: 824 IEMDLIPGEEMQS 836
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 862 | ||||||
| 224111986 | 858 | predicted protein [Populus trichocarpa] | 0.988 | 0.993 | 0.702 | 0.0 | |
| 359477216 | 857 | PREDICTED: receptor-like protein kinase | 0.990 | 0.996 | 0.694 | 0.0 | |
| 255556384 | 854 | ATP binding protein, putative [Ricinus c | 0.962 | 0.971 | 0.712 | 0.0 | |
| 225437596 | 857 | PREDICTED: receptor-like protein kinase | 0.954 | 0.960 | 0.665 | 0.0 | |
| 224099143 | 748 | predicted protein [Populus trichocarpa] | 0.834 | 0.961 | 0.755 | 0.0 | |
| 224123448 | 861 | predicted protein [Populus trichocarpa] | 0.982 | 0.983 | 0.602 | 0.0 | |
| 242087379 | 870 | hypothetical protein SORBIDRAFT_09g00932 | 0.980 | 0.971 | 0.613 | 0.0 | |
| 297833154 | 850 | kinase family protein [Arabidopsis lyrat | 0.979 | 0.992 | 0.599 | 0.0 | |
| 15229329 | 850 | receptor-like protein kinase ANXUR1 [Ara | 0.979 | 0.992 | 0.594 | 0.0 | |
| 297813101 | 857 | kinase family protein [Arabidopsis lyrat | 0.982 | 0.988 | 0.600 | 0.0 |
| >gi|224111986|ref|XP_002316044.1| predicted protein [Populus trichocarpa] gi|222865084|gb|EEF02215.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1250 bits (3234), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 610/868 (70%), Positives = 712/868 (82%), Gaps = 16/868 (1%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNS--YVLACGASSDGTDSNDRKWTSDS 58
M ++QILFS+ S+ LS I+ V S+ ++S+SNS Y+LACGAS GTDS+ R W D+
Sbjct: 1 MKCNSQILFSLIILSICLSTIS-VTSKYSKSESNSDSYILACGASGAGTDSDSRDWQPDA 59
Query: 59 KFLTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASY 118
K + +SGNSIT+TA++QD SLPSTIPYMTARIF S S+YKF+V +K R W+RLHFYP++Y
Sbjct: 60 KHINSSGNSITSTAENQDPSLPSTIPYMTARIFTSESTYKFSVPTKSRLWVRLHFYPSTY 119
Query: 119 GNLDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSD 178
+LDP+N+YFSV AN FTLLNNFSASITA+ALT AYI+REFSL+P SG L +TFTPSS
Sbjct: 120 SSLDPNNSYFSVTANSFTLLNNFSASITAQALTLAYIIREFSLIPIDSGTLNLTFTPSSK 179
Query: 179 HKDSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG 238
+ DSYAFVNGIEVIPMPDI+ A LVGFSDQ+V+V SSTLQTM+RLNVGG+FIP+ DSG
Sbjct: 180 YNDSYAFVNGIEVIPMPDIYQPAALVGFSDQAVDVGSSTLQTMFRLNVGGQFIPANKDSG 239
Query: 239 LTRTWYDDSPYLFGAAFGVASQADNKTKIEYPS-NLSQEIAPLSVYETARSMGPDPNVNR 297
LTR WYDD+PYLFGAA GV SQA I+YP+ NL IAPL VY TAR+MGPD VN+
Sbjct: 240 LTRIWYDDTPYLFGAAGGVTSQA--SISIQYPTDNLPNSIAPLDVYSTARTMGPDSKVNQ 297
Query: 298 NYNLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVP 357
YNLTW+FQ+DANFTY RFHFCE TK+NQRVFDI++NN+TAQEG DVIGWAG QGVP
Sbjct: 298 KYNLTWVFQVDANFTYAFRFHFCEYQETKVNQRVFDIYVNNRTAQEGGDVIGWAGSQGVP 357
Query: 358 VYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPS 417
+YKDYA Y D GDDELWVAL+PSVS+ PEYYDAILNGLEIFK ND+ GNLAGPNPVPS
Sbjct: 358 IYKDYAFYVSDRSGDDELWVALNPSVSVKPEYYDAILNGLEIFKLNDSRGNLAGPNPVPS 417
Query: 418 AMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRC- 476
M+L AEA KK F+PS S + V VIGG+ GG G+AVA I +V K++ + GS+
Sbjct: 418 PMMLQAEA-KKGFSPSVS---SFVPVIGGILGGSAGVAVAVTISIFVYRKRRTDYGSQSG 473
Query: 477 STSSWLPLYGTSHTTG-KSTGTGKST-SSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVI 534
S+++WLPLYG SHT+ +ST +GKS+ +SHL+ LA GLC HFSL IKH T+NF ES VI
Sbjct: 474 SSANWLPLYGNSHTSASRSTISGKSSCNSHLSTLAQGLCHHFSLPGIKHATKNFDESQVI 533
Query: 535 GVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594
GVGGFGKVY+G ID KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE+
Sbjct: 534 GVGGFGKVYKGIIDQGIKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEE 593
Query: 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654
GEM+LVYDYMANGTLREHLYK + P L WK+RLEICIGAA+GLHYLHTGAR+TIIHRDVK
Sbjct: 594 GEMVLVYDYMANGTLREHLYKSNNPALSWKKRLEICIGAAKGLHYLHTGARHTIIHRDVK 653
Query: 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYS 714
TTNILLDEKW AKVSDFGLSKTGP+L QTHVST++KGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 654 TTNILLDEKWVAKVSDFGLSKTGPDLKQTHVSTVIKGSFGYLDPEYFRRQQLTEKSDVYS 713
Query: 715 FGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFT 774
FGVVLFEVLC RPALN + PKEQVSLADWALHCQR GT+ DIIDP++K +I +C KF
Sbjct: 714 FGVVLFEVLCGRPALNPSSPKEQVSLADWALHCQRKGTLWDIIDPHIKEDIDPECYNKFA 773
Query: 775 ETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAMLNI 834
ETA KCL+D G +RPSMGDVLWNL+F+LQ+QDNP G KL++ K DTY++H+ M +
Sbjct: 774 ETAVKCLADHGCNRPSMGDVLWNLDFSLQMQDNPAGAKLVADSETK--DTYSIHREMAGV 831
Query: 835 DEESVLSDEIDTSNTTDIFSQIVNPKGR 862
+E V D T++ FSQIVNPKGR
Sbjct: 832 EETGVREGN-DEPYTSEFFSQIVNPKGR 858
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477216|ref|XP_002272797.2| PREDICTED: receptor-like protein kinase ANXUR1-like [Vitis vinifera] gi|296083244|emb|CBI22880.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1241 bits (3211), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 601/865 (69%), Positives = 719/865 (83%), Gaps = 11/865 (1%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
MN D+ +LF + FFS + N VLS ++SDS S++L+CG SS G D++ RKW D+KF
Sbjct: 1 MNLDSHVLFCLVFFSFVV-NPVHVLSGSSESDSVSFILSCGDSSGGADADGRKWVPDTKF 59
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
L + G SI+ATAQ QD SLPS +PYM+ARIF S S+Y+F+VS K+R W+RLHFYP+ Y
Sbjct: 60 LASPGKSISATAQLQDPSLPSPVPYMSARIFTSESTYQFSVSPKNRLWVRLHFYPSFYSA 119
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ S+++FSV A GFTLLNNFSAS TA+ALTQAYI+++FSL+P +SG L ITF PS +H
Sbjct: 120 LNASDSFFSVTAGGFTLLNNFSASTTAQALTQAYIIKDFSLMPPESGHLNITFKPSPNHN 179
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLT 240
SYAF+NGIEVI MPDIFGSA +VG+SD ++ S+LQTMYRLNVGG++I + NDSGL+
Sbjct: 180 GSYAFINGIEVISMPDIFGSATMVGYSD--LDAAGSSLQTMYRLNVGGQYIAANNDSGLS 237
Query: 241 RTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYN 300
RTWYDDSPYL+GAAFGV S+AD+ I+YPS++ + IAP+ VY TAR+MGPDP +N+NYN
Sbjct: 238 RTWYDDSPYLYGAAFGVTSEADSNVTIQYPSHVPEYIAPVDVYRTARTMGPDPKINQNYN 297
Query: 301 LTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYK 360
LTW+FQ+DANFTYIVRFHFCE LL+KINQRVFDI++NNQTAQ AD+I WA +GVPVYK
Sbjct: 298 LTWVFQVDANFTYIVRFHFCEFLLSKINQRVFDIYVNNQTAQPAADLIAWAESEGVPVYK 357
Query: 361 DYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAML 420
D+A++ +D PGD++LWVALHPSVSM PE+YDAILNGLEIFK ND+ GNLAGPNPVPS ML
Sbjct: 358 DFAVFVKDEPGDEQLWVALHPSVSMKPEFYDAILNGLEIFKLNDSNGNLAGPNPVPSPML 417
Query: 421 LHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTSS 480
+ AE T+ +P SS + V+ I G A G+ + A+I + K + GSR TS
Sbjct: 418 VKAEETRNFASPESSDNAQVIGGIAGGAAGLVVVVAVVAVIAFRRKKMLDRSGSR--TSG 475
Query: 481 WLPLYGTSHTTG-KSTGTGKST-SSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGG 538
WLP++G+S TT KST +GKST SSHL+++AA LCRHF+LAE++HGT+NF ES VIGVGG
Sbjct: 476 WLPVHGSSGTTASKSTISGKSTASSHLSSMAAALCRHFTLAEMRHGTKNFDESQVIGVGG 535
Query: 539 FGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598
FGKVY+G +DG TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH+HLVSLIG+CEED EMI
Sbjct: 536 FGKVYKGVVDGSTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEDNEMI 595
Query: 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNI 658
LVYDYMANGTLREHLYK DKP L WKQRLEICIGAARGLHYLHTGA+YTIIHRDVKTTNI
Sbjct: 596 LVYDYMANGTLREHLYKSDKPQLSWKQRLEICIGAARGLHYLHTGAKYTIIHRDVKTTNI 655
Query: 659 LLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 718
LLDEKW AKVSDFGLSKTGP LNQTHVST+VKGSFGYLDPEYFRRQQLTEKSDVYSFGVV
Sbjct: 656 LLDEKWVAKVSDFGLSKTGPELNQTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 715
Query: 719 LFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAE 778
LFE LCARPALN +LPKEQVSLADWAL CQ+ G +E+IIDP+LKGNIT +CL KF ETAE
Sbjct: 716 LFEALCARPALNPSLPKEQVSLADWALQCQKKGILEEIIDPHLKGNITPECLMKFAETAE 775
Query: 779 KCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKAN-DTYAMHKAMLNIDEE 837
KCLSD G++RPSMGDVLWNLEFALQLQ+ P G K I +K N D AMH++ML+IDEE
Sbjct: 776 KCLSDHGLERPSMGDVLWNLEFALQLQEKPQGAK---IDVEKVNADINAMHRSMLSIDEE 832
Query: 838 SVLSDEIDTSNTTDIFSQIVNPKGR 862
S +S++ + +T+++FS +VNPKGR
Sbjct: 833 SAVSEDTEDLSTSEVFSHMVNPKGR 857
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556384|ref|XP_002519226.1| ATP binding protein, putative [Ricinus communis] gi|223541541|gb|EEF43090.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1200 bits (3105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 605/849 (71%), Positives = 700/849 (82%), Gaps = 19/849 (2%)
Query: 20 NIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKFLTNSGNSITATAQSQDSSL 79
N VLS+ + +SYVLACGAS+ GTD + RKW D+K++ +SGNSI ATA +QD SL
Sbjct: 19 NTIPVLSK----EPDSYVLACGASNAGTDGDGRKWEPDTKYVKSSGNSIMATADNQDPSL 74
Query: 80 PSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLN 139
PST+PYMT R+F S +Y F V +K R W+RLHFYP++Y +LDP+NAYFSV AN LL
Sbjct: 75 PSTVPYMTGRLFTSAFTYTFPVPAKGRLWVRLHFYPSTYSSLDPNNAYFSVTANKLQLLK 134
Query: 140 NFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIFG 199
NFSASITAKALT AYI+RE+SL P +SG L +TFTPS DH D+YAFVNGIEVIPMP+I+
Sbjct: 135 NFSASITAKALTMAYIIREYSLSPIESGTLNLTFTPSQDHDDAYAFVNGIEVIPMPEIYQ 194
Query: 200 SAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVAS 259
SA +VGFSDQ ++V +S++QTM+RLNVGG+FIPSTNDSGLTR WYDD+PYLFGA G+ +
Sbjct: 195 SAGMVGFSDQMIDVTTSSMQTMFRLNVGGQFIPSTNDSGLTRIWYDDTPYLFGAGAGITN 254
Query: 260 QADNKTKIEYPSN-LSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFH 318
QA+ KI+YP+ L + IAP VY +ARSMGPD VN N+NLTW+F +DANFTY+VRFH
Sbjct: 255 QAN--IKIQYPTQELPKAIAPYDVYSSARSMGPDSKVNMNFNLTWLFDVDANFTYLVRFH 312
Query: 319 FCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVA 378
FCE +T+ NQR F+I+INNQTAQEGADVIGWAG +GVP+YKDYAI+ D GDDELWVA
Sbjct: 313 FCEYEMTRSNQRAFNIYINNQTAQEGADVIGWAGSKGVPIYKDYAIHVGDQSGDDELWVA 372
Query: 379 LHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSK 438
LHPSV + PEYYDAILNGLEIFK N+ GN+AGPNPVPSAM+ AE KK F S S
Sbjct: 373 LHPSVELKPEYYDAILNGLEIFKLNEPDGNMAGPNPVPSAMMQKAEE-KKSFKSSGSNGP 431
Query: 439 TVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTSSWLPLYGTSHTTG-KSTGT 497
VIGG+AGG G+A+A I +V KK+ GS+ + +WLPLYG SHT+G KST +
Sbjct: 432 ----VIGGIAGGAAGLAIAAIISIFVLRKKRGLTGSQSGSHNWLPLYGHSHTSGSKSTIS 487
Query: 498 GKST-SSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIK 556
GKST SSHL+ LA GLCRHFSL EIK T+NF ES+VIGVGGFGKVY+G ID TKVA+K
Sbjct: 488 GKSTASSHLSTLAQGLCRHFSLPEIKQATKNFDESNVIGVGGFGKVYKGIIDQGTKVAVK 547
Query: 557 RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKG 616
RSNPSSEQGV+EFQTEIEMLSKLRHKHLVSLIGFCEEDGEM LVYDYMANGTLREH+YKG
Sbjct: 548 RSNPSSEQGVNEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMALVYDYMANGTLREHIYKG 607
Query: 617 DKP--GLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674
+KP L WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW AKVSDFGLS
Sbjct: 608 NKPTSSLSWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWVAKVSDFGLS 667
Query: 675 KTGPNL-NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNL 733
KTGPNL NQ+HVST+VKGSFGYLDPEYF+RQQLTEKSDVYSFGVVLFEVLCARPALN NL
Sbjct: 668 KTGPNLNNQSHVSTVVKGSFGYLDPEYFKRQQLTEKSDVYSFGVVLFEVLCARPALNPNL 727
Query: 734 PKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGD 793
KEQVSLADWALHCQ+ G IED+IDP++K +I +CLRKF ETAEKCLSD GI RPSMGD
Sbjct: 728 AKEQVSLADWALHCQKKGIIEDLIDPHIKADIQPECLRKFAETAEKCLSDHGIHRPSMGD 787
Query: 794 VLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAMLNIDEESVLSDEIDTSNTTDIF 853
VLWNLEFALQLQDNP G KL+S +K DTY M++ M +I+EES +S++ D N T+IF
Sbjct: 788 VLWNLEFALQLQDNPAGAKLVS--ENKGLDTYGMNRQMHSIEEESSISEDTDDLNNTEIF 845
Query: 854 SQIVNPKGR 862
SQIVNP+GR
Sbjct: 846 SQIVNPRGR 854
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437596|ref|XP_002271113.1| PREDICTED: receptor-like protein kinase ANXUR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1174 bits (3036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/838 (66%), Positives = 684/838 (81%), Gaps = 15/838 (1%)
Query: 33 SNSYVLACGASSDGTDSNDRKWTSDSKFLTNSGNSITATAQSQDSSLPSTIPYMTARIFK 92
++S +L+CG++S GTD++ RKW SDS +L S SI+ATAQSQD SLPS +PYM+ARIF
Sbjct: 27 ADSLILSCGSASGGTDADGRKWVSDSAYLV-SDESISATAQSQDPSLPSPVPYMSARIFS 85
Query: 93 STSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKALTQ 152
+ SSYKF+V + R+WLRLHFYP++Y +LDP++AYFS A G TL+ NFSASITA+ALTQ
Sbjct: 86 AESSYKFSVKTNQRYWLRLHFYPSTYSSLDPADAYFSAVAGGVTLMTNFSASITAQALTQ 145
Query: 153 AYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVE 212
AYIVRE+SL P L +TF PS HK SYAFVNGIE++P+PD+F A +VGFSDQS++
Sbjct: 146 AYIVREYSLAPMDFEILNVTFKPSDQHKGSYAFVNGIELVPIPDLFDKASMVGFSDQSLD 205
Query: 213 VNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSN 272
V ++ +QTM+RLNVGG++IP++NDSGLTRTWYDDSPYL+GAAFGV S+A +K KI+Y
Sbjct: 206 VGTANVQTMFRLNVGGQYIPASNDSGLTRTWYDDSPYLYGAAFGVTSEASDKLKIQY-QG 264
Query: 273 LSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILLTKINQRVF 332
+ +AP+ VY T+RSMGPDP +N+N+NLTW+FQ+D NFTY+VR HFCE +L KINQRVF
Sbjct: 265 MEDYVAPVDVYRTSRSMGPDPKLNQNFNLTWVFQVDGNFTYLVRLHFCEFILNKINQRVF 324
Query: 333 DIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDA 392
DI++NNQTA ADVI W G + VP YKDY++Y D GD+ELWVALHPS+++ PEYYD+
Sbjct: 325 DIYVNNQTAMASADVIAWTGSKAVPTYKDYSVYVTDGTGDEELWVALHPSIAVKPEYYDS 384
Query: 393 ILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVF 452
+LNGLE+FK ++ +LAGPNP PS ML+ AEA + FA ++ S +V+ GV+ G
Sbjct: 385 LLNGLEVFKISNANKSLAGPNPTPSDMLVKAEAARS-FASNTKSSNSVI----GVSAGGI 439
Query: 453 GIAVATAIIFYVSNKKKNND-GSRCSTSSWLPLYGTSHTTG-KSTGTGKST-SSHLTNLA 509
A A + V ++KN G+ T+SWLPLYG SH+T KST +G+ST SSH++ +A
Sbjct: 440 AAAGLAAAVCIVLYQRKNRQPGTDSRTTSWLPLYGNSHSTASKSTISGRSTASSHVSTMA 499
Query: 510 AGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEF 569
A LCRHFSL EIKH T+NF E+ VIGVGGFGKVY+G IDG TKVAIKRSNPSSEQGV+EF
Sbjct: 500 ASLCRHFSLPEIKHATKNFDENLVIGVGGFGKVYKGIIDGGTKVAIKRSNPSSEQGVNEF 559
Query: 570 QTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
QTEIEMLSKLRH+HLVSLIG+CEEDGEM LVYDYMA+GTLREHLYK +KP L WKQRLEI
Sbjct: 560 QTEIEMLSKLRHRHLVSLIGYCEEDGEMALVYDYMAHGTLREHLYKSNKPHLSWKQRLEI 619
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
CIGAARGLHYLHTGA+YTIIHRDVKTTNIL+DEKW AKVSDFGLSKTGP++NQ HVST+V
Sbjct: 620 CIGAARGLHYLHTGAKYTIIHRDVKTTNILVDEKWVAKVSDFGLSKTGPDINQNHVSTVV 679
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749
KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALN +LPKEQVSLADWALHCQ+
Sbjct: 680 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLPKEQVSLADWALHCQK 739
Query: 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPD 809
G +EDIIDP+LKG I +CL+KF +TAEKCLSD G+DRPSMGD+LWNLEFALQLQ+NPD
Sbjct: 740 KGILEDIIDPHLKGTINPECLKKFADTAEKCLSDHGLDRPSMGDILWNLEFALQLQENPD 799
Query: 810 GDKLISIQTDKA----NDTYAMHKAMLNI-DEESVLSDEIDTSNTTDIFSQIVNPKGR 862
G K +S + + N+ MH+ ML++ ++S +++ D N +++FSQIV PKGR
Sbjct: 800 GAKAVSERENPEEFNHNNIMGMHRNMLSLGSDDSDMNEVSDDLNGSEVFSQIVKPKGR 857
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099143|ref|XP_002311383.1| predicted protein [Populus trichocarpa] gi|222851203|gb|EEE88750.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1146 bits (2965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/729 (75%), Positives = 622/729 (85%), Gaps = 10/729 (1%)
Query: 86 MTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASI 145
MTARIF S S+YKF+V K R W+RLHFYP++Y +LDP+ +YFSV AN FTLLNNFSAS+
Sbjct: 1 MTARIFSSESTYKFSVPKKGRLWVRLHFYPSTYSSLDPNTSYFSVTANTFTLLNNFSASV 60
Query: 146 TAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIFGSAPLVG 205
TA+ALTQA+IVREFSL+P SG L +TFTPSS++ ++YAFVNGIEVIPMPDI+ A LVG
Sbjct: 61 TAQALTQAFIVREFSLIPIDSGTLNLTFTPSSNYDNAYAFVNGIEVIPMPDIYQPAALVG 120
Query: 206 FSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKT 265
FSDQ+++V SSTLQTM+RLNVGG+FIP+ DSGLTRTWYDD+PYLFGA GV SQA+
Sbjct: 121 FSDQTLDVGSSTLQTMFRLNVGGRFIPAIKDSGLTRTWYDDTPYLFGAGSGVTSQAN--I 178
Query: 266 KIEYPS-NLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILL 324
I+YP+ NL + IAPL VY TARSMGPD VN+NYNLTWIFQ+D NFTY RFHFCE
Sbjct: 179 SIQYPTDNLPKSIAPLDVYSTARSMGPDSKVNQNYNLTWIFQVDPNFTYAFRFHFCEYQE 238
Query: 325 TKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVS 384
TK+NQRVFDI++NNQTAQEGADVIGWAG QGVP+YKDYA+Y D GDD+LWVALHPSVS
Sbjct: 239 TKVNQRVFDIYVNNQTAQEGADVIGWAGSQGVPIYKDYAVYVGDRSGDDDLWVALHPSVS 298
Query: 385 MHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTVVHVI 444
M PEYYDAILNGLEIFK ND+ GNLAGPNPVPS M+L AEA KK F+PS S + V VI
Sbjct: 299 MKPEYYDAILNGLEIFKLNDSRGNLAGPNPVPSLMMLQAEA-KKGFSPSGS---SFVPVI 354
Query: 445 GGVAGGVFGIAVATAIIFYVSNKKKNNDGSRC-STSSWLPLYGTSHTTG-KSTGTGKS-T 501
GG+ GG GIA+A I +V K + G++ S+++WLPLYG SHT+ +ST +GKS
Sbjct: 355 GGILGGSAGIAIAALISIFVYRKMSCDHGNQYGSSANWLPLYGHSHTSASRSTISGKSNC 414
Query: 502 SSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS 561
SSHL+ LA GLCRHFSL +IKH T+NF ES VIGVGGFGKVY+G ID VAIKRSNPS
Sbjct: 415 SSHLSTLAQGLCRHFSLPDIKHATKNFDESQVIGVGGFGKVYKGIIDQGIAVAIKRSNPS 474
Query: 562 SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGL 621
SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM+LVYDYMANGTLREHLYKG+ P L
Sbjct: 475 SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMVLVYDYMANGTLREHLYKGNNPAL 534
Query: 622 PWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681
WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW AKVSDFGLSKTGPNLN
Sbjct: 535 SWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPNLN 594
Query: 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741
QTHVST+VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALN +LPKEQVSLA
Sbjct: 595 QTHVSTIVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLPKEQVSLA 654
Query: 742 DWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801
DWALHCQ+ GT+ DI+DP +KG+I +C KF ETAEKCL+D G +RPSMGDVLWNLE++
Sbjct: 655 DWALHCQKKGTLWDIVDPYIKGDINPECYNKFAETAEKCLADHGYNRPSMGDVLWNLEYS 714
Query: 802 LQLQDNPDG 810
LQLQDNP G
Sbjct: 715 LQLQDNPAG 723
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123448|ref|XP_002319081.1| predicted protein [Populus trichocarpa] gi|222857457|gb|EEE95004.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1051 bits (2718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/876 (60%), Positives = 645/876 (73%), Gaps = 29/876 (3%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
M+++ L S+ F+L + + G S S L CG+ + GTD + RKW SD K+
Sbjct: 1 MHTNIHALLSLACFALVFN---ALYVSGIGSQPRSLSLNCGSENGGTDGDGRKWESDVKY 57
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
+ +GN A AQ QDSS+ S +PYM ARIF S +Y + K R+WLRL+FYP+ Y
Sbjct: 58 I--AGNYPHARAQYQDSSIVSEVPYMDARIFTSEVTYNLPIMLKTRYWLRLYFYPSEYSG 115
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ +N+YFSV A G TLLNNFSASITA+ALTQAY+++E+SL P L +TF P+ D
Sbjct: 116 LNIANSYFSVVAGGVTLLNNFSASITAQALTQAYLIKEYSLAPMNHQILNVTFKPA-DRP 174
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-L 239
D++AF+N IE++PM D+FGS +VGF+DQ+ + S+ L+TMYRLNV G++I T DSG L
Sbjct: 175 DAFAFINAIELVPMTDLFGSGTMVGFADQNFDAESANLETMYRLNVAGQYISPTKDSGNL 234
Query: 240 TRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299
TRTWY+D+PYLFGAA GV Q + K++Y L++ +AP VY TAR MG ++N +
Sbjct: 235 TRTWYNDAPYLFGAATGVNLQTNESYKVQY-GELTESVAPPDVYRTARGMGYHKDLNLAF 293
Query: 300 NLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQ---EGADVIGWAGEQGV 356
NLTW+FQ DANFTY+VR HFCE LTK+NQ+VF+I+INNQTAQ AD+IGW GE GV
Sbjct: 294 NLTWLFQADANFTYVVRLHFCEFQLTKVNQKVFNIYINNQTAQVEPNAADIIGWTGEIGV 353
Query: 357 PVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVP 416
P YKDYA++ +D PGD+E+ V LHP+ PE+YDA LNG+E+FK +D NLAGPNPV
Sbjct: 354 PTYKDYAVFVKDRPGDEEIRVDLHPATYSKPEFYDATLNGIEVFKMSDRNNNLAGPNPVL 413
Query: 417 SAMLLH--AEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGS 474
S M A+A+ KKF + ++ T+V GGV G F +A A + +KK G
Sbjct: 414 SEMQAQHIAKASHKKFQ-TDHKTLTIVGTAGGV--GFFFVAAACIAAY---RRKKIIPGF 467
Query: 475 RCSTSSWLPLYGTSHTTGKSTGTGKSTSS-HLTNLAAGLCRHFSLAEIKHGTRNFSESHV 533
TSSWLP+YG SHT KST +GKST S HL++LA GL RHF+L EI T+NF +S+V
Sbjct: 468 DSHTSSWLPVYGNSHTGTKSTISGKSTQSGHLSSLAQGLSRHFTLPEILRATKNFDDSNV 527
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
IGVGGFGKVY+G ID TKVAIKRSNP SEQGV+EF TEIEMLSKLRHKHLVSLIGFC+E
Sbjct: 528 IGVGGFGKVYKGVIDQTTKVAIKRSNPQSEQGVNEFMTEIEMLSKLRHKHLVSLIGFCDE 587
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
DGEM LVYDYMA GT+REHLY KP L WKQRLE+C+GAARGLHYLHTGA+YTIIHRDV
Sbjct: 588 DGEMCLVYDYMALGTMREHLYNTKKPRLSWKQRLEVCVGAARGLHYLHTGAKYTIIHRDV 647
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
K+TNILLDE W AKVSDFGLSKTGP++++ HVST+VKGSFGYLDPEYFRRQQLTEKSDVY
Sbjct: 648 KSTNILLDENWVAKVSDFGLSKTGPDMDKGHVSTVVKGSFGYLDPEYFRRQQLTEKSDVY 707
Query: 714 SFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKF 773
SFGVVLFE LC RPALN NLPKEQVSLADWALHCQR G IEDIIDP++KG IT +CL+KF
Sbjct: 708 SFGVVLFEALCGRPALNPNLPKEQVSLADWALHCQRKGIIEDIIDPHVKGKITTECLKKF 767
Query: 774 TETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISI-------QTDKANDTYA 826
+TAEKCL++ G +RP+MGDVLWNLE ALQLQDNP+G K S + N
Sbjct: 768 ADTAEKCLAESGPERPNMGDVLWNLELALQLQDNPEGSKRSSKGEGSETSEESIRNRKLE 827
Query: 827 MHKAMLNIDEESVLSDEIDTSNTTDIFSQIVNPKGR 862
MH + L++ S + E D S DIFSQIVNPKGR
Sbjct: 828 MHYSNLSLGSNSEKTAESDDSG--DIFSQIVNPKGR 861
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242087379|ref|XP_002439522.1| hypothetical protein SORBIDRAFT_09g009320 [Sorghum bicolor] gi|241944807|gb|EES17952.1| hypothetical protein SORBIDRAFT_09g009320 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 1047 bits (2708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/867 (61%), Positives = 646/867 (74%), Gaps = 22/867 (2%)
Query: 13 FFSLTLSNIACVLSQGTQ-SDSNSYVLACGASSDGTDSNDRKWTSD--SKFLTNSG-NSI 68
F ++ + A +L+ + S ++ CG++ +G D++ RKW +D S +L + G +SI
Sbjct: 9 FLAVIIGINAVILASAAKYKPPESILVDCGSAKEGQDADGRKWVTDQGSNWLIDGGKSSI 68
Query: 69 TATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYF 128
A A QD SLPS +PYM+AR+F + Y F++ DR WLRLHFYPA+Y + +F
Sbjct: 69 MADADVQDPSLPSPVPYMSARVFTKEAVYNFSIGDTDRHWLRLHFYPAAYHGVPAEQFFF 128
Query: 129 SVN-ANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVN 187
SV+ + G TLL NFS ITAKAL+QAYI+REF+L P G L +TFTP++ + SYAFVN
Sbjct: 129 SVSTSTGITLLRNFSVYITAKALSQAYIIREFTLPPMTDGKLSLTFTPTAMNNASYAFVN 188
Query: 188 GIEVIPMPDIFGS-APLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDD 246
GIE+I MPDIF A +VG SDQ+V+ +S+LQTMYRLNVGG +I TNDSGL+R WYDD
Sbjct: 189 GIEIISMPDIFADPATMVGLSDQTVDTAASSLQTMYRLNVGGSYIAPTNDSGLSRDWYDD 248
Query: 247 SPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQ 306
+PYL+GAA GV +AD+K +I++ S ++ AP S+Y ++RSMGP+P VN+NYNLTW+F+
Sbjct: 249 TPYLYGAAVGVTYKADDKVQIKFSSPEAEYAAPTSLYLSSRSMGPNPKVNQNYNLTWVFE 308
Query: 307 IDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYA 366
+D+NFTYIVR HFCE+LLTK+NQR FDI+INN+TAQ ADVIGW E+ VPVYKDYA +
Sbjct: 309 VDSNFTYIVRLHFCELLLTKVNQRAFDIYINNKTAQADADVIGWTSEKDVPVYKDYATFM 368
Query: 367 EDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAE-- 424
D PGD LW+ALHPSVSM PE+YDA+LNGLEIFK +D+ GNLAGPNP PS ML AE
Sbjct: 369 PDSPGDKILWIALHPSVSMKPEFYDAVLNGLEIFKMSDSSGNLAGPNPDPSRMLEEAEMD 428
Query: 425 ATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTSSWLPL 484
T KF S + +V FGI A ++ Y S K++ S +S WLP+
Sbjct: 429 VTTGKFKAKPSNLRAMVIGGAAGGAAAFGIVAAICVVAYHSKKRRVLGNSVSHSSGWLPV 488
Query: 485 Y-GTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVY 543
Y G SHT + GKS + + N+ A +CRHFS EIK T+NF ES VIGVGGFGKVY
Sbjct: 489 YGGNSHTNASKSSGGKSAALN-PNITA-MCRHFSFQEIKAATKNFDESLVIGVGGFGKVY 546
Query: 544 EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603
G +DG TKVAIKRSNPSSEQGV EFQTEIEMLSKLRHKHLVSLIG CE+DGEMILVYDY
Sbjct: 547 RGIVDGDTKVAIKRSNPSSEQGVLEFQTEIEMLSKLRHKHLVSLIGCCEDDGEMILVYDY 606
Query: 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK 663
MA+GTLREHLYK KP L W+QRLEI IGAARGLHYLHTGA+YTIIHRDVKTTNIL+DE
Sbjct: 607 MAHGTLREHLYKSGKPALSWRQRLEITIGAARGLHYLHTGAKYTIIHRDVKTTNILVDEN 666
Query: 664 WEAKVSDFGLSKTGPN-LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
W AKVSDFGLSKTGP +NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYS+GVVLFEV
Sbjct: 667 WVAKVSDFGLSKTGPTAMNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSYGVVLFEV 726
Query: 723 LCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLS 782
LCARPALN +LP+EQVSLAD AL CQR GT++DIIDP LKG I CL+K+ ETAEKCL+
Sbjct: 727 LCARPALNPSLPREQVSLADHALSCQRKGTLQDIIDPVLKGKIAPDCLKKYAETAEKCLA 786
Query: 783 DQGIDRPSMGDVLWNLEFALQLQD------NPDGDKLIS-IQTDKANDTYAMHKAMLNID 835
D G+DRPSMGDVLWNLEFALQ+QD P+G+ +S T D+ A A L +
Sbjct: 787 DHGVDRPSMGDVLWNLEFALQMQDTFENGGKPEGEGSMSNSSTVSMADSMAASAAALELI 846
Query: 836 EESVLSDEIDTSNTTDIFSQIVNPKGR 862
E + DE D +N+ +FSQ+V+P GR
Sbjct: 847 SEDM--DEEDIANSV-VFSQLVHPTGR 870
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297833154|ref|XP_002884459.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297330299|gb|EFH60718.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1047 bits (2707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/868 (59%), Positives = 654/868 (75%), Gaps = 24/868 (2%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
MN T+ILF LS ++ +L+ T+S+ + L+CGAS D + +KW D+KF
Sbjct: 1 MNGKTRILF-------FLSCLSILLAFPTRSNGQDFALSCGASEASADQDKKKWEPDTKF 53
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
L +GNSI ATA QD SL STIPYMTARIF + ++Y+ + R LRL+FYP++Y
Sbjct: 54 L-KTGNSIHATATYQDPSLLSTIPYMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTG 112
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ SN+YF+V AN TLL+NFSA+IT +ALTQAY+V+E+SL P + L ITFTPS ++
Sbjct: 113 LNISNSYFNVQANDVTLLSNFSAAITCQALTQAYLVKEYSLAPIEKDVLSITFTPSDKYR 172
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-L 239
D++AF+NGIEVI MP++F +A LVGF+DQ+V+ ++ Q+M+RLNVGG+ IP + DSG L
Sbjct: 173 DTFAFINGIEVIQMPELFDTAALVGFTDQTVDAKTANFQSMFRLNVGGQDIPGSQDSGGL 232
Query: 240 TRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299
TRTWY+D+PY+F A GV QA N +I Y + IAP VY+TARS GP+ ++N
Sbjct: 233 TRTWYNDAPYIFSAGLGVTLQASNNFRINY-QKMPVSIAPADVYKTARSQGPNGDINLKS 291
Query: 300 NLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEG---ADVIGWAGEQGV 356
NLTW+FQID NFTYI+R HFCE L+KINQ+VF+I+INN+TAQ AD++GW GE+G+
Sbjct: 292 NLTWMFQIDKNFTYILRLHFCEFQLSKINQKVFNIYINNRTAQADTNPADILGWTGEKGI 351
Query: 357 PVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVP 416
P YKDYAIY + G +E+ + + PSV PEYYD+ LNGLEIFK DT+ NLAGPNP P
Sbjct: 352 PTYKDYAIYVDANNGGEEITLQMTPSVFGEPEYYDSSLNGLEIFKM-DTLKNLAGPNPEP 410
Query: 417 SAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRC 476
S M AE KK + R+ ++ G AGGV + V A+ F KK G
Sbjct: 411 SPM--QAEGEVKKEFKNEKRNAFII----GSAGGVLAVLVC-ALCFTAYKKKHGYQGGDS 463
Query: 477 STSSWLPLYGTSHTTG-KSTGTGKSTS-SHLTNLAAGLCRHFSLAEIKHGTRNFSESHVI 534
TSSWLP+YG S T+G KST +GKS + SHL+NLAAGLCR FSL EIKHGT+NF +S+VI
Sbjct: 464 HTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVI 523
Query: 535 GVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594
GVGGFGKVY+G IDG TKVA+KRSNP+SEQG++EF+TEIE+LS+LRHKHLVSLIG+C++
Sbjct: 524 GVGGFGKVYKGVIDGTTKVAVKRSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDDG 583
Query: 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654
GEM L+YDYMA GTLREHLY KP L WK+RLEI IGAARGLHYLHTGA+YTIIHRDVK
Sbjct: 584 GEMCLIYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVK 643
Query: 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYS 714
TTNIL+DE W AKVSDFGLSKTGPN+N HV+T+VKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 644 TTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYS 703
Query: 715 FGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFT 774
FGVVLFE+LCARPALN +LPKEQVSL DWA++C+R G +EDIIDPNLKG I +CL+KF
Sbjct: 704 FGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINSECLKKFA 763
Query: 775 ETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAMLNI 834
+TAEKCL+D G++RP+MGDVLWNLEFALQLQ+ DG + + + +++ +N+
Sbjct: 764 DTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTPNSGGSSEDLGGGGMAVNV 823
Query: 835 DEESVLSDEIDTSNTTDIFSQIVNPKGR 862
+SD + + + T+IFSQIVNPKGR
Sbjct: 824 AGRDDVSD-LSSEDNTEIFSQIVNPKGR 850
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229329|ref|NP_187120.1| receptor-like protein kinase ANXUR1 [Arabidopsis thaliana] gi|75337541|sp|Q9SR05.1|ANX1_ARATH RecName: Full=Receptor-like protein kinase ANXUR1; Flags: Precursor gi|6175184|gb|AAF04910.1|AC011437_25 putative protein kinase [Arabidopsis thaliana] gi|332640599|gb|AEE74120.1| receptor-like protein kinase ANXUR1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/868 (59%), Positives = 650/868 (74%), Gaps = 24/868 (2%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
M+ T+ILF L+ ++ +L T+S+ L+CG S D + +KW D+KF
Sbjct: 1 MSGKTRILF-------FLTCLSFLLVFPTRSNGQDLALSCGTSEASADQDKKKWEPDTKF 53
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
L +GNSI ATA QD SL ST+PYMTARIF + ++Y+ + R LRL+FYP++Y
Sbjct: 54 L-KTGNSIHATATYQDPSLLSTVPYMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTG 112
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ SN+YF+V AN TLL+NFSA+IT +ALTQAY+V+E+SL P L I FTPS ++
Sbjct: 113 LNISNSYFTVEANDVTLLSNFSAAITCQALTQAYLVKEYSLAPTDKDVLSIKFTPSDKYR 172
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-L 239
D++AF+NGIEVI MP++F +A LVGF+DQ+++ ++ LQ+M+RLNVGG+ IP + DSG L
Sbjct: 173 DAFAFINGIEVIQMPELFDTAALVGFTDQTMDAKTANLQSMFRLNVGGQDIPGSQDSGGL 232
Query: 240 TRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299
TRTWY+D+PY+F A GV QA N +I Y N+ IAP +Y+TARS GP+ ++N
Sbjct: 233 TRTWYNDAPYIFSAGLGVTLQASNNFRINY-QNMPVSIAPADIYKTARSQGPNGDINLKS 291
Query: 300 NLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEG---ADVIGWAGEQGV 356
NLTW+FQID NFTYI+R HFCE L+KINQ+VF+I+INN+TAQ AD+IGW GE+G+
Sbjct: 292 NLTWMFQIDKNFTYILRLHFCEFQLSKINQKVFNIYINNRTAQADTTPADIIGWTGEKGI 351
Query: 357 PVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVP 416
P+YKDYAIY + G +E+ + + PS PEYYD+ LNGLEIFK DTM NLAGPNP P
Sbjct: 352 PMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLNGLEIFKM-DTMKNLAGPNPEP 410
Query: 417 SAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRC 476
S M AE KK + R ++ G AGGV + + A+ F KK+ G
Sbjct: 411 SPM--QAEEEVKKEFKNEKRHAFII----GSAGGVLAVLIG-ALCFTAYKKKQGYQGGDS 463
Query: 477 STSSWLPLYGTSHTTG-KSTGTGKSTS-SHLTNLAAGLCRHFSLAEIKHGTRNFSESHVI 534
TSSWLP+YG S T+G KST +GKS + SHL+NLAAGLCR FSL EIKHGT+NF +S+VI
Sbjct: 464 HTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVI 523
Query: 535 GVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594
GVGGFGKVY+G IDG TKVA+K+SNP+SEQG++EF+TEIE+LS+LRHKHLVSLIG+C+E
Sbjct: 524 GVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEG 583
Query: 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654
GEM LVYDYMA GTLREHLY KP L WK+RLEI IGAARGLHYLHTGA+YTIIHRDVK
Sbjct: 584 GEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVK 643
Query: 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYS 714
TTNIL+DE W AKVSDFGLSKTGPN+N HV+T+VKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 644 TTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYS 703
Query: 715 FGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFT 774
FGVVLFE+LCARPALN +LPKEQVSL DWA++C+R G +EDIIDPNLKG I +CL+KF
Sbjct: 704 FGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFA 763
Query: 775 ETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAMHKAMLNI 834
+TAEKCL+D G++RP+MGDVLWNLEFALQLQ+ DG + + +++ +N+
Sbjct: 764 DTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTPNNGGSSEDLGRGGMAVNV 823
Query: 835 DEESVLSDEIDTSNTTDIFSQIVNPKGR 862
+SD + + + T+IFSQIVNPKGR
Sbjct: 824 AGRDDVSD-LSSEDNTEIFSQIVNPKGR 850
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813101|ref|XP_002874434.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320271|gb|EFH50693.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1034 bits (2673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/872 (60%), Positives = 645/872 (73%), Gaps = 25/872 (2%)
Query: 1 MNSDTQILFSIFFFSLTLSNIACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKF 60
MN +ILFS+ F L L +QS+ L+CGAS D + +KW D+KF
Sbjct: 1 MNEKLRILFSVLCFFYVL------LVSLSQSNGQDISLSCGASEPAVDQDKKKWEPDTKF 54
Query: 61 LTNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN 120
L + N++ A A QD SL ST+PYMT+RIF + ++Y+ V R LRLHFYP++Y
Sbjct: 55 L-KTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIPVKGDKRHLLRLHFYPSTYTG 113
Query: 121 LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180
L+ S++YFSV AN TLL+NFSA+IT +ALTQAY+VRE+SL P++ L ITFTPS H
Sbjct: 114 LNISDSYFSVAANDVTLLSNFSAAITCQALTQAYLVREYSLAPSEKDVLSITFTPSDKHP 173
Query: 181 DSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-L 239
++AF+NGIEVI MP++F +A LVGFSDQ+ + ++ LQTM+RLNVGG+ IP + DSG L
Sbjct: 174 KAFAFINGIEVIQMPELFDTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGL 233
Query: 240 TRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299
TRTWY+D+PY+F A GV QA N +I+Y + AP VY+TARS GP+ ++N
Sbjct: 234 TRTWYNDAPYIFSAGLGVTLQASNNFRIDY-QKMPVSTAPADVYKTARSQGPNGDINMKS 292
Query: 300 NLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQ---EGADVIGWAGEQGV 356
NLTW+FQ+D NFTYI+R HFCE L+KINQ+VF+IFINN+TAQ AD++ W+G +GV
Sbjct: 293 NLTWMFQVDTNFTYIMRLHFCEFQLSKINQKVFNIFINNRTAQGDTNPADILAWSGGKGV 352
Query: 357 PVYKDYAIY--AEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNP 414
P YKDYAIY A G +E+ + + PS PEYYDA LNGLEIFK DTM NLAGPNP
Sbjct: 353 PTYKDYAIYVDANTGGGGEEISLQMTPSTFGKPEYYDAQLNGLEIFKM-DTMKNLAGPNP 411
Query: 415 VPSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGS 474
PS M + E KK+F +K + + G AGGV + + A+ F + +K+ GS
Sbjct: 412 KPSPMQAN-EDVKKEF----QGNKRITAFVIGSAGGVATVLLC-ALCFTMYQRKQKFSGS 465
Query: 475 RCSTSSWLPLYGTSHTTG-KSTGTGKSTS-SHLTNLAAGLCRHFSLAEIKHGTRNFSESH 532
TSSWLP+YG SHT+ KST +GKS + SHL+NLAAGLCR FSL+EIKHGT NF ES+
Sbjct: 466 ESHTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESN 525
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
VIGVGGFGKVY+G IDG TKVAIK+SNP+SEQG++EF+TEIE+LS+LRHKHLVSLIG+C+
Sbjct: 526 VIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCD 585
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
E GEM L+YDYM+ GTLREHLY +P L WK+RLEI IGAARGLHYLHTGA+YTIIHRD
Sbjct: 586 EGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRD 645
Query: 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDV 712
VKTTNILLDE W AKVSDFGLSKTGPN+N HV+T+VKGSFGYLDPEYFRRQQLTEKSDV
Sbjct: 646 VKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDV 705
Query: 713 YSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRK 772
YSFGVVLFEVLCARPALN +L KEQVSL DWA++C+R GT+EDIIDPNLKG I +CL+K
Sbjct: 706 YSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKK 765
Query: 773 FTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGD--KLISIQTDKANDTYAMHKA 830
F +TAEKCLSD G+DRP+MGDVLWNLEFALQLQ+ DG + S + A
Sbjct: 766 FADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHRTPSHGGGSVDLGGGGGVA 825
Query: 831 MLNIDEESVLSDEIDTSNTTDIFSQIVNPKGR 862
+ ES L D++ + + IFSQIVNPKGR
Sbjct: 826 VNIGAGESDLGDDLSSEENSGIFSQIVNPKGR 857
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 862 | ||||||
| TAIR|locus:2084953 | 850 | ANX1 "ANXUR1" [Arabidopsis tha | 0.954 | 0.968 | 0.584 | 3.6e-263 | |
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.962 | 0.967 | 0.583 | 1.8e-259 | |
| TAIR|locus:2081895 | 895 | FER "FERONIA" [Arabidopsis tha | 0.907 | 0.873 | 0.575 | 5.1e-245 | |
| TAIR|locus:2177202 | 873 | AT5G39000 [Arabidopsis thalian | 0.933 | 0.922 | 0.463 | 1.2e-182 | |
| TAIR|locus:2152312 | 880 | AT5G38990 [Arabidopsis thalian | 0.946 | 0.927 | 0.437 | 5e-170 | |
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.493 | 0.512 | 0.516 | 1.1e-168 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.932 | 0.940 | 0.438 | 7.6e-167 | |
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.881 | 0.895 | 0.44 | 6.3e-163 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.454 | 0.472 | 0.542 | 6.6e-162 | |
| TAIR|locus:2136338 | 878 | AT4G39110 [Arabidopsis thalian | 0.390 | 0.383 | 0.622 | 1.4e-160 |
| TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2532 (896.4 bits), Expect = 3.6e-263, P = 3.6e-263
Identities = 491/840 (58%), Positives = 611/840 (72%)
Query: 29 TQSDSNSYVLACGASSDGTDSNDRKWTSDSKFLTNSGNSITATAQSQDSSLPSTIPYMTA 88
T+S+ L+CG S D + +KW D+KFL +GNSI ATA QD SL ST+PYMTA
Sbjct: 22 TRSNGQDLALSCGTSEASADQDKKKWEPDTKFL-KTGNSIHATATYQDPSLLSTVPYMTA 80
Query: 89 RIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAK 148
RIF + ++Y+ + R LRL+FYP++Y L+ SN+YF+V AN TLL+NFSA+IT +
Sbjct: 81 RIFTAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAITCQ 140
Query: 149 ALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIFGSAPLVGFSD 208
ALTQAY+V+E+SL P L I FTPS ++D++AF+NGIEVI MP++F +A LVGF+D
Sbjct: 141 ALTQAYLVKEYSLAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTAALVGFTD 200
Query: 209 QSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-LTRTWYDDSPYLFGAAFGVASQADNKTKI 267
Q+++ ++ LQ+M+RLNVGG+ IP + DSG LTRTWY+D+PY+F A GV QA N +I
Sbjct: 201 QTMDAKTANLQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRI 260
Query: 268 EYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILLTKI 327
Y N+ IAP +Y+TARS GP+ ++N NLTW+FQID NFTYI+R HFCE L+KI
Sbjct: 261 NY-QNMPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQLSKI 319
Query: 328 NQRVFDIFINNQTAQEG---ADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVS 384
NQ+VF+I+INN+TAQ AD+IGW GE+G+P+YKDYAIY + G +E+ + + PS
Sbjct: 320 NQKVFNIYINNRTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMTPSTF 379
Query: 385 MHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTXXXXX 444
PEYYD+ LNGLEIFK DTM NLAGPNP PS M E KK+F K
Sbjct: 380 GQPEYYDSSLNGLEIFKM-DTMKNLAGPNPEPSPMQAEEEV-KKEF----KNEKRHAFII 433
Query: 445 XXXXXXXXXXXXXXXXXFYVSNKKKNNDGSRCSTSSWLPLYXXXXXXXXXXXXXXXXX-- 502
Y KK+ G TSSWLP+Y
Sbjct: 434 GSAGGVLAVLIGALCFTAY--KKKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNG 491
Query: 503 XXLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS 562
L+NLAAGLCR FSL EIKHGT+NF +S+VIGVGGFGKVY+G IDG TKVA+K+SNP+S
Sbjct: 492 SHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNS 551
Query: 563 EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP 622
EQG++EF+TEIE+LS+LRHKHLVSLIG+C+E GEM LVYDYMA GTLREHLY KP L
Sbjct: 552 EQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLT 611
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
WK+RLEI IGAARGLHYLHTGA+YTIIHRDVKTTNIL+DE W AKVSDFGLSKTGPN+N
Sbjct: 612 WKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNG 671
Query: 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742
HV+T+VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE+LCARPALN +LPKEQVSL D
Sbjct: 672 GHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGD 731
Query: 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802
WA++C+R G +EDIIDPNLKG I +CL+KF +TAEKCL+D G++RP+MGDVLWNLEFAL
Sbjct: 732 WAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFAL 791
Query: 803 QLQDNPDGDKLISIQTDKANDTYAMHKAMLNIDEESVLSDEIDTSNTTDIFSQIVNPKGR 862
QLQ+ DG + + +++ +N+ +SD + + + T+IFSQIVNPKGR
Sbjct: 792 QLQETADGTRHRTPNNGGSSEDLGRGGMAVNVAGRDDVSD-LSSEDNTEIFSQIVNPKGR 850
|
|
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2497 (884.0 bits), Expect = 1.8e-259, P = 1.8e-259
Identities = 496/850 (58%), Positives = 609/850 (71%)
Query: 24 VLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDSKFLTNSGNSITATAQSQDSSLPSTI 83
+L +QS+ L+CGAS D + +KW D+KFL + N++ A A QD SL ST+
Sbjct: 18 LLVSPSQSNGQDISLSCGASEPAVDQDKKKWEPDTKFL-KTPNTVHAPATYQDPSLLSTV 76
Query: 84 PYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSA 143
PYMT+RIF + ++Y+ V R LRLHFYP++Y L+ ++YFSV AN TLL+NFSA
Sbjct: 77 PYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDLTLLSNFSA 136
Query: 144 SITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIFGSAPL 203
+IT +ALTQAY+VRE+SL P++ L I FTPS H ++AF+NGIEVIPMP++F +A L
Sbjct: 137 AITCQALTQAYLVREYSLAPSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMPELFDTASL 196
Query: 204 VGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSG-LTRTWYDDSPYLFGAAFGVASQAD 262
VGFSDQ+ + ++ LQTM+RLNVGG+ IP + DSG LTRTWY+D+PY+F A GV QA
Sbjct: 197 VGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQAS 256
Query: 263 NKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEI 322
N +I+Y + AP VY+TARS GP+ ++N NLTW+FQ+D NFTYI+R HFCE
Sbjct: 257 NNFRIDY-QKMPVSTAPADVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEF 315
Query: 323 LLTKINQRVFDIFINNQTAQ---EGADVIGWAGEQGVPVYKDYAIY--AEDLPGDDELWV 377
L KINQ+VF+IFINN+TAQ AD++GW G +G+P YKDYAIY A G +E+ +
Sbjct: 316 QLAKINQKVFNIFINNRTAQGDTNPADILGWTGGKGIPTYKDYAIYVDANTGGGGEEISL 375
Query: 378 ALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRS 437
+ PS PEYYD+ LNGLEIFK DTM NLAGPNP PS M + E KK F +
Sbjct: 376 QMTPSTFGQPEYYDSQLNGLEIFKI-DTMKNLAGPNPKPSPMQAN-EDVKKDF-----QG 428
Query: 438 KTXXXXXXXXXXXXXXXXXXXXXXFYVSNKKKNNDGSRCSTSSWLPLYXXXXXXXXXXXX 497
F + +K+ GS TSSWLP+Y
Sbjct: 429 DKRITAFVIGSAGGVAAVLFCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSATKSTI 488
Query: 498 XXXXX--XXLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAI 555
L+NLAAGLCR FSL+EIKHGT NF ES+VIGVGGFGKVY+G IDG TKVAI
Sbjct: 489 SGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAI 548
Query: 556 KRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK 615
K+SNP+SEQG++EF+TEIE+LS+LRHKHLVSLIG+C+E GEM L+YDYM+ GTLREHLY
Sbjct: 549 KKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYN 608
Query: 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
+P L WK+RLEI IGAARGLHYLHTGA+YTIIHRDVKTTNILLDE W AKVSDFGLSK
Sbjct: 609 TKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 668
Query: 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPK 735
TGPN+N HV+T+VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALN +L K
Sbjct: 669 TGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSK 728
Query: 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
EQVSL DWA++C+R GT+EDIIDPNLKG I +CL+KF +TAEKCLSD G+DRP+MGDVL
Sbjct: 729 EQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVL 788
Query: 796 WNLEFALQLQDNPDGDKLISIQTDKAN-DTYAMHKAM-LNIDE-ESVLSDEIDTSNTTDI 852
WNLEFALQLQ+ DG + + + D + +NI ES L D++ + + I
Sbjct: 789 WNLEFALQLQETADGSRHRTPSNGGGSVDLGGGGGGVTVNISAGESDLGDDLSSEENSGI 848
Query: 853 FSQIVNPKGR 862
FSQIVNPKGR
Sbjct: 849 FSQIVNPKGR 858
|
|
| TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2318 (821.0 bits), Expect = 5.1e-245, Sum P(2) = 5.1e-245
Identities = 462/803 (57%), Positives = 572/803 (71%)
Query: 22 ACVLSQGTQSDSNSYVLACGA-SSDGTDSNDRKWTSD--SKFLTNSG-NSITATAQSQDS 77
A ++S S + +L CG +S+ TD+++R W SD SKFL++S +S T+ A +QD
Sbjct: 22 ATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDP 81
Query: 78 SLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTL 137
S+P +PYMTAR+F+S +Y F V+S +F +RL+FYP SY L+ +N+ FSV+ +TL
Sbjct: 82 SVPE-VPYMTARVFRSPFTYTFPVASGRKF-VRLYFYPNSYDGLNATNSLFSVSFGPYTL 139
Query: 138 LNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDI 197
L NFSAS TA+ALT A+I++EF +V + G L +TFTP S ++YAFVNGIEV MPD+
Sbjct: 140 LKNFSASQTAEALTYAFIIKEF-VVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDM 198
Query: 198 F----GSAPLVGFSDQSVEVNSST-LQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFG 252
+ G+ +VG S SV +++ST L+ +YRLNVGG I + D+GL R+WYDD PY+FG
Sbjct: 199 YSSTDGTLTMVG-SSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFG 257
Query: 253 AAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFT 312
A G+ AD I+YP+ +AP+ VY TARSMGP +N NYNLTWIF ID+ FT
Sbjct: 258 AGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFT 317
Query: 313 YIVRFHFCEIL--LTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLP 370
Y+VR HFCE+ +TKINQRVF I++NNQTA+ ADVI W GVP +KDY + +
Sbjct: 318 YLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGN 377
Query: 371 GDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKF 430
G +LW+ALHP+ PEYYD++LNG+EIFK N + GNLAG NP+P + A+ +K
Sbjct: 378 GQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVT-ADPSKV-L 435
Query: 431 APSSSRSKTXXXXXXXXXXXXXXXXXXXXX-XFYVSNKKKNNDGSRCS--TSSWLPLYXX 487
P++ +SK+ F ++K D S TS WLPL
Sbjct: 436 RPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLY 495
Query: 488 XXXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYI 547
++L + LCRHFS AEIK T+NF ES V+GVGGFGKVY G I
Sbjct: 496 GNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEI 555
Query: 548 DG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606
DG TKVAIKR NP SEQGVHEFQTEIEMLSKLRH+HLVSLIG+CEE+ EMILVYDYMA+
Sbjct: 556 DGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAH 615
Query: 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666
GT+REHLYK P LPWKQRLEICIGAARGLHYLHTGA++TIIHRDVKTTNILLDEKW A
Sbjct: 616 GTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA 675
Query: 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
KVSDFGLSKTGP L+ THVST+VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCAR
Sbjct: 676 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCAR 735
Query: 727 PALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGI 786
PALN L KEQVSLA+WA +C + G ++ I+DP LKG IT +C +KF ETA KC+ DQGI
Sbjct: 736 PALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGI 795
Query: 787 DRPSMGDVLWNLEFALQLQDNPD 809
+RPSMGDVLWNLEFALQLQ++ +
Sbjct: 796 ERPSMGDVLWNLEFALQLQESAE 818
|
|
| TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1772 (628.8 bits), Expect = 1.2e-182, P = 1.2e-182
Identities = 407/878 (46%), Positives = 530/878 (60%)
Query: 29 TQSDSNSYVLACGASSDGTDSNDRKWTSDSKFLTNSG--N-SITATAQSQDSSLPSTIPY 85
T ++ ++ CG +S+ D + R WT++++ + +S N S TA A Q+S + S IPY
Sbjct: 25 TYEPTDVFLFNCGDTSNNVDVSGRNWTAENQKILSSNLVNASFTAQASYQESGV-SQIPY 83
Query: 86 MTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN-LDPSNAYFSVNANGFTLLNNFSAS 144
MTARIF+S +Y F V+ F LRL+FYP YG+ + ++FSV NGFTLLNNFSA
Sbjct: 84 MTARIFRSEFTYSFPVTPGSNF-LRLYFYPTRYGSQFNAVKSFFSVKVNGFTLLNNFSAD 142
Query: 145 ITAKALTQA--YIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPDIFGSAP 202
+T KA +I++EF ++P L +TFTPS D S AFVNGIE++ +P+ F S
Sbjct: 143 LTVKASKPQTEFIIKEF-IIPVYQ-TLNLTFTPSLD---SLAFVNGIEIVSIPNRFYSKG 197
Query: 203 LVGFSD------QSVEV---NSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGA 253
GF D SV+ NS+ +T+YRLNVGGK + DSG+ R W D +
Sbjct: 198 --GFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTV---GDSGMFRRWVSDDEIILSE 252
Query: 254 AFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMG--PDPNVNRNYNLTWIFQIDANF 311
+ G++ + KI Y +AP VY T+RSMG P N N+NLTW+F +DA F
Sbjct: 253 SSGISPIVPD-IKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLNFNLTWLFTVDAGF 311
Query: 312 TYIVRFHFCEIL--LTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDL 369
+Y+VR HFCE L + K QRVF IFI NQTA DV +G +P+Y DY + A
Sbjct: 312 SYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPMYLDYTVIAGSG 371
Query: 370 PGD-DELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKK 428
G +L + LHP VS++P+YYDAILNG+EI K ND GNLAGPNP P L+ +
Sbjct: 372 SGRRHDLRLDLHPLVSINPKYYDAILNGVEILKMNDPDGNLAGPNPDP---LVSPDLIPN 428
Query: 429 KFAPSSSRSKTXXXXXXXXXXXXXXXXXXXXXXFYVSNKKKNNDGSRCST-SSWLPLYXX 487
+ P ++K+ V KKK S+ ST SSW PL
Sbjct: 429 RATPRIRKNKSHILPITLAVVGSLVVLAMFVVGVLVIMKKKKK--SKPSTNSSWCPLPHG 486
Query: 488 XXXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYI 547
+L A LCR FS+ EIK T +F + +IGVGGFG VY+G I
Sbjct: 487 TDSTNTKPAK---------SLPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQI 537
Query: 548 DG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606
DG T VA+KR +S QG EF+TE+EMLSKLRH HLVSLIG+C+ED EM+LVY+YM +
Sbjct: 538 DGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPH 597
Query: 607 GTLREHLYKGDK---PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK 663
GTL++HL++ DK P L WK+RLEICIGAARGL YLHTGA+YTIIHRD+KTTNILLDE
Sbjct: 598 GTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDEN 657
Query: 664 WEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
+ KVSDFGLS+ GP + +QTHVST+VKG+FGYLDPEY+RRQ LTEKSDVYSFGVVL EV
Sbjct: 658 FVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEV 717
Query: 723 LCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLS 782
LC RP ++P EQ L W R GT++ IID +L +IT L KF E A +C+
Sbjct: 718 LCCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQ 777
Query: 783 DQGIDRPSMGDVLWNLEFALQLQ-------DN-------PDGDKLISIQTDKANDTYAM- 827
D+G++RP M DV+W LEFALQL DN P G+ + TD +D ++
Sbjct: 778 DRGMERPPMNDVVWALEFALQLHETAKKKNDNVESLDLMPSGE--VGTTTDGEDDLFSRT 835
Query: 828 --HKAMLNIDEESVLSDEIDTSNTT-DIFSQIVNPKGR 862
H ++SVL + S ++ +FS+I PK R
Sbjct: 836 TGHVGKSTTTDDSVLVVGDERSGSSWGVFSEINEPKAR 873
|
|
| TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1653 (586.9 bits), Expect = 5.0e-170, P = 5.0e-170
Identities = 390/891 (43%), Positives = 520/891 (58%)
Query: 22 ACVLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSDS-KFLTNSG---NSITATAQSQDS 77
A V + + ++ +++ CG +S+ D + R WT+++ KF++++ S T++A Q+S
Sbjct: 15 AVVDATASYEPTDVFLINCGDTSNNMDYSGRNWTTENPKFMSSNAVDDASFTSSASYQES 74
Query: 78 SLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGN-LDPSNAYFSVNANGFT 136
+P +PY+ ARIF+ +Y F VS +F LRL+FYP YG+ D ++FSVN N FT
Sbjct: 75 GIPQ-VPYLKARIFRYDFTYSFPVSPGWKF-LRLYFYPTRYGSDFDAVKSFFSVNVNRFT 132
Query: 137 LLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPD 196
LL+NFS + A + +++EF +VP L +TFTPS + S AFVNGIE+I MPD
Sbjct: 133 LLHNFS--VKASIPESSSLIKEF-IVPVNQ-TLDLTFTPSPN---SLAFVNGIEIISMPD 185
Query: 197 IFGSAPLVGFSD--QSV------EVNSST-LQTMYRLNVGGKFIPSTNDSGLTRTWYDDS 247
F S GF D ++V E+++ST +T+YR+NVGGK + DSG+ R W D
Sbjct: 186 RFYSKG--GFDDVVRNVGRDVDFEIDNSTAFETVYRVNVGGKVVGDVGDSGMFRRWLSDE 243
Query: 248 PYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMG--PDPNVNRNYNLTWIF 305
+L G G KI Y +AP VY T R MG P +N N+NLTW+F
Sbjct: 244 GFLLGINSGAIPNITG-VKINYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFNLTWLF 302
Query: 306 QIDANFTYIVRFHFCEIL--LTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYA 363
++DA F YIVR HFCE + K RVF IF Q A DV +G +P+Y D+
Sbjct: 303 EVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPMYLDFK 362
Query: 364 IYAEDLPGDDE---LWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAML 420
+ D G + L V L P +P YYDAIL+G+EI K +++ GNLAG NP+P
Sbjct: 363 VLV-DADGTSQRPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIPQLSP 421
Query: 421 LHAEATKKKFAPSSSRSKTXXXXXXXXXXXXXXXXXXXXXXFYVSNKKKNNDGS-----R 475
T K SS + KKK+N+ S +
Sbjct: 422 PPQSITPLKGKGKSSHVLPIIIAVVGSAVALAFFVLVVVLVV-MKRKKKSNESSVDTTNK 480
Query: 476 CST-SSWLPLYXXXXXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEIKHGTRNFSESHVI 534
ST SSW PL ++L + LCR FS+ EIK T +F E +I
Sbjct: 481 PSTNSSWGPLLHGTGSTNTKSA---------SSLPSDLCRRFSIYEIKSATNDFEEKLII 531
Query: 535 GVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
GVGGFG VY+G IDG T VA+KR +S QG EF TE+EMLSKLRH HLVSLIG+C++
Sbjct: 532 GVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSLIGYCDD 591
Query: 594 DGEMILVYDYMANGTLREHLYKGDK---PGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
D EM+LVY+YM +GTL++HL++ DK P L WK+RLEICIGAARGL YLHTGA+YTIIH
Sbjct: 592 DNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIH 651
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEK 709
RD+KTTNILLDE + AKVSDFGLS+ GP + +QTHVST+VKG+FGYLDPEY+RRQ LTEK
Sbjct: 652 RDIKTTNILLDENFVAKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQILTEK 711
Query: 710 SDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769
SDVYSFGVVL EVLC RP ++P EQ L W T++ IID +L +IT
Sbjct: 712 SDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSDLTADITSTS 771
Query: 770 LRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ-------DN-------PDGDKLIS 815
+ KF E A +C+ D+G++RP M DV+W LEFALQL DN P G+ +
Sbjct: 772 MEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVESLDLMPSGE--VG 829
Query: 816 IQTDKANDTYAM---HKAMLNIDEESVLSDEIDTSNTT-DIFSQIVNPKGR 862
TD +D ++ H ++SVL + S ++ +FS+I PK R
Sbjct: 830 TTTDGEDDLFSRTTGHVGKSTTTDDSVLVVGDERSGSSWGVFSEINEPKAR 880
|
|
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 1.1e-168, Sum P(2) = 1.1e-168
Identities = 231/447 (51%), Positives = 291/447 (65%)
Query: 430 FAP-SSSRSKTXXXXXXXXXXXXXXXXXXXXXXFYVSNKKKNNDGSRCSTSSWLPLYXXX 488
F P SSS SK+ F + K+K T W+P
Sbjct: 392 FVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKRGQDGHSKT--WMPF---- 445
Query: 489 XXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID 548
LT++ A +K T NF ES IGVGGFGKVY+G ++
Sbjct: 446 SINGTSMGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELN 505
Query: 549 GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGT 608
TKVA+KR NP S+QG+ EF+TEIEMLS+ RH+HLVSLIG+C+E+ EMIL+Y+YM NGT
Sbjct: 506 DGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGT 565
Query: 609 LREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668
++ HLY P L WKQRLEICIGAARGLHYLHTG +IHRDVK+ NILLDE + AKV
Sbjct: 566 VKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKV 625
Query: 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA 728
+DFGLSKTGP L+QTHVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARP
Sbjct: 626 ADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPV 685
Query: 729 LNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDR 788
++ LP+E V+LA+WA+ Q+ G ++ IID +L+GNI LRKF ET EKCL+D G+DR
Sbjct: 686 IDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDR 745
Query: 789 PSMGDVLWNLEFALQLQDNP-DGD------KLISIQTDKANDTYAMHKAMLNID------ 835
PSMGDVLWNLE+ALQLQ+ DG+ +I + N+ ++ +N+
Sbjct: 746 PSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINN-FSQGDTSVNVPGTAGRF 804
Query: 836 EESVLSDEIDTSNTTDIFSQIVNPKGR 862
EES + D++ + + +FSQ+V +GR
Sbjct: 805 EESSI-DDLSGVSMSKVFSQLVKSEGR 830
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1623 (576.4 bits), Expect = 7.6e-167, P = 7.6e-167
Identities = 373/851 (43%), Positives = 511/851 (60%)
Query: 34 NSYVLACGASSDGTDSNDRKWTSDS---KFLTNSGNSITATAQSQDSSLPSTIPYMTARI 90
++Y+++CG+S + T N R + DS + GNS AT+ + ++S S Y TAR+
Sbjct: 30 DNYLISCGSSQNITFQN-RIFVPDSLHSSLVLKIGNSSVATSTTSNNSTNSI--YQTARV 86
Query: 91 FKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKAL 150
F S +SY+F ++S R W+RLHF P + + ++A +V F LLNNFS +
Sbjct: 87 FSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFSFN----NF 142
Query: 151 TQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPD--IFGSAPLVGFSD 208
+YI +E++ V S L ++F PS++ S FVN IEV+ +PD I A + S
Sbjct: 143 NGSYIFKEYT-VNVTSEFLTLSFIPSNN---SVVFVNAIEVVSVPDNLIPDQALALNPST 198
Query: 209 QSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIE 268
++ +T+YRLN+GG + S ND+ L R W +D+ YL + + A N + I+
Sbjct: 199 PFSGLSLLAFETVYRLNMGGPLLTSQNDT-LGRQWDNDAEYLHVNSSVLVVTA-NPSSIK 256
Query: 269 YPSNLSQEIAPLSVYETARSMGPDPNV-NRNYNLTWIFQIDANFTYIVRFHFCEILLTKI 327
Y +++QE AP VY TA +MG D NV + ++N+TW+ +D +F Y VR HFC+I+ +
Sbjct: 257 YSPSVTQETAPNMVYATADTMG-DANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQAL 315
Query: 328 NQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSMHP 387
N VF++++N+ A D+ VP +KD+ I + L V++ P
Sbjct: 316 NTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDF-ISNGSVESSGVLTVSVGPD--SQA 372
Query: 388 EYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTXXXXXXXX 447
+ +A +NGLE+ K ++ +L+G + V S LL + K S+ K
Sbjct: 373 DITNATMNGLEVLKISNEAKSLSGVSSVKS--LLPGGSGSK------SKKKAVIIGSLVG 424
Query: 448 XXXXXXXXXXXXXXFYVSNKKKNNDGSRCSTSS--WLPL--YXXXXXXXXXXXXXXXXXX 503
V+++K+ + + + WLPL Y
Sbjct: 425 AVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATA 484
Query: 504 XLTNLAAG-LCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS 562
+LA+ L R F EI T F ES ++GVGGFG+VY+G ++ TKVA+KR NP S
Sbjct: 485 SCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRS 544
Query: 563 EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP 622
EQG+ EF+TEIEMLSKLRH+HLVSLIG+C+E EMILVY+YMANG LR HLY D P L
Sbjct: 545 EQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLS 604
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
WKQRLEICIGAARGLHYLHTGA +IIHRDVKTTNILLDE AKV+DFGLSKTGP+L+Q
Sbjct: 605 WKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQ 664
Query: 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742
THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL EVLC RPALN LP+EQV++A+
Sbjct: 665 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAE 724
Query: 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802
WA+ Q+ G ++ I+D NL G + L+KF ETAEKCL++ G+DRPSMGDVLWNLE+AL
Sbjct: 725 WAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYAL 784
Query: 803 QLQDN------PDGDKLISIQTDKANDTYAMHKAMLNIDEESVLS-----DEIDTSNTTD 851
QL++ PD + I +M ID V S D+ + + T+
Sbjct: 785 QLEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSA 844
Query: 852 IFSQIVNPKGR 862
+FSQ+V+P+GR
Sbjct: 845 VFSQLVHPRGR 855
|
|
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1586 (563.4 bits), Expect = 6.3e-163, P = 6.3e-163
Identities = 352/800 (44%), Positives = 488/800 (61%)
Query: 24 VLSQGTQSDSNSYVLACGASSDGTDSNDRKWTSD---SKFLTNSG-NSITATAQSQDSSL 79
V+ G ++ S S+++ CG+++ T+ + R W D +K +T G ++ITA+ S+ SS+
Sbjct: 22 VIGYG-EAQSKSFLVDCGSNAT-TEVDGRTWVGDLSPNKSVTLQGFDAITAST-SKGSSV 78
Query: 80 PSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLN 139
+ I Y TAR+F + +Y F ++ +++RLHF P + N + + + FSV A+G L+
Sbjct: 79 YAEI-YKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLML 137
Query: 140 --NFSASITAKAL---TQAYIVREFSLV-----PAQSGDLIITFTPSSDHKDSYAFVNGI 189
N + I K L + + SLV P G L+++F P K S+ FVN I
Sbjct: 138 DINIAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPE---KGSFGFVNAI 194
Query: 190 EVIPMPD-IFG-SAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDSGLTRTWYDDS 247
E++ + D +F S VG S+ + + ++TMYRLNVGG + + D L RTW D
Sbjct: 195 EIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDL 254
Query: 248 PYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQI 307
Y+ GV + N + I Y +APL VYETAR M + + +N++W F++
Sbjct: 255 SYMVIENAGV--EVKNSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEV 312
Query: 308 DANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAE 367
D NF Y+VR HFCE+L+ K NQR+F I+INNQTA D+ AG + +Y+DY
Sbjct: 313 DPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVS 372
Query: 368 DLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAMLLHAEATK 427
+D LW+ L P S+ DA+L+GLEIFK + GNLA L+ ++T
Sbjct: 373 SK--NDVLWIQLGPDSSVGASG-DALLSGLEIFKLSKN-GNLAH--------LIRFDSTG 420
Query: 428 KKFAPSSSRSKTXXXXXXXXXXXXXXXXXXXXXXFYVSNKKKN-NDGSRCSTSSWLPLYX 486
S S+ + + K+++ +D S+ + W PL+
Sbjct: 421 HSV--SDSKMRIIWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFL 478
Query: 487 XXXXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGY 546
T A+ + R F+LAEI+ T+NF + IGVGGFGKVY G
Sbjct: 479 HVNNSTANAKATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGE 538
Query: 547 IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606
++ T +AIKR+ P S+QG+ EF+TEI MLS+LRH+HLVSLIGFC+E EMILVY+YMAN
Sbjct: 539 LEDGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMAN 598
Query: 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666
GTLR HL+ + P L WKQRLE CIG+ARGLHYLHTG+ IIHRDVKTTNILLDE + A
Sbjct: 599 GTLRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVA 658
Query: 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
K+SDFGLSK GP+++ THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE +CAR
Sbjct: 659 KMSDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCAR 718
Query: 727 PALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGI 786
+N LPK+Q++LA+WAL Q+ +E IID NL+GN + + L K+ E AEKCL+D+G
Sbjct: 719 AVINPTLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGK 778
Query: 787 DRPSMGDVLWNLEFALQLQD 806
+RP MG+VLW+LE+ LQ+ +
Sbjct: 779 NRPMMGEVLWSLEYVLQIHE 798
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 6.6e-162, Sum P(2) = 6.6e-162
Identities = 225/415 (54%), Positives = 282/415 (67%)
Query: 462 FYVSNKKKNNDGSRCSTSSWLPLYXXXXXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEI 521
F+V KK+ D ++ +W+PL L ++A+ L +
Sbjct: 424 FFVLYKKRGRDQDG-NSKTWIPL-------SSNGTTSSSNGTTLASIASNSSYRIPLVAV 475
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH 581
K T +F E+ IGVGGFGKVY+G + TKVA+KR+NP S+QG+ EF+TEIEMLS+ RH
Sbjct: 476 KEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRH 535
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
+HLVSLIG+C+E+ EMILVY+YM NGTL+ HLY L WKQRLEICIG+ARGLHYLH
Sbjct: 536 RHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLH 595
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
TG +IHRDVK+ NILLDE AKV+DFGLSKTGP ++QTHVST VKGSFGYLDPEYF
Sbjct: 596 TGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 655
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
RRQQLTEKSDVYSFGVV+FEVLCARP ++ L +E V+LA+WA+ Q+ G +E IIDP+L
Sbjct: 656 RRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSL 715
Query: 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNP-DGD-----KLIS 815
+G I LRKF ET EKCL+D G+DRPSMGDVLWNLE+ALQLQ+ DGD +I
Sbjct: 716 RGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDPEDSTNMIG 775
Query: 816 IQTDKANDTYAMHKAMLNI--------DEESVLSDEIDTSNTTDIFSQIVNPKGR 862
+ ND Y +N DEE D+ + + +FSQ++ +GR
Sbjct: 776 ELPLRFND-YNHGDTSVNFSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829
|
|
| TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 1.4e-160, Sum P(3) = 1.4e-160
Identities = 213/342 (62%), Positives = 254/342 (74%)
Query: 467 KKKNNDGS-RCSTSSWL-PLYXXXXXXXXXXXXXXXXXXXLTNLAAGLCRHFSLAEIKHG 524
KK+ D R S SSWL P++ N GL R+FSL+E++
Sbjct: 465 KKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFY--NSTLGLGRYFSLSELQEA 522
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
T+NF S +IGVGGFG VY G +D TKVA+KR NP SEQG+ EFQTEI+MLSKLRH+HL
Sbjct: 523 TKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 582
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
VSLIG+C+E+ EMILVY++M+NG R+HLY + L WKQRLEICIG+ARGLHYLHTG
Sbjct: 583 VSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGT 642
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
IIHRDVK+TNILLDE AKV+DFGLSK Q HVST VKGSFGYLDPEYFRRQ
Sbjct: 643 AQGIIHRDVKSTNILLDEALVAKVADFGLSKDVA-FGQNHVSTAVKGSFGYLDPEYFRRQ 701
Query: 705 QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764
QLT+KSDVYSFGVVL E LCARPA+N LP+EQV+LA+WA+ +R G +E IIDP+L G
Sbjct: 702 QLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGT 761
Query: 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQD 806
I + ++KF E AEKCL D G+DRP+MGDVLWNLE+ALQLQ+
Sbjct: 762 INPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQE 803
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SR05 | ANX1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5944 | 0.9791 | 0.9929 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.X.621.1 | hypothetical protein (796 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 862 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 5e-63 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-22 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-17 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 6e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 5e-63
Identities = 91/376 (24%), Positives = 149/376 (39%), Gaps = 54/376 (14%)
Query: 38 LACGASSDGTDSND---RKWTSDSKFLTNSGNSITATAQSQDSSLPSTIPYMTARIF--K 92
+ CG S+ + ++ W SD+ F ++G S + ++ S L PY T R F
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGF-IDTGKSGNISKENSSSFLS--KPYKTLRSFPDG 57
Query: 93 STSSYKFTVSS--KDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLN--NFSASITAK 148
+ Y V+ ++ +R F YGN D N+ S + F L N ++
Sbjct: 58 KRNCYTLPVTPGKGTKYLIRATFL---YGNYDGLNSVSSPPS--FDLYLGVNLWTTVNLS 112
Query: 149 ALTQAYIVREFSLVPAQSGDLIITFTPSSDHKDSYAFVNGIEVIPMPD-IFGSAPLVGFS 207
+ +V+E+ + +S L + + F++ +E+ P+PD ++ S+
Sbjct: 113 NDSGDSVVKEYIIHVTKSDTLSVCLVNT---GTGTPFISALELRPLPDSLYPSSG----- 164
Query: 208 DQSVEVNSSTLQTMYRLNVG--GKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKT 265
S L+ + RLN G I +D R W + + D
Sbjct: 165 ------GSQALKLVARLNFGGSEGTIRYPDDV-YDRIWEPFFSSPGWSQISTSLSVD--- 214
Query: 266 KIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILLT 325
SN + I P +V +TA + N + N TW +D NF Y V HF EI
Sbjct: 215 ---ISSNNAPYIPPSAVLQTAVTPT---NASAPLNFTWDL-VDPNFEYYVYLHFAEIQSL 267
Query: 326 KINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSM 385
+ R FDI+IN +T + G +Y D+ + G L ++L P+
Sbjct: 268 E--TREFDIYINGKTVYGDVSPK-YLGTDTGALYLDFPVNV---SGGGLLNISLVPTSGS 321
Query: 386 HPEYYDAILNGLEIFK 401
+LN LEIFK
Sbjct: 322 T---LPPLLNALEIFK 334
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 6e-52
Identities = 84/280 (30%), Positives = 129/280 (46%), Gaps = 40/280 (14%)
Query: 533 VIGVGGFGKVYEGYIDGK----TKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FG+VY+G + GK T+VA+K +SE+ +F E ++ KL H ++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHL-------YKGDKPGLPWKQRLEICIGAARGLHYL 640
+G C E+ + LV +YM G L ++L +K L K L I A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
+HRD+ N L+ E K+SDFGLS+ + + T K ++ PE
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 701 FRRQQLTEKSDVYSFGVVLFEV--LCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
+ T KSDV+SFGV+L+E+ L A P L E+V +E +
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--------------LEYLR- 221
Query: 759 PNLKGNITDQ---CLRKFTETAEKCLSDQGIDRPSMGDVL 795
KG + C + E C DRP+ +++
Sbjct: 222 ---KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 10/198 (5%)
Query: 533 VIGVGGFGKVYEGYIDG-----KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
+G G FG+VY+G + G +TKVA+K +SE+ EF E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L+G C + + +V +YM G L + L + L K L++ + A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
+HRD+ N L+ E K+SDFGLS+ + K ++ PE + +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 707 TEKSDVYSFGVVLFEVLC 724
T KSDV+SFGV+L+E+
Sbjct: 182 TSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 12/204 (5%)
Query: 532 HVIGVGGFGKVYEGYIDGK-----TKVAIKRS-NPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G FG+VY+G + GK +VA+K +SEQ + EF E ++ KL H ++V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L+G C E+ +++V +YM G L ++L K L L + ARG+ YL +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
IHRD+ N L+ E K+SDFGLS+ + + + K ++ PE + +
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 706 LTEKSDVYSFGVVLFEV--LCARP 727
T KSDV+SFGV+L+E+ L P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-51
Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 13/205 (6%)
Query: 531 SHVIGVGGFGKVYEGYIDGK-----TKVAIKRS-NPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FG+VY+G + GK +VA+K +SEQ + EF E ++ KL H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
V L+G C E+ + +V +YM G L +L + ++P L L + ARG+ YL +
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
IHRD+ N L+ E K+SDFGLS+ + + + K ++ PE +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEG 178
Query: 705 QLTEKSDVYSFGVVLFEV--LCARP 727
+ T KSDV+SFGV+L+E+ L +P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-50
Identities = 70/192 (36%), Positives = 102/192 (53%), Gaps = 10/192 (5%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G GGFG VY KVAIK S + E EIE+L KL H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E++ + LV +Y G+L++ L + ++ L + L I + GL YLH IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 652 DVKTTNILLDEK-WEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ-LTEK 709
D+K NILLD + K++DFGLSK + + + G+ Y+ PE + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEK 174
Query: 710 SDVYSFGVVLFE 721
SD++S GV+L+E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSLIGF 590
+G G FGKVY VAIK + E EI++L KL+H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
E++ ++ LV +Y G L + L K + L + L YLH I+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKS 710
RD+K NILLDE K++DFGL++ L+ T G+ Y+ PE + +
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 711 DVYSFGVVLFEVLCARP 727
D++S GV+L+E+L +P
Sbjct: 178 DIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 528 FSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHL 584
+ +G G FG VY+ VA+K SE + + EI +L +L H ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
V LI E+ + LV +Y G L ++L +G L + +I + RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLH--- 115
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE-YFRR 703
IIHRD+K NILLDE K++DFGL+K + + ++T V G+ Y+ PE
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763
K DV+S GV+L+E+L +P + L L + +G + +P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKP-----PFSGENILDQLQLIRRILGPPLEFDEPKW-- 226
Query: 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ + +KCL+ RP+ ++L
Sbjct: 227 ---SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHK 582
++ ++G G FG VY +D T +A+K SE+ + + EI +LS L+H
Sbjct: 1 EWTRGELLGRGSFGSVYLA-LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP 59
Query: 583 HLVSLIGFC-EEDGEMILVY-DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
++V G +E+ + ++ +Y++ G+L L K K P ++ I GL YL
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYL 117
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H I+HRD+K NIL+D K++DFG +K ++ + V+G+ ++ PE
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
R ++ +D++S G + E+ +P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 65/196 (33%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 528 FSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
F IG GGFG+VY+ GK +VAIK S++ + EI++L K +H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGK-EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
G + E+ +V ++ + G+L++ L K L Q +C +GL YLH+
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
IIHRD+K NILL E K+ DFGLS + + TMV G+ ++ PE +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMV-GTPYWMAPEVINGKP 173
Query: 706 LTEKSDVYSFGVVLFE 721
K+D++S G+ E
Sbjct: 174 YDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 533 VIGVGGFGKVY--EGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
IG G FGKVY DGK +K + SE+ + E+++L KL H +++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGK-LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPG--LPWKQRLEICIGAARGLHYLHTGARY 646
EE G++ +V +Y G L + + K K G P +Q L+ + L YLH+
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT--HVSTMVKGSFGYLDPEYFRRQ 704
I+HRD+K NI L K+ DFG+SK L+ T T+V G+ YL PE + +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVV-GTPYYLSPELCQNK 178
Query: 705 QLTEKSDVYSFGVVLFEVLCARPA 728
KSD++S G VL+E+ +
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/189 (33%), Positives = 98/189 (51%), Gaps = 10/189 (5%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
IG G FG V G G+ KVA+K S F E +++ LRH +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQ-KVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ +V +YMA G+L ++L + + Q+L + G+ YL +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
N+L+ E AKVSDFGL+K + Q VK + PE R ++ + KSDV+
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEA-SQGQDSGKLPVK----WTAPEALREKKFSTKSDVW 183
Query: 714 SFGVVLFEV 722
SFG++L+E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 71/208 (34%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 526 RNFSESHVIGVGGFGKVYEGYID---GKT--KVAIKRSNPSS-EQGVHEFQTEIEMLSKL 579
R+ +G G FGKV D T +VA+K N S EQ +F+ EIE+L L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 580 RHKHLVSLIGFCEEDGEMI--LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGL 637
H+++V G CE+ G L+ +Y+ +G+LR++L + + + K+ L +G+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGM 122
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS--FGY 695
YL + RY IHRD+ NIL++ + K+SDFGL+K P + S F Y
Sbjct: 123 DYLGS-QRY--IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
PE R + + SDV+SFGV L+E+
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 69/191 (36%), Positives = 104/191 (54%), Gaps = 10/191 (5%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG V+ GY K KVAIK R SE+ +F E +++ KL H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E + LV+++M +G L ++L + + + L +C+ G+ YL + +IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D+ N L+ E KVSDFG+++ + +Q ST K + PE F + + KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 712 VYSFGVVLFEV 722
V+SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 61/189 (32%), Positives = 97/189 (51%), Gaps = 5/189 (2%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+EG + +VAIK +FQ E++ L +LRHKHL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ ++ + M G+L L + LP +++ A G+ YL IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDL 130
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
NIL+ E KV+DFGL++ ++S+ K + + PE + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 714 SFGVVLFEV 722
SFG++L+E+
Sbjct: 189 SFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 11/211 (5%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG VY+G + G T+VA+K RS + +F E E+L + H ++V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + +V + + G+L L + K L K+ L++ + AA G+ YL + IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHR 117
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D+ N L+ E K+SDFG+S+ T + + + PE + T +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 712 VYSFGVVLFEVL----CARPALNVNLPKEQV 738
V+S+G++L+E P ++ +E++
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPS--SEQGVHEFQTEIEMLSKLRHK 582
N+ +IG G FG VY+G ++ +T VAIK+ + E+ + EI++L L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA---RGLHY 639
++V IG E + ++ +Y NG+LR+ + K P + + +GL Y
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FP---ESLVAVYVYQVLQGLAY 114
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN-QTHVSTMVKGSFGYLDP 698
LH +IHRD+K NIL + K++DFG++ LN + V G+ ++ P
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVAT---KLNDVSKDDASVVGTPYWMAP 168
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
E + SD++S G + E+L P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 69/191 (36%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG V+ G GK VAIK R SE +F E +++ KL H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + +V +YMANG L +L + K L + L++C + YL IHR
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHR 124
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D+ N L+ E KVSDFGL++ + +Q S K + PE F + + KSD
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 712 VYSFGVVLFEV 722
V+SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 527 NFSESHVIGVGGFGKVYEGYI------DGKTKVAIKRSNPSSEQGVH-EFQTEIEMLSKL 579
N E +G G FG+V+ G+T V +K + ++ + EF+ E++M KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHL-------YKGDKPGLPWKQRLEICIG 632
HK++V L+G C E ++ +Y G L++ L K P L KQ++ +C
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN-----LNQTHVST 687
A G+ +L AR+ +HRD+ N L+ + E KVS LSK N L +
Sbjct: 126 IALGMDHLSN-ARF--VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747
+L PE + + KSDV+SFGV+++EV L E+V
Sbjct: 183 R------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--------- 227
Query: 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ + L+ + + C + + +C + DRPS +++
Sbjct: 228 -----LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 533 VIGVGGFGKVYEGYI------DGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHLV 585
+G G FGKV+ G + K VA+K ++ + F+ E E+L+ +H+++V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHL-----------YKGDKPG-LPWKQRLEICIGA 633
G C E I+V++YM +G L + L G L Q L+I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKG 691
A G+ YL A +HRD+ T N L+ K+ DFG+S+ + V TM+
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-- 186
Query: 692 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
++ PE ++ T +SDV+SFGVVL+E+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 80/319 (25%), Positives = 134/319 (42%), Gaps = 23/319 (7%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHE---FQTEIEMLSKLRH-KHLVSLI 588
+G G FG+VY + VA+K E E F EI++L+ L H ++V L
Sbjct: 7 KLGEGSFGEVYLARD--RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPG-LPWKQRLEICIGAARGLHYLHTGARYT 647
F +++G + LV +Y+ G+L + L K + G L + L I L YLH+
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 648 IIHRDVKTTNILLDEK-WEAKVSDFGLSK----TGPNLNQTHVSTMVKGSFGYLDPEYFR 702
IIHRD+K NILLD K+ DFGL+K G + + + G+ GY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 703 RQQL---TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759
L + SD++S G+ L+E+L P E+ S A + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTD 819
L + + + ++ +K L+ +R S L + + L+ + D
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH-DLLAHLKLKESDLSDLLKPDD 296
Query: 820 KANDTYAMHKAMLNIDEES 838
A ++ ++ +
Sbjct: 297 SAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/281 (27%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 532 HVIGVGGFGKVYEG-YIDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
V+G G G VY+ + A+K+ + E+ + E++ L ++V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
++GE+ +V +YM G+L + L K +P I +GL YLHT II
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEYFRRQQLT 707
HRD+K +N+L++ K E K++DFG+SK L T +T V G+ Y+ PE + + +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKV---LENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 708 EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767
+D++S G+ L E + LP Q S + L I D P+L
Sbjct: 179 YAADIWSLGLTLLECALGKFPF---LPPGQPSF--FELMQA----ICDGPPPSLPAEEFS 229
Query: 768 QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNP 808
R F CL RPS A +L +P
Sbjct: 230 PEFRDFI---SACLQKDPKKRPS----------AAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 5/189 (2%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ G +G TKVA+K P + F E +++ KLRH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + +V +YM+ G+L + L G+ L Q +++ A G+ YL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
NIL+ E K++DFGL++ + ++ K + PE + T KSDV+
Sbjct: 130 AARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 714 SFGVVLFEV 722
SFG++L E+
Sbjct: 189 SFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 71/229 (31%), Positives = 114/229 (49%), Gaps = 31/229 (13%)
Query: 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGK------TKVAIKRSNPSSEQGVH- 567
L+ ++ F E +G G FGKVY+G + G T VAIK ++E V
Sbjct: 1 EIPLSAVR-----FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53
Query: 568 EFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK------------ 615
EF+ E E++S L+H ++V L+G C ++ ++++Y+A+G L E L +
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 616 --GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673
K L L I I A G+ YL + + +HRD+ N L+ E K+SDFGL
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
S+ + + V + ++ PE + T +SD++SFGVVL+E+
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 7/191 (3%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+EG + T VA+K P + +F E +++ KLRH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + +V + M G+L E+L G L Q +++ A G+ YL IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDL 129
Query: 654 KTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDV 712
N+L+ E KV+DFGL++ ++ + K + PE + + KSDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGA--KFPIKWTAPEAALYNRFSIKSDV 187
Query: 713 YSFGVVLFEVL 723
+SFG++L E++
Sbjct: 188 WSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 73/210 (34%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 527 NFSESHVIGVGGFGKVYE-GYIDGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHK 582
+F VIG G FGKV D K A+K N + V E +L +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 583 HLVSL-IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ---RLEIC-IGAARGL 637
LV+L F +E+ M LV D + G LR HL + K + + + IC I A L
Sbjct: 61 FLVNLWYSFQDEE-NMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLA--L 113
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS-KTGPNLNQTHVSTMVKGSFGYL 696
YLH+ IIHRD+K NILLDE+ ++DF ++ K P+ T S G+ GY+
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS----GTPGYM 166
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
PE RQ + D +S GV +E L +
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 66/193 (34%), Positives = 100/193 (51%), Gaps = 14/193 (7%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIK-RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG- 589
IG G FG V G G KVA+K N ++ Q F E ++++LRH +LV L+G
Sbjct: 12 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV 67
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
EE G + +V +YMA G+L ++L + L L+ + + YL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEK 709
HRD+ N+L+ E AKVSDFGL+K + T K + PE R ++ + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTK 179
Query: 710 SDVYSFGVVLFEV 722
SDV+SFG++L+E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 68/192 (35%), Positives = 102/192 (53%), Gaps = 12/192 (6%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG V G G+ VAIK + SE EF E +++ KL H+ LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + +V +YM+NG L +L + K Q LE+C G+ YL + IHR
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-VKGSFGYLDPEYFRRQQLTEKS 710
D+ N L+D++ KVSDFGLS+ L+ + S++ K + PE + + KS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 711 DVYSFGVVLFEV 722
DV++FGV+++EV
Sbjct: 183 DVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 534 IGVGGFGKVYEGYI---DGK-TKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG V +G GK +VA+K G EF E ++++L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G C+ + ++LV + G L Y + +P E+ A G+ YL +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAYLE-SKHF-- 116
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSK-TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+HRD+ N+LL + +AK+SDFG+S+ G + +T + + PE + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 708 EKSDVYSFGVVLFEVL 723
KSDV+S+GV L+E
Sbjct: 177 SKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 18/211 (8%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
+IG G FG V +G G+ KVA+K N + F E +++KL HK+LV L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQ-KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
+G + +V + M+ G L L + + Q L+ + A G+ YL + ++HRD
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 653 VKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
+ NIL+ E AKVSDFGL++ G ++ + + VK + PE + ++ + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VK----WTAPEALKHKKFSSKSD 179
Query: 712 VYSFGVVLFEVLC----ARPALNVNLPKEQV 738
V+S+GV+L+EV P +++ KE V
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 534 IGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FGKV+ K VA+K +SE +FQ E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLY------------KGDKPG-LPWKQRLEICIGAA 634
G C E +++V++YM +G L L + PG L Q L I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
G+ YL A +HRD+ T N L+ + K+ DFG+S+ + + V
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ PE ++ T +SD++SFGVVL+E+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 533 VIGVGGFGKVYEG-YIDG---KTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG VY G ID K A+K N ++ + V +F E ++ H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 588 IGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
+G C +G ++V YM +G LR + + + K + + A+G+ YL A
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLR-NFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
+HRD+ N +LDE + KV+DFGL++ H T K ++ E + Q
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 705 QLTEKSDVYSFGVVLFEVLC--ARPALNVN 732
+ T KSDV+SFGV+L+E++ A P +V+
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/213 (33%), Positives = 111/213 (52%), Gaps = 27/213 (12%)
Query: 528 FSESHVI-----GVGGFGKV----YEGYIDGKTK-VAIKRSNPSSEQGVHEFQTEIEMLS 577
F E H+ G G FG V Y+ D + VA+K+ S+ + + +F+ EIE+L
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 578 KLRHKHLVSLIGFCEEDG--EMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICI 631
L+H ++V G C G + LV +Y+ G+LR++L K + L ++ L +IC
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQIC- 118
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
+G+ YL RY +HRD+ T NIL++ + K+ DFGL+K P + +
Sbjct: 119 ---KGMEYL-GSKRY--VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 692 S--FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
S F Y PE + + SDV+SFGVVL+E+
Sbjct: 173 SPIFWYA-PESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 528 FSESHVIGVGGFGKVYEGY--IDGKTKVAIKR---SNPSSEQGVHEFQTEIEMLSKLRHK 582
+ IG G G+VY+ GK +VAIK+ + E + EI ++ +H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGK-EVAIKKMRLRKQNKELII----NEILIMKDCKHP 75
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
++V E+ +V +YM G+L + + + + Q +C +GL YLH+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFG----LSKTGPNLNQTHVSTMVKGSFGYLDP 698
IHRD+K+ NILL + K++DFG L+K N ++V G+ ++ P
Sbjct: 135 QNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-----SVV-GTPYWMAP 185
Query: 699 EYFRRQQLTEKSDVYSFGVVLFE 721
E +R+ K D++S G++ E
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 534 IGVGGFGKVY--EGY----IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FGKV+ E Y K VA+K +S+ +F E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 588 IGFCEEDGEMILVYDYMANGT----LREH------LYKGDKPG-LPWKQRLEICIGAARG 636
G C E +I+V++YM +G LR H + +G++P L Q L I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
+ YL A +HRD+ T N L+ E K+ DFG+S+ + + V ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEVL 723
PE ++ T +SDV+S GVVL+E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 533 VIGVGGFGKVYEGY--IDGKT--KVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG+V G + GK VAIK SS++ +F TE ++ + H +++ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
G + ++++ +YM NG+L + L + D Q + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+HRD+ NIL++ KVSDFGLS+ + T+ + K + PE ++ T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 708 EKSDVYSFGVVLFEVL 723
SDV+SFG+V++EV+
Sbjct: 187 SASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 3e-23
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 534 IGVGGFGKVYEGYI--DGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FGKV GK KV +K+ + V TE +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 589 -GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ-RL---EICIGAARGLHYLHTG 643
F + + ++ LV +Y G L HL K + ++ R EI + L YLH
Sbjct: 60 YAF-QTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLA----LEYLH-- 110
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
II+RD+K NILLD K++DFGL+K + +T G+ YL PE
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFC-GTPEYLAPEVLLG 167
Query: 704 QQLTEKSDVYSFGVVLFEVLCARP 727
+ + D +S GV+L+E+L +P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKR-----SNPSSEQGVHEFQTEIEMLSKLR 580
N+ ++G G FG+VY Y +D ++A+K+ +P +++ V+ + EI++L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAARGLH 638
H+ +V G +D + + +YM G++++ L Y + K +I G+
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVE 118
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVSTMVKGSFGYL 696
YLH I+HRD+K NIL D K+ DFG SK + T + + V G+ ++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
PE + K+DV+S G + E+L +P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 10/197 (5%)
Query: 533 VIGVGGFGKVYEGYID--GKTK--VAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG+V+ G + G+ + VAIK P +E+ +F +E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
G + +++ +YM NG L ++L D + Q + + G A G+ YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL---SDMN 127
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-THVSTMVKGSFGYLDPEYFRRQQL 706
+HRD+ NIL++ E KVSDFGLS+ + + T+ ++ K + PE ++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 707 TEKSDVYSFGVVLFEVL 723
T SDV+SFG+V++EV+
Sbjct: 188 TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 61/192 (31%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ GY + TKVA+K P + V F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 594 DGEMILVYDYMANGTLREHLY--KGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + ++ +YMA G+L + L +G K LP + ++ A G+ Y+ R IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D++ N+L+ E K++DFGL++ + N+ K + PE T KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 712 VYSFGVVLFEVL 723
V+SFG++L+E++
Sbjct: 187 VWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 63/190 (33%), Positives = 101/190 (53%), Gaps = 6/190 (3%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ G +G TKVAIK P + F E +++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + +V ++M G+L + L +GD L Q +++ A G+ Y+ R IHRD+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
+ NIL+ + K++DFGL++ + N+ K + PE + T KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 714 SFGVVLFEVL 723
SFG++L E++
Sbjct: 188 SFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 7e-23
Identities = 70/234 (29%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ G +G TKVA+K P + F E +++ KLRH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + +V +YM+ G+L + L G+ L +++ A G+ Y+ R IHRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
++ NIL+ + K++DFGL++ + N+ K + PE + T KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 714 SFGVVLFEVLCA----RPALNVNLPKEQV--------------SLADWALHCQR 749
SFG++L E++ P +N EQV SL + L C +
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWK 241
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 534 IGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGV--HEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG V++ D + A+K+ + S E E +L+KL +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRV-YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
+ G++ +V +Y NG L + L LP Q I GL +LH+ I+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KIL 123
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
HRD+K+ N+ LD K+ D G++K N N +T+V G+ YL PE + E
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIV-GTPYYLSPELCEDKPYNE 180
Query: 709 KSDVYSFGVVLFEVLC 724
KSDV++ GVVL+E C
Sbjct: 181 KSDVWALGVVLYE-CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
H +G G +G+VYEG + ++ V EF E ++ +++H +LV L+G C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ ++ ++M G L ++L + ++ + L + + + YL + IHR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 128
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS---FGYLDPEYFRRQQLTE 708
D+ N L+ E KV+DFGLS+ L T G+ + PE + +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 709 KSDVYSFGVVLFEV 722
KSDV++FGV+L+E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-22
Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 27/214 (12%)
Query: 534 IGVGGFGKVYEGYIDGK--------TKVAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKH 583
+G G FG+V G TKVA+K + ++E+ + + +E+EM+ + +HK+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW--------------KQRLEI 629
+++L+G C +DG + ++ +Y + G LRE+L PG+ + K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
ARG+ YL A IHRD+ N+L+ E K++DFGL++ +++ +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ ++ PE + T +SDV+SFGV+L+E+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 80/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 533 VIGVGGFGKVYEGYI---DGKT-KVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
++G G FG V EG + DG KVA+K + + + + EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 587 LIGFCEEDGEM------ILVYDYMANGTLREHLYK---GDKP-GLPWKQRLEICIGAARG 636
LIG C E + +++ +M +G L L G P LP + L+ + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT---GPNLNQTHVSTM-VKGS 692
+ YL IHRD+ N +L E V+DFGLSK G Q ++ M VK
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPALNVNLPKEQVSLADWALHCQRM 750
++ E + T KSDV++FGV ++E+ P V E + D+ H R+
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV----ENHEIYDYLRHGNRL 234
Query: 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
ED CL + + C DRP+ + LE
Sbjct: 235 KQPED-------------CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ GY +G TKVAIK S F E ++ +L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + ++ +YM NG+L + L + L + +++ A G+ ++ R IHRD+
Sbjct: 73 E-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
+ NIL+ E K++DFGL++ + N+ K + PE T KSDV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 714 SFGVVLFEVL 723
SFG++L E++
Sbjct: 188 SFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 533 VIGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G +G VY+ + + VAIK E+ + E EI +L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
++ ++ +V +Y G++ + + +K L ++ I +GL YLH IHR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK-----GSFGYLDPEYFRRQQL 706
D+K NILL+E+ +AK++DFG+S TM K G+ ++ PE +
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 707 TEKSDVYSFGVVLFEVLCARP 727
K+D++S G+ E+ +P
Sbjct: 177 NNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 527 NFSESHVIGVGGFGKVY--EGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHK 582
+ + V+G G FG V+ D K V IK+ ++ Q E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQK-LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
+++ ED +++V +Y GTL E++ K L L + LH++HT
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 643 GARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I+HRD+KT NILLD+ K K+ DFG+SK L+ + V G+ Y+ PE
Sbjct: 120 ---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELC 173
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALN-VNLP 734
+ +KSD+++ G VL+E+ + A NLP
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 534 IGVGGFGKVYEGYI-------DGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKH 583
+G G FG+VYEG G +VA+K + E+ EF E ++S H +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK-----PGLPWKQRLEICIGAARGLH 638
+V L+G C + ++ + M G L +L P L K+ L+IC+ A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEA-----KVSDFGLSKTGPNLNQTHVSTMVKGSF 693
YL + IHRD+ N L+ EK K+ DFGL++ +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC----ARPALN 730
++ PE + T +SDV+SFGV+++E+L PALN
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 10/195 (5%)
Query: 534 IGVGGFGKVYEGYID---GKT-KVAIKRSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG V G GK VA+K + +F E ++ L H++L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G +++V + G+L + L K + + A G+ YL +
Sbjct: 63 GVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-VKGSFGYLDPEYFRRQQLT 707
IHRD+ NILL + K+ DFGL + P +V +K F + PE R + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 708 EKSDVYSFGVVLFEV 722
SDV+ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 533 VIGVGGFGKVYEGYIDGKTK--VAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG+VY+ ID +T VAIK + +E + + Q EI+ LS+ R ++ G
Sbjct: 8 CIGKGSFGEVYKA-IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPG-LPWKQRLEICIGAARGLHYLHTGARYTI 648
+ ++ ++ +Y G+ + L KPG L I GL YLH +
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEEGK--- 119
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
IHRD+K NILL E+ + K++DFG+S + +T V F ++ PE ++ E
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS-GQLTSTMSKRNTFVGTPF-WMAPEVIKQSGYDE 177
Query: 709 KSDVYSFGVVLFEVLCARPAL 729
K+D++S G+ E+ P L
Sbjct: 178 KADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 62/189 (32%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ G +G T+VAIK P + F E +++ KLRH+ LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + +V +YM+ G+L + L L Q +++ A G+ Y+ R +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
+ NIL+ E KV+DFGL++ + N+ K + PE + T KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 714 SFGVVLFEV 722
SFG++L E+
Sbjct: 188 SFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 533 VIGVGGFGKVYEG---YIDG---KTKVAIK-RSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G FG+VYEG DG + +VA+K SEQ +F E ++SK H+++V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 586 SLIGFCEEDGEMILVYDYMANGT----LREHLYKGDKPG-LPWKQRLEICIGAARGLHYL 640
LIG E ++ + MA G LRE+ + ++P L K L A+G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 641 HTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGLSKT--GPNLNQTHVSTM--VKGSF 693
+ IHRD+ N LL K AK++DFG+++ + + M +K
Sbjct: 133 EE-NHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK--- 186
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
++ PE F T K+DV+SFGV+L+E+
Sbjct: 187 -WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-21
Identities = 64/229 (27%), Positives = 117/229 (51%), Gaps = 27/229 (11%)
Query: 534 IGVGGFGKVYEGYIDGKTK--------VAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKH 583
+G G FG+V G K VA+K + ++++ + + +E+EM+ + +HK+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG--------------LPWKQRLEI 629
+++L+G C +DG + ++ +Y + G LRE+L PG L +K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
ARG+ YL A IHRD+ N+L+ E K++DFGL++ N++ +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
+ ++ PE + T +SDV+SFGV+L+E+ + +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 533 VIGVGGFGKVYEGY--IDG---KTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
V+G G FG VY+G +G K VAIK +S + E E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L+G C ++ L+ M G L +++ + K + + L C+ A+G+ YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
++HRD+ N+L+ K++DFGL+K + + + K ++ E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 707 TEKSDVYSFGVVLFEVLC--ARPALNVNL 733
T KSDV+S+GV ++E++ A+P +
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPA 217
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIGF 590
IG G +G VY+ VAIK+ E EI++L +L H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
G++ LV+++M + L L K + GLP +GL + H + I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDL-YKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTH-VSTMVKGSFGYLDPE-YFRRQQL 706
RD+K N+L++ + K++DFGL+++ P TH V T Y PE +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176
Query: 707 TEKSDVYSFGVVLFEVLCARP 727
+ D++S G + E+L RP
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 534 IGVGGFGKVYEGYIDGKTK--------VAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKH 583
+G G FG+V G K VA+K + ++E+ + + +E+EM+ + +HK+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW--------------KQRLEI 629
+++L+G C +DG + ++ +Y + G LRE+L PG+ + K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
ARG+ YL A IHRD+ N+L+ E K++DFGL++ N++ +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ ++ PE + T +SDV+SFGV+++E+
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 534 IGVGGFGKVY--EGY----IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FGKV+ E Y K VA+K + +FQ E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 588 IGFCEEDGEMILVYDYMANGT----LREH------LYKGD----KPGLPWKQRLEICIGA 633
G C + +I+V++YM +G LR H L G K L Q L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
A G+ YL A +HRD+ T N L+ K+ DFG+S+ + + V
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ PE ++ T +SDV+SFGV+L+E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 533 VIGVGGFGKVYEGYI--DG-KTKVAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKHLVSL 587
VIG G FG+V I DG K AIK +SE +F E+E+L KL H ++++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYK--------------GDKPGLPWKQRLEICIGA 633
+G CE G + + +Y G L + L K G L +Q L+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV-STMVKGS 692
A G+ YL + IHRD+ N+L+ E +K++DFGLS+ + +V TM +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVKKTMGRLP 181
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ E T KSDV+SFGV+L+E++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 58/215 (26%), Positives = 112/215 (52%), Gaps = 27/215 (12%)
Query: 532 HVIGVGGFGKVYEG-YID-----GKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKL-RHK 582
+G G FG+V + + + VA+K + + ++E+ + + +E+EM+ + +HK
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHK 76
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHL---------YKGDKPGLPWKQR-----LE 628
++++L+G C ++G + +V +Y A+G LR+ L D P P + +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688
ARG+ +L A IHRD+ N+L+ E K++DFGL++ +++ +T
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 689 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ ++ PE + T +SDV+SFGV+L+E+
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 12/192 (6%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG V+ G + KVAIK SE+ +F E +++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + +V ++M NG L +L + + L L +C G+ YL R + IHR
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-VKGSFGYLDPEYFRRQQLTEKS 710
D+ N L+ KVSDFG+++ L+ + S+ K + PE F + + KS
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 711 DVYSFGVVLFEV 722
DV+SFGV+++EV
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 533 VIGVGGFGK--VYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLI 588
V+G G FG+ +Y D + V K N + SE+ + EI +LS L+H ++++
Sbjct: 7 VLGKGAFGEATLYRRTEDD-SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
+D +++ +Y GTL + + + + L + Y+H + I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
+HRD+KT NI L + K+ DFG+SK + T+V G+ Y+ PE + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 709 KSDVYSFGVVLFEVLCARPALNV-NLPK 735
KSD+++ G VL+E+L + + N
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSLIGFC 591
++G G FG+V++G + KT VA+K Q + +F +E +L + H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + +V + + G L K K L KQ ++ + AA G+ YL + IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG-SFGYLDPEYFRRQQLTEKS 710
D+ N L+ E K+SDFG+S+ + + S+ +K + PE + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 711 DVYSFGVVLFEV----LCARPALNVNLPKEQV 738
DV+S+G++L+E +C P + +EQV
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 526 RNFSESHVIGVGGFGKV----YEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLS 577
R + V+G G FGKV Y+ DG ++ +KR +Q ++ EI +L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILK 61
Query: 578 KLRHKHLVSLIGFCEEDGEMI--LVYDYMANGTLREHLYKGDKPGLPWKQRL----EICI 631
L H+++V G C E G L+ +Y+ G+LR++L K K L Q L +IC
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNL--AQLLLFAQQIC- 117
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH-VSTMVK 690
G+ YLH+ Y IHRD+ N+LLD K+ DFGL+K P ++ + V
Sbjct: 118 ---EGMAYLHS-QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ E + + + SDV+SFGV L+E+L
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 27/211 (12%)
Query: 533 VIGVGGFGKVYEGYI--DG-KTKVAIKRSNPSSEQGVH-EFQTEIEMLSKL-RHKHLVSL 587
VIG G FG+V + I DG + AIKR + + H +F E+E+L KL H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKG--------------DKPGLPWKQRLEICIGA 633
+G CE G + L +Y +G L + L K L +Q L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV-STMVKGS 692
ARG+ YL ++ IHRD+ NIL+ E + AK++DFGLS+ + +V TM +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMGRLP 186
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ E T SDV+S+GV+L+E++
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 98/326 (30%), Positives = 137/326 (42%), Gaps = 58/326 (17%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQ---TEIEMLSKLRHK 582
F++ IG G FG VY D +T VAIK+ + S +Q ++Q E+ L +LRH
Sbjct: 17 FTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 583 HLVSLIGFCEEDGEMILVYDYM---ANGTLREHLYKGDKPGLPWKQRLEI---CIGAARG 636
+ + G + LV +Y A+ L H K L Q +EI C GA +G
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVH-----KKPL---QEVEIAAICHGALQG 127
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L YLH+ + IHRD+K NILL E K++DFG S + + + V T ++
Sbjct: 128 LAYLHS---HERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPY-----WM 178
Query: 697 DPEY---FRRQQLTEKSDVYSFGVVLFEVLCARPAL-NVNLPKEQVSLADWALHCQRMGT 752
PE Q K DV+S G+ E+ +P L N+N A AL+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALY-----H 225
Query: 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDK 812
I P L N R F + CL DRPS + L F L++ P
Sbjct: 226 IAQNDSPTLSSNDWSDYFRNFV---DSCLQKIPQDRPS-SEELLKHRFV--LRERPPTVI 279
Query: 813 LISIQTDKA------NDTYAMHKAML 832
+ IQ K N Y K +L
Sbjct: 280 IDLIQRTKDAVRELDNLQYRKMKKIL 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 42/222 (18%)
Query: 534 IGVGGFGKVYEGYIDG------KTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
IG G FG+V++ G T VA+K +S +FQ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHL--------------------YKGDKPGLPWKQR 626
L+G C M L+++YMA G L E L + L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 627 LEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686
L I A G+ YL + +HRD+ T N L+ E K++DFGLS+ + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSA 183
Query: 687 TMVKGS------FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
K S ++ PE + T +SDV+++GVVL+E+
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 80/291 (27%), Positives = 127/291 (43%), Gaps = 53/291 (18%)
Query: 534 IGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQG-VHEFQTEIEMLSKLRHKHLVS 586
+G G FG VYEG G +T+VAIK N ++ EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYK-------GDKPGLPWKQR-LEICIGAARGLH 638
L+G ++V + MA G L+ +L G P Q+ +++ A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL-- 696
YL A+ +HRD+ N ++ E K+ DFG+++ ++ +T KG G L
Sbjct: 134 YLA--AKK-FVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYR--KGGKGLLPV 185
Query: 697 ---DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPALNVNLPKEQVSLADWALHCQRMG 751
PE + T KSDV+SFGVVL+E+ L +P L E+V
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ--GLSNEEV------------- 230
Query: 752 TIEDIIDPNLKGNITDQ---CLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
++ +ID G D C K E C RP+ +++ +L+
Sbjct: 231 -LKFVID----GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 27/211 (12%)
Query: 533 VIGVGGFGKVYEGYI--DG-KTKVAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKHLVSL 587
VIG G FG+V + I DG + AIKR +S+ +F E+E+L KL H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYK--------------GDKPGLPWKQRLEICIGA 633
+G CE G + L +Y +G L + L K L +Q L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV-STMVKGS 692
ARG+ YL ++ IHRD+ NIL+ E + AK++DFGLS+ + +V TM +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMGRLP 174
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ E T SDV+S+GV+L+E++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 64/200 (32%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 534 IGVGGFGKVY------EGYIDGKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVS 586
+G G FGKV EG G+ +VA+K P S + + + EIE+L L H+++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGE-QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 587 LIGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
G C EDG + L+ +++ +G+L+E+L + +K + KQ+L+ + +G+ YL G+
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRR 703
R +HRD+ N+L++ + + K+ DFGL+K + V + + PE +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 704 QQLTEKSDVYSFGVVLFEVL 723
+ SDV+SFGV L+E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 534 IGVGGFGKVYEGYIDGKTKV-AIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G GGFG+V + K+ A K+ + +G E ++L K+ + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICIGAARGLHYLHTGAR 645
E ++ LV M G L+ H+Y +PG P + + +I GL +LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC----GLEHLH---Q 113
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
I++RD+K N+LLD+ ++SD GL+ + G+ GY+ PE + +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170
Query: 706 LTEKSDVYSFGVVLFEVLCAR 726
D ++ G L+E++ R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 70/253 (27%), Positives = 107/253 (42%), Gaps = 53/253 (20%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEF-QT---EIEMLSKLRHKHLVSL 587
IG G +G+VY+ + KT VA+K+ E F T EI++L KLRH ++V L
Sbjct: 7 IGEGTYGQVYKA-RNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 588 IGFCEED--GEMILVYDYMA---NGTLREHLYKGDKPGLP--WKQRLEICIGAARGLHYL 640
G + +V++YM G L K + + KQ LE GL YL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYL 116
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL----SKTGPNLNQTHVSTMVKGSFGYL 696
H+ I+HRD+K +NIL++ K++DFGL +K V T+ Y
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL-----WYR 168
Query: 697 DPE-------YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749
PE Y + D++S G +L E+ +P + EQ+ +
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI-----FEL 217
Query: 750 MGTIEDIIDPNLK 762
G+ D P +
Sbjct: 218 CGSPTDENWPGVS 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 534 IGVGGFGKVYEGYI-----DGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G FGK+Y+G++ D VAIK + ++ Q EFQ E ++++L H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLY----------KGDKPG-----LPWKQRLEICIG 632
+G ++ + ++++Y+ G L E L D+ G L L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
A G+ YL + + +H+D+ NIL+ E+ K+SD GLS+ + + V
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ PE + + SD++SFGVVL+E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKR----SNPSSEQG--VHEFQTEIEMLSKL 579
+ + +G G F Y+ + T +A+K+ N SSEQ V + EI ++++L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI--CIGAARGL 637
H H++ ++G ED L ++MA G++ L K +K+ + I RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGL 116
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWE-AKVSDFGLSK------TGPNLNQTHVSTMVK 690
YLH IIHRDVK N+L+D + +++DFG + TG Q +
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL---- 169
Query: 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALN 730
G+ ++ PE R +Q DV+S G V+ E+ A+P N
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 531 SHVIGVGGFGKVY------EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+ IG G FGKVY G + ++ I+ ++P + + + + E+++L L+H +L
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLELLKHPNL 61
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA-----ARGLHY 639
V G ++ + +Y + GTL E L G + E I GL Y
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAY 114
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG---YL 696
LH+ I+HRD+K NI LD K+ DFG + N N T + V+ G Y+
Sbjct: 115 LHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-NTTTMGEEVQSLAGTPAYM 170
Query: 697 DPEYFRRQQLTEK---SDVYSFGVVLFEVLCARP 727
PE + +D++S G V+ E+ +
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 533 VIGVGGFGKVYEGYI----DGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVS 586
IG G FG V + + DGK + K + +E+ + +E+ +L +L+H ++V
Sbjct: 7 TIGKGSFGTVRK--VRRKSDGKI-LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 587 LIG--FCEEDGEMILVYDYMANGTLREHL--YKGDKPGLP----WKQRLEICIGAARGLH 638
+ + +V +Y G L + + K ++ + W+ ++ + L+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LY 119
Query: 639 YLHTG--ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFG 694
H T++HRD+K NI LD K+ DFGL+K L T V G+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK---ILGHDSSFAKTYV-GTPY 175
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 725
Y+ PE EKSD++S G +++E LCA
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYE-LCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 43/245 (17%)
Query: 527 NFSESHVIGVGGFGKVY-------EGYI----------DGKTKVAIKRSNPS-SEQGVHE 568
NF E +G G FG+V+ + + D VA+K P S+ +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 569 FQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK---------GDKP 619
F E+++LS+L ++ L+G C D + ++ +YM NG L + L K +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 620 GLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679
L + L + A G+ YL +HRD+ T N L+ + + K++DFG+S+ N
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---N 179
Query: 680 LNQTHVSTMVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPALNVNL 733
L + V+G ++ E + T KSDV++FGV L+E+ LC L
Sbjct: 180 LYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH-L 237
Query: 734 PKEQV 738
+QV
Sbjct: 238 TDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKR-----SNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FG VYEG +D A+K + ++ V + + EI +LSKL+H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW-----KQRLEICIGAARGLHYLHT 642
+G E+ + + + + G+L + L K P +Q L GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLHD 120
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-----VKGSFGYLD 697
+HRD+K NIL+D K++DFG++K V KGS ++
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMA 169
Query: 698 PEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 727
PE +Q +D++S G + E+ +P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 533 VIGVGGFGKVYEG-YI---DGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSL 587
IG G FG VY+G Y+ + K VA+K + V E F E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
IG E+ + +V + G LR +L +K L + + L YL R+
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLE-SKRF- 128
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG-----YLDPEYFR 702
+HRD+ N+L+ K+ DFGLS+ + K S G ++ PE
Sbjct: 129 -VHRDIAARNVLVSSPDCVKLGDFGLSRY------LEDESYYKASKGKLPIKWMAPESIN 181
Query: 703 RQQLTEKSDVYSFGVVLFEVL 723
++ T SDV+ FGV ++E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-19
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 30/282 (10%)
Query: 530 ESHVIGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
E +VI G G Y+G I + +K N + +EI + KL+H ++V LI
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLI 749
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G C + L+++Y+ L E L L W++R +I IG A+ L +LH +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
+ ++ I++D K E L + P L T + S Y+ PE + +TE
Sbjct: 805 VVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCFI--SSAYVAPETRETKDITE 857
Query: 709 KSDVYSFGVVLFEVLCAR----PALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764
KSD+Y FG++L E+L + V+ S+ +WA +C ++ IDP+++G+
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVH-----GSIVEWARYCYSDCHLDMWIDPSIRGD 912
Query: 765 ITDQCLRKFTET---AEKCLSDQGIDRPSMGDVLWNLEFALQ 803
++ + E A C + RP DVL LE A +
Sbjct: 913 VSVN-QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 13/211 (6%)
Query: 533 VIGVGGFGKVYEGYI--DG---KTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
++G G FG V++G +G K VAIK + S Q E + + L H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L+G C + LV G+L +H+ + + L ++ L C+ A+G++YL +
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLE---EH 128
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
++HR++ NILL +++DFG++ ++ + + K ++ E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 707 TEKSDVYSFGVVLFEVLC--ARPALNVNLPK 735
T +SDV+S+GV ++E++ A P + +
Sbjct: 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGF 590
VIGVG VY + KVAIKR + Q V E + E++ +S+ H ++V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 591 CEEDGEMILVYDYMANGTLRE---HLYKGDKPGLPWKQRLEICIGAA-----RGLHYLHT 642
E+ LV Y++ G+L + Y GL E I +GL YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG--GLD-----EAIIATVLKEVLKGLEYLH- 119
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTHVSTMVKGSFGYLDPEY 700
IHRD+K NILL E K++DFG+S + V G+ ++ PE
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 701 FRRQQ-LTEKSDVYSFGVVLFE 721
+ K+D++SFG+ E
Sbjct: 178 MEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 9e-19
Identities = 57/214 (26%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 534 IGVGGFGKVY--EGY------IDGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKH 583
+G G FG+V E Y D VA+K + ++++ + + +E+E++ + +HK+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG--------------LPWKQRLEI 629
+++L+G C ++G + ++ +Y A G LRE L PG L +K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
ARG+ YL + IHRD+ N+L+ E K++DFGL++ +++ ++
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ ++ PE + T +SDV+SFG++++E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 9e-19
Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 32/273 (11%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHL 584
F++ IG G FG+V++G ID +T+ VAIK + +E + + Q EI +LS+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG-LPWKQRLEICIGAARGLHYLHTG 643
G +D ++ ++ +Y+ G+ + L +PG L Q I +GL YLH+
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE 120
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS-TMVKGSFGYLDPEYFR 702
+ IHRD+K N+LL E E K++DFG++ L T + G+ ++ PE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762
+ K+D++S G+ E+ P + P + + L I P L+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------------IPKNNPPTLE 222
Query: 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
GN + + E E CL+ + RP+ ++L
Sbjct: 223 GNYS----KPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSL 587
+IG G F V + + AIK + E+ V + E E+L++L H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARY 646
+++ + V +Y NG L +++ K L K L YLH+ G
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG--- 122
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSK----TGPNLNQTHVSTMV----------KGS 692
IIHRD+K NILLD+ K++DFG +K + +T + S
Sbjct: 123 -IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 693 F-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
F G Y+ PE + + SD+++ G +++++L +P
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 47/229 (20%)
Query: 534 IGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
I G +G+V+ + G KV IK+++ + V + TE ++LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKV-IKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58
Query: 589 GFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA-----AR------ 635
+ G+ + LV +Y+ G L L +G+ AR
Sbjct: 59 -YYSFQGKKNLYLVMEYLPGGDLA---------------SLLENVGSLDEDVARIYIAEI 102
Query: 636 --GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK--- 690
L YLH IIHRD+K NIL+D K++DFGLSK G Q +++ K
Sbjct: 103 VLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 691 ---GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736
G+ Y+ PE Q ++ D +S G +L+E L P + P+E
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 41/277 (14%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKR-----SNPSSEQGVHEFQTEIEMLSKLR 580
N+ ++G G FG+VY Y D ++A+K+ +P + + V+ + EI++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 581 HKHLVSLIGFCEEDGEMIL--VYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAARG 636
H+ +V G + E L ++M G++++ L Y + K +I G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EG 118
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-VKGSFGY 695
+ YLH+ I+HRD+K NIL D K+ DFG SK + + V G+ +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755
+ PE + K+D++S G + E+L +P WA + M I
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP--------------WA-EFEAMAAIFK 220
Query: 756 I----IDPNLKGNITDQCL----RKFTETAEKCLSDQ 784
I +P L +++D C R F E + +D+
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 534 IGVGGFGKVYEGYIDGKTK---VAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSLIG 589
+G G FG V +G + K VAIK +E+ V E E E++ +L + ++V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
CE + M LV + + G L + L G K + +E+ + G+ YL +
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
HRD+ N+LL + AK+SDFGLSK G + + + K + PE ++ +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 709 KSDVYSFGVVLFEVL 723
+SDV+S+G+ ++E
Sbjct: 178 RSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 533 VIGVGGFGKVYEGY------IDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FGKV + G T VA+K + N SS + + + +E +L ++ H H+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVNHPHV 65
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG----------------------LP 622
+ L G C +DG ++L+ +Y G+LR L + K G L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
+ +RG+ YL A ++HRD+ N+L+ E + K+SDFGLS+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-----DV 177
Query: 683 THVSTMVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ VK S G ++ E T +SDV+SFGV+L+E++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 42/284 (14%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKR-----SNPSSEQGVHEFQTEIEMLSKLR 580
N+ ++G G FG+VY Y +D ++A K+ +P + + V + EI++L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 581 HKHLVSLIGFCEEDGE--MILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAARG 636
H+ +V G + E + + +YM G++++ L Y + K +I G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-VKGSFGY 695
+ YLH+ I+HRD+K NIL D K+ DFG SK + + V G+ +
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755
+ PE + K+DV+S G + E+L +P WA + + M I
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP--------------WAEY-EAMAAIFK 220
Query: 756 I----IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
I +P L +I++ R F C+ + RPS ++L
Sbjct: 221 IATQPTNPQLPSHISEHA-RDFL----GCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
+G G FGKVY+ + + A K SE+ + +F EI++LS+ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
+ ++ ++ ++ G L + + ++ L Q +C L++LH + +IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY-----FRRQQLT 707
+K NILL + K++DFG+S + Q T + G+ ++ PE F+
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 708 EKSDVYSFGVVLFEVLCARP 727
K+D++S G+ L E+ P
Sbjct: 187 YKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-18
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 34/268 (12%)
Query: 552 KVAIK--RSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLI--GFCEEDGEMILVYDYMAN 606
+VAIK R++ P E F+ E + ++L H ++V+L+ G G + V++Y+
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVPG 63
Query: 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEK 663
TLRE L D LP + + + L H I+HRD+K NI++ +
Sbjct: 64 RTLREVL-AADGA-LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118
Query: 664 WEAKVSDFGLSKTGPNLNQTHVSTM-----VKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 718
AKV DFG+ P + V+T+ V G+ Y PE R + +T SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 719 LFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAE 778
E L + + + S+A+ + Q++ ++ + P + G+ Q LRK
Sbjct: 179 FLECLTGQRVV------QGASVAE--ILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDP 230
Query: 779 KCLSDQGIDRPSMGDVLWNLEFALQLQD 806
+ R + L AL+L
Sbjct: 231 R-------QRAASAPALAERFRALELCA 251
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 36/271 (13%)
Query: 534 IGVGGFGKVY--EGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G +G VY + D + A+K + S++ + EI +L+ + H ++ I
Sbjct: 8 LGKGSYGSVYKVKRLSDNQF-YALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---IS 63
Query: 590 FCEE--DG-EMILVYDYMANGTLREHLYKGDKPGLPWKQRL--EICIGAARGLHYLHTGA 644
+ E DG ++ +V +Y G L + + K K ++ I I RGL LH
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-- 121
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
I+HRD+K+ NILL K+ D G+SK L + T + G+ Y+ PE ++ +
Sbjct: 122 -QKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQI-GTPHYMAPEVWKGR 176
Query: 705 QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764
+ KSD++S G +L+E+ P P E S+ D L + I P +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAP------PFEARSMQD--LRYKVQRGKYPPIPPIYSQD 228
Query: 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ + L + RP+ +L
Sbjct: 229 LQNFI--------RSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 21/263 (7%)
Query: 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG+V+ G + T VA+K + + +F E +L + H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + +V + + G L + + P L K+ +++ AA G+ YL + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D+ N L+ EK K+SDFG+S+ + M + + PE + + +SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 712 VYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLR 771
V+SFG++L+E NL +Q + I+ ++ + C
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQT---------------REAIEQGVRLPCPELCPD 223
Query: 772 KFTETAEKCLSDQGIDRPSMGDV 794
E+C RPS V
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 28/225 (12%)
Query: 534 IGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVS 586
+G G FG VYEG G +T+VAIK N + S + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYK-----GDKPGL---PWKQRLEICIGAARGLH 638
L+G + +++ + M G L+ +L + P K+ +++ A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG---- 694
YL+ +HRD+ N ++ E + K+ DFG+++ ++ +T KG G
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR--KGGKGLLPV 185
Query: 695 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
++ PE + T SDV+SFGVVL+E+ + EQV
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 47/151 (31%), Positives = 84/151 (55%), Gaps = 7/151 (4%)
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI 631
E+++L K ++V G +G++ + +YM G+L + + K + +P + +I +
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAV 107
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
+GL YLH ++ IIHRDVK +NIL++ + + K+ DFG+S L + T V G
Sbjct: 108 AVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV-G 161
Query: 692 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
+ Y+ PE + + KSD++S G+ L E+
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 533 VIGVGGFGKVYEGYID--GKTK--VAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG+V G + GK + VAIK +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
G + ++++ ++M NG L L + D Q + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVSTM-VKGSFGYLDPEYFRRQ 704
+HRD+ NIL++ KVSDFGLS+ + T+ S++ K + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ T SDV+S+G+V++EV+
Sbjct: 187 KFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 38/278 (13%)
Query: 526 RNFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSN-PSSEQGVHEFQTEIEMLSKLRHK 582
F++ IG G FG+VY+G ID +TK VAIK + +E + + Q EI +LS+
Sbjct: 4 ELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL--EICIGAARGLHYL 640
++ G + ++ ++ +Y+ G+ + L KPG P ++ I +GL YL
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPG-PLEETYIATILREILKGLDYL 117
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDP 698
H+ + IHRD+K N+LL E+ + K++DFG++ L T + +T V F ++ P
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPF-WMAP 170
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR-MGTIEDII 757
E ++ K+D++S G+ E+ P + LH R + I
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNS-------------DLHPMRVLFLIPKNS 217
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
P L+G Q + F E E CL+ RP+ ++L
Sbjct: 218 PPTLEG----QYSKPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 55/217 (25%), Positives = 108/217 (49%), Gaps = 25/217 (11%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTKVAIKR-----SNP-SSEQGVHEFQTEIEMLSKLRH 581
+++ V+G G +G VY G + +A+K+ SN ++E+ + Q E+++L L+H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK-GDKPGLPW----KQRLEICIGAARG 636
++V +G C +D + + +++ G++ L + G P + KQ L+ G
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------G 114
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK----TGPNLNQTHVSTMVKGS 692
+ YLH ++HRD+K N++L K+ DFG ++ G + +++ + G+
Sbjct: 115 VAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPAL 729
++ PE KSD++S G +FE+ +P L
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 30/213 (14%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSN-PSSEQGVHE---------FQTEIEMLSKLRH 581
+IG G +G+VY + +A+K+ P++ G H+ ++EIE L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGT----LREHLYKGDKPGLPW--KQRLEICIGAAR 635
++V +GF + + + +Y+ G+ LR + + ++ + + +Q LE
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLE------- 119
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
GL YLH+ I+HRD+K N+L+D K+SDFG+SK ++ + ++GS +
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 696 LDPE--YFRRQQLTEKSDVYSFGVVLFEVLCAR 726
+ PE + Q + K D++S G V+ E+ R
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 533 VIGVGGFGKV--YEGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
V+G G +G+V DGK V IK+ N +S + + E ++LS+L+H ++V+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 589 GFCE-EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
E EDG + +V + G L L + LP Q +E + A L YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKH 122
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
I+HRD+KT N+ L KV D G+++ N Q +++ + G+ Y+ PE F +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPYN 180
Query: 708 EKSDVYSFGVVLFEVLCARPALN 730
KSDV++ G ++E+ + A N
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 533 VIGVGGFGKVYEGYI--DGKT---KVAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVS 586
V+G G FG VY+G +G+T VAIK N ++ + EF E +++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L+G C + LV M +G L +++++ K + + L C+ A+G+ YL
Sbjct: 74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 128
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
++HRD+ N+L+ K++DFGL++ + + + K ++ E ++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 707 TEKSDVYSFGVVLFEVL 723
T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 534 IGVGGFGKVYEGYIDGKTKV-AIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G GGFG+V + K+ A K+ N +G E +L+K+ + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDK--PGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ ++ LV M G LR H+Y D+ PG P + GL +LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLS---KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
II+RD+K N+LLD ++SD GL+ K G + + + G+ G++ PE + +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQGE 172
Query: 705 QLTEKSDVYSFGVVLFEVLCAR 726
+ D ++ GV L+E++ AR
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 533 VIGVGGFGKVYEGYIDGKTK----VAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG+V G + K VAIK +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
G + +++V +YM NG+L L K D Q + + G A G+ YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
+HRD+ NIL++ KVSDFGLS+ + + + K + PE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 707 TEKSDVYSFGVVLFEVL 723
T SDV+S+G+V++EV+
Sbjct: 187 TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHL 584
F++ IG G FG+V++G ID +T+ VAIK + +E + + Q EI +LS+ ++
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
G + ++ ++ +Y+ G+ + L G L+ + +GL YLH+
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEK 121
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEYFR 702
+ IHRD+K N+LL E+ + K++DFG++ L T + +T V F ++ PE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPF-WMAPEVIQ 174
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR-MGTIEDIIDPNL 761
+ K+D++S G+ E+ P P +H R + I P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP------PNSD-------MHPMRVLFLIPKNNPPTL 221
Query: 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
G + + F E + CL+ RP+ ++L
Sbjct: 222 TGEFS----KPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 63/268 (23%), Positives = 122/268 (45%), Gaps = 36/268 (13%)
Query: 542 VYEGYIDGKTKVAI---KRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF----CEED 594
+Y+G + K +V I K+ + + + + EI+ L ++ +++ + GF ++
Sbjct: 36 IYKGIFNNK-EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654
+ L+ +Y G LRE L K + L +K +L++ I +GL+ L+ ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLT 150
Query: 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR--QQLTEKSDV 712
+ + L+ E ++ K+ GL K + +V+ MV Y + + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205
Query: 713 YSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED-IIDPNLKGNITDQCLR 771
YS GVVL+E+ +P E ++ + I D II+ N + C
Sbjct: 206 YSLGVVLWEIFTG------KIPFENLTTKE----------IYDLIINKNNSLKLPLDCPL 249
Query: 772 KFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ E C S I RP++ ++L+NL
Sbjct: 250 EIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 6/190 (3%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593
+G G FG+V+ + TKVA+K P S V F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653
+ + ++ ++MA G+L + L + P + ++ A G+ ++ + IHRD+
Sbjct: 73 E-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128
Query: 654 KTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVY 713
+ NIL+ K++DFGL++ + N+ K + PE T KSDV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 714 SFGVVLFEVL 723
SFG++L E++
Sbjct: 188 SFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
F + V+G GGFG+V + K+ +++ +G E ++L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICIGAARGLHY 639
+VSL E + LV M G L+ H+Y + G + + EIC G L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LED 117
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LH + I++RD+K NILLD+ ++SD GL+ P QT + V G+ GY+ PE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTVGYMAPE 171
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVL 723
+ ++ T D ++ G +L+E++
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 527 NFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHL 584
E +G G G V + + + A+K + + E+E+ + ++
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 585 VSLIGFC--EEDGEMILVYDYMANGTLREHLYK---------GDKPGLPWKQRLEICIGA 633
V G E + + +Y G+L + +YK G+K +I
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKV------LGKIAESV 114
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
+GL YLH+ IIHRD+K +NILL K + K+ DFG+S L + T SF
Sbjct: 115 LKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSF 168
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
Y+ PE + + + SDV+S G+ L EV
Sbjct: 169 -YMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 534 IGVGGFGKVYEGYI--DGKTKVAIKR-SNPSSEQGV-HEFQTEIEMLSKLRHKHLVSLIG 589
IG G G V++ G+T VA+K+ + E G+ ++ EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGET-VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
+LV +YM L E L ++P LP Q +G+ Y+H I+
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH-ANG--IM 121
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLS---KTGPNLNQTH-VSTMVKGSFGYLDPE-YFRRQ 704
HRD+K N+L+ K++DFGL+ +H V+T Y PE + +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAPELLYGAR 176
Query: 705 QLTEKSDVYSFGVVLFEVLCARP 727
+ D+++ G + E+L P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 527 NFSESHVIGVGGFGKVYEG--YIDGKT----KVAIKRSNPSSEQGVHE-FQTEIEMLSKL 579
N S +G G FGKV E Y K+ KVA+K P++ E +E++++S L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 580 -RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
H+++V+L+G C G ++++ +Y G L L + + L + L A+G+
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS----FG 694
+L A IHRD+ N+LL K+ DFGL++ N + + +VKG+
Sbjct: 156 FL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS----NYVVKGNARLPVK 208
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
++ PE T +SDV+S+G++L+E+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 46/219 (21%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQ--GVHEFQT---EIEMLSKLRHKHL 584
+G G + VY+ D +T VAIK + E G++ T EI++L +L+H ++
Sbjct: 8 LGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQELKHPNI 64
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA---------- 634
+ L+ + LV+++M T E + K DK I + A
Sbjct: 65 IGLLDVFGHKSNINLVFEFME--TDLEKVIK-DK---------SIVLTPADIKSYMLMTL 112
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTH-VSTMVKG 691
RGL YLH I+HRD+K N+L+ K++DFGL+++ PN TH V T
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-- 167
Query: 692 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPAL 729
Y PE F + D++S G + E+L P L
Sbjct: 168 ---YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 534 IGVGGFGK--VYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FGK + + DGK V IK N S S + E + E+ +LS ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
EE+G + +V DY G L + + P Q L+ + L ++H I+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKIL 123
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTE 708
HRD+K+ NI L + K+ DFG+++ LN T ++ G+ YL PE +
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 709 KSDVYSFGVVLFEVLCARPAL 729
KSD+++ G VL+E+ + A
Sbjct: 181 KSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 534 IGVGGFGKVYEGYIDGKTKV--AIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FGKVY+ + +T A K SE+ + ++ EIE+L+ H ++V L+G
Sbjct: 20 LGDGAFGKVYKAK-NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
DG++ ++ ++ G + + + D+ GL Q IC L YLH+ IIHR
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHS---MKIIHR 134
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE--- 708
D+K N+LL + K++DFG+S Q S + G+ ++ PE + + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPY 192
Query: 709 --KSDVYSFGVVLFEVLCARP 727
K+D++S G+ L E+ P
Sbjct: 193 DYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 537 GGFGKVYEG-YID---GKTKVAIKRS--NPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
G FG+++ G ID GK + ++ + +SE V E +L L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 591 CEEDGEMILV-YDYMANGTLREHLYK---GDKPG---LPWKQRLEICIGAARGLHYLHTG 643
C EDGE V Y YM G L+ L + G+ L +Q + + I A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT---------GPNLNQTHVSTMVKGSFG 694
+ +IH+D+ N ++DE+ + K++D LS+ G N N+ VK
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP-----VK---- 184
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFE 721
++ E ++ + SDV+SFGV+L+E
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 534 IGVGGFGKVYEGYI---DGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG V EG + D KVA+K + + + +F +E + + H +++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 589 GFCEEDGEM------ILVYDYMANGTLREHLYK---GDKPG-LPWKQRLEICIGAARGLH 638
G C + E +++ +M +G L L GD P LP + ++ A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698
YL + + IHRD+ N +L+E V+DFGLSK N + + K ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEV 722
E + T KSDV+SFGV ++E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 21/234 (8%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYE----GYIDGKTKVAIKRSNPS-SEQGVHEFQTEIEML 576
K G F E H+ G + + VA+K ++ ++F EI+++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK----------GDKPGLPWKQR 626
S+L++ +++ L+G C D + ++ +YM NG L + L + + P +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 627 LEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686
L + + A G+ YL A +HRD+ T N L+ + K++DFG+S+ + + +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPALNVNLPKEQV 738
++ E + T SDV++FGV L+E+ LC ++ L EQV
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL-LSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 42/264 (15%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRS--NPSSEQG---VHEFQTEIEMLSKLR 580
N+ ++G G FG+VY Y D ++A+K+ +P S++ V+ + EI++L LR
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 581 HKHLVSLIGFCEEDGE---MILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAAR 635
H +V G C D E + + +YM G++++ L Y + + +I +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN--LNQTHVSTMVKGSF 693
G+ YLH+ I+HRD+K NIL D K+ DFG SK ++ T + + V G+
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTP 173
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753
++ PE + K+DV+S + E+L +P WA + + M I
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP--------------WAEY-EAMAAI 218
Query: 754 EDI----IDPNLKGNITDQCLRKF 773
I P L ++D C R F
Sbjct: 219 FKIATQPTKPMLPDGVSDAC-RDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 527 NFSESHVIGVGGFGKVY--EGYIDGK---------TKVAIKRSNPSSEQGVHEFQTEIEM 575
+ IG G FGK+Y + D + TK+ +K S + E+ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--------KKEVIL 52
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
L+K++H ++V+ +E+G + +V +Y G L + + + Q L + +
Sbjct: 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWE-AKVSDFGLSKTGPNLNQT-HVSTMVKGSF 693
GL ++H I+HRD+K+ NI L + AK+ DFG+++ LN + ++ G+
Sbjct: 113 GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ---LNDSMELAYTCVGTP 166
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 725
YL PE + + K+D++S G VL+E LC
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRS-NPSSEQGVHEFQT---EIEMLSKLRHKHLVSLI 588
+G G +G VY+ VA+K+ + E+G+ T EI +L +L+H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHPNIVKLL 64
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
+ ++ LV++Y L+++L L I RGL Y H + I
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRI 119
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQ-THV 685
+HRD+K NIL++ K++DFGL++ G L TH
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 49/149 (32%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+ IG G +G VY+ D T VAIK Q EI ML + RH ++V
Sbjct: 5 YELIQRIGSGTYGDVYKA-RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
+ G ++ +V +Y G+L++ P L Q +C +GL YLH +
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHETGK 122
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLS 674
IHRD+K NILL E + K++DFG+S
Sbjct: 123 ---IHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
F + V+G GGFG+V + K+ +++ +G E ++L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICIGAARGLHY 639
+V+L E + LV M G L+ H+Y PG ++ L EI G L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LH R ++RD+K NILLD+ ++SD GL+ P G+ GY+ PE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPE 171
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVL 723
Q+ T D + G +++E++
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 26/225 (11%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKT------KVAIKRSNPSSEQGV-HEFQTE 572
EI T F E +G FGKVY+G++ G VAIK +E + EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 573 IEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLY--------------KGDK 618
M S+L+H ++V L+G ++ + +++ Y ++ L E L K K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 619 PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678
L + I A G+ +L + + ++H+D+ T N+L+ +K K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ + ++ PE + + SD++S+GVVL+EV
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK 578
E ++ E V+G G +G VY + + ++AIK + V EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 579 LRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHL------YKGDKPGLPW--KQRLEIC 630
L+H+++V +G E+G + + + G+L L K ++ + + KQ LE
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-- 119
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNLNQTHVSTMV 689
GL YLH I+HRD+K N+L++ K+SDFG SK +N +
Sbjct: 120 -----GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETF 169
Query: 690 KGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747
G+ Y+ PE + +D++S G + E+ +P + L + Q ++
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQAAMF------ 222
Query: 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
++G + I P + +++ + + F +C R S D+L
Sbjct: 223 -KVGMFK--IHPEIPESLSAEA-KNFI---LRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 12/194 (6%)
Query: 534 IGVGGFGKVYEGYID---GKTKVAIK-RSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSLI 588
+G G FG V +G + VA+K N +++ + E E ++ +L + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G CE + M LV + G L + L K + K E+ + G+ YL
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLE---ETNF 116
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+HRD+ N+LL + AK+SDFGLSK G + N T K + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 708 EKSDVYSFGVVLFE 721
KSDV+SFGV+++E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 17/161 (10%)
Query: 528 FSESHVIGVGGFGKVYEG--YIDGKTKVAIKRSN-PSSEQGVHEFQT-EIEMLSKLR--- 580
+ E IG G +G VY+ G+ VA+K+ P SE+G+ EI +L +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRF-VALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 581 HKHLVSLIGFC---EEDGEMI--LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
H ++V L+ C D E+ LV++++ + L +L K KPGLP + ++ R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676
G+ +LH+ I+HRD+K NIL+ + K++DFGL++
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 528 FSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRH---K 582
+ +IG G +G VY G + VA+K N + + V + Q E+ +LS+LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA-----RGL 637
++ G + + ++ +Y G++R + K G P ++ I L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAG-PIAEK---YISVIIREVLVAL 114
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
Y+H + +IHRD+K NIL+ K+ DFG++ N N + ST V G+ ++
Sbjct: 115 KYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-GTPYWMA 169
Query: 698 PEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756
PE + K+D++S G+ ++E+ P P V + M I
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNP------PYSDVDAF------RAMMLIPKS 217
Query: 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
P L+ N + LR+F CL ++ +R S ++L
Sbjct: 218 KPPRLEDNGYSKLLREFVAA---CLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 54/273 (19%)
Query: 553 VAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLRE 611
VA+K P +++ ++F E+++LS+L+ +++ L+G C ++ + ++ +YM NG L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 612 -----HLYKGDKPGLP------------WKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654
HL ++ G + L + + A G+ YL + +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA 165
Query: 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYS 714
T N L+ E K++DFG+S+ + + ++ E + T SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 715 FGVVLFEVLCARPALNVNLPKEQV--SLADWALHCQRMGTIEDIIDPNLKGNITDQ---- 768
FGV L+E+L L KEQ L D E +I+ N DQ
Sbjct: 226 FGVTLWEIL--------MLCKEQPYGELTD-----------EQVIE-NAGEFFRDQGRQV 265
Query: 769 -------CLRKFTETAEKCLSDQGIDRPSMGDV 794
C + E +C S +RPS D+
Sbjct: 266 YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 534 IGVGGFGKVYEGYI------DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVS 586
+G G FG VYEG + +T+VA+K N S S + EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLY-----KGDKPGLP---WKQRLEICIGAARGLH 638
L+G + ++V + MA+G L+ +L + PG P ++ +++ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG---- 694
YL+ +HRD+ N ++ + K+ DFG+++ ++ +T KG G
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIYETDYYR--KGGKGLLPV 185
Query: 695 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
++ PE + T SD++SFGVVL+E+ L EQV
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 533 VIGVGGFGKVY--EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FGKV + DGK KV K++ ++ H +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAARGLHYLHTGA 644
+ ++ V DY+ G L HL + ++ + R EI A L YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEI----ASALGYLHS-- 114
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
II+RD+K NILLD + ++DFGL K G ++T ST G+ YL PE R+Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFC-GTPEYLAPEVLRKQ 171
Query: 705 QLTEKSDVYSFGVVLFEVLCARP 727
D + G VL+E+L P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 73/271 (26%), Positives = 112/271 (41%), Gaps = 55/271 (20%)
Query: 511 GLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHE 568
G CR + F + + IG G +G VY D + VA+K+ +E+
Sbjct: 1 GRCRSVT---------EFEKLNRIGEGTYGIVYRAR-DTTSGEIVALKKVRMDNERDGIP 50
Query: 569 FQT--EIEMLSKLRHKHLVSL---------------IGFCEEDGEMILVYDYMANGTLRE 611
+ EI +L LRH ++V L + +CE+D +L D M E
Sbjct: 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT-PFSE 107
Query: 612 HLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671
K + + RGL YLH IIHRD+K +N+LL +K K++DF
Sbjct: 108 SQVKC------------LMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADF 152
Query: 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPALN 730
GL++T + +V + Y PE T D+++ G +L E+L +P L
Sbjct: 153 GLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210
Query: 731 VNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
EQ+ L Q +GT + I P
Sbjct: 211 GKSEIEQLDLI-----IQLLGTPNESIWPGF 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 45/281 (16%)
Query: 534 IGVGGFGKVY--EGYIDGKTKVAIKR---SNP-------SSEQGVHEFQTEIEMLSK-LR 580
+G G FG VY +G+ +A+K NP ++ + + +E+ ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLP----WKQRLEICIGAA 634
H ++V E+ + +V D + L EH K K W +++ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK-TGPNLNQTHVSTMVKGSF 693
L YLH R I+HRD+ NI+L E + ++DFGL+K P T V G+
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV----GTI 177
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753
Y PE + + EK+DV++FG +L+++ +P +SLA +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSLA--------TKIV 226
Query: 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDV 794
E + +P +G ++ T+ CL+ RP + V
Sbjct: 227 EAVYEPLPEGMYSED----VTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 528 FSESHVIGVGGFGKVY--EGYIDGKT-------KVAIKRSNPSSEQGVHEFQTEIEMLSK 578
F V+G GGFG+V + GK K IK+ +G E ++L K
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEK 56
Query: 579 LRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICIGAA 634
+ + +VSL E + LV M G L+ H+Y PG ++ + EI G
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG-- 114
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L LH R I++RD+K NILLD+ ++SD GL+ P +T + V G+ G
Sbjct: 115 --LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE-GET-IRGRV-GTVG 166
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
Y+ PE + ++ T D + G +++E++
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 52/297 (17%)
Query: 528 FSESHVIGVGGFGKVYEGYI----DGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRH 581
F+ ++G G FG V E + KVA+K +++ S + EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 582 KHLVSLIGFC---EEDGEM---ILVYDYMANGTLREHLYK---GDKP-GLPWKQRLEICI 631
+++ LIG G + +++ +M +G L L G++P LP + + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK---TGPNLNQTHVSTM 688
A G+ YL + IHRD+ N +L+E V+DFGLSK +G Q S +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 689 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747
VK +L E T SDV++FGV ++E++ + Q A
Sbjct: 178 PVK----WLALESLADNVYTTHSDVWAFGVTMWEIMT----------RGQTPYAG----- 218
Query: 748 QRMGTIE--DIIDPNLKGNITDQ---CLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+E +I + +KGN Q CL E +C S + RPS + LE
Sbjct: 219 -----VENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 533 VIGVGGFGKVYEGY--IDGKTKVAIKRSNPSS--EQG-------VHEFQTEIEMLSKLRH 581
+IG G FG VY G G+ +A+K+ S + EI +L +L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGEL-MAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 582 KHLVSLIGFCEEDGEMILVY-DYMANGTLREHL--YKGDKPGLPW---KQRLEICIGAAR 635
+++V +G D + + ++ +Y+ G++ L Y + L +Q L +
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------K 117
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS-KTGPNLNQTHVSTM---VKG 691
GL+YLH IIHRD+K NIL+D K K+SDFG+S K N T + ++G
Sbjct: 118 GLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 692 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
S ++ PE ++ T K+D++S G ++ E+L
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 73/254 (28%), Positives = 112/254 (44%), Gaps = 36/254 (14%)
Query: 533 VIGVGGFGKVY--EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FGKV + +DGK KV K+ + ++ H +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ ++ V D++ G L HL + + P + A L YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
I++RD+K NILLD + ++DFGL K G + Q+ +T G+ YL PE R+Q
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 708 EKSDVYSFGVVLFEVLCARPAL----------NVNLPKE-----QVSLADWAL------- 745
D + G VL+E+L P N+ L K SL W++
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI-LHKPLVLRPGASLTAWSILEELLEK 233
Query: 746 -HCQRMGTIEDIID 758
+R+G ED ++
Sbjct: 234 DRQRRLGAKEDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 86/284 (30%), Positives = 122/284 (42%), Gaps = 42/284 (14%)
Query: 528 FSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQ---TEIEMLSKLRHKH 583
FS+ IG G FG VY + VAIK+ + S +Q ++Q E+ L KLRH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI---GAARGLHYL 640
+ G + LV +Y G+ + L KP Q +EI GA +GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYL 131
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H+ + +IHRDVK NILL E K+ DFG + N G+ ++ PE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEV 182
Query: 701 ---FRRQQLTEKSDVYSFGVVLFEVLCARPAL-NVNLPKEQVSLADWALHCQRMGTIEDI 756
Q K DV+S G+ E+ +P L N+N A AL+ I
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALY-----HIAQN 229
Query: 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800
P L+ + R F ++ CL DRP+ +VL F
Sbjct: 230 ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVLLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 43/280 (15%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQ---TEIEMLSKLRHK 582
F++ IG G FG VY D +T VAIK+ + S +Q ++Q E++ L +++H
Sbjct: 27 FTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI---GAARGLHY 639
+ + G + LV +Y G+ + L KP Q +EI GA +GL Y
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAITHGALQGLAY 140
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LH+ + +IHRD+K NILL E + K++DFG + N G+ ++ PE
Sbjct: 141 LHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 700 Y---FRRQQLTEKSDVYSFGVVLFEVLCARPAL-NVNLPKEQVSLADWALHCQRMGTIED 755
Q K DV+S G+ E+ +P L N+N A AL+ I
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALY-----HIAQ 238
Query: 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
P L+ N R F ++ CL DRP+ ++L
Sbjct: 239 NESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 533 VIGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQ-----TEIEMLSKLRHKHLVS 586
+G G FG+V + A+K S + V Q E +L +RH LV+
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR---GLHYLHTG 643
L G ++D + LV +Y+ G L HL K + P AA+ L YLH+
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLALEYLHS- 119
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST---MVKGSFGYLDPEY 700
I++RD+K N+LLD K++DFG +K V + G+ YL PE
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAPEI 169
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ + D ++ G++++E+L P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 44/217 (20%)
Query: 532 HVIGVGGFGKVYE------GYIDGKTKVAIK--RSNPSSEQGVHEF-QTEIEMLSKLRHK 582
V+G G +G V + G I VAIK + + E V + E+++L +LRH+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEI-----VAIKKFKESEDDED-VKKTALREVKVLRQLRHE 60
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
++V+L G + LV++Y+ L L + GLP + + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQLLQAIAYCH- 117
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT---GPNLNQT-HVST--------MVK 690
+ IIHRD+K NIL+ E K+ DFG ++ P T +V+T +V
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
D Y + DV++ G ++ E+L P
Sbjct: 176 ------DTNY------GKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 8/155 (5%)
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI 631
E+++L + ++V G DGE+ + ++M G+L + L K + +P +I I
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENILGKISI 106
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
RGL YL ++ I+HRDVK +NIL++ + E K+ DFG+S L + ++ V G
Sbjct: 107 AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-G 160
Query: 692 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
+ Y+ PE + T +SD++S G+ L E+ R
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 22/162 (13%)
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEIC- 630
E++++ + R ++VS G + + + ++M G+L + +YK P +EI
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP-----IPVEILG 106
Query: 631 ---IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN---QTH 684
+ GL YL+ R I+HRD+K +NIL++ + + K+ DFG+S G +N T
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTF 162
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
V T Y+ PE + + T KSDV+S G+ + E+ +
Sbjct: 163 VGTST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 1e-14
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 72/234 (30%)
Query: 532 HVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT---------EIEMLSKLR 580
IG G +G V D +T KVAIK+ + + F EI++L LR
Sbjct: 6 KPIGSGAYGVVCSAV-DKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLR 57
Query: 581 HKHLVSLIGF-----CEEDGEMILVYDYM---------ANGTLRE-H----LYKGDKPGL 621
H++++ L+ E+ ++ +V + M + L + H LY
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------- 110
Query: 622 PWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNL 680
Q L RGL YLH+ +IHRD+K +NIL++ + K+ DFGL++ P+
Sbjct: 111 ---QIL-------RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 681 NQTHVSTMVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARP 727
++ T Y+ ++R + T+ D++S G + E+L +P
Sbjct: 158 DEKGFLT------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 26/158 (16%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIG 589
VIG G +GKVY+ KT VAIK + ++ E + E +L K H ++ + G
Sbjct: 13 VIGEGTYGKVYKA-RHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYG 70
Query: 590 -------FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLE------ICIGAARG 636
+D ++ LV + G++ + L KG +RL+ I RG
Sbjct: 71 AFIKKNPPGNDD-QLWLVMELCGGGSVTD-LVKGL---RKKGKRLKEEWIAYILRETLRG 125
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674
L YLH +IHRD+K NILL + E K+ DFG+S
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 43/280 (15%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTK-VAIKRSNPSSEQGVHEFQ---TEIEMLSKLRHKH 583
F H IG G FG VY + VA+K+ + S +Q ++Q E++ L +L+H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI---GAARGLHYL 640
+ G ++ LV +Y G+ + L KP Q +EI GA +GL YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAITHGALQGLAYL 137
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFG-LSKTGPNLNQTHVSTMVKGSFGYLDPE 699
H+ + +IHRD+K NILL E + K++DFG SK+ P + G+ ++ PE
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPE 187
Query: 700 Y---FRRQQLTEKSDVYSFGVVLFEVLCARPAL-NVNLPKEQVSLADWALHCQRMGTIED 755
Q K DV+S G+ E+ +P L N+N A AL+ I
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALY-----HIAQ 234
Query: 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
P L+ N R F + CL +RP+ ++L
Sbjct: 235 NDSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 14/220 (6%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIE 574
++ + + ++ IG G G VY ID T +VAIK+ N + EI
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQQPKKELIINEIL 68
Query: 575 MLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA 634
++ + +H ++V+ + E+ +V +Y+A G+L + + + + Q +C
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 125
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL-SKTGPNLNQTHVSTMVKGSF 693
+ L +LH+ +IHRD+K+ NILL K++DFG ++ P Q+ STMV G+
Sbjct: 126 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTP 179
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA-LNVN 732
++ PE R+ K D++S G++ E++ P LN N
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
F V+G GGFG+V + K+ +++ +G E +L K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICIGAARGLHY 639
+VSL E + LV M G L+ H+Y PG ++ + E+C G L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LED 117
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
L R I++RD+K NILLD++ ++SD GL+ P +T V V G+ GY+ PE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-GET-VRGRV-GTVGYMAPE 171
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVL 723
++ T D + G +++E++
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 34/278 (12%)
Query: 527 NFSESHVIGVGGFGKVY-----EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSK 578
NF V+G G +GKV+ G+ GK KV K + + +TE ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 579 LRHK-HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG----A 633
+R LV+L + D ++ L+ DY+ G L HLY+ + + + I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVLA 117
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVSTMVKG 691
LH L II+RD+K NILLD + ++DFGLSK + + G
Sbjct: 118 LDHLHQL------GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---G 168
Query: 692 SFGYLDPEYFRRQQLTEKS--DVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749
+ Y+ PE R D +S GV+ FE+L V+ EQ S ++ + +R
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD--GEQNSQSEIS---RR 223
Query: 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID 787
+ + + D + + +K L G D
Sbjct: 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGAD 261
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 8/155 (5%)
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI 631
E+++L + ++V G DGE+ + ++M G+L + L K + +P + ++ I
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 110
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
+GL YL ++ I+HRDVK +NIL++ + E K+ DFG+S L + ++ V G
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-G 164
Query: 692 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
+ Y+ PE + + +SD++S G+ L E+ R
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSL 587
V+G G FGKV + G ++ +K+ + V TE +L+ +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ + V +Y+ G L H+ + + P + I GL +LH
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLH---ERG 116
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
II+RD+K N+LLD + K++DFG+ K G L ST G+ Y+ PE Q
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI-LGGVTTSTFC-GTPDYIAPEILSYQPYG 174
Query: 708 EKSDVYSFGVVLFEVLCARP 727
D ++ GV+L+E+L +
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 8/155 (5%)
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI 631
E+++L + ++V G DGE+ + ++M G+L + L + + +P + ++ I
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 110
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
RGL YL ++ I+HRDVK +NIL++ + E K+ DFG+S L + ++ V G
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-G 164
Query: 692 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
+ Y+ PE + + +SD++S G+ L E+ R
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 534 IGVGGFGKVYEGYIDGKTKV--AIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI-GF 590
+G G FGKVY+ + +T V A K + SE+ + ++ EI++L+ H ++V L+ F
Sbjct: 13 LGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
E+ IL+ ++ A G + + + ++P L Q +C L+YLH IIH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF-----RRQQ 705
RD+K NIL + K++DFG+S Q S + G+ ++ PE + +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRP 184
Query: 706 LTEKSDVYSFGVVLFEVLCARP 727
K+DV+S G+ L E+ P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 528 FSESHVIGVGGFGKVYEGYI--DG---KTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRH 581
F + V+G G FG VY+G +G K VAIK +S + E E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTL----REHLYKGDKPGLPWKQRLEICIGAARGL 637
H+ L+G C + L+ M G L REH D G + L C+ A+G+
Sbjct: 69 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQY--LLNWCVQIAKGM 122
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
+YL ++HRD+ N+L+ K++DFGL+K + + + K ++
Sbjct: 123 NYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVL 723
E + T +SDV+S+GV ++E++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 525 TRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIKR-SNPSSEQGVH-EFQTEIEMLSKLRH 581
R++ +G G FG+VY+ I VA+K+ + + G EI++L KL+H
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 582 KHLVSLI--------GFCEEDGEMILVYDYMA---NGTLREHLYKGDKPGLP--WKQRLE 628
++V LI + G + +V YM +G L K + + Q LE
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVS 686
G++YLH I+HRD+K NIL+D + K++DFGL++ GP N
Sbjct: 127 -------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 687 TMVKGSFG-------YLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARPAL 729
+ Y PE ++ T D++ G V E+ RP L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 46/140 (32%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 592 EEDGEMI-LVYDYMANGTLREHLYKGDKPGLPWKQRLE--ICIGAARGLHYLHTGARYTI 648
E+ MI LV DY G LR+ + K +++ + I +H++H+ +
Sbjct: 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHM 164
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
IHRD+K+ NILL K+ DFG SK V G+ Y+ PE +RR+ ++
Sbjct: 165 IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224
Query: 709 KSDVYSFGVVLFEVLC-ARP 727
K+D++S GV+L+E+L RP
Sbjct: 225 KADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 533 VIGVGGFGKVY--EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FGKV + DG KV K++ ++ H +L L+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ ++ V DY+ G L HL + P + + +A G YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG--YLHS---LN 116
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
II+RD+K NILLD + ++DFGL K G +T ST G+ YL PE R++
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFC-GTPEYLAPEVLRKEPYD 174
Query: 708 EKSDVYSFGVVLFEVLCARP 727
D + G VL+E+L P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 534 IGVGGFGKVYEG--YIDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLR---HKHLVS 586
IG G +GKV++ +G VA+KR + + T E+ +L L H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 587 LIGFC-----EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
L C + + ++ LV++++ + L +L K +PG+P + ++ RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
+ + ++HRD+K NIL+ + K++DFGL++ + T V + Y PE
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 181
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
+ D++S G + E+ +P + +Q+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEM 575
++ I + ++ IG G G V+ + +VAIK+ N + EI +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
+ +L++ ++V+ + E+ +V +Y+A G+L + + + + Q +C +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQ 126
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL-SKTGPNLNQTHVSTMVKGSFG 694
L +LH +IHRD+K+ N+LL K++DFG ++ P Q+ STMV G+
Sbjct: 127 ALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA-LNVN 732
++ PE R+ K D++S G++ E++ P LN N
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 525 TRNFSESHVIGVGGFGKVYEG--YIDGKTKVAIKR------SNPSSEQGVHEFQTEIEML 576
NF IG G F VY+ +DG+ VA+K+ + + Q + EI++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRV-VALKKVQIFEMMDAKARQ---DCLKEIDLL 56
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLR---EHLYKGDKPGLP----WKQRLEI 629
+L H +++ + E+ E+ +V + G L +H K + +P WK +++
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQL 115
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL-----SKTGPNLNQTH 684
C L ++H+ I+HRD+K N+ + K+ D GL SKT T
Sbjct: 116 C----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TA 162
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
++V G+ Y+ PE KSD++S G +L+E+ +
Sbjct: 163 AHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTE---IEMLSKLRHKHLV 585
V+G G FGKV ++ A+K+ + + V E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
+L + + + V +Y A G L H++ D P C+ GL YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACV--VLGLQYLH---E 119
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
I++RD+K N+LLD + K++DFGL K G ST G+ +L PE
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTFC-GTPEFLAPEVLTETS 177
Query: 706 LTEKSDVYSFGVVLFEVL 723
T D + GV+++E+L
Sbjct: 178 YTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 37/290 (12%)
Query: 527 NFSESHVIGVGGFGKVYEG--YIDGKTKVAIKRSNPSSEQGVHEFQ---TEIEMLSKLRH 581
NF IG G F +VY +D K VA+K+ Q EI++L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRK-PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLP----WKQRLEICIGAAR 635
+++ + ED E+ +V + G L + + +K K +P WK +++C
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----S 117
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
+ ++H+ ++HRD+K N+ + K+ D GL + ++T + + G+ Y
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYY 172
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755
+ PE KSD++S G +L+E+ AL ++++L CQ+ IE
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSL---CQK---IEQ 222
Query: 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805
P L + K E C+ RP +G V + A Q+
Sbjct: 223 CDYPPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYV---HQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 534 IGVGGFGKVYEGYIDGKTK----------VAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
+G G FG VY D K + + NP+ + V Q E ++LSKL H
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPN--ETVQANQ-EAQLLSKLDHPA 63
Query: 584 LVSL-IGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAARGLHYL 640
+V F E D I+ +Y L L K L Q E I G+HY+
Sbjct: 64 IVKFHASFLERDAFCIIT-EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H + I+HRD+K NI L K+ DFG+S+ + ++T G+ Y+ PE
Sbjct: 123 H---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEA 176
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLC 724
+ Q KSD++S G +L+E+ C
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 533 VIGVGGFGK-VYEGYIDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
V+G G FG+ + +++ K A+K P S V + + E +L+K++H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
E DG + +V +Y G L + + P L+ + G+ ++H ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLH 123
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
RD+K+ NI L + + K+ DFG ++ T P + T V G+ Y+ PE +
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GTPYYVPPEIWENMPYNN 179
Query: 709 KSDVYSFGVVLFEVLC 724
KSD++S G +L+E LC
Sbjct: 180 KSDIWSLGCILYE-LC 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 534 IGVGGFGKVYEG----YIDG----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G F K+++G D KT+V +K + S F M+S+L HKHLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHTGA 644
G C E I+V +Y+ G+L +L K + + WK LE+ A LH+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDK- 119
Query: 645 RYTIIHRDVKTTNILLDEKWEA--------KVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
+ H +V N+LL + + K+SD G+S T ++ ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT------VLPKEILLERIPWV 171
Query: 697 DPEYFRR-QQLTEKSDVYSFGVVLFEVLC 724
PE Q L+ +D +SFG L+E+
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 29/233 (12%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTK------VAIK--RSNPSSEQGVHEFQTEI 573
K G F E H+ G K + VA+K R + +++ ++F EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEI 70
Query: 574 EMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHL---------YKGDKPGLPWK 624
+++S+L+ +++ L+ C + ++ +YM NG L + L K D + +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 625 QRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684
+ + A G+ YL + +HRD+ T N L+ + + K++DFG+S+ + +
Sbjct: 131 TLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737
+ ++ E + T SDV++FGV L+E+L L KEQ
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL--------TLCKEQ 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSN-PSSEQGVHEFQT--EIEMLSKLR---HKHLVS 586
IGVG +G VY+ VA+K ++E G+ T E+ +L +L H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-PLSTVREVALLKRLEAFDHPNIVR 66
Query: 587 LIGFC-----EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
L+ C + + ++ LV++++ + LR +L K PGLP + ++ RGL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS-TMVKGSFGYLDPEY 700
I+HRD+K NIL+ + K++DFGL++ + ++ T V + Y PE
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWYRAPEV 178
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ D++S G + E+ +P
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA-ARGLHYLHTGARYTIIH 650
+ D ++ LV DYM+ G L HL K G + R + I L +LH +Y I++
Sbjct: 66 QTDSDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIAELVLALEHLH---KYDIVY 119
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ-LTEK 709
RD+K NILLD + DFGLSK NL + G+ YL PE ++ T+
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 710 SDVYSFGVVLFEVLC 724
D +S GV++FE+ C
Sbjct: 178 VDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 533 VIGVGGFGKVY-----EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIE--MLSKLRHKHLV 585
V+G G FGKV+ G D A+K ++ + +T++E +L+++ H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA-ARGLHYLHTGA 644
L + +G++ L+ D++ G L L K + ++ ++ + A L +LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS-- 116
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
II+RD+K NILLDE+ K++DFGLSK ++ + G+ Y+ PE R+
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 705 QLTEKSDVYSFGVVLFEVL 723
T+ +D +SFGV++FE+L
Sbjct: 174 GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEM 575
S+ + + ++ IG G G VY I +VAIK+ N + EI +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
+ + ++ ++V+ + E+ +V +Y+A G+L + + + + Q +C +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQ 126
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL-SKTGPNLNQTHVSTMVKGSFG 694
L +LH+ +IHRD+K+ NILL K++DFG ++ P Q+ STMV G+
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA-LNVN 732
++ PE R+ K D++S G++ E++ P LN N
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 72/290 (24%)
Query: 482 LPLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGK 541
LPL S ++ S+ + S S+ SL+E++ R IG G G
Sbjct: 45 LPLPPPSSSSSSSSSSSASGSAPSAAK--------SLSELERVNR-------IGSGAGGT 89
Query: 542 VYEGYIDGKTKVAIKRSNPSSEQ-------GVHE------FQTEIEMLSKLRHKHLVSLI 588
VY KV P+ G HE EIE+L + H ++V
Sbjct: 90 VY--------KV---IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP--WKQRLEICIGAARGLHYLHTGARY 646
+ +GE+ ++ ++M G+L E + D+ L +Q L G+ YLH R
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLADVARQILS-------GIAYLH---RR 187
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH--VSTMVKGSFGYLDPEYFRRQ 704
I+HRD+K +N+L++ K++DFG+S+ L QT ++ V G+ Y+ PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSSV-GTIAYMSPERI-NT 242
Query: 705 QLTE------KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWA-LHC 747
L D++S GV + E R V Q DWA L C
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG---RQ---GDWASLMC 286
|
Length = 353 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 533 VIGVGGFGKVYEGYIDGKTK----VAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
++G G FG++ G + +K VAI R+ S +Q F E L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSNIVR 70
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L G M++V +YM+NG L L K + L Q + + G A G+ YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEM 126
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL--DPEYFRRQ 704
+H+ + +L++ K+S F + T + G L PE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ SDV+SFG+V++EV+
Sbjct: 184 HFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 527 NFSESHVIGVGGFGKVY-----EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSK 578
NF V+G G +GKV+ G+ GK KV K + + V +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 579 LRHK-HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA-RG 636
+R LV+L + + ++ L+ DY++ G + HLY+ D + + G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILA 117
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L +LH + I++RD+K NILLD + ++DFGLSK + + + G+ Y+
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYM 173
Query: 697 DPEYFRRQQLTEKS-DVYSFGVVLFEVL 723
PE R + K+ D +S G+++FE+L
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 76/293 (25%), Positives = 132/293 (45%), Gaps = 38/293 (12%)
Query: 518 LAEIKHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEML 576
L+ ++ F V+G G +G+VY+G ++ AIK + + ++ E + EI ML
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINML 66
Query: 577 SKL-RHKHLVSLIG-FCEE-----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
K H+++ + G F ++ D ++ LV ++ G++ + + L I
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT--HVST 687
C RGL +LH + +IHRD+K N+LL E E K+ DFG+S L++T +T
Sbjct: 127 CREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNT 180
Query: 688 MVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742
+ G+ ++ PE + + +SD++S G+ E+ P L P + L
Sbjct: 181 FI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237
Query: 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
I P LK + + +KF + E CL + RPS +L
Sbjct: 238 ----------IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 533 VIGVGGFGKVYEGYI--DG---KTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
V+G G FG VY+G DG K VAIK R N +S + E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVC 72
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L+G C + LV M G L +++ + +K + + L C+ A+G+ YL
Sbjct: 73 RLLGICLTS-TVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLE---E 127
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
++HRD+ N+L+ K++DFGL++ + + K ++ E ++
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 706 LTEKSDVYSFGVVLFEVL 723
T +SDV+S+GV ++E++
Sbjct: 188 FTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSL 587
VIG G + KV + ++ +K+ + ++ + QTE + + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ + + V +Y+ G L H+ + K LP + + L+YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG--- 116
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
II+RD+K N+LLD + K++D+G+ K G L ++ G+ Y+ PE R +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 708 EKSDVYSFGVVLFEVLCARPALNV 731
D ++ GV++FE++ R ++
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 533 VIGVGGFGKVYE-----GYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
V+G GG+GKV++ G GK KV K + +++ + E +L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL-----EICIGAARGLHY 639
V LI + G++ L+ +Y++ G L HL ++ G+ + EI + L +
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLA----LEH 115
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-THVSTMVKGSFGYLDP 698
LH II+RD+K NILLD + K++DFGL K + TH G+ Y+ P
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
E R + D +S G +++++L P
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 534 IGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQ---TEIEMLSKLRHKHLVSLIG 589
+G GG+G+V+ D VA+KR S ++E + TE ++L+ + + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 590 FCEEDGEMILVYDYM----------ANGTLREHLYKGDKPGLPWKQRLEIC--IGAARGL 637
++D + L +Y+ G L E R + A L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----------HARFYMAEMFEAVDAL 117
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
H L IHRD+K N L+D K++DFGLSK +++V GS Y+
Sbjct: 118 HEL------GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY----ANSVV-GSPDYMA 166
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736
PE R + D +S G +L+E LC P + + P E
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 533 VIGVGGFGKVYEGYIDGK-----TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FGKV + KV K++ ++ H +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAARGLHYLHTGA 644
+ ++ V DY+ G L HL + ++ L + R EI A L YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEI----ASALGYLHS-- 114
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
I++RD+K NILLD + ++DFGL K N+ ++ G+ YL PE +Q
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 705 QLTEKSDVYSFGVVLFEVLCARP 727
D + G VL+E+L P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 533 VIGVGGFGKV--YEGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
++G G FGKV GK K+ K + ++ H TE +L RH L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSL 60
Query: 588 IGFCEEDGEMILVYDYMANGTL-----REHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
+ + V +Y+ G L RE ++ D+ + L YLH+
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHS 113
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK--GSFGYLDPEY 700
G I++RD+K N++LD+ K++DFGL K G T +TM G+ YL PE
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI----TDAATMKTFCGTPEYLAPEV 166
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCAR 726
D + GVV++E++C R
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
G+ LH IIHRD+K N+L+D+ K++DFGLS+ G + G+ Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDY 159
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736
L PE + SD +S G V+FE L P + P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSL- 587
IG G +G+VY+ D T VA+K+ +E+ EI++L +L H+++V+L
Sbjct: 14 QIGEGTYGQVYKA-RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 588 ---------IGFCEEDGEMILVYDYMAN---GTLREHL--YKGDKPGLPWKQRLEICIGA 633
+ F ++ G LV++YM + G L L + D KQ LE
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE----- 127
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
GL+Y H + +HRD+K +NILL+ K + K++DFGL++ N ++ T +
Sbjct: 128 --GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESRPYTNKVITL 181
Query: 694 GYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL 740
Y PE ++ DV+S G +L E+ +P N Q+ L
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 534 IGVGGFGKVYE-GYIDGKTKVAIKRSNPSSEQGVHE--FQTEIEMLSKLRHKHLVSLIGF 590
IG G +G V++ + VAIK+ S + V + EI ML +L+H +LV+LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
++ LV++Y + L E L K + G+P +I + +++ H ++ IH
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNE-LEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIH 123
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQT-HVSTMVKGSFGYLDPEYF-RRQQL 706
RDVK NIL+ ++ + K+ DFG ++ TGP + T +V+T Y PE Q
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVGDTQY 178
Query: 707 TEKSDVYSFGVVLFEVLCARP 727
DV++ G V E+L +P
Sbjct: 179 GPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 527 NFSESHVIGVGGFGKVY-----EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSK 578
NF V+G G +GKV+ G+ GK KV K + + +TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 579 LRHK-HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA-ARG 636
+R LV+L + D ++ L+ DY+ G L HL + ++ +Q ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L +LH + II+RD+K NILLD ++DFGLSK ++ + G+ Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYM 173
Query: 697 DPEYFRRQQLTEKS--DVYSFGVVLFEVLCARPALNVN 732
P+ R D +S GV+++E+L V+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 60/237 (25%), Positives = 89/237 (37%), Gaps = 58/237 (24%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPS----SEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG+V+ D A+K S Q H + E ++L+ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKL 66
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----------EICIGAARGL 637
+++ + LV +YM G L L + K E+ A L
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIR--------KDVFPEETARFYIAELV--LA--L 114
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP-------NLNQTHVSTMVK 690
+H + IHRD+K NIL+D K++DFGL K LN +H
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 691 --------------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ Y+ PE R + D +S GV+L+E+L P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 48/229 (20%)
Query: 534 IGVGGFGKVYEGY--IDGKTKVAIKR------SNPSSEQ-------GVHEFQT--EIEML 576
+G G +GKV + Y + GK VAIK+ SN ++ G+H F T E++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGK-IVAIKKVKIIEISNDVTKDRQLVGMCGIH-FTTLRELKIM 74
Query: 577 SKLRHKHLVSLIG-FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
++++H++++ L+ + E D + LV D MA L++ + K L Q I +
Sbjct: 75 NEIKHENIMGLVDVYVEGD-FINLVMDIMA-SDLKKVV--DRKIRLTESQVKCILLQILN 130
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK----------------TGPN 679
GL+ LH ++ +HRD+ NI ++ K K++DFGL++
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 680 LNQTHVSTMVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
T S +V + Y PE ++ D++S G + E+L +P
Sbjct: 188 EEMT--SKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 40/213 (18%)
Query: 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG- 589
+G G +G+V + KVAIK+ + + +H +T E+ +L + H++++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 590 FC-----EEDGEMILVYDYMA---NGTLREHLYKGDKPGLPWKQRL---EICIGA---AR 635
F E+ ++ LV M N ++ Q+L I R
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGADLNNIVK-------------CQKLSDDHIQFLVYQILR 129
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
GL Y+H+ IIHRD+K +NI ++E E K+ DFGL++ + +V+T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181
Query: 696 LDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
PE + D++S G ++ E+L +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 8e-12
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEM 575
S+ + + ++ IG G G VY + +VAI++ N + EI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
+ + ++ ++V+ + E+ +V +Y+A G+L + + + + Q +C +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQ 127
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL-SKTGPNLNQTHVSTMVKGSFG 694
L +LH+ +IHRD+K+ NILL K++DFG ++ P Q+ STMV G+
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 181
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA-LNVN 732
++ PE R+ K D++S G++ E++ P LN N
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 38/278 (13%)
Query: 528 FSESHVIGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLV 585
F ++G G +G+VY+G ++ AIK + + ++ E + EI ML K H+++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 586 SLIG-FCEE-----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
+ G F ++ D ++ LV ++ G++ + + L + IC RGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT--HVSTMVKGSFGYLD 697
LH ++ +IHRD+K N+LL E E K+ DFG+S L++T +T + G+ ++
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI-GTPYWMA 179
Query: 698 PEYFRRQQLTE-----KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752
PE + + KSD++S G+ E+ P L P + L
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------ 227
Query: 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS 790
I P LK + + +KF E CL RP+
Sbjct: 228 IPRNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPT 262
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLS-KLRHKHLVSL 587
V+G G FGKV + G + A+K+ + V E +L+ H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 588 IGFC--EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAARGLHYLHT 642
FC + + V +Y+ G L H+ + + R EI G L +LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE-ARARFYAAEIICG----LQFLHK 114
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
II+RD+K N+LLD+ K++DFG+ K N+N ++ G+ Y+ PE +
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPEILK 169
Query: 703 RQQLTEKSDVYSFGVVLFEVL 723
Q+ E D +SFGV+L+E+L
Sbjct: 170 GQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKR-SNPSSEQGV--HEFQTEIEMLSKL 579
T + + +G+G FG V + G+ VAIK+ P S + ++ E+++L L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQN-VAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66
Query: 580 RHKHLVSLIG-FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
RH++++SL F ++ V + + GT L + Q I RGL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQI--LRGLK 122
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698
Y+H+ ++HRD+K +NIL++E + K+ DFGL++ Q T GY+
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMT------GYVST 168
Query: 699 EYFRR-------QQLTEKSDVYSFGVVLFEVLCARP 727
Y+R Q+ + D++S G + E+L +P
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 10/116 (8%)
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
+I + + L YLH+ + ++IHRDVK +N+L++ + K+ DFG+S L + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKT 161
Query: 688 MVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCAR-PALNVNLPKEQV 738
+ G Y+ PE ++ KSDV+S G+ + E+ R P + P +Q+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 30/188 (15%)
Query: 553 VAIKRSNPSSEQG-VHEFQT-EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLR 610
VAIK+ S + V + EI ML +LRH++LV+LI + LV++++ + L
Sbjct: 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD 88
Query: 611 E-HLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669
+ Y GL + + RG+ + H + IIHRD+K NIL+ + K+
Sbjct: 89 DLEKYPN---GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLC 142
Query: 670 DFGLSKT--GPNLNQT-HVST-------MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 719
DFG ++T P T +V+T ++ G D +Y R D+++ G ++
Sbjct: 143 DFGFARTLAAPGEVYTDYVATRWYRAPELLVG-----DTKYGR------AVDIWAVGCLV 191
Query: 720 FEVLCARP 727
E+L P
Sbjct: 192 TEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSL 587
VIG G + KV + ++ +K+ ++ + QTE + + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQR----LEICIGAARGLHYLHTG 643
+ + LV +Y+ G L H+ + K LP + EICI L++LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIA----LNFLHER 115
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
II+RD+K N+LLD K++D+G+ K G L ++ G+ Y+ PE R
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRG 170
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNV 731
++ D ++ GV++FE++ R ++
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 534 IGVGGFGKV------YEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G GGFG+V G + K+ KR S + + + EI L K+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
E + LV M G L+ H+Y + GL ++ + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
I++RD+K N+LLD++ ++SD GL+ + T G+ GY+ PE + + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYS 172
Query: 708 EKSDVYSFGVVLFEVLCAR 726
D ++ G ++E++ R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSL 587
VIG G + KV + ++ IK+ + ++ + QTE + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ----RLEICIGAARGLHYLHTG 643
+ + + V ++++ G L H+ + K LP + EI + L++LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLA----LNFLHER 115
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
II+RD+K N+LLD + K++D+G+ K G + ++ G+ Y+ PE R
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRG 170
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNV 731
+ D ++ GV++FE++ R ++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 52/198 (26%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 534 IGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSLIGFC 591
+G G + V++G + VA+K E+G E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI-GAARGLHYLHTGARYTIIH 650
D + LV++Y+ + L++ Y D + ++I + RGL Y H R ++H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQ--YMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-RQQLTEK 709
RD+K N+L++E+ E K++DFGL++ +T+ + +V + Y P+ + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQ 185
Query: 710 SDVYSFGVVLFEVLCARP 727
D++ G + FE+ RP
Sbjct: 186 IDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLS-KLRHKHLVSL 587
++G G FGKV+ + G + A+K+ + V E +LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHL---YKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
+ + V +Y+ G L H+ +K D P + IC GL +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHSKG 116
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
I++RD+K NILLD K++DFG+ K L T G+ Y+ PE Q
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ D +SFGV+L+E+L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 16/200 (8%)
Query: 534 IGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+GVGGFG+V + +T K KR + Q H F E E+L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA-RGLHYLHTGARYT 647
++ + ++ +Y G L L GL + I YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
II+RD+K N+LLD K+ DFG +K + +T T G+ Y+ PE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYD 170
Query: 708 EKSDVYSFGVVLFEVLCARP 727
D +S G++L+E+L RP
Sbjct: 171 FSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 26/218 (11%)
Query: 534 IGVGGFGKVYEGYIDGKTK-----VAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSL 587
+G G + V++G ++K VA+K E+G E+ +L L+H ++V+L
Sbjct: 13 LGEGTYATVFKG----RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPG-LPWKQRLEICI-GAARGLHYLHTGAR 645
+ + LV++Y+ + L+++L D G L ++I + RGL Y H +
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---K 121
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
I+HRD+K N+L++EK E K++DFGL++ +T+ + +V + Y P+
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS- 178
Query: 706 LTEKS---DVYSFGVVLFEVLCARPALNVNLPKEQVSL 740
TE S D++ G +L+E+ RP + KE++ L
Sbjct: 179 -TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 527 NFSESHVIGVGGFGKVYEG-YIDGKTKVAIKRS---NPSSEQGVHEFQTEIEMLSKLRHK 582
NF IG G F +VY + VA+K+ + + + EI++L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLP----WKQRLEICIGAARG 636
+++ ED E+ +V + G L + +K K +P WK +++C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L ++H+ ++HRD+K N+ + K+ D GL + + +T + + G+ Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYM 173
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEV 722
PE KSD++S G +L+E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 1/176 (0%)
Query: 548 DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607
D K KV K + E+ ++E+ L+ H +V + D +++L+ +Y + G
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAK 667
L + + + K LP+++ E+ + + + L ++HRD+K+ NI L K
Sbjct: 151 DLNKQIKQRLKEHLPFQEY-EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK 209
Query: 668 VSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ DFG SK + V++ G+ YL PE + R++ ++K+D++S GV+L+E+L
Sbjct: 210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 67/252 (26%), Positives = 103/252 (40%), Gaps = 28/252 (11%)
Query: 534 IGVGGFGKVYEG--------YIDGKTK-VAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKH 583
+G G F +Y+G I G + V++ S+ F ++S+L HKH
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHT 642
LV L G C D E I+V +Y+ G L L++ + L WK L++ A LHYL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 643 GARYTIIHRDVKTTNILL--DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
++H +V NIL+ E V LS G + V+ ++ PE
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-PWIAPEC 175
Query: 701 FRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
R Q LT +D +SFG L E+ N P +S ++ + + D
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICS-----NGEEPLSTLSSSE-KERFYQDQHRLPMPD 229
Query: 759 PNLKGNITDQCL 770
N+ +QC
Sbjct: 230 CAELANLINQCW 241
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLS-KLRHKHLVSL 587
V+G G FGKV + G +V +K+ + V TE +L+ +H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ + V +Y+ G L + + K P + + A L +LH R+
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLH---RHG 116
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+I+RD+K NILLD + K++DFG+ K G T +T G+ Y+ PE + +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYG 174
Query: 708 EKSDVYSFGVVLFEVLCARP 727
D ++ GV+++E++ +P
Sbjct: 175 PSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 35/165 (21%)
Query: 534 IGVGGFGKVYEGYI---DGKTKVAIKRSNPSSEQGVHEFQT---EIEMLSKLRHKHLVSL 587
IG G +G+VY+ + AIK+ EQ Q+ EI +L +L+H+++VSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 588 IGFCEEDGEMI--LVYDYMANGTL-----------REHLYKGDKPGLPWKQRLEICIGAA 634
+ E + L++DY A L R + L W Q L
Sbjct: 68 VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN------ 119
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLSK 675
G+HYLH+ ++HRD+K NIL+ E+ K+ D GL++
Sbjct: 120 -GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
+ L+YL + IIHRDVK +NILLD K+ DFG+S L + T G
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRP 172
Query: 695 YLDPEY---FRRQQLTEKSDVYSFGVVLFEV 722
Y+ PE R +SDV+S G+ L+EV
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 53/213 (24%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 534 IGVGGFGKVYEGYIDGKTK-----VAIKRSNPSSEQGVH-EFQTEIEMLSKLRHKHLVSL 587
+G G + VY+G ++K VA+K E+G E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVYKG----RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI-GAARGLHYLHTGARY 646
+ + LV++Y+ + L+++L D +++ + RGL+Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNSINMHNVKLFLFQLLRGLNYCH---RR 123
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE-YFRRQQ 705
++HRD+K N+L++E+ E K++DFGL++ +T+ + +V + Y P+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181
Query: 706 LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
+ + D++ G + +E+ RP + +EQ+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPSSEQGVHEFQT-------EIEMLS 577
+ IG G +G V KVAIK+ +P E QT EI++L
Sbjct: 6 RYQNLSYIGEGAYGMVCSA-THKPTGVKVAIKKISP------FEHQTFCQRTLREIKILR 58
Query: 578 KLRHKHLVSLI-----GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EI 629
+ +H++++ ++ E ++ +V + M LYK L Q L I
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-----DLYK-----LIKTQHLSNDHI 108
Query: 630 CI---GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK-TGPNLNQTHV 685
RGL Y+H+ ++HRD+K +N+LL+ + K+ DFGL++ P + T
Sbjct: 109 QYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165
Query: 686 STMVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARP 727
T + Y PE + K+ D++S G +L E+L RP
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 534 IGVGGFGKVYEGYIDGK-----TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG+V G K KR +Q H Q E +L +L H +V+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ-EKSILMELSHPFIVNMM 84
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
+++ + + +++ G L HL K + P YLH+ I
Sbjct: 85 CSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHS---KDI 139
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
I+RD+K N+LLD K KV+DFG +K P+ T + G+ YL PE + + +
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGHGK 194
Query: 709 KSDVYSFGVVLFEVLCARP 727
D ++ GV+L+E + P
Sbjct: 195 AVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 38/212 (17%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIKR-SNP-SSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G +G V +D +T KVAIK+ P SE E+ +L ++H++++ L+
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 590 FCEED------GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI-GAARGLHYLHT 642
D + LV +M GT L K +K + R++ + +GL Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS---EDRIQFLVYQMLKGLKYIHA 136
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
IIHRD+K N+ ++E E K+ DFGL++ QT S M GY+ ++R
Sbjct: 137 AG---IIHRDLKPGNLAVNEDCELKILDFGLAR------QTD-SEMT----GYVVTRWYR 182
Query: 703 RQQL-------TEKSDVYSFGVVLFEVLCARP 727
++ T+ D++S G ++ E+L +P
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 41/153 (26%), Positives = 82/153 (53%), Gaps = 9/153 (5%)
Query: 527 NFSESHVIGVGGFGKVYEG--YIDGKTKVAIKRSNPSSE-QGVHEFQT-EIEMLSKLRHK 582
NF + IG G +G VY+ + G+ VA+K+ +E +GV EI +L +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNHP 59
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
++V L+ + ++ LV++++ + L++ + G+P +GL + H+
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
+ ++HRD+K N+L++ + K++DFGL++
Sbjct: 119 ---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 534 IGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
+G G + VY+G I+G+ VA+K + +E+GV F E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQL-VALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPG--LPWKQRLEICIGAARGLHYLHTGARYT 647
+ V++YM + Y PG P+ RL RGL Y+H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQH 123
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-RQQL 706
I+HRD+K N+L+ E K++DFGL++ +QT+ S +V + Y P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181
Query: 707 TEKSDVYSFGVVLFEVLCARPAL 729
+ D++ G + E+L +PA
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 534 IGVGGFGKVYEGYID---GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSL 587
IG G FGKV G K +V +K S+ EQ F E++ +L H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYK--GDKPGLPWKQRLE-ICIGAARGLHYLHTGA 644
+G C E +LV ++ G L+ +L G + K L+ + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG--YLDPEYF- 701
+ IH D+ N L K+ D+GL+ + + T + +L PE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALE--QYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 702 -RRQQL-----TEKSDVYSFGVVLFEV--LCARPALNVNLPKEQV 738
R Q L T+KS+++S GV ++E+ +P +L EQV
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 74/226 (32%), Positives = 105/226 (46%), Gaps = 34/226 (15%)
Query: 525 TRNFSESHVIGVGGFGKVYE--GYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RH 581
T + IG G +GKVY+ DG + A+K +P S+ E + E +L L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDG-SLAAVKILDPISDVD-EEIEAEYNILQSLPNH 78
Query: 582 KHLVSLIG-FCEED----GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLE------IC 630
++V G F + D G++ LV + G++ E L KG L QRL+ I
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE-LVKGL---LICGQRLDEAMISYIL 134
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STM 688
GA GL +LH IIHRDVK NILL + K+ DFG+S L T + +T
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTS 188
Query: 689 VKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARPAL 729
V F ++ PE +Q + S DV+S G+ E+ P L
Sbjct: 189 VGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 533 VIGVGGFGKVY--EGYIDGK---TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
++G G FGKV GK K+ K + ++ H TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTAL 60
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA--ARGLHYLHTGAR 645
+ + V +Y G L HL + + + R GA L YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARF-YGAEIVSALGYLHSC-- 114
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
+++RD+K N++LD+ K++DFGL K G + T + T G+ YL PE
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC-GTPEYLAPEVLEDND 171
Query: 706 LTEKSDVYSFGVVLFEVLCAR 726
D + GVV++E++C R
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-10
Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 534 IGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
I G FGKVY G +K+ +K+++ ++ VH+ Q E + L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 590 FCEEDGEMILVYDYMANGTLRE--HLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ + LV +Y+ G ++ H+Y + K E A L YLH R+
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----VALALDYLH---RHG 124
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSK 675
IIHRD+K N+L+ + K++DFGLSK
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTK---VAIKRSNPSSEQGVHEFQT-EIEMLSKLRHK 582
NF + +G G + VY+G +T VA+K + +E+G EI ++ +L+H+
Sbjct: 1 NFKQLEKLGEGTYATVYKGR--NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
++V L + +++LV++YM + G + L +G+ + H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYF 701
++HRD+K N+L++++ E K++DFGL++ G +N T + +V + Y P+
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV--TLWYRAPDVL 172
Query: 702 RRQQLTEKS-DVYSFGVVLFEVLCARP 727
+ S D++S G ++ E++ RP
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSL 587
V+G G FGKV + ++ +K+ + V TE +LS R H L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ + V +++ G L H+ K + + I +A L +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHDKG--- 116
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
II+RD+K N+LLD + K++DFG+ K G + ++ G+ Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 708 EKSDVYSFGVVLFEVLC 724
D ++ GV+L+E+LC
Sbjct: 175 PSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 21/161 (13%)
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKG--DKPGLPWKQRLEI 629
E+++L K ++V G +G + + +YM G+L + LY G G+P I
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRI 107
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
+GL +L + IIHRDVK TN+L++ + K+ DFG+S NL V+++
Sbjct: 108 TYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG---NL----VASLA 158
Query: 690 KGSFG---YLDPEYFR------RQQLTEKSDVYSFGVVLFE 721
K + G Y+ PE + T +SDV+S G+ + E
Sbjct: 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLS-KLRHKHLVSL 587
V+G G FGKV + GK + A+K+ + V E +L+ + L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI---CIGAAR---GLHYLH 641
+ + V +++ G L H+ K R ++ AA GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD--------KGRFDLYRATFYAAEIVCGLQFLH 113
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
+ II+RD+K N++LD K++DFG+ K N+ + ++ G+ Y+ PE
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEIL 168
Query: 702 RRQQLTEKSDVYSFGVVLFEVL 723
+ + T D +SFGV+L+E+L
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 571 TEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL-----REHLYKGDKPGLPWKQ 625
TE +L RH L +L + + V +Y G L RE ++ ++
Sbjct: 44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---- 99
Query: 626 RLEICIGA--ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683
GA L YLH+ +++RD+K N++LD+ K++DFGL K G +
Sbjct: 100 -----YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----S 147
Query: 684 HVSTMVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
+TM G+ YL PE D + GVV++E++C R
Sbjct: 148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 552 KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLRE 611
+VA+K+ + +Q E+ ++ H+++V + E+ +V +++ G L +
Sbjct: 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108
Query: 612 HLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671
+ + +Q +C+ R L YLH +IHRD+K+ +ILL K+SDF
Sbjct: 109 IV---THTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDF 162
Query: 672 G----LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G +SK P + G+ ++ PE R + D++S G+++ E++ P
Sbjct: 163 GFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 728 ALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762
N P Q M I D + P +K
Sbjct: 217 PY-FNEPP-----------LQAMRRIRDNLPPRVK 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 48/221 (21%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLI 588
IG G +G V ID ++ KVAIK+ + + +T E+++L +H +++++
Sbjct: 12 NIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 589 G-FCEEDGEMILVY---DYM---------ANGTLREH-----LYKGDKPGLPWKQRLEIC 630
+ VY D M ++ L E LY Q L
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY----------QLL--- 117
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK---TGPNLNQTHVST 687
RGL Y+H+ +IHRD+K +N+L++E E ++ DFG+++ + P ++ ++
Sbjct: 118 ----RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 688 MVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
V + Y PE + T D++S G + E+L R
Sbjct: 171 YV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
+G G +G V Y D + KVA+K+ + + +H +T E+ +L ++H++++ L+
Sbjct: 23 VGSGAYGSVCSAY-DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 590 F------CEEDGEMILVYDYMA---NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
E E+ LV + M N ++ + Q L RGL Y+
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL-------RGLKYI 134
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE- 699
H+ IIHRD+K +N+ ++E E ++ DFGL++ + +V+T Y PE
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEI 186
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVL 723
+ D++S G ++ E+L
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
IG G G V +VA+K+ + +Q E+ ++ +H ++V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
E+ +V +++ G L + + + +Q +C+ + L +LH +IHRD
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQG---VIHRD 140
Query: 653 VKTTNILLDEKWEAKVSDFG----LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
+K+ +ILL K+SDFG +SK P ++V G+ ++ PE R
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK-----SLV-GTPYWMAPEVISRLPYGT 194
Query: 709 KSDVYSFGVVLFEVLCARP 727
+ D++S G+++ E++ P
Sbjct: 195 EVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVA--------IKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
++G G FGKV I K K +K+ ++ V TE +L RH L
Sbjct: 2 LLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA--ARGLHYLHT 642
+L + + V +Y G L HL + ++ + R GA L YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARF---YGAEIVSALDYLH- 112
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
+ +++RD+K N++LD+ K++DFGL K G T + T G+ YL PE
Sbjct: 113 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFC-GTPEYLAPEVLE 169
Query: 703 RQQLTEKSDVYSFGVVLFEVLCAR 726
D + GVV++E++C R
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 43/214 (20%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQT--------EIEMLSKL-RHKH 583
+G G FG VY + VAIK+ +F + E++ L KL H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG-LPWKQRLEICIGAARGLHYLHT 642
+V L E+ E+ V++YM G L L K K I +GL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHIH- 116
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK--------TGPNLNQTHVSTMVKGSFG 694
++ HRD+K N+L+ K++DFGL++ T +VST
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT------DYVSTR-----W 163
Query: 695 YLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 727
Y PE R + D+++ G ++ E+ RP
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 534 IGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FGKV + ++ I++++ S V E +L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
+ ++ LV ++ G L HL + + L + R A L L ++ +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL-SRARFYT----AELLCALENLHKFNVI 115
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEK 709
+RD+K NILLD + + DFGL K N+ + G+ YL PE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 710 SDVYSFGVVLFEVLCARP 727
D ++ GV+L+E+L P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 73/321 (22%), Positives = 109/321 (33%), Gaps = 75/321 (23%)
Query: 537 GGFGKVYEGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594
+ + + T VA+K+ N S++ + Q EI +L+H +++ + D
Sbjct: 13 LMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI---GAARGLHYLHTGARYTIIHR 651
E+ +V MA G+ + L GLP L I L Y+H IHR
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH---SKGFIHR 125
Query: 652 DVKTTNILLDE-------------------KWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
VK ++ILL K + V DF S NL
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK-NLP----------- 173
Query: 693 FGYLDPEYFRRQQL---TEKSDVYSFGVVLFEV-------------LCARPALNVNLPKE 736
+L PE +Q L EKSD+YS G+ E+ + +P
Sbjct: 174 --WLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP-- 228
Query: 737 QVSLADWALHCQRMGTIEDIIDPNLKGNITDQ----CLRKFTET----AEKCLSDQGIDR 788
L D + + ++ N N D R F+E E CL R
Sbjct: 229 --CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 789 PSMGDVLWNLEFALQLQDNPD 809
PS +L N F Q +
Sbjct: 287 PSASQLL-NHSFFKQCKRRNT 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIK----RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
++G G G VY+ Y + + +A+K ++ + +E+E+L K +++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK---QIMSELEILYKCDSPYIIGF 64
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
G + + + ++M G+L +Y+ +P I + +GL YL +
Sbjct: 65 YGAFFVENRISICTEFMDGGSL--DVYRK----IPEHVLGRIAVAVVKGLTYLWS---LK 115
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN-LNQTHVSTMVKGSFGYLDPEYFRRQQL 706
I+HRDVK +N+L++ + + K+ DFG+S N + +T+V G+ Y+ PE +Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQY 170
Query: 707 TEKSDVYSFGVVLFEVLCAR 726
SDV+S G+ E+ R
Sbjct: 171 GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688
+ + + LHYL ++ +IHRDVK +NILLD K+ DFG+S L + T
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG---RLVDSKAKTR 173
Query: 689 VKGSFGYLDPEYFRRQQLTEK----SDVYSFGVVLFE 721
G Y+ PE K +DV+S G+ L E
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKV-AIK---RSNPSSEQGVHEFQTEIEMLSKLRHK 582
+F+ V+G G FGKV G ++ AIK + + V E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 583 H-LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA--ARGLHY 639
L L + + V +Y+ G L H+ + K +K+ + A A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFF 116
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LH+ II+RD+K N++LD + K++DFG+ K N+ + G+ Y+ PE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKE--NIFGGKTTRTFCGTPDYIAPE 171
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Q + D ++FGV+L+E+L +P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
IG G +G VY+ ++ AIK + Q EI M+ +H ++V+ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
++ + ++ G+L++ +Y P L Q + +GL+YLH+ + +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGP-LSESQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF----GYLDPEYF---RRQQ 705
+K NILL + K++DFG+S Q + + SF ++ PE R+
Sbjct: 132 IKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 706 LTEKSDVYSFGVVLFEVLCARPAL 729
+ D+++ G+ E+ +P +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 37/113 (32%), Positives = 55/113 (48%), Gaps = 16/113 (14%)
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG-----PNLNQTHVST---- 687
L YLH Y I+HRD+K N+L+ K++DFGLSK G NL + H+
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 688 ----MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736
V G+ Y+ PE RQ + D ++ G++L+E L + P+E
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 12/145 (8%)
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
+ + + L +L+ DY+ +G L + L K K L + +I L+ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDL 125
Query: 641 HTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
H ++ IIH D+K N+L D K + D+GL K + G+ Y PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPSCYDGTLDYFSPE 176
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLC 724
+ D ++ GV+ +E+L
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 54/185 (29%), Positives = 77/185 (41%), Gaps = 21/185 (11%)
Query: 550 KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609
+ KV +K G EI++L + H+ +++LI + +V M
Sbjct: 119 RKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKC 170
Query: 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669
Y LP +Q + I L YLH IIHRDVKT NI LDE A +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLG 227
Query: 670 DFGLS-KTG--PNLNQTH--VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
DFG + K P+ Q + T+ S PE K+D++S G+VLFE+
Sbjct: 228 DFGAACKLDAHPDTPQCYGWSGTLETNS-----PELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 725 ARPAL 729
L
Sbjct: 283 KNVTL 287
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHK 582
+F+ V+G G FGKV G ++ +K+ + V E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 583 HLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
++ + C + + V +Y+ G L H+ + K P Q + + GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
R II+RD+K N++LD + K++DFG+ K ++ + G+ Y+ PE
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDYIAPEII 173
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALN 730
Q + D +++GV+L+E+L +P +
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
+G G +G V + D KT +VA+K+ + + +H +T E+ +L ++H++++ L+
Sbjct: 25 VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 590 F------CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
EE ++ LV M G ++ K K Q L I RGL Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA 139
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE-YFR 702
IIHRD+K +N+ ++E E K+ DFGL++ + +V+T Y PE
Sbjct: 140 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 191
Query: 703 RQQLTEKSDVYSFGVVLFEVLCAR 726
+ D++S G ++ E+L R
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 527 NFSESHVIGVGGFGKV-YEGYIDGK-TKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRH 581
+F+ +G G FG+V Y + VAIKR S ++ V +E ++L+ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
V+L G +++ + LV +++ G L + + P C AA+ +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVG---CFYAAQIVLIFE 145
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I++RD+K N+LLD+ K++DFG +K + T T+ G+ Y+ PE
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK----VVDTRTYTLC-GTPEYIAPEIL 200
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLP 734
+ +D ++ G+ ++E+L P N P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 34/145 (23%), Positives = 61/145 (42%), Gaps = 21/145 (14%)
Query: 220 TMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAP 279
+ +N GG P DS T+ D+ + G+A S + + I ++ E+
Sbjct: 1 VVLAINCGG---PEHTDSD-GITYEADTYFTGGSADYYVSDTNGSSSIAGTTD--PEL-- 52
Query: 280 LSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILLT--KINQRVFDIFIN 337
Y+T R P + ++ N Y V HF EI + +RVFD+++
Sbjct: 53 ---YQTER-YSPS-------SFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQ 101
Query: 338 NQTAQEGADVIGWAGEQGVPVYKDY 362
+ + D++ AG +G +K+Y
Sbjct: 102 GKLVLKDFDIVAEAGGKGKTAHKEY 126
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 527 NFSESHVIGVGGFGKVY-EGYIDGKTKVAIKRSNPS------SEQGVHEFQTEIEMLSKL 579
+ +G G FG+V+ + A+K EQ VH E +L ++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKEV 58
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK----PGLPWKQRLEICIGAAR 635
H ++ L + + ++ +Y+ G L +L + GL + + +C
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VC----- 112
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
L YLH+ I++RD+K NILLD++ K++DFG +K + T + G+ Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEY 164
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
L PE + + + D ++ G++++E+L P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 40/121 (33%), Positives = 58/121 (47%), Gaps = 13/121 (10%)
Query: 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665
+ L +L K +P LP Q L I GL YLH IIHRDVKT NI +++ +
Sbjct: 140 SSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQ 195
Query: 666 AKVSDFGLSK---TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
+ D G ++ P + G+ PE R + K+D++S G+VLFE+
Sbjct: 196 VCIGDLGAAQFPVVAPAF------LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
Query: 723 L 723
L
Sbjct: 250 L 250
|
Length = 357 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/257 (22%), Positives = 113/257 (43%), Gaps = 33/257 (12%)
Query: 552 KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLRE 611
+VA+K + +Q E+ ++ +H+++V + E+ ++ +++ G L +
Sbjct: 48 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107
Query: 612 HLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671
+ + L +Q +C + L YLH+ +IHRD+K+ +ILL K+SDF
Sbjct: 108 IV---SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDF 161
Query: 672 G----LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G +SK P + G+ ++ PE R + D++S G+++ E++ P
Sbjct: 162 GFCAQISKDVPKRKS------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 728 ALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG-NITDQCLRKFTETAEKCLSDQGI 786
+ P Q M + D P LK + LR F E+ L+ +
Sbjct: 216 PYFSDSP------------VQAMKRLRDSPPPKLKNAHKISPVLRDFL---ERMLTREPQ 260
Query: 787 DRPSMGDVLWNLEFALQ 803
+R + ++L + F LQ
Sbjct: 261 ERATAQELL-DHPFLLQ 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 533 VIGVGGFG-----------KVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH 581
VIG G FG KVY + K ++ IKRS+ + F E ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAF------FWEERDIMAFANS 102
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
+V L ++D + +V +YM G L + D P K + A +H +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM- 161
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
+IHRDVK N+LLD+ K++DFG T V G+ Y+ PE
Sbjct: 162 -----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVL 215
Query: 702 RRQ----QLTEKSDVYSFGVVLFEVL 723
+ Q + D +S GV LFE+L
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 67/223 (30%), Positives = 94/223 (42%), Gaps = 51/223 (22%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQ--GVHEFQTEIEMLSKLRHKHLVSLI 588
VIG G +G V ID T KVAIK+ N E EI++L LRH +V +
Sbjct: 7 VIGKGSYGVVCSA-IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 589 GFC-----EEDGEMILVYDYM---------ANGTL-REH----LYKGDKPGLPWKQRLEI 629
E ++ +V++ M AN L EH LY Q L
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY----------QLL-- 113
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS-TM 688
R L Y+HT + HRD+K NIL + + K+ DFGL++ N T + T
Sbjct: 114 -----RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 689 VKGSFGYLDPE----YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ Y PE +F + T D++S G + EVL +P
Sbjct: 166 YVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 63/226 (27%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
IG G +G V + +T KVAIK+ + + + +T EI++L L H++++++
Sbjct: 13 IGRGAYGIVCSA-KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 590 FCEEDGEMI-----LVYDYM---------ANGTL-REH----LYKGDKPGLPWKQRLEIC 630
+VY+ M ++ TL +H LY Q L
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY----------QLL--- 118
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690
RGL Y+H+ ++HRD+K +N+LL+ + K+ DFGL++T T K
Sbjct: 119 ----RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART----------TSEK 161
Query: 691 GSF--GYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARP 727
G F Y+ ++R +L T DV+S G + E+L +P
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 533 VIGVGGFGKVYE-GYIDGKTKVAIKRSNPSSE-QGVHEFQ-TEIEMLSKLRHKHLVSLIG 589
V+G G +G V + + + K VAIK+ S E + V E E++ML L+ +++V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
G++ LV++Y+ L E L + P K R I + +H+ H + I+
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH---KNDIV 122
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKT---GPNLNQT-HVSTMVKGSFGYLDPEYFRRQQ 705
HRD+K N+L+ K+ DFG ++ G N N T +V+T Y PE
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR-----WYRSPELLLGAP 177
Query: 706 LTEKSDVYSFGVVLFEVLCARP 727
+ D++S G +L E+ +P
Sbjct: 178 YGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSN-PSSEQGVHEFQT-EIEMLSKLRHKHLVSLIG 589
IG G +G VY+G + KT VA+K+ S E+GV EI +L +L+H ++V L
Sbjct: 8 IGEGTYGVVYKGR-NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA------RGLHYLHTG 643
++ + L++++++ L+++L LP Q ++ + + +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYL-----DSLPKGQYMDAELVKSYLYQILQGILFCH-- 118
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG--PNLNQTH-VSTMVKGSFGYLDPEY 700
++HRD+K N+L+D K K++DFGL++ P TH V T+ Y PE
Sbjct: 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL-----WYRAPEV 172
Query: 701 FR-RQQLTEKSDVYSFGVVLFEVLCARP 727
+ + D++S G + E+ +P
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 9/195 (4%)
Query: 534 IGVGGFGKVYEGYIDGKTK-VAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
IG G G V + K VA+K+ + +Q E+ ++ +H+++V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652
E+ +V +++ G L + + + +Q +C+ + L LH +IHRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRD 141
Query: 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDV 712
+K+ +ILL K+SDFG S + G+ ++ PE R + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPEVDI 199
Query: 713 YSFGVVLFEVLCARP 727
+S G+++ E++ P
Sbjct: 200 WSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
A GL +LH+ II+RD+K N++LD + K++DFG+ K N+ + G+
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTP 165
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE Q + D ++FGV+L+E+L +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 45/213 (21%)
Query: 533 VIGVGGFGKVYE-GYIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+IG GGFG+VY D A+K + +QG E MLS LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53
Query: 589 GFC----------EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--- 635
G C ++ + D M G L HL + G+ + E+ AA
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEA--EMRFYAAEIIL 108
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL----SKTGPNLNQTHVSTMVKG 691
GL ++H R+ +++RD+K NILLDE ++SD GL SK P H S G
Sbjct: 109 GLEHMHN--RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---G 157
Query: 692 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 723
+ GY+ PE ++ + S D +S G +LF++L
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 41/152 (26%), Positives = 82/152 (53%), Gaps = 21/152 (13%)
Query: 534 IGVGGFGKVYEG--YIDGKTKVAIKRSNPSSE-QGVHEFQT-EIEMLSKLRHKHLVSLIG 589
IG G +G VY+ + G+ VA+K+ +E +GV EI +L +L H ++V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEI-VALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL------EICIGAARGLHYLHTG 643
+ ++ LV++++ + L++++ GL L ++ +G+ Y H+
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLD--PPLIKSYLYQLL----QGIAYCHS- 117
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
+ ++HRD+K N+L+D + K++DFGL++
Sbjct: 118 --HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 28/155 (18%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKR-SNPSSEQGVHEFQT-EIEMLSKLRHKHLVSLIGF 590
IG G +G V++ + VA+KR ++GV EI +L +L+HK++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 591 CEEDGEMILVYDYM----------ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
D ++ LV++Y NG + + K Q L +GL +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-----SFMFQLL-------KGLAFC 115
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
H+ + ++HRD+K N+L+++ E K++DFGL++
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 30/161 (18%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQT----EIEMLSKLRHKHLVSLI 588
IG G FG+V++ + K VA+K+ +E+ F EI++L L+H+++V+LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 77
Query: 589 GFCEED--------GEMILVYDYMANGTLREHLYKGDKPGLP-----WKQRLEICIGAAR 635
C G LV+++ + K K L K L
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN------- 130
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676
GL+Y+H R I+HRD+K NIL+ + K++DFGL++
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 533 VIGVGGFGKVYE-GYIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRH---KHLV 585
+IG GGFG+VY D A+K + +QG E MLS + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL-----EICIGAARGLHYL 640
+ ++ + D M G L HL + G+ ++ + EI +G L ++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILG----LEHM 113
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL----SKTGPNLNQTHVSTMVKGSFGYL 696
H R+ +++RD+K NILLDE ++SD GL SK P H S G+ GY+
Sbjct: 114 HN--RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHGYM 162
Query: 697 DPEYFRRQQLTEKS-DVYSFGVVLFEVL 723
PE ++ + S D +S G +LF++L
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 14/146 (9%)
Query: 534 IGVGGFGKVYEG---YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG- 589
+G G +G VY+ + V I + P + + Q EI M+ + +H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFGS 74
Query: 590 -FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
E ++ + +Y G+L++ +Y P L Q +C +GL YLH+ +
Sbjct: 75 YLSRE--KLWICMEYCGGGSLQD-IYHVTGP-LSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLS 674
+HRD+K NILL + + K++DFG++
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSLI 588
IG GG G+VY Y D +VA+K R + S + + F E ++ + L H +V +
Sbjct: 10 IGKGGMGEVYLAY-DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 589 GFCEEDGEMILVY---DYMANGTLR---------EHLYKGDKPGLPWKQRLEICIGAARG 636
C DG+ VY Y+ TL+ E L K L I
Sbjct: 69 SICS-DGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT--------------GPNLNQ 682
+ Y+H+ ++HRD+K NILL E + D+G + N+
Sbjct: 126 IEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 683 THVSTMVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ ++ K G+ Y+ PE +E +D+Y+ GV+L+++L
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 61/226 (26%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKR-----SNPSSEQGVHEFQT--EIEMLSKLR-HKH 583
+G G +G V++ ID +TK VA+K+ N + Q +T EI L +L H +
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHPN 68
Query: 584 LVSLIGF--CEEDGEMILVYDYM---------ANGTLREH----LYKGDKPGLPWKQRLE 628
+V L+ E D ++ LV++YM AN H +Y Q L
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY----------QLL- 117
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688
+ L Y+H+G +IHRD+K +NILL+ K++DFGL+++ L + + +
Sbjct: 118 ------KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 689 VKGSFGYLDPEYFRRQQLTEKSDVYSFGV-------VLFEVLCARP 727
+ Y+ ++R ++ S Y+ GV +L E+L +P
Sbjct: 169 LT---DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
G +F E V+ G +Y KV +K+S +++ V F+ E ++LS
Sbjct: 10 GRGHFGEVQVVREKATGDIY------AMKV-MKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKP---GLPWKQRLEICIGAARGLHYL 640
+ L ++ + LV +Y G L L + + + E+ + +H +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA----IHSV 118
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H +HRD+K N+L+D K++DFG S N+ S + G+ Y+ PE
Sbjct: 119 HQ---MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 701 FRRQQLTEKS------DVYSFGVVLFEVLCAR 726
K D +S GV+ +E++ R
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 6e-08
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 49/218 (22%)
Query: 537 GGFGKVYEGYIDGKTK--VAIKRSNPSSE-QGVHEFQT----EIEMLSKLRHKHLVSL-- 587
G +G VY D KT VA+K+ E +G F EI +L KL+H ++V++
Sbjct: 16 GTYGVVYRA-RDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKE 71
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKG-----DKPGLP------WKQRLEICIGAARG 636
+ ++ +V +Y+ EH K +P L Q L G
Sbjct: 72 VVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLL-------SG 118
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTH-VSTMVKGSF 693
+ +LH + I+HRD+KT+N+LL+ + K+ DFGL++ P T V T+
Sbjct: 119 VAHLH--DNW-ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL----- 170
Query: 694 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPALN 730
Y PE ++ + D++S G + E+L +P
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 58/234 (24%), Positives = 90/234 (38%), Gaps = 52/234 (22%)
Query: 533 VIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
++G G G+V+ + G K+ + + V TE E+L+ L H L +L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYL 640
+ + + LV DY G L L + +PG + L AR L YL
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQR--QPG----KCL--SEEVARFYAAEVLLALEYL 119
Query: 641 HT-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-----------------GPNLNQ 682
H G I++RD+K NILL E +SDF LSK ++N
Sbjct: 120 HLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 683 THVSTMVK----------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
T + G+ Y+ PE D ++ G++L+E+L
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 534 IGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
+G G + VY+G ++GK VA+K E+G F E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKL-VALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHD 70
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI-GAARGLHYLHTGARYTI 648
+ LV++Y+ + Y PG + +++ + RGL Y+H RY I
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQ--RY-I 124
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
+HRD+K N+L+ + E K++DFGL++ + T+ + +V + Y P+ TE
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS--TE 180
Query: 709 KS---DVYSFGVVLFEVL 723
S D++ G + E++
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFG-----------KVYEGYIDGKTKVAIKRSNPSSEQG 565
+ +++ +F VIG G FG +VY + K ++ IKRS+ +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF--- 89
Query: 566 VHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ 625
F E ++++ + +V L ++D + +V +YM G L + D P W +
Sbjct: 90 ---FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWAR 145
Query: 626 --RLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG----LSKTGPN 679
E+ + L +H+ IHRDVK N+LLD+ K++DFG + G
Sbjct: 146 FYTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-- 196
Query: 680 LNQTHVSTMVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 723
T V G+ Y+ PE + Q + D +S GV L+E+L
Sbjct: 197 --MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 43/126 (34%), Positives = 62/126 (49%), Gaps = 28/126 (22%)
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK---TGPNLNQTHVSTMVK 690
ARG+ +L A IHRD+ NILL E K+ DFGL++ P+ + K
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------VRK 233
Query: 691 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPALNVNLPKEQVSLADWA 744
GS ++ PE + T +SDV+SFGV+L+E+ L A P V + +E
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------- 285
Query: 745 LHCQRM 750
CQR+
Sbjct: 286 -FCQRL 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSNPSSE-QGVHEFQT-EIEMLSKLRHKHLVSLIG 589
IG G +G VY+ D T +A+K+ E +GV EI +L +++H ++V L
Sbjct: 10 IGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL--EICIGAARGLHYLHTGARYT 647
+ + LV++Y+ + L++H+ P RL RG+ Y H+ +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHS---HR 122
Query: 648 IIHRDVKTTNILLDEKWEA-KVSDFGLSKTG--PNLNQTH-VSTMVKGSFGYLDPE-YFR 702
++HRD+K N+L+D + A K++DFGL++ P TH V T+ Y PE
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL-----WYRAPEILLG 177
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARP 727
+ + D++S G + E++ +P
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 39/122 (31%), Positives = 55/122 (45%), Gaps = 39/122 (31%)
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
ARG+ +L A IHRD+ NILL E K+ DFGL++
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD----------------- 222
Query: 694 GYLDPEYFRR-----------------QQLTEKSDVYSFGVVLFEV--LCARPALNVNLP 734
Y DP+Y R+ + T +SDV+SFGV+L+E+ L A P V +
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID 282
Query: 735 KE 736
+E
Sbjct: 283 EE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 534 IGVGGFGKVYEGYIDG---KTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
IG G FGKV G ++ +V +K R + S ++ + F E + L+H +L+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQCL 61
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDK-----PGLPWKQRLEICIGAARGLHYLHTG 643
G C E +LV ++ G L+ +L K P QR+ I A GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLH-- 117
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674
+ IH D+ N LL K+ D+GLS
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 29/221 (13%)
Query: 518 LAEIKHGTRNFSESHVIGVGGFG-----------KVYEGYIDGKTKVAIKRSNPSSEQGV 566
+ +++ ++ VIG G FG KVY + K ++ IKRS+ +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF---- 89
Query: 567 HEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQR 626
F E ++++ +V L ++D + +V +YM G L + D P +
Sbjct: 90 --FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 147
Query: 627 LEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686
+ A +H + IHRDVK N+LLD+ K++DFG
Sbjct: 148 TAEVVLALDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201
Query: 687 TMVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 723
T V G+ Y+ PE + Q + D +S GV L+E+L
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 44/217 (20%)
Query: 532 HVIGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSL 587
+G G + VY+G + G+ VA+K E+G F E +L L+H ++V+L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL 68
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA------------- 634
+ LV++Y+ D KQ ++ C G
Sbjct: 69 HDIIHTKKTLTLVFEYL------------DTD---LKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
RGL Y H + ++HRD+K N+L+ E+ E K++DFGL++ ++T+ + +V +
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168
Query: 695 YLDPEYFRRQQLTEKS---DVYSFGVVLFEVLCARPA 728
Y P+ TE S D++ G + +E+ RP
Sbjct: 169 YRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 9/160 (5%)
Query: 571 TEIEMLSKLRHKHLVSLIG-FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
TE +L + H ++ L G F +++ Y + + Y K + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD----LYCYLAAKRNIAICDILAI 187
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
R + YLH IIHRD+K NI ++ + + DFG + ++N
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPAL 729
G+ PE R D++S G+VLFE+ +L
Sbjct: 245 -GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 42/238 (17%)
Query: 534 IGVGGFGKVYEGYIDGKTKVA------IKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
IG G FGKV I T VA +K + S EQ +EF + + L+H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 588 IGFCEEDGEMILVYDYMANGTLREHL-----YKGDKPGLPWKQRLEICIGAARGLHYLHT 642
+G C E +LV++Y G L+ +L ++ + L QR+ I A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL-QRMACEIAA--GVTHMH- 116
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFG--YLDPE 699
++ +H D+ N L KV D+G+ GP + ++ T +L PE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 700 YFRRQQ-------LTEKSDVYSFGVVLFEV----------LCARPALNVNLPKEQVSL 740
T+ S+V++ GV L+E+ L R LN + +QV L
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 16/125 (12%)
Query: 279 PLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEI--LLTKINQRVFDIFI 336
P S+Y++A + + +L++ +D N Y V HF EI +T +RVFD+ I
Sbjct: 251 PESLYQSALV-----STDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLI 305
Query: 337 NNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNG 396
N TA + D++ +GE+ Y + L + L P H AI+N
Sbjct: 306 NGDTAFKDVDIVKMSGER----YTALVLNKTVAVSGRTLTIVLQPKKGTH-----AIINA 356
Query: 397 LEIFK 401
+E+F+
Sbjct: 357 IEVFE 361
|
Length = 623 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 46/231 (19%)
Query: 534 IGVGGFGKVYE--GYIDGKTKVAIKRSNPSSEQGVHEFQT---------EIEMLSKLRHK 582
IG G FG V+ DGK +VA+K+ + FQ E++ML +H
Sbjct: 8 IGYGAFGVVWSVTDPRDGK-RVALKKM-------PNVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 583 HLVS--------LIGFCEEDGEMILVYDYMA----NGTLREHLYKGDKPGLPWKQRLEIC 630
+++S I EE + +V + M + D + Q L
Sbjct: 60 NVLSALDILQPPHIDPFEE---IYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL--- 113
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690
RGL YLH+ A I+HRD+K N+L++ K+ DFGL++ H++ V
Sbjct: 114 ----RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 691 GSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL 740
+ Y PE + T D++S G + E+L R P +Q+ L
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 21/174 (12%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSS-EQGVHEFQ-TEIEMLSKLRHK 582
+ + IG G +GKVY+ D T VA+K++ E+G+ EI +L L
Sbjct: 2 AYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 583 -HLVSLIGF--CEEDG---EMILVYDYMANGTLREHL---YKGDKPGLPWKQRLEICIGA 633
++V L+ EE + LV++Y+ + L++ + +G LP K
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSK--TGPNLNQTH 684
+G+ + H ++ ++HRD+K N+L+D +K K++D GL + + P + TH
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 526 RNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNP-SSEQGVHEFQTEIEMLSKLRH 581
++ +G G +G V ID +T KVAIK+ S P SE E+ +L ++H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 582 KHLVSLIGF------CEEDGEMILVYDYMAN--GTLREHLYKGDKPGLPWKQRLEICIGA 633
++++ L+ +E + LV YM + H DK Q L
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML------ 127
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
GL Y+H+ IIHRD+K N+ ++E E K+ DFGL++ +V T
Sbjct: 128 -CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----- 178
Query: 694 GYLDPEY-FRRQQLTEKSDVYSFGVVLFEVL 723
Y PE + D++S G ++ E+L
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLR-HKHLVSLI 588
IG G F +V + AIK S EQ V+ + EI+ L +L H +++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLR-EIQALRRLSPHPNILRLI 64
Query: 589 G--FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
F + G + LV++ M + L E L KG K LP K+ + L ++H R
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RN 119
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE------Y 700
I HRD+K NIL+ + K++DFG + + T + Y PE Y
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRG---IYSKPPYTEYISTRWYRAPECLLTDGY 175
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ K D+++ G V FE+L P
Sbjct: 176 Y-----GPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKV-AIKRSNPSSEQGVHE---FQTEIEMLSKLRHK 582
+F VIG G FG+V + KV A+K N E F+ E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP------WKQRLEICIGAARG 636
+ +L +++ + LV DY G L L K + LP + + I I +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQ 120
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG----LSKTGPNLNQTHVSTMVKGS 692
LHY +HRD+K NIL+D +++DFG L + G T S++ G+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGT 166
Query: 693 FGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVL 723
Y+ PE + + + + D +S GV ++E+L
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 11/108 (10%)
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK---TGPNLNQTHVSTMVK 690
A+G+ +L A IHRD+ NILL E K+ DFGL++ P+ + + +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPALNVNLPKE 736
++ PE + T +SDV+SFGV+L+E+ L A P V + +E
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 63/253 (24%), Positives = 96/253 (37%), Gaps = 60/253 (23%)
Query: 527 NFSESHVIGVGGFGKV--YEGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRH 581
+F VIG G FG+V + GK K +K +Q H + E ++L++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESDS 60
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI--CIGAARGLHY 639
+VSL ++ + L+ +++ G L L K D R + C+ A +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYMAECVLAIEAVHK 119
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS------------------KTGPNLN 681
L IHRD+K NIL+D K+SDFGLS K+ N
Sbjct: 120 L------GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 682 QTHVSTMVK---------------------------GSFGYLDPEYFRRQQLTEKSDVYS 714
S V G+ Y+ PE F +Q ++ D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 715 FGVVLFEVLCARP 727
G ++FE L P
Sbjct: 234 LGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 68/220 (30%), Positives = 101/220 (45%), Gaps = 40/220 (18%)
Query: 534 IGVGGFGKVYE--GYIDGKTKVAIKRSNPSSEQGVHEFQTEIE----MLSKLR-HKHLVS 586
IG G +GKV++ +G +K A+K +P +H+ EIE +L L H ++V
Sbjct: 26 IGKGTYGKVFKVLNKKNG-SKAAVKILDP-----IHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 587 LIG-FCEED---GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLE------ICIGAARG 636
G + ++D G+ + + + NG L KG L +R+E I A G
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMG 136
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFG 694
L +LH IHRDVK NILL + K+ DFG+S L T + +T V F
Sbjct: 137 LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPF- 189
Query: 695 YLDPEYFR-RQQL----TEKSDVYSFGVVLFEVLCARPAL 729
++ PE QQL + DV+S G+ E+ P L
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 48/250 (19%)
Query: 527 NFSESHVIGVGGFGKVY------EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR 580
+F VIG G FG+V G+I K+ K EQ H + E ++L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYA-MKILRKADMLEKEQVAH-IRAERDILVEAD 59
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ-RLEICIGAARGLHY 639
+V + ++ + L+ +++ G + L K D Q + + A +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS-------KTGPNLNQTH-------- 684
L IHRD+K N+LLD K K+SDFGL +T N TH
Sbjct: 120 L------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 685 ------------------VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
++ G+ Y+ PE F + + D +S GV+++E+L
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 727 PALNVNLPKE 736
P P+E
Sbjct: 234 PPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK---TGPNLNQTHVSTMVKG 691
GL Y+H+ ++HRD+K N+L++ E K+ DFGL++ P N ++ V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 692 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARP 727
+ Y PE Q K+ DV+S G +L E+L +P
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 572 EIEMLSKLRHKHLVSL--IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
EI +L +L+H +++SL + D ++ L++DY + H+ K + K+ +++
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQL 105
Query: 630 CIGAAR--------GLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLSK-- 675
G + G+HYLH ++HRD+K NIL+ E+ K++D G ++
Sbjct: 106 PRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 676 TGPNLNQTHVSTMVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARP 727
P + +V +F Y PE + T+ D+++ G + E+L + P
Sbjct: 163 NSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 527 NFSESHVIGVGGFGKVY------EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR 580
+F VIG G FG+V G++ +++++ ++ V + E ++L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMK--ILRKADMLEKEQVGHIRAERDILVEAD 59
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ-RLEICIGAARGLHY 639
+V + ++ + L+ +++ G + L K D Q + + A +H
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK----------------------TG 677
L IHRD+K N+LLD K K+SDFGL T
Sbjct: 120 L------GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 678 PNLNQTHVSTMVK-----------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 726
N+N + K G+ Y+ PE F + + D +S GV+++E+L
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 727 PALNVNLPKE 736
P P+E
Sbjct: 234 PPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 78/381 (20%), Positives = 140/381 (36%), Gaps = 77/381 (20%)
Query: 528 FSESHVIGVGGFGKV-YEGYIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKH 583
F + +G+G FG+V +D K A+K + + V + E ++L++ ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHT 642
+V L ++ + V DY+ G + L + G P + + A +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---- 118
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLS------------KTGPNLNQTH------ 684
+ IHRD+K NIL+D K++DFGL ++G ++ Q
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 685 ---------------------------VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 717
++ + G+ Y+ PE R T+ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 718 VLFEVLCARPALNVNLPKE-QVSLADW--ALHCQRMGTIEDIIDPNLKGNITDQCLRKFT 774
+L+E+L +P P E Q+ + +W +LH L +D + K
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIP--------PQAKLSPEASDLII-KLC 287
Query: 775 ETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDG-DKLISIQTDKANDTYAMHKAMLN 833
E L G D ++F+ L+ I+ TD +N
Sbjct: 288 RGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSN--------FDP 339
Query: 834 IDEESVLSDEIDTSNTTDIFS 854
+D + + SD+ N D +
Sbjct: 340 VDPDKLWSDDDKEGNVNDTLN 360
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 30/115 (26%), Positives = 43/115 (37%), Gaps = 36/115 (31%)
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSK-----------------TGPNLNQTHVSTMVK- 690
IHRD+K N+LLD K K+SDFGL N M
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 691 ------------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ Y+ PE F + ++ D +S GV+++E+L P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL--IGF 590
+G G +G VY+ DGK + EI +L +L+H ++++L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 591 CEEDGEMILVYDYMANGTLREHLYK-------GDKP-GLPWKQRLEICIGAARGLHYLHT 642
D ++ L++DY + H+ K KP LP + G+HYLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 643 GARYTIIHRDVKTTNILL----DEKWEAKVSDFGLSK--TGPNLNQTHVSTMVKGSFGYL 696
++HRD+K NIL+ E+ K++D G ++ P + +V +F Y
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 182
Query: 697 DPEYFR-RQQLTEKSDVYSFGVVLFEVLCARP 727
PE + T+ D+++ G + E+L + P
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
A+G+ +L A IHRDV N+LL + AK+ DFGL++ N + V +
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722
++ PE T +SDV+S+G++L+E+
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 13/128 (10%)
Query: 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660
Y A R + P L + + A G+ +L A +HRD+ N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272
Query: 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMV-KGS----FGYLDPEYFRRQQLTEKSDVYSF 715
E K+ DFGL++ + S + KGS ++ PE T SDV+SF
Sbjct: 273 CEGKLVKICDFGLAR-----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327
Query: 716 GVVLFEVL 723
G++L+E+
Sbjct: 328 GILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 14/179 (7%)
Query: 550 KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609
+ KV +K +PS F M+ ++ HKH+V L G C D E I+V +++ G L
Sbjct: 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91
Query: 610 REHLYKGDKP-GLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668
+++ PWK ++ A L YL ++H +V T NILL E
Sbjct: 92 DLFMHRKSDVLTTPWK--FKVAKQLASALSYLEDK---DLVHGNVCTKNILLAR--EGID 144
Query: 669 SDFG----LSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEV 722
+ G LS G + V+ ++ PE + L+ +D +SFG L+E+
Sbjct: 145 GECGPFIKLSDPGIPITVLSRQECVE-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 551 TKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGT 608
T V ++ ++ +E+ + Q E+ + RH ++++ + ++ +MA G+
Sbjct: 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85
Query: 609 LREHLYKGDKP-GLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAK 667
L K P G+ I GA RGL+YLH IHR++K ++IL+ +
Sbjct: 86 AN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG--DGL 139
Query: 668 VSDFGLSKTGPNLNQTHVSTMV-------KGSFGYLDPEYFRRQQL---TEKSDVYSFGV 717
VS GLS + + +V +L PE RQ L KSD+YS G+
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL-RQDLYGYNVKSDIYSVGI 198
Query: 718 VLFEVLCAR 726
E+ R
Sbjct: 199 TACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 534 IGVGGFGKV---YEGYIDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLI 588
IG G G V Y+ +D VAIK+ + + H + E+ ++ + HK+++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 589 GF------CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
EE ++ LV + M + + D + + +C G+ +LH+
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 137
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQT-HVSTMVKGSFGYLDPEY 700
IIHRD+K +NI++ K+ DFGL++T G + T +V T Y PE
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 189
Query: 701 FRRQQLTEKSDVYSFGVVLFEVL 723
E D++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 515 HFSLAEIKHGT----RNFSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPSSEQGVHE 568
+F EI T + + IG G G V Y D + VAIK+ + + H
Sbjct: 9 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAY-DAILERNVAIKKLSRPFQNQTHA 67
Query: 569 FQT--EIEMLSKLRHKHLVSLIGF------CEEDGEMILVYDYMANGTLREHLYKGDKPG 620
+ E+ ++ + HK+++ L+ EE ++ +V + M + + D
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 621 LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN- 679
+ + +C G+ +LH+ IIHRD+K +NI++ K+ DFGL++T
Sbjct: 128 MSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 680 -LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
+ +V T Y PE E D++S G ++ E++
Sbjct: 180 FMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 69/332 (20%), Positives = 127/332 (38%), Gaps = 64/332 (19%)
Query: 528 FSESHVIGVGGFGKV-YEGYIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKH 583
F + +G+G FG+V +D A+K + + + V + E ++L++ ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHT 642
+V L ++ + V DY+ G + L + P + + + A +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---- 118
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLS---------------------------- 674
+ IHRD+K NIL+D K++DFGL
Sbjct: 119 --KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 675 -------KTGPNL----------NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 717
+ G L +Q ++ + G+ Y+ PE R+ T+ D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 718 VLFEVLCARPALNVNLPKE-QVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTET 776
+LFE+L +P P E Q+ + +W ++ + P IT C +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK--LSPEAVDLITKLCC-----S 289
Query: 777 AEKCLSDQGIDRPSMGDVLWNLEFALQLQDNP 808
AE+ L G D ++F+ ++ P
Sbjct: 290 AEERLGRNGADDIKAHPFFSEVDFSSDIRTQP 321
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
A+G+ +L A IHRD+ NILL K+ DFGL++ N + V +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++ PE T +SDV+S+G++L+E+
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
F E V+ + G+VY I K ++ +KR+ + F+ E ++L + + +L
Sbjct: 14 FGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETAC------FREERDVLVNGDRRWITNL 66
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYK-GDK-PGLPWKQRLEICIGAARGLHYLHTGAR 645
+++ + LV DY G L L K D+ P + L + A +H L
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---- 122
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR--- 702
+HRD+K N+LLD+ +++DFG S + T S + G+ Y+ PE +
Sbjct: 123 --YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 703 --RQQLTEKSDVYSFGVVLFEVL 723
+ + + D +S GV ++E+L
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 38/141 (26%), Positives = 56/141 (39%), Gaps = 50/141 (35%)
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS---------------------- 686
IHRD+K NIL+D K++DFGL TG TH S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC-TG--FRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 687 -----------------------TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
++V G+ Y+ PE R T+ D +S GV+L+E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 724 CARPALNVNLPKE-QVSLADW 743
+P + P E Q+ + +W
Sbjct: 239 VGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660
Y + ++ L GL L ARG+ +L A +HRD+ N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMV-KGS----FGYLDPEYFRRQQLTEKSDVYSF 715
+ K+ DFGL++ + H S V KGS ++ PE T SDV+S+
Sbjct: 271 AQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 716 GVVLFEVL 723
G++L+E+
Sbjct: 326 GILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 45/235 (19%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV------ 585
+G G G V+ +D +VA+K+ + Q V EI+++ +L H ++V
Sbjct: 13 LGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 586 --------SLIGFCEEDGEMILVYDYMANGTLREHLYKG----DKPGLPWKQRLEICIGA 633
+G E + +V +YM L L +G + L Q L
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLL------ 124
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSK-TGPN------LNQTHV 685
RGL Y+H+ ++HRD+K N+ ++ E K+ DFGL++ P+ L++ V
Sbjct: 125 -RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL 740
+ + L P + T+ D+++ G + E+L +P EQ+ L
Sbjct: 181 TKWYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 40/219 (18%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK-----LRH 581
+F VIG G FG+V A+ + + + + EML + R
Sbjct: 2 DFEIIKVIGRGAFGEV-----------AVVKMKHTERIYAMKILNKWEMLKRAETACFRE 50
Query: 582 KHLVSLIGFCE----------EDGEMILVYDYMANGTLREHLYKGDK--PGLPWKQRLEI 629
+ V + G C+ ++ + LV DY G L L K + P + +
Sbjct: 51 ERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE 110
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
+ A +H LH +HRD+K N+LLD +++DFG S N + T S++
Sbjct: 111 MVLAIHSIHQLH------YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVA 163
Query: 690 KGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVL 723
G+ Y+ PE + + + D +S GV ++E+L
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 533 VIGVGGFGKVYE------GYIDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKL-RHKHL 584
+G G FGKV E G D +VA+K S+ E +E+++LS L +HK++
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYK 615
V+L+G C G ++++ +Y G L L K
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 25/182 (13%)
Query: 553 VAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIGF------CEEDGEMILVYDYM 604
VA+K+ + + H + E+ +L + HK+++SL+ EE ++ LV + M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 605 -ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK 663
AN H+ + D + + +C G+ +LH+ IIHRD+K +NI++
Sbjct: 109 DANLCQVIHM-ELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSD 159
Query: 664 WEAKVSDFGLSKTG-PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 721
K+ DFGL++T N T +V T Y PE E D++S G ++ E
Sbjct: 160 CTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 722 VL 723
++
Sbjct: 215 LV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKR--SNPSSEQGVHEFQTEIEMLSKLRH 581
+++ ++IG G FG VYE ID KVAIK+ +P + E+ ++ L H
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNH 118
Query: 582 KHLVSLIGF----CEEDGE----MILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICI 631
+++ L + C + E + +V +++ T+ +++ Y + LP
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA-KVSDFGLSKTGPNL--NQTHVSTM 688
R L Y+H+ I HRD+K N+L+D K+ DFG +K NL Q VS
Sbjct: 178 QLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVS-- 229
Query: 689 VKGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARP 727
Y+ ++R +L T D++S G ++ E++ P
Sbjct: 230 ------YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKT------------KVAIKRSNPSSEQGV 566
A + GTR + V G G+ E ++ + +V +K +PS
Sbjct: 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIA 60
Query: 567 HEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQR 626
F ++S++ H HL + G C E I+V +++ +G L L K +K +P +
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWK 119
Query: 627 LEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA-------KVSDFGLSKTGPN 679
+ + A L YL ++H +V NILL A K+SD G+S T +
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 680 LNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEV 722
+ V + ++ PE L+ +D +SFG L E+
Sbjct: 177 -REERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG--AARGLHYL 640
++V L + + + LV + G L H+ K +P E C+ AA + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK--FLNIP-----EECVKRWAAEMVVAL 98
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFG-LSKTGPNLNQTHVSTMVKGSFGYLDPE 699
R I+ RD+ NILLD++ +++ F S+ + + V M Y PE
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVL 723
+ TE D +S G +LFE+L
Sbjct: 153 VGGISEETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 18/97 (18%)
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
G+ +LH+ IIHRD+K +NI++ K+ DFGL++T S M+ Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMMT---PY 177
Query: 696 LDPEYFRRQQL------TEKSDVYSFGVVLFEVLCAR 726
+ Y+R ++ E D++S G ++ E++
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 71/354 (20%), Positives = 128/354 (36%), Gaps = 61/354 (17%)
Query: 400 FKQNDTMGNLAGPNPVPSAMLLHAEATKKKFAPSSSRSKTVVHVIGGVAGGVFGIAVATA 459
F ++ + ++A P AEA +K + R+ G + A A
Sbjct: 40 FDEDGRLAHIAEILPNAEEC---AEAAEKVSIMAPERADPT-----GAHRALEDAAPAGE 91
Query: 460 IIFYVSNKKKNNDGSRCSTSSWLPLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLA 519
++ SN + S G + ++ + + A
Sbjct: 92 LLVPRSNAD-LFASAGDGPS------GAEDSDASHLDFDEAPPDAAGPVP------LAQA 138
Query: 520 EIKHGTRNFSESHVIG---VGGFGKVYEGYIDGKTKVA-IKRSNPSSEQGVH-------- 567
++KH + VI G FGK++ + T+ A +R S+ QG
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 568 ----------EFQTEIEMLSKLRHKHLVSL--IGFCEEDGEMIL------VYDYMANGTL 609
+ + EI L +L H++++ + I E + MI +Y +M +
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF 258
Query: 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669
+K D+P L KQ I + Y+H +IHRD+K NI L+ + +
Sbjct: 259 D---WK-DRPLL--KQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309
Query: 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
DFG + + V G+ PE E +D++S G++L ++L
Sbjct: 310 DFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 12/93 (12%)
Query: 533 VIGVGGFGKVYEGYIDGKT------KVAIKRSNP---SSEQGVHEFQTEIEMLSKL-RHK 582
++G G FGKV EG G + KVA+K P SSE+ +E+++++ L H
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK--QALMSELKIMTHLGPHL 101
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYK 615
++V+L+G C + G + ++ +Y G L +L+K
Sbjct: 102 NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 45/169 (26%), Positives = 61/169 (36%), Gaps = 56/169 (33%)
Query: 534 IGVGGFGKVYEGYIDGKT-----KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG VY+ + K K +K++ E G EI M ++R S
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---EYG----AVEIWMNERVRRACPNSCA 192
Query: 589 GFC---------EEDGEMILVYDYMANGTL------REHLYK------GDKPGLP----- 622
F +++ E LV+ Y TL +E Y G LP
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLER 252
Query: 623 --------WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK 663
+Q L A GLH TG I+HRDVK NI+ E
Sbjct: 253 ENKIIQTIMRQILF----ALDGLH--STG----IVHRDVKPQNIIFSEG 291
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 14/147 (9%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVS--LIGFC 591
+ G +VY + K + + + NPS E+G + E+ +L L K L ++
Sbjct: 6 LKGGLTNRVY--LLGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E DG L+ +++ TL E + +++ +I A L LH + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGP 678
D+ NIL+D+ + D+ + GP
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 30/108 (27%), Positives = 43/108 (39%), Gaps = 28/108 (25%)
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL--SKTGPNLNQTHVS 686
+C+ L LH R K+ NILL W+ + G KT
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILL--TWDGLLKLDGSVAFKTPEQSRPDPY- 69
Query: 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLP 734
++ PE + Q TEK+D+YS G+ L+E AL+ LP
Sbjct: 70 --------FMAPEVIQGQSYTEKADIYSLGITLYE------ALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 25/83 (30%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698
Y+H IIHRD+KT N+L++ + + DFG + T + G+ P
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 699 EYFRRQQLTEKSDVYSFGVVLFE 721
E T D++S G+V+FE
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 862 | |||
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.57 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.27 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.97 | |
| PLN02236 | 344 | choline kinase | 96.52 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.18 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.05 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.04 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.89 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.5 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.06 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.05 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.32 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.14 |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=492.88 Aligned_cols=322 Identities=37% Similarity=0.572 Sum_probs=249.4
Q ss_pred EecCCCC----CCCCCCCCeeecCCccc-cCCCCcceeeccCCCCCCCCCCccceeeeeecCceEEEEc--C--CCCeEE
Q 041565 38 LACGASS----DGTDSNDRKWTSDSKFL-TNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTV--S--SKDRFW 108 (862)
Q Consensus 38 I~CG~~~----~~~~~~~~~w~~D~~~~-~g~~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~~~~y~~--~--~~~~yl 108 (862)
||||++. +.++.+||+|++|..|+ +|.++++++.... ......++|+|||+||.+.++||++ . +++|||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~--~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yl 78 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDS--SSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYL 78 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCC--cCCccccccceEEEcCCCCccEEEeeccCCCCceEE
Confidence 8999853 34557899999999999 7888888432211 1234567799999999888899988 3 456999
Q ss_pred EEEEEecCCCCCCCCCC------c-ee--EEEeCceEEEecccchhhhhhcccccEEEEEEEccCCCCcEEEEEecCCCC
Q 041565 109 LRLHFYPASYGNLDPSN------A-YF--SVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDH 179 (862)
Q Consensus 109 vR~~F~~~~yg~~d~~~------~-~~--~v~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~l~f~~~~~~ 179 (862)
||+||+ |||||+.+ . .| ++++|.|.+|+..+ + ...++++||++....++.+.|||+|++
T Consensus 79 iRl~F~---~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~-~------~~~~~~~E~ii~v~~~~~l~vclv~~~-- 146 (347)
T PF12819_consen 79 IRLHFY---YGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSN-S------PSSPVVKEFIINVTWSDTLSVCLVPTG-- 146 (347)
T ss_pred EEEEec---cccccccccccccCCcceEEEECCceeEEEEecC-C------CcceEEEEEEEEEcCCCcEEEEEEeCC--
Confidence 999999 99999764 1 24 88889999998764 2 236789999887776799999999987
Q ss_pred CCCc-ceeeeeEEEECCCcCCCCCccccccccccccccceeeeEEeecCccc-cCCCCCCCCcccccCCCCceecCCCcc
Q 041565 180 KDSY-AFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKF-IPSTNDSGLTRTWYDDSPYLFGAAFGV 257 (862)
Q Consensus 180 ~~~~-pfisaiE~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~G~~~-v~~~~dd~~~R~W~~d~~~~~~~~~~~ 257 (862)
.|+ |||||||||||++ .+|+... ...+++|++++|+||||.. .+||+||++||+|.+ |. ..
T Consensus 147 -~g~~pFIsaiEl~~lp~---~ly~~~~-----~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~---~~-----~~ 209 (347)
T PF12819_consen 147 -SGTFPFISAIELRPLPD---SLYPDTD-----ANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQP---YS-----SS 209 (347)
T ss_pred -CCCCCceeEEEEEECCc---cceeccc-----cCCCceeEEEEeecCCCcccccCCCCCcceeeccc---cc-----cC
Confidence 465 9999999999994 5552210 1256789999999999874 479999999999962 20 02
Q ss_pred ccccCCCceeec--CCCCCccccchHHHHHhhhcCCCCCcccceeeEEEEecCCCceEEEEEeeeeeee--eccCcEEEE
Q 041565 258 ASQADNKTKIEY--PSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILL--TKINQRVFD 333 (862)
Q Consensus 258 ~~~~~~~~~~~~--~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~l~~~~~~~~~~~y~v~lhFae~~~--~~~~~R~F~ 333 (862)
..|...++.... ....+.|.||.+||+||++|+..+ ..++|+|.+ +++++.|+|+||||||+. ...++|+||
T Consensus 210 ~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~ 285 (347)
T PF12819_consen 210 PGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFD 285 (347)
T ss_pred ccccccccceeeecccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEE
Confidence 234444443323 245677999999999999987653 338899998 999999999999999995 455689999
Q ss_pred EEEcCccccccCchhc-ccccCCcceEEEEEEEEcCCCCCceeEEEeCCCCCCCchhhhhhccceeeeec
Q 041565 334 IFINNQTAQEGADVIG-WAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQ 402 (862)
Q Consensus 334 i~ing~~~~~~~di~~-~~~~~~~p~y~~~~v~v~~~~~~~~l~v~l~~~~~~~~s~l~~iln~l~i~~~ 402 (862)
|||||+.+.+ |+.. +.+...+|+|.++.+.++.. +.++|+|++ +..+.++||||++|||++
T Consensus 286 IyiN~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~---~~~~isL~~---t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 286 IYINGQTAYS--DVSPPYLGADTVPYYSDYVVNVPDS---GFLNISLGP---TPDSTLPPILNALEIYKV 347 (347)
T ss_pred EEECCeEccC--ccCcccccCcceEeecceEEEecCC---CEEEEEEEe---CCCCCcCceeEeeeeEeC
Confidence 9999999987 6554 45567889999999887653 378899999 667778999999999963
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=492.96 Aligned_cols=291 Identities=50% Similarity=0.846 Sum_probs=259.4
Q ss_pred cccccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEE
Q 041565 512 LCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591 (862)
Q Consensus 512 ~~~~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 591 (862)
..+.|++.||+.||++|+..++||+|+||.||+|.++++..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45789999999999999999999999999999999999989999988765443156799999999999999999999999
Q ss_pred eecC-eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEee
Q 041565 592 EEDG-EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSD 670 (862)
Q Consensus 592 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~D 670 (862)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999976543699999999999999999999999888999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc
Q 041565 671 FGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
||+|+..+.. .....+...||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+.....+.+|++.....
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999876541 122221117999999999999999999999999999999999999999876656666799999999999
Q ss_pred CccccccCCCCC-CCCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 751 GTIEDIIDPNLK-GNITD-QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 751 ~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+.+.+++|+.+. +.... ++..++..++.+|++.+|.+||+|.||+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999998 56554 688889999999999999999999999999966543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=501.70 Aligned_cols=326 Identities=22% Similarity=0.318 Sum_probs=249.0
Q ss_pred CCCcEEEecCCCCCC-CCCCCCeeecCCccccCCCCcceeeccCCCCCCCCCCccceeeeeec--CceEEEEc--CCCCe
Q 041565 32 DSNSYVLACGASSDG-TDSNDRKWTSDSKFLTNSGNSITATAQSQDSSLPSTIPYMTARIFKS--TSSYKFTV--SSKDR 106 (862)
Q Consensus 32 ~~~~~~I~CG~~~~~-~~~~~~~w~~D~~~~~g~~~~~~~~~~~~~~~~~~~~~~~t~R~F~~--~~~~~y~~--~~~~~ 106 (862)
++++|+||||++.+. +|.+||+|++|..|..|.....+ .+ ....++|+|+|+||. +.++||++ .++||
T Consensus 22 ~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~----~~---~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~ 94 (623)
T PLN03150 22 EPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANAT----RP---SFIAPPLKTLRYFPLSDGPENCYNINRVPKGH 94 (623)
T ss_pred CCccEEEeCCCCCCcccCCCCCEEcCCcccccCcccccc----Cc---ccccchhhccccCCcccccccceEeeecCCCc
Confidence 468999999998765 56689999999888654443333 11 123456999999995 44777777 68899
Q ss_pred EEEEEEEecCCCCCCCCCCc--eeEEEeCc--eEEEec-ccchhhhhhcccccEEEEEEEccCCCCcEEEEEecCCCCCC
Q 041565 107 FWLRLHFYPASYGNLDPSNA--YFSVNANG--FTLLNN-FSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHKD 181 (862)
Q Consensus 107 ylvR~~F~~~~yg~~d~~~~--~~~v~~~~--~~~~~~-~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~l~f~~~~~~~~ 181 (862)
|+||+||+ |||||+.++ .|+|.+++ |.+|.. ++. ....+++|+++ .+.++.+.|||+|.+ +
T Consensus 95 ylVRl~F~---~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~-------~~~~v~~E~i~-~~~~~~l~vcf~~~~---~ 160 (623)
T PLN03150 95 YSVRVFFG---LVAEPNFDSEPLFDVSVEGTQISSLKSGWSS-------HDEQVFAEALV-FLTDGSASICFHSTG---H 160 (623)
T ss_pred EEEEEEee---cCCcCCCCCCCceEEEECcEEEEEEecCccc-------CCCcEEEEEEE-EecCCcEEEEEecCC---C
Confidence 99999999 888887654 46666655 777754 332 24578999976 455678999999865 6
Q ss_pred CcceeeeeEEEECCCcCCCCCccccccccccccccceeeeEEeecCcccc---CCCCCCCC--cccccCCCCceecCCCc
Q 041565 182 SYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFI---PSTNDSGL--TRTWYDDSPYLFGAAFG 256 (862)
Q Consensus 182 ~~pfisaiE~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~G~~~v---~~~~dd~~--~R~W~~d~~~~~~~~~~ 256 (862)
++||||+||||+|+| .+|..... .. .+.+|+++||+||||+.+ .+|+||++ ||+|.+|++|+.+.
T Consensus 161 ~~pFIs~iEv~~l~~---~~y~~~~~---~~-~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~--- 230 (623)
T PLN03150 161 GDPAILSIEILQVDD---KAYNFGPS---WG-QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGS--- 230 (623)
T ss_pred CCCceeEEEEEEcCc---cccccccc---cc-CceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCc---
Confidence 899999999999995 44432210 01 245799999999998754 68999999 99999999987332
Q ss_pred cccccCCCceeecCCCCCccccchHHHHHhhhcCCCCCcccceeeEEEEecCCCceEEEEEeeeeeee--eccCcEEEEE
Q 041565 257 VASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILL--TKINQRVFDI 334 (862)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~l~~~~~~~~~~~y~v~lhFae~~~--~~~~~R~F~i 334 (862)
....+....|++. ..+.+.+|+.|||||+++.. ...+++|.|+++++..|+|||||||++. ...++|+|||
T Consensus 231 -~~~~st~~~I~~~-~~~~~~~P~~VyqTA~~~~~-----~~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V 303 (623)
T PLN03150 231 -DQAISTENVIKKA-SNAPNFYPESLYQSALVSTD-----TQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDV 303 (623)
T ss_pred -ccccccccccccc-cCCCccChHHHhhhhccccC-----CCCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEE
Confidence 1123333445443 34678999999999999553 2257999999999899999999999972 4668899999
Q ss_pred EEcCccccccCchhcccccCCcceEEEEEEEEcCCCCCceeEEEeCCCCCCCchhhhhhccceeeeeccC
Q 041565 335 FINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQND 404 (862)
Q Consensus 335 ~ing~~~~~~~di~~~~~~~~~p~y~~~~v~v~~~~~~~~l~v~l~~~~~~~~s~l~~iln~l~i~~~s~ 404 (862)
||||+.+++++||..++++...++|+++.+.++. +.++|+++| ...+ +|+||++|+|++..
T Consensus 304 ~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~----g~l~isl~p---~~~s--~pilNaiEI~~~~~ 364 (623)
T PLN03150 304 LINGDTAFKDVDIVKMSGERYTALVLNKTVAVSG----RTLTIVLQP---KKGT--HAIINAIEVFEIIT 364 (623)
T ss_pred EECCEEeecccChhhhcCCcccceEEEeEEeecC----CeEEEEEee---CCCC--cceeeeeeeeeccc
Confidence 9999999999999998888889999999887652 569999988 3333 69999999998765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=405.91 Aligned_cols=255 Identities=36% Similarity=0.589 Sum_probs=214.0
Q ss_pred cceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh--hhHHHHHHHHHHHHhccccceeeEEEEEeecC-eEEEEEEeCCC
Q 041565 530 ESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG-EMILVYDYMAN 606 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~ 606 (862)
..+.||+|+||+||+|.+++...||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3456999999999999998876799999876432 22669999999999999999999999999887 79999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCCCCCccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 685 (862)
|+|.++|++.....+++..+++|+.|||+||+|||+++. ||||||||+||||+.++ ++||+|||+++...... ..
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 999999988544559999999999999999999998753 99999999999999997 99999999998743211 23
Q ss_pred cccccCCCCCCChhhhh--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~--~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.+...||..|||||++. ...++.|+|||||||+||||+||+.||..... .+ .+.. ++....+.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~--~~~~------------v~~~~~Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ--VASA------------VVVGGLRP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH--HHHH------------HHhcCCCC
Confidence 34467999999999999 66999999999999999999999999976543 11 1111 11222334
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.++..++..+..++.+||+.+|..||++.+++..|+.+..
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 4444578889999999999999999999999999998865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=396.37 Aligned_cols=253 Identities=30% Similarity=0.445 Sum_probs=213.7
Q ss_pred cceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 530 ESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
..+.||+|-||.||.|.+++...||+|.++.. ....++|.+|+.+|++|+|+|||+++|+|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 36789999999999999999989999988765 33457899999999999999999999999999899999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.++|....+..+...+++.++.|||+||+||++++ +|||||.++||||+++..+||+||||||... .+........
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~~ 364 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASEGG 364 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC-CCceeecCCC
Confidence 99999866667999999999999999999999887 9999999999999999999999999999533 2333444445
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQ 768 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 768 (862)
.-...|.|||.+..++++.|||||||||+||||+| |+.|+......+ ......+ ..+-..+..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~----------GyRlp~P~~ 428 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLER----------GYRLPRPEG 428 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhc----------cCcCCCCCC
Confidence 56778999999999999999999999999999997 777765433222 2222222 222223445
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 769 CLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 769 ~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
|+..+.+++..||+.+|++|||++.+...|+....
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 88999999999999999999999999988887643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=378.11 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=214.2
Q ss_pred ccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEe
Q 041565 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592 (862)
Q Consensus 515 ~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 592 (862)
..++.||+. .+.||+|..|+|||+.++. +..+|+|.+... .....+++.+|++++++.+||+||.++|.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355666654 5789999999999999874 678899988543 4556789999999999999999999999999
Q ss_pred ecC-eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 593 EDG-EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 593 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
.++ +..++||||++|+|++++...++ +++..+-+|+.++++||.|||+. ..||||||||+|||++..|++|||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 998 59999999999999999986643 99999999999999999999962 35999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
|.++...+. ......||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+. .. +|...
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~---~~~~L----- 290 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL---DIFEL----- 290 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC---CHHHH-----
Confidence 999875432 344567999999999999999999999999999999999999999754211 11 12111
Q ss_pred ccccccCCCCCCCCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 TIEDIIDPNLKGNITD-QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+..+++... ...+. .++.+++.++..||+++|.+||++.|+++|-.-.
T Consensus 291 -l~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 291 -LCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred -HHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 122222111 11222 4788899999999999999999999999887654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=403.48 Aligned_cols=261 Identities=30% Similarity=0.488 Sum_probs=218.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
+.+....+.||+|.||+||+|...+ ...||||.++..... ..++|++|+++|+.++|||||+|+|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3344556789999999999998543 357999999876544 789999999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCC------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc
Q 041565 598 ILVYDYMANGTLREHLYKGD------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 665 (862)
++|+|||..|+|.++|+... +.+|+..+.+.||.|||.||+||-++. +|||||..+|+|+.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997421 223889999999999999999999876 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 041565 666 AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWA 744 (862)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 744 (862)
|||+||||+|..-..++.+......-.++||+||.+..+++|.+||||||||+|||+++ |+.|+.+-...+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------- 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------- 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence 99999999998766555554434445679999999999999999999999999999996 8888866544332
Q ss_pred HhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 745 LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 745 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..+.+.+++. ..++.|+.++.+|+..||+.+|.+||+++||-..|+...+.
T Consensus 715 Ie~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2223333321 23556899999999999999999999999999999988643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.65 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=205.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.+|...+.||+|+||+||+|+++ .+..||||.+... .++..+....|+.+|+.++|||||+|++++...+.++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777788999999999999976 4688999988765 56666778899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC------CceEEeecccccc
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK------WEAKVSDFGLSKT 676 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~------~~~kl~DFGla~~ 676 (862)
||.+|+|.++|+++.. +++.....++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998764 999999999999999999999988 9999999999999764 4689999999998
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
+.. .......+|++-|||||+++.++|+.|+|+||.|+++||+++|++||+.....+-.. ....
T Consensus 165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~------~~~k------- 228 (429)
T KOG0595|consen 165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL------YIKK------- 228 (429)
T ss_pred CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhc-------
Confidence 653 344566899999999999999999999999999999999999999998665444321 1111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
+..+...++......+.++....++.++.+|-+..+-..+
T Consensus 229 -~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 229 -GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred -cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1112222233344445677777777777777776665544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=376.81 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=211.9
Q ss_pred cCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
..|...+.||+|||+.||+++. ..|..||+|.+... .....+...+|+++.+.|+|||||++++++++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999997 77899999987652 3344567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|+|++++|.+++.++ ..+++.+++.+++||+.||.|||+.+ |||||||..|+||+++.++||+|||||.......
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999998744 34999999999999999999999877 9999999999999999999999999998865432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
+.....+||+.|.|||++.....+..+||||+||+||-||.|++||+...-.+.- ..-...+..
T Consensus 173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety----------~~Ik~~~Y~---- 236 (592)
T KOG0575|consen 173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY----------NKIKLNEYS---- 236 (592)
T ss_pred --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH----------HHHHhcCcc----
Confidence 2345678999999999999999999999999999999999999999754221111 000111111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+...+.+..+||.++|+.+|.+|||+.+|+.+-.+
T Consensus 237 ---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 ---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ---cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 122345677899999999999999999999988776
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=360.33 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=205.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-------hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-------QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
.|...+.||+|+||.|-+|..+ .|+.||||++....- .......+|+++|++|+|||||+++++++..+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 3566789999999999999854 688999998764311 12234579999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeeccccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDFGLSK 675 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DFGla~ 675 (862)
+|||||+||.|.+.+-.+.. +.+..-..++.|++.|+.|||++| |+||||||+||||..+ ..+||+|||+|+
T Consensus 253 mVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999987654 778888899999999999999988 9999999999999766 779999999999
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCC---CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL---TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
.... ...+...+||+.|.|||++.++.. ..|.|+||+||+||-++||.+||...... .++.+- ...|+
T Consensus 328 ~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQ----I~~G~ 398 (475)
T KOG0615|consen 328 VSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQ----ILKGR 398 (475)
T ss_pred cccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHH----HhcCc
Confidence 8543 345667899999999999977543 34889999999999999999999754322 112111 11111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
... ......+..++..+++.+||..||++|||+.|++++.|.-
T Consensus 399 y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 399 YAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 110 0112235677889999999999999999999999998875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=345.25 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=209.2
Q ss_pred CcccceeEeeeCcEEEEEEEE-cCccEEEEEecCC--CChhhHHHHHHHHHHHHhccccceeeEEEE-EeecCe-EEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNP--SSEQGVHEFQTEIEMLSKLRHKHLVSLIGF-CEEDGE-MILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 601 (862)
+|.+.++||+|.||+|||+.. .+|..+|.|.+.- .+.+..++...|+.+|++|+|||||+.+++ +.++.+ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 477788999999999999984 5788899998763 355667889999999999999999999984 455555 89999
Q ss_pred EeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCC-cccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGA-RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
|+|..|+|...+.. ..+..++++.+++++.|+++||+++|++- +..|+||||||.||+|+.+|.+||+||||+|...
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999874 34456999999999999999999999843 1349999999999999999999999999999865
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. ........||+.||+||.+....|+.||||||+||++|||+.-++||.+. ++.+.-... ..+
T Consensus 180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI-~qg------- 243 (375)
T KOG0591|consen 180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI-EQG------- 243 (375)
T ss_pred ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH-HcC-------
Confidence 42 23345578999999999999999999999999999999999999999765 222211111 111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.......+-.+.++.+++..|+..||..||+...+++.+...+
T Consensus 244 -d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 244 -DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred -CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 1111122457889999999999999999998766666665543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=384.31 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=213.6
Q ss_pred cccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
..+.++||.|.||.||+|+++- ...||||.++.. .+....+|+.|+.||.+..||||++|.|........++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3457899999999999999763 356999999875 45567899999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||+||+|+.+|+.++.+ +++.++..++++||.||.||-+.+ +|||||.++|||++.+..+||+||||+|...+...
T Consensus 711 yMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999988765 999999999999999999999766 99999999999999999999999999997654332
Q ss_pred cc-ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCC-CCCCccccccHHHHHHhhhccCccccccCC
Q 041565 683 TH-VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPAL-NVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 683 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.. ....-+-..+|.|||.+...+++.+||||||||+|||.++ |.+|+ ++.+.+-. ..++.
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-----------------kaIe~ 849 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-----------------KAIEQ 849 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-----------------HHHHh
Confidence 21 2222233578999999999999999999999999999875 66665 33321111 11222
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..+-..+.+|+..|.+|++.||+++..+||.+.||+..|+.++.-
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 333344567999999999999999999999999999999998743
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=366.59 Aligned_cols=270 Identities=27% Similarity=0.459 Sum_probs=217.7
Q ss_pred ccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEe
Q 041565 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592 (862)
Q Consensus 515 ~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 592 (862)
+.+.++.....+.+...+.||+|.||+||+|.+.+. ||||.+... ..+..+.|+.|+.++++-+|.||+-+.|||.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 344466666666677788999999999999998875 999987654 4567889999999999999999999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
+.+. .+|+.+|++.+|..+|+... ..+...+.+.||+|||+||.|||.++ |||||||..||+|+++++|||+|||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 8877 99999999999999998765 34999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
|+................|...|||||++.. ..|+..+||||||+|+|||+||..|+.....++..- .
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif---------m 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF---------M 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE---------E
Confidence 9965332222222333457889999999975 468999999999999999999999998433333221 1
Q ss_pred cCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.++-.-..|.. .....|++++.+|+..||..++++||.+.+|+..|+.++.
T Consensus 605 VGrG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 VGRGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ecccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11110011111 1223578899999999999999999999999999988864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.48 Aligned_cols=266 Identities=27% Similarity=0.423 Sum_probs=217.8
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+.......++||+|-||.|..+..+++..||||.++.... ...++|.+|+++|.+|+|||||+|+|.|..++.+++++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3445566789999999999999999999999999987644 445899999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++|+|.++|.++..+.+.-...++||.|||.||+||.+-. +|||||.++|+|+|.++++||+|||++|.....+.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999999886555677788899999999999999766 99999999999999999999999999997655555
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHH--hCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL--CARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.+......-.++|||+|.+..++++.++|||+||++|||++ |...|+.....++.. +-+......+....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQV----- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcce-----
Confidence 55555556778999999999999999999999999999975 667777544332221 11111111111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....+.-|+.++.+++.+||..+-.+||+++++...|...
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112334788999999999999999999999999888754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.97 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=206.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|+..++||+|+||+||.++.++ ++.+|+|.++.. .....+...+|..+|.+++||.||+++-.+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4578899999999999999998654 678999987653 234567788999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
+||+.||.|..+|.+... +++....-++.+|+.||.|||+++ ||||||||+|||||++|.++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 999999999999987655 899999999999999999999988 99999999999999999999999999996433
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
....+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||......+. ....... +
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~---------k 241 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKG---------K 241 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcC---------c
Confidence 22344557999999999999999999999999999999999999999976543221 1111111 1
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP----SMGDVLWN 797 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP----t~~evl~~ 797 (862)
+ ...+.-...+.++++...++.+|++|. ...+|.+|
T Consensus 242 ~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 0 111111345678999999999999995 56666554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.88 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=205.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEeec-
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED- 594 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 594 (862)
+.++|...++||+|+||.||+|... .+..||+|++.... ....+.+.+|++++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888999999999999999742 23579999886533 33456789999999999 899999999998764
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCC---------------------------------------------------------
Q 041565 595 GEMILVYDYMANGTLREHLYKGD--------------------------------------------------------- 617 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 617 (862)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999997532
Q ss_pred ---CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCC
Q 041565 618 ---KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694 (862)
Q Consensus 618 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (862)
...+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 124788899999999999999999877 99999999999999999999999999986432221112223346678
Q ss_pred CCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHH
Q 041565 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKF 773 (862)
Q Consensus 695 y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 773 (862)
|+|||++.+..++.++|||||||++|||++ |+.||......+. ...... .+.. .. .+..++..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~-~~~~-----~~----~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLK-DGTR-----MR----APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHh-cCCC-----CC----CCCCCCHHH
Confidence 999999999999999999999999999997 9999865432211 111111 1110 01 112345678
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 774 TETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 774 ~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.+++.+||+.+|.+|||+.|+++.|+.+++
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.15 Aligned_cols=265 Identities=24% Similarity=0.307 Sum_probs=209.0
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.|+...++|+|+||.|||++.++ |+.||||++.... +...+-.++|+++|++|+|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667789999999999999765 7899999986543 34456688999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|+. ++.+-|.+.. .+++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||.||.... ..
T Consensus 83 ~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG 155 (396)
T ss_pred cch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence 987 5555555544 34999999999999999999999877 99999999999999999999999999998653 23
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH---------hhhccCcc
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL---------HCQRMGTI 753 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~ 753 (862)
...+....|..|.|||.+.+ ..|....|||+.||++.||++|.+.|.+...-++..++.... .....+-+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44566778999999999988 789999999999999999999999998877666654432211 01111111
Q ss_pred ccccCCCC--CCCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 754 EDIIDPNL--KGNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 754 ~~~~d~~l--~~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
..+.-|.. .... -.....-+.+++..|++.||++|++.+|++.+-
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 11111111 1111 112345678999999999999999999998663
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=385.72 Aligned_cols=262 Identities=29% Similarity=0.479 Sum_probs=215.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC--c----cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG--K----TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
..+.+..+.||+|.||.||+|...+ + ..||+|.+... +.+...+|++|..+|++++|||||+++|.|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4455667899999999999999654 2 24899988764 567788999999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCC-----CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 598 ILVYDYMANGTLREHLYKGD-----KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
++++|||++|+|..+|++.. ...|+..+++.++.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998751 335899999999999999999999887 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccC
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
|||.....+.........-...|||||.++.+.++.|+|||||||+|||++| |..|+......+... .| .+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~----~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DV----LEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HH----HhCC
Confidence 9996544444333333234568999999999999999999999999999997 777876544333221 11 1222
Q ss_pred ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 752 TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
++ ..+..|+.++.+++..||+.+|++||+++.+++.+..+.+..
T Consensus 922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 22 224458889999999999999999999999999888877543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=362.17 Aligned_cols=271 Identities=27% Similarity=0.448 Sum_probs=217.9
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcCc----cE-EEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEE
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGK----TK-VAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLI 588 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~ 588 (862)
....++...++....++||+|.||.||+|.++-+ .. ||||..+. ..+....+|.+|+++|++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 3344444555556678999999999999997542 23 89998774 4577789999999999999999999999
Q ss_pred EEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEE
Q 041565 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668 (862)
Q Consensus 589 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl 668 (862)
|++..+..+++|||+|+||+|.++|.+... .++..+++.++.++|+||+|||+++ +|||||.++|+|++.++.+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999987654 5999999999999999999999887 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+||||++.... .........-...|+|||.+..+.++.++|||||||++||+.+ |..|+.+....+ ...++.
T Consensus 304 SDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~-- 376 (474)
T KOG0194|consen 304 SDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV-- 376 (474)
T ss_pred CccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH--
Confidence 99999987541 1111112245678999999999999999999999999999997 788886543221 111110
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCCCC
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNP 808 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~~~ 808 (862)
....+-..+...+..+..++.+||..+|++||+|.++.+.|+.+......+
T Consensus 377 ----------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 377 ----------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ----------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111112223345677888999999999999999999999999987665544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=347.06 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=207.8
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC--eEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG--EMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~ 603 (862)
++...+.||+|.||.||++...+ |...|||.....+....+.+.+|+.+|.+++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45667899999999999999765 7789999876554333677899999999999999999999854443 69999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeeccccccCCC-CC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPN-LN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~~~~-~~ 681 (862)
+++|+|.+++.+... .|++..+...++||++||+|||+++ ||||||||+||||+. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999988765 6999999999999999999999887 999999999999999 79999999999986542 11
Q ss_pred CccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.........||+.|||||++..+ ....++|||||||+++||+||++||... .+ ..++........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~---~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE---EAEALLLIGRED--------- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc---hHHHHHHHhccC---------
Confidence 12223456799999999999964 3445999999999999999999999653 11 111111111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..+.++...+.+..+++..|++.+|.+|||+.+++++.....+.
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11234445677889999999999999999999999988765433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=352.40 Aligned_cols=241 Identities=29% Similarity=0.516 Sum_probs=203.6
Q ss_pred cceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 530 ESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
+.+-||.|+.|.||+|++++. .||||+++... ..+|+-|++|+|+||+.+.|+|.....+|+|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~ne-tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNE-TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeeccCc-eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 467899999999999999876 69999876432 3578889999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+.|+.... ++...+..|.++||.||.|||.+. |||||||+-||||..+-.+||+|||-++..... ...-.+
T Consensus 200 ~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 200 YEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 999986543 888999999999999999999765 999999999999999999999999999865432 223346
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
+||..|||||++.+...++|.|||||||||||||||..|+..-...... | .. -...|.-..+..|
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-----GV------GsNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-----GV------GSNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-----ec------cCCcccccCcccC
Confidence 7999999999999999999999999999999999999998533221111 1 11 1122333456678
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+..|.-|+++||+..|.+||++++++.||+-+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999999999999999865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.67 Aligned_cols=266 Identities=25% Similarity=0.377 Sum_probs=211.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.+.|...++||.|..++||+|+. ..+..||||++... .....+.+.+|+..|+.++||||++.+..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 45678889999999999999995 45688999998754 33446889999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||.+|++.+.+...-...+++..+..|.+++++||.|||++| .||||||+.||||+++|.+||+|||.+-.+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999999877777999999999999999999999887 99999999999999999999999998754433221
Q ss_pred cc-cc-ccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 683 TH-VS-TMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 683 ~~-~~-~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .. ....||+.|||||+++. ..|+.|+|||||||+.+||.+|+.||....+-+.. + ..++ +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-l----~tLq--n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-L----LTLQ--NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-H----HHhc--CCCCCccc
Confidence 11 11 45679999999999654 57999999999999999999999999755432221 0 1111 11111001
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+..+........+.+++..||+.||.+|||+++++++-.+
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 111112222345678999999999999999999999987554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.16 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=204.4
Q ss_pred ccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh---hHHHHHHHHHHHHhccccceeeEEEEE
Q 041565 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ---GVHEFQTEIEMLSKLRHKHLVSLIGFC 591 (862)
Q Consensus 515 ~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~ 591 (862)
.++.+++.. .....||+|++|.||+|.++ +..||||.+...... ..+.|.+|+.+|++++||||++++|++
T Consensus 14 ~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDIDK-----YTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHcCC-----CCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 345555532 22368999999999999984 568999988754322 257788999999999999999999998
Q ss_pred ee----cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceE
Q 041565 592 EE----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAK 667 (862)
Q Consensus 592 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~k 667 (862)
.+ ....++||||+++|+|.+++.... .+++...++++.+++.||+|||+.. .++||||||+|||+++++.+|
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEE
Confidence 76 357899999999999999997653 4899999999999999999999742 378999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 041565 668 VSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 745 (862)
|+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..
T Consensus 164 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~--- 232 (283)
T PHA02988 164 IICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD--- 232 (283)
T ss_pred EcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH---
Confidence 99999998643211 12357889999999976 6899999999999999999999999975432211 11
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.....+ .....+..++..+.+++.+||+.+|.+|||+.|+++.|+...
T Consensus 233 ~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 110000 011122235678999999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.42 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=202.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-----------------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-----------------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSL 587 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 587 (862)
++|...++||+|+||.||++.+++ +..||+|.+... ......+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999998542 236999987754 34456789999999999999999999
Q ss_pred EEEEeecCeEEEEEEeCCCCcHHHHHhcCC-----------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEe
Q 041565 588 IGFCEEDGEMILVYDYMANGTLREHLYKGD-----------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650 (862)
Q Consensus 588 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 650 (862)
++++.+.+..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986431 123788899999999999999999877 999
Q ss_pred eCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCC
Q 041565 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPA 728 (862)
Q Consensus 651 rDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt--G~~p 728 (862)
|||||+|||+++++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986433222222233446788999999999999999999999999999987 4556
Q ss_pred CCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 729 LNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+......+ ............... .....+..++..+.+++.+||+.+|.+|||+.||.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 65432211 112221111111000 000112235678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.14 Aligned_cols=268 Identities=22% Similarity=0.295 Sum_probs=213.5
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChh--hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQ--GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|...++||+|.||.||+|+.. .|+.||||+++..... ......+|++.|+.++|+||+.|++++...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5667789999999999999954 5789999998765322 235678999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|+. +|...++.... .++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++.....+..
T Consensus 83 m~t-dLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ccc-cHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 975 89988876554 4899999999999999999999988 999999999999999999999999999987654333
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc-------
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED------- 755 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------- 755 (862)
.+...-|..|.|||.+.+ +.|+...|+||.||++.||+-|.+-|.+..+-++...+--+.....+..+.+
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 233367889999999987 5799999999999999999999998888776666544322222111111111
Q ss_pred -----ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 756 -----IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 756 -----~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.-.+.+.. .-..+.....+++..++..+|.+|+++.|++++-.+..
T Consensus 236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 11111111 22235567799999999999999999999999877663
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.64 Aligned_cols=270 Identities=24% Similarity=0.303 Sum_probs=209.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 599 (862)
...|+..++||+|.||.|||++. ..|..||+|+++... .....-..+||.+|++|+||||++|.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34577788999999999999995 568899999877554 33445567999999999999999999998776 78999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|+|||+. +|.-++.... -.+++.++..+++|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||++...
T Consensus 196 VFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999986 8888876543 34999999999999999999999888 99999999999999999999999999997543
Q ss_pred CCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh-----ccCcc
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ-----RMGTI 753 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----~~~~~ 753 (862)
.. ....+..+-|+.|.|||++.+ ..|+.+.|+||.||+|.||+.|++.+.+..+.++...+--...-. ....+
T Consensus 271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 32 223455567999999999987 579999999999999999999999998887766654432110000 00011
Q ss_pred c--cccCCCCC--CCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 754 E--DIIDPNLK--GNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 754 ~--~~~d~~l~--~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. ..+.+... ..+ -...+....+|+..+|..||.+|.|+.++++.-.+
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 0 11111100 000 01133456889999999999999999999987665
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.23 Aligned_cols=250 Identities=36% Similarity=0.572 Sum_probs=196.4
Q ss_pred cceeEeeeCcEEEEEEEEc-----CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 530 ESHVIGVGGFGKVYEGYID-----GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..+.||.|.||.||+|.+. .+..|+||.+... .....++|.+|++.+++++||||++++|+|.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 2467999998653 344578999999999999999999999999988889999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|+|.++|.......+++.++++|+.|+++||+|||+.+ ++|+||+++|||+++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999875556999999999999999999999876 999999999999999999999999999875322222
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ +.... ..+..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~~~~~--------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-KQGQR--------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-HTTEE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-ccccc---------
Confidence 22333446678999999999999999999999999999999 678875432211 11111 11111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
...+..++..+.+++.+||+.+|.+||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223566789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.39 Aligned_cols=269 Identities=20% Similarity=0.275 Sum_probs=212.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHH--HHHHHHHHHhcc-ccceeeEEEEEeecC-eEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHE--FQTEIEMLSKLR-HKHLVSLIGFCEEDG-EMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 600 (862)
++|...++||.|.||.||+|+.. .+..||||+++..-.. .++ -++|+..|++|. |||||+|...+.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46777899999999999999854 5778999998765332 233 468999999998 999999999998877 99999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||||+ .+|.+++..+ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+||||||....
T Consensus 89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc-
Confidence 99996 5999999887 556999999999999999999999887 99999999999999888999999999997543
Q ss_pred CCccccccccCCCCCCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc-----
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE----- 754 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----- 754 (862)
....+....|..|.|||++. .+-|+.+.|+|++||+++|+.+-++.|.+..+.++..-+.-+........+.
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 33456677899999999875 5789999999999999999999999998876665543222111111111110
Q ss_pred -cccC---CCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 755 -DIID---PNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 755 -~~~d---~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+. |...+ ..-..++.++.+++.+|++.||.+|||+.|++++.-+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 0111 11111 1112367889999999999999999999999998765543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=355.00 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=203.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEE------cCccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI------DGKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
.++|+..+.||+|+||.||+|+. +.+..||||+++... ....+.+.+|+++++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44678889999999999999974 234579999886432 33456788999999999 89999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCC-----------------------------------------------------------
Q 041565 597 MILVYDYMANGTLREHLYKGD----------------------------------------------------------- 617 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 617 (862)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred --------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 618 --------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 618 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
...++|..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999876 999999999999999999999999999865332221
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+... +. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~----~~---------~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKE----GY---------R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHh----Cc---------c
Confidence 12222345678999999999999999999999999999998 888885432211 11111111 10 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...+...+.++.+++.+||+.+|++||++.||++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.70 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=211.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
..|..-++||+|..|.||.+... .+..||||++........+-..+|+.+|+..+|+|||+++..+...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35666789999999999999854 56789999988776666677899999999999999999999998889999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+.+.... +++.++..|++++++||+|||.++ |+|||||..||||+.++.+||+|||++........
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999986543 899999999999999999999888 99999999999999999999999999987543221
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......||+.|||||++....|..|.||||||++++||+-|.+||-...+-... |... ..+ .|.+ .
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl----yLIa--~ng------~P~l--k 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIA--TNG------TPKL--K 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH----HHHh--hcC------CCCc--C
Confidence 344567999999999999999999999999999999999999999643332222 1111 111 1112 2
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.++..+..|.+++.+||+.|+.+||++.|+|+|--.
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 234467789999999999999999999999988654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.41 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=211.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|...+.||+|+||.||||+.+. .+.||+|.+... .++..+...+|+++++.|+|||||.++++++...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 468888999999999999999765 567999987643 44567789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+.+ +|..+|..... ++++.+..|+.++..||.|||+.. |+|||+||.||||+..+.+|+||||+||.+.. .
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9976 99999987655 999999999999999999999876 99999999999999999999999999998643 3
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
..+.+.++||+-|||||.+.++.|+..+|+||+||++||+..|++||.... . ...+..... ||..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i---~~Lv~~I~~--------d~v~- 218 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---I---TQLVKSILK--------DPVK- 218 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---H---HHHHHHHhc--------CCCC-
Confidence 456677899999999999999999999999999999999999999996432 1 111111111 1211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.+......+..++...|.+||.+|.+..+++.|-
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 2335678899999999999999999999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=391.88 Aligned_cols=269 Identities=28% Similarity=0.483 Sum_probs=220.4
Q ss_pred ccCHHHHHhhccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee
Q 041565 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593 (862)
Q Consensus 515 ~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 593 (862)
.++++++.. .+...++||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|+|.+
T Consensus 682 ~~~~~~~~~---~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 682 SITINDILS---SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhhHHHHHh---hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 345555543 466778999999999999997 46789999988654322 2346889999999999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
.+..++|||||++|+|.++++. ++|.++.+|+.|+|+||+|||+.+..+|+||||||+||+++.++.+++. ||.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 9999999999999999999952 8999999999999999999997666679999999999999999888876 666
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
...... .....++..|+|||++.+..++.|+|||||||++|||++|+.|++... .....+.+|+.........
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHL 901 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccch
Confidence 543211 112357899999999999999999999999999999999999985432 2334567788766666666
Q ss_pred ccccCCCCCCC--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 754 EDIIDPNLKGN--ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 754 ~~~~d~~l~~~--~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..++|+.+... .+.++..++.+++.+||+.+|++||+|.||++.|+...+
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 67778777543 345667788999999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.54 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=204.5
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999864 57899999875432 2334568899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999998887654446899999999999999999999877 9999999999999999999999999997643211
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... ....... .. ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~~-~~----------~~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRRV-KE----------DQ 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHHh-hc----------cc
Confidence 123346899999999999999999999999999999999999999754332111 0000000 00 00
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
..++...+..+.+++.+||+.+|.+||+ +.+++++.+.
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 1122234567889999999999999997 8888877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=352.73 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=203.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
.++|+..+.||+|+||.||+++.. ++..||+|++... .......+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 346888899999999999998742 2347999998654 333456788999999999 89999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCC-----------------------------------------------------------
Q 041565 597 MILVYDYMANGTLREHLYKGD----------------------------------------------------------- 617 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 617 (862)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred ---------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccccc
Q 041565 618 ---------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688 (862)
Q Consensus 618 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (862)
...+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123788899999999999999999877 99999999999999999999999999976432211112222
Q ss_pred ccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcH
Q 041565 689 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767 (862)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 767 (862)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ +..... .+ .....+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~~~~~-~~---------~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FYKMVK-RG---------YQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HHHHHH-cc---------cCccCCC
Confidence 345678999999999999999999999999999997 9999865432111 001000 00 0000111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 768 QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 768 ~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+..+.+++.+||+.+|.+||++.++++.|+.++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 13467899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.04 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=209.9
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
+...++|..++.||+|+|++|++|+.. .+..+|||++... .+...+-...|-++|.+| .||.|++|+-.+.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455678999999999999999999965 4788999987643 223344567789999999 89999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+|+|+||+++|.|.++|.+.+. +++.....++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||-|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999988754 999999999999999999999887 99999999999999999999999999987
Q ss_pred CCCCCCc---------ccc--ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 041565 677 GPNLNQT---------HVS--TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 677 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 745 (862)
+...... ... ...+||..|.+||++..+..+..+|+|+|||+||+|+.|.+||....+- .-+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----liF-- 296 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----LIF-- 296 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----HHH--
Confidence 6432111 111 4478999999999999999999999999999999999999999654321 111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+.+++- .-.+++..++...+|+.+.|..+|.+|+|..+|.+|.-
T Consensus 297 --------qkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 297 --------QKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred --------HHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 111111 11223334567889999999999999999999998853
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.64 Aligned_cols=255 Identities=28% Similarity=0.467 Sum_probs=206.7
Q ss_pred CcccceeEeeeCcEEEEEEEEcCc------cEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGK------TKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+|+..+.||+|+||.||+|...+. ..|++|.+.... ....++|.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 577788999999999999986542 468999876443 3445679999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCC--------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc
Q 041565 600 VYDYMANGTLREHLYKGDK--------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 665 (862)
+|||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999975421 34788999999999999999999877 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 041565 666 AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWA 744 (862)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 744 (862)
+||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +....
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999986533322222333456788999999999999999999999999999998 999986543322 11111
Q ss_pred HhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 745 LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 745 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. .+ .....+..++..+.+++.+||+.+|.+||++.||+++|+.
T Consensus 240 ~----~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R----SR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H----cC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11 1111233467789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.47 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=204.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|+..+.||+|+||.||+|.++ .+..||+|.++... ....+.|.+|+.++++++||||++++|++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999864 34689999887543 3445679999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 34899999999999999999999877 99999999999999999999999998765322
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......+. . .... .+.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~---~~~~-~~~------ 225 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I---KAVE-DGF------ 225 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H---HHHH-CCC------
Confidence 111 11112235678999999999999999999999999999775 9999865432211 1 1111 110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....+..++..+.+++.+||+.+|.+||++.|+++.|..+
T Consensus 226 ---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111233567789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=333.09 Aligned_cols=271 Identities=24% Similarity=0.390 Sum_probs=205.0
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHh--ccccceeeEEEEEeecC----eEEEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK--LRHKHLVSLIGFCEEDG----EMILVYD 602 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E 602 (862)
+..++||+|+||.||||.+++ +.||||++... ..+.|.+|-++.+. ++|+||++++++-.... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 345689999999999999987 58999998754 44678888877665 58999999999876554 8999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC------CcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG------ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
|.++|+|.++|..+- ++|....+|+..+++||+|||+. .+++|+|||||++||||..|++..|+|||||..
T Consensus 289 fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999997653 89999999999999999999974 357899999999999999999999999999987
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcC-CCC-----chhHHHHHHHHHHHHHhCCCCCC-CCCccccccHHHHHHhhhc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLT-----EKSDVYSFGVVLFEVLCARPALN-VNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~ksDVyS~Gvvl~elltG~~p~~-~~~~~~~~~l~~~~~~~~~ 749 (862)
..............||.+|||||++.+. .+. .+.||||+|.|||||++....+. +..++-+..+..-+.....
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 6533332333346799999999999763 222 47999999999999999876553 2222222222211111111
Q ss_pred cCccccc-cCCCCCCCCcH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCC
Q 041565 750 MGTIEDI-IDPNLKGNITD-----QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQD 806 (862)
Q Consensus 750 ~~~~~~~-~d~~l~~~~~~-----~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~ 806 (862)
.+.+++. +..+.++.+++ ..+..+++.++.||..|++-|.|+.=|.+++..+..+.+
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1112211 12222333322 346678999999999999999999999999988876544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=339.44 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=207.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|+..+.||+|+||.||+++.. .+..+|+|.+... .....+++.+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888999999999999999976 4678899987654 33445679999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997654 3899999999999999999999743 4999999999999999999999999998764321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc----------
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT---------- 752 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------- 752 (862)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+..............+.
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 12334689999999999999999999999999999999999999964432211000000000000000
Q ss_pred ---------------------cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 ---------------------IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 ---------------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...+.............+.++.+++.+||+.+|++|||+.|++++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 0000000000001112456789999999999999999999999987764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.18 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=217.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..+....++||-|-||.||.|.++. ...||||.++.. ....++|+.|..+|+.++|||+|+|+|+|..+...|+|+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3455667899999999999999876 457999998854 45679999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|.+|+|.++|++.++..++--.++.++.||+.||+||..++ +|||||.++|+|+.++..+||+||||+|++.....
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY- 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY- 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce-
Confidence 99999999999888777888899999999999999999877 99999999999999999999999999998754332
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......+-.+.|.|||.+....++.|+|||+|||+|||+.| |-.|+.+-.-.+ . -+++....+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq---V-------------Y~LLEkgyR 484 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V-------------YGLLEKGYR 484 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH---H-------------HHHHhcccc
Confidence 22333456788999999999999999999999999999986 667775432111 1 111222233
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
-+.++.|++++.+|++.||+..|.+||+++|+-+.+|.+.+
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 33455699999999999999999999999999999988754
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.21 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=212.8
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.+..+|+..++||.|+||.||+|...++..+++|.+.........++.+|+.+++.++|+||+++++++......++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34556888899999999999999988888999999887666567789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.......+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999998765556899999999999999999999877 99999999999999999999999999976533211
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+......+. ...... ..
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~-------------~~ 221 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQITA-------------GY 221 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHHh-------------CC
Confidence 1223345678999999998899999999999999999998 8998865432211 111110 01
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....+..++..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111122356678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.11 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=209.4
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC----Ch-hhHHHHHHHHHHHHhcc-ccceeeEEEEEeecC
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS----SE-QGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDG 595 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 595 (862)
...++|...+.||+|+||+|+.|... .+..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34567888999999999999999854 5689999976543 11 23456678999999998 999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeecccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLS 674 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla 674 (862)
..++||||+.+|+|.+++.+.. .+.+.+..++++|++.|++|+|+.+ |+||||||+||||+.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999998843 3899999999999999999999887 9999999999999999 99999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +. +. ...+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~-~k---i~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY-RK---IRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH-HH---HhcCC
Confidence 9863 1223445678999999999999977 75 78999999999999999999997532111 10 00 11110
Q ss_pred cccccCCCCCCCCcHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 753 IEDIIDPNLKGNITDQC-LRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
. .++... ..++..++.+|+..+|.+|+|+.|++++-+...
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 0 111122 667899999999999999999999998887765
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=337.49 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=203.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-cc----EEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KT----KVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.+|+..+.||+|+||.||+|++.. +. .||+|.+... .....+++..|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 458889999999999999998642 32 4899988654 334567899999999999999999999999765 5679
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|+||+++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998654 34899999999999999999999877 99999999999999999999999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......+ +..........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~----- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERL----- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhCCCCC-----
Confidence 222111222334678999999999999999999999999999997 999986532211 11111111000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+..+...+.+++.+||+.+|.+||++.+++..+..+..
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0111245578899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.53 Aligned_cols=254 Identities=24% Similarity=0.436 Sum_probs=207.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|+..++||+|+||.||+|..+++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4678889999999999999998888889999876543 345789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++.......+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 999999998655556899999999999999999999876 99999999999999999999999999986533211 11
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++..|+|||++.++.++.++|||||||++|||++ |+.||......+ ...+... ... .+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~---~~~-----~~----- 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR---GYR-----MP----- 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc---CCC-----CC-----
Confidence 222345678999999999999999999999999999998 999986543221 1111111 000 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....++.++.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111245678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=346.42 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=206.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecC
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDG 595 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 595 (862)
..+.|...++||+|+||.||+|+... +..||||++.... ....+.+.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678888999999999999998532 2469999986543 334567999999999996 999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCC----------------------------------------------------------
Q 041565 596 EMILVYDYMANGTLREHLYKGD---------------------------------------------------------- 617 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 617 (862)
..++|||||++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999986421
Q ss_pred ------------------------------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 618 ------------------------------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 618 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
...+++.++++++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999877 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccH
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSL 740 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l 740 (862)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 999999999999986433222112223346778999999999999999999999999999997 88888643221110
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+ .... .+ .....+..++..+.+++.+||+.+|++||++.+|.+.|+.+++
T Consensus 350 --~-~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 --Y-NKIK-SG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --H-HHHh-cC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 0000 00 0011122356778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.84 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=207.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..++|+..+.||+|++|.||+|..+++..||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345688889999999999999998777889999887543 3457799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997755456899999999999999999999877 99999999999999999999999999986542111
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
........+..|+|||++.+..++.++||||||++++||++ |+.||......... . ...... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~---~~~~~~----------~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---Q---QVDQGY----------R 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---H---HHHcCC----------C
Confidence 11111223457999999999999999999999999999999 99888644321111 0 000000 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
...+..++..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=326.45 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=206.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
..|+..+.||+|+||.||+|..+. +..+|+|..... ....+++.+|++++++++|+||++++++|..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 347778899999999999999764 678999987644 344678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 9999999997665556899999999999999999999876 999999999999999999999999999865432111
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||.+.+..++.++|||||||+++||++ |..|+......+ +...... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~----------~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEK----------GYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHC----------CCCC
Confidence 1112234568999999999999999999999999999998 888886432211 1111110 0111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=331.05 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=209.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999753 235689999877666666789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc
Q 041565 600 VYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 665 (862)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997532 124899999999999999999999887 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 041565 666 AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWA 744 (862)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 744 (862)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-
Confidence 99999999976433222222333456788999999999999999999999999999998 9999865433221 111
Q ss_pred HhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 745 LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 745 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...+.... ....++..+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 238 ---~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111 112245678999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=352.54 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=217.1
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcCc-cEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEE-e----e-
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGK-TKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFC-E----E- 593 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~----~- 593 (862)
.....+.++.++|.+|||+.||.+....+ ..+|+|++...++...+...+|+++|++|+ |+|||.+++.. . .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456678889999999999999998776 899999988888899999999999999997 99999999932 1 1
Q ss_pred -cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 594 -DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 594 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
.-+.+|.||||++|.|-+++..+....|++.++++|+.++|+|+++||.. +++|||||||-+||||+.++..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 24789999999999999999877666699999999999999999999986 5889999999999999999999999999
Q ss_pred ccccCCCCC-Cccc------cccccCCCCCCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 673 LSKTGPNLN-QTHV------STMVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 673 la~~~~~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
.+....... .... .-..--|+-|.|||++ .+..+++|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 987532211 1100 0112368899999987 4678999999999999999999999999754222
Q ss_pred HHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 743 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
.|++.+..-.........|.+||..||+.+|.+||++-+|+..+-.++..+
T Consensus 265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 223333322222457889999999999999999999999999998887653
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.01 Aligned_cols=257 Identities=25% Similarity=0.428 Sum_probs=203.7
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
.+++|+..+.||+|+||.||+|..++ +..||+|.+... ......+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46778999999999999999997542 357999987543 23445678999999999999999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCC--------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEE
Q 041565 597 MILVYDYMANGTLREHLYKGD--------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl 668 (862)
.++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999987532 123678899999999999999999876 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+|||+++...............++..|+|||++.++.++.++|||||||+++||++ |..||......+. ..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH--
Confidence 99999976433222222222345678999999999999999999999999999998 6888864432211 11111
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..... ..+..++..+.+++.+|++.+|++|||+.|++++|+
T Consensus 236 --~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11110 112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.80 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=206.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|+..+.||+|+||.||+|.+.. ...||+|..... ......+|.+|+.++++++|+||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568889999999999999998753 357899987654 33445689999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++++|.+++..... .+++.++++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999976443 5899999999999999999999876 99999999999999999999999999987542
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||.+.+..++.++||||||++++||++ |+.|+......+ +.+... .+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~------ 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVE----DGY------ 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCC------
Confidence 222222222345678999999999999999999999999999998 998885432111 111111 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....+..++..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=324.54 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=202.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
+.|+..+.||+|+||.||++..+++..+|+|.+.... ...++|..|++++++++||||++++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3477788999999999999998888789999876432 334678999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 9999999875432 4899999999999999999999877 99999999999999999999999999886432211 11
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ...... .... ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~---~~~~---~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMIS---RGFR---LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH---CCCC---CCCCC----
Confidence 122335668999999998899999999999999999999 899986443211 111111 1100 11111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
..+..+.+++.+||+.+|.+||++.|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=341.45 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=206.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||+|+... +..||+|++... .....+.+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999999764 678999987643 2234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997644 3899999999999999999999877 99999999999999999999999999986432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~ 760 (862)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..|.. .+. .+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~---~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------TLQ---RPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------ccc---CCC
Confidence 2234568999999999999999999999999999999999999997544322211 111110 000 010
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. .......+.++.+++.+||..+|.+||++.|++++...
T Consensus 222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence 0 00011245678899999999999999999999988544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.18 Aligned_cols=236 Identities=24% Similarity=0.379 Sum_probs=198.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.+|+..+.||.|+||.|..++.+ +|..+|+|.+.... ....+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777889999999999999976 46789999887543 234566778999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||.++|.|..+|++.++ ++++...-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 99999999999987655 999999999999999999999887 99999999999999999999999999997543
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
..-+.+||+.|+|||.+..+.+..++|.|+|||++|||++|.+||....+.+ -+.. ++..++
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-----iY~K----------I~~~~v 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-----IYEK----------ILEGKV 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----HHHH----------HHhCcc
Confidence 2456899999999999999999999999999999999999999997665421 1111 222221
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCC
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDR 788 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~R 788 (862)
+ ++.-....+.+|+...++.|-.+|
T Consensus 259 ~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 K--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 222244567888888998888888
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.93 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=203.4
Q ss_pred cCcccceeEeeeCcEEEEEEEE-----cCccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYI-----DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.+|+..+.||+|+||.||+|.. ..+..+++|.+... ..+...++.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567788999999999999984 23468999988643 34455789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCC---------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC
Q 041565 600 VYDYMANGTLREHLYKGD---------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW 664 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 664 (862)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999986321 234789999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 041565 665 EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADW 743 (862)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 743 (862)
.+||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..||......+ ..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986433222222233345678999999998899999999999999999998 888886432211 1111
Q ss_pred HHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 744 ALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 744 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.. .... ...+..++..+.+++.+|++.+|.+||++.+++++|..
T Consensus 239 ~~----~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR----KRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 1110 01122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.27 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=197.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc--CccEEEEEecCCCC--hhhHHHHHHHHHHHHhc---cccceeeEEEEEe-----e
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID--GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKL---RHKHLVSLIGFCE-----E 593 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~ 593 (862)
++|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36788899999999999999863 46789999875432 22234566777777766 6999999999985 3
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
...+++||||++ ++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 69999997765556899999999999999999999877 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHhhhccCc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LADWALHCQRMGT 752 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~ 752 (862)
++..... .......|+..|+|||.+.+..++.++|||||||++|||++|++||......+... ..+... ......
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhh
Confidence 9764321 22334568999999999999999999999999999999999999997654332211 111000 000000
Q ss_pred c-------ccccCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 I-------EDIIDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ~-------~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. .....+.... .........+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 0001110000 0111234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.09 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=208.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999852 234689998877666667889999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCC-----------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEE
Q 041565 600 VYDYMANGTLREHLYKGD-----------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl 668 (862)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999997432 124899999999999999999999877 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |++||......+. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~~---- 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC---- 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----
Confidence 99999986433222122223345778999999999999999999999999999998 8988865432211 111
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...+.... .+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111100 111234578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=351.83 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=203.8
Q ss_pred cccceeEeeeCcEEEEEEEEcC--ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
|...+.||+|+||.||++.... +..||+|............+.+|+++|+.++||||++++++|..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 7788999999999999998543 46788887765555556778899999999999999999999999999999999999
Q ss_pred CCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 606 NGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 606 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+|+|.++|... ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 2335889999999999999999999876 999999999999999999999999999865432222
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+.. ++
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~------~~~~-~~~~----~~---- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM------QQVL-YGKY----DP---- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCCC----CC----
Confidence 2334556999999999999999999999999999999999999999654322111 1100 0110 01
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.+..++..+.+++.+||+.+|++||++.+++.+
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 112245678999999999999999999999754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=339.13 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=204.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEee-cC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE-DG 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~ 595 (862)
.++|+..+.||+|+||.||+|...+ +..||+|++.... ....+.+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3468888999999999999997432 3579999886542 33456788999999999 89999999998864 45
Q ss_pred eEEEEEEeCCCCcHHHHHhcCC----------------------------------------------------------
Q 041565 596 EMILVYDYMANGTLREHLYKGD---------------------------------------------------------- 617 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 617 (862)
..+++|||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6889999999999999986432
Q ss_pred -CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCC
Q 041565 618 -KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696 (862)
Q Consensus 618 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 696 (862)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125899999999999999999999876 9999999999999999999999999998653322111222334667899
Q ss_pred ChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHH
Q 041565 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTE 775 (862)
Q Consensus 697 aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 775 (862)
|||++.+..++.++|||||||+++||++ |+.||......+. + ..... .+. ....+...+.++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~---~~~~~-~~~---------~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F---CRRLK-EGT---------RMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H---HHHHh-ccC---------CCCCCccCCHHHHH
Confidence 9999999999999999999999999998 9999865332211 1 11110 110 01112234567899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 776 TAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 776 li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
++.+||+.+|++||++.|++++|+.+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=328.88 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=205.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|...+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 367999988755433 5678999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCC------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 599 LVYDYMANGTLREHLYKGD------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
+||||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997542 234789999999999999999999877 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |+.||......+ ..+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 9999999975432222222233345778999999999999999999999999999998 999986543222 111111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+... ..+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 239 ----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.66 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=203.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||++..+ ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999976 46789999875422 234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999997654 3899999999999999999999877 999999999999999999999999999864321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+. .
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~------~~i~-~~~------~-- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY------EKIL-AGK------L-- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCC------c--
Confidence 12346899999999999999999999999999999999999999754322111 1000 000 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
.++......+.+++.+||+.+|.+||+ +.|++++.+.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 111223456889999999999999995 8898877665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=331.77 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=208.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..|+..++||+|.||.||||... .++.||+|.+... .+...++...|+.+|.+++|+||.+.+|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666789999999999999965 4678999987654 445578889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|.+|++.+.|..... +.+....-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++-........
T Consensus 93 ~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999976543 588888889999999999999887 999999999999999999999999999765543222
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.....||+-|||||+++...|+.|+||||||++.+||++|.+|+....+...+.+ +-..-.+
T Consensus 168 --r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk~~PP 229 (467)
T KOG0201|consen 168 --RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPKSAPP 229 (467)
T ss_pred --cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccCCCCC
Confidence 2456799999999999998999999999999999999999999975544222111 1111112
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.....+.+.|.+++..||..+|+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2223567789999999999999999999999876
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.81 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=202.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|+||.||+++.+ ++..+|+|++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999986 4678999987643 23345678899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++++.|..+.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99987766554332 34899999999999999999999876 99999999999999999999999999986532211
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH---------HHhhhccCcc
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW---------ALHCQRMGTI 753 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~ 753 (862)
.......|+..|+|||++.+..++.++|||||||++|||++|++||......+....... ..........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 122334689999999999998999999999999999999999999976433221111100 0000011111
Q ss_pred ccccCCCCC------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 754 EDIIDPNLK------GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 754 ~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.....+... .......+..+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111110 01111245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.72 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=204.3
Q ss_pred CcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+|+..+.||+|+||.||+|+... ...+++|.+.... ....+++.+|+.+++.++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36677899999999999998532 2468888876543 3445789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCC----------------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCC
Q 041565 600 VYDYMANGTLREHLYKGD----------------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTN 657 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 657 (862)
|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 124789999999999999999999876 9999999999
Q ss_pred eeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccc
Q 041565 658 ILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKE 736 (862)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~ 736 (862)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986433222111223345678999999999999999999999999999998 999986543221
Q ss_pred cccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 737 QVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+.++.. .. .....+..++..+.+++.+|++.+|.+||++.|+++.|+.++
T Consensus 238 ---~~~~~~----~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 ---LFNLLK----TG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ---HHHHHh----CC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111 00 111112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=338.44 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=198.8
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
++||+|+||.||++..+ ++..+|+|.+... ......++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 5788999987643 2334567889999999999999999999999999999999999999
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (862)
+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 9999987654 4899999999999999999999887 999999999999999999999999998753221 12223
Q ss_pred cccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcH
Q 041565 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767 (862)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 767 (862)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+ +.. ++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~----~~------~~~----~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELIL----ME------EIR----FPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHHH----cC------CCC----CCC
Confidence 45699999999999999999999999999999999999999965432111 11100 00 011 122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 768 QCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 768 ~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
....++.+++.+||+.+|++|| ++.+++++-+
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 3456788999999999999999 8999987644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.54 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=203.2
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
.+++|...+.||+|++|.||+|.+.+ +..|++|...... ......|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999999764 4578999876443 3445679999999999999999999999999889
Q ss_pred EEEEEEeCCCCcHHHHHhcCCC-----CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC---ceEE
Q 041565 597 MILVYDYMANGTLREHLYKGDK-----PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW---EAKV 668 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~~kl 668 (862)
.++||||+++++|.+++.+... ..+++..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976431 24899999999999999999999877 99999999999998654 5999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+. .+ ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~---~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME---FV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---HH
Confidence 99999986532211111112223567999999999999999999999999999997 9999865432221 11 11
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.... ....+..++..+.+++.+|++.+|++||++.+|+++|.
T Consensus 235 ~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 11112234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.33 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=201.7
Q ss_pred CcccceeEeeeCcEEEEEEEEc-Ccc----EEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKT----KVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.|...+.||+|+||.||+|... ++. .+++|...... .....++..|+.++++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 5666789999999999999864 232 47888775433 3345678889999999999999999999864 457789
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
+||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999976433 4899999999999999999999877 999999999999999999999999999865433
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
..........++..|+|||++.++.++.++|||||||++|||++ |+.|+........ .++.. .+. ....+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~----~~~--~~~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDLLE----KGE--RLAQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----CCC--cCCCC
Confidence 22222334557789999999999999999999999999999998 9999865432221 11111 111 00111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
. .+...+.+++.+|+..+|.+|||+.|+++.|..+.+
T Consensus 234 ~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 Q-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 134567889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.47 Aligned_cols=265 Identities=21% Similarity=0.328 Sum_probs=200.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...++||+|+||.||+|..+ ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45888899999999999999876 46789999876432 22345678999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 97 59999887543 34789999999999999999999877 9999999999999999999999999997543211
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH----------HHHhhhccCc
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD----------WALHCQRMGT 752 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~~~~~~~~~~ 752 (862)
.......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+...... |.. ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-ITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc-cccchh
Confidence 11223457899999999875 568999999999999999999999997654333221110 000 000000
Q ss_pred cccccCCCCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 753 IEDIIDPNLKGNI----TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 753 ~~~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
......+...... ......++.+++.+||+.+|.+|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 1111111111000 011345678999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.46 Aligned_cols=262 Identities=24% Similarity=0.460 Sum_probs=208.0
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEee
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE 593 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 593 (862)
....++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|++++.++ +|+||++++++|..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445568888999999999999998643 257899987653 334456789999999999 79999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcC--------------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 594 DGEMILVYDYMANGTLREHLYKG--------------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
++..+++|||+++|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999999642 2235899999999999999999999876 999999999999
Q ss_pred ccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 041565 660 LDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQV 738 (862)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~ 738 (862)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999986543222222222345678999999999999999999999999999997 88888643221111
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
. ... .......+..++..+.+++.+|+..+|.+|||+.|+++.|+.++
T Consensus 245 ---~---~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 ---K---LLK----------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---H---HHH----------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 000 00011122234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=304.22 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=209.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|..++.||+|.||.||.|+.+ ++-.||+|.+... ..+..+++.+|+++-+.|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 45778899999999999999965 4568999987643 2234578999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||.++|+|...|.......+++.....++.|+|.||.|+|.++ ||||||||+|+|++.++..||+|||-+...+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999998665556899999999999999999999876 9999999999999999999999999987643
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......+||.-|.+||...+...+.+.|+|++|++.+|++.|.+||+.....+. +... .-.++.+|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-----YkrI-----~k~~~~~p-- 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-----YKRI-----RKVDLKFP-- 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-----HHHH-----HHccccCC--
Confidence 2234457899999999999999999999999999999999999999975432111 1111 11112222
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
...+....+++.+|+..+|.+|.+..|++.+.+-
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 2345678899999999999999999999988764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.33 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=197.3
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
+.||+|+||.||+|+.. ++..+|+|..... .......+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 5778999987643 344567799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99997543 34899999999999999999999877 999999999999999999999999998754321111111112
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQ 768 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 768 (862)
..+..|+|||.+.++.++.++||||||++++||++ |..|+......... .... .......+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~------~~~~----------~~~~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR------EAIE----------QGVRLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH------HHHH----------cCCCCCCccc
Confidence 23457999999999999999999999999999997 88887543221110 0000 0111112223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 769 CLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 769 ~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
++..+.+++.+|++.+|++||++.|+++.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4667899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.52 Aligned_cols=259 Identities=23% Similarity=0.396 Sum_probs=205.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
.++|...+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+++++++ +|+||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 346888899999999999999742 23479999876543 34456789999999999 79999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997654445899999999999999999999877 99999999999999999999999999986
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
..............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+. +..... .+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~---- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EG---- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cC----
Confidence 543222112222345678999999999999999999999999999998 9998864332111 111111 00
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011112345789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.84 Aligned_cols=260 Identities=26% Similarity=0.446 Sum_probs=207.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC--------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG 595 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 595 (862)
++|...+.||+|+||.||++...+ ...+|+|.+... ......++..|+++++++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468888999999999999997532 246999988754 334567788999999999 7999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCC--------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 596 EMILVYDYMANGTLREHLYKGDK--------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
..++||||+++|+|.+++..... ..+++.++++++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999976421 24899999999999999999999876 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccH
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSL 740 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l 740 (862)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.|+......+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence 999999999999876543222111222234568999999999999999999999999999998 888885432211
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
......... ....+..++.++.+++.+|++.+|.+||++.|+++.|+.+++.
T Consensus 251 --~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 --LFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111110 1112223456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.24 Aligned_cols=251 Identities=29% Similarity=0.414 Sum_probs=201.9
Q ss_pred CcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+|...+.||+|+||.||+|..+++..+|+|.+.... ....+|.+|+.++++++||||++++++|.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466788999999999999998877789999877443 3346799999999999999999999999998899999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....... ...
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 999999976433 4899999999999999999999877 99999999999999999999999999876432211 111
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
....++..|++||++.+..++.++|||||||++|||++ |+.||......+ ..+... .... ...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~~~~----------~~~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS---QGLR----------LYR 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh---cCCC----------CCC
Confidence 22335678999999998899999999999999999998 999986433211 111111 0000 001
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1113567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.49 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=198.4
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
++||+|+||.||++..+ ++..+|+|.+... ......++.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 4788999987643 2344567889999999999999999999999999999999999999
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (862)
+|..++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 9999887643 3899999999999999999999877 999999999999999999999999998753221 11223
Q ss_pred cccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcH
Q 041565 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767 (862)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 767 (862)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .. +.. ++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------~~~~-~~------~~~----~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELIL-ME------DIK----FPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------HHhc-cC------Ccc----CCC
Confidence 456899999999999999999999999999999999999999654322111 0000 00 011 122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 768 QCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 768 ~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
.....+.+++.+||+.+|.+|| ++.|++++.+
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 3456788999999999999997 8999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=337.36 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=202.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|+.+ ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45788899999999999999976 4678999987542 2234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999997654 3889999999999999999999877 999999999999999999999999999864321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +.. ...+.+
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~--i~~~~~-------- 232 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-----YEK--ILAGRL-------- 232 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-----HHH--HhcCCc--------
Confidence 1234689999999999999999999999999999999999999965432111 111 011110
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
.++......+.+++.+||+.+|.+||+ +.|++.+.++
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 011123456889999999999999996 7888877543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.89 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=203.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-----CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-----GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 597 (862)
.++|+..+.||+|+||.||++..+ .+..||+|++........+.+.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 346778899999999999999753 467899999887776777889999999999999999999998754 3468
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++|+|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999997543 34899999999999999999999877 999999999999999999999999999875
Q ss_pred CCCCCcc-ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC-----
Q 041565 678 PNLNQTH-VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG----- 751 (862)
Q Consensus 678 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 751 (862)
....... ......++..|+|||++.+..++.++|||||||+++||++|..++...... +........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 231 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMI 231 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccc
Confidence 4322111 111122345699999999989999999999999999999988765322110 000000000
Q ss_pred --ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 --TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 --~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+.+.+...........++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00011111111111223456799999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.94 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=198.4
Q ss_pred ccceeEeeeCcEEEEEEEEcCcc---EEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------CeE
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKT---KVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------GEM 597 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 597 (862)
...++||+|+||.||+|...... .+|+|.++.. .....+.+..|+++++.++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45689999999999999976532 5899987643 345567899999999999999999999988532 256
Q ss_pred EEEEEeCCCCcHHHHHhcC----CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 598 ILVYDYMANGTLREHLYKG----DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999988532 2234899999999999999999999876 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
++...............++..|++||++.+..++.++||||||+++|||++ |+.||......+ +.+ .. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~~-~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD---YL-RQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HH-HcCC
Confidence 986543222111223345678999999999999999999999999999999 788886432211 111 11 1111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.. ..+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01112456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.40 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=199.4
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec-----CeEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----GEMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 598 (862)
+|+..++||+|+||.||+|+.. ++..||+|++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999965 5788999987642 223456788999999999999999999987543 3589
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+|||||+ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68999887544 3899999999999999999999887 9999999999999999999999999998643
Q ss_pred CCCC-ccccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH-H--------HHHh
Q 041565 679 NLNQ-THVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA-D--------WALH 746 (862)
Q Consensus 679 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~-~--------~~~~ 746 (862)
.... ........||..|+|||++.+ ..++.++|||||||+++||++|++||............ + +...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2111 111233568999999999876 67899999999999999999999999654322211100 0 0000
Q ss_pred hhccCccccc---cCCCCCCCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 747 CQRMGTIEDI---IDPNLKGNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 747 ~~~~~~~~~~---~d~~l~~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. ......+. +........ .......+.+++.+||+.+|++|||+.|++++-.+.
T Consensus 235 i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 235 V-RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred h-hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 0 00000000 000000000 011345678999999999999999999999886653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.77 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=197.6
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
+.||+|+||.||++... ++..||+|.+... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999865 5788999987643 2334567788999999999999999999999999999999999999
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (862)
+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 9999887654 3899999999999999999999877 999999999999999999999999998753221 11223
Q ss_pred cccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcH
Q 041565 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767 (862)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 767 (862)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... . +.. ++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-----~~~~--~------~~~----~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-----LILM--E------EIR----FPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-----HHhc--C------CCC----CCC
Confidence 3568999999999999999999999999999999999999996543221110 0000 0 001 122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 041565 768 QCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNL 798 (862)
Q Consensus 768 ~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L 798 (862)
..+..+.+++.+||+.+|.+|| ++.+++++-
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 3456788999999999999998 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=331.66 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=205.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|+..++||+|+||.||++..+ .+..+|+|.+... ......++.+|++++++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467888999999999999999976 4677888877654 33445679999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +++||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999997644 3889999999999999999999742 4999999999999999999999999998754221
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc--------
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE-------- 754 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 754 (862)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+... .......+...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL----MFGCPVEGDPAESETSPRP 231 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH----HhcCcccCCccccccCccc
Confidence 1223468899999999999999999999999999999999999986543211100 00000000000
Q ss_pred ---------------------c----ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 755 ---------------------D----IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 755 ---------------------~----~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. +...............++.+++.+||+.+|.+|||+.|++++-...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 0 0000000000011345688999999999999999999999886654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.19 Aligned_cols=259 Identities=21% Similarity=0.309 Sum_probs=212.2
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
+...++|+...+||+|+||.||.++-+ .|..+|+|+++... ....+..+.|-.+|....+++||+|+-.+.+...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 446678999999999999999999965 47889999988653 34566788999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
||||||++||++..+|.+.+. |++......+.+++.|++-||+.| +|||||||+|+|||..|++||+||||+.-.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999987654 999999999999999999999877 999999999999999999999999998421
Q ss_pred CC----------------------CCCcc----c-------------------cccccCCCCCCChhhhhcCCCCchhHH
Q 041565 678 PN----------------------LNQTH----V-------------------STMVKGSFGYLDPEYFRRQQLTEKSDV 712 (862)
Q Consensus 678 ~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~ksDV 712 (862)
.. .+... . .-...||+-|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 00 00000 0 012469999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC--
Q 041565 713 YSFGVVLFEVLCARPALNVNLPKEQ-VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-- 789 (862)
Q Consensus 713 yS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-- 789 (862)
|||||+|||||.|.+||....+.+. ..+..|......... ..+..+..++|.+|+. +|.+|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999999988766542 334555543322211 1234678899999999 999997
Q ss_pred -CHHHHHHHHHH
Q 041565 790 -SMGDVLWNLEF 800 (862)
Q Consensus 790 -t~~evl~~L~~ 800 (862)
.+.||.+|..+
T Consensus 437 ~G~~EIK~HPfF 448 (550)
T KOG0605|consen 437 KGAEEIKKHPFF 448 (550)
T ss_pred ccHHHHhcCCcc
Confidence 58888877655
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.99 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=204.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-c--cEEEEEecCC-CChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-K--TKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
++|+..++||+|+||.||+|..++ + ..+++|.++. ......+.|.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998754 3 2478887764 3344567899999999999 799999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 601 YDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999997532 124889999999999999999999876 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||++...... ........+..|+|||++.+..++.++|||||||+++||++ |+.||......+. ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YE 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 99999998643211 11112223567999999999899999999999999999997 9999865432211 11
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
... .......+..++..+.+++.+||+.+|.+||++.++++.|+.+++..
T Consensus 230 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLP----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 110 00111112234567899999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=319.99 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=204.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++|...++||+|+||.||+|..++...||+|++.... ...++|.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35688899999999999999998777789999887533 234678999999999999999999998754 5678999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 9999999998654445899999999999999999999877 999999999999999999999999999764322211
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||+..+..++.++||||||++++||++ |+.||......+.. . . ...+ ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-----~-~-~~~~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----D-Q-VERG---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-----H-H-HhcC---------CCC
Confidence 1122346678999999999999999999999999999999 88888644322111 0 0 0000 000
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....+++..+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11224567789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.47 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=208.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEee-cCe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DGE 596 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 596 (862)
..++|...++||+|+||.||+|.... +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999765 678999987643 34456778999999999999999999999876 467
Q ss_pred EEEEEEeCCCCcHHHHHhcCCC------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEee
Q 041565 597 MILVYDYMANGTLREHLYKGDK------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSD 670 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~D 670 (862)
.++++||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999875421 35899999999999999999999876 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhc
Q 041565 671 FGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +..+.. .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---D 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---c
Confidence 999986533222222223346778999999999899999999999999999998 999986543211 211111 1
Q ss_pred cCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
...+. ....++..+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 235 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11100 11124567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.80 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=201.4
Q ss_pred cccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe-----
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE----- 596 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 596 (862)
|...+.||+|+||.||+|.+.. +..||+|++... ......++.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998653 257999987643 33456789999999999999999999999876554
Q ss_pred -EEEEEEeCCCCcHHHHHhcC----CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 597 -MILVYDYMANGTLREHLYKG----DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 597 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
.+++|||+++|+|..++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 2235899999999999999999999877 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhcc
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
|+++...............++..|+|||.+.+..++.++|||||||+++||++ |..||......+ +.++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence 99986543222212222335678999999998999999999999999999999 888886433211 1111111
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+. ....+..++..+.+++.+||+.+|.+||++.|+++.|+.+
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0011223566899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.13 Aligned_cols=250 Identities=29% Similarity=0.425 Sum_probs=200.8
Q ss_pred CcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+|+..+.||+|+||.||++..+++..+|+|.+.... ....+|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467788999999999999998777789999876432 2345788999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...... ....
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~ 158 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSS 158 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-cccc
Confidence 999999976443 4899999999999999999999877 9999999999999999999999999997643211 1111
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ..... + .....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---~~~~~-~---------~~~~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V---ESVSA-G---------YRLYR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H---HHHHc-C---------CcCCC
Confidence 11224457999999999999999999999999999998 7888865432211 1 11110 0 00011
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
+..++..+.+++.+||+.+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122566799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.29 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=212.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC---c--cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG---K--TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
+.+.....++||.|-||.||+|+..+ | -.||||..+.. .....+.|+.|..+|++++|||||+|+|.|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 33445557889999999999998543 2 35899987763 445578899999999999999999999999875 78
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++|||.++.|.|+.+|..+.. .|+...+..++.||+.||+|||+.. .|||||.++|||+...-.+||+||||+|..
T Consensus 466 WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999987653 4999999999999999999999876 999999999999999999999999999987
Q ss_pred CCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL-CARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.+....... ..+-.+.|||||.+.-.+++.++|||.|||+|||++ -|..||.+-...+... .
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~ 604 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------H 604 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------E
Confidence 665444333 445677899999999999999999999999999987 4999997643332210 0
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+...-+...++.|+..|..++.+||..+|.+||++.|+...|...++
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11111223455689999999999999999999999999999988776
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=337.63 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=207.9
Q ss_pred cccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 528 FSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
|..++.||+|+.|.|-.|++ ..|+.+|||++... .......+.+|+-+|+.+.|||++++++.++++.++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 45578899999999999985 46899999987654 223345678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|.|.++|.+++. +++.+..+.+.||+.|+.|+|..+ |+||||||+|+|||...++||+|||+|..... .
T Consensus 94 v~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---g 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP---G 165 (786)
T ss_pred cCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---C
Confidence 999999999988765 999999999999999999999877 99999999999999999999999999987432 2
Q ss_pred cccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
..-...+|++.|++||++++..| ..++||||+||+||.||+|+.||+.+.... +..-+ +.|.+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlKV----~~G~f--------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLKV----QRGVF--------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHHH----HcCcc---------
Confidence 33455789999999999999988 468999999999999999999997443221 11111 11111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+.+...+.+..+|+.+|+..||..|.|++||++|.+..
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 12234567789999999999999999999999997653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.91 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=204.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+++...++||+|+||.||++... .+..+++|.+........+.|.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999742 245789998887777777889999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCC-------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 600 VYDYMANGTLREHLYKGDK-------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
+|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975431 24889999999999999999999877 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |++||......+.. ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHH-
Confidence 9999999975433222122223335678999999999999999999999999999998 89988543322111 100
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..+. ....+..++..+.+++.+||+.+|.+||++.||++.|+
T Consensus 238 ---~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ---TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 00111234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.76 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=202.1
Q ss_pred cccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
|...+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|+.++++++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5567889999999999998643 46799999875433 3346789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 601 YDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
+||+++++|.+++.... ...+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 224788899999999999999999877 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..|+......+ +..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VIE 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 9999999886533222222223345778999999998899999999999999999998 888876432211 111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.... +. ....+..++..+.+++.+|++.+|.+||++.+|+..|+.
T Consensus 238 ~i~~-~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRN-RQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHc-CC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111 11 011223456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=327.55 Aligned_cols=261 Identities=24% Similarity=0.426 Sum_probs=208.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc--------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeec
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID--------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED 594 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 594 (862)
..+|...+.||+|+||.||++... .+..+|+|..... .....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 445777899999999999999742 2346899987643 234567899999999999 899999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
...++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+.+ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999997642 134788999999999999999999877 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987544332222233346678999999999999999999999999999998 7777754322
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.++......... ...+..++..+.+++.+||+.+|.+||++.|+++.|+.++.+
T Consensus 246 -~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 112221111111 011223567789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.81 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=203.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 596 (862)
.++|...++||+|+||.||+|++.+ +..||+|++.... ....+.+..|+++|.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 3456678899999999999998643 3579999987543 333457899999999997 9999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCC----------------------------------------------------------
Q 041565 597 MILVYDYMANGTLREHLYKGDK---------------------------------------------------------- 618 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 618 (862)
.++||||+++|+|.++|++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred --------------------------------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 619 --------------------------------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 619 --------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
..+++..+++++.|++.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 23677888999999999999999876 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~- 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF- 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-
Confidence 9999999999999986432111111122346788999999999899999999999999999998 88888543222110
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
......+ .....+..++..+.+++.+||+.+|.+||+++|+++.|+.++
T Consensus 352 -----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 -----YNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000001 011112234567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.30 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=201.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC--ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
++|...+.||+|+||.||+|..++ +..||+|++... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458888999999999999998654 357999987532 233456788999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999997654 3899999999999999999999887 999999999999999999999999999864321
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.... .+..
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~i~--~~~~------- 245 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-----YQKIL--EGII------- 245 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-----HHHHh--cCCC-------
Confidence 2235689999999999999999999999999999999999999975432111 11110 1100
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
.++......+.+++.+|++.+|.+|+ ++.|++++.++
T Consensus 246 ---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 246 ---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 01122345678999999999999995 89999887543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.46 Aligned_cols=242 Identities=24% Similarity=0.263 Sum_probs=196.0
Q ss_pred EeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|+||.||++...+ +..||+|.+... .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999764 678999987532 334456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 99997643 3899999999999999999999877 999999999999999999999999999863221 1223345
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.||+.|+|||++.+..++.++|||||||+++||++|+.||......+ ....... +. ..++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EP----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CC----------CCCCCcC
Confidence 69999999999999999999999999999999999999996542211 1111110 00 0112234
Q ss_pred HHHHHHHHHHccccCCCCCCC---HHHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPS---MGDVLWNLE 799 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt---~~evl~~L~ 799 (862)
+..+.+++.+||+.+|.+||+ +.|++.+..
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 567889999999999999974 677776643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=319.07 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=203.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|+..++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+ ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 45777899999999999999988888899998875432 34679999999999999999999998854 56789999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+++|.+++.......+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence 999999998655455899999999999999999999877 99999999999999999999999999976432211 11
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++..|+|||++.+..++.++||||||++++||++ |+.||......+ ..++. ... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~---~~~----------~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV---ERG----------YRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---HcC----------CCCC
Confidence 122235668999999998999999999999999999999 888886432211 11111 100 0111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122345679999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=319.14 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=204.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-c---cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-K---TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+++|+..+.||+|+||.||+|.... + ..+++|..... .....+++..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999999753 2 36899988654 33446789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 34899999999999999999999877 99999999999999999999999999976533
Q ss_pred CCCccc-cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 680 LNQTHV-STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
...... ......+..|+|||++.+..++.++|||||||++|||++ |+.|+......+ +........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~~------ 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGF------ 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcCC------
Confidence 221111 111223457999999999999999999999999999997 999986433211 111111100
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.......++..+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=349.10 Aligned_cols=260 Identities=25% Similarity=0.314 Sum_probs=206.8
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC-
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG- 595 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~- 595 (862)
++....++|...++||+|+||.||++... ++..||||.+... .......+.+|+.++..++|+|++++...+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34455678999999999999999999854 5789999987543 3455677889999999999999999987764322
Q ss_pred -------eEEEEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 596 -------EMILVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 596 -------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
.+++||||+++|+|.++|... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 368999999999999999753 2345899999999999999999999876 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHH
Confidence 9999999986543222223344679999999999999999999999999999999999999996543211 1111
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.. .+.. + ..+...+..+.+++.+||+.+|.+||++.+++++.
T Consensus 257 ~~-~~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 257 TL-AGRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred Hh-cCCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 10 1110 1 11223456789999999999999999999998763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=323.38 Aligned_cols=267 Identities=25% Similarity=0.381 Sum_probs=202.8
Q ss_pred cccceeEeeeCcEEEEEEEE-----cCccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYI-----DGKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMIL 599 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 599 (862)
|...+.||+|+||.||++.. .++..||+|...... ......|.+|++++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 345689999876543 33457789999999999999999999998653 46889
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999753 3899999999999999999999877 99999999999999999999999999986543
Q ss_pred CCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.... .......++..|+|||++.+..++.++||||||++++||++|+.|+....... ..+..+.........+.+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 2211 11122335667999999998899999999999999999999999875432210 001111100000111111222
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.......+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222222334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.45 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=205.3
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
..+++|+..++||+|+||.||+|..++ +..||+|.+.... .....++.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345678889999999999999997542 3479999876443 233456889999999999999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCC--------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceE
Q 041565 596 EMILVYDYMANGTLREHLYKGD--------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAK 667 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~k 667 (862)
..++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 233567889999999999999999877 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHh
Q 041565 668 VSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 746 (862)
|+|||+++...............++..|+|||.+.++.++.++|||||||+++||++ |..|+......+ +...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLKF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 999999986433222222222335678999999999999999999999999999998 788886432221 1111
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
....+. ...+..++..+.+++.+|++.+|++|||+.++++.|+..+
T Consensus 234 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 110000 0111224567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=300.33 Aligned_cols=266 Identities=20% Similarity=0.299 Sum_probs=212.4
Q ss_pred HhhccCcccceeEeeeCcEEEEEEE-EcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec-----C
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----G 595 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 595 (862)
....++|.+.+.||+|||+.||.++ ..++..+|+|++...+.++.+..++|++..++++|||++++++++..+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456789999999999999999998 456678999998887788889999999999999999999999987544 3
Q ss_pred eEEEEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 596 EMILVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
+.+++++|...|+|.+.+... +...+++.+.++|+.++++||++||+.. +++.||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 589999999999999999754 3345999999999999999999999874 6899999999999999999999999999
Q ss_pred cccCCCCCCcc-------ccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 041565 674 SKTGPNLNQTH-------VSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW 743 (862)
Q Consensus 674 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 743 (862)
++..+-..... ......-|..|.|||.+. +...++++|||||||+||+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 87643211110 012234688999999985 45689999999999999999999999964322
Q ss_pred HHhhhccCcccc-ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 744 ALHCQRMGTIED-IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 744 ~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+.+.- +..+.+.-.-....++.+.+++++|++.||.+||++.+++.+++.++
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111 11222211111126778999999999999999999999999988764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.52 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=204.0
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+|+..++||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++|+||+++++++..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677899999999999999865 57789999876432 2234567889999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999987655456999999999999999999999877 9999999999999999999999999997643211
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....... .. ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~~~~~~-~~----------~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EEVERRV-KE----------DQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HHHHHHh-hh----------cc
Confidence 122346899999999999999999999999999999999999999754322111 0010000 00 01
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
...+...+..+.+++.+|++.+|.+|| ++.+++++.+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 112233566789999999999999999 78888776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.73 Aligned_cols=265 Identities=25% Similarity=0.304 Sum_probs=208.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChh-hH-HHHHHHHHHHHhccccceeeEEEEEe--ecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQ-GV-HEFQTEIEMLSKLRHKHLVSLIGFCE--EDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV 600 (862)
++|+..+.|++|.||.||+|+.+ .+..||+|+++...+. +. =.-++|+.+|.+++|||||.+..... +-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35677889999999999999976 4678999998764321 11 23579999999999999999988764 34679999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||||+. +|...+.... +++...++..++.|+++|++|||... |+|||||++|+|++..|.+||+||||||.....
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999976 8999998765 45999999999999999999999888 999999999999999999999999999976542
Q ss_pred CCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
....+...-|..|.|||.+.+ ..|++..|+||+||++.||+++++.|.+..+.++...+- ...|...+.+.|
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If-----~llGtPte~iwp 303 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF-----KLLGTPSEAIWP 303 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH-----HHhCCCccccCC
Confidence 233556678999999999887 579999999999999999999999998876655544321 111111111111
Q ss_pred -------------------CCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 760 -------------------NLKGNITDQ-CLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 760 -------------------~l~~~~~~~-~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+++.+... ..+.-.+++...+..||.+|-|+.|.+++=.+.-
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 122222221 2355678999999999999999999999877653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=336.02 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=195.2
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
|+..++||+|+||.||+++.. ++..||||.+... .....+.+.+|+++++.++|+||+++++++..++..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999975 5789999987543 33445678999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 224 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP 224 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence 99986432 2567788899999999999999877 9999999999999999999999999998643211 11
Q ss_pred cccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 686 STMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+ |........ . .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~~~-~------~ 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAIC-M------S 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHh-c------c
Confidence 233468999999998743 234568999999999999999999997332211 211110000 0 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
........+..++.+++.+||+.+|++||++.|++++-+...
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 001112235567899999999999999999999998866543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.11 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=200.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC---------------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG---------------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 589 (862)
++|...++||+|+||.||++...+ ...||+|..... ......+|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987542 124899988654 3444567999999999999999999999
Q ss_pred EEeecCeEEEEEEeCCCCcHHHHHhcCC----------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 590 FCEEDGEMILVYDYMANGTLREHLYKGD----------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 590 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
++...+..++||||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986532 123788999999999999999999877 999999999999
Q ss_pred ccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCcccc
Q 041565 660 LDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPALNVNLPKEQ 737 (862)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt--G~~p~~~~~~~~~ 737 (862)
+++++.+||+|||+++...............++..|+|||++.++.++.++|||||||+++||++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976433222222223345678999999999999999999999999999998 5566654322211
Q ss_pred ccHHHHHHhhhcc-CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 738 VSLADWALHCQRM-GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 738 ~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. ......... +.... ...+...+..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 I---ENTGEFFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHhhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 111110100 00000 0111124567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=321.16 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=205.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
.++|...+.||+|+||.||+|...+ +..+|+|...... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998653 2579999876543 34456789999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCC--------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 598 ILVYDYMANGTLREHLYKGD--------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 123788999999999999999999876 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhh
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.|+......+. ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHHh---
Confidence 9999986543322222233446788999999998899999999999999999998 8888864432221 11111
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+.. ...+..++..+.+++.+||+.+|.+|||+.|++..|+
T Consensus 236 -~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110 0112224667899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=317.37 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=204.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.+.|+..++||+|+||.||+|..+++..+|+|.+.... ....++.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35678889999999999999998888899999887543 33568999999999999999999999874 45789999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.......+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 9999999997765556899999999999999999999876 99999999999999999999999999976432111 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++.+..++.++||||||++++||++ |+.||......+. . ..... + ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~~~~-~---------~~~ 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---I---QNLER-G---------YRM 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---H---HHHHc-C---------CCC
Confidence 1223345678999999999999999999999999999999 9999964432211 1 11100 0 000
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+...+.++.+++.+|++.+|++||++.+++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112245679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.71 Aligned_cols=270 Identities=22% Similarity=0.300 Sum_probs=200.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888999999999999999976 567899998764332 223467889999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 68888886543 34889999999999999999999887 9999999999999999999999999987532211
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc-cccHHHHHHhhhccCcc---cc--
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE-QVSLADWALHCQRMGTI---ED-- 755 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~---~~-- 755 (862)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......+.......... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233457899999999875 458899999999999999999999997543211 10000000000000000 00
Q ss_pred ccCCC-CC----CCCcH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 IIDPN-LK----GNITD-----QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 ~~d~~-l~----~~~~~-----~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..++. .. ..... ..+..+.+++.+||+.+|.+|||+.|++++-.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 00000 00 00000 1224678999999999999999999999876653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.56 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=205.0
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|++|.||++..+ ++..+++|.+... .....+++.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 4678999986532 345567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998764456899999999999999999999876 9999999999999999999999999988643321
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......|+..|+|||++.+..++.++||||||++++||++|+.||......+ ..... ..+. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~---------~~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKI----IRGV---------FP 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCC---------CC
Confidence 12233468889999999999999999999999999999999999996543211 11111 0111 11
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222355678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.83 Aligned_cols=247 Identities=25% Similarity=0.438 Sum_probs=198.8
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHH
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLR 610 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 610 (862)
++||+|+||.||+|..+++..+|+|...... ......+.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888899999877543 333457899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccccccc
Q 041565 611 EHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690 (862)
Q Consensus 611 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 690 (862)
+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....... .......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence 9987543 34899999999999999999999877 99999999999999999999999999875332111 1111223
Q ss_pred CCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 691 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
++..|+|||++.++.++.++||||||+++|||++ |+.||........ . ... ..+ .....+..+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~---~~~-~~~---------~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R---EQV-EKG---------YRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H---HHH-HcC---------CCCCCCCCC
Confidence 4568999999999999999999999999999998 9999864422111 0 000 011 011112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.40 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=195.4
Q ss_pred eEeeeCcEEEEEEEEc---CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 533 VIGVGGFGKVYEGYID---GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
.||+|+||.||+|.++ ++..+|+|++.... ....+++..|+.+++.++|+||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 45789999876432 3456789999999999999999999999864 5678999999999
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc-cc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH-VS 686 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 686 (862)
+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997543 3899999999999999999999877 9999999999999999999999999998653322111 11
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+ +..... .+. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~i~-~~~---------~~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQMIE-SGE---------RMEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-CCC---------CCCC
Confidence 22234578999999988889999999999999999998 999986543221 111111 111 1112
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+..++.++.+++.+||+.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22355678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.69 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=203.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-Ccc----EEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKT----KVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.+|+..++||+|+||.||+|... ++. .||+|.+... .....+++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 46778899999999999999853 333 4899987643 334467889999999999999999999999754 5679
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999997643 34899999999999999999999877 99999999999999999999999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||.+.+..++.++|||||||++|||++ |..|+....... +..+... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~------ 229 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK---GER------ 229 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC---CCc------
Confidence 222111222335678999999999999999999999999999998 888886432211 1122111 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
...+..++..+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 230 ----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 ----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 001122456789999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.62 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=202.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|...+.||+|++|.||++..+++..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4577788999999999999998877789999876433 334678999999999999999999998854 56789999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 999999998755555899999999999999999999876 99999999999999999999999999976432211 11
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++..|+|||.+.+..++.++||||||++++||++ |+.|+......+ ...+... ... ..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~----------~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER---GYR----------MP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc---CCC----------CC
Confidence 122345678999999999999999999999999999999 888886543221 1111110 000 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.42 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=205.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++|+..+.||+|+||.||++... +..||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346778899999999999999876 56899999876544 5678999999999999999999999999899999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999998765556999999999999999999999877 9999999999999999999999999998653211
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.....+..|+|||++.++.++.++||||||++++||++ |+.||......+ +..... . + ...
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~---~-~---------~~~ 218 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVE---K-G---------YRM 218 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh---c-C---------CCC
Confidence 12335668999999998899999999999999999997 999886442221 111111 0 0 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+...+..+.+++.+|+..+|.+||++.|++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.15 Aligned_cols=272 Identities=24% Similarity=0.322 Sum_probs=210.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecC--CCChhhHHHHHHHHHHHHhccccceeeEEEEEee-----cC
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-----DG 595 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~ 595 (862)
....|...+.||+|+||.|+++..+ +|..||||++. -......++-.+|+++|++++|+||+.+.+.... -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445555688999999999999865 57899999987 3455567888999999999999999999998754 46
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..|+|+|+|+ -+|...++.+.. |+.....-++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+||||||
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 7899999994 589998876543 899999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
...........+...-|..|.|||.+.. ..|+...||||.||++.||++|++.|.+...-.+..++-.......+..+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8654323334466678999999998754 789999999999999999999999998876655544432111111111111
Q ss_pred cc--------cC--CCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 755 DI--------ID--PNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 755 ~~--------~d--~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+ +. |...+ ..-........+++++||..||.+|+|++|.+++.-..
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 11 00 00000 00112345678999999999999999999999886543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.68 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=207.7
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..++|...++||+|+||.||++..+++..+|+|.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998887889999887543 3457899999999999999999999999988999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...... .
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence 99999999998765556999999999999999999999877 9999999999999999999999999987654211 1
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
........+..|+|||.+.+..++.++||||||++++||++ |+.||........ .+... .. ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~---~~----------~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVE---RG----------YR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---cC----------CC
Confidence 11122234568999999999999999999999999999998 9999864432111 11110 00 00
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
...+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11112235678999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.27 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred eeEeeeCcEEEEEEEEc----CccEEEEEecCCC----ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYID----GKTKVAIKRSNPS----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++||+|+||.||++... .+..||+|.+... .......+..|+++|+.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 4678999987642 223345678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|+|.+++.+.. .+.+..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence 99999999997654 3788899999999999999999877 999999999999999999999999998753221 1
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+. .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~-~~~----------~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKIL-KGK----------L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHH-cCC----------C
Confidence 122345689999999999998899999999999999999999999975432211 01100 010 0
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
..+......+.+++.+||+.+|.+|| ++.+++++..
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 11222456788999999999999999 8899887643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.28 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=202.9
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-c---cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-K---TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.|...+.||+|+||.||+|.... + ..||+|.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999999753 2 36999988754 3445678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999976533 4899999999999999999999877 9999999999999999999999999987643322
Q ss_pred Cccccc-ccc--CCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 682 QTHVST-MVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 682 ~~~~~~-~~~--gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
...... ... .+..|+|||++.+..++.++|||||||+++||++ |+.||......+ ...+... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~---~~~----- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQ---DYR----- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHc---CCc-----
Confidence 111111 111 2357999999999999999999999999999886 999986443221 1222111 000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
-..+.+++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011123456789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.23 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=206.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||+|+.. ++..||+|.+.. .......++.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999965 568899997643 23344567899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 602 DYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 602 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 2334889999999999999999999877 99999999999999999999999999886433
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...++.......+ .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~------~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD------YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC------CC
Confidence 211 11234588899999999988899999999999999999999999854321 1111221111100 11
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.......+..+.+++.+||+.+|.+||++.+|++.++.+
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111233556789999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=329.94 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=199.7
Q ss_pred CcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCC----ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPS----SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 597 (862)
+|+..+.||+|+||.||+++.. .+..+|+|.+... .....+.+..|+.+++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998753 4678999987532 223345688899999999 599999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997654 3899999999999999999999877 999999999999999999999999999764
Q ss_pred CCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~------- 225 (332)
T cd05614 156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK------- 225 (332)
T ss_pred cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-------
Confidence 32211 122345699999999999875 4788999999999999999999999643322111 111111100
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
.++.+ +...+..+.+++.+||+.+|++|| ++.+++++.+
T Consensus 226 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 226 CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 11212 222455688999999999999999 7888887654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.90 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=205.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-----------------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceee
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-----------------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVS 586 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 586 (862)
.++|+..+.||+|+||.||++...+ +..||+|.+... .....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4568888999999999999988643 235899987654 3445678999999999999999999
Q ss_pred EEEEEeecCeEEEEEEeCCCCcHHHHHhcCC---------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCC
Q 041565 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGD---------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTN 657 (862)
Q Consensus 587 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 657 (862)
++++|..++..++||||+++++|.+++.+.. ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997643 124899999999999999999999877 9999999999
Q ss_pred eeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCcc
Q 041565 658 ILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPALNVNLPK 735 (862)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt--G~~p~~~~~~~ 735 (862)
|++++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986443322223334456788999999999899999999999999999998 66676543221
Q ss_pred ccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+ ................. ...+..++.++.+++.+|++.+|.+|||+.|+++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11112111111111100 0111224567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.74 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=197.1
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
+.||+|+||.||++... .+..+|+|.+... ......++..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 5778999987642 2334567788999999999999999999999999999999999999
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
+|..++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 9999887644 38999999999999999999997 45 999999999999999999999999998753221 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+.... . ... ... ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---i----~~~------~~~----~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I----LME------EIR----FP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---H----hcC------CCC----CC
Confidence 335699999999999999999999999999999999999999965432211110 0 000 001 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
.....++.+++.+||+.+|.+|+ ++.+++++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 22455788999999999999996 8999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=331.43 Aligned_cols=261 Identities=24% Similarity=0.375 Sum_probs=201.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEE------cCccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEeec-C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI------DGKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED-G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 595 (862)
.++|...+.||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34688899999999999999974 235689999987533 33456788999999999 689999999988654 5
Q ss_pred eEEEEEEeCCCCcHHHHHhcCC----------------------------------------------------------
Q 041565 596 EMILVYDYMANGTLREHLYKGD---------------------------------------------------------- 617 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 617 (862)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986431
Q ss_pred -------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccccccc
Q 041565 618 -------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690 (862)
Q Consensus 618 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 690 (862)
...+++..+.+++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123688889999999999999999877 9999999999999999999999999997643222111122234
Q ss_pred CCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 691 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ . ... ...+... ..+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~---~~~-~~~~~~~---------~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F---CRR-LKEGTRM---------RAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H---HHH-HhccCCC---------CCCCCC
Confidence 5678999999999999999999999999999997 8888864322111 0 010 1111100 011113
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..++.+++.+||+.+|.+||++.|++++|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3568899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.65 Aligned_cols=257 Identities=29% Similarity=0.459 Sum_probs=202.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-cc--EEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KT--KVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
++|+..+.||+|+||.||+|.++. +. .+++|++... .....+++.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999998653 33 4678876543 344567889999999999 899999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 601 YDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
|||+++|+|.+++.+.. ...+++.+++.++.|+++||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997542 124789999999999999999999877 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++.... ........++..|+|||++.+..++.++|||||||+++||++ |..||......+ ...
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 234 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence 9999999864221 111111234567999999988889999999999999999998 999986433221 111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..... .....+...+..+.+++.+|++.+|++||++.+++++|+.+++-
T Consensus 235 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11000 00011112345789999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.74 Aligned_cols=260 Identities=23% Similarity=0.436 Sum_probs=205.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc--------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeec
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID--------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED 594 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 594 (862)
..+|...+.||+|+||.||++... ....+|+|.+... ......++..|+++++++ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 2346899987743 334567789999999999 699999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
+..++||||+++|+|.+++.... ...+++.++++++.|++.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997532 134889999999999999999999877 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
++++.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999986543222111222234567999999999999999999999999999999 8888854322111
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..... .+.. ...+..++.++.+++.+|++.+|.+||++.|+++.|+.+..
T Consensus 246 -~~~~~----~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 -FKLLR----EGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHHHH----cCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111 1100 01122345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.99 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=195.5
Q ss_pred eEeeeCcEEEEEEEEc---CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 533 VIGVGGFGKVYEGYID---GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
.||+|+||.||+|.+. .+..||+|...... ....++|.+|+.++++++|+||++++++|.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 34569999886553 3345679999999999999999999999864 57899999999999
Q ss_pred HHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc-cccc
Q 041565 609 LREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT-HVST 687 (862)
Q Consensus 609 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~ 687 (862)
|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++........ ....
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999987543 34899999999999999999999877 999999999999999999999999999754322111 1112
Q ss_pred cccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +...... +. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-~~---------~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQ-GK---------RLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHC-CC---------CCCCC
Confidence 2234578999999998899999999999999999996 999986543221 1111111 10 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..++.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23567889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=336.31 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=198.8
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.|...+.||+|+||.||+|+.. .+..+|+|++... .....+.+.+|++++++++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999865 4678999987643 23445678999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997654 3889999999999999999999877 99999999999999999999999999753210000
Q ss_pred ---------------------------------------------ccccccccCCCCCCChhhhhcCCCCchhHHHHHHH
Q 041565 683 ---------------------------------------------THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 717 (862)
Q Consensus 683 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gv 717 (862)
........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccc-cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHH--ccccCCCCCCCHHHH
Q 041565 718 VLFEVLCARPALNVNLPKEQV-SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEK--CLSDQGIDRPSMGDV 794 (862)
Q Consensus 718 vl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~~p~~RPt~~ev 794 (862)
++|||++|+.||......+.. ....| ...+ .... ......++.+++.+ |+..++..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINW------ENTL------HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcc------cccc------CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999754432211 01001 0000 0000 01134567778877 556677779999999
Q ss_pred HHHHHH
Q 041565 795 LWNLEF 800 (862)
Q Consensus 795 l~~L~~ 800 (862)
+.+..+
T Consensus 303 l~hp~f 308 (381)
T cd05626 303 KAHPFF 308 (381)
T ss_pred hcCccc
Confidence 988654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.76 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=198.9
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||++..+ ++..||+|.+... .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999976 4678999987642 233456688999999998 799999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 99999887553 4999999999999999999999877 999999999999999999999999998753211 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHhhhccCccccccCCCCCCC
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE--QVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+ .....++......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~---- 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IR---- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CC----
Confidence 34568999999999999999999999999999999999999996432211 1111222222111111 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPS------MGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt------~~evl~~L~~ 800 (862)
.+...+..+.+++.+||+.+|.+||+ +.|++++-+.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 12224557889999999999999997 7888876443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.68 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=204.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||++... ++..||+|++... .....+.+..|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999976 5778999987643 2234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999865 34899999999999999999999876 9999999999999999999999999997643322
Q ss_pred ---------------------------CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 041565 682 ---------------------------QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLP 734 (862)
Q Consensus 682 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~ 734 (862)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112334689999999999999999999999999999999999999975432
Q ss_pred cccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHH
Q 041565 735 KEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-MGDVLWNLEF 800 (862)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-~~evl~~L~~ 800 (862)
.+. +.........+ .-+. ....+..+.+++.+|++ +|.+||+ +.|++++...
T Consensus 236 ~~~-----~~~i~~~~~~~---~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 236 QET-----YNKIINWKESL---RFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred HHH-----HHHHhccCCcc---cCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 211 11100000000 0010 01145678899999997 9999999 9999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.19 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=204.2
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--------------hhhHHHHHHHHHHHHhccccceee
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--------------EQGVHEFQTEIEMLSKLRHKHLVS 586 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~ 586 (862)
.+--+.|...+.||+|.||.|-+|+.. ++..||||++.... ....+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344567888899999999999999965 46789999875421 112357889999999999999999
Q ss_pred EEEEEee--cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC
Q 041565 587 LIGFCEE--DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW 664 (862)
Q Consensus 587 l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 664 (862)
|+.+..+ .+.+|||+|||..|.+... ......++..+.+++++++..||+|||.++ ||||||||+|+||+++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9999865 4689999999998887532 112223899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccccccCCCC---CCccccccccCCCCCCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 041565 665 EAKVSDFGLSKTGPNL---NQTHVSTMVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737 (862)
Q Consensus 665 ~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~ 737 (862)
++||+|||.+...... +.........||+.|+|||++.++. .+.+.||||+||+||.|+.|+.||......+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~- 326 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE- 326 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence 9999999998754221 1111223367999999999998743 4578999999999999999999996543211
Q ss_pred ccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 738 VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 738 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+ ...++...|.-....++.+.+.+|++++|.+||..|.+..+|..|++-...
T Consensus 327 --l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 --L------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --H------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 122233333222223456788999999999999999999999999887654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.66 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=208.0
Q ss_pred cceeEeeeCcEEEEEEEEcC--c--cEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 530 ESHVIGVGGFGKVYEGYIDG--K--TKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
..++||+|.||.|++|.++. | ..||||.++..... ...+|++|+.+|.+|+|+|+++|+|...+ ..+.||+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35789999999999999763 3 36899999876544 67899999999999999999999999887 6789999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
+.|+|.+.|++..+..|-...+..++.|||.||+||.+++ +|||||.++|+||-....+||+||||.|.....+...
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999866666889999999999999999999887 9999999999999999999999999999765444333
Q ss_pred ccc-cccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 685 VST-MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 685 ~~~-~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
+.. ..+-.+.|+|||.+....++.++|||+|||++|||++ |..||.+-...+.+ +.+|..-+
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhcccccc
Confidence 332 2334678999999999999999999999999999997 66788654433322 22232222
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
-.-+..|++++.+++..||..+|++|||+..+.+.+-.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 22345689999999999999999999999999855433
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.40 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=196.8
Q ss_pred eeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.||+|+||.||++..+. +..+|+|.+... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 678999987643 233456678899988877 799999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 99999887653 3899999999999999999999877 999999999999999999999999999753221 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHhhhccCccccccCCCCCCC
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE--QVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... .....++......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 34568999999999999999999999999999999999999995322111 1111122221111111 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPS------MGDVLWNL 798 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt------~~evl~~L 798 (862)
++......+.+++.+||+.+|.+||+ +.+++++-
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 22234567889999999999999998 57887664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.70 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=205.7
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
|++.++.++.....||+|+||.||+|... ++..|++|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45667788888889999999999999965 46789999887766667788999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCC--ChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeeccccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGL--PWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSK 675 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~ 675 (862)
+|+||+++++|.+++..... .+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999976432 24 78889999999999999999876 999999999999976 6789999999987
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
....... ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+........ ..|.....
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~----- 227 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF----- 227 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-----
Confidence 5432211 122335788999999987643 78999999999999999999999864322111 11111000
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
......+.....++.+++.+||+.+|.+|||+.|++.+
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111223355678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.30 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=200.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEe-ecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE-EDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 604 (862)
.+|...+.||+|+||.||++..+ +..+++|...... ..+.|.+|+.++++++|+|++++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36777899999999999999866 5578999876432 3467899999999999999999999764 456789999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998765556899999999999999999999877 9999999999999999999999999987543211
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+..... .+........ ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~----------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKG----------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC----------CCC
Confidence 22334568999999999999999999999999999997 9988854321 1111111110 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.....++..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1122356678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.41 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=195.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||++... .+..+|+|.+... .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 4678999987643 2233467888999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997654 4899999999999999999999877 9999999999999999999999999987532110
Q ss_pred Cc---------------------------------cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 041565 682 QT---------------------------------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA 728 (862)
Q Consensus 682 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p 728 (862)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001234699999999999999999999999999999999999999
Q ss_pred CCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHHH
Q 041565 729 LNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLS--DQGIDRPSMGDVLWNL 798 (862)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~--~~p~~RPt~~evl~~L 798 (862)
|......+.. ......... +..|. .. .....+.+++.+++. .++..||++.|++++-
T Consensus 236 f~~~~~~~~~-----~~i~~~~~~---~~~p~---~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 236 FCSETPQETY-----KKVMNWKET---LIFPP---EV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred CCCCCHHHHH-----HHHHcCcCc---ccCCC---cC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence 9754332211 111000000 00111 00 123445666665332 3445679999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=331.40 Aligned_cols=264 Identities=22% Similarity=0.240 Sum_probs=200.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|+..+.||+|+||.||++... .+..||+|... ...+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 457999999999999999999865 46789999643 23567899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+. ++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 95 68988886643 3899999999999999999999877 99999999999999999999999999975322111
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHhhhccC----------
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV--SLADWALHCQRMG---------- 751 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~---------- 751 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ............+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 1223456999999999999999999999999999999999999876432211100 0000000000000
Q ss_pred --ccccc---------cCCCCCCCC--cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 --TIEDI---------IDPNLKGNI--TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 --~~~~~---------~d~~l~~~~--~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+... ..+..+... ....+.++.+++.+||+.+|.+|||+.|++++-.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 00000 000000000 112456789999999999999999999999887764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.10 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=196.6
Q ss_pred eeEeeeCcEEEEEEEEcC-cc--EEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KT--KVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+|.+++ +. .+++|.+... .....+.+..|+++++++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 32 4688887643 344567889999999999 799999999999999999999999999
Q ss_pred CcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 607 GTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 607 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 124789999999999999999999876 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccC
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
+++.... .........+..|+|||++....++.++|||||||+++||++ |+.||......+ ........
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~- 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQG- 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhCC-
Confidence 9864221 111112234567999999998899999999999999999997 999985432211 11111100
Q ss_pred ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 752 TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.....+..++..+.+++.+|++.+|.+|||+.|++..|+.++
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111224557899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.71 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=197.3
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhcccc-ceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHK-HLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 601 (862)
+|+..+.||+|+||.||+|..++ +..||+|.+... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47778999999999999999764 568999987642 234456788899999999765 5888999999899999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999987654 3899999999999999999999877 9999999999999999999999999987532111
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .. ..
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~i~----~~------~~-- 218 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QSIM----EH------NV-- 218 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHH----cC------CC--
Confidence 1223456899999999999999999999999999999999999999754322111 0000 00 01
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSM-----GDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~-----~evl~~ 797 (862)
.++......+.+++.+||+.+|.+|++. .+++++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122245578899999999999999976 676655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.82 Aligned_cols=263 Identities=21% Similarity=0.377 Sum_probs=201.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-----------------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceee
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-----------------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVS 586 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 586 (862)
.++|+..+.||+|+||.||++...+ ...+|+|.+... .....++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3568889999999999999985322 346899988754 3445678999999999999999999
Q ss_pred EEEEEeecCeEEEEEEeCCCCcHHHHHhcCCC---------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCC
Q 041565 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDK---------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTN 657 (862)
Q Consensus 587 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 657 (862)
+++++...+..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976421 23778899999999999999999877 9999999999
Q ss_pred eeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCcc
Q 041565 658 ILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPALNVNLPK 735 (862)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt--G~~p~~~~~~~ 735 (862)
||+++++.+||+|||+++...............++..|++||...++.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999976433221111222334678999999988899999999999999999998 66777543222
Q ss_pred ccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+.. ............ ....+ .+..++..+.+++.+||+.+|.+||++.||++.|+
T Consensus 241 ~~~---~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVI---ENTGEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 001110000000 00001 11224567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.99 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=203.5
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
..++|+..+.||+|+||.||++... .+..+|+|.+... .....+++.+|+.++++++||||++++++|..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999864 3467999987654 33445779999999999999999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCC--------------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCC
Q 041565 597 MILVYDYMANGTLREHLYKGD--------------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTT 656 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 656 (862)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997431 124788899999999999999999877 999999999
Q ss_pred CeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 041565 657 NILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPK 735 (862)
Q Consensus 657 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~ 735 (862)
||++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432221111222334667999999999999999999999999999997 87787543222
Q ss_pred ccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+ +.... ..+... ..+..++.++.+++.+|++.+|.+|||+.|+++.|+
T Consensus 240 ~------~~~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 E------VIYYV-RDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H------HHHHH-hcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11111 111110 011224567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.45 Aligned_cols=242 Identities=25% Similarity=0.371 Sum_probs=191.8
Q ss_pred eeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+|..++ +..||+|.+... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 678999987642 223345566677777654 899999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999987654 3899999999999999999999877 9999999999999999999999999997543221 223
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... . .+ .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~-~------~~----~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSILN-D------RP----HFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHc-C------CC----CCC
Confidence 3456899999999999999999999999999999999999999754322111 11000 0 01 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMG-DVLWN 797 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~-evl~~ 797 (862)
.....++.+++.+||+.+|.+||++. +++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 22455678999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.35 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=202.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-----hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-----EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...+.||+|++|.||++... .+..+++|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999864 57889999765321 2234678899999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999987653 3889999999999999999999877 99999999999999999999999999876432
Q ss_pred CCCccc-cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHV-STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...... .....++..|+|||++.+..++.++||||||+++|||++|+.||......... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~------------~ 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIA------------T 221 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHh------------c
Confidence 211111 12345778999999999999999999999999999999999998643221110 0000 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.......+..+...+.+++.+||..+|.+|||+.|++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0111122334566789999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.35 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=193.4
Q ss_pred EeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|+||.||++..+ .+..+|+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 47889999875321 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 99987665556899999999999999999999877 999999999999999999999999998764321 122334
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..... .. ..... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~-----~~----~~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRT-----LE----DEVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHh-----hc----ccccc-ccccC
Confidence 689999999999998899999999999999999999999864322111 11111110 00 00000 01124
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLW 796 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~ 796 (862)
+.++.+++.+||+.+|.+||+++|+++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchh
Confidence 556899999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.40 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=206.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||++... ++..++||.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777889999999999999964 6788999976542 3344568899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 602 DYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 602 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 2345899999999999999999999877 99999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.. .......++..|+|||++.+..++.++||||||+++|||++|..||...... ...+... +.....+
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~------~~~~~~~ 226 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK------IEQCDYP 226 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh------hhcCCCC
Confidence 21 1122345888999999999989999999999999999999999998643211 1111111 1111111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+ .....+..+.+++.+||+.+|.+||||.+|++.++.+
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 1223566799999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.89 Aligned_cols=249 Identities=31% Similarity=0.510 Sum_probs=203.5
Q ss_pred eeEeeeCcEEEEEEEEcC----ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG----KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.||+|+||.||++.... +..+++|.+...... ..+++.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 678999988765433 367899999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCC-------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 607 GTLREHLYKGD-------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 607 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
++|.+++.... ...+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998652 245899999999999999999999877 99999999999999999999999999987654
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||.+....++.++||||||++++||++ |+.||......+ + ...... +.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~-~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---V---LEYLRK-GY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHHc-CC------
Confidence 332222334557889999999998899999999999999999999 689986552211 1 111111 10
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
....+..++..+.+++.+|++.+|.+||++.|++++|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112234678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.18 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=201.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|+..+.||+|+||.||+|+.. ++..+|+|+...........+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888899999999999999964 56789999887554455567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 9999999987543 4899999999999999999999876 9999999999999999999999999998643211 1
Q ss_pred ccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......++..|+|||.+. ...++.++|||||||+++||++|+.|+......+... . ..... ...+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~---~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKSN---FQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecCC---CCCCCC
Confidence 122345888999999884 3557889999999999999999999985332211100 0 00000 001111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.. ....+..+.+++.+||+.+|++||++.+++++|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 10 112456789999999999999999999999765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.34 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=200.6
Q ss_pred eeEeeeCcEEEEEEEEcC--c--cEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG--K--TKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|++|.||+|.+.. + ..+|+|.+..... ...+++..|+.++++++|+||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3689999877655 567789999999999999999999999988 889999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc-cc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT-HV 685 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~ 685 (862)
|+|.+++.+.....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998755345899999999999999999999876 999999999999999999999999999865432211 11
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++..|+|||++.+..++.++|||||||+++||++ |+.|+......+.. ........ . ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~--~-------~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL------KKIDKEGE--R-------LE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCC--c-------CC
Confidence 123457789999999999999999999999999999998 99998644322211 11110000 0 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11234567899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.59 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=194.8
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHH---HhccccceeeEEEEEeecCeEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEML---SKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
|...+.||+|+||.||++..+ .+..||||.+... .....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999875 4688999987643 223345566676655 566899999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|..++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888543 4899999999999999999999877 999999999999999999999999998753221
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... +. +.
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~-~~------~~ 219 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVN-DE------VR 219 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CC------CC
Confidence 1 1223456899999999999999999999999999999999999999754332211 11000 00 01
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNL 798 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L 798 (862)
.+...+..+.+++.+||+.+|.+|| ++.+++++.
T Consensus 220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 1222456788999999999999999 577777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=347.94 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=205.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...++||+|+||.||+|... .+..||+|++... .....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999975 4788999987643 2334567999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCC---------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 602 DYMANGTLREHLYKGD---------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
||+++|+|.+++.... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 123677888999999999999999877 9999999999999999999999999
Q ss_pred ccccCCCCCC----------------ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 041565 673 LSKTGPNLNQ----------------THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736 (862)
Q Consensus 673 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~ 736 (862)
+++....... ........||+.|+|||++.+..++.++|||||||+++||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976421100 001122468999999999999999999999999999999999999996532211
Q ss_pred cccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhcC
Q 041565 737 QVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-SMGDVLWNLEFALQL 804 (862)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-t~~evl~~L~~~l~~ 804 (862)
.. +.. .+.++... ....+.+..+.+++.+|++.+|++|| ++.++++.|+..++.
T Consensus 239 i~----~~~---------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS----YRD---------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh----hhh---------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 000 00011000 00113456788999999999999996 678888888887654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.38 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=203.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.+|...+.||+|+||.||+|... .+..+|+|.+.... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999864 23368999876532 34457899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997654 34899999999999999999999877 999999999999999999999999999865432
Q ss_pred CCccc-cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 681 NQTHV-STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 681 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
..... .....++..|+|||++.++.++.++||||||++++|+++ |+.||......+ ...+... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~---~~~------ 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE---GYR------ 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC---CCc------
Confidence 21111 111223567999999999999999999999999999886 999986443221 1111111 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...+..++..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001122456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.53 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=195.5
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||++..+ ++..||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 4678999987642 223456678899988877 699999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 99999987654 3899999999999999999999877 999999999999999999999999998753221 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+. . ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~-~~~------~----~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAIL-NDE------V----VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHh-cCC------C----CCC
Confidence 3456899999999999999999999999999999999999999754332211 1100 000 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSM------GDVLWNLE 799 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~------~evl~~L~ 799 (862)
...+..+.+++.+||+.+|.+||++ .+++++-.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 1234578899999999999999998 66666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=335.40 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=203.8
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
+....++|+..++||+|+||.||++... .+..+|+|.+... .....+.+..|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445668999999999999999999976 4678999987532 22334567889999999999999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999998653 3788889999999999999999877 99999999999999999999999999976
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ +.........
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~~ 265 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHKNS 265 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCCCc
Confidence 432111 112345699999999998653 478999999999999999999999975432111 1111100000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID--RPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~--RPt~~evl~~L~~ 800 (862)
+. ... ....+..+.+++.+||+.+|.+ ||++.|++.+.+.
T Consensus 266 ~~------~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 266 LT------FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CC------CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 00 000 1124567889999999999987 9999999988654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=336.87 Aligned_cols=268 Identities=22% Similarity=0.269 Sum_probs=197.0
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec-------
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------- 594 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 594 (862)
...++|...++||+|+||.||+|... .+..||||++.... ....+|+.+|+.++|+||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34567999999999999999999975 46789999875432 2345799999999999999999876322
Q ss_pred -CeEEEEEEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEee
Q 041565 595 -GEMILVYDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSD 670 (862)
Q Consensus 595 -~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~D 670 (862)
..+++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 24679999997 477777653 23345899999999999999999999887 99999999999999664 799999
Q ss_pred ccccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 671 FGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.............
T Consensus 215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99998643221 1223468999999999876 4689999999999999999999999976543322111000000000
Q ss_pred -------cCccccc-----cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 750 -------MGTIEDI-----IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 750 -------~~~~~~~-----~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....++ ....+...++...+.++.+++.+||+.+|.+|||+.|++++..+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 0000000 000111112223456789999999999999999999999887764
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.37 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=199.1
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHH
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLR 610 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 610 (862)
++||+|+||.||++..+++..|++|....... ....++..|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987788999998765433 35678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccccccc
Q 041565 611 EHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690 (862)
Q Consensus 611 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 690 (862)
+++..... .+++..++.++.+++.||+|||+++ ++||||||+|||++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99976433 4889999999999999999999877 9999999999999999999999999997643211111111223
Q ss_pred CCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 691 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.+..|+|||.+.++.++.++|||||||+++||++ |..|+........ ..... . ......+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~~~---~----------~~~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERIE---S----------GYRMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHHHh---c----------CCCCCCCccC
Confidence 4567999999998999999999999999999998 7888754432111 11110 0 0001112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=334.43 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=201.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..++||+|+||.||++... .+..||||++... .......+.+|++++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 4788999987642 2234566889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997654 3899999999999999999999877 9999999999999999999999999987532110
Q ss_pred Cc------------------------------------cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhC
Q 041565 682 QT------------------------------------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 725 (862)
Q Consensus 682 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG 725 (862)
.. .......||+.|+|||++.+..++.++|||||||+++||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 001123589999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHHH
Q 041565 726 RPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS---MGDVLWNLEF 800 (862)
Q Consensus 726 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt---~~evl~~L~~ 800 (862)
+.||......+.. ..... ....+. -+ . ....+..+.+++.+|+. +|.+|++ +.|++++.+.
T Consensus 236 ~~Pf~~~~~~~~~---~~i~~--~~~~~~---~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 236 YPPFCSDNPQETY---RKIIN--WKETLQ---FP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred CCCCCCCCHHHHH---HHHHc--CCCccC---CC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 9999754332111 00000 000000 00 0 01134567889999996 8999997 9999887543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.76 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=196.7
Q ss_pred eeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+|+..+ +..||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999764 678999987643 233456678899998876 799999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 99999987654 3899999999999999999999877 9999999999999999999999999987532211 122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... +. .. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~~-~~---~~-------~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESILH-DD---VL-------YP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHHc-CC---CC-------CC
Confidence 3456899999999999999999999999999999999999999755332211 11000 00 00 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRP-------SMGDVLWNLE 799 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RP-------t~~evl~~L~ 799 (862)
.....++.+++.+||+.+|.+|| ++.+++++..
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 12345788999999999999999 8888887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.63 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=197.5
Q ss_pred EeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|+||+||++... ++..+|+|.+.... ....+.+..|+++++.++|+||+++.+++..+...++|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999865 56789999876432 23346678899999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccc
Q 041565 610 REHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687 (862)
Q Consensus 610 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (862)
..++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9888542 2345899999999999999999999877 9999999999999999999999999997643321 1123
Q ss_pred cccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcH
Q 041565 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767 (862)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 767 (862)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...... +.... ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~---------~~~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR---------ILNDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh---------hcccC--CCCcc
Confidence 356899999999999999999999999999999999999999654321110 000000 00000 01222
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 768 QCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 768 ~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
..+..+.+++.+||+.+|.+|| ++.+++++.+.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 3556789999999999999999 77888877554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.37 Aligned_cols=265 Identities=25% Similarity=0.311 Sum_probs=201.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC-----eEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG-----EMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l 599 (862)
-.|...+++|.|+||.||+|.+.. +..||||+.....+ ---+|+.+|++++|||||+|+-++.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 346668999999999999999764 57899998765433 1246999999999999999998875432 3468
Q ss_pred EEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeecccccc
Q 041565 600 VYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKT 676 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~ 676 (862)
|||||+. +|.+.++.. .+..++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999986 999998742 2344888888889999999999999876 9999999999999976 8999999999997
Q ss_pred CCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc--
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI-- 753 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 753 (862)
..... ......-|.-|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....++...+--+........+
T Consensus 176 L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 54322 2233456788999999887 67999999999999999999999999887665554332111111111111
Q ss_pred -----ccccCCCCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 754 -----EDIIDPNLKGN-----ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 754 -----~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+.-.|.+... .......+..+++.++++.+|.+|.++.|++.+--+-
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 11112222221 2334567889999999999999999999999875543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.30 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=207.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||+|... ++..+|+|.++. ......+++.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 678899997653 22334678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 602 DYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 602 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||+++|+|.+++... ....+++.+++.++.++++||+|||+.+ ++||||+|+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 2345899999999999999999999877 99999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.... ..+.++..... .+.
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~------- 224 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCD------- 224 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCC-------
Confidence 21 11223457889999999999899999999999999999999999985432 11211111110 010
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.........+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01111123556789999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.03 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=205.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.+|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999864 56789999887655555678899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 999999998643 3889999999999999999999877 9999999999999999999999999987643211 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||.+.+..++.++|||||||+++||++|+.||........ +... ...+. +.+ .
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~------~~~--~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLI-ATNGT------PEL--Q 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHHH-hcCCC------CCC--C
Confidence 12234588899999999998899999999999999999999999965432111 1110 00000 000 1
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+......+.+++.+||..+|++||++.|++++-...
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~ 274 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence 1223456788999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.08 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=192.7
Q ss_pred eeEeeeCcEEEEEEEEcCc---cEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 532 HVIGVGGFGKVYEGYIDGK---TKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
+.||+|+||.||+|...++ ..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 3689999999999986543 468999876543 334467899999999999999999999999999999999999999
Q ss_pred cHHHHHhcCC---CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 608 TLREHLYKGD---KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 608 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
+|.+++.... ....++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 223677888899999999999999877 9999999999999999999999999997543322212
Q ss_pred ccccccCCCCCCChhhhhcC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 685 VSTMVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+.. .+. ..+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT----VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH----hhcccCCC
Confidence 22234567889999998642 35789999999999999996 99999654322211 111 01111112
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.++.+.. .....+.+++..|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 13345788999998 57999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=333.00 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=203.5
Q ss_pred HHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeec
Q 041565 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 519 ~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
.++....++|+..+.||+|+||.||++.... +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3445566789999999999999999999764 678999987532 223345688999999999999999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999998653 3889999999999999999999877 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.......
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----~~~i~~~~ 263 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----YSKIMDHK 263 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC
Confidence 86432211 112345699999999999764 378899999999999999999999975432111 11110000
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID--RPSMGDVLWNLEF 800 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~--RPt~~evl~~L~~ 800 (862)
..+ ... .....+..+.+++.+|+..++.+ ||++.|++++.+.
T Consensus 264 ~~~------~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 264 NSL------NFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred ccc------CCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 000 000 01123566788999999865543 8999999998665
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.17 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=198.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..++||+|+||.||++... ++..||+|.+... .....+++.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999865 5678999987542 2334567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997643 3889999999999999999999887 9999999999999999999999999996321100
Q ss_pred Cc---------------------------------------------cccccccCCCCCCChhhhhcCCCCchhHHHHHH
Q 041565 682 QT---------------------------------------------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFG 716 (862)
Q Consensus 682 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~G 716 (862)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124589999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC---CCCHHH
Q 041565 717 VVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID---RPSMGD 793 (862)
Q Consensus 717 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~---RPt~~e 793 (862)
|++|||++|+.||......+.. .........+ . -+ . .......+.+++.+|+. +|.+ |+++.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~-----~~i~~~~~~~-~--~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETY-----RKIINWRETL-Y--FP---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHH-----HHHHccCCcc-C--CC---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999754332211 0000000000 0 01 0 01134568899999997 5665 569999
Q ss_pred HHHHHHH
Q 041565 794 VLWNLEF 800 (862)
Q Consensus 794 vl~~L~~ 800 (862)
++++.+.
T Consensus 302 ~l~hp~~ 308 (377)
T cd05629 302 IKSHPFF 308 (377)
T ss_pred HhcCCCc
Confidence 9988653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=331.08 Aligned_cols=268 Identities=23% Similarity=0.319 Sum_probs=201.7
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC-----eEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG-----EMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 598 (862)
+|+..+.||+|+||.||++... ++..||+|++... .....+++.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 5788999987643 2344567899999999999999999999998766 789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+. ++|.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 58888876543 4899999999999999999999877 9999999999999999999999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH----------HHHhh
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD----------WALHC 747 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~~~~~ 747 (862)
... ........++..|+|||++.+. .++.++|||||||+++||++|+.||......++..... +....
T Consensus 155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 221 1122334578899999998874 57999999999999999999999997654432221110 00000
Q ss_pred h--ccCccccccCCC-CC--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 Q--RMGTIEDIIDPN-LK--GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 ~--~~~~~~~~~d~~-l~--~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. ..........+. .. .........++.+++.+||+.+|.+|||+.|++++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 292 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence 0 000000000000 00 001112356788999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.35 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=197.0
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+|...+.||+|+||.||+|...+ +..+|+|.+... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778999999999999998764 578999987643 223345677788888877 5889999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 9999999999987654 3899999999999999999999877 999999999999999999999999999753221
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..... ... .
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~i~----~~~------~-- 218 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIM----EHN------V-- 218 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCC------C--
Confidence 1122345689999999999999999999999999999999999999975432211 11100 000 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSM-----GDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~-----~evl~~ 797 (862)
.++.....++.+++.+|++.+|.+|++. .++.++
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1122345678899999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.59 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=189.4
Q ss_pred eeEeeeCcEEEEEEEEcC-------------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 532 HVIGVGGFGKVYEGYIDG-------------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258899877655555678899999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc-------eEEeec
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE-------AKVSDF 671 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-------~kl~DF 671 (862)
+||||+++|+|..++.... ..+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999887543 34899999999999999999999877 999999999999987654 899999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhh-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCccccccHHHHHHhhhc
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL-CARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+.. . ...
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~-~~~ 223 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------R-FYE 223 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------H-HHh
Confidence 998754221 1234778899999987 467899999999999999998 588877543211110 0 000
Q ss_pred cCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
+.. .. .......+.+++.+||+.+|.+||++.++++.+
T Consensus 224 -~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -GQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 00 011245688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.76 Aligned_cols=269 Identities=21% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...+.||+|+||.||+|+.+ .+..||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999876 46789999876432 22335678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++ +|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 975 8888886543 34889999999999999999999877 9999999999999999999999999987533211
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc---------Ccc
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM---------GTI 753 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~~~ 753 (862)
.......++..|+|||.+.+ ..++.++|||||||+++||++|++||......+.............. ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 11223457889999999865 56899999999999999999999999765433222111100000000 000
Q ss_pred ccccCCCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 754 EDIIDPNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 754 ~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...-.+.... ......+.++.+++.+||+.+|.+|||+.|++++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 0000000000 00112345678999999999999999999999887764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.97 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=197.1
Q ss_pred eeEeeeCcEEEEEEEEcC----ccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG----KTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+|.... +..+|+|....... ...+++.+|+.+++.+.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997533 25799998875443 35578999999999999999999999876 4567999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc-c
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH-V 685 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 685 (862)
|+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998654 4899999999999999999999876 9999999999999999999999999998653222111 1
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +..+.... .. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~---~~----------~~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESG---ER----------LP 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcC---Cc----------CC
Confidence 112224567999999999999999999999999999998 999986543211 22221111 00 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+..++..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.31 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=203.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-----CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-----GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 597 (862)
+.|+..+.||+|+||.||++..+ .+..||+|.+.... ......+.+|++++++++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45678899999999999999743 45689999887543 44457899999999999999999999998775 568
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++++|.+++.+... .+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999999975432 4899999999999999999999877 999999999999999999999999999865
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHHhh
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPK---------EQVSLADWALHC 747 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~ 747 (862)
...... .......++..|+|||++.+..++.++|||||||+++||++++.|....... .......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 332211 1122345677899999999889999999999999999999988764322110 000011111110
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+ .....+..++..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 240 -~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 -EEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 01111223567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=326.52 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=211.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe-EEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE-MILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 601 (862)
++|...++||+|+||.++..+.+. +..+++|.+... .....+....|+.++++++|||||...+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 467778999999999999888664 567899976543 33445578899999999999999999999998888 99999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
+||+||+|.+.|.+.....++++++.+++.|++.|+.|||++. |+|||||+.||+++.+..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998877667999999999999999999999766 9999999999999999999999999999865533
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||+.||.||.+.+..|..|+|||||||++|||++-+++|....... ++ .. ......
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li---~k-----i~~~~~---- 223 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI---LK-----INRGLY---- 223 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH---HH-----HhhccC----
Confidence 23455789999999999999999999999999999999999999997653222 11 11 011111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
...+...+.++..++..|++.+|..||++.+++.+..
T Consensus 224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~ 260 (426)
T KOG0589|consen 224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH 260 (426)
T ss_pred -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence 2233446778999999999999999999999998743
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.56 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=197.2
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||++... ++..+|+|.+... .....+.+..|+.++.++ +|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 4578999987643 233456688999999888 699999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 99999887543 3999999999999999999999877 999999999999999999999999998753221 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............++.......... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3456899999999999999999999999999999999999999654322222222222221111110 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC------HHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPS------MGDVLWNL 798 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt------~~evl~~L 798 (862)
...+..+.+++.+||+.+|.+|++ +.+++.+-
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 223456789999999999999998 45776653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.77 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=196.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.|...++||+|+||.||+|+.. .+..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999865 46789999876432 3345678899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC-
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN- 681 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~- 681 (862)
||++|+|.+++.+.. .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997653 3889999999999999999999877 9999999999999999999999999975321000
Q ss_pred --------------------------------------------CccccccccCCCCCCChhhhhcCCCCchhHHHHHHH
Q 041565 682 --------------------------------------------QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 717 (862)
Q Consensus 682 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gv 717 (862)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000012246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 041565 718 VLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS---MGDV 794 (862)
Q Consensus 718 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt---~~ev 794 (862)
++|||++|++||....+.+.. ....... ..+..........++.+++.+|+ .+|.+|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQ------MKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHH------HHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999754332211 0000000 00000001113345667777765 48999987 8888
Q ss_pred HHHHH
Q 041565 795 LWNLE 799 (862)
Q Consensus 795 l~~L~ 799 (862)
+++-.
T Consensus 303 ~~hp~ 307 (382)
T cd05625 303 KAHPF 307 (382)
T ss_pred hcCCC
Confidence 87643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=311.12 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=194.3
Q ss_pred eeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEe-ecCeEEEEEEeCC
Q 041565 532 HVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE-EDGEMILVYDYMA 605 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~ 605 (862)
+.||+|+||.||+|...+ ...+|+|+.... .....+.+.+|+.+++.++||||++++++|. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999987543 3445678899999999999999999999875 4556899999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc--
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT-- 683 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 683 (862)
+|+|.+++.+... .+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976433 3688889999999999999999876 999999999999999999999999999754321111
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......++..|+|||++.+..++.++|||||||++|||++| .+|+...... .+.... ..... +
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~---~~~~~------~--- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL---LQGRR------L--- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---hcCCC------C---
Confidence 111233456789999999999999999999999999999995 5555432211 111111 11100 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+...+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.17 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=192.4
Q ss_pred eeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.||+|+||.||+|...+ +..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 6789999876431 23345567788888764 899999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence 99999997643 3889999999999999999999877 999999999999999999999999998753211 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+. ..... .. .+.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~i~----~~------~~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQSIR----MD------NPCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hC------CCCC----C
Confidence 345689999999999999999999999999999999999999965432211 11110 00 1111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMG-DVLWN 797 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~-evl~~ 797 (862)
.....++.+++.+||+.+|.+||++. ++.++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 12345678999999999999999997 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.28 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=204.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++|...+.||+|+||.||++..+++..+++|.+... ....+.|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3568888999999999999999877778999987754 3345788999999999999999999999877 7789999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.+.....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 9999999998755556899999999999999999999876 99999999999999999999999999876432211 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++..+.++.++|||||||+++|+++ |+.||....... +..+... +. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~---------~~ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER----GY---------RM 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhC----CC---------CC
Confidence 1222345678999999999899999999999999999998 899886432211 1111111 00 00
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.25 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=203.2
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
|+..++||+|+||.||++... .+..+|+|.+.... ....+.+..|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999876 46789999875432 23345678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.......+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999987655556999999999999999999999876 9999999999999999999999999987643211
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ...... .. .. ..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~-~~--~~--------~~ 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERL-VK--EV--------QE 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhh-hh--hh--------hh
Confidence 112346899999999999999999999999999999999999999754321110 000000 00 00 00
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEFA 801 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~~ 801 (862)
.........+.+++.+||+.+|.+||| +.|++++-+..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 112224556889999999999999999 89999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.94 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=195.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhc---cccceeeEEEEEee-----cC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKL---RHKHLVSLIGFCEE-----DG 595 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 595 (862)
+|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777899999999999999876 47789999876432 12233456677777665 69999999998754 34
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||++ ++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999997 58999987765556999999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHhhhccCc--
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LADWALHCQRMGT-- 752 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~-- 752 (862)
..... .......++..|+|||++.+..++.++|||||||+++||++|++||......+... ...+.........
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 64321 11233457899999999999999999999999999999999999996543322110 1110000000000
Q ss_pred ----cccccCCCCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 ----IEDIIDPNLK---GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ----~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
......+... .....+....+.+++.+||+.||.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 01112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=330.44 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=202.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999865 5678999987643 2234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997653 34899999999999999999999877 9999999999999999999999999997643321
Q ss_pred CccccccccCCCCCCChhhhh------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 682 QTHVSTMVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+. +. ..........
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~-~i~~~~~~~~ 229 (330)
T cd05601 157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YN-NIMNFQRFLK 229 (330)
T ss_pred c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HH-HHHcCCCccC
Confidence 1 1223346899999999986 45678999999999999999999999965432211 11 1111111000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. + . ....+..+.+++..|++ +|.+||++.+++.+-..
T Consensus 230 ~--~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 230 F--P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred C--C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 0 0 0 11235668899999998 99999999999977543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=315.52 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=201.1
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
|+..+.||+|+||+||++... ++..+|+|.+.... ......+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999875 46789999875432 22345678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987655456999999999999999999999877 9999999999999999999999999987643211
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......|+..|+|||++.+..++.++|||||||+++||++|+.||......... ..+...... . . .
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~~~~-~--~--------~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRRVLE-T--E--------E 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhhhc-c--c--------c
Confidence 122346899999999999999999999999999999999999999754322111 111111000 0 0 0
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLE 799 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~ 799 (862)
.+.......+.+++.+|++.+|.+||+ +.+++.+-.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 112234556789999999999999999 667776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=324.24 Aligned_cols=261 Identities=25% Similarity=0.443 Sum_probs=206.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC--------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG 595 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 595 (862)
.+|...+.||+|+||.||++...+ ...+|+|..... .....+++.+|+++++++ +|+||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457788999999999999997421 236899987643 334567899999999999 7999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 596 EMILVYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
..+++|||+++|+|.+++.+.. ...+++.+++.++.|+++||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999997532 234789999999999999999999877 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccH
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSL 740 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l 740 (862)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999986543222212222334567999999999999999999999999999998 88888543221
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
++........ ....+..++..+.+++.+|++.+|.+||++.|+++.|+.+....
T Consensus 244 -~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 -ELFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111111110 01112234567899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.62 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=196.0
Q ss_pred eeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||++.... +..+|+|.+... .......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 678999987643 233456678899999888 699999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.+.. .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 99999987654 3899999999999999999999877 9999999999999999999999999987532211 122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ...... .. . ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------~~~i~~-~~------~----~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------FQSILE-DE------V----RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------HHHHHc-CC------C----CCC
Confidence 334689999999999999999999999999999999999999965432111 111000 00 0 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSM-----GDVLWNL 798 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~-----~evl~~L 798 (862)
...+..+.+++.+||+.+|.+||++ .+++.+-
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 2245678999999999999999999 8887664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.44 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=204.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-c----cEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-K----TKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.+|+..+.||+|+||.||+|..+. + ..+|+|...... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778899999999999998643 2 258999876543 3456789999999999999999999999987 78899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976543 3899999999999999999999876 99999999999999999999999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||.+....++.++||||||++++||++ |+.||......+ +.........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~------ 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLEKGER------ 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhCCCC------
Confidence 222111122224568999999998899999999999999999998 999986543222 1111111100
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...+..+...+.+++.+||..+|.+||++.++++.|+.+++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00111234568899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.38 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=204.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|+||.||++... .+..+|+|.+... .....+++.+|++++++++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999865 4667888887644 333456789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.+.. .+++..+..++.|+++||.|||+. .+++||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999997653 389999999999999999999973 24999999999999999999999999998754321
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc-----------
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT----------- 752 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------- 752 (862)
......++..|+|||++.+..++.++||||||++++||++|+.|+........ ..+.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCC
Confidence 12234688999999999888899999999999999999999999864332111 110000000000
Q ss_pred -------------cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 -------------IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 -------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...++...............+.+++.+||+.+|++||++.|++++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0000000000000112445689999999999999999999999987764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.08 Aligned_cols=238 Identities=25% Similarity=0.396 Sum_probs=188.3
Q ss_pred eEeeeCcEEEEEEEEcC-------------------------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeE
Q 041565 533 VIGVGGFGKVYEGYIDG-------------------------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 587 (862)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13588998876555556788999999999999999999
Q ss_pred EEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC---
Q 041565 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW--- 664 (862)
Q Consensus 588 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~--- 664 (862)
+++|.+....++||||+++|+|..++.+.. ..+++..++.++.|+++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999987543 34899999999999999999999876 99999999999997643
Q ss_pred ----ceEEeeccccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCCccccc
Q 041565 665 ----EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVL-CARPALNVNLPKEQV 738 (862)
Q Consensus 665 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ell-tG~~p~~~~~~~~~~ 738 (862)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+......+..
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3799999988653221 12246788999999876 56899999999999999984 789888654332211
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.+.. .. ..+ +......+.+++.+||+.+|.+||++.++++.|
T Consensus 232 ---~~~~---~~--------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 ---RFYE---KK--------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---HHHH---hc--------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1100 00 001 111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.63 Aligned_cols=242 Identities=22% Similarity=0.329 Sum_probs=192.5
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||++..+ .+..||+|.+.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 46789999876431 23345667788888765 899999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 99999987643 3899999999999999999999877 999999999999999999999999998753211 1123
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+. . ... ... .+.+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~---~~~-~~~------~~~~----~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---F---ESI-RVD------TPHY----P 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHH-HhC------CCCC----C
Confidence 345689999999999999999999999999999999999999965432211 1 000 000 1111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMG-DVLWN 797 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~-evl~~ 797 (862)
.....++.+++.+||+.+|.+||++. +++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12345788999999999999999985 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=332.03 Aligned_cols=265 Identities=21% Similarity=0.227 Sum_probs=197.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
...|...+.||+|+||.||++.... +..||||.... ..+.+|+++|++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3468889999999999999999765 67899996432 3457899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+. ++|.+++..... .++|.+++.|+.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 789988865433 4999999999999999999999877 999999999999999999999999999865332222
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-ccccc----cHHHHHHhhhcc-Cccccc-
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNL-PKEQV----SLADWALHCQRM-GTIEDI- 756 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~-~~~~~----~l~~~~~~~~~~-~~~~~~- 756 (862)
.......||..|+|||++.+..++.++|||||||+||||++|..++.... ..... .+.......... ......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22234569999999999999999999999999999999999886553221 11100 011111100000 000000
Q ss_pred ---------------cCCCCC-CCCc--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 757 ---------------IDPNLK-GNIT--DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 757 ---------------~d~~l~-~~~~--~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+... .... ......+.+++.+||+.||.+|||+.|++++-++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 000000 0000 0122467899999999999999999999987543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.41 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=204.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|+..+.||+|+||.||+|.... +..+++|.+..... .+++.+|++++++++|+||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578888999999999999999875 67899998865432 67899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999986543 34899999999999999999999877 99999999999999999999999999886543221
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++.+..++.++||||||++++||++|+.|+......+.. ... ... ..+.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~~--~~~-----~~~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FMI--PNK-----PPPTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hhh--ccC-----CCCCC--
Confidence 222345788999999999999999999999999999999999998653322111 000 000 00000
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..+......+.+++.+|++.+|.+|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1122345678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.61 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=201.5
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeec-----
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED----- 594 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----- 594 (862)
+.+++.|+..+.||+|+||.||+|... .+..+|+|...... ....++..|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456778888999999999999999875 46789999876433 3346788999999998 799999999998653
Q ss_pred -CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 595 -GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 595 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
...++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 46899999999999999998755556899999999999999999999876 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
++...... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+........ +... .
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~~-~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLI-P 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHHH-h
Confidence 87643211 1223456889999999986 34688899999999999999999999864322111 1100 0
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. .. .+.+ ....++..+.+++.+||+.+|.+|||+.|++++
T Consensus 230 ~-~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 R-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred c-CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 00 0111 111245678999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.19 Aligned_cols=249 Identities=27% Similarity=0.471 Sum_probs=197.0
Q ss_pred eeEeeeCcEEEEEEEEcC-------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYIDG-------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+.||+|+||.||+|+..+ +..+++|.+.... .....++.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2468999775432 24467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCC-----CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-----ceEEeeccc
Q 041565 604 MANGTLREHLYKGD-----KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-----EAKVSDFGL 673 (862)
Q Consensus 604 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-----~~kl~DFGl 673 (862)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234789999999999999999999876 99999999999999877 899999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......+ ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~---~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV---TAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---hcCC-
Confidence 976433222222222345678999999999999999999999999999998 999986432211 11111 0000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01112235677899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=328.52 Aligned_cols=242 Identities=25% Similarity=0.335 Sum_probs=194.1
Q ss_pred eeEeeeCcEEEEEEEE----cCccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 532 HVIGVGGFGKVYEGYI----DGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
+.||+|+||.||++.. ..+..+|+|++.... ......+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 346789999876432 2234567789999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 999999997643 3899999999999999999999877 9999999999999999999999999997643221 12
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... .. ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~~-~~----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMILK-AK----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHHc-CC----------CCC
Confidence 23456899999999999988999999999999999999999999754322111 11000 00 011
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWN 797 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~ 797 (862)
+...+..+.+++.+||+.+|.+||+ +.+++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 2224567889999999999999999 4555544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.69 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=201.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
.+|+..+.||+|+||.||++....+..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567788999999999999998777789999876433 234678999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 9999999876432 4889999999999999999999877 99999999999999999999999999875432111 11
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....++.+|+|||++.++.++.++||||||+++|||++ |+.|+......+ ......... ....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~---~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGF---RLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCCC---CCCCCCC---
Confidence 122235678999999998999999999999999999998 899886433211 111111100 1111111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.+..+.+++.+||+.+|++||++.|++++|
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.07 Aligned_cols=270 Identities=26% Similarity=0.410 Sum_probs=204.8
Q ss_pred CcccceeEeeeCcEEEEEEEEc-----CccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEee--cCeEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-----GKTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 598 (862)
.|...+.||+|+||.||++..+ .+..+|+|.+...... ..++|.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999864 2568999988755443 56789999999999999999999999877 55789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999976543 4899999999999999999999877 9999999999999999999999999998754
Q ss_pred CCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
..... .......++..|++||.+.+..++.++||||||++++||++|+.|+............. .........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHHH
Confidence 22111 11122335567999999998899999999999999999999998875432211000000 00000000001111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
........+..++.++.+++.+||+.+|++||++.||+++|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111233557799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.82 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=218.8
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecC-CCChhhHHHHHHHHHHHHhccccceeeEEE
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g 589 (862)
.+.||.....+++...++-+|.||.||+|.+.+ .+.|.+|.++ ..++-+...++.|..++..+.|||+.++.|
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345666667778888899999999999996543 3467778654 346666788999999999999999999999
Q ss_pred EEeec-CeEEEEEEeCCCCcHHHHHhc------CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC
Q 041565 590 FCEED-GEMILVYDYMANGTLREHLYK------GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE 662 (862)
Q Consensus 590 ~~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 662 (862)
.|.+. ...+++|.++.-|+|..+|.. ...+.++..++..++.|++.||+|||..+ |||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98665 567899999999999999972 23445888999999999999999999777 999999999999999
Q ss_pred CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHH
Q 041565 663 KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLA 741 (862)
Q Consensus 663 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 741 (862)
..++||+|=.|+|.....+.............||+||.+.+..++.++|||||||+||||+| |+.|+..-++.+...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 99999999999998877777777766777889999999999999999999999999999986 788876554443221
Q ss_pred HHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 742 DWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 742 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......++. .+..|+.+|..++..||...|++||+++|++..|...
T Consensus 510 ----ylkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 510 ----YLKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----HHhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111111111 2334888999999999999999999999999988653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.60 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=198.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+|+..+.||+|+||.||++... .+..+|+|.+.... ....+.+.+|+++|++++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999865 46789999876422 2334668899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC-
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN- 681 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~- 681 (862)
|+++|+|.+++.+.. .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999997654 3888999999999999999999877 9999999999999999999999999975321000
Q ss_pred ----------------------------------------CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHH
Q 041565 682 ----------------------------------------QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 721 (862)
Q Consensus 682 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~e 721 (862)
.........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHH
Q 041565 722 VLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP---SMGDVLWNL 798 (862)
Q Consensus 722 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP---t~~evl~~L 798 (862)
|++|+.||......+.. ........ ....+. ....+..+.+++.+|+ .+|.+|+ ++.|++++.
T Consensus 237 ll~G~~Pf~~~~~~~~~------~~i~~~~~--~~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 237 MLVGQPPFLADTPAETQ------LKVINWET--TLHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred hhhCCCCCCCCCHHHHH------HHHhccCc--cccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 99999999765432211 10000000 000000 1123455677888876 4999999 899999885
Q ss_pred HH
Q 041565 799 EF 800 (862)
Q Consensus 799 ~~ 800 (862)
..
T Consensus 303 ~~ 304 (376)
T cd05598 303 FF 304 (376)
T ss_pred Cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.85 Aligned_cols=245 Identities=25% Similarity=0.366 Sum_probs=203.8
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
...-++|...++||+|.||+|+++.+++ +..+|||.++.. .....+..+.|-+++... +||.|++|+.++...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445678999999999999999999875 567899988764 345567788899998888 49999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+++||||+.||++..+. ....+++....-++..|+.||+|||+++ ||+||||..|||||.+|.+||+||||++.
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999944333 2234999999999999999999999887 99999999999999999999999999997
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
... ....+...+||+.|||||++.++.|+...|.|||||+|||||.|..||.++.+++...-+ ...
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----------~~d-- 583 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----------VND-- 583 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------hcC--
Confidence 542 233566789999999999999999999999999999999999999999877655432110 001
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSM 791 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~ 791 (862)
|+ .++.-++.+...++++++..+|.+|.-+
T Consensus 584 -~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 1233466788999999999999999965
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=312.20 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=189.5
Q ss_pred eEeeeCcEEEEEEEEcCc---cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 533 VIGVGGFGKVYEGYIDGK---TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
.||+|+||.||+|...++ ..+++|.+... ......+|.+|+++++.++|+||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999975443 46888876543 33445678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCC---CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 609 LREHLYKGDK---PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 609 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
|.+++..... ...++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 23567888999999999999999876 99999999999999999999999999875332211111
Q ss_pred cccccCCCCCCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 686 STMVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||......+.. .. ..... ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----~~-~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL-----KQ-VVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-----HH-Hhhcc-CccCC
Confidence 222345678999999753 456889999999999999999 77787543322110 00 01111 11111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
++.+ +...+..+.+++..|+ .+|++|||+.||++.|
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2222 2234556778888898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=314.40 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=202.0
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|+|++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4566789999999999999765 567889988766666678899999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
++|..++.+.. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...... ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 99999886533 34899999999999999999999877 9999999999999999999999999987643211 122
Q ss_pred ccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 687 TMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
....++..|+|||++. +..++.++|||||||++|||++|++||......+.. ... .. .. .+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~----~~-~~-----~~~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKI----AK-SE-----PPTL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHH----hh-cC-----CCCC
Confidence 3345889999999984 455788999999999999999999998643321110 000 00 00 0000
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+..++..+.+++.+||+.+|.+||++.+++++...
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 0112245678999999999999999999999877653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=308.72 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=202.9
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC-CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|+..+.||+|+||.||++... ++..+|+|.+.. ......+.+..|+.+++.++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999875 467899998753 23445677889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 9999999987654455899999999999999999999877 9999999999999999999999999987643321 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||++.+..++.++||||||+++++|++|+.||........ ..... .+... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~---------~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVC-QGSYK---------P 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHh-cCCCC---------C
Confidence 22335688899999999999999999999999999999999999964322111 11110 11111 1
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.+...+..+.+++.+||+.+|++||++.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.15 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=200.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-Ccc----EEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKT----KVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...+.||+|+||.||+|... ++. .+|+|.+.... .....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677789999999999999864 332 47889876543 33345789999999999999999999999754 4679
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999987653 24899999999999999999999876 99999999999999999999999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......+ ..++... ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~----- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEK---GERL----- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC---CCCC-----
Confidence 222111222345678999999999999999999999999999997 888886432211 1112111 1000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=330.21 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=205.4
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEe
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 592 (862)
.+.++....++|+..+.||+|+||.||++..+. +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 355666777899999999999999999999764 678999987532 2233456789999999999999999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
++...++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999998653 3788899999999999999999877 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
+++...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.....
T Consensus 188 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMN 261 (371)
T ss_pred ceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHc
Confidence 998643221 1122345699999999998764 378999999999999999999999975432111 111111
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID--RPSMGDVLWNLEF 800 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~--RPt~~evl~~L~~ 800 (862)
.... .... .....+..+.+++.+|+...+.+ ||++.|++++...
T Consensus 262 ~~~~-~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 262 HKNS-LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred CCCc-ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 0000 0000 01124567889999999854443 7899999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=337.40 Aligned_cols=271 Identities=20% Similarity=0.317 Sum_probs=200.9
Q ss_pred HHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcccc------ceeeEEEEE
Q 041565 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK------HLVSLIGFC 591 (862)
Q Consensus 519 ~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~ 591 (862)
+++...+++|...++||+|+||.||+|... .+..||||+++... ...+++..|++++++++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 455567789999999999999999999875 46789999886432 2345567788888777654 588899888
Q ss_pred eec-CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeeccCCC-----
Q 041565 592 EED-GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLDEKW----- 664 (862)
Q Consensus 592 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~----- 664 (862)
..+ +.+++|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 654 5789999998 678999887653 489999999999999999999974 5 99999999999998765
Q ss_pred -----------ceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 041565 665 -----------EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNL 733 (862)
Q Consensus 665 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~ 733 (862)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886422 12334579999999999999999999999999999999999999997655
Q ss_pred ccccccHH---------HHHHhhhc---------cCccccccCCCC-----CC--CCcHHHHHHHHHHHHHccccCCCCC
Q 041565 734 PKEQVSLA---------DWALHCQR---------MGTIEDIIDPNL-----KG--NITDQCLRKFTETAEKCLSDQGIDR 788 (862)
Q Consensus 734 ~~~~~~l~---------~~~~~~~~---------~~~~~~~~d~~l-----~~--~~~~~~~~~l~~li~~Cl~~~p~~R 788 (862)
..+...+. +|...+.. .+.+....++.. .. .........+++|+.+||+.||.+|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 43322221 11111000 000000000000 00 0000123567899999999999999
Q ss_pred CCHHHHHHHHHHH
Q 041565 789 PSMGDVLWNLEFA 801 (862)
Q Consensus 789 Pt~~evl~~L~~~ 801 (862)
||+.|+++|-+..
T Consensus 430 ~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 430 LNARQMTTHPYVL 442 (467)
T ss_pred CCHHHHhcCcccc
Confidence 9999999987764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.95 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=203.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCc----cEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGK----TKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
++|...++||+|+||.||+|...+. ..|++|...... .+..+.+.+|+.++++++|+||++++++|.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577789999999999999986432 468999876554 4556789999999999999999999999875 457899
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999976433 4899999999999999999999876 999999999999999999999999999865432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.. .......++..|+|||.+....++.++||||||++++||++ |+.||......+. ..+.. ....+
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~---~~~~~------ 227 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE---NGERL------ 227 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH---cCCcC------
Confidence 11 11222334568999999988889999999999999999986 9999865432221 11111 10000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+..++..+.+++.+|+..+|.+|||+.+++..|+.+..
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.74 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=206.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|+..+.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888899999999999999964 57899999887655555677899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~ 170 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 170 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc--c
Confidence 999999998643 3889999999999999999999876 9999999999999999999999999987643221 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||.+.+..++.++|||||||+++||++|+.||........... ....+ .+. ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~--~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPE--LQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCC--CC
Confidence 12234578899999999999999999999999999999999999965433221100 00000 000 01
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+...+..+.+++.+||+.+|.+||++.+++++-+..
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 273 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence 1223456688999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.19 Aligned_cols=272 Identities=24% Similarity=0.387 Sum_probs=201.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHh--ccccceeeEEEEEeec----CeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK--LRHKHLVSLIGFCEED----GEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 598 (862)
.+.....+.||+|.||.||+|.++++ .||||++...++ +.+.+|.++.+. |+|+||+.+++.-..+ .+++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccccCC-ceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34566788999999999999999876 799999876544 456777777765 5999999999986433 4789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-----CCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-----GARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
||.+|.++|||.++|.+ ..++....++++..+|.||++||. ++++.|.|||||++|||+..++..-|+|+||
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999976 349999999999999999999994 5789999999999999999999999999999
Q ss_pred cccCCCC-CCc-cccccccCCCCCCChhhhhcCC----C--CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 041565 674 SKTGPNL-NQT-HVSTMVKGSFGYLDPEYFRRQQ----L--TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 674 a~~~~~~-~~~-~~~~~~~gt~~y~aPE~~~~~~----~--s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 745 (862)
|-..... +.- .......||.+|||||++...- + -..+||||||.++||++....- .+...+-+..+.+|+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~-ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES-GGIVEEYQLPYYDVVP 441 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc-CCEehhhcCCcccCCC
Confidence 9754332 111 1223456999999999986421 1 2469999999999999753210 0011111122222222
Q ss_pred hhhccCcccccc-CCCCCCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 746 HCQRMGTIEDII-DPNLKGNI-----TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 746 ~~~~~~~~~~~~-d~~l~~~~-----~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.-.....+.+++ ..++++.+ ..+++..+.++++.||..+|.-|-|+-.+-+.|..+.+.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 111111111111 12233222 356889999999999999999999999999999887654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.27 Aligned_cols=251 Identities=23% Similarity=0.433 Sum_probs=200.5
Q ss_pred cccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC------hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
|...+.||+|+||.||+|...++..+|+|.+.... ....+.+.+|++++++++|+||++++++|.+.+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56778999999999999998788889999865321 233466889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 82 EFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999997643 3889999999999999999999876 9999999999999999999999999987542111
Q ss_pred ----CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 682 ----QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 682 ----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.........++..|+|||++.+..++.++||||||++++||++|+.||......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~----- 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRGL----- 226 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccCC-----
Confidence 111122345888999999999999999999999999999999999999643221110 000000000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.+. .+......+.+++.+||+.+|.+||++.|++.+
T Consensus 227 ~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111 122345678999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=309.88 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=212.1
Q ss_pred cCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.+|+..+.||+|.||.|-+++. ..|+.||||.++.. ++++.-.+.+|+++|+.|+||||++++.+++..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999985 67889999977643 5666777899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||..+|.|.+++.+... |++.+..++++||..|+.|+|.+. ++|||||.+|||||+++++||+||||+.+...
T Consensus 133 EYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 99999999999987654 999999999999999999999766 99999999999999999999999999987543
Q ss_pred CccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
....+..+|++-|.+||.+.+..| .+..|-|||||+||.|+.|..||++.+... ++ .+ ...|...+
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lv---rQ-Is~GaYrE----- 272 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LV---RQ-ISRGAYRE----- 272 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HH---HH-hhcccccC-----
Confidence 233456789999999999999887 578999999999999999999998754321 11 11 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.+.+...+-||+|||-.+|++|-|+.+|..+.|-.+..
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 12344567899999999999999999999998866543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=314.57 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=199.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|+..++||+|+||.||+|... .+..+|+|..... .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677889999999999999864 5678999987543 3344567999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999997642 2788899999999999999999877 999999999999999999999999999754321
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ....+... +.++....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 219 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC---------IVDEDPPV 219 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH---------HhccCCCC
Confidence 122346889999999999999999999999999999999999998643222111 01111110 00111011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
........++.+++.+|++.+|++||++.|++++.+.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1111234568899999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.72 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=204.8
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..++||+|+||.||.+... ++..+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999988854 4678999986543 345567889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.+.....+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999998764456899999999999999999999876 99999999999999999999999999976533221
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++.+...+.++||||||++++||++|+.||......+. ..... .+...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~--------- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNYT--------- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCCC---------
Confidence 22334588999999999988899999999999999999999999865432211 11111 11111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
......+.++.+++.+||+.+|.+||++.|+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01123456789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=321.17 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=195.8
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 601 (862)
+|...+.||+|+||.||++... ++..||+|.+... .....+.+..|.++++.+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999865 4678999987642 2234566788999998885 577888999999889999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 9999999999987654 3899999999999999999999877 999999999999999999999999998753221
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........||..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ... .
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~~------~-- 218 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EHN------V-- 218 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCC------C--
Confidence 1122345689999999999999999999999999999999999999975432211 11000 000 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSM-----GDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~-----~evl~~ 797 (862)
..+...+..+.+++.+||+.+|.+|++. .++.++
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1112244578899999999999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.61 Aligned_cols=242 Identities=27% Similarity=0.352 Sum_probs=190.9
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHH-HHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIE-MLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+|... ++..||+|.+.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 57889999876431 222344555554 56789999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.+.. .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 99999987643 4899999999999999999999877 999999999999999999999999998753221 1223
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... +. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~-~~------~~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNILN-KP------LRLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHHc-CC------CCCCC---
Confidence 345689999999999999999999999999999999999999965432111 111100 00 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH----HHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMG----DVLWN 797 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~----evl~~ 797 (862)
..+..+.+++.+||+.+|.+||++. |++++
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 2356788999999999999999874 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.74 Aligned_cols=237 Identities=26% Similarity=0.386 Sum_probs=189.0
Q ss_pred eeEeeeCcEEEEEEEEcCcc-----------EEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 532 HVIGVGGFGKVYEGYIDGKT-----------KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999976533 4778876644333 6789999999999999999999999988 778999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-------ceEEeeccc
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-------EAKVSDFGL 673 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-------~~kl~DFGl 673 (862)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 4899999999999999999999876 99999999999999887 799999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhcc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
++.... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......+ +.......
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~~~ 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQDQ 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHhcC
Confidence 886432 1223466789999999876 78999999999999999999 566665432211 11111100
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
. .... .....+.+++.+||..+|.+||++.|+++.|
T Consensus 223 ~---------~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 H---------RLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred C---------CCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0000 0115788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.64 Aligned_cols=265 Identities=25% Similarity=0.260 Sum_probs=201.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC---ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG---KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
..+|...+.||+|+||.||++...+ +..|++|.+... +.+.+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3468999999999999999997543 467899987643 23568999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|++. ++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6898888543 34999999999999999999999877 9999999999999999999999999997654332
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHhhhccCccc------
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SLADWALHCQRMGTIE------ 754 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~------ 754 (862)
.........||..|+|||++.+..++.++|||||||++|||++|+.||......... .+..-... .......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccc
Confidence 222233456999999999999999999999999999999999999999654332111 01000000 0000000
Q ss_pred ----c---ccCCCCCCCC--c-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 755 ----D---IIDPNLKGNI--T-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 755 ----~---~~d~~l~~~~--~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. ......+... + ......+.+++.+||..+|++|||+.|++.+-.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 0 0000000000 0 11235678899999999999999999999987664
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.55 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=203.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+.|+..++||+|+||.||+|.... +..+++|.+........+++.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 467788999999999999999765 6789999988777677788999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|..++.+.. ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 9999998876543 34899999999999999999999876 999999999999999999999999998753221 11
Q ss_pred ccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 685 VSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
......++..|+|||++. ...++.++|||||||++|||++|++|+......+. ...... .. .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~-----~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-SE-----PP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhc-CC-----Cc
Confidence 123345788999999984 34568899999999999999999999864332111 111110 00 01
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. ..+.....++.+++.+||+.+|++||++.|++++..
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 112234567899999999999999999999987644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.32 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=202.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.|+..+.||+|+||.||+|... ++..||+|..... .....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566778999999999999865 4678999987643 2344567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++... .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++...... .
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--h
Confidence 999999988642 4899999999999999999999876 9999999999999999999999999987643321 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||++.+..++.++|||||||+++||++|+.|+......... .. . .......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~---------~~~~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-I---------PKNSPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-h---------hcCCCCC
Confidence 122345788999999999999999999999999999999999998643221110 00 0 0001111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....++..+.+++.+|++.+|.+||++.|++++...
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 222355678999999999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.60 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=199.6
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhH--HHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGV--HEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
|+..+.||+|+||+||++.... +..+|+|.+........ .....|+.++++++|+||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999876 45899999876544332 23456999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.... .+++..++.++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccc
Confidence 9999999998332 3899999999999999999999887 9999999999999999999999999987531 1122
Q ss_pred ccccccCCCCCCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++. +...+.++||||+|+++++|++|+.|+......+.......... ..... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~---~~~-- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----RPLPS---SSQ-- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----THHHH---HTT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc----ccccc---ccc--
Confidence 333456888999999998 88899999999999999999999999975521121111111000 00000 000
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
........+.+++.+||+.+|++||++.+++++-
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 0001136899999999999999999999998753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.56 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=199.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|+..+.||+|+||.||++... .+..||+|++... ......++.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 367888999999999999999865 4778999987543 334456788999999999999999999988544 3
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999965 67766643 2788999999999999999999887 9999999999999999999999999997
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH---------HHH---
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL---------ADW--- 743 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l---------~~~--- 743 (862)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.... .++
T Consensus 172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 5322 1122335689999999999999999999999999999999999999975532211000 000
Q ss_pred ----HHhhh-ccCc-----cccccCCCCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 744 ----ALHCQ-RMGT-----IEDIIDPNLK---GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 744 ----~~~~~-~~~~-----~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..... .... +.+....... ..........+.+++.+||+.+|++|||+.|++++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00000 0000 0000000000 000111245688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.15 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=207.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..+|+..+.||.|++|.||+|.. .++..|++|.+........+.+.+|+++++.++|+|++++++++......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34688899999999999999986 45788999987655555567889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++... .+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 98 LAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred cCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 9999999988643 3899999999999999999999877 99999999999999999999999999876432211
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||.+.+..++.++|||||||++|||++|+.||......+... .. .... . +.+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~---~~~~-~-----~~~-- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LI---ATNG-T-----PEL-- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH---HhcC-C-----ccc--
Confidence 1223458889999999999999999999999999999999999996543322110 00 0000 0 000
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+...+..+.+++.+||..+|.+||++.+++.+-+...
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 111234567889999999999999999999998776653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.41 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=201.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45788899999999999999876 46789999876432 22345678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ ++|.+++..... .+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 599998876433 4889999999999999999999877 9999999999999999999999999987543211
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc-----
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII----- 757 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----- 757 (862)
.......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+......-.........+..++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 11223346889999999876 457899999999999999999999997554322211000000000000000000
Q ss_pred ----CCCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 758 ----DPNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 758 ----d~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+.... ......+..+.+++.+|++.+|.+|||+.|++++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 011000 0111234567899999999999999999999987665
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.69 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=196.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-----ChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 597 (862)
.+|+..+.||+|+||.||++... .+..+++|++... ..+..+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999875 4778999986532 22345678899999999999999999998865 3578
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999997654 3889999999999999999999876 999999999999999999999999998754
Q ss_pred CCCCC-ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 678 PNLNQ-THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 678 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||......+. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~----- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP----- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----
Confidence 32111 1111234578899999999999999999999999999999999999964322111 01100000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
..+ ..+......+.+++ +||..+|++||+++|++++-
T Consensus 226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 011 22223445566666 68888999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=303.30 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=205.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChh--hHHHHHHHHHHHHhccccc-eeeEEEEEeecC------
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQ--GVHEFQTEIEMLSKLRHKH-LVSLIGFCEEDG------ 595 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 595 (862)
..|...++||+|.||+||+|+.+ .|..||+|+++...++ .-....+|+.+|++|+|+| |++|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666778999999999999965 5789999987755432 2345689999999999999 999999998876
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCC--CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDK--PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
.+++|+||++. +|..++..... ..++...+..++.||++||+|||+++ |+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 88999999964 99999987553 35777899999999999999999887 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
|+...- .....+...+|..|.|||++.+. .|+...||||+||++.||+++++.|.+..+.++...+--......+..
T Consensus 167 Ara~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 996432 12224556788999999999886 799999999999999999999999987765444322211111111111
Q ss_pred ccccc---CCC--CCC-----CCcHHH---HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 753 IEDII---DPN--LKG-----NITDQC---LRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~~~~---d~~--l~~-----~~~~~~---~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+..+. +-+ ... ...... .....+++.+|++.+|.+|.|+..++.|--+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 11110 111 000 001111 1367899999999999999999999987544
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.12 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=205.9
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.|+..+.||.|+||.||+|... .+..||+|.+... .....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999975 4678999987643 3455678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++... .+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence 999999998643 3889999999999999999999876 9999999999999999999999999997643322 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||++.+..++.++|||||||+++||++|+.|+......... .. +.......
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~----------~~~~~~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL----------IPKNNPPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh----------hhcCCCCC
Confidence 122345788999999999989999999999999999999999998654322111 00 00111122
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....++..+.+++.+||+.+|.+||++.+++++....
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 3345677899999999999999999999999886654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.53 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=201.3
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee-cCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 602 (862)
+|+..+.||+|++|.||++..+. +..+|+|++... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47778999999999999999654 578999987543 33445678999999999999999999988764 456899999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.......+++.+++.++.+++.||++||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998755556899999999999999999999877 9999999999999999999999999997653221
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......++..|+|||++.+..++.++||||||++++||++|+.||....... +..... .+.+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~-~~~~--------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII-EGKL--------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCC---------
Confidence 12233457889999999999999999999999999999999999986432211 111110 1111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...+...+..+.+++.+|++.+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122355678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.39 Aligned_cols=239 Identities=26% Similarity=0.398 Sum_probs=190.0
Q ss_pred eeEeeeCcEEEEEEEEcC--------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+.||+|+||.||+|.... ...+++|.+........+++.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 234788887655555567889999999999999999999999998999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc--------eEEeeccccc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE--------AKVSDFGLSK 675 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------~kl~DFGla~ 675 (862)
+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 4899999999999999999999877 999999999999987765 6999999886
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCC-CCCCCCCccccccHHHHHHhhhccCcc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR-PALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+......... ......
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~------~~~~~~--- 221 (258)
T cd05078 157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL------QFYEDR--- 221 (258)
T ss_pred ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH------HHHHcc---
Confidence 5322 123457889999999987 45899999999999999999995 555432211111 000000
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
. ..+.....++.+++.+||+.+|++|||++++++.|
T Consensus 222 -----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 -----H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 11112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.70 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=204.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|+..+.||.|++|.||+|... ++..+++|.+.... ......+.+|++++++++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999976 46789999876543 344567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...... .
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 999999998754 4899999999999999999999877 9999999999999999999999999998754321 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||++.+..++.++||||||+++|||++|+.||....+.+.. ... ... ..+.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~~-~~~-----~~~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FLI-PKN-----NPPSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HHh-hhc-----CCCCCccc
Confidence 223345788999999999988999999999999999999999999654321110 000 000 01111111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.++..+.+++.+||..+|++||++++++++-..
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 145578899999999999999999999986554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.81 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=194.5
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
....+|...+.||+|+||.||+|...+ +..||+|..... ....|+.++++++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 344579999999999999999999764 567899975432 2356899999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|++. ++|.+++.... ..+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred EccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 9995 68988887543 34899999999999999999999877 99999999999999999999999999975321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cH----HHHHHhhhccC----c
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SL----ADWALHCQRMG----T 752 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l----~~~~~~~~~~~----~ 752 (862)
........||..|+|||++.+..++.++|||||||++|||+++..++......... .. ..........+ .
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 11223456899999999999999999999999999999999866554222111100 00 00000000000 0
Q ss_pred cc---------cccCCC-CC-CCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 753 IE---------DIIDPN-LK-GNI-------TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~---------~~~d~~-l~-~~~-------~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+. ..++.. .. ... ....+..+.+++.+||+.+|.+|||+.|++++-.+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 00 000000 00 000 00123455679999999999999999999987554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.61 Aligned_cols=247 Identities=29% Similarity=0.462 Sum_probs=198.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|...+.||+|+||.||++.. .+..+|+|...... ..+.+.+|+.++++++|+|++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3477789999999999999975 45679999876532 346789999999999999999999998765 4789999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999998765556899999999999999999999876 999999999999999999999999998753221
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......+..|+|||++.++.++.++||||||++++||++ |+.||......+ +...... + ....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-~---------~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEK-G---------YRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhC-C---------CCCC
Confidence 112234567999999998999999999999999999997 999986443221 1111111 1 0111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122345678899999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.47 Aligned_cols=250 Identities=28% Similarity=0.515 Sum_probs=201.2
Q ss_pred ccceeEeeeCcEEEEEEEEcC-----ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+..+.||.|+||.||++...+ +..+|+|.+...... ..+.+..|+++++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999764 367999998755433 56789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.......+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999997654433899999999999999999999877 99999999999999999999999999986543322
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
... ....++..|+|||.+.+..++.++||||||++++||++ |++|+......+ +.... .....
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~---~~~~~--------- 222 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL---KKGYR--------- 222 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---hcCCC---------
Confidence 111 12336789999999988899999999999999999998 788876432211 11111 11110
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
...+...+..+.+++.+|+..+|.+|||+.|+++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011112466789999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.19 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=199.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|+..+.||+|+||.||++... .+..+|+|++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 467888999999999999999865 4678999987643 334456788999999999999999999987543 3
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 57999999964 67777643 3889999999999999999999877 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH---------HH---
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA---------DW--- 743 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~--- 743 (862)
.... ........||..|+|||++.+..++.++|||||||+++||++|+.||......+..... ++
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6432 12223356899999999999999999999999999999999999999754322110000 00
Q ss_pred ----HHhh-hccCccccccCCCCC--------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 744 ----ALHC-QRMGTIEDIIDPNLK--------GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 744 ----~~~~-~~~~~~~~~~d~~l~--------~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.... ........+..+... ..........+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0000 000000000000000 011112345688999999999999999999999986553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.58 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=206.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|+..+.||.|+||.||++..+ ++..+|+|..........+.|..|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999975 4678999998776666778899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++..... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 999999999876433 4899999999999999999999887 9999999999999999999999999987543221
Q ss_pred cccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 684 HVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+......+. +..+ .. +. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~-~~-----~ 225 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI----LK-SE-----P 225 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH----hc-CC-----C
Confidence 1223345889999999985 34577899999999999999999999865422111 1111 00 00 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+.+ ..+..++..+.+++.+||+.+|.+||++.+++++-+.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 111 1112345678899999999999999999999987554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.15 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=205.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|+||.||++... ++..+|+|.+... .....+++.+|+++++.++|+||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999865 4678999976543 234467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.+.. .+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999987643 4899999999999999999999732 3999999999999999999999999998653221
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc-----ccHHHHHHhhhccCccccccC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ-----VSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~d 758 (862)
......|+..|+|||++.+..++.++|||||||+++||++|+.||......+. ..+.++..... .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 227 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV---------Q 227 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh---------h
Confidence 11234688999999999888999999999999999999999999975433211 11112211111 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.........+++..+.+++.+|++.+|.+|||+.|+++++...
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 1111111122556789999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.09 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=197.9
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|++|.||+|+.+ ++..||+|++... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 5788999987543 223346788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCC-CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGD-KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
++ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68988886543 245899999999999999999999877 9999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-H---------HHHHHhhhccC
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-L---------ADWALHCQRMG 751 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l---------~~~~~~~~~~~ 751 (862)
.......++..|+|||.+.+ ..++.++|||||||+++||++|++||......+... . ..|.... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT-SLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch-hhH
Confidence 11223356889999998875 457899999999999999999999997543221110 0 0000000 000
Q ss_pred ccccccCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 752 TIEDIIDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 752 ~~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
............ ......+.++.+++.+||+.+|.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0011245677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.76 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=189.7
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHH-HHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIE-MLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+++.. ++..+|+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 46789999875421 222344555554 67889999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.+.. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 99999887543 3888999999999999999999877 999999999999999999999999998753221 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +. ..... . . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~-~--------~--~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MY---DNILH-K--------P--LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HH---HHHhc-C--------C--CCCC
Confidence 34568999999999999999999999999999999999999996543211 11 11000 0 0 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH----HHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMG----DVLWNL 798 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~----evl~~L 798 (862)
......+.+++.+||+.+|.+||+.. |++++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 22345788999999999999999753 555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=327.47 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=198.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||++..+ .+..+|+|.+... .......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999876 4678999987532 2334567888999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999997654 3899999999999999999999877 9999999999999999999999999987432110
Q ss_pred C---------------------------------ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 041565 682 Q---------------------------------THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA 728 (862)
Q Consensus 682 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p 728 (862)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 0001234689999999999999999999999999999999999999
Q ss_pred CCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHHH
Q 041565 729 LNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP---SMGDVLWNLE 799 (862)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP---t~~evl~~L~ 799 (862)
|......+.. .........+ .-+ ... ....++.+++.+|+. +|.+|+ ++.|++++-.
T Consensus 236 f~~~~~~~~~-----~~i~~~~~~~---~~p---~~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 236 FCSETPQETY-----RKVMNWKETL---VFP---PEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCCHHHHH-----HHHHcCCCce---ecC---CCC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 9754432211 0000000000 001 000 134567778887764 899998 4788887754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.11 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=198.7
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh---------hhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE---------QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
|.....||+|++|.||+|... ++..+|+|.+..... +..+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999865 467899997654321 2235688999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999997653 3889999999999999999999876 999999999999999999999999999865
Q ss_pred CCCCC----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 678 PNLNQ----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 678 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
..... ........|+..|+|||.+.+..++.++|||||||+++||++|+.||......... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~------~ 224 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FK------I 224 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HH------H
Confidence 42111 11112245788999999999989999999999999999999999999653221110 00 0
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.....+ ..+...+..+.+++.+||+.+|.+||++.|++++
T Consensus 225 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 001111 1222345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.08 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=199.8
Q ss_pred CcccceeEeeeCcEEEEEEEEcC--ccEEEEEecCCC----------ChhhHHHHHHHHHHHHh-ccccceeeEEEEEee
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPS----------SEQGVHEFQTEIEMLSK-LRHKHLVSLIGFCEE 593 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 593 (862)
+|+..+.||+|+||.||+|..+. +..+|+|.+... ......++..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 578999976422 23345667889988875 799999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 594 DGEMILVYDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
++..+++|||+++++|.+++.. .....+++..+++++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998853 22345899999999999999999999632 4999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
|++....... ......++..|++||.+.+..++.++||||||+++|||++|+.|+....... ...... .+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~-~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIV-EA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHh-hc
Confidence 9998643321 2234568899999999999889999999999999999999999986432211 111110 01
Q ss_pred ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 752 TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. .+ ......+..+.+++.+||+.+|++||++.|+..+++
T Consensus 229 ~~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 01 011124567899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.01 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=205.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|...+.||+|+||.||++... .+..+++|.+........+.+.+|++++++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888899999999999999875 4678999988766555678899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 99999999987642 34899999999999999999999876 9999999999999999999999999987643211
Q ss_pred cccccccCCCCCCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......++..|+|||.+.+. .++.++||||||++++||++|+.|+......+... ... ... ...+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~~-----~~~---~~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LIS-----KSN---FPPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-----hcc---CCCcc
Confidence 122334578899999999877 88999999999999999999999986543222110 000 000 00011
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
+ ......+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 1122356779999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.76 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=201.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-----hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-----EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
+|+..+.||+|++|.||+|... ++..|++|.+.... .+..+.+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 67889999765332 34567899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997653 3889999999999999999999877 999999999999999999999999998764332
Q ss_pred CCccccccccCCCCCCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. ......++..|++||.+.... ++.++|+||||++++||++|+.||......+. ..........
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~------ 220 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKEL------ 220 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcccC------
Confidence 2 223455888999999998776 89999999999999999999999865431111 1111110000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...+......+.+++.+||+.+|.+||++.+++.+
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11122345678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.73 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=209.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+-|...++||+|+||.|||+.++ .|..+|+|.+... ...+++..|+.+|++++.|++|+.+|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34777889999999999999976 5788999988754 45689999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
.-|++.+.++.+. .+|++.++..|++..++||+|||.. +-||||||+.||||+-+|.+||+|||.+-...+ ...
T Consensus 111 GAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 9999999997654 4599999999999999999999954 489999999999999999999999999875432 223
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
....+.||+-|||||++..-.|+.++||||||++..||..|++|+..-.+-....++ -..|...-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCCC
Confidence 344577999999999999999999999999999999999999998654332111000 001111123
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.+++.+.++.++++.||-.+|++|-|+.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 456788899999999999999999999999876
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=317.47 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=197.1
Q ss_pred ceeEeee--CcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 531 SHVIGVG--GFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 531 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
.++||+| +|++||++..+ ++..||+|++... .....+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 5689999 78999999865 5788999988653 23344567789999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc--
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT-- 683 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 683 (862)
+|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999997654445899999999999999999999877 999999999999999999999999865432111110
Q ss_pred ---cccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh----------
Q 041565 684 ---HVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ---------- 748 (862)
Q Consensus 684 ---~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---------- 748 (862)
.......++..|+|||++.+ ..++.++|||||||+++||++|+.||......... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccchhh
Confidence 01122346778999999976 46899999999999999999999999643211100 000000000
Q ss_pred --------c---cCcccccc-----CC----CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 749 --------R---MGTIEDII-----DP----NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 749 --------~---~~~~~~~~-----d~----~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. .....+.. .+ .............+.+++.+||+.+|.+|||+.|++++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 0 00000000 00 000011223456789999999999999999999999877653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.43 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=200.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|...+.||+|+||.||++... ++..+|+|.+..........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999865 46789999877655555667889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.... .+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 9999999987554 3899999999999999999999877 999999999999999999999999998754321 11
Q ss_pred ccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+.... +.. ...... .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~----~~~---~~~~~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FLM---TKSNFQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH----Hhh---hccCCC---CCcc
Confidence 223346889999999985 456889999999999999999999998543322111 000 000000 0111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.. ....+..+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 10 01234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.66 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=202.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|+..+.||+|+||.||+|+.+. ...+++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467888999999999999998642 356899987654433 4678999999999999999999999999989999
Q ss_pred EEEEeCCCCcHHHHHhcCCC-------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 599 LVYDYMANGTLREHLYKGDK-------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976541 24899999999999999999999877 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhcc
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
|+++....... .......++..|+|||.+.+...+.++||||||++++||++ |..||....... ..... ..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~----~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL----QA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH----Hc
Confidence 99875332111 11222345678999999998889999999999999999998 777875432211 11111 11
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+... ......++..+.+++.+||+.+|.+||++.|++..|+
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 0111234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=323.35 Aligned_cols=237 Identities=27% Similarity=0.341 Sum_probs=187.9
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHH-HHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIE-MLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||++... ++..+|+|.+... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 5788999987543 2233445566655 46778999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|..++.... .+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 99999887543 3899999999999999999999877 999999999999999999999999998753221 1122
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+. ...... .. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~-~~------~~~~~--- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH-KP------LVLRP--- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc-CC------ccCCC---
Confidence 345689999999999999999999999999999999999999965432211 011000 00 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMG 792 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~ 792 (862)
.....+.+++.+|++.+|.+||+++
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCC
Confidence 2345678999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.38 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=203.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|+||.||++... ++..+++|++... .....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777899999999999999865 5678999987532 334456889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.......+++.++++++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997654445899999999999999999999876 9999999999999999999999999997643321
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......|+..|+|||++.++..+.++|||||||+++||++|+.|+......+ ...... .+.. .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~---------~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-RGSY---------P 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-cCCC---------C
Confidence 11223457889999999999999999999999999999999999986432221 111111 1110 1
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..+......+.+++.+|++.+|.+||++.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=321.56 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=187.6
Q ss_pred eeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHH-HHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEI-EMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.||+|+||.||++.... +..+|+|.+.... .....++..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999764 5679999875421 12233444444 456788999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.... .+++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence 99999997643 3788889999999999999999877 999999999999999999999999999753221 1223
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .... ... . .. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i--~~~--~------~~----~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNI--LNK--P------LQ----LK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHH--HhC--C------cC----CC
Confidence 345699999999999999999999999999999999999999965432211 1111 000 0 00 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMGDV 794 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~ev 794 (862)
...+..+.+++.+|++.+|.+||++.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 1235578899999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.02 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=204.4
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEe-
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCE- 592 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 592 (862)
+.+..+..+.++|+..+.||+|+||.||++... .+..+|+|.+.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445667788899999999999999999999875 46789999876432 2235688899999999 6999999999884
Q ss_pred ----ecCeEEEEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 593 ----EDGEMILVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 593 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
.+...++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999988642 2345889999999999999999999876 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~ 741 (862)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.........
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--- 238 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--- 238 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH---
Confidence 999999987643221 11223468999999999853 45788999999999999999999998644321111
Q ss_pred HHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 742 DWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 742 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
... . ........++ ..+...+.+++.+||+.+|++|||+.|+++++
T Consensus 239 --~~~-~-~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 --FKI-P-RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --hhc-c-ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0 0000011111 11345789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.59 Aligned_cols=263 Identities=26% Similarity=0.346 Sum_probs=205.6
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEee
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE 593 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 593 (862)
+.+.++..++++|+..+.||+|+||.||++... ++..+|+|.+.... ....++.+|+.+++++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 556777888999999999999999999999975 56789999876432 2345678899999999 79999999999865
Q ss_pred c-----CeEEEEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 594 D-----GEMILVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 594 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
. +..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999988642 2335899999999999999999999876 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~ 741 (862)
||+|||+++....... ......++..|+|||.+... .++.++|||||||++|||++|+.|+......+. +.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 9999999876432211 12234578899999998653 368999999999999999999999864432111 11
Q ss_pred HHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 742 DWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 742 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.+.. .....+. .+.+....+.+++.+|++.+|++||++.|++++-
T Consensus 244 ~~~~-----~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 244 KIPR-----NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred HHhc-----CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 1110 1000111 1123445789999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.47 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=199.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC----------hhhHHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS----------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
+|...+.||+|+||.||+|... ++..+|+|.+.... ....+.+..|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999864 57789999765321 112346788999999999999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997653 4899999999999999999999876 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
...............++..|+|||.+.... ++.++||||||++++||++|+.|+......+. +. .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~-~~~~-~~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MF-KLGN-KRS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HH-Hhhc-ccc
Confidence 644322222223446888999999987754 89999999999999999999999853321111 10 0000 000
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. +........+++..+.+++.+|++.+|.+||++.||+++
T Consensus 230 ~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 A----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred C----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 111111122346778999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.04 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=197.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-----ChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 597 (862)
++|+..++||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999875 4778999976432 123456788999999999999999999988653 467
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++++|.+++.+.. .+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987653 3789999999999999999999877 999999999999999999999999998754
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......... . ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~-~~~~------- 223 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-----F-KIAT------- 223 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-----H-HHhc-------
Confidence 321111 1122345888999999999888999999999999999999999998643211110 0 0000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.......+......+.+++.+|+. +|.+||++.|++++.
T Consensus 224 --~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 224 --QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred --CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 001112233455677889999985 899999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=316.07 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=197.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+++.. .+..||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999975 4678999987532 2233466889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999997533 34899999999999999999999877 9999999999999999999999999987543211
Q ss_pred CccccccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
. .......||+.|+|||++.. +.++.++|||||||++|||++|+.||......+. ............+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~ 229 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF 229 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC
Confidence 1 11223458999999999873 4578899999999999999999999965422111 1111111100000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQ--GIDRPSMGDVLWNLEF 800 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~--p~~RPt~~evl~~L~~ 800 (862)
+ .. ....+..+.+++.+|+... +..||++.+++.+.+.
T Consensus 230 --~---~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 230 --P---PD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred --C---Cc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 0 00 1113456778888877543 3448899999988553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=304.98 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=189.2
Q ss_pred eEeeeCcEEEEEEEEcCc---cEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 533 VIGVGGFGKVYEGYIDGK---TKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975443 346677665432 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 609 LREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 609 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|.+++.+.. ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997642 234677788899999999999999876 999999999999999999999999998643221111122
Q ss_pred ccccCCCCCCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 687 TMVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
....++..|+|||++.. ..++.++|||||||++|||++ |..|+......+. ..... .+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHH-hhcccccCC
Confidence 33457889999998753 245789999999999999996 5667754322111 11111 111122233
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+.+... ....+.+++..|+ .+|++||++.||++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322 3456788999999 56999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=306.03 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=200.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|+||.||+|..+ ++..+|+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999976 47889999875432 2234568899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++++.|..++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988888775433 3899999999999999999999876 99999999999999999999999999986543221
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh----------ccC
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ----------RMG 751 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----------~~~ 751 (862)
......++..|+|||++.+ ..++.++||||||++++||++|+.||......+... ....... ...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY--LIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCChHHhhhcccc
Confidence 1223457788999999876 567899999999999999999999997554322211 1110000 000
Q ss_pred c-cccccCCCCCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 752 T-IEDIIDPNLKGNIT-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 752 ~-~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. ......+......+ ...+..+.+++.+||+.+|++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000111110000 1234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.66 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=198.1
Q ss_pred cccceeEeeeCcEEEEEEEEc----CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC------
Q 041565 528 FSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG------ 595 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 595 (862)
|...+.||+|+||.||+|.+. .+..+|+|.+... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455788999999999999864 2568999987643 3445678999999999999999999999886432
Q ss_pred eEEEEEEeCCCCcHHHHHhcC----CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 596 EMILVYDYMANGTLREHLYKG----DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
..++++||+++|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 347889999999999887532 1224789999999999999999999877 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhcc
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
|+++...............++..|++||.+....++.++||||||+++|||++ |++|+...... .+..+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc---C
Confidence 99986533222112223345678999999999999999999999999999999 88888643221 11111111 1
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
... . .+..++..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 232 ~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0 1112456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=292.19 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=202.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-----C---hhhHHHHHHHHHHHHhc-cccceeeEEEEEeec
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-----S---EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED 594 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 594 (862)
-+.|...+.||+|..+.|-++..+ ++...|+|++... . ..-.++-..|+.+|+++ .||+|+++.++++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 345677889999999999988765 5678888876432 1 11234456799999998 699999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
..+++|+|.|+.|.|.++|...- .+++++..+|++|+.+|++|||..+ ||||||||+|||+|++.++||+|||.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999997654 4999999999999999999999877 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
+..+. ...-+..+||++|+|||.+.. ..|+...|.|++||+||.|+.|.+||-.. .+.+.+ . ..
T Consensus 171 ~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlML-R----~I 240 (411)
T KOG0599|consen 171 CQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLML-R----MI 240 (411)
T ss_pred eccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHH-H----HH
Confidence 87654 334566899999999998854 35888999999999999999999999422 111111 0 01
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..|..+ .....-.+......+++.+||+.||.+|.|.+|+++|..+.
T Consensus 241 meGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 241 MEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred Hhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 111110 01111123556788999999999999999999999988774
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=320.54 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=204.3
Q ss_pred eEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHH
Q 041565 533 VIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLRE 611 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 611 (862)
+||+|.||+||.|++.+ ...+|||.+.....+..+-+..|+.+-++|+|+|||+.+|.|.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999665 46799999887777777788999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCC--ChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEEeeccccccCCCCCCcccccc
Q 041565 612 HLYKGDKPGL--PWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQTHVSTM 688 (862)
Q Consensus 612 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (862)
+|+..-.+ + ++...--+.+||++||.|||++. |||||||-.|||++ -.|.+||+|||-++.....+ ..+..
T Consensus 662 LLrskWGP-lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGP-LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET 735 (1226)
T ss_pred HHHhccCC-CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence 99876432 4 67788889999999999999876 99999999999996 56889999999998754433 33455
Q ss_pred ccCCCCCCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 689 VKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 689 ~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
..||..|||||++..+ .|..++|||||||++.||.|||+||..-...+... .+.|. -+..+.++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVGm------yKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVGM------YKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhcc------eecCCCCc
Confidence 6799999999999764 58999999999999999999999996433222110 01111 12234567
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.+...+...++.+|+.++|.+||++.++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7888899999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.65 Aligned_cols=257 Identities=20% Similarity=0.263 Sum_probs=197.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+++.. .+..+|+|.+... .......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 4678999987542 2233456888999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997643 24899999999999999999999877 9999999999999999999999999997643221
Q ss_pred CccccccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+. +.........+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~~~--- 227 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHEERF--- 227 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-----HHHHHcCCCcc---
Confidence 1 12223569999999999876 5678999999999999999999999965432111 11111100000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGID--RPSMGDVLWNLE 799 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~--RPt~~evl~~L~ 799 (862)
.+... ....+..+.+++.+|+...+++ |+++.+++++..
T Consensus 228 ---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 228 ---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 00010 1123567888999988865544 568999987743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=312.67 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=203.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCCh---hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSE---QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|++|.||++...+ +..+|+|.+..... ...+.+..|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999765 78899998765422 35567899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+.+++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999998655556999999999999999999999876 9999999999999999999999999987532211
Q ss_pred Cc---------------------------cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 041565 682 QT---------------------------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLP 734 (862)
Q Consensus 682 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~ 734 (862)
.. .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 001123578899999999998999999999999999999999999965432
Q ss_pred cccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC----HHHHHHHHH
Q 041565 735 KEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS----MGDVLWNLE 799 (862)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt----~~evl~~L~ 799 (862)
... +... .+....-......+..+.+++.+|++.+|++||+ +.|++.+-+
T Consensus 238 ~~~-----~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 238 DET-----FSNI----------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHH-----HHHH----------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 211 1111 0111100011114678999999999999999999 777776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.18 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=196.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...++||+|+||.||++..+. +..+|+|.+... .....+.+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999765 567999987532 2223455888999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976432 4899999999999999999999877 9999999999999999999999999987543211
Q ss_pred CccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 682 QTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ......... ..
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~--~~ 227 (332)
T cd05623 157 -TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKE--RF 227 (332)
T ss_pred -cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCc--cc
Confidence 11223356999999999986 34688999999999999999999999965432111 111111000 00
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCC--CCCCHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGI--DRPSMGDVLWNLE 799 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~--~RPt~~evl~~L~ 799 (862)
.-+. ....++..+.+++.+|+..++. .|+++.|++++-.
T Consensus 228 ~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 228 QFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred cCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0010 1112456678888888755443 4789999998843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.56 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=198.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|...+.||+|+||.||++... .+..||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999865 4678999987643 334456788999999999999999999987533 3
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57999999964 77777743 3789999999999999999999877 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH---------HHHHh
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA---------DWALH 746 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~~ 746 (862)
.... ........+|..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++...
T Consensus 175 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 6432 11223356899999999999999999999999999999999999999755432211000 00000
Q ss_pred h--------hccCcc-----ccccCCCC---CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 747 C--------QRMGTI-----EDIIDPNL---KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 747 ~--------~~~~~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. ...... .......+ ...........+.+++.+|++.||.+|||+.|++++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0 000000 00000000 000111123568899999999999999999999998665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.32 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=206.6
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEee
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE 593 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 593 (862)
.++.++..+.+.|+..+.||+|+||.||+|... .+..+|+|...... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 467777788899999999999999999999975 46789999875443 3446788999999998 69999999999853
Q ss_pred ------cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceE
Q 041565 594 ------DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAK 667 (862)
Q Consensus 594 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~k 667 (862)
....+++|||+++|+|.+++.......+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 467899999999999999997655556889999999999999999999877 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 668 VSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
|+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+......
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 99999987543211 1122345889999999986 35678899999999999999999999964332211100
Q ss_pred HHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 743 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
... ..........++..+.+++.+||+.+|.+||++.|++++
T Consensus 238 ----------~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 ----------IPR---NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------Hhh---CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 000111112355679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.19 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=201.6
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|+||.||++... .+..+|+|.+... .....+++.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999865 4678999987543 334467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 682 (862)
+++++|.+++.......+++..+.+++.++++||+|||+++ ++|+||||+||+++++ +.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998765556899999999999999999999877 9999999999999865 468999999998653321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......++..|+|||.+.+..++.++||||||++++||++|+.|+....... . ...... ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~---~~~~~~-~~~--------- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L---VLKIMS-GTF--------- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H---HHHHHh-cCC---------
Confidence 1223457889999999998889999999999999999999999986543221 1 111110 000
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...+...+..+.+++.+||+.+|.+|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=313.66 Aligned_cols=197 Identities=24% Similarity=0.388 Sum_probs=159.6
Q ss_pred ceeEeeeCcEEEEEEEEc---CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeEEEEEEeCC
Q 041565 531 SHVIGVGGFGKVYEGYID---GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMILVYDYMA 605 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 605 (862)
.++||+|+||.||+|... .+..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 34679999876432 23457889999999999999999998854 456899999995
Q ss_pred CCcHHHHHhcC-------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec----cCCCceEEeecccc
Q 041565 606 NGTLREHLYKG-------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLS 674 (862)
Q Consensus 606 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~~kl~DFGla 674 (862)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888887532 1224889999999999999999999887 9999999999999 45678999999999
Q ss_pred ccCCCCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 041565 675 KTGPNLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNL 733 (862)
Q Consensus 675 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~ 733 (862)
+....... ........||+.|+|||++.+ ..++.++||||+||+++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86432211 112234568999999999977 458999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.88 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=208.9
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecC--CCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 598 (862)
......|+..++||+||.+.||++...+.+.+|+|++. ..+.+...-|..|++.|.+|+ |.+||+|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34455688889999999999999998887888888754 456777889999999999995 999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
||||+= .-+|..+|.++......| .+..+..|++.++.++|+++ |||.||||.|+|+- .|.+||+|||+|....
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 999986 459999998876654556 78889999999999999887 99999999999995 4689999999999877
Q ss_pred CCCCccccccccCCCCCCChhhhhcC-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
.....-.....+||+.||+||.+... +.+.++||||+||+||+|+.|++||..... .|+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a--- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA--- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH---
Confidence 66555566677899999999998542 256799999999999999999999953210 122
Q ss_pred hccCccccccCCCCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQ-CLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
++..+.||...-+++.- ...++.++++.||+.||.+||+..|++++.-
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 24455566443222221 1123899999999999999999999998653
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.28 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=211.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCCh---hhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSE---QGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 599 (862)
...|...+.||+|.||.||+++.+. |..+|+|.+..... ...+.+.+|+.+|+++. |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3457777899999999999999876 88999998765432 34568999999999998 9999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC----CceEEeeccccc
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK----WEAKVSDFGLSK 675 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~~kl~DFGla~ 675 (862)
|||++.+|.|.+.+... .+++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999877 2999999999999999999999877 9999999999999643 579999999999
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
.... .......+||+.|+|||.+....++...||||+||++|.|++|.+||......+... ....+.+
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-- 255 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-- 255 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC--
Confidence 8654 334556789999999999999999999999999999999999999997665333221 0011111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
......-+.....+.+++..|+..+|..|+|+.++++|.|
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1122222335677899999999999999999999999866
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.08 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=200.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..++||+|+||.||+|..+ ++..+|+|++.... ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999986 47889999865432 2235678899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++++.|.++..... .+++.+++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988775443 3899999999999999999999876 9999999999999999999999999987643322
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHhh-------hccCc-
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LADWALHC-------QRMGT- 752 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~-------~~~~~- 752 (862)
.......++..|+|||++.+ ..++.++||||||++++||++|++|+......+... ...+.... .....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233457889999999875 457889999999999999999999986543221110 00000000 00000
Q ss_pred cccccCCCCCC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 IEDIIDPNLKG-----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...+..+.... ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000111000 0011245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.78 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=201.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|+||.||+|..+ ++..|++|.+... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999976 4678999987643 23345778999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++++.|..++.+. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987776655443 33899999999999999999999877 99999999999999999999999999987543322
Q ss_pred ccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH---------hhhccCc
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL---------HCQRMGT 752 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~ 752 (862)
.......++..|+|||++.+. .++.++||||||+++|||++|++||......+......... .......
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122334578899999999887 88999999999999999999999986543222110000000 0000000
Q ss_pred cc-----cccCCCC-CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 IE-----DIIDPNL-KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ~~-----~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.. +..++.. ....+..++.++.+++++||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000000 001122236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.90 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=204.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+......++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 56789999876432 23567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 45899999999999999999999877 99999999999999999999999999876543222
Q ss_pred c--cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 683 T--HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 683 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. .......++..|+|||++... ..+.++|||||||+++||++|+.||......+. +.... ... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~---~~~-------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL---QND-------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh---cCC-------CC
Confidence 1 122334588899999999877 789999999999999999999999964432211 11111 000 01
Q ss_pred CCCCCC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 760 NLKGNI-TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 760 ~l~~~~-~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.+.... ....+..+.+++.+|++.+|++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 12345778999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.39 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=201.6
Q ss_pred CcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCC------hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSS------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+|+..+.||+|++|.||++.. .++..+|+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999986 456789999875432 2235778999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGP 678 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~ 678 (862)
||||+++++|.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997643 4899999999999999999999887 99999999999998775 59999999987653
Q ss_pred CCCC--ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 679 NLNQ--THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 679 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.... ........++..|+|||.+.+..++.++||||+|++++||++|+.||.......... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~--------- 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKI--------- 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHH---------
Confidence 3211 111223457889999999998899999999999999999999999986433211111 11100
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.........+.....++.+++.+|+..+|.+||++.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00011122333456788999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.98 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=201.4
Q ss_pred ceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 531 SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
...||+|+||.||++... .+..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999875 4678999988765556667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... ......
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 178 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL 178 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence 9988543 3899999999999999999999877 9999999999999999999999999987543221 112234
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.++..|+|||.+.+..++.++||||||++++||++|+.||......+... . +...+.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~----------~~~~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR--R----------IRDNLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----------HHhcCCCcccc--cccc
Confidence 58899999999998899999999999999999999999986443221110 0 00011111111 1123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
...+.+++.+|+..+|.+|||+.|++++-....
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 456889999999999999999999998866553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.96 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=203.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 601 (862)
++|...+.||.|++|.||++... .+..+|+|.+... ......++.+|++++++++|+||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 4678999987643 234567799999999999999999999998653 4789999
Q ss_pred EeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 602 DYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 602 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988754 22345889999999999999999999877 99999999999999999999999999875432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc--ccccHHHHHHhhhccCcccccc
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPK--EQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ....+..|.... . ...+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~- 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---P-NPEL- 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---C-chhh-
Confidence 11 12345788999999999999999999999999999999999999755321 111222222110 0 0000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..... .....+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 229 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 229 KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 00000 011245678999999999999999999999987664
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=312.06 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=187.5
Q ss_pred ceeEeeeCcEEEEEEEEcC---ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeEEEEEEeCC
Q 041565 531 SHVIGVGGFGKVYEGYIDG---KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMILVYDYMA 605 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 605 (862)
+.+||+|+||.||+|+..+ +..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999754 3679999876442 23467889999999999999999998853 567899999996
Q ss_pred CCcHHHHHhcC-------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec----cCCCceEEeecccc
Q 041565 606 NGTLREHLYKG-------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLS 674 (862)
Q Consensus 606 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~~kl~DFGla 674 (862)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4787776421 1224889999999999999999999877 9999999999999 56678999999999
Q ss_pred ccCCCCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-------cH-----
Q 041565 675 KTGPNLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-------SL----- 740 (862)
Q Consensus 675 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-------~l----- 740 (862)
+....... ........+|..|+|||++.+ ..++.++|||||||++|||++|++||......... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86432211 111233468899999999876 45899999999999999999999999654321100 00
Q ss_pred -------HHHHHhhhcc--Ccccccc-C-----CCCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 741 -------ADWALHCQRM--GTIEDII-D-----PNLK---GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 741 -------~~~~~~~~~~--~~~~~~~-d-----~~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.+|....... ....... . +.+. ..........+.+++.+|++.||.+|||+.|++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 1111100000 0000000 0 0000 000011234578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.57 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=207.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|++|.||+++.+. +..+++|++..... ...+++.+|++.+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367788999999999999999875 78899998776543 4567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999765 348999999999999999999998 76 99999999999999999999999999886533221
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+..+.. . ...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~---------~~~- 220 (264)
T cd06623 156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D---------GPP- 220 (264)
T ss_pred --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c---------CCC-
Confidence 1123457889999999999999999999999999999999999986553211111111111 0 000
Q ss_pred CCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 763 GNITDQ-CLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 763 ~~~~~~-~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
...+.. .+..+.+++.+|++.+|.+||++.|++++-.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 111112 4568999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.84 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=202.4
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
-|+..+.||+|+||.||+|... ++..+|+|...... ....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3566789999999999999864 56789999875432 344567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...... .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--h
Confidence 999999998643 3899999999999999999999877 9999999999999999999999999987643321 1
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||.+.+...+.++|||||||+++||++|..|+....... +...... . ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~---------~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLIPK-N---------NPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHHhc-C---------CCCC
Confidence 1223457889999999998899999999999999999999999986432211 1111000 0 0111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....++..+.+++.+|++.+|.+||++.+++++....
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 2223456788999999999999999999999975443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=308.13 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=202.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|+..+.||+|+||.||++..+ .+..+|+|.+... ......++.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999976 5788999987643 3344578999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCC-CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 605 ANGTLREHLYKGD-KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 605 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++++|..++.... ...+++..+..++.|++.||.|||++ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 9999999887542 23589999999999999999999964 24999999999999999999999999998754221
Q ss_pred cccccccCCCCCCChhhhhcCC------CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||......... ... ..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~------~~~------~~~~ 223 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF------AQL------SAIV 223 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH------HHH------HHHh
Confidence 122345788999999986543 488999999999999999999999643221110 000 0011
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+.. ....+..+...+.+++.+|++.+|.+||++.+++.+.+..
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~ 266 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence 100 1112233567789999999999999999999999876654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.76 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=209.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-c-----cceeeEEEEEeecCeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-H-----KHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 599 (862)
+|.+.++||+|.||.|-|+... .++.||||+++.. ..-.++...|+.+|..|+ | -|+|++++++...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999965 4789999998853 455677889999999997 4 389999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC--CceEEeeccccccC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK--WEAKVSDFGLSKTG 677 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~~kl~DFGla~~~ 677 (862)
|+|.+. -+|.++|..+...+++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.++..
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999995 59999999988888999999999999999999999776 9999999999999754 46999999999874
Q ss_pred CCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh-----------
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH----------- 746 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------- 746 (862)
... .. ...-+.-|.|||++.+..|+.+.|||||||++.||++|.+.|.+..+.++...+--...
T Consensus 342 ~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 332 11 34567789999999999999999999999999999999998888776655433211000
Q ss_pred ----hhcc--Ccc-------------------------ccccCC-CCC---CCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041565 747 ----CQRM--GTI-------------------------EDIIDP-NLK---GNITDQCLRKFTETAEKCLSDQGIDRPSM 791 (862)
Q Consensus 747 ----~~~~--~~~-------------------------~~~~d~-~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~ 791 (862)
.... +.+ .+..-| ... .......-..+.+++++|+..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0000 000 000001 000 00111234568999999999999999999
Q ss_pred HHHHHHHHHH
Q 041565 792 GDVLWNLEFA 801 (862)
Q Consensus 792 ~evl~~L~~~ 801 (862)
.|+++|-..-
T Consensus 497 ~qal~Hpfl~ 506 (586)
T KOG0667|consen 497 AQALNHPFLT 506 (586)
T ss_pred HHHhcCcccc
Confidence 9999987654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.53 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=205.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++|||++++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56788899999999999999864 56789999886555555678899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999998653 3789999999999999999999877 99999999999999999999999999875433221
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......+.... ....+ .....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCCC
Confidence 12234588899999999988899999999999999999999999965433222110 00000 00001
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
........+.+++.+||..+|.+||++.+++.+-.+.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 1222456788999999999999999999999886654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=304.58 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=200.8
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC-----
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG----- 595 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 595 (862)
.++++|+..+.||+|++|.||+|..+ .+..+++|.+..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46788999999999999999999975 467899998765443 346799999999999 6999999999996644
Q ss_pred -eEEEEEEeCCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 596 -EMILVYDYMANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 596 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999987533 345899999999999999999999877 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
++....... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||........ +...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~---- 230 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI---- 230 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh----
Confidence 987543211 12233458889999998754 3467899999999999999999999964321111 1000
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.... .+.+ ..+......+.+++.+||..+|.+|||+.|++++
T Consensus 231 -~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 -PRNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -hccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 0111 1122356678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.58 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=198.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||++.... +..|++|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999764 5789999876542 234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997653 4899999999999999999999876 9999999999999999999999999987421100
Q ss_pred -------------CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 682 -------------QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 682 -------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
.........++..|+|||++.+..++.++|+|||||++|||++|+.||......+ +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 0001122457889999999998899999999999999999999999986443221 111110
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. +. ...+... ...+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 230 ~-~~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 230 S-DD---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred h-cc---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 00 0111111 124566899999999999999998544444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.03 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=205.7
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 601 (862)
+|+..+.||+|++|.||+|..+ ++..+++|...... ....+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999977 57889999876543 35567899999999999999999999999888 8999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998654 5999999999999999999999876 9999999999999999999999999988654432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.........++..|++||.+.+...+.++||||||++++||++|+.||...... . .-..... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~---------~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--M---AALYKIG---------SSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--H---HHHHhcc---------ccCC
Confidence 211123356888999999999888999999999999999999999999754311 0 0011100 1111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
....+...+..+.+++.+|++.+|.+||++.|++.+
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 122233346789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.77 Aligned_cols=265 Identities=21% Similarity=0.320 Sum_probs=196.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|++|.||+|..+ ++..||+|.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999976 568899998764322 2234577899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ ++|.+++.+... .+++.....++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 499998876543 5899999999999999999999877 9999999999999999999999999987532211
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-cccccHHHHHHhhhccCccccc-----
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLP-KEQVSLADWALHCQRMGTIEDI----- 756 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~----- 756 (862)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .+....................
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11122346788999999876 5589999999999999999999999965431 1111100000000000000000
Q ss_pred --------c-CCCCCCCCc-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 757 --------I-DPNLKGNIT-DQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 757 --------~-d~~l~~~~~-~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. ...+..... ......+.+++.+||+.+|.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000000000 0012567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=338.51 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=199.3
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEM 597 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 597 (862)
...++|...+.||+|+||.||++.... +..+|+|.+... .......|..|+.+|++|+|||||++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 344679999999999999999999764 567888876542 33446779999999999999999999998754 4578
Q ss_pred EEEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCc----ccEEeeCCCCCCeeccC---------
Q 041565 598 ILVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGAR----YTIIHRDVKTTNILLDE--------- 662 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDIkp~NILl~~--------- 662 (862)
+|||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999753 22359999999999999999999998532 34999999999999964
Q ss_pred --------CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 041565 663 --------KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVN 732 (862)
Q Consensus 663 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~ 732 (862)
.+.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 234899999999864321 12234568999999999864 45889999999999999999999999643
Q ss_pred CccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 733 LPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.... ......... +.+. ....+..+.+|+..||+.+|.+||++.|++.+-.
T Consensus 247 ~~~~-----qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 247 NNFS-----QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CcHH-----HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 2211 111111111 1110 0113467899999999999999999999996544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=298.71 Aligned_cols=255 Identities=27% Similarity=0.325 Sum_probs=209.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCc-cEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGK-TKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+.|...+.||.|.-|+||++.+++. ..+|+|.+... .++...+...|-+||+.++||.+..|++.++.+...||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3456678999999999999998874 78999998754 3445667788999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC-
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL- 680 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~- 680 (862)
|||+||+|...++++....+++..+.-++.+++.||+|||-.| ||.|||||+||||.++|++.|+||.|+..+...
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999999888888999999999999999999999777 999999999999999999999999997532100
Q ss_pred --------------------------------CCc---------------------cccccccCCCCCCChhhhhcCCCC
Q 041565 681 --------------------------------NQT---------------------HVSTMVKGSFGYLDPEYFRRQQLT 707 (862)
Q Consensus 681 --------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~s 707 (862)
... ......+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 001124688999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC
Q 041565 708 EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID 787 (862)
Q Consensus 708 ~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~ 787 (862)
.+.|+|+|||+||||+.|+.||.+...++.. ..++-..+.-....+.+..+.+||++.|.+||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999877654432 1222222211111145677899999999999999
Q ss_pred CCC----HHHHHHHH
Q 041565 788 RPS----MGDVLWNL 798 (862)
Q Consensus 788 RPt----~~evl~~L 798 (862)
|.. +.||-+|-
T Consensus 379 Rlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHP 393 (459)
T ss_pred hhccccchHHhhcCc
Confidence 998 88888775
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.38 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=204.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|+..+.||+|++|.||++..+ .+..+++|++.... ....+++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999976 46789999876543 345678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++++|.+++.... ..+++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999997653 348999999999999999999998 65 999999999999999999999999998754221
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||++.+..++.++||||||++++||++|+.|+....... ....+......... .+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~~- 225 (265)
T cd06605 155 -LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRLP- 225 (265)
T ss_pred -HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCCC-
Confidence 1111568889999999999999999999999999999999999986442111 11111111111000 01111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....+..+.+++.+|+..+|.+|||+.|++.+-+.
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 226 --SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred --hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 11155678999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.14 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=201.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-----hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-----QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
+|+..+.||+|+||.||+|... ++..|++|.+..... .....+..|++++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999975 578999998765432 2345677899999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+ +|+|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997654 35999999999999999999999887 999999999999999999999999999865432
Q ss_pred CCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh--------ccC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ--------RMG 751 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~ 751 (862)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++......+... ....... ...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG--KIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH--HHHHHcCCCchhhhhhcc
Confidence 21 1222346778999999865 467899999999999999999988876543221110 0000000 000
Q ss_pred ccccccCCCCCC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 TIEDIIDPNLKG-----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 ~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
............ ......+..+.+++.+||+.+|++|||+.|++++-+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 000000000000 01122456789999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.63 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=201.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 601 (862)
+|+..+.||.|+||.||++... ++..+|+|.+... .....+++..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999865 5678999987532 34456778999999999999999999998753 45679999
Q ss_pred EeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCC--cccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 602 DYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGA--RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 602 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
||+++++|.+++... ....+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998753 2345899999999999999999999332 334999999999999999999999999999875
Q ss_pred CCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
..... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... +.... ..+.
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~----- 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI----KEGK----- 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH----hcCC-----
Confidence 43221 1233468899999999999899999999999999999999999997543111 11111 1111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
....+...+..+.+++.+|++.+|.+||++.+|+++
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233456788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=306.30 Aligned_cols=262 Identities=20% Similarity=0.294 Sum_probs=198.6
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|++|.||+|+.. ++..+|||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 57789999876432 22345788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+. ++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 68999987765566999999999999999999999876 9999999999999999999999999987543211
Q ss_pred cccccccCCCCCCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc------------
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM------------ 750 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 750 (862)
.......++..|+|||++.+.. ++.++||||||++++||++|+.||......+. +..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence 1122234678899999887644 68899999999999999999999965432211 11100000000
Q ss_pred ---CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 751 ---GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 751 ---~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..........+ ..........+.+++.+|++.+|.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 00011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.02 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=201.8
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|+||.||+|... ++..|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999975 57889999876543 33456799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999987644 44899999999999999999999877 99999999999999999999999999986543221
Q ss_pred cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc------------
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM------------ 750 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 750 (862)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++......+.. .+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCc
Confidence 122334688899999998654 4689999999999999999998887654322111 111100000
Q ss_pred CccccccCCCCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 751 GTIEDIIDPNLK----GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 751 ~~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.....+..+... .....+....+.+++.+|++.+|.+||++++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000000 001112357889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.66 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=200.9
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh--hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|...+.||+|+||.||+|... ++..+++|.+..... ...+++..|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999865 567899998765433 3678899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.... .+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997643 3789999999999999999999877 999999999999999999999999998765432221
Q ss_pred cc--cccccCCCCCCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 684 HV--STMVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 684 ~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .....++..|+|||++.+.. .+.++||||||++++||++|+.||........ ....... +. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~~-~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVGA-GH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHhc-CC-----C
Confidence 11 11345788999999998766 89999999999999999999999964321111 0100000 00 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
+.+.. .......+.+++.+||+.+|.+||++.|++.+
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111 01235678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=308.84 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=201.4
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
|.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999865 5778999988655545567788999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
++|.+++... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...... ...
T Consensus 103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 174 (297)
T cd06659 103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR 174 (297)
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence 9999987542 3899999999999999999999877 9999999999999999999999999987543211 112
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....++..|+|||++.+..++.++|||||||+++||++|+.||......+.. ..... .. .+... ..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-~~-----~~~~~--~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRD-SP-----PPKLK--NA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-cC-----CCCcc--cc
Confidence 3345889999999999989999999999999999999999998644322211 00000 00 00000 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......+.+++.+|++.+|.+||++.+++++....
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 12345688999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.33 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=201.0
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhcc---ccceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLR---HKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 601 (862)
.|+..+.||+|+||.||+|... ++..+++|.+... ......++.+|++++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999964 5788999987643 3345577889999999997 999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 4899999999999999999999877 9999999999999999999999999997654322
Q ss_pred CccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......|+..|+|||++.++ .++.++|||||||++|||++|+.||........ .... .....+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~------~~~~~~~ 221 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MMLI------PKSKPPR 221 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhcc------ccCCCCC
Confidence 112334588899999998764 468999999999999999999999965422111 1000 0000111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+... ..+..+.+++.+||+.+|++||++.|++.+-+.
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 1111 145678899999999999999999999986554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.87 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=196.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHH-HHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEM-LSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|+||.||++... ++..||+|++.... .....++..|+.. ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 47899999876532 2334556667665 666789999999999999999999999
Q ss_pred eCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 603 YMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 603 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|++ |+|.+++... ....+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888887642 2345899999999999999999999751 3999999999999999999999999998864321
Q ss_pred CCccccccccCCCCCCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... ........ .+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~--~~----- 223 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQVV--EE----- 223 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHHH--hc-----
Confidence 11223457889999998865 45688999999999999999999998532211 11001000 00
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+.+ .....+..+.+++.+||+.+|.+||++.+++++-....
T Consensus 224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 224 PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 01111 11124567899999999999999999999998766543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.92 Aligned_cols=251 Identities=29% Similarity=0.396 Sum_probs=200.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.+.|...+.||+|+||.||+|... ++..||+|.+... .....+++.+|+++++.++||||+++.++|.+....++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999875 5788999987533 234456789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99996 67877775433 34899999999999999999999877 999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
....++..|+|||++. .+.++.++||||||+++|||++|++|+........ ........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~------ 230 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND------ 230 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCC------
Confidence 2245788999999874 45688999999999999999999999864322111 00000000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+.+ ....++..+.+++.+||+.+|.+||++.+++.+.+..
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 231 SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0111 1223566799999999999999999999999887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.90 Aligned_cols=244 Identities=25% Similarity=0.310 Sum_probs=189.2
Q ss_pred EeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhc---cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 534 IGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKL---RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
||+|+||.||+|+.. .+..||+|++.... ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 47889999875321 22334456677777665 699999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.+.. .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 99999987644 3899999999999999999999877 9999999999999999999999999987532211 122
Q ss_pred ccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 687 TMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
....||..|+|||++.+. .++.++|||||||++|||++|+.||......+. .... ..+. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i-~~~~------~~~~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNI-AFGK------VRFPK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHH-HcCC------CCCCC--
Confidence 345699999999998764 489999999999999999999999965432211 0110 0110 01111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCC----CHHHHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRP----SMGDVLWNLEF 800 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RP----t~~evl~~L~~ 800 (862)
......+.+++.+||+.+|.+|| ++.|++++.+.
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 11345678999999999999998 57777766443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=316.73 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=200.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+.|+..+.||.|+||.||.++.. +...||||++.-.. ...++++..|+..|++++|||+|...||+..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45777889999999999999865 45689999987553 345678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||| -|+-.++|.-... ++-+-++..|+.+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|.....
T Consensus 106 EYC-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHH-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 999 5688888765433 4889999999999999999999877 99999999999999999999999999877433
Q ss_pred CccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.....||+.|||||++. .+.|+-|.|||||||+..||...++|+-..+.- ..+ +-..... .
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SAL--YHIAQNe--------s 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL--YHIAQNE--------S 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHH--HHHHhcC--------C
Confidence 23467999999999975 478999999999999999999999987422110 001 0000001 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
|.|. ..+++..|+.++..||+.-|.+|||..+++.+
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2222 34678889999999999999999999988776
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.20 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=204.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
.|+..+.||+|++|.||++... ++..+++|++........+++.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999976 577899999876655567889999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+++|.+++.... ..+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999987653 34899999999999999999999876 99999999999999999999999999876543221
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
.....++..|++||.+.+...+.++||||||++++||++|+.|+......... ..... ........
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~~~~------- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT-NGPPGLRN------- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh-cCCCCcCc-------
Confidence 23456888999999999888999999999999999999999998643221111 00000 11111100
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
....+..+.+++.+|++.+|.+|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11125678999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.17 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=197.5
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec------
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------ 594 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 594 (862)
..++|+..+.||+|+||.||++... .+..||||++.... ....+++.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467888999999999999999864 56789999876432 23346678999999999999999999887532
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 4578999998 77998877532 3899999999999999999999877 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc----
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR---- 749 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 749 (862)
+..... .....||..|+|||++.+ ..++.++|||||||+++||++|+.||......+.. ..+......
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 238 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPSPE 238 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCCHH
Confidence 864321 223468999999999877 57899999999999999999999999654322111 000000000
Q ss_pred ------cCccccccC--CCCCCC----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 750 ------MGTIEDIID--PNLKGN----ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 750 ------~~~~~~~~d--~~l~~~----~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.......+. +..... ........+.+++.+|++.+|.+|||+.|++.+-+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 000000000 000000 0001233578999999999999999999999987664
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.72 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=197.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++++|...+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++|+||+++.+++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999865 46789999876443 222346788999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67877775543 34788899999999999999999876 9999999999999999999999999997543211
Q ss_pred CccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh----------hc-
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC----------QR- 749 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----------~~- 749 (862)
. ......++..|+|||++.+ ..++.++|||||||+++||++|+.||.............|.... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 1223346889999999876 45789999999999999999999999754322111000011000 00
Q ss_pred cCccccccCCCCCCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 750 MGTIEDIIDPNLKGNI-----TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
................ .......+.+++.+|+..+|.+|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000 00124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.87 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=201.4
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|+||.||++..+. +..+|+|.+... .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47778999999999999999764 678999987543 223456788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 682 (862)
+++++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999998765556899999999999999999999877 99999999999999885 46999999987653321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......|+..|+|||++.+..++.++||||||++++||++|+.|+...... ++...... +.. .
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~----~---- 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYF----A---- 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccC----C----
Confidence 1222345888999999999888999999999999999999999998643221 12211111 111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
......+..+.+++.+|++.+|++|||+.|++++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.13 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=194.8
Q ss_pred cceeEeeeCcEEEEEEEEcC-ccEEE---EEecC-CCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC--eEEEEEE
Q 041565 530 ESHVIGVGGFGKVYEGYIDG-KTKVA---IKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG--EMILVYD 602 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~-~~~va---vK~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 602 (862)
...+||+|.|-+||||.+.. |..|| ||.-. ..+....++|..|+++|+.|+|+|||+++.++.+.. ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35689999999999999753 55554 33211 124455689999999999999999999999886654 4889999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeeccccccCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~~~~~~ 681 (862)
.|..|+|+.++.+..+ ++.+.+.+|++||++||.|||++ .+||||||||..||+|+.+ |.|||+|+|||.....
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 9999999999988765 88999999999999999999997 5899999999999999865 8999999999987543
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.+ ...+.||+.|||||+.. ..|++..||||||++|+||+|+..|+..=....+. ..-+.....+..+..+-
T Consensus 199 -s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YKKV~SGiKP~sl~kV~---- 269 (632)
T KOG0584|consen 199 -SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YKKVTSGIKPAALSKVK---- 269 (632)
T ss_pred -cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HHHHHcCCCHHHhhccC----
Confidence 22 23378999999999987 88999999999999999999999998532211111 00011111111111111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+++.++|.+|+.. ..+|||+.|++.+--+..
T Consensus 270 --------dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 270 --------DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred --------CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 24578999999998 899999999998765543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=325.66 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=207.5
Q ss_pred ceeEeeeCcEEEEEEEE-cCc----cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 531 SHVIGVGGFGKVYEGYI-DGK----TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++||+|+||+||||.+ ..| .+||+|.+... ..+...++++|+-+|.+|+||||++|+|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 57999999999999985 223 46899987643 4556789999999999999999999999998765 88999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
+.|+|.++++.++ ..+.-+.++.|+.|||+||.|||.+. +|||||.++|||+..-..+||.|||+++.........
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998754 45899999999999999999999766 9999999999999999999999999999876554444
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.....+-.+.|||-|.+....++.++|||||||.+||++| |..|+++...++..++.+ ... +-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle------~ge----------RL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE------KGE----------RL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh------ccc----------cC
Confidence 4444455678999999999999999999999999999987 888887655444433221 111 11
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..++-|..++..++.+||..|++.||+++++...+....
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 123347888999999999999999999999998887654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.17 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=208.8
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
...++.|...+.||+|++|.||+|..+ .+..+++|.+..... ..+.+.+|++++++++|+|++++++++......++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677888899999999999999987 567899998876544 567789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999998754 35999999999999999999999876 999999999999999999999999988654322
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
. .......++..|++||.+.+..++.++|||||||++|||++|+.|+......... ..+. ......
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~-----~~~~~~----- 235 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLIT-----TKGIPP----- 235 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-----hcCCCC-----
Confidence 1 1122345788999999999888999999999999999999999998643322111 0000 000000
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. .....++..+.+++.+|++.+|.+||++.+++++....
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 236 L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 0 01112456789999999999999999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.15 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=195.5
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|...+.||+|+||.||+++.. .|..+|+|++.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999975 57789999875432 22335678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ ++|.+++.... ..+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 97 58888876543 34899999999999999999999877 9999999999999999999999999997543211
Q ss_pred cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc-ccc----------HHHHHHhhhccC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKE-QVS----------LADWALHCQRMG 751 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~-~~~----------l~~~~~~~~~~~ 751 (862)
.......++..|+|||++.+. .++.++|||||||+++||++|+.|+......+ ... ...|.......
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP- 232 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc-
Confidence 112234578899999998775 47899999999999999999998864322211 100 00011000000
Q ss_pred ccccccCCCCCC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 752 TIEDIIDPNLKG-----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 752 ~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.... -+.... .........+.+++.+||+.+|.+|||+.|++++.
T Consensus 233 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 233 DYKP--YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred cccc--cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 0000 000000 11112456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=288.27 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=203.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++.|+..++||+|.|+.||+.... .|+.+|+|.+... +..+.+++.+|+++.+.|+||||++|.....+.+..++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345666789999999999998754 5777888865432 3346788999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DFGla~~~~ 678 (862)
|+|.||.|..-+-.+ .-.++...-..++||+++|.|+|.++ |||||+||+|+||... .-+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998766554 33788888999999999999999887 9999999999999543 458999999998765
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.........||++|||||++....++..+|||+.||+||-|+.|++||.+.... .+.+-. ..+.. -++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I----~~g~y--d~~ 232 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQI----KAGAY--DYP 232 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH----hcccc--CCC
Confidence 233445567999999999999999999999999999999999999999753221 111111 01110 012
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+..... ..+...+++.+||..||.+|.|+.|.+.+.+-.
T Consensus 233 ~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 233 SPEWDT----VTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred CcccCc----CCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 222222 345678999999999999999999999887643
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.39 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=201.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999975 4678999987542 2234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997653 4899999999999999999999877 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....++..|+|||.+.+...+.++||||||++++||++|+.||......+. +.... .+. ..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~--~~~------~~- 216 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKIL--EGK------VR- 216 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHh--cCC------cc-
Confidence 2234688999999999888899999999999999999999999865431110 11110 110 11
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
.+......+.+++.+||..+|.+|| +++|++++..
T Consensus 217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 1122356788999999999999999 7778776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=305.48 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=200.0
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
|...+.||+|+||.||+++.. ++..+|+|.+... .....+++..|++++++++|+|+++++++|.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999965 5678999987533 233456788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ |+|.+.+.... ..+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 58888776443 34899999999999999999999877 99999999999999999999999999875432
Q ss_pred cccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.....++..|+|||++. .+.++.++|||||||+++||++|+.|+........ +..+.. ..
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~----~~--------- 240 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ----NE--------- 240 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHh----cc---------
Confidence 12345788999999974 46789999999999999999999999854321111 111111 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.........+..+.+++.+|++.+|.+||++.++++++......
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 00111223456789999999999999999999999998876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=301.45 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=201.1
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
|...+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5678999988665555567789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++....... ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~ 172 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR 172 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence 999999876 23899999999999999999999877 9999999999999999999999999887543211 112
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....|+..|+|||.+.+..++.++|||||||+++||++|+.||......+. ....... . .+.+. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~-~-----~~~~~--~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDN-L-----PPKLK--NL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhc-C-----CCCCc--cc
Confidence 234588899999999988899999999999999999999999864322111 1111100 0 01111 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
...+..+.+++.+||+.+|.+||++.+++++-.
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 124567899999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.19 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=199.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 600 (862)
++|+..+.||+|+||.||+|..+ ++..+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999976 46789999876432 22234677899999999999999999998777 899999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||++ ++|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 599998876443 5899999999999999999999877 999999999999999999999999999865432
Q ss_pred CCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-H---------HHHHHhhh-
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-L---------ADWALHCQ- 748 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l---------~~~~~~~~- 748 (862)
. .......++..|+|||.+.+. .++.++|+||||++++||++|++||......+... + ..|.....
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 1 112234478899999998764 46899999999999999999999997543221110 0 01111000
Q ss_pred ---ccCccccccCCCCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 749 ---RMGTIEDIIDPNLKGNITDQ-CLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 749 ---~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
............+...++.. ....+.+++.+||+.+|++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000111111111112221 35678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.19 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=197.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|...+.||+|+||.||++... .+..+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999875 46889999876432 344567899999999996 99999999999999999999999
Q ss_pred CCCCcHHHH---HhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 604 MANGTLREH---LYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 604 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
+.. +|.++ +.......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443 3333334589999999999999999999974 23999999999999999999999999998754321
Q ss_pred CCccccccccCCCCCCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+-...... + .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~ 227 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----D 227 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----C
Confidence 1 11233578899999999876 689999999999999999999999864321 1100111000 0 0
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+.+.......++..+.+++.+|++.+|.+|||+.||+++-...
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 12222222234567899999999999999999999999876653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=301.17 Aligned_cols=268 Identities=20% Similarity=0.265 Sum_probs=198.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|++|.||+|..+ ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 57789999875432 2334678899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeeccccccCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~ 681 (862)
|++ ++|.+++.......+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 58888886654444688889999999999999999876 999999999999985 5679999999997643211
Q ss_pred CccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHhhhccCcc------
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LADWALHCQRMGTI------ 753 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~------ 753 (862)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||......+... ...+... .....+
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSL 234 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccc
Confidence 11223356889999999876 457899999999999999999999996543321110 0000000 000000
Q ss_pred cccc--CCCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 754 EDII--DPNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 754 ~~~~--d~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+.. -+.... ......+.++.+++.+|++.+|++||++.+++++-.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 0000 000000 0011234568899999999999999999999976443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.93 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=197.6
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
|+..+.||.|++|.||+|... ++..||+|++.... ......+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999875 57899999876432 223467889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
+ ++|.+++.......+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+++...... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 5 69999987665445899999999999999999999876 9999999999999999999999999997543211 1
Q ss_pred ccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC-----------c
Q 041565 685 VSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG-----------T 752 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~ 752 (862)
......++..|+|||++.+. .++.++||||||+++|||++|++||......+. +........... .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 11223467899999988664 578999999999999999999999975433211 111100000000 0
Q ss_pred ----cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 ----IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ----~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
......+.. .......+..+.+++.+|++.+|.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 01111234578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=301.37 Aligned_cols=265 Identities=21% Similarity=0.267 Sum_probs=194.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCe-----
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGE----- 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 596 (862)
++|+..+.||+|+||.||+|... ++..||+|...... ......+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 57889999865432 223467888999999995 6999999999877655
Q ss_pred EEEEEEeCCCCcHHHHHhcCC---CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeecc
Q 041565 597 MILVYDYMANGTLREHLYKGD---KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFG 672 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFG 672 (862)
.++||||+++ +|.+++.... ...+++..++.++.||++||+|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8988886532 235899999999999999999999877 999999999999998 8899999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHhhhcc
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SLADWALHCQRM 750 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~ 750 (862)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||......+.. ....... ....
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TPTE 233 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CCCh
Confidence 987542211 11122346788999998865 45799999999999999999999998654322110 0000000 0000
Q ss_pred Ccccccc---C----CCCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 751 GTIEDII---D----PNLK----GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 751 ~~~~~~~---d----~~l~----~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
....... + +... ..........+.+++.+||+.+|.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 0 0000 00111245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=298.32 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=199.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|+..+.||.|++|.||+|+.. ++..||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999976 477899998765432 23466788999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCC-CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 605 ANGTLREHLYKGD-KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 605 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 84 8988886543 245899999999999999999999877 9999999999999999999999999997543211
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH-HH---------HHHhhhccCc
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL-AD---------WALHCQRMGT 752 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l-~~---------~~~~~~~~~~ 752 (862)
.......++..|++||++.+ ..++.++|||||||++|||++|+.||......+.... .. |.... ....
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCch
Confidence 11223346889999999866 4578999999999999999999999976543321110 00 10000 0000
Q ss_pred cccccCCCCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 IEDIIDPNLK----GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..... +... .......+..+.+++.+|++.+|.+||++.|++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTF-PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccc-cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0000 01112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=303.08 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=196.8
Q ss_pred CcccceeEeeeCcEEEEEEEEcC---ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG---KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 598 (862)
.|+..+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999754 6789999887532 33346778899999999999999999999887 8899
Q ss_pred EEEEeCCCCcHHHHHhcC---CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC----CCceEEeec
Q 041565 599 LVYDYMANGTLREHLYKG---DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE----KWEAKVSDF 671 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~----~~~~kl~DF 671 (862)
+||||+++ +|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766432 1225889999999999999999999877 999999999999999 899999999
Q ss_pred cccccCCCCCC-ccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-------cHHH
Q 041565 672 GLSKTGPNLNQ-THVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-------SLAD 742 (862)
Q Consensus 672 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-------~l~~ 742 (862)
|+++....... ........++..|+|||.+.+. .++.++|||||||+++||++|++||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986533221 1112234578899999988764 5799999999999999999999999755433210 0111
Q ss_pred HHHhhh-----------ccCccccccCCCCCCCCc-----H------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 743 WALHCQ-----------RMGTIEDIIDPNLKGNIT-----D------QCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 743 ~~~~~~-----------~~~~~~~~~d~~l~~~~~-----~------~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...... .........+.......+ . ....++.+++.+||+.+|.+|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 100000 000000000000000000 0 233568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.29 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=198.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-----ChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 597 (862)
.+|+..+.||+|+||.||+|... .+..+|+|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999865 4788999976421 234456889999999999999999999998653 568
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++|+||+++++|.+++.... .+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987643 3889999999999999999999877 999999999999999999999999999864
Q ss_pred CCCCC-ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 678 PNLNQ-THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 678 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
..... ........++..|+|||++.+..++.++|||||||+++||++|+.||......+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~---------- 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-----FKI---------- 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH-----HHH----------
Confidence 32111 11112345888999999999988999999999999999999999999643221111 000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.........+....+.+.+++.+|++ +|..||+..+++.+
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00111122333456778999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.23 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=203.9
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.+...||.|+||.||++..+. +...|.|.+...+....++|+-|+++|..+.||+||+|++.+..++.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455679999999999999765 344577888878888899999999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|..+..+..-++ .|++.++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+-.... .....
T Consensus 114 GAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred chHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 999998876554 4999999999999999999999887 99999999999999999999999998754221 22233
Q ss_pred ccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 687 TMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
....||+.|||||+.+ ...|+.++||||||++|.||..+.+|-..-.+ + ..... .......-++.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----M-RVllK-iaKSePPTLlq--- 257 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----M-RVLLK-IAKSEPPTLLQ--- 257 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----H-HHHHH-HhhcCCCcccC---
Confidence 4577999999999875 46799999999999999999999988642211 1 00000 00111111111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+..+...|.+++.+||..+|..||+++++++|...
T Consensus 258 ----PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 258 ----PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred ----cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 33467889999999999999999999999987543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=295.55 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=198.1
Q ss_pred EeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|++|.||+++... +..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999764 6789999875432 23456799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99997653 3899999999999999999999877 9999999999999999999999999998654321 12234
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.++..|++||.+.+..++.++|+||||+++|||++|..|+....... .+.... +.+.......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYND---------ILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHH---------HhccCCCCCCCccc
Confidence 57889999999988889999999999999999999999996543211 111111 11111111222334
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
+..+.+++.+||+.+|.+||+ +.|++++-++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 668999999999999999999 7888776554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=300.32 Aligned_cols=264 Identities=24% Similarity=0.297 Sum_probs=198.1
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMILVYD 602 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 602 (862)
|+..+.||+|+||.||+|...+ +..+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4567899999999999999764 6789999887542 33456788999999999999999999999887 89999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 8998887653 35899999999999999999999876 99999999999999999999999999986543221
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc---ccc---
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT---IED--- 755 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~--- 755 (862)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....................... ...
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 11223346788999998765 4678999999999999999999999975543221111000000000000 000
Q ss_pred --------ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 756 --------IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 756 --------~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.....+.......++..+.+++.+||+.+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000001111135678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=309.45 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=197.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeec-----CeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----GEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 597 (862)
+++|...++||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999865 57889999886432 33456788999999999999999999987544 357
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++|+||++ ++|.+.+... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 4888877543 3899999999999999999999877 999999999999999999999999998764
Q ss_pred CCCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc---Cc
Q 041565 678 PNLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM---GT 752 (862)
Q Consensus 678 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 752 (862)
..... ........|+..|+|||.+.+ ..++.++|||||||+++||++|+.||......... ..+ ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~--~~~-~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL--NLI-LGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-HHHcCCCCHHH
Confidence 32111 111223467899999998765 56899999999999999999999999654321110 000 000000 00
Q ss_pred cccccCCCC---------CCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 753 IEDIIDPNL---------KGNI-----TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~~~~d~~l---------~~~~-----~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+..+.+... .... ......++.+++.+||+.+|.+|||+.|++++-..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 010010000 0000 01234568899999999999999999999988544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=308.87 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=200.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec-----Ce
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----GE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 596 (862)
.++|...+.||+|+||.||++... .+..||+|.+... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999865 4688999987643 233456678899999999999999999987644 35
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 68998887543 4899999999999999999999877 99999999999999999999999999986
Q ss_pred CCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------hh
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL--------HC 747 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~ 747 (862)
..... .......++..|+|||.+.. ..++.++|||||||+++||++|++||.............-.. ..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 53321 12233457889999998865 568999999999999999999999996543211111000000 00
Q ss_pred hccCccccc-------cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 QRMGTIEDI-------IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 ~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......... .++... .....++.++.+++.+||+.+|.+|||+.|++++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 000000000 000000 01123456789999999999999999999999985543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=298.15 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=189.2
Q ss_pred eEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHh---ccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 533 VIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSK---LRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
+||+|+||.||++... ++..+|+|.+.... ......+.+|..+++. .+|+|++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 46789999775421 1222334455544443 479999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 999999987654 3999999999999999999999877 999999999999999999999999998754321 1
Q ss_pred cccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||..........+. .... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHhh----------cCCcC
Confidence 123468999999999864 56899999999999999999999999654322211110 0000 00111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
.+...+.++.+++.+||+.+|.+|| +++|++++..+
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 2233566789999999999999999 69999887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=297.72 Aligned_cols=256 Identities=16% Similarity=0.188 Sum_probs=184.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCc----cEEEEEecCCCChhhH-----------HHHHHHHHHHHhccccceeeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGK----TKVAIKRSNPSSEQGV-----------HEFQTEIEMLSKLRHKHLVSLIG 589 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 589 (862)
.++|...++||+|+||.||+|...+. ..+|+|.......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788899999999999999997653 3556665332221110 11223444566678999999999
Q ss_pred EEeecC----eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc
Q 041565 590 FCEEDG----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665 (862)
Q Consensus 590 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 665 (862)
++.... ..++++|++. .++.+.+.... ..++..+..|+.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 876543 3467778764 46766665432 2578889999999999999999876 999999999999999999
Q ss_pred eEEeeccccccCCCCCC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-c
Q 041565 666 AKVSDFGLSKTGPNLNQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-S 739 (862)
Q Consensus 666 ~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~ 739 (862)
+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+++||++|+.||......... .
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999976432111 11122346999999999999999999999999999999999999999765322211 0
Q ss_pred --HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 740 --LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 740 --l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
..++.... ..+.+. ...++..+.+++..|++.+|++||++.++++.+
T Consensus 245 ~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRL---------HEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHh---------hhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 01111111 011110 112456789999999999999999999999865
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.14 Aligned_cols=268 Identities=23% Similarity=0.324 Sum_probs=199.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeec--CeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED--GEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~ 598 (862)
.++|+..+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +|+||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456888899999999999999976 4678999987532 333456678899999999 999999999998643 4689
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||++ ++|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5999988654 4889999999999999999999876 9999999999999999999999999998654
Q ss_pred CCCCc---cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh------
Q 041565 679 NLNQT---HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ------ 748 (862)
Q Consensus 679 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 748 (862)
..... .......|+..|+|||.+.+ ...+.++||||||+++|||++|+.||......+............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 12233458899999998765 567899999999999999999999996543322111000000000
Q ss_pred --ccCccccccC----CCCC--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 749 --RMGTIEDIID----PNLK--GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 749 --~~~~~~~~~d----~~l~--~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.......+++ .... .......+..+.+++.+|++.+|.+|||+.+++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 0000000010 0000 0011124567899999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.07 Aligned_cols=248 Identities=28% Similarity=0.327 Sum_probs=201.9
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+|+..+.||.|+||.||++..+ .+..+|+|.+... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 4778999987643 22456789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 34899999999999999999999876 9999999999999999999999999987643321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......|+..|+|||.+.+..++.++||||||+++++|++|+.|+....... .++....... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence 2233557889999999998889999999999999999999999997544321 1111111110 01
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSM--GDVLW 796 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~--~evl~ 796 (862)
...+...+..+.+++.+||+.+|.+||++ .|++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11222345788999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.95 Aligned_cols=261 Identities=25% Similarity=0.313 Sum_probs=196.0
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--hhhHHHHHHHHHHHHhc---cccceeeEEEEEeecCe-----
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--EQGVHEFQTEIEMLSKL---RHKHLVSLIGFCEEDGE----- 596 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 596 (862)
|+..+.||+|+||.||+|..+. +..+|+|++.... ......+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999999874 7899999876432 22234566788877766 59999999999987766
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.+++|||+. ++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 58999887654445999999999999999999999876 99999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc--
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE-- 754 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 754 (862)
..... ......++..|+|||.+.+..++.++|||||||+++||++|++||......+.. ..+...........
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhcC
Confidence 43221 112234788899999999999999999999999999999999998754432211 11111000000000
Q ss_pred -------cccCCCCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 755 -------DIIDPNLK---GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 755 -------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
........ .....+....+.+++.+||+.+|.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 11112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=301.05 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=197.8
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecC----
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG---- 595 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 595 (862)
...++|+..+.||+|+||.||+|..+ ++..||+|.+.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888999999999999999986 46789999876432 233456788999999999999999999987654
Q ss_pred ------eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 596 ------EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 596 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
..++|+||+++ +|...+... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 777777654 235899999999999999999999876 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
|||+++....... .......++..|+|||.+.+ ...+.++|||||||+++||++|++||......+.. ........
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~~~~~~~~ 235 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--ELISRLCG 235 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhC
Confidence 9999986543221 11122345778999998865 45789999999999999999999999754322211 11111000
Q ss_pred c--cCccccc--------cCC------CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 749 R--MGTIEDI--------IDP------NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 749 ~--~~~~~~~--------~d~------~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. ......+ .++ ..... ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000000 000 00000 11235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=302.39 Aligned_cols=269 Identities=25% Similarity=0.266 Sum_probs=199.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 599 (862)
.++|+..+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999975 47889999875432 22234567899999999999999999998654 56899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||++ ++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58988887543 34899999999999999999999887 99999999999999999999999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH-HHHHHhhhccCcccccc
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL-ADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~ 757 (862)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+.... .++.. ...........
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (309)
T cd07845 161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLG-TPNESIWPGFS 237 (309)
T ss_pred cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCChhhchhhh
Confidence 21 11222345778999999876 5678999999999999999999999975543222111 00000 00000000000
Q ss_pred ------CCCCCCC----C---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 ------DPNLKGN----I---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 ------d~~l~~~----~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...+... . .......+.+++.+|++.+|.+|||+.|++++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0000000 0 011356678999999999999999999999887764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=283.00 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=196.7
Q ss_pred ceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC-ChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 531 SHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
...||.|..|.|++.+.+. |..+|||.+... +.+..++++..+.++.+-+ +|.||+.+||+..+...++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 5579999999999999765 778999987654 5566778888888877765 8999999999999999999999994 3
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (862)
.++.+|.+-. .++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++-.+.+ ....+
T Consensus 176 C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAht 249 (391)
T KOG0983|consen 176 CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHT 249 (391)
T ss_pred HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec---ccccc
Confidence 5666665543 45899999999999999999999854 799999999999999999999999999865432 33445
Q ss_pred cccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 688 MVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 688 ~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
...|.+.|||||.+.- ..|+.++|||||||.++||.||+.|+.....+-.. .......+ -|.|.+.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----ltkvln~e-------PP~L~~~ 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----LTKVLNEE-------PPLLPGH 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----HHHHHhcC-------CCCCCcc
Confidence 6679999999999864 47899999999999999999999999764322111 11111110 1333322
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
. ..+..+++++..||+.|+.+||.+.+++++-
T Consensus 319 ~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 319 M--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred c--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 1 2567899999999999999999999998763
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.40 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=193.1
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeec--CeEEEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEED--GEMILVYD 602 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 602 (862)
|+..+.||+|+||.||+|... ++..+|+|++.... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999965 46789999876532 222234557888999885 99999999999887 89999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++ |+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 58888886543 34899999999999999999999877 999999999999999 9999999999986432211
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-H--------HHHHHhhhccCc
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-L--------ADWALHCQRMGT 752 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~~~~~~~~~~ 752 (862)
.....++..|+|||++.. +.++.++|||||||+++||++|++||......+... . ..|..... ...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR-KSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc-ccc
Confidence 122457889999998654 567899999999999999999999997654322110 0 01100000 000
Q ss_pred cccccCCCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 753 IEDIIDPNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 753 ~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
......+...+ ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000111000 0112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.82 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=195.8
Q ss_pred EeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|+||+||++..+ ++..+|+|.+.... ....+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 47789999875422 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++.+.....+++.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99998765556999999999999999999999877 99999999999999999999999999876432 1112234
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.++..|+|||.+.++.++.++|||||||+++||++|+.||......... ...... ... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~-----~~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELKRR-----TLE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHHhc-----ccc------ccccCCccC
Confidence 5778999999999888999999999999999999999999654321111 000000 000 001112234
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
...+.+++.+||+.+|.+|| +..+++.+.+.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 56789999999999999999 67777765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.44 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=194.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecC-------
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG------- 595 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 595 (862)
++|+..+.||+|+||.||++..+ ++..||+|.+.... ......+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 36888899999999999999975 47789999875432 222345678999999999999999999986654
Q ss_pred -eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 596 -EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 596 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
..++||||+. ++|.+.+.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 58888876543 34899999999999999999999876 999999999999999999999999999
Q ss_pred ccCCCCCCc--cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 675 KTGPNLNQT--HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 675 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
......... .......++..|+|||++.+. .++.++||||||++++||++|++|+......................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 764322111 111233567889999998764 47889999999999999999999997654332222111110000000
Q ss_pred ------------------ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 752 ------------------TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 752 ------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.....+...+... .....+.+++.+||+.+|.+|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 0000000000000 1234567999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.64 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=204.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|+||.||++... ++..+++|++.... ....+++.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999976 46789999876543 35567889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 604 MANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
+++++|.+++.... ...+++.++..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997653 345999999999999999999999876 9999999999999999999999999997654322
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......|+..|+|||.+.+..++.++||||+|+++++|++|+.|+......+ ....... ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~-------- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK-GQY-------- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc-CCC--------
Confidence 12233467889999999999899999999999999999999999986543211 1111111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...+......+.+++.+||..+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.30 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=202.7
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|+||.||++..+ ++..+++|.+... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999865 5678999987643 334456788999999999999999999999989999999999
Q ss_pred CCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 604 MANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
+++++|.+++.+. ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998762 2245899999999999999999999877 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......++..|++||.+.+..++.++|+||||++++||++|+.||......+. .... ..+.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~----~~~~--------- 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKV----QRGK--------- 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----hcCC---------
Confidence 22234578899999999999999999999999999999999999965432211 1100 0111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
....+.....++.+++.+|++.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111222456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.06 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=202.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh--hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|+..+.||+|++|.||++... .+..+++|....... ...+++.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 467899998765543 4567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999765 34899999999999999999999877 999999999999999999999999999865432221
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+....... ..|...... .+
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~--------~~---- 217 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIVQDD--------HP---- 217 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhccC--------CC----
Confidence 233457889999999988889999999999999999999999986432111 111111000 01
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..+...+..+.+++.+||..+|++||++.|++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1122235678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=304.23 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=200.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|+..+.||+|+||.||++... .+..||+|.+... ......++.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467888999999999999999965 5788999987532 334456788899999999999999999987543 3
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+. ++|.+.+... +++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 5799999996 5888887542 889999999999999999999877 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-H--------HHHHHh
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-L--------ADWALH 746 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~~~~ 746 (862)
..... .......++..|+|||++.+..++.++|||||||+++||++|+.||.......... + .+|...
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 64321 11223457889999999999999999999999999999999999996543211100 0 000000
Q ss_pred --------hhccC-----ccccccCCCC----CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 747 --------CQRMG-----TIEDIIDPNL----KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 747 --------~~~~~-----~~~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..... .+.++....+ ........+..+.+++.+||+.+|.+|||+.|++.+-+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00000 0001111100 0111123456788999999999999999999999886654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.65 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=197.9
Q ss_pred eeEeee--CcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVG--GFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
..||+| +||+||++... .+..||+|..... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999874 5789999987643 333457789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc--
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH-- 684 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 684 (862)
++|.+++.+.....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556899999999999999999999877 9999999999999999999999998653321110000
Q ss_pred ---ccccccCCCCCCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh------------
Q 041565 685 ---VSTMVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC------------ 747 (862)
Q Consensus 685 ---~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------------ 747 (862)
......++..|+|||++.+. .++.++|||||||+++||++|+.||........ +.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence 01112345679999999763 578999999999999999999999965432111 00000000
Q ss_pred -----------h---------ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 -----------Q---------RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 -----------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. .......+.+..+.......+...+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 0 00000011111122222345677899999999999999999999999887765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=326.15 Aligned_cols=263 Identities=26% Similarity=0.461 Sum_probs=209.1
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEcC--------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEE
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGF 590 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 590 (862)
++...++....+.||+|.||.|++|...+ ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34445555666799999999999998542 346999987753 345678899999999999 59999999999
Q ss_pred EeecCeEEEEEEeCCCCcHHHHHhcCC------------C--CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCC
Q 041565 591 CEEDGEMILVYDYMANGTLREHLYKGD------------K--PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTT 656 (862)
Q Consensus 591 ~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 656 (862)
|...+..++|+||+..|+|.++|+... . ..++..+++.++.|||.||+||++.. +|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998655 0 13889999999999999999999876 999999999
Q ss_pred CeeccCCCceEEeeccccccCCCCCCcccccccc--CCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 041565 657 NILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNL 733 (862)
Q Consensus 657 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~ 733 (862)
|||+.++..+||+|||++|...+....... ... -...|||||.+....++.|+|||||||+||||++ |..|+.+-.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999999975543333211 112 2446999999999999999999999999999997 667775421
Q ss_pred ccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 734 PKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
... .+.++.. .|. +-..+..|..++.++++.||+.+|++||++.|+++.++..+
T Consensus 527 ~~~--~l~~~l~----~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTE--ELLEFLK----EGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHH--HHHHHHh----cCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 1122222 121 12223447788999999999999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.08 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=199.8
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh--hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
|...+.||+|++|.||++... ++..+++|.+..... .....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 445678999999999999875 577899998765432 24567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 8888887644 34899999999999999999999877 9999999999999999999999999987654322 1
Q ss_pred ccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC-----
Q 041565 685 VSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID----- 758 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 758 (862)
......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+......-..............+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12234577889999999876 789999999999999999999999865543221111000000000000000000
Q ss_pred ----CC--C--CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 759 ----PN--L--KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 759 ----~~--l--~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
+. . ........+.++.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0 011122356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=320.93 Aligned_cols=271 Identities=20% Similarity=0.236 Sum_probs=190.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCc--cEEEE------------------EecCCCChhhHHHHHHHHHHHHhccccce
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGK--TKVAI------------------KRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~--~~vav------------------K~~~~~~~~~~~~~~~E~~~l~~l~H~ni 584 (862)
.++|...+.||+|+||.||++..+.. ...++ |+.. .......++.+|+++|++++|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 46799999999999999999875431 11111 1111 122345678899999999999999
Q ss_pred eeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCC---CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGD---KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 585 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
+++++++...+..++|+|++. ++|.+++.... .......+...|+.|++.||+|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999995 57877776432 112345667889999999999999877 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCccccccH
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA-LNVNLPKEQVSL 740 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p-~~~~~~~~~~~l 740 (862)
.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999986543211 122335689999999999999999999999999999999998754 432221111111
Q ss_pred HHHHHhhhc-cC-------ccccccCCC-C---CCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 741 ADWALHCQR-MG-------TIEDIIDPN-L---KGNIT-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 741 ~~~~~~~~~-~~-------~~~~~~d~~-l---~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......... .. .+.+.++.. + ....+ ...+..+.+++.+||+.||.+|||+.|++.+..+.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 111100000 00 000000000 0 00000 01234567889999999999999999999887764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=296.94 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=200.0
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHH
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLR 610 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 610 (862)
.+||+|+||.||++..+ ++..||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 57789999886655556677999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccccccc
Q 041565 611 EHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690 (862)
Q Consensus 611 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 690 (862)
+++... .+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 987543 3899999999999999999999877 9999999999999999999999999987543221 1123345
Q ss_pred CCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHH
Q 041565 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCL 770 (862)
Q Consensus 691 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 770 (862)
++..|+|||++.+..++.++||||||++++||++|..||......+... .... ...+.+.. ....+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~---------~~~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRD---------NLPPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh---------hCCcccCC--cccCC
Confidence 8899999999988889999999999999999999999986543221111 0000 00111110 11234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 771 RKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 771 ~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+.+++.+||+.+|.+||++.+++++-...
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~ 274 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcChHHh
Confidence 5688999999999999999999999875554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.68 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=195.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC-hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|+||.||+|..+. +..+|||.+.... .....++..|+.++.++. |+||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999999875 7889999876432 234556777888777775 9999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++ ++|.+++..... .+++..+..++.|+++||+|||+. .+|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 985 477777655333 589999999999999999999973 139999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||........ .+. ...... .
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~~-~----- 236 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLT----KILQEE-P----- 236 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHH----HHhcCC-C-----
Confidence 112234778999999987654 78899999999999999999999864221110 011 000000 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+... ....+..++.+++.+||+.+|.+||++.+++++....
T Consensus 237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 0000 0012456789999999999999999999999876643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.85 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=193.5
Q ss_pred EeeeCcEEEEEEEEcC-ccEEEEEecCCCCh---hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPSSE---QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|+||.||++.... +..+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 78899998765432 4567789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC------c
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ------T 683 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~------~ 683 (862)
.+++.+.. .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997654 4899999999999999999999877 99999999999999999999999999876432211 1
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......++..|++||.+.....+.++||||||++++||++|+.||......+. ...... +... . ..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~----~--~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILN-GKIE----W--PE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-CCcC----C--Cc
Confidence 122334578899999999988899999999999999999999999865432211 111110 1100 0 00
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~ 796 (862)
....+..+.+++.+|++.+|.+|||+.++.+
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred --cccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 0012567899999999999999999944443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.52 Aligned_cols=264 Identities=23% Similarity=0.256 Sum_probs=195.8
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
+.+|.|+++.||++.. .+..+|+|++... .....+.+..|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455556666666654 5678999987643 445567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC-----cc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-----TH 684 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~~ 684 (862)
.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........ ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998754455899999999999999999999877 99999999999999999999999998865422111 11
Q ss_pred ccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh-----------hccC
Q 041565 685 VSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC-----------QRMG 751 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~~~~ 751 (862)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ +.+..... ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcC
Confidence 1223456788999999876 4588999999999999999999999975432111 11100000 0000
Q ss_pred cccc----ccCCCCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 TIED----IIDPNLK----GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 ~~~~----~~d~~l~----~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.... ..++... .........++.+++.+||+.+|++|||+.+++++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 0000 0011110 011223456788999999999999999999999887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=307.46 Aligned_cols=271 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEe----ecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCE----EDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~ 597 (862)
..+|+..+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.+|++++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999965 47889999876532 234567788999999999999999998875 33568
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+. |+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 68999886543 3899999999999999999999876 999999999999999999999999999754
Q ss_pred CCCCCc--cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh-------
Q 041565 678 PNLNQT--HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC------- 747 (862)
Q Consensus 678 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------- 747 (862)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 322111 11223468889999999866 56899999999999999999999999654322211110000000
Q ss_pred -hccCccccccCC-CCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 -QRMGTIEDIIDP-NLKGN-----ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 -~~~~~~~~~~d~-~l~~~-----~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+....+. ..... .....+.++.+++.+||+.+|.+||++.+++.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 000000000000 00000 0112457789999999999999999999999987765
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.72 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=209.5
Q ss_pred HHHHHhhcc-CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEe
Q 041565 518 LAEIKHGTR-NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592 (862)
Q Consensus 518 ~~el~~at~-~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 592 (862)
.-|+..-|. .|+.-++||+||||.||-++.+ .|..+|.|++... .+++....+.|-.+|.+++.+.||.+--.++
T Consensus 176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 334444444 4888999999999999998865 4777898876432 3455667889999999999999999988899
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
..+.++||+..|.||+|.-||.+.+++.+++...+-++.+|+.||++||... ||.||+||+|||||+.|+++|+|+|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence 9999999999999999999999988888999999999999999999999876 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
||...+... ..+...||.||||||+++++.|+...|.|||||+||||+.|+.||........ |..
T Consensus 333 LAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~eE------- 397 (591)
T KOG0986|consen 333 LAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----REE------- 397 (591)
T ss_pred eEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----HHH-------
Confidence 998765422 22333799999999999999999999999999999999999999965432211 100
Q ss_pred cccccCCCC---CCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 041565 753 IEDIIDPNL---KGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNL 798 (862)
Q Consensus 753 ~~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L 798 (862)
+|.+. ...+++..+++...+.+..|+.+|.+|.- ..+|.+|.
T Consensus 398 ----vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 398 ----VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred ----HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 01111 12334556677888889999999999874 45666553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=294.91 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=197.3
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCCh-hhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEeC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
|+..+.||+|++|.||+|+..+ +..|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567899999999999999864 67899998764322 22334567999999999 999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
+|+|.+++.......+++.+++.++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999988765455899999999999999999999877 9999999999999999999999999997643211
Q ss_pred ccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH----------HHHHHhhhccCcc
Q 041565 685 VSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL----------ADWALHCQRMGTI 753 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l----------~~~~~~~~~~~~~ 753 (862)
......++..|+|||++.+ ..++.++|+||||++++||++|++||......+.... ..|.........+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 1123457889999998754 5679999999999999999999999865533221100 0111111111111
Q ss_pred ccccCCCCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 754 EDIIDPNLK---GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 754 ~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...+..... ..........+.+++++|++.+|.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 110000000 00001124678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=297.92 Aligned_cols=251 Identities=28% Similarity=0.379 Sum_probs=198.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+.|+..+.||+|+||.||+|+.. ++..+++|.+.. ......+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999975 467899998653 23344567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+. |+|.+.+.... ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9996 68888776443 34899999999999999999999876 99999999999999999999999999876432
Q ss_pred CccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.....++..|+|||.+. .+.++.++|||||||++|||++|+.|+......+.. ..... +. .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-~~-----~ 231 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NE-----S 231 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHhh-cC-----C
Confidence 12345788999999985 356788999999999999999999998543221111 11000 00 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+.. ....+...+.+++.+||+.+|.+||++.+++.+.+...
T Consensus 232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 111 11234567889999999999999999999998876654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=288.70 Aligned_cols=250 Identities=19% Similarity=0.225 Sum_probs=191.7
Q ss_pred HHHhhccCcccceeE--eeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC
Q 041565 520 EIKHGTRNFSESHVI--GVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG 595 (862)
Q Consensus 520 el~~at~~f~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 595 (862)
++....++|...+.+ |+|+||.||++..+ ++..+|+|........ + .|+.....+ +|+|++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 333344556665555 99999999999865 4677888886543211 1 122222222 6999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeecccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLS 674 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla 674 (862)
..++||||+++++|.+++.... .+++.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997654 5999999999999999999999877 99999999999999998 9999999998
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+..... ....++..|+|||++.+..++.++||||||++++||++|+.||..... +......|........
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~--- 227 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQKKL--- 227 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhcccC---
Confidence 764321 223588899999999999999999999999999999999999974322 2222233322211000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-MGDVLWNL 798 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-~~evl~~L 798 (862)
......+..+.+++.+||+.+|.+||+ +.|++++-
T Consensus 228 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 228 ---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred ---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 011135667899999999999999995 69988653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.92 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=203.4
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecC-----eEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG-----EMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 598 (862)
+|...+.||+|++|.||+++... +..+++|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778999999999999999764 7889999876543 344577899999999999999999999987765 789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||++ ++|.+++.+.. .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58998887644 5999999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCc-cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh--------h
Q 041565 679 NLNQT-HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC--------Q 748 (862)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~ 748 (862)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|++||......+......-.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 32210 112234578899999999887 8999999999999999999999999765432211100000000 0
Q ss_pred ccCccccccCC-CCC-----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 749 RMGTIEDIIDP-NLK-----GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 749 ~~~~~~~~~d~-~l~-----~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......+.+.. ... .......+..+.+++.+||+.+|.+||++.+++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 00000000000 000 001112456789999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=303.44 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=193.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------Ce
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------GE 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 596 (862)
++|...+.||+|+||.||+|+.. .+..||+|++... .......+.+|+.++++++|+||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888999999999999999965 5788999987542 223345688999999999999999999988654 35
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++|+||+.. +|..++. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 6999999964 7776652 23899999999999999999999877 99999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH---------HHh
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW---------ALH 746 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~ 746 (862)
.... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||............-. ...
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 4321 123457888999999876 5689999999999999999999999975432211100000 000
Q ss_pred hhccCccccccC--CCC-CCCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 747 CQRMGTIEDIID--PNL-KGNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 747 ~~~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. .......+. +.. .... .......+.+++.+||+.+|.+||++.|++.+-.
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 242 LE-DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred hc-ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00 000000000 000 0000 0113456889999999999999999999997733
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=295.21 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=194.9
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
|...+.||+|+||.||+|+.. .+..+++|++... .....+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999865 4678999987532 233456788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+. |+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 68888776543 34899999999999999999999877 99999999999999999999999999865321
Q ss_pred cccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.....|+..|+|||++. ...++.++|||||||++|||++|++|+......... ....... . +.
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-~-----~~ 239 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND-S-----PT 239 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-C-----CC
Confidence 12345888999999984 456889999999999999999999998644221111 1111000 0 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. .....+..+.+++.+||+.+|.+||++.+++.+-..
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 1 111234568899999999999999999999977543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=302.67 Aligned_cols=275 Identities=22% Similarity=0.295 Sum_probs=205.5
Q ss_pred cccCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEE
Q 041565 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590 (862)
Q Consensus 514 ~~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 590 (862)
+.....++...+++|+..+.||+|+||.||++... ++..||+|++... .....+.+.+|++++++++|+||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 44556778888899999999999999999999864 5788999988643 22335678899999999999999999998
Q ss_pred Eeec------CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC
Q 041565 591 CEED------GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW 664 (862)
Q Consensus 591 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 664 (862)
+... ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 7543 3468888887 78998887543 3899999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH-HH
Q 041565 665 EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL-AD 742 (862)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l-~~ 742 (862)
.+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........... ..
T Consensus 158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999876422 1223457889999999876 5688999999999999999999999865432211100 00
Q ss_pred HH-------HhhhccCc-------cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 743 WA-------LHCQRMGT-------IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 743 ~~-------~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+. ........ +......... ........++.+++.+|++.+|.+||++.+++.+-...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 00 00000000 0000000000 00001345688999999999999999999999887654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=287.66 Aligned_cols=244 Identities=24% Similarity=0.334 Sum_probs=188.7
Q ss_pred eeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHH-HhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEML-SKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.||+|+||.||+|... .+..||+|.+.... ......+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 46789999876432 22233445555544 445899999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997643 3889999999999999999999876 99999999999999999999999999875332 2
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
....++..|+|||.+.+..++.++||||||++++||++|..||......+. +..... +.. .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~--~~~------~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILS--RRI------NWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHh--ccc------CCCCccc
Confidence 234578899999999988899999999999999999999999965432211 111100 000 0011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH---HHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSM---GDVLWNLE 799 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~---~evl~~L~ 799 (862)
..++..+.+++.+||+.+|++||++ .|++.+..
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence 2345678999999999999999965 56655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=291.22 Aligned_cols=245 Identities=23% Similarity=0.307 Sum_probs=188.6
Q ss_pred eEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHH---HHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 533 VIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIE---MLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
+||+|+||.||++... .+..||+|.+.... ......+..|.. .++...|+||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 46789999875432 122223444444 3444579999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++.... .+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999887543 4999999999999999999999876 9999999999999999999999999987543211
Q ss_pred cccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....|+..|+|||.+.++ .++.++|||||||+++||++|+.||........... .... . ...+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~---~------~~~~~---- 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMT---L------TMAVE---- 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHh---h------ccCCC----
Confidence 1234588999999999754 689999999999999999999999975432221110 0000 0 00111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
.+...+..+.+++.+|+..+|.+|| ++.|++++.+.
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 1222456789999999999999999 99999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=293.03 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 600 (862)
++|...+.||+|+||.||++... ++..+++|..... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999976 5788999987642 2334567889999999998 99999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||++++++|.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997654 4999999999999999999999877 999999999999999999999999998754322
Q ss_pred CCc------------------cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 681 NQT------------------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 681 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
... .......++..|+|||.+.+..++.++||||||++++|+++|+.|+........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence 210 112234578899999999988899999999999999999999999975431110 00
Q ss_pred HHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 041565 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSM----GDVLWN 797 (862)
Q Consensus 743 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~----~evl~~ 797 (862)
... ......+...+..+.+++.+||+.+|.+||++ +|++++
T Consensus 233 ~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 KIL--------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHH--------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 000 00111222345678999999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=300.07 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=195.4
Q ss_pred ceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhh--------------HHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 531 SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQG--------------VHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
.+.||+|+||.||+|... .+..||+|.+....... ...+.+|++++++++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999965 57889999875432111 125788999999999999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||++ |+|.+++.... .+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 9999999996 69999986543 3899999999999999999999877 9999999999999999999999999987
Q ss_pred cCCCCC------------CccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 676 TGPNLN------------QTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 676 ~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
...... .........++..|+|||++.+. .++.++|||||||+++||++|++||......+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--- 244 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG--- 244 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 543110 01111223467889999998764 46899999999999999999999997654322211
Q ss_pred HHHhhhccC---ccccc--------cCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 743 WALHCQRMG---TIEDI--------IDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 743 ~~~~~~~~~---~~~~~--------~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......... .+.+. ....... ......+.++.+++.+||+.+|.+||++.|++.+.+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 110000000 00000 0000000 00112356788999999999999999999999877664
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=297.33 Aligned_cols=269 Identities=22% Similarity=0.282 Sum_probs=200.7
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee-cC
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DG 595 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 595 (862)
++...+++|+..+.||+|+||.||++... ++..+|+|++... .....+.+..|++++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44557889999999999999999999865 5788999986532 22345678899999999999999999998865 56
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++++||+ +++|.+++... .+++.....++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 56898887643 3788889999999999999999877 9999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HH--------HHHH
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LA--------DWAL 745 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~~~ 745 (862)
..... .....++..|+|||.+.+ ..++.++||||||++++||++|++||.......... +. +|..
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 53221 122356788999998766 568999999999999999999999996543321110 00 1111
Q ss_pred hhhccCccccccCCCCCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNIT-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.........-+..-......+ ......+.+++.+|++.+|++||++.+++.+-..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 000000000000000001111 1234678999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=290.50 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=207.3
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
-|...+.||+|.|..|-.+++- .|..||||++... +......+..|++.|+.++|||||+||.+...+..+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3555678999999999988743 5779999998754 233456788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~~~~~~~ 682 (862)
-++|+|.++|.++.. .+++....+++.||+.|+.|+|+.+ +|||||||+||++- .-|-+||.|||++..+..
T Consensus 99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--- 171 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--- 171 (864)
T ss_pred cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC---
Confidence 999999999987754 4999999999999999999999776 99999999998774 568899999999876543
Q ss_pred ccccccccCCCCCCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
....+..+|++.|-|||.+.+..|+ ++.|||||||+||-|+||++||+.....+.. ..++|-+.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKY 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKY 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccc
Confidence 2334567899999999999998886 5789999999999999999999765443332 22333322
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..+.....++.+||..||..+|.+|-+.+||+..-|
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 245567788999999999999999999999997765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=320.20 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=187.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEee---------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--------- 593 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 593 (862)
..+|++.++||+||||.|||++.+ +|+.+|||++... +.+......+|++.|++|+|||||+.+..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346778889999999999999976 6889999997654 44455678899999999999999998721000
Q ss_pred --------------------------------------------------------------------------------
Q 041565 594 -------------------------------------------------------------------------------- 593 (862)
Q Consensus 594 -------------------------------------------------------------------------------- 593 (862)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------c--------CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC
Q 041565 594 ----------------------D--------GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643 (862)
Q Consensus 594 ----------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 643 (862)
+ ..+|+=||||+.-.|+++++++... -.....++++++|++||+|+|++
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 1257889999998888877765421 14678899999999999999988
Q ss_pred CcccEEeeCCCCCCeeccCCCceEEeeccccccCC----C------------CCCccccccccCCCCCCChhhhhcC---
Q 041565 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP----N------------LNQTHVSTMVKGSFGYLDPEYFRRQ--- 704 (862)
Q Consensus 644 ~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~--- 704 (862)
+ ||||||||.||+||++..+||+|||+|+... . .......+...||.-|+|||++.+.
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 7 9999999999999999999999999998611 0 0111133556799999999999764
Q ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC--CcHHHHHHHHHHHHHccc
Q 041565 705 QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN--ITDQCLRKFTETAEKCLS 782 (862)
Q Consensus 705 ~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~Cl~ 782 (862)
.|+.|.|+||+||+++||+. ||....+. +.. +..+-++.+... +.......-.++++++++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--------a~i------L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMER--------ASI------LTNLRKGSIPEPADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHH--------HHH------HHhcccCCCCCCcccccccchHHHHHHHHHhc
Confidence 59999999999999999984 35432211 111 111112222211 122233345789999999
Q ss_pred cCCCCCCCHHHHHHH
Q 041565 783 DQGIDRPSMGDVLWN 797 (862)
Q Consensus 783 ~~p~~RPt~~evl~~ 797 (862)
.||.+|||+.|++..
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999853
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.72 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=196.9
Q ss_pred CcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCC----hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSS----EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 597 (862)
+|+..+.||+|++|.||++... ++..+|+|.+.... ....+.+..|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999998753 45689999876421 22345688999999999 599999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987543 4899999999999999999999876 999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
..... .......++..|+|||.+.+.. .+.++||||||++++||++|+.|+...... ....+........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS----- 227 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc-----
Confidence 33221 1122345788999999987765 788999999999999999999998533211 1111111111110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+. .+......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 228 --~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 --KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred --CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 111 12224456889999999999999999887765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=296.14 Aligned_cols=268 Identities=25% Similarity=0.291 Sum_probs=194.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec-------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------- 594 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 594 (862)
.++|+..++||+|+||.||+|... ++..+|+|++.... ......+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999975 46789999865332 22234677899999999999999999887443
Q ss_pred -CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 595 -GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 595 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
..+++||||+.. +|...+.... ..+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999964 7777776543 34999999999999999999999877 99999999999999999999999999
Q ss_pred cccCCCCCCc---------cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 041565 674 SKTGPNLNQT---------HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW 743 (862)
Q Consensus 674 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 743 (862)
++........ ...+...++..|+|||.+.+ ..++.++|||||||+++||++|++||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9754321111 11123456788999998865 4589999999999999999999999975443222111100
Q ss_pred HHhhhccC------cccc----ccCCCCCCCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 744 ALHCQRMG------TIED----IIDPNLKGNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 744 ~~~~~~~~------~~~~----~~d~~l~~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
........ .+.. .......... .......+.+++.+||+.+|.+|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 0000 0000110000 01123568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=290.06 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=196.6
Q ss_pred CcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCC----hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSS----EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 597 (862)
+|+..+.||+|+||.||++... ++..+|+|++.... ....+.+..|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 56789999876432 22346788899999999 599999999999998999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999997653 3889999999999999999999877 999999999999999999999999999764
Q ss_pred CCCCCccccccccCCCCCCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
..... .......|+..|+|||.+.+. .++.++||||||++++||++|+.|+...... ....++........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~---- 228 (290)
T cd05613 156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE---- 228 (290)
T ss_pred ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC----
Confidence 32211 112234588899999998753 4688999999999999999999998643221 11122222111100
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNL 798 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L 798 (862)
...+......+.+++.+|++.+|.+|| +..+++.+-
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~ 269 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence 111223456788999999999999997 667776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=297.43 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=194.4
Q ss_pred CcccceeEeeeCcEEEEEEEEcC---ccEEEEEecCCC--ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeec----Ce
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG---KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED----GE 596 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 596 (862)
+|+..+.||+|+||.||++.... +..+|+|++... .....+.+.+|+++++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999653 568999987642 223356788999999999 599999999976432 45
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899986 68999986543 4899999999999999999999877 99999999999999999999999999976
Q ss_pred CCCCCCc--cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH---------HHH
Q 041565 677 GPNLNQT--HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA---------DWA 744 (862)
Q Consensus 677 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~ 744 (862)
....... .......|+..|+|||++.+ ..++.++|||||||+++||++|++||............ ++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4322111 11223468899999998866 56899999999999999999999998754322111000 000
Q ss_pred HhhhccC--ccccccC--CCC-CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 745 LHCQRMG--TIEDIID--PNL-KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 745 ~~~~~~~--~~~~~~d--~~l-~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....... ....... +.. ...........+.+++.+|++.+|.+|||+.|++.+-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 0000000 0000000 000 000011124578899999999999999999999977654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=330.10 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=203.0
Q ss_pred hccCcccceeEeeeCcEEEEEEE-EcCccEEEEEecC--CCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
-+-+++....||.|.||.||-+. .+.|...|+|-+. ...........+|+.++..|+|||+|+.+|.-.+.++.++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34466678899999999999988 4567788999644 33345567788999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||||++|+|.+.+..... .++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|....+.
T Consensus 1313 MEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999976543 667777778899999999999888 999999999999999999999999999875443
Q ss_pred CCc--cccccccCCCCCCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 681 NQT--HVSTMVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 681 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
.+. .......||+-|||||.+.+. .-.-++||||+|||.+||+||++||...+. +|+..+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V------ 1454 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHV------ 1454 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHH------
Confidence 211 112345799999999999763 345689999999999999999999964322 24443211
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
...-.+.+++....+-.+++..||..||++|.++.|++++
T Consensus 1455 --~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 --AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111234455567778899999999999999988887754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=286.92 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=193.2
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCC-----CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNP-----SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
+|...+.||+|+||.||++.... +..+++|.++. .......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998654 23344444332 1223345677899999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 601 YDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
|||+++++|.+++.. .....+++.+++.++.|+++||+|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 22345899999999999999999999876 999999999999976 569999999987643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ....... .+
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~-~~------- 220 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV-EG------- 220 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH-cC-------
Confidence 221 1222345788999999998888999999999999999999999998543211 1111100 01
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
.....+..++..+.+++.+|++.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0111223456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=297.14 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=211.3
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
......|.....||+|.|+.|..++.. .+..||+|.+... +....+.+.+|+++|..|+|||||+++.+......++
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 344667888999999999999999965 4789999988754 2333455889999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+.+|.+.++|.+..+ +.......++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999998766 666889999999999999999988 9999999999999999999999999998753
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
........+|++.|.|||++.+..+ .++.|+||+|++||-|++|..||++..-.+-.
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------------------- 264 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------------------- 264 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------------
Confidence 3445566789999999999999776 67999999999999999999999765322211
Q ss_pred CCCCCCC--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 758 DPNLKGN--ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 758 d~~l~~~--~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
++.+++. ++.-...++.+++++++-.+|.+|+++.++.++-+-...
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 1112221 122234567889999999999999999999987655433
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=300.35 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=195.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec----------
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED---------- 594 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 594 (862)
.+|...+.||.|+||.||+|... .+..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999975 4678999987665556667889999999999999999999766543
Q ss_pred ----CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEEe
Q 041565 595 ----GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVS 669 (862)
Q Consensus 595 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl~ 669 (862)
...++||||++ ++|.+++... .+++.....++.|+++||+|||+.+ ++||||||+||+++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898888543 3889999999999999999999877 99999999999997 45678999
Q ss_pred eccccccCCCCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 670 DFGLSKTGPNLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 670 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
|||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||......+...........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999975432111 111122357888999998755 56889999999999999999999999654432211100000000
Q ss_pred hcc---Cc----c-cccc-CCCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 748 QRM---GT----I-EDII-DPNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 748 ~~~---~~----~-~~~~-d~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
... .. . ..+. +..... ........++.+++.+||+.+|.+|||+.|++.+-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 000 00 0 0000 000000 0011234568899999999999999999999987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.42 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=198.4
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
|+..+.||+|++|.||+|+... +..+++|...... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999764 7889999877542 333567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
+ ++|.+++.+.. ..+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 59999998653 34899999999999999999999877 99999999999999999999999999986533221
Q ss_pred ccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-H---------HHHHHhhhc---c
Q 041565 685 VSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-L---------ADWALHCQR---M 750 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l---------~~~~~~~~~---~ 750 (862)
......++..|+|||.+.+. .++.++|||||||+++||++|++||......+... . ..|...... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12223456789999998776 88999999999999999999999986543221110 0 001000000 0
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
............... ......+.+++.+||..+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000000001 1125678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=295.37 Aligned_cols=265 Identities=22% Similarity=0.337 Sum_probs=198.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC-----
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG----- 595 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 595 (862)
..++|+..+.||+|+||.||++... ++..||+|++... .....+.+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4667999999999999999999864 5788999987532 2334467889999999999999999999886543
Q ss_pred -eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 596 -EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 596 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
..++||||+ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999 67998887642 3899999999999999999999877 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-c--------HHHHH
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-S--------LADWA 744 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~--------l~~~~ 744 (862)
+..... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||......... . ..+|.
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 764321 123457889999999876 46889999999999999999999999754321110 0 00111
Q ss_pred HhhhccCccccccC--CCCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 745 LHCQRMGTIEDIID--PNLK----GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 745 ~~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...... ....... +... ......+...+.+++.+|++.+|.+|||+.+++.+-...
T Consensus 241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 241 QKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred Hhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 100000 0000000 0000 001112345688999999999999999999999775554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=279.75 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=195.1
Q ss_pred cceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-hhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 530 ESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
....||.|.||+|+|-.++ .|+..|||+++.... ...++++.|.+...+- ++||||+++|.+..++..++.||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3567999999999998875 578899999876543 5667888898875554 79999999999999999999999995
Q ss_pred CcHHHHHh---cCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 607 GTLREHLY---KGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 607 gsL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
-+|+.+-. .-....+++..+-+|......||.||.. ...||||||||+|||||..|.+||||||++-...+ +
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S 221 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S 221 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence 47665432 2334459999999999999999999987 45799999999999999999999999999865432 2
Q ss_pred cccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
-..+...|...|||||.+.. ..|+.+|||||||++|+|+.||+.|+..-.. ..+..... ..+... .+
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V-v~gdpp-----~l 290 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV-VIGDPP-----IL 290 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH-HcCCCC-----ee
Confidence 33455678999999999864 4589999999999999999999999853211 11111111 111111 11
Q ss_pred CCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGN-ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~-~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
... -..+....+++++.-|+.++..+||.+.++.++--.
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 111 112356789999999999999999999998865433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=300.57 Aligned_cols=270 Identities=26% Similarity=0.381 Sum_probs=199.7
Q ss_pred cccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------CeEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------GEMIL 599 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 599 (862)
+...+.||+|+||.||+|+. ..|..||||.++.. .....+...+|+++|++++|+|||++++.-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34467899999999999994 56889999987653 334456788999999999999999999875543 46799
Q ss_pred EEEeCCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc--CCCc--eEEeecccc
Q 041565 600 VYDYMANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD--EKWE--AKVSDFGLS 674 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~--~kl~DFGla 674 (862)
|||||.+|+|+..|.+..+ .+|++.+.+.+..+++.||.|||+++ ||||||||.||++- ++|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999987533 46999999999999999999999877 99999999999993 3343 699999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
|...+ ....+...||..|++||++.. +.++...|.|||||++||.+||..||..........-.-|..........
T Consensus 172 rel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 98543 335667889999999999995 88999999999999999999999999755443322222343322222111
Q ss_pred ccccCCCCCC------------CCcHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHhc
Q 041565 754 EDIIDPNLKG------------NITDQCLRKFTETAEKCLSDQGIDRP--SMGDVLWNLEFALQ 803 (862)
Q Consensus 754 ~~~~d~~l~~------------~~~~~~~~~l~~li~~Cl~~~p~~RP--t~~evl~~L~~~l~ 803 (862)
.-.+++...+ .........+-.....++..+|++|- ..-+....+..++.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111111111 11122334455666667777788887 55555555555543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=294.89 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=198.2
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe----
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE---- 596 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 596 (862)
..++|+..+.||+|++|.||+|... ++..+|+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999976 4678999987643 23344667889999999999999999987765544
Q ss_pred --EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 597 --MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 597 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 5699998865 24899999999999999999999877 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-HHH--------HH
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS-LAD--------WA 744 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------~~ 744 (862)
...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+... +.+ +.
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 864321 223457888999999866 467899999999999999999999996543221110 000 00
Q ss_pred HhhhccCccccccCC---CCCCCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 745 LHCQRMGTIEDIIDP---NLKGNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 745 ~~~~~~~~~~~~~d~---~l~~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.... .......+.. .....+ ....+.++.+++.+||+.+|.+|||+.|++++-+.
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 241 QKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred hhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0000 0000000000 000000 01135678999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=272.78 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=202.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
-++|...++||+|.||.|-.++-+ .++.+|+|+++.. .+.....-+.|-++|+..+||.+..|.-.+...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356888999999999999999865 4678999988764 234445567799999999999999998888899999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||..||.|.-+|.+.. .+++....-.-..|..||.|||+++ ||.||||.+|.|||.+|++||+||||++...
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 99999999998887643 3888888889999999999999977 9999999999999999999999999998643
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.........+||+.|+|||++....|....|.|.+||+||||+|||.||..........++ .++++ +
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----------l~ed~---k 386 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----------LMEDL---K 386 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------Hhhhc---c
Confidence 2344566789999999999999999999999999999999999999999754433222111 01111 1
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNL 798 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L 798 (862)
++....++...++...|..+|.+|. .+.||.++-
T Consensus 387 ----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 387 ----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred ----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 1222345567788899999999996 467776654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=275.21 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=206.2
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEE-EcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeec
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEED 594 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 594 (862)
+++|+.+-| .+.||+|+|+.|--++ +..+.++|||++.........+..+|++++.+.+ |+||++|+.|++++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666555 3789999999999877 6778899999998776667788999999999985 99999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc---eEEeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE---AKVSDF 671 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---~kl~DF 671 (862)
...|||||-|.||+|..+|.++.. +++.+..++.++|+.||.+||.++ |.||||||+|||..+... +|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999987654 899999999999999999999988 999999999999976543 799999
Q ss_pred cccccCCCC-C----CccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH
Q 041565 672 GLSKTGPNL-N----QTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741 (862)
Q Consensus 672 Gla~~~~~~-~----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~ 741 (862)
.|..-.... + ........+|+..|||||+.. ...|+.++|.|||||+||-|++|.+||.+.-..+..
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG--- 300 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG--- 300 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---
Confidence 987532111 1 111122356888999999863 346899999999999999999999999876543322
Q ss_pred HHHHhhh----ccCccccccCCCCCCCCcHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 742 DWALHCQ----RMGTIEDIIDPNLKGNITDQ----CLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 742 ~~~~~~~----~~~~~~~~~d~~l~~~~~~~----~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
|-.... ...-++.+-+... +++++ .+.+..+++...+..++.+|.++.+++.+.+..
T Consensus 301 -WdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~ 365 (463)
T KOG0607|consen 301 -WDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ 365 (463)
T ss_pred -ccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence 211000 0000111111111 22332 445667899999999999999999999876554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=278.45 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=193.1
Q ss_pred EeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
||+|+||.||++...+ +..+++|.+.... ......+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999764 7789999876432 23456889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99997654 3899999999999999999999876 9999999999999999999999999987643321 123345
Q ss_pred cCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
.++..|++||.+.+...+.++|+||||++++||++|+.||......+ .. ..... .. . ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~---~~~~~-~~------~----~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY---EKILK-DP------L----RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHhc-CC------C----CCCCCC
Confidence 67889999999998889999999999999999999999996543211 11 11000 00 0 112223
Q ss_pred HHHHHHHHHHccccCCCCCCCH---HHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPSM---GDVLW 796 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~---~evl~ 796 (862)
+..+.+++.+|+..+|++||++ .+++.
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 5678899999999999999999 45543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=272.17 Aligned_cols=272 Identities=25% Similarity=0.308 Sum_probs=198.2
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-----ccEEEEEecCCCCh--hhHHHHHHHHHHHHhccccceeeEEEEEee-cCeEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DGEMI 598 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 598 (862)
.|.....||+|.||.||++...+ ...+|+|+++.... .......+|+.+++.++||||+.|...+.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46677899999999999996433 13689998875422 113457899999999999999999998866 78899
Q ss_pred EEEEeCCCCcHHHHHhcCC---CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC----CceEEeec
Q 041565 599 LVYDYMANGTLREHLYKGD---KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK----WEAKVSDF 671 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~~kl~DF 671 (862)
|++||.+. +|...++.+. ...++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999986 8888886432 235889999999999999999999998 9999999999999877 89999999
Q ss_pred cccccCCCCCCc-cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc----cHHHHHH
Q 041565 672 GLSKTGPNLNQT-HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV----SLADWAL 745 (862)
Q Consensus 672 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~----~l~~~~~ 745 (862)
|++|...+.-.. .....+.-|+.|.|||.+.+ ..|+.+.|||+.||++.||++-.+-|.+....-.. ......+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999976443221 12334567889999999987 56999999999999999999999888654322100 0011111
Q ss_pred hhhccCccccccCCCCCCC--C-----------cHH------------HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGN--I-----------TDQ------------CLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~--~-----------~~~------------~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.....|...+-..|.+..- . ... -.+...+++.++|..||.+|.|+++.+++.-+
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 1111111111111111100 0 000 01225789999999999999999999998877
Q ss_pred Hh
Q 041565 801 AL 802 (862)
Q Consensus 801 ~l 802 (862)
..
T Consensus 341 ~~ 342 (438)
T KOG0666|consen 341 TE 342 (438)
T ss_pred cc
Confidence 64
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=312.71 Aligned_cols=145 Identities=30% Similarity=0.419 Sum_probs=130.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...++||+|+||.||+|... .+..||+|++... .....+++..|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999976 4678999987643 2344577899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
||+++++|.+++.... .+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 3889999999999999999999876 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=296.85 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=212.0
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEee
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE 593 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 593 (862)
..+..+...+.-|.+.++||.|.+|.||+++. ++++.+|+|++.... ...++...|.++|+.+ +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34555666778899999999999999999984 467889999877543 3346778899999988 69999999999853
Q ss_pred -----cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEE
Q 041565 594 -----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668 (862)
Q Consensus 594 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl 668 (862)
+++++||||||.+|+.-+++.+.....+.|..+..|++.++.||++||... ++|||||-.||||+.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 578999999999999999998766667999999999999999999999765 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW 743 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 743 (862)
+|||++...... ........||+.|||||++... .|+.++|+||||++..||.-|.+|+....+-..+-
T Consensus 165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---- 238 (953)
T KOG0587|consen 165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---- 238 (953)
T ss_pred eeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----
Confidence 999998764321 1222345699999999998653 47789999999999999999999986543321110
Q ss_pred HHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 744 ALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 744 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.-.-.|...-.-+....+++.++|..||..+-.+||++.+++++-
T Consensus 239 ----------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 239 ----------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred ----------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 001122222233556889999999999999999999999998763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=268.10 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=196.9
Q ss_pred ccCcccc-eeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEee----cCeE
Q 041565 525 TRNFSES-HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE----DGEM 597 (862)
Q Consensus 525 t~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 597 (862)
|++|++. ++||-|-.|.|-.+..+ .+.++|+|.+.... ..++|+++--.. .|||||.+++.+.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455543 58999999999998865 46789999887442 345677764333 69999999998753 3567
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeecccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLS 674 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla 674 (862)
++|||.|+||.|...+..+....+++++...|++||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999888888999999999999999999999876 999999999999964 456899999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+.... .......+-|+.|.|||++...+|+..+|+||+||+||-|+||.+||......... .+.-.
T Consensus 212 K~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------pgMk~ 277 (400)
T KOG0604|consen 212 KETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKR 277 (400)
T ss_pred cccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------hhHHh
Confidence 87432 22234457899999999999999999999999999999999999999765432110 00000
Q ss_pred cccCCCCC-CCCc-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 755 DIIDPNLK-GNIT-DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 755 ~~~d~~l~-~~~~-~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+...... .+.. ...++...++++.+|..+|.+|.|+.|++.+-+-.
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 11000000 0111 23456778999999999999999999999887754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.68 Aligned_cols=219 Identities=21% Similarity=0.195 Sum_probs=175.3
Q ss_pred eCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhc
Q 041565 537 GGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK 615 (862)
Q Consensus 537 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 615 (862)
|.+|.||++... ++..+|+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 56789999886543 234455555666799999999999999999999999999999999876
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCC
Q 041565 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695 (862)
Q Consensus 616 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 695 (862)
.. .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 54 3899999999999999999999876 999999999999999999999999987654321 1223456789
Q ss_pred CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHH
Q 041565 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTE 775 (862)
Q Consensus 696 ~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 775 (862)
+|||.+.+..++.++||||+|++++||++|+.|+....... ..... ...+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT----LNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc----cCCcccCCHHHHH
Confidence 99999988889999999999999999999998764321100 00000 0112224567889
Q ss_pred HHHHccccCCCCCCCH
Q 041565 776 TAEKCLSDQGIDRPSM 791 (862)
Q Consensus 776 li~~Cl~~~p~~RPt~ 791 (862)
++.+|++.+|.+||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.90 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=200.0
Q ss_pred ceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 531 SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
.++||+|-||+||-|+++ .|+.||||.+... ...+..+.++|+.+|++++||.||.|..-|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 479999999999999965 6889999987543 2344578899999999999999999999999999999999999 56
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeeccccccCCCCCCcc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 684 (862)
+..+.+.......|++....-++.||+.||.|||.++ |+|+||||+||||.+. .++||||||.||..... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence 7777777666667999999999999999999999887 9999999999999643 57999999999986542 3
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
....+.||+.|+|||++.++.|...-|+||.||++|--++|..||..+.. ..+.+. +..-+.-+...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQ---------NAaFMyPp~PW-- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQ---------NAAFMYPPNPW-- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhh---------ccccccCCCch--
Confidence 34557899999999999999999999999999999999999999975422 111110 00111112222
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+......++|...|+..-.+|-+..+.+.+.+
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 234566789999999999999999888876654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=267.11 Aligned_cols=239 Identities=28% Similarity=0.352 Sum_probs=193.3
Q ss_pred CcEEEEEEEEcC-ccEEEEEecCCCChhh-HHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhc
Q 041565 538 GFGKVYEGYIDG-KTKVAIKRSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK 615 (862)
Q Consensus 538 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 615 (862)
+||.||+|...+ +..+++|+........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 7889999987655444 68899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCC
Q 041565 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695 (862)
Q Consensus 616 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 695 (862)
... +++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 543 899999999999999999999876 9999999999999999999999999998754321 22345578899
Q ss_pred CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHH
Q 041565 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTE 775 (862)
Q Consensus 696 ~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 775 (862)
++||.+.+..++.++||||||++++||++|+.|+...... ....++... .... . .......+.++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~----~~~~----~---~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGK----PKPP----F---PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhc----cCCC----C---ccccccCCHHHHH
Confidence 9999999888999999999999999999999998652111 111111110 0000 0 0000014567899
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 041565 776 TAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 776 li~~Cl~~~p~~RPt~~evl~~ 797 (862)
++.+|+..+|++||++.+++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHccCCchhccCHHHHhhC
Confidence 9999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=290.82 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=184.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEE-----------------cCccEEEEEecCCCChhhHHHH--------------HHH
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYI-----------------DGKTKVAIKRSNPSSEQGVHEF--------------QTE 572 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 572 (862)
..++|...++||+|+||.||+|.+ ..+..||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999964 2345799999875443333333 347
Q ss_pred HHHHHhccccce-----eeEEEEEee--------cCeEEEEEEeCCCCcHHHHHhcCCC---------------------
Q 041565 573 IEMLSKLRHKHL-----VSLIGFCEE--------DGEMILVYDYMANGTLREHLYKGDK--------------------- 618 (862)
Q Consensus 573 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 618 (862)
+.++.+++|.++ ++++++|.. ++..+|||||+++|+|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 677888753 3578999999999999999874211
Q ss_pred -CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCC
Q 041565 619 -PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697 (862)
Q Consensus 619 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 697 (862)
..++|..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 12467888999999999999999876 99999999999999999999999999975432111 11112234789999
Q ss_pred hhhhhcCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCCCCccc------cccHHHHHHhhh
Q 041565 698 PEYFRRQQL----------------------TEKSDVYSFGVVLFEVLCARP-ALNVNLPKE------QVSLADWALHCQ 748 (862)
Q Consensus 698 PE~~~~~~~----------------------s~ksDVyS~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~ 748 (862)
||.+..... ..+.||||+||+++||++|.. |+....... ...+..|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 998754321 234799999999999999875 553211100 1111222211
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQG---IDRPSMGDVLWNLEF 800 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p---~~RPt~~evl~~L~~ 800 (862)
..... + -...+.......+++.+|+..+| .+|+|+.|+++|.++
T Consensus 457 ~~~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 457 KGQKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred cccCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 00100 0 01122245677899999998765 689999999988765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.83 Aligned_cols=243 Identities=20% Similarity=0.273 Sum_probs=196.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+..|.....+|.|+|+.|-++... .++..++|++.... .+-.+|+.++... +|+||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556666777999999999998865 45678999887552 2334577665555 79999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec-cCCCceEEeeccccccCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL-DEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-~~~~~~kl~DFGla~~~~~~~ 681 (862)
.+.++-|.+.+..... .. .++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988888776543 23 778889999999999999987 9999999999999 58899999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
....+-|..|.|||++....+++++|+||||++|||||+|+.|+...... ..+ .....
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~------------ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQ------------ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhc------------
Confidence 22335688999999999999999999999999999999999999755332 100 11111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+.+....+....+|+.+||+.+|.+||+|.++..+-+.
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 122224466788999999999999999999999998887
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=241.10 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=199.9
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+|...++||+|.||+||||+..+ +..||+|+++.. ++..-...++|+.+|+.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556899999999999999654 578999987643 223345678999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|. ..|.++...-+ ..++......++.|+++||.++|+++ +.|||+||.|.|++.+|++|++|||++|...-. .
T Consensus 83 cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--v 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--V 155 (292)
T ss_pred hh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc--e
Confidence 95 48888876543 34889999999999999999999887 999999999999999999999999999865321 1
Q ss_pred cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCc---cccccC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGT---IEDIID 758 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d 758 (862)
.......-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+..-.++..-+-|......+.. +..+.|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 122334568899999998875 58999999999999999984 7777776655555443434333222222 222222
Q ss_pred CCCCCCCcH-----HHH----HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 759 PNLKGNITD-----QCL----RKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 759 ~~l~~~~~~-----~~~----~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
-...+.++. +.. ..=+++.+..+.-+|.+|.++++.+++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 222222211 112 2236788888889999999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=295.79 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=172.5
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-----ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEE------Ee
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF------CE 592 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 592 (862)
..++|...++||+|+||.||+|++.+ +..||+|++...... +.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999754 578999987643221 111111 1122222222222111 34
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCC------------------CCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCC
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKP------------------GLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIk 654 (862)
.+.+.++||||+++++|.+++...... ......+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999998754211 0122345679999999999999876 9999999
Q ss_pred CCCeeccC-CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC----------------------CCCchhH
Q 041565 655 TTNILLDE-KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ----------------------QLTEKSD 711 (862)
Q Consensus 655 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD 711 (862)
|+|||+++ ++.+||+|||+++..... .........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 578999999999864321 12223445689999999976422 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcc-------ccccHHHHHHhhhccCccccccCCCCCC--CCcHHHHHHHHHHHHHccc
Q 041565 712 VYSFGVVLFEVLCARPALNVNLPK-------EQVSLADWALHCQRMGTIEDIIDPNLKG--NITDQCLRKFTETAEKCLS 782 (862)
Q Consensus 712 VyS~Gvvl~elltG~~p~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~ 782 (862)
||||||+||||+++..+.+..... ....+..|....... ..+.+.. ...+.......+++.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999977654321000 001122222111110 0000000 0001112345689999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 041565 783 DQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 783 ~~p~~RPt~~evl~~L~~~ 801 (862)
.||.+|||+.|+++|-...
T Consensus 436 ~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFD 454 (566)
T ss_pred CCcccCCCHHHHhCCcCcC
Confidence 9999999999999986653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=268.87 Aligned_cols=268 Identities=21% Similarity=0.282 Sum_probs=209.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccc--c----ceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH--K----HLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~~ 597 (862)
+++|.....+|+|.||.|-++.... +..||||+++.- ..-.+..+-|+++|+++.+ | -+|++.+|++-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7788899999999999999998654 578999988743 3334567789999999942 2 378899999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---------------
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE--------------- 662 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--------------- 662 (862)
|+|+|.| |-++.++|..+.-.+++...+..|+.|+++++++||+.. ++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 459999999877777999999999999999999999766 999999999999931
Q ss_pred -----CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 041565 663 -----KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737 (862)
Q Consensus 663 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~ 737 (862)
+..+||+|||-|+.... ....+..|..|.|||++.+-..+.++||||+||+|.|+.+|...|+.....+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 34589999999987322 22456789999999999999999999999999999999999999987765554
Q ss_pred ccHHHHHHh--------------hhccCccc-----------cccCCCCC----CCCcHHHHHHHHHHHHHccccCCCCC
Q 041565 738 VSLADWALH--------------CQRMGTIE-----------DIIDPNLK----GNITDQCLRKFTETAEKCLSDQGIDR 788 (862)
Q Consensus 738 ~~l~~~~~~--------------~~~~~~~~-----------~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~~p~~R 788 (862)
+.+.+.... ....+.++ ...++... -...+.+..+|.+|++++|..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 444332211 11111111 01111100 01234566789999999999999999
Q ss_pred CCHHHHHHHHHHHh
Q 041565 789 PSMGDVLWNLEFAL 802 (862)
Q Consensus 789 Pt~~evl~~L~~~l 802 (862)
+|++|++.+..+..
T Consensus 398 iTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 398 ITLREALSHPFFAR 411 (415)
T ss_pred ccHHHHhcCHHhhc
Confidence 99999999877654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=268.63 Aligned_cols=240 Identities=25% Similarity=0.353 Sum_probs=193.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCc-cEEEEEecCCCC---hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGK-TKVAIKRSNPSS---EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
.+|....+||+|+||.|.++..++. ..+|||+++... ....+--+.|-++|... +-|.++++..++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 3577789999999999999987763 568999877542 22233345566777766 467899999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+.+|+|--++.+-++ +.+....-+|.+||-||-+||+++ ||.||||..|||||.+|.+||+|||+++....
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc-
Confidence 999999999999877654 778888999999999999999988 99999999999999999999999999986432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
....+...+||+.|+|||.+..+.|+...|.|||||+||||+.|++||++..+.+... .+.+.+
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~ehn 566 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIMEHN 566 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHHcc
Confidence 2334567899999999999999999999999999999999999999998875543221 111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP 789 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP 789 (862)
-.++...+.+...+....+...|.+|.
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 123344566778888889999999886
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=248.46 Aligned_cols=205 Identities=23% Similarity=0.386 Sum_probs=168.1
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeE
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 597 (862)
++...+.......||+|++|.|=+-++ .+|...|+|++... +.+..++.+.|+.+..+. .+|.+|.++|...+++..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 334444555567899999999988775 46888999987654 345567788888875554 799999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 598 ILVYDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
++.||.|+. +|+.+-.+ .....+++.-+-+|+..+.+||.|||+ +..+||||+||+|||++.+|++|+||||++-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999964 88776543 233458999999999999999999998 4579999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPALNV 731 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVyS~Gvvl~elltG~~p~~~ 731 (862)
...+ +-..+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 198 ~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 6543 223344568899999998853 4799999999999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=301.41 Aligned_cols=262 Identities=24% Similarity=0.294 Sum_probs=209.7
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEe
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 592 (862)
...+++....+|.+.++||+|+||.|..++.+. +..+|.|++.. .......-|..|-.+|..-+.+-|++|.-.+.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 456777888899999999999999999999865 67789998875 22344567999999999999999999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
++.++|+|||||+||+|..+|.+.. .+++....-++..|.-||.-||+.| +|||||||.|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999998776 4899999999999999999999776 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
-+-.+... ........+|||-|.+||++.. +.|...+|.||+||++|||+.|..||.... +++-
T Consensus 221 sClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveT---- 289 (1317)
T KOG0612|consen 221 SCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVET---- 289 (1317)
T ss_pred hHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHH----
Confidence 88665432 2333445679999999999853 578999999999999999999999996431 2111
Q ss_pred hccCccccccCCCCCCCCc--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNIT--DQCLRKFTETAEKCLSDQGIDRPS---MGDVLWNLEF 800 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~~p~~RPt---~~evl~~L~~ 800 (862)
...|++-.-.-.+| .+.+....+||++.+. +|..|.. +.|+..|..+
T Consensus 290 -----Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 290 -----YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred -----HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 11111111111112 2356778889988876 4667776 9999888654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=267.15 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=194.0
Q ss_pred CcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC--C-----hhhHHHHHHHHHHHHhccccceeeEEEEEe-ecCeE
Q 041565 527 NFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS--S-----EQGVHEFQTEIEMLSKLRHKHLVSLIGFCE-EDGEM 597 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~ 597 (862)
+|-..++||+|||+.|||+.+ ...+.||||+-... - ..-.+...+|.++-+.|.||.||++++|+. +....
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 455578899999999999984 44567899974322 1 112345678999999999999999999985 55678
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeecccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLS 674 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla 674 (862)
|-|+|||+|.+|+-+|..+.. +++++...|+.||+.||.||.+. +++|||-||||.||||-+ -|.+||.||||+
T Consensus 544 CTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 999999999999999876544 89999999999999999999986 589999999999999954 478999999999
Q ss_pred ccCCCCCCc-----cccccccCCCCCCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 041565 675 KTGPNLNQT-----HVSTMVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 675 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 745 (862)
+.+...... ..+....||..|++||++.- .+.+.|.||||.||++|..+.|+.||..+...... .+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lq--- 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQ--- 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hh---
Confidence 987654333 23344579999999998753 35788999999999999999999999765432211 11
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~ 796 (862)
...+.....-... ..+....+...+|++||+..-++|....++..
T Consensus 696 ----eNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ----ENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----hhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111110110 01123456788999999999999987776654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=255.42 Aligned_cols=270 Identities=24% Similarity=0.341 Sum_probs=196.9
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC-Chhh-HHHHHHHHHHHHhccccceeeEEEEEee--------cCe
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS-SEQG-VHEFQTEIEMLSKLRHKHLVSLIGFCEE--------DGE 596 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~ 596 (862)
|....+||+|.||.||+++.++ ++.||+|+.... .+.+ -....+|+++|..|+|+|++.++..|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3445689999999999999654 567888865432 2222 2346899999999999999999998843 245
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+++|+++|+. +|.-.|.... ..++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++|.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 8999999976 8888876542 34899999999999999999999665 99999999999999999999999999986
Q ss_pred CCCCCCc--cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 677 GPNLNQT--HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 677 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
....... ...+...-|..|.+||.+.+ ..++++.|||.-||+|.||.+|.+-+.++....+..++.-...-.....+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 4322111 11233445889999999877 67999999999999999999999988877655554443211100000000
Q ss_pred c--------ccc--CCCCCCCC--cHHHH------HHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 754 E--------DII--DPNLKGNI--TDQCL------RKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 754 ~--------~~~--d~~l~~~~--~~~~~------~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
. +-+ .|-..+.. -.+.. ...++++..++..||.+|+...+++.+-.+..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 0 000 11000000 00111 25688999999999999999999999888764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=265.96 Aligned_cols=205 Identities=25% Similarity=0.385 Sum_probs=172.1
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
-|...+.||-|+||.|.++... ....+|.|.++..+ +......+.|-.||.....+-||+|+-.+.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4777889999999999998743 35568999876543 3445667889999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC-----
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG----- 677 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~----- 677 (862)
|++||++-.+|-+.+- +.+....-++.++.+|+++.|..| +|||||||.|||||.+|.+||.||||+.-+
T Consensus 710 YIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999987654 778888888999999999999766 999999999999999999999999998521
Q ss_pred ----CCCCCc-------------------------------cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHH
Q 041565 678 ----PNLNQT-------------------------------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722 (862)
Q Consensus 678 ----~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~el 722 (862)
...+.. .......||..|+|||++....++..+|.||.||+|+||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 110000 001135699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccc
Q 041565 723 LCARPALNVNLPKE 736 (862)
Q Consensus 723 ltG~~p~~~~~~~~ 736 (862)
+.|++||-...+.+
T Consensus 865 ~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGE 878 (1034)
T ss_pred hhCCCCccCCCCCc
Confidence 99999997766544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=269.88 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=203.5
Q ss_pred ceeEeeeCcEEEEEEEEcCcc-EEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 531 SHVIGVGGFGKVYEGYIDGKT-KVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
.-.||-||||.|=....+... .+|+|+++. ......+....|-.+|.+.+.+.||+++..+.+.+..|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 456999999999988876653 367776543 3445566788999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|.|+..|+.++. ++.....-++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||.|+.... ...+
T Consensus 505 GElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KT 576 (732)
T KOG0614|consen 505 GELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKT 576 (732)
T ss_pred chhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc---CCce
Confidence 999999987654 888888899999999999999888 99999999999999999999999999998543 3345
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
-..+||+.|.|||.+.++..+.+.|.||||++++||++|.+||.+.++-.. +...+.. ++.+ .++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-----Yn~ILkG---id~i-------~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-----YNLILKG---IDKI-------EFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-----HHHHHhh---hhhh-------hcc
Confidence 568999999999999999999999999999999999999999987654322 1111111 1111 122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEFA 801 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~~ 801 (862)
....+...+++++.+..+|.+|.. +.||.+|-++.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 335566788999999999999985 88999888764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=277.43 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=188.1
Q ss_pred CcccceeEeeeCcEE-EEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGK-VYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
-|...+++|.|.-|+ ||+|..++. .||||++-... ..-..+|+..|+.- +|||||+.++.-.+.+..|++.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R-~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGR-EVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCc-eehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 356678899998865 799998764 89999976443 23457899999988 5999999999888899999999999
Q ss_pred CCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---C--CceEEeeccccccC
Q 041565 605 ANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---K--WEAKVSDFGLSKTG 677 (862)
Q Consensus 605 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~--~~~kl~DFGla~~~ 677 (862)
. .+|.+++... ......-...+.+..|+++||++||+-+ ||||||||.||||+- + ..++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 6999999874 2111222456788999999999999865 999999999999975 2 56899999999976
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
...... .......||-||+|||++....-+...||||+||++|+.++| ..||......+.. .......+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCccceee
Confidence 543221 123456799999999999998888899999999999999886 7898654322211 1111111111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
+ . ...++ ...+||.+|++++|..||++.+|+.|
T Consensus 735 L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 L-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred e-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 1 11122 67899999999999999999999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=245.11 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=195.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCC---CChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNP---SSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 599 (862)
-++|...++||+|+|.+|..++++. .+.+|+|.++. ...+.+.-...|-.+..+. +||.+|.|..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4578889999999999999998764 56788887653 2344455667777777776 69999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|.||+++|+|--++.++.+ |+++...-....|+.||.|||+.+ ||.||||..|||||..|.+||.|+|+++....
T Consensus 329 vieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999777765443 999999999999999999999988 99999999999999999999999999987433
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-cccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLP-KEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
....+...+||+.|.|||.+.+..|....|.|++||+|+||+.||.||+.-.. ....+-.++..+...+..
T Consensus 404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------ 475 (593)
T KOG0695|consen 404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------ 475 (593)
T ss_pred --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence 33445678999999999999999999999999999999999999999963221 111122233222111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRP 789 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP 789 (862)
++ ++...+.+...+++.-|.+||.+|.
T Consensus 476 --ir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 --IR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 1222345567788889999999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=236.05 Aligned_cols=210 Identities=36% Similarity=0.578 Sum_probs=182.7
Q ss_pred EeeeCcEEEEEEEEcC-ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHH
Q 041565 534 IGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLRE 611 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 611 (862)
||+|.+|.||++...+ +..+++|+....... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 778999998765432 35779999999999999999999999999899999999999999999
Q ss_pred HHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeeccccccCCCCCCcccccccc
Q 041565 612 HLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNLNQTHVSTMVK 690 (862)
Q Consensus 612 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 690 (862)
++.... ..+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 987653 34899999999999999999999876 999999999999999 89999999999976533211 122345
Q ss_pred CCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHH
Q 041565 691 GSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769 (862)
Q Consensus 691 gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 769 (862)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77889999999887 889999999999999998
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 770 LRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 770 ~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..+.+++.+|++.+|.+||++.+++++
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367889999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=247.75 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=197.3
Q ss_pred ccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee-----cCeEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-----DGEMILV 600 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV 600 (862)
+..+-||-|+||.||..++. +|+.||+|++..- +-..-+.+.+|+++|.-.+|.|++..++...- -.++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999998864 6789999987643 22345778999999999999999988776532 2467889
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
+|.|. .+|++.+-.. +.++-..+.-+..||++||.|||+.+ |.||||||.|.|++.+..+|||||||+|....
T Consensus 136 TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~- 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ- 208 (449)
T ss_pred HHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch-
Confidence 99995 4888877654 34888888899999999999999887 99999999999999999999999999997543
Q ss_pred CCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH--------HHhhhccC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW--------ALHCQRMG 751 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~ 751 (862)
++....+...-|..|.|||.+++ ..|+.+.||||.||++.||+..|..|....+.++..++.- +.....+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 33334444556888999999998 5699999999999999999999988877666665544321 11111122
Q ss_pred ccccccCCCCCC---------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 752 TIEDIIDPNLKG---------NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 752 ~~~~~~d~~l~~---------~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.-..++....+. ..+...-.+...+.+.++..+|+.|.+..+.+.++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 222222222211 011122234567788889999999999999887654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=243.45 Aligned_cols=132 Identities=27% Similarity=0.454 Sum_probs=113.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-----c---cceeeEEEEEee--
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-----H---KHLVSLIGFCEE-- 593 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~-- 593 (862)
.++|...++||.|.|++||++.+. +.+.||+|+.+.. +.-.+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 467899999999999999999865 4578999988743 333466789999999994 3 369999999864
Q ss_pred --cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 594 --DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 594 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
+.+.|||+|++ |-+|..+|....-+.++...+.+|++||+.||.|||.++ +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 46899999999 669999998877777999999999999999999999976 79999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=232.57 Aligned_cols=199 Identities=32% Similarity=0.460 Sum_probs=172.0
Q ss_pred cccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
|+..+.||+|++|.||++...+ +..+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4557899999999999999876 778999998765544 57889999999999999999999999999899999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+++|.+++...... +++..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 99999999765432 789999999999999999999876 999999999999999999999999998875432211 1
Q ss_pred cccccCCCCCCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPALNV 731 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~elltG~~p~~~ 731 (862)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334577889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-27 Score=238.49 Aligned_cols=257 Identities=22% Similarity=0.274 Sum_probs=192.4
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC--CChhhHHHHHHHHHHHHhccccceeeEEEEEee------cCeE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP--SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE------DGEM 597 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 597 (862)
+|.....+|.|.- .|..+.+. .++.||+|++.. .+....++..+|+.++..+.|+|+++++.++.- ..+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667788877 55555433 357899997643 234556778899999999999999999998853 3567
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++|||+|. ++|...+.- .++-..+..|..|+++|++|||+.+ |+||||||+||++..+..+||.|||+++..
T Consensus 97 y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 99999995 699998872 2778899999999999999999887 999999999999999999999999999873
Q ss_pred CCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc----
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI---- 753 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---- 753 (862)
.. ....+....|.-|.|||++-+..+.+..||||.||++.||++|+-.|.+...- ..|.+.....|..
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-----dQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-----DQWNKIIEQLGTPDPSF 240 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-----HHHHHHHHHhcCCCHHH
Confidence 22 23456677889999999999888999999999999999999999888654322 2232222111110
Q ss_pred -----------------------cccc-CCCCCC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 754 -----------------------EDII-DPNLKG--NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 754 -----------------------~~~~-d~~l~~--~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+.+ |..... +.+......+.+++.+||-.+|++|-+..++++|.-.
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 1111 111111 0111123456899999999999999999999988543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=224.30 Aligned_cols=252 Identities=19% Similarity=0.333 Sum_probs=187.3
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEE-EeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGF-CEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E~ 603 (862)
.|.+.+.||+|.||.+.++.++. .+.+++|.+.. .....++|.+|..---.| .|.||+.-++. +...+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 57778899999999999999876 56788887654 334568999998876666 58999987764 5666788999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc--CCCceEEeeccccccCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD--EKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~~kl~DFGla~~~~~~~ 681 (862)
++.|+|.+-+.. .++.+....+++.|++.||.|||+++ +||||||.+|||+- +.-++||||||+.+....
T Consensus 104 aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred CccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 999999988754 34888899999999999999999988 99999999999993 345799999999876432
Q ss_pred CccccccccCCCCCCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
......-+..|.+||.+... ...+.+|||.||++++.+++|+.||+.. ......+.+|.....+..
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~----- 246 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKN----- 246 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccC-----
Confidence 11223456789999987542 3567899999999999999999999833 223344555544333221
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP---SMGDVLWNLE 799 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP---t~~evl~~L~ 799 (862)
+++...+.. ..+.+.++.++-+.+++.+|- +.++....++
T Consensus 247 --~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 247 --PALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred --ccCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 122222211 345677888899999999994 4444444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-27 Score=256.69 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=201.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..+|....++|.|.||.|||++.. .+...|+|.++........-...|+-+++..+|+||+.++|.+.....++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 456777899999999999999965 4678899988776666667778899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|.+|+|.+.-+... ++++.++..+++..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.... .-
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--hh
Confidence 99999998766543 4999999999999999999999887 79999999999999999999999998865322 12
Q ss_pred cccccccCCCCCCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 684 HVSTMVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......||+.|||||+. ..+.|..++|||+.|+...|+-.-++|.....+-....+ ..... .+|.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTkS~----~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTKSG----FQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhccC----CCCC
Confidence 233456799999999986 357799999999999999999887777643332211111 11111 1111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
-.++ .....+.|-++++.|+..+|++||++..++.+
T Consensus 236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cccC-CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1111 11356678899999999999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=218.61 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=192.9
Q ss_pred ccCcccceeEeeeCcEEEEEEE-EcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeec--CeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEED--GEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV 600 (862)
..+|+..+++|+|.|+.||.|. ..+..+++||.+++.. .+.+.+|+.+|+.|+ ||||++|++...+. ....|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3468888999999999999998 4556789999988653 356789999999997 99999999987654 567899
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeeccccccCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTGPN 679 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~~~~ 679 (862)
+||+.+.+..... +.|+...+...+.++++||.|+|+.| |+|||+||.|+++|.. ..++|+|+|||.+.-.
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999887766543 23788889999999999999999988 9999999999999864 5799999999987532
Q ss_pred CCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-ccccc----------HHHHHHhh
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLP-KEQVS----------LADWALHC 747 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~-~~~~~----------l~~~~~~~ 747 (862)
.... .....+.-|..||.+.. +.++..-|+|||||+|.+|+..+.||-.... .++.- +..+...+
T Consensus 186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 2111 11234567889999865 6788899999999999999999999854332 12211 11111111
Q ss_pred h--ccCccccccCCCCCCCC-------c-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 Q--RMGTIEDIIDPNLKGNI-------T-DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 ~--~~~~~~~~~d~~l~~~~-------~-~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. -.....+++....+... . --..++..+++.+.|..|-.+|||+.|.+.+..+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 1 01111222211111100 0 01235678999999999999999999999887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=241.45 Aligned_cols=194 Identities=21% Similarity=0.370 Sum_probs=163.7
Q ss_pred CcccceeEeeeCcEEEEEEEEcCc-cEEEEEecCCCCh--------hhHHHHHHHHHHHHhcc---ccceeeEEEEEeec
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGK-TKVAIKRSNPSSE--------QGVHEFQTEIEMLSKLR---HKHLVSLIGFCEED 594 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 594 (862)
+|...+.+|+|+||.|+.+.++.. ..|+||.+....- ...-..-.|+.+|..|+ |+||++++++++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 477789999999999999998754 6788997654310 11122456999999997 99999999999999
Q ss_pred CeEEEEEEeCC-CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 595 GEMILVYDYMA-NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 595 ~~~~lV~E~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
+.++|+||--. +-+|.+++..+.+ +++.+..-|++|++.|+++||+++ |||||||-+||.++.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 99999999763 5589999987655 999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCC
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPAL 729 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~ 729 (862)
+.+... ......+||..|.|||++.+..| ...-|||++|++||.++....|+
T Consensus 717 aa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 717 AAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 876432 23345789999999999999776 56789999999999998777666
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=271.44 Aligned_cols=200 Identities=19% Similarity=0.238 Sum_probs=141.5
Q ss_pred hccc-cceeeEEEEE-------eecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEE
Q 041565 578 KLRH-KHLVSLIGFC-------EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649 (862)
Q Consensus 578 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 649 (862)
.++| .||++++++| .+...+++++|++ +++|.++|.... ..+++.+++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5888888877 2334577889988 569999997543 34999999999999999999999887 99
Q ss_pred eeCCCCCCeeccCC-------------------CceEEeeccccccCCCCCC--------------ccccccccCCCCCC
Q 041565 650 HRDVKTTNILLDEK-------------------WEAKVSDFGLSKTGPNLNQ--------------THVSTMVKGSFGYL 696 (862)
Q Consensus 650 HrDIkp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 696 (862)
||||||+||||+.. +.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999653 4456666666653211000 00011235788899
Q ss_pred ChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHH
Q 041565 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTET 776 (862)
Q Consensus 697 aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 776 (862)
|||++.+..++.++|||||||+||||++|.+|+.... ..+..+... .+.+... ....+...+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQIL-----LNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhhh-----hcCHHHHHH
Confidence 9999999999999999999999999999988764211 001111100 0111110 112345678
Q ss_pred HHHccccCCCCCCCHHHHHHHHHH
Q 041565 777 AEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 777 i~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+.+||+.+|.+||+|.|++++...
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHhCCCChhhCcChHHHhhchhh
Confidence 899999999999999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=235.33 Aligned_cols=272 Identities=22% Similarity=0.259 Sum_probs=202.2
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhcc------ccceeeEE
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR------HKHLVSLI 588 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~ 588 (862)
+.+.|+. ..+|.+.-..|+|-|++|.+|.... +..||||++... +...+.=+.|+++|++|. -.|+++|+
T Consensus 424 v~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 424 VRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred Eehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 3444444 4568777888999999999998653 679999998854 344556688999999995 34889999
Q ss_pred EEEeecCeEEEEEEeCCCCcHHHHHhcCC-CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ce
Q 041565 589 GFCEEDGEMILVYDYMANGTLREHLYKGD-KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EA 666 (862)
Q Consensus 589 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~ 666 (862)
-.|...+++|||+|-+ ..+|.+.|.+.+ +-+|....+..++.|+.-||..|...+ |+|.||||.|||+++.. .+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999988 459999998753 346889999999999999999999766 99999999999999764 57
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH-HHH-
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA-DWA- 744 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~- 744 (862)
||||||.|...... .. +...-+.-|.|||++.+..|+...|+||.||+||||.||+..|.+....+.+.+. +..
T Consensus 577 KLCDfGSA~~~~en---ei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASEN---EI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccccc---cc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 99999998764321 11 1222345699999999999999999999999999999999988776544332221 000
Q ss_pred ---HhhhccC---------------------------ccccccCC------CCCC--CCcH---HHHHHHHHHHHHcccc
Q 041565 745 ---LHCQRMG---------------------------TIEDIIDP------NLKG--NITD---QCLRKFTETAEKCLSD 783 (862)
Q Consensus 745 ---~~~~~~~---------------------------~~~~~~d~------~l~~--~~~~---~~~~~l~~li~~Cl~~ 783 (862)
....+.+ .+...+.| .|.+ .++. .....|.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 0000000 01111122 0111 1222 3456789999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 041565 784 QGIDRPSMGDVLWNL 798 (862)
Q Consensus 784 ~p~~RPt~~evl~~L 798 (862)
||++|.|..+.|+|.
T Consensus 733 dP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 733 DPEKRITVNQALKHP 747 (752)
T ss_pred ChhhcCCHHHHhcCC
Confidence 999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=227.28 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=195.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 598 (862)
-.+.|...++||+|.|++||++++.. ...||+|.+...+.. ....+|+++|..+. +.||+++.++...++..+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34567788999999999999998643 467999998765443 56889999999994 999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeeccccccC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTG 677 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~~ 677 (862)
+|+||++.....+++.. ++..++...++.++.||+++|.+| ||||||||+|+|.+.. +.-.|.|||||...
T Consensus 112 ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999998888754 778899999999999999999888 9999999999999854 66899999999610
Q ss_pred CC--------------CCC----------------------------ccccccccCCCCCCChhhhhc-CCCCchhHHHH
Q 041565 678 PN--------------LNQ----------------------------THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYS 714 (862)
Q Consensus 678 ~~--------------~~~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS 714 (862)
.. ... ........||+||.|||++.. ...+.+.||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 00 000 000112359999999999865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHhh---------hccCc--c---------ccc------cC-CC-------
Q 041565 715 FGVVLFEVLCARPALNVNLPKEQVSLADWALHC---------QRMGT--I---------EDI------ID-PN------- 760 (862)
Q Consensus 715 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~~--~---------~~~------~d-~~------- 760 (862)
.||+++-+++++.||-.... +...+.+-+... ...+. + .+. ++ ..
T Consensus 264 ~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred ccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999854321 111121111000 00011 0 000 00 00
Q ss_pred -CC-CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 761 -LK-GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 761 -l~-~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+. ....+..+..+.+++.+|+..+|.+|.|++|.+++.-
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 00 0111223346789999999999999999999997743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=211.64 Aligned_cols=168 Identities=23% Similarity=0.213 Sum_probs=126.9
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
|+|.+++.... ..++|.+++.|+.|+++||+|||+.+ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 78999997643 34999999999999999999999754 999999999999999 9998864321
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .+..+...... . ++.. ....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~-~------~~~~-~~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA-D------DPRD-RSNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc-C------Cccc-cccH
Confidence 12588999999999999999999999999999999999999864322111 11111111000 0 0000 0111
Q ss_pred HHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 767 DQCLR--KFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 767 ~~~~~--~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..... .+.+++.+||+.+|.+||++.|+++++....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 22333 6899999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-22 Score=216.28 Aligned_cols=262 Identities=20% Similarity=0.234 Sum_probs=196.2
Q ss_pred CcccceeEeeeCcEEEEEEEEcCc--cEEEEEecCCCChhhHHHHHHHHHHHHhccc----cceeeEEEEE-eecCeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGK--TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH----KHLVSLIGFC-EEDGEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 599 (862)
+|...++||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997654 4788887655433322367889999998873 5888888888 47778899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-----CceEEeecccc
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-----WEAKVSDFGLS 674 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~~kl~DFGla 674 (862)
||+.+ +.+|.++........++....++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 779999886655566999999999999999999999888 9999999999999754 46999999999
Q ss_pred ccCC--CCC-C----ccc-cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 675 KTGP--NLN-Q----THV-STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 675 ~~~~--~~~-~----~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
+... ... . ... .....||..|+++..+.+...+.+.|+||++.++.|++.|..||......... ......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~~~~~ 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SKFEKD 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HHHHHH
Confidence 8321 111 1 111 23456999999999999999999999999999999999999999654322111 111110
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
. .. ..... .....+..+.++...+-..+..++|....+...++....-
T Consensus 253 ~-~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 P-RK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred h-hh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 00 00000 1112345566777777778999999999999888777543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=218.13 Aligned_cols=167 Identities=23% Similarity=0.199 Sum_probs=128.3
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc--CccEEEEEecCCC-----ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID--GKTKVAIKRSNPS-----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
....+|...++||+|+||+||+|.++ ++..+|||++... .....+.|.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567888999999999999999865 4667899986532 22335679999999999999999853322 24
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCC-CCCCeeccCCCceEEeecccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV-KTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~~kl~DFGla 674 (862)
..++||||+++++|.. + .. .. ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+|||++
T Consensus 92 ~~~LVmE~~~G~~L~~-~-~~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A-RP----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHH-h-Cc----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 6799999999999963 2 11 11 1467899999999999877 999999 999999999999999999999
Q ss_pred ccCCCCCCccc------cccccCCCCCCChhhhhcC
Q 041565 675 KTGPNLNQTHV------STMVKGSFGYLDPEYFRRQ 704 (862)
Q Consensus 675 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 704 (862)
+.......... -+...+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 86543221111 1345688899999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=202.31 Aligned_cols=246 Identities=20% Similarity=0.312 Sum_probs=191.2
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
.+|.+...|..|+|++++.. +++|++... .....++|..|.-.|+...||||++++|.|.....+.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35778889999999998764 555655432 333457899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (862)
...|+....-..+..+..+++.++|+||+|||+.. +-|.---|.+..|++|++.+++|.- +-+++. ......
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs------fqe~gr 346 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEVGR 346 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee------eecccc
Confidence 99999877666788899999999999999999875 3344557899999999999988741 212221 111122
Q ss_pred cCCCCCCChhhhhcCCCC---chhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCc
Q 041565 690 KGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766 (862)
Q Consensus 690 ~gt~~y~aPE~~~~~~~s---~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 766 (862)
.-.+.||+||.++....+ .++|+|||.+++|||.|...||..-.+-+... .+.-..++..++
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv~ip 411 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRVHIP 411 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccccccCC
Confidence 346789999999876543 47999999999999999999996543333211 111123444556
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 767 ~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+..+..+.+++.-|+..||.+||.+..|+-.||..
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 66778899999999999999999999999888865
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=192.72 Aligned_cols=262 Identities=18% Similarity=0.202 Sum_probs=192.2
Q ss_pred CcccceeEeeeCcEEEEEEE-EcCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeC
Q 041565 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+|.++++||+|.||..+.|+ +-++..||||.-...++ .-++..|.+..+.| ..++|...+-|..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 58889999999999999998 45678999997554332 35677888888888 4789999888878888889999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-----CceEEeeccccccCCC
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-----WEAKVSDFGLSKTGPN 679 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~~kl~DFGla~~~~~ 679 (862)
|-+|.++..-. ...++.+.++.||+|+..-++|+|++. +|.|||||+|+||... ..+.|+|||+|+...+
T Consensus 107 -GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 67898876533 344999999999999999999999987 9999999999999743 3589999999987654
Q ss_pred CCC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 680 LNQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 680 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
... ........||.+||+-.-..+.+.+.+.|+-|||-|++..|.|..||.+-.......-.+-.....+...+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 322 122345679999999999999999999999999999999999999998754332211100000001111111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
+ |... .+.++..-+.-.-..+-.+-|...-+..-+..++..
T Consensus 262 ~-----Lc~g----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 262 V-----LCEG----FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred H-----HHhc----CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 1 1122 334455544444455667778877766666655543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-19 Score=197.03 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=196.3
Q ss_pred cccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh---hHHHHHHHHHHHHhcccc-ceeeEEEEEeecCeEEEEEEe
Q 041565 528 FSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ---GVHEFQTEIEMLSKLRHK-HLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 603 (862)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999977 67888887654322 467899999999999988 799999999777778999999
Q ss_pred CCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCCCC
Q 041565 604 MANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~ 681 (862)
+.+++|.+++..... ..+.......++.|++.++.|+|+.+ ++||||||+||+++... .+|++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765432 24889999999999999999999887 99999999999999988 79999999998543322
Q ss_pred Ccc----ccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHhhhccCcc
Q 041565 682 QTH----VSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPK-EQVSLADWALHCQRMGTI 753 (862)
Q Consensus 682 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 753 (862)
... ......|+..|++||.+.+ ...+...|+||+|++++++++|..|+...... ......+........ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 211 2355679999999999988 67899999999999999999999996544321 001111111111000 00
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
. ..............+.+++..|+..+|..|.++.+....
T Consensus 236 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 A----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 001100001223567899999999999999999888765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=185.29 Aligned_cols=265 Identities=19% Similarity=0.206 Sum_probs=196.7
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEE-EcCccEEEEEecCCCChhhHHHHHHHHHHHHhccc-cceeeEEEEEeec
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHLVSLIGFCEED 594 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~ 594 (862)
+++++..+ ++|...++||.|+||.+|.|. ..+|..||||.-.... ...++..|.++.+.|+| ..|..+..|..+.
T Consensus 7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 44454443 468889999999999999998 5678899999865433 23567889999999975 5777778888888
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDF 671 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DF 671 (862)
..-.+|||.+ +.+|.+++.-- ...++.++++-++-|++.-++|+|..+ +|||||||.|+|..-+ ..+.++||
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred ccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEec
Confidence 8889999998 67898877533 334899999999999999999999887 9999999999999644 45899999
Q ss_pred cccccCCCCCC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 672 GLSKTGPNLNQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 672 Gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
||++...+... ....+...||.+|.+-....+.+.+.+.|+-|+|.+|..+.-|..||++-.......-.+...+
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 99986543322 1223456799999999999988999999999999999999999999987654333221111111
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
......+ ..|+.. .+.++.-.+..|-..--++-|...-+.+..
T Consensus 239 kK~s~~i-----e~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 239 KKMSTPI-----EVLCKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred hhcCCCH-----HHHhCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 1111111 112222 345677788888888888888765544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=221.16 Aligned_cols=257 Identities=20% Similarity=0.218 Sum_probs=187.4
Q ss_pred cceeEeeeCcEEEEEEEEcC-ccEEEEEecC----C-CCh-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 530 ESHVIGVGGFGKVYEGYIDG-KTKVAIKRSN----P-SSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
..+++|.|.+|.|+...... ....+.|... . ... +....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 35789999999777766432 2223333221 1 111 112226678888888999999888777766666666699
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++ +|..++..... ++..++..+++|+..|+.|||+.+ |.|||||++|+++..++.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 99999876533 888999999999999999999888 99999999999999999999999999976543323
Q ss_pred c--cccccccCCCCCCChhhhhcCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 683 T--HVSTMVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 683 ~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. .......|+..|+|||.+.+..|.. ..||||.|+++..|++|+.||......+.... .... ..+.-..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~~-~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNNY-SDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhcc-ccccccc
Confidence 2 5556778999999999999999876 58999999999999999999976544333210 0000 0000000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.-...+....+.....++.++|+.+|.+|-|+.+|++.-|.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 00011222455667889999999999999999999976554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=201.02 Aligned_cols=219 Identities=24% Similarity=0.400 Sum_probs=165.9
Q ss_pred HHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCC
Q 041565 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKT 655 (862)
Q Consensus 576 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp 655 (862)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+.... ..++|.-...+.++|++||+|||... --.|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 457899999999999999999999999999999999998744 34999999999999999999999753 239999999
Q ss_pred CCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-------CCCchhHHHHHHHHHHHHHhCCCC
Q 041565 656 TNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLCARPA 728 (862)
Q Consensus 656 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVyS~Gvvl~elltG~~p 728 (862)
+|+++|..+.+||+|||+....................-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998775421111111222234569999998763 257789999999999999999999
Q ss_pred CCCCCcccc-ccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 729 LNVNLPKEQ-VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 729 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
|........ ..++.++.. .....+.|.+... .+....+..++..||..+|.+||++.+|-..++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 976433222 222222221 1111122222211 13445789999999999999999999999988887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=181.13 Aligned_cols=139 Identities=17% Similarity=0.165 Sum_probs=107.1
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh--h-------HHH-----------------HHHHHHHHHhccccce
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ--G-------VHE-----------------FQTEIEMLSKLRHKHL 584 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 584 (862)
...||+|+||.||+|...+|..||||.++..... . ... ...|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888889999987643211 0 112 2349999999988776
Q ss_pred eeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHh-hcCCcccEEeeCCCCCCeeccCC
Q 041565 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL-HTGARYTIIHRDVKTTNILLDEK 663 (862)
Q Consensus 585 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp~NILl~~~ 663 (862)
.....+.. ...++||||+++++|...+... ..+++.+.++++.|++.+|.+| |+.+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333222 2238999999988776553332 2488999999999999999999 6766 99999999999998 4
Q ss_pred CceEEeeccccccC
Q 041565 664 WEAKVSDFGLSKTG 677 (862)
Q Consensus 664 ~~~kl~DFGla~~~ 677 (862)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=183.00 Aligned_cols=171 Identities=14% Similarity=0.130 Sum_probs=131.8
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh---hhHHH------HHHHHHHHHhccccceeeEEEEEeec
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE---QGVHE------FQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
-.++|...++||.|+||.||.... ++..+|+|.+..... ..... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999665 456899998865422 22222 67999999999999999998875432
Q ss_pred --------CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 595 --------GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 595 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
+..++||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||++++++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35799999999999988732 222 34569999999999887 99999999999999988 9
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ell 723 (862)
+|+|||..+...... .. ..+.....+..++|+|+||+.+.-+.
T Consensus 174 ~liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999876542111 00 11444555678999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=174.81 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=109.6
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh--------------------------hHHHHHHHHHHHHhccccce
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ--------------------------GVHEFQTEIEMLSKLRHKHL 584 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 584 (862)
...||+|+||.||+|...+|..||||.++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878899999987653210 01224578999999999987
Q ss_pred eeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCC
Q 041565 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEK 663 (862)
Q Consensus 585 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~ 663 (862)
.....+... ..+|||||++++++....... ..++..+..+++.|++.+|.+||+ .+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 544443332 248999999987654432222 237788999999999999999998 76 99999999999999 7
Q ss_pred CceEEeeccccccCC
Q 041565 664 WEAKVSDFGLSKTGP 678 (862)
Q Consensus 664 ~~~kl~DFGla~~~~ 678 (862)
+.++|+|||+++...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=167.66 Aligned_cols=185 Identities=18% Similarity=0.147 Sum_probs=139.1
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh----hHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEe
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ----GVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.....|++|+||+||.+.. ++.+++.+.+.....- ....|.+|+++|++|+ |+++.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 5567877776654321 1235889999999995 5889999886 346899999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCC-CCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV-KTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
+.+.+|.+.+.. ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654321 12457889999999999887 999999 79999999999999999999985432211
Q ss_pred c----c------c-cccccCCCCCCChhhhhcC-CCC-chhHHHHHHHHHHHHHhCCCCCC
Q 041565 683 T----H------V-STMVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLFEVLCARPALN 730 (862)
Q Consensus 683 ~----~------~-~~~~~gt~~y~aPE~~~~~-~~s-~ksDVyS~Gvvl~elltG~~p~~ 730 (862)
. . . ......++.|++|+...-- ..+ ...+.++-|..+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 0 1112367889999875432 334 67899999999999999997764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-19 Score=207.42 Aligned_cols=249 Identities=20% Similarity=0.206 Sum_probs=178.1
Q ss_pred CcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC-ChhhHHHHHHHHHH--HHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS-SEQGVHEFQTEIEM--LSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++...+.||++.|=+|.+++.+.|. |+||.+-.. ..-..+.|.++++- ...++|||.+++.-+-..+..-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998885 888875433 23344455544433 4455899999998877777777888899
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc--CCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~--~~~~~ 681 (862)
..+ +|.+.|..+. -+...+..-|+.|++.||.-+|..+ |+|+|||.+||||+.-.-+.|+||.--+- .+..+
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 855 8998886543 3778888999999999999999877 99999999999999988899999987653 23222
Q ss_pred Ccc---ccccccCCCCCCChhhhhcC-----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHh
Q 041565 682 QTH---VSTMVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 682 ~~~---~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 746 (862)
... .....+.-.+|.|||.+... ..+++.||||+||++.||++ |+++|+.. .|..+...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~ 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc
Confidence 211 11222334579999987431 26789999999999999976 68888522 11111110
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
. ....+.. ...+ +...++.++..|++.+|.+|.++.+.++.-
T Consensus 251 ~--~~~~e~~-----Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 251 N--ADDPEQL-----LEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred C--ccCHHHH-----HHhC---cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 0 0000000 0111 112578999999999999999999999883
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=173.85 Aligned_cols=232 Identities=19% Similarity=0.299 Sum_probs=148.8
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCC---CChhhHHHHHHHHHHHHhcc----------ccceeeEEEEE-
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLR----------HKHLVSLIGFC- 591 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~----------H~niv~l~g~~- 591 (862)
.+...+.||.|+++.||.+++.. ++.+|+|.... ......+++++|.-....+. |-.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34457899999999999999875 78899996432 23445677777775555532 22222222221
Q ss_pred --------eec---C-----eEEEEEEeCCCCcHHHHHh---cCCC--CCCChhhHHHHHHHHHHHHHHhhcCCcccEEe
Q 041565 592 --------EED---G-----EMILVYDYMANGTLREHLY---KGDK--PGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650 (862)
Q Consensus 592 --------~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 650 (862)
... . ..+++|+-+ -++|.+++. .... ..+....++.+..|+.+.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 1 236788888 468888754 2221 22455667788899999999999888 999
Q ss_pred eCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC--------CCCchhHHHHHHHHHHHH
Q 041565 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ--------QLTEKSDVYSFGVVLFEV 722 (862)
Q Consensus 651 rDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDVyS~Gvvl~el 722 (862)
+||||+|++++.+|.++|+||+....... .... ...+..|.+||..... .++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999987765321 1111 3355789999987542 578899999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCC
Q 041565 723 LCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDR 788 (862)
Q Consensus 723 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~R 788 (862)
.||+.||+......... | . ..... +.++.+..++..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~---~----------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE---W----------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG---G----------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc---c----------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999997653322211 1 0 01112 467789999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=167.69 Aligned_cols=137 Identities=21% Similarity=0.212 Sum_probs=106.4
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhc-----cccceeeEEEEEeecC---e-EEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-----RHKHLVSLIGFCEEDG---E-MIL 599 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 599 (862)
...+.||+|+||.||. +......+||+.........+++.+|+++++.+ .||||++++|++..+. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467999999999996 333333478887655444567899999999999 5799999999998763 3 347
Q ss_pred EEEe--CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHH-HHhhcCCcccEEeeCCCCCCeeccC----CCceEEeecc
Q 041565 600 VYDY--MANGTLREHLYKGDKPGLPWKQRLEICIGAARGL-HYLHTGARYTIIHRDVKTTNILLDE----KWEAKVSDFG 672 (862)
Q Consensus 600 V~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDIkp~NILl~~----~~~~kl~DFG 672 (862)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999653 25554 35678888787 9999887 999999999999974 3479999965
Q ss_pred ccc
Q 041565 673 LSK 675 (862)
Q Consensus 673 la~ 675 (862)
.++
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=194.11 Aligned_cols=254 Identities=20% Similarity=0.208 Sum_probs=182.6
Q ss_pred HHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc---ccceeeEEEEEeecC
Q 041565 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR---HKHLVSLIGFCEEDG 595 (862)
Q Consensus 519 ~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~ 595 (862)
.+++.....|.+.+.||+|+||+||+|...+|..||+|.-+..+.- +|.--.+++.+|+ -+.|..+..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 4555667788899999999999999999888999999987766532 2333334444454 233444444455567
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-------CCCceEE
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-------EKWEAKV 668 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-------~~~~~kl 668 (862)
..+||+||.+.|+|.+++... ..++|..+..++.|+++.+++||..+ |||+||||.|+||. +...++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 789999999999999999733 34999999999999999999999877 99999999999994 2345899
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
+|||-+-.+.-..........++|-++-.+|+..+...+...|.|.+.-+++-||.|+.-- .
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~ 904 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------V 904 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------h
Confidence 9999885433222233455677889999999999999999999999999999999997311 0
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+ -...++.+++..+..+...+ +...+|..+-..=|...++...++..+
T Consensus 905 ~~g-~~~~~~~~~~Ry~~~~~W~~---~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 905 KNG-SSWMVKTNFPRYWKRDMWNK---FFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred cCC-cceeccccchhhhhHHHHHH---HHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 011 11112233333333344444 444445555555577777777777665
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.4e-18 Score=189.62 Aligned_cols=225 Identities=24% Similarity=0.285 Sum_probs=170.5
Q ss_pred eEeeeCcEEEEEEE----EcCccEEEEEecCCCChh--hHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEeCC
Q 041565 533 VIGVGGFGKVYEGY----IDGKTKVAIKRSNPSSEQ--GVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|+|.||.|+... .+.+..+|.|.+...... .......|..++...+ ||.+|++.-.+..++..+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998654 334556777765543211 1114556788888887 9999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|.|...+..... +...........++-+++++|+.+ ++|||+|++||+++.+|.+|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 9999888765443 677777778888999999999776 9999999999999999999999999998743211
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
..+||..|||||.+. ......|.||||++++||++|..||.. +.. . .+ ++.+-..
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~------~---------~I--l~~~~~~ 206 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTM------K---------RI--LKAELEM 206 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHH------H---------HH--hhhccCC
Confidence 117999999999998 556789999999999999999999965 111 0 00 0111223
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSM 791 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~ 791 (862)
+.+......+++..++..+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 44556666777777888888777643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-17 Score=181.66 Aligned_cols=175 Identities=26% Similarity=0.388 Sum_probs=131.0
Q ss_pred CeEEEEEEeCCCCcHHHHHhcC-CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 595 GEMILVYDYMANGTLREHLYKG-DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
..+++.|++|...+|.+||.++ .....++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999754 33457889999999999999999 55 89999999999999999999999999
Q ss_pred cccCCCCC----CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHhhh
Q 041565 674 SKTGPNLN----QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 674 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
........ .....+...||..||+||.+.+..|+.|+||||||++|+||+.- ...+ .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~------------------e 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF------------------E 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH------------------H
Confidence 87654432 12234556799999999999999999999999999999999862 1111 1
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDV 794 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~ev 794 (862)
+.+.+.++-|..+.+.+..+.+ +-..++.+++.+.|.+||++.++
T Consensus 465 r~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 465 RIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 1122222222222222212222 22578999999999999954444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=161.72 Aligned_cols=134 Identities=23% Similarity=0.347 Sum_probs=112.5
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCCh--------hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE--------QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 445788887543221 1234678899999999999998877777777788999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+++++|.+++.... + ++..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 88899999999999999877 99999999999999 78899999998875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=157.76 Aligned_cols=145 Identities=20% Similarity=0.157 Sum_probs=113.0
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh----------------------hhHHHHHHHHHH
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE----------------------QGVHEFQTEIEM 575 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~ 575 (862)
+.++......|...+.||+|+||.||++...++..||||+...... .....+..|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 3455555555777899999999999999988889999997543210 011236778999
Q ss_pred HHhccccc--eeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCC
Q 041565 576 LSKLRHKH--LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653 (862)
Q Consensus 576 l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI 653 (862)
+.++.|++ +...++. ...++||||+++++|.+.... .....++.++++++.++|+.+ ++||||
T Consensus 87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 99998874 4555543 345899999999998765321 345678999999999999876 999999
Q ss_pred CCCCeeccCCCceEEeeccccccC
Q 041565 654 KTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 654 kp~NILl~~~~~~kl~DFGla~~~ 677 (862)
||+||++++++.++|+|||++...
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=183.07 Aligned_cols=138 Identities=22% Similarity=0.323 Sum_probs=112.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC-------ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS-------SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
...|...++||+|+||.||+|.+.+...++.++.... .....+++.+|++++++++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445667899999999999998766543332222111 112245688999999999999999888888777788
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 35679999999999999877 9999999999999 677999999999986
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=161.63 Aligned_cols=149 Identities=15% Similarity=0.132 Sum_probs=113.1
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEE--EcCccEEEEEecCCCChh------------------------hHHHHHHHH
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQ------------------------GVHEFQTEI 573 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~ 573 (862)
.+.....-|+..+.||+|+||.||+|. ..+|..||+|........ ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 344444457888999999999999998 567889999987643210 112356899
Q ss_pred HHHHhccccc--eeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEee
Q 041565 574 EMLSKLRHKH--LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651 (862)
Q Consensus 574 ~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 651 (862)
+++.++.+.. +.+++++ ...++||||+++++|...+.... .+...+...++.|++.+|++||+.+ .++||
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 9999997633 4455543 23489999999988876543322 2556677899999999999999754 39999
Q ss_pred CCCCCCeeccCCCceEEeeccccccC
Q 041565 652 DVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 652 DIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
||||+||+++ ++.++|+|||++...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 789999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.3e-16 Score=157.04 Aligned_cols=130 Identities=25% Similarity=0.369 Sum_probs=105.7
Q ss_pred eEeeeCcEEEEEEEEcCccEEEEEecCCCC--------hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSS--------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.||+|+||.||+|... +..+++|...... .....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 4678888754321 112356788999999999987665555556666778999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
++++|.+.+..... .++.+++++|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754211 78999999999999877 99999999999999 78999999999876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-16 Score=153.89 Aligned_cols=134 Identities=25% Similarity=0.388 Sum_probs=83.0
Q ss_pred eEEeecCccccCCCCCCCCcccccCCCCceecCC-CccccccCCCceeecCCCCCccccchHHHHHhhhcCCCCCcccce
Q 041565 221 MYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAA-FGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRNY 299 (862)
Q Consensus 221 ~~R~n~G~~~v~~~~dd~~~R~W~~d~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~ 299 (862)
++|+|+||+.. +|..+..|++|..|..+.. +........... .......+..+..+|||+|....
T Consensus 2 ~~~IN~Gg~~~----~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~--~~~~~i~~t~d~~Lyqt~R~g~~-------- 67 (174)
T PF11721_consen 2 VLRINAGGPAY----TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTS--STNSSIPGTTDDPLYQTERYGPS-------- 67 (174)
T ss_dssp EEEEEETSSSE----EETTTEEE-SSSSSTTSS-----------SST--TS--TTS-HHHHHTTT-----SS--------
T ss_pred EEEEECCCCcc----cCCCCCEEcCCCCCCCCCcccccccccccccc--cccccccCCCchhhhHhhcCCCC--------
Confidence 57999999865 4558999999999866543 100000000000 01223336777899999998211
Q ss_pred eeEEEEecCCCceEEEEEeeeeeeeec------cCcEEEEEEEcCccccccCchhcccccCCcceEEEE-EEEEcC
Q 041565 300 NLTWIFQIDANFTYIVRFHFCEILLTK------INQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDY-AIYAED 368 (862)
Q Consensus 300 ~l~~~~~~~~~~~y~v~lhFae~~~~~------~~~R~F~i~ing~~~~~~~di~~~~~~~~~p~y~~~-~v~v~~ 368 (862)
+|+|.+|+.++-+|.|+|||||+.... .|+|+|||+|||+++.++|||.+.+|+...+.++.+ .+.++.
T Consensus 68 ~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~d 143 (174)
T PF11721_consen 68 SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTD 143 (174)
T ss_dssp SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEET
T ss_pred ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeC
Confidence 499999944444899999999999766 999999999999999999999999998887888877 677755
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.1e-15 Score=154.45 Aligned_cols=183 Identities=20% Similarity=0.210 Sum_probs=127.8
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec--cCCC--ceEEee
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL--DEKW--EAKVSD 670 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl--~~~~--~~kl~D 670 (862)
..+|+||.-.+ .+|+++|..+. .+.....-|+.|+++|+.|||.++ |.|||+|+.|||| |+|. .+.|+|
T Consensus 316 ~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 316 KTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred ceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcc
Confidence 46799998875 49999997654 556667778999999999999877 9999999999999 3443 478999
Q ss_pred ccccccCCC----CCCccccccccCCCCCCChhhhhcCC------CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH
Q 041565 671 FGLSKTGPN----LNQTHVSTMVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL 740 (862)
Q Consensus 671 FGla~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l 740 (862)
||.+-.... ...........|...-||||+..... --.|+|.|+.|-+.||+++...||.... +...+.
T Consensus 389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~ 467 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDT 467 (598)
T ss_pred cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheech
Confidence 997643211 11111122334777899999976422 1258999999999999999999996521 111111
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. +++.. ....++.++..+.+++...|+.+|.+|++..-....|.
T Consensus 468 r~-----Yqe~q---------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 468 RT-----YQESQ---------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hh-----hhhhh---------CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11 11111 11234456778899999999999999998665554444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.8e-15 Score=174.81 Aligned_cols=209 Identities=23% Similarity=0.317 Sum_probs=142.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..+|...+.|..|+||.||..+++. .+++|+|+-+ .+- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee------------------
Confidence 4568888999999999999998764 4567775322 111 0110 22222233332
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC-
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ- 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~- 682 (862)
|+-...+...+. ++.. ++.+++|||+.+ |+|||+||.|.+|+.-|.+|+.|||+.+.......
T Consensus 136 ---gDc~tllk~~g~--lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333333433222 3322 278899999877 99999999999999999999999999875321111
Q ss_pred ------------ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc
Q 041565 683 ------------THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 683 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
......++||+.|.|||++..+.|....|+|++|+++||.+-|+.||.++.+++....+ +.. .
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v--isd---~ 274 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISD---D 274 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh--hhh---h
Confidence 01123468999999999999999999999999999999999999999888666532110 110 0
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP 789 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP 789 (862)
. ...+..+....+..+++.+.|+.+|..|-
T Consensus 275 i---------~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 I---------EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred c---------cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0 01111223456788999999999999996
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.8e-14 Score=137.85 Aligned_cols=134 Identities=19% Similarity=0.207 Sum_probs=114.6
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccc--cceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH--KHLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
.+.||+|.++.||++..++ ..+++|....... ..++..|+.+++.++| .++.+++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4689999999999999766 5799998765433 4678999999999987 589999998888888999999998876
Q ss_pred HHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 609 LREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 609 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||+++.
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 5567788999999999999986545699999999999999989999999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.8e-14 Score=142.43 Aligned_cols=136 Identities=18% Similarity=0.203 Sum_probs=97.3
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh--hHHH----------------------HHHHHHHHHhccccc--e
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ--GVHE----------------------FQTEIEMLSKLRHKH--L 584 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 584 (862)
.+.||+|+||.||+|...++..||||........ .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999887889999986543211 1111 135666666665443 4
Q ss_pred eeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCC
Q 041565 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEK 663 (862)
Q Consensus 585 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~ 663 (862)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 445543 245899999998543221111110 11 5678899999999999998 65 99999999999999 8
Q ss_pred CceEEeeccccccC
Q 041565 664 WEAKVSDFGLSKTG 677 (862)
Q Consensus 664 ~~~kl~DFGla~~~ 677 (862)
+.++|+|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 89999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=145.15 Aligned_cols=135 Identities=17% Similarity=0.181 Sum_probs=105.2
Q ss_pred ceeEe-eeCcEEEEEEEEcCccEEEEEecCCCC-------------hhhHHHHHHHHHHHHhccccce--eeEEEEEeec
Q 041565 531 SHVIG-VGGFGKVYEGYIDGKTKVAIKRSNPSS-------------EQGVHEFQTEIEMLSKLRHKHL--VSLIGFCEED 594 (862)
Q Consensus 531 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 594 (862)
...|| .||.|+||+....+ ..++||+..... ......+.+|++++.+|+|+++ ++.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~-~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPG-VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeCC-ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 89999999998764 578888764311 1223567889999999998875 6777775443
Q ss_pred C----eEEEEEEeCCC-CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 595 G----EMILVYDYMAN-GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 595 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
. ..++|||++++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6899888542 24443 3678999999999887 9999999999999998899999
Q ss_pred ecccccc
Q 041565 670 DFGLSKT 676 (862)
Q Consensus 670 DFGla~~ 676 (862)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-14 Score=167.19 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=189.1
Q ss_pred CcccceeEeeeCcEEEEEEEEcC--ccEEEEEecCCCC--hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 601 (862)
.|...+.||+|.|+.|-...... ...+|+|...... .........|..+-..+. |+|++++++...+.+..++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34455679999999998776543 3456777655433 233344455777777776 999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhh-cCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH-TGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPN 679 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~ 679 (862)
||..++++.+.+........+....-....|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999988873222223666777889999999999999 666 99999999999999999 999999999987655
Q ss_pred -CCCccccccccC-CCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 680 -LNQTHVSTMVKG-SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 680 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|.... +..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~~--- 250 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GRF--- 250 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---ccc---
Confidence 333333344567 9999999998884 456789999999999999999999976554332 222232221 000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
...... .......++..+++..+|..|.+.+++...-+.
T Consensus 251 -~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~ 289 (601)
T KOG0590|consen 251 -TQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKLDNWL 289 (601)
T ss_pred -ccCccc----cCChhhhhcccccccCCchhccccccccccccc
Confidence 001111 123446777888888999999999888755443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.2e-12 Score=146.88 Aligned_cols=140 Identities=19% Similarity=0.244 Sum_probs=100.1
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhH----------------------------------------HHHH
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGV----------------------------------------HEFQ 570 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 570 (862)
.+.||.|++|.||+|++++|+.||||..++...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999998766432110 0245
Q ss_pred HHHHHHHhcc----ccceeeEEEEE-eecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHH-HHHHhhcCC
Q 041565 571 TEIEMLSKLR----HKHLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR-GLHYLHTGA 644 (862)
Q Consensus 571 ~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 644 (862)
.|++.+.+++ |.+-+.+-..+ ...+..+|||||++|++|.+....... .. .+.+++..+++ .+..+|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 5666666653 22222222222 223457999999999999887653211 12 34567777766 467888776
Q ss_pred cccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 645 ~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++|+|+||.||++++++.++++|||++...
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.9e-13 Score=130.49 Aligned_cols=152 Identities=26% Similarity=0.352 Sum_probs=90.2
Q ss_pred EEEecCCCCCCCCCCCCeeecCCccccCCC-Ccce-------eeccCCCCCCCCCCccceeeeeecCceEEEEcCCCCeE
Q 041565 36 YVLACGASSDGTDSNDRKWTSDSKFLTNSG-NSIT-------ATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRF 107 (862)
Q Consensus 36 ~~I~CG~~~~~~~~~~~~w~~D~~~~~g~~-~~~~-------~~~~~~~~~~~~~~~~~t~R~F~~~~~~~y~~~~~~~y 107 (862)
++||||+..+ ++..|+.|.+|..|.+|.. -... ......-....+...|+|.|+=+..++|.+|+.++|.|
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y 81 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTY 81 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEE
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEE
Confidence 7899999877 6678999999999985544 0000 00000001122345699999966678999997788999
Q ss_pred EEEEEEecCCCCC----CCCCCceeEEEeCceEEEecccchhhhhhcccccEEEEEEEccCCCCcEEEEEecCCC-----
Q 041565 108 WLRLHFYPASYGN----LDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSD----- 178 (862)
Q Consensus 108 lvR~~F~~~~yg~----~d~~~~~~~v~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~l~f~~~~~----- 178 (862)
.|||||....++. ...+.+.|+|.++|-.++.+|+....+... ..+..++|.-+.+.++.|.|.|.+..+
T Consensus 82 ~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~-~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i 160 (174)
T PF11721_consen 82 TVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGF-NKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCI 160 (174)
T ss_dssp EEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSS-S---EEEEEEEEEETTEEETTEEEE--SEEEE
T ss_pred EEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCC-ceEEEEEEEEEEEeCCcEEEEEEecCCCcEEe
Confidence 9999999777765 445667899999999999999875433322 236677774445577888888883110
Q ss_pred ---CCCCcceeeee
Q 041565 179 ---HKDSYAFVNGI 189 (862)
Q Consensus 179 ---~~~~~pfisai 189 (862)
...+.|.||||
T Consensus 161 ~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 161 PFIGSYGNPLISAI 174 (174)
T ss_dssp EEESSSSSSSEEEE
T ss_pred eccccCCCcEEeeC
Confidence 02467888887
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.4e-13 Score=137.02 Aligned_cols=206 Identities=22% Similarity=0.337 Sum_probs=142.3
Q ss_pred HHHHHhccccceeeEEEEEee-----cCeEEEEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCc
Q 041565 573 IEMLSKLRHKHLVSLIGFCEE-----DGEMILVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGAR 645 (862)
Q Consensus 573 ~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 645 (862)
...|-++.|.|||++..|..+ ..+..++.|||..|+|..+|++. ....+......+++.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 344566789999999988754 34678999999999999999863 334588888999999999999999985 6
Q ss_pred ccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC--CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHH
Q 041565 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN--QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723 (862)
Q Consensus 646 ~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ell 723 (862)
++|+|+++...-|++..++-+|++--.-....+... .........+-++|.+||+-.....+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999888885321111100000 011122334678999999988888888999999999999998
Q ss_pred hCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 724 CARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 724 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
-+..-......... .+..+... +.+.. -..-+.++..|++..|..||+|++++.|.
T Consensus 277 ilEiq~tnseS~~~-----------~ee~ia~~----i~~le----n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE-----------VEENIANV----IIGLE----NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceee-----------hhhhhhhh----eeecc----CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 77532111100000 00000000 00000 00124578899999999999999998663
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.8e-11 Score=139.52 Aligned_cols=157 Identities=21% Similarity=0.297 Sum_probs=109.4
Q ss_pred cEEEecCCCC------CCCCCC--CCeeecCCccccCCCCcceeec--cC--CCCCCCCCCccceeeeeec---CceEEE
Q 041565 35 SYVLACGASS------DGTDSN--DRKWTSDSKFLTNSGNSITATA--QS--QDSSLPSTIPYMTARIFKS---TSSYKF 99 (862)
Q Consensus 35 ~~~I~CG~~~------~~~~~~--~~~w~~D~~~~~g~~~~~~~~~--~~--~~~~~~~~~~~~t~R~F~~---~~~~~y 99 (862)
.++||||+.. +.+|.- .|.|.+|..|..+....++... .. ..+...+...|+|+|.+.. ..+|.+
T Consensus 193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~ 272 (623)
T PLN03150 193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTM 272 (623)
T ss_pred EEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEe
Confidence 4689999732 122222 7999999888744322332211 11 1111123345999999865 348888
Q ss_pred EcCCCCeEEEEEEEecCCCCCCCCCCceeEEEeCceEEEecccchhhhhhcccccEEEEEEEccCCCCcEEEEEecCCCC
Q 041565 100 TVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDH 179 (862)
Q Consensus 100 ~~~~~~~ylvR~~F~~~~yg~~d~~~~~~~v~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~l~f~~~~~~ 179 (862)
++.++++|+||+||++........+.+.|+|.+|+..++++++....... ...++++++.+... ++.+.|+|+|..
T Consensus 273 ~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~-~~~~~~~~~~v~~~-~g~l~isl~p~~-- 348 (623)
T PLN03150 273 DVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGE-RYTALVLNKTVAVS-GRTLTIVLQPKK-- 348 (623)
T ss_pred ecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCC-cccceEEEeEEeec-CCeEEEEEeeCC--
Confidence 88889999999999977654445567889999999999998876432211 24688888877544 489999999975
Q ss_pred CCCcceeeeeEEEECCC
Q 041565 180 KDSYAFVNGIEVIPMPD 196 (862)
Q Consensus 180 ~~~~pfisaiE~~~l~~ 196 (862)
...||||||||+.+..
T Consensus 349 -~s~pilNaiEI~~~~~ 364 (623)
T PLN03150 349 -GTHAIINAIEVFEIIT 364 (623)
T ss_pred -CCcceeeeeeeeeccc
Confidence 4469999999999883
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.9e-11 Score=117.72 Aligned_cols=131 Identities=18% Similarity=0.159 Sum_probs=97.2
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEEEeCCCCcH
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
.+.|+.|.++.||++... +..+++|....... ....+..|+++++.+.+.+++ +++.+.. ...++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 357889999999999866 55799998764432 223567899999999766654 4454432 335799999999877
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC--cccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA--RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
... . . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 542 0 1 12345788999999999865 23469999999999999 66899999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-11 Score=136.86 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=174.7
Q ss_pred cccceeEee--eCcEEEEEEEE---cCccEEEEEecCCC--ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEE
Q 041565 528 FSESHVIGV--GGFGKVYEGYI---DGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 528 f~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 599 (862)
|...+.+|. |.+|.||.+.. .++..+|+|+-+.. .......-.+|+....++ .|+|.++........+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445678899 99999999886 34567888874322 223333345677666666 49999998888888999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHH----HHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeecccc
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR----GLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLS 674 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla 674 (862)
-+|++. .+|.++.+..... ++...++.+..+..+ ||.++|+.. ++|-|+||.||++..+ ...+++|||+.
T Consensus 196 qtE~~~-~sl~~~~~~~~~~-~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCNF-LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eecccc-chhHHhhhccccc-CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCccee
Confidence 999995 6888887765432 667777778888877 999999877 9999999999999999 78999999998
Q ss_pred ccCCCCCCcc---ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 675 KTGPNLNQTH---VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 675 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
.......... ......|...|++||..++ .++.++|+|++|.+.+|..++-........ ..|.... ..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~~r--~~ 341 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQLR--QG 341 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCccccc--cc
Confidence 8654433221 1223357778999997654 567899999999999999888755432210 1122110 00
Q ss_pred ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041565 752 TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~ 796 (862)
. +..++-..-..++...+..++..+|..|++.+.+..
T Consensus 342 -----~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 -----Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 001111112344556889999999999998877753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-09 Score=122.99 Aligned_cols=165 Identities=18% Similarity=0.243 Sum_probs=124.4
Q ss_pred cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHH
Q 041565 548 DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL 627 (862)
Q Consensus 548 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~ 627 (862)
.++.+|.|...+..+........+-++.|+.++||||++++...+.++..|+|+|-+. .|..++.+ +......
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v~ 107 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEVC 107 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHHH
Confidence 3455676666655544334556777888999999999999999999999999999983 67777764 3355666
Q ss_pred HHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCC
Q 041565 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707 (862)
Q Consensus 628 ~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 707 (862)
-.+.||++||.+||+.+ .++|++|.-..|++++.|+.||++|.++......+. ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 68899999999999755 699999999999999999999999998865432221 011111223567777654333
Q ss_pred chhHHHHHHHHHHHHHhC
Q 041565 708 EKSDVYSFGVVLFEVLCA 725 (862)
Q Consensus 708 ~ksDVyS~Gvvl~elltG 725 (862)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.7e-10 Score=131.32 Aligned_cols=141 Identities=14% Similarity=0.134 Sum_probs=90.9
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhh----------------------------------HH----
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQG----------------------------------VH---- 567 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~---- 567 (862)
.|+. +.||+|++|.||+|++++ |+.||||..++...+. .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 689999999999999987 9999999887542110 11
Q ss_pred --HHHHHHHHHHhcc----ccceeeEEEEEee-cCeEEEEEEeCCCCcHHHHH--hcCCC--CCCChhhHHHHHHHHHHH
Q 041565 568 --EFQTEIEMLSKLR----HKHLVSLIGFCEE-DGEMILVYDYMANGTLREHL--YKGDK--PGLPWKQRLEICIGAARG 636 (862)
Q Consensus 568 --~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~g 636 (862)
+|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.|.+.- ...+. ..+.......++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 2344555555543 3333332222222 34678999999999998742 22211 012222222233333
Q ss_pred HHHhhcCCcccEEeeCCCCCCeeccCCC----ceEEeeccccccCC
Q 041565 637 LHYLHTGARYTIIHRDVKTTNILLDEKW----EAKVSDFGLSKTGP 678 (862)
Q Consensus 637 L~yLH~~~~~~ivHrDIkp~NILl~~~~----~~kl~DFGla~~~~ 678 (862)
+..+ ++|+|+||.||+++.++ .++++|||++....
T Consensus 277 ----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3344 99999999999999888 99999999987653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=113.61 Aligned_cols=142 Identities=22% Similarity=0.360 Sum_probs=111.1
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCCh-hhHHHHHHHHHHHHhcccc--ceeeEEEEEeec---CeEEEEEEeCC
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHK--HLVSLIGFCEED---GEMILVYDYMA 605 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~ 605 (862)
+.|+.|..+.||++...+|..+++|....... ....++..|+++++.+++. ++.+++.++.+. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987767899998764322 1346788999999999764 457788887664 35689999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA----------------------------------------- 644 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 644 (862)
+.+|.+.+.. ..++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888765532 23677788888889999998888521
Q ss_pred ------------cccEEeeCCCCCCeeccC--CCceEEeecccccc
Q 041565 645 ------------RYTIIHRDVKTTNILLDE--KWEAKVSDFGLSKT 676 (862)
Q Consensus 645 ------------~~~ivHrDIkp~NILl~~--~~~~kl~DFGla~~ 676 (862)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256899999999999998 66789999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.8e-09 Score=101.75 Aligned_cols=143 Identities=21% Similarity=0.236 Sum_probs=106.5
Q ss_pred cceeEeeeCcEEEEEEEEcCccEEEEE-ecCCC-------ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 530 ESHVIGVGGFGKVYEGYIDGKTKVAIK-RSNPS-------SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~~~~vavK-~~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
....|-+|+-+.|+++.+.+. ...|| ++... .+-..++-++|+++|.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge-~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE-AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCc-eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 356889999999999998775 34455 33221 2223566788999999997666654444555555667999
Q ss_pred EeCCC-CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC---ceEEeecccccc
Q 041565 602 DYMAN-GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW---EAKVSDFGLSKT 676 (862)
Q Consensus 602 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~~kl~DFGla~~ 676 (862)
||+++ .++.+++...............++..|-+.+.-||.++ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48888887665443444445789999999999999887 99999999999997554 458999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=107.25 Aligned_cols=136 Identities=15% Similarity=0.139 Sum_probs=96.6
Q ss_pred eeEeeeCcEEEEEEEEcC-------ccEEEEEecCCCC----------------------hhhHHHHH----HHHHHHHh
Q 041565 532 HVIGVGGFGKVYEGYIDG-------KTKVAIKRSNPSS----------------------EQGVHEFQ----TEIEMLSK 578 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 578 (862)
..||.|.-+.||.|...+ +..+|||..+... ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 4689999643210 01122333 79999999
Q ss_pred ccc--cceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHh-hcCCcccEEeeCCCC
Q 041565 579 LRH--KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL-HTGARYTIIHRDVKT 655 (862)
Q Consensus 579 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp 655 (862)
+.. -++.+++++ ..-++||||+.+..+.....+. ..++..+...+..+++.+|..| |..+ +||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 964 456666754 4568999999765442211111 1245566778889999999999 7666 99999999
Q ss_pred CCeeccCCCceEEeeccccccC
Q 041565 656 TNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 656 ~NILl~~~~~~kl~DFGla~~~ 677 (862)
.|||+++ +.+.|+|||.+...
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeC
Confidence 9999974 68999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.7e-09 Score=100.76 Aligned_cols=131 Identities=22% Similarity=0.307 Sum_probs=100.6
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEe-cCCC-------ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKR-SNPS-------SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..+++|+-+.+|.+.+.+. .+++|. +... .+-...+-.+|++++.+++--.|.-.+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977554 366663 2211 111234567899999999876666555566677778899999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+++-.|.+.+... ...++..+-.-+.-||..+ |||+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 2567778888888999887 99999999999998764 99999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.9e-10 Score=124.33 Aligned_cols=250 Identities=18% Similarity=0.193 Sum_probs=172.7
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc--CccEEEEEecCCCChhhHHH--HHHHHHHHHhc-cccceeeEEEEEeecCeE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID--GKTKVAIKRSNPSSEQGVHE--FQTEIEMLSKL-RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 597 (862)
.-+.+|.....||.|.|+.|++...+ ++..+++|.+...-.....+ -..|+-+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34557888899999999999987744 56788999765443222222 23455555555 478888766666666667
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeecccccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKT 676 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~ 676 (862)
++=-|||+++++...+.- ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||....
T Consensus 342 ~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 788999999988776632 234788899999999999999999776 9999999999999876 7889999998864
Q ss_pred CCCCCCccccccccCCCCC-CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 677 GPNLNQTHVSTMVKGSFGY-LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
... ........+..| .+++......+-.+.|++|||.-+.|.+++...-.... .|.. .+.+.
T Consensus 417 ~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~--- 479 (524)
T KOG0601|consen 417 LAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGD--- 479 (524)
T ss_pred cce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eeccc---
Confidence 211 011111223334 35666666788899999999999999999875432110 1110 01110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
-+.+. . ....+..+.+.+...++..||.+.+...+.++.
T Consensus 480 --~p~~~----~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 --TPNLP----G-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --ccCCC----c-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111 1 125667788889999999999998888766654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.4e-08 Score=107.09 Aligned_cols=215 Identities=17% Similarity=0.208 Sum_probs=150.3
Q ss_pred EEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEe----ecCeEEEEEEeCCC-CcHHHHH
Q 041565 540 GKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE----EDGEMILVYDYMAN-GTLREHL 613 (862)
Q Consensus 540 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l 613 (862)
.+.||+..+ +|..+++||+.....+.......-+++++++.|.|+|++...+. .+..+++||+|.++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578898854 67889999984333232223345678899999999999988764 34578999999985 5676655
Q ss_pred hcC-------------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 614 YKG-------------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 614 ~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
... .+..+++..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 422 1223678899999999999999999988 888999999999999999999988877654332
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
. . |-+.. -.+-|.=.||.+++.|.||+..-........ . .+
T Consensus 447 ~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-----s--------~~------- 487 (655)
T KOG3741|consen 447 P--------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQS-----S--------HL------- 487 (655)
T ss_pred C--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHH-----H--------HH-------
Confidence 1 0 11111 2467889999999999999743211110000 0 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..+......++++++......++++ -+..+++.++-
T Consensus 488 --~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 488 --TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred --HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 1112235677888888888888877 57777776653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.6e-08 Score=102.69 Aligned_cols=141 Identities=13% Similarity=0.062 Sum_probs=102.0
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCChh-hH----------HHHHHHHHHHHhccccce--eeEEEEEee-----
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ-GV----------HEFQTEIEMLSKLRHKHL--VSLIGFCEE----- 593 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~H~ni--v~l~g~~~~----- 593 (862)
+.+-......|.+..+. |..+.||+....... .. ..+.+|...+.+|...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 45555455567777664 457999976433211 11 147899999999865444 455666543
Q ss_pred cCeEEEEEEeCCCC-cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-------CCc
Q 041565 594 DGEMILVYDYMANG-TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-------KWE 665 (862)
Q Consensus 594 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~~~ 665 (862)
...-+||+|++++. +|.+++........+...+..++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23578999999875 7999885432233556677899999999999999888 999999999999975 467
Q ss_pred eEEeecccccc
Q 041565 666 AKVSDFGLSKT 676 (862)
Q Consensus 666 ~kl~DFGla~~ 676 (862)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=8e-09 Score=121.86 Aligned_cols=246 Identities=20% Similarity=0.256 Sum_probs=158.1
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.|...+-+-+|.++.++.+.-.. +...+.|..... .....+....+-.++-..+||-++...--+.-.....||++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 34445566778888887655322 222222221111 11111222223223222344555544433344567899999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC--
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL-- 680 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~-- 680 (862)
|..+++|...|+... ..+..-.......+..+++|||... +.|+|++|.|+|...++..+++|||..+.....
T Consensus 885 ~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999988654 2455555556667888999999754 899999999999999999999999844321100
Q ss_pred ----------------------CC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 041565 681 ----------------------NQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNL 733 (862)
Q Consensus 681 ----------------------~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~ 733 (862)
.+ ........||..|.+||...+......+|.|+.|++++|.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 011223468999999999999999999999999999999999999997665
Q ss_pred ccccccHHHHHHhhhccCccccccCCCC-CCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 041565 734 PKEQVSLADWALHCQRMGTIEDIIDPNL-KGNITDQCLRKFTETAEKCLSDQGIDRPSMG 792 (862)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~ 792 (862)
+.+.. +.++.... ....+.+......+++...+..+|.+|-.|.
T Consensus 1040 pq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 43321 11111111 1122334455677888888899999998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2e-07 Score=93.43 Aligned_cols=124 Identities=20% Similarity=0.238 Sum_probs=82.0
Q ss_pred EEEEEEEcCccEEEEEecCCCC--------------------------hhhHHHHHHHHHHHHhcccc--ceeeEEEEEe
Q 041565 541 KVYEGYIDGKTKVAIKRSNPSS--------------------------EQGVHEFQTEIEMLSKLRHK--HLVSLIGFCE 592 (862)
Q Consensus 541 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 592 (862)
.||.|...++..+|||..+... ........+|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998888899999643210 01123467899999999765 456666543
Q ss_pred ecCeEEEEEEeCC--CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHh-hcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 593 EDGEMILVYDYMA--NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL-HTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 593 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
.-++||||++ +..+..+.. .. ++......++.+++..+..+ |..+ |+|+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-VD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-CG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHh-cc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3379999998 545544332 11 22456677888888866664 6665 9999999999999988 99999
Q ss_pred ecccccc
Q 041565 670 DFGLSKT 676 (862)
Q Consensus 670 DFGla~~ 676 (862)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-07 Score=100.45 Aligned_cols=156 Identities=23% Similarity=0.328 Sum_probs=98.3
Q ss_pred CcEEEecCCCC----CCCCCCCCeeecCC---ccc-cCCCCcceeeccCCCCCCCCCCccceeeeeecCc-----eEEEE
Q 041565 34 NSYVLACGASS----DGTDSNDRKWTSDS---KFL-TNSGNSITATAQSQDSSLPSTIPYMTARIFKSTS-----SYKFT 100 (862)
Q Consensus 34 ~~~~I~CG~~~----~~~~~~~~~w~~D~---~~~-~g~~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~-----~~~y~ 100 (862)
-.+++|||+.. +.+|.-+|.|.+.. ... .....++. .........++...|+|||.-.... +|.+
T Consensus 179 ~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~-~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~- 256 (347)
T PF12819_consen 179 TVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNIN-INSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSF- 256 (347)
T ss_pred EEEeecCCCcccccCCCCCcceeeccccccCccccccccceeee-cccCCccCcChHHHHHhhhcccccccceEEEecc-
Confidence 36799999854 66777899999641 111 11112222 0111112233444499999754332 3444
Q ss_pred cCCCCeEEEEEEEecCCCCCCCCCCceeEEEeCceEEEecccchhhhhhcccccEEEEEEEccCCCCcEEEEEecCCCCC
Q 041565 101 VSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFTPSSDHK 180 (862)
Q Consensus 101 ~~~~~~ylvR~~F~~~~yg~~d~~~~~~~v~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~l~f~~~~~~~ 180 (862)
+.++..|+||+||+......-....+.|+|..|+......++.. .......+++..+++....++.+.|+..|+.++.
T Consensus 257 ~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~ 334 (347)
T PF12819_consen 257 VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPP--YLGADTVPYYSDYVVNVPDSGFLNISLGPTPDST 334 (347)
T ss_pred CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcc--cccCcceEeecceEEEecCCCEEEEEEEeCCCCC
Confidence 46788999999999554322223357899999999888633321 1111234567888776666668888889987664
Q ss_pred CCcceeeeeEEEEC
Q 041565 181 DSYAFVNGIEVIPM 194 (862)
Q Consensus 181 ~~~pfisaiE~~~l 194 (862)
- .|+|||+||..|
T Consensus 335 l-ppiLNalEIy~v 347 (347)
T PF12819_consen 335 L-PPILNALEIYKV 347 (347)
T ss_pred c-CceeEeeeeEeC
Confidence 4 899999999864
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.1e-06 Score=90.33 Aligned_cols=260 Identities=13% Similarity=0.129 Sum_probs=153.9
Q ss_pred cceeEeeeCcEEEEEEE-EcCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEE------Eeec-CeEEEE
Q 041565 530 ESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGF------CEED-GEMILV 600 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~------~~~~-~~~~lV 600 (862)
.++.||+|+-+.+|--- ..+ .+.|+..........+. ++.|... .||-+-.-+.| .-++ ....+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 35789999999999532 222 23455443322222222 2233333 46643331222 1122 236777
Q ss_pred EEeCCCCc-HHHHHhc----CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 601 YDYMANGT-LREHLYK----GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 601 ~E~~~~gs-L~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
|..+.+.. +..++.. +.-+...|.-++++++.+|.+.+-||..| .+-+|++++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88776542 3333321 12234789999999999999999999887 8889999999999999999998854333
Q ss_pred cCCCCCCccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCccc--cccHH-HHHHh
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCA-RPALNVNLPKE--QVSLA-DWALH 746 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG-~~p~~~~~~~~--~~~l~-~~~~~ 746 (862)
... .........|...|.+||.-. +..-+...|-|.|||++++++.| +.|+.+-.... ...+. +-+..
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 221 122233456888999999753 44567789999999999999876 89986532111 11110 00000
Q ss_pred hhcc-CccccccCCCCCCCCcHH-HHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHh
Q 041565 747 CQRM-GTIEDIIDPNLKGNITDQ-CLRKFTETAEKCLSDQ--GIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 747 ~~~~-~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~~--p~~RPt~~evl~~L~~~l 802 (862)
.... .+-..-..+. ...++.+ .+..+..+..+|+... +.-|||.+..+..|..+.
T Consensus 243 ~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 243 RFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred eeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 0000 0000000011 1122222 3456677888888643 568999999888877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=86.74 Aligned_cols=138 Identities=18% Similarity=0.169 Sum_probs=105.2
Q ss_pred EeeeCcEEEEEEEEcCccEEEEEecCC-C--C---hhhHHHHHHHHHHHHhcccc--ceeeEEEEEe-e----cCeEEEE
Q 041565 534 IGVGGFGKVYEGYIDGKTKVAIKRSNP-S--S---EQGVHEFQTEIEMLSKLRHK--HLVSLIGFCE-E----DGEMILV 600 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~~~~vavK~~~~-~--~---~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~-~----~~~~~lV 600 (862)
-|+||-+.|++-.+++. .+-+|+... . + .-+...|.+|+..|.+|... .+.+++ ++. . .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789899999877666 688997541 1 1 33567899999999999643 344555 332 1 1246899
Q ss_pred EEeCCC-CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc--eEEeecccccc
Q 041565 601 YDYMAN-GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE--AKVSDFGLSKT 676 (862)
Q Consensus 601 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--~kl~DFGla~~ 676 (862)
+|-+++ -+|.+++........+...+..++.++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 58998887654445678888999999999999999887 999999999999986666 99999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.7e-07 Score=91.25 Aligned_cols=144 Identities=22% Similarity=0.178 Sum_probs=98.0
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC----------------------hhhHHHHHHHHHH
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS----------------------EQGVHEFQTEIEM 575 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~ 575 (862)
+..+.....-...+..||.|.-+.||.|....|.++|||.-+... .-......+|.++
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 344444433445578999999999999999989999999533210 0112346789999
Q ss_pred HHhcccc--ceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCC
Q 041565 576 LSKLRHK--HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653 (862)
Q Consensus 576 l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI 653 (862)
|.+|.-. .+.+.+++ +...+|||++++-.|...- ++....-.|+..|++-+.-+-..| |||+|+
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDl 228 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDL 228 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 9999655 67777754 4558999999885554321 122233334444444444343444 999999
Q ss_pred CCCCeeccCCCceEEeeccccc
Q 041565 654 KTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 654 kp~NILl~~~~~~kl~DFGla~ 675 (862)
.+-||+++++|.+.++||--+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999996543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-06 Score=88.73 Aligned_cols=106 Identities=24% Similarity=0.264 Sum_probs=85.4
Q ss_pred HHHHHHHHHHHHhcccc--ceeeEEEEEeec----CeEEEEEEeCCCC-cHHHHHhcCCCCCCChhhHHHHHHHHHHHHH
Q 041565 566 VHEFQTEIEMLSKLRHK--HLVSLIGFCEED----GEMILVYDYMANG-TLREHLYKGDKPGLPWKQRLEICIGAARGLH 638 (862)
Q Consensus 566 ~~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 638 (862)
.....+|...+..|... ...+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34678899988888644 445677776553 2458999999874 79999876433 566778899999999999
Q ss_pred HhhcCCcccEEeeCCCCCCeeccCCC---ceEEeecccccc
Q 041565 639 YLHTGARYTIIHRDVKTTNILLDEKW---EAKVSDFGLSKT 676 (862)
Q Consensus 639 yLH~~~~~~ivHrDIkp~NILl~~~~---~~kl~DFGla~~ 676 (862)
-||+.+ |+|+|++++|||++.+. .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999888 99999999999999887 899999997765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-07 Score=106.32 Aligned_cols=151 Identities=18% Similarity=0.328 Sum_probs=101.6
Q ss_pred HHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC-------ccccccccCCCCCCChhhhhc
Q 041565 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-------THVSTMVKGSFGYLDPEYFRR 703 (862)
Q Consensus 631 ~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 703 (862)
.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+.+........ ............|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999974 4799999999999999999999999998754322100 011112234567999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCC-CCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccc
Q 041565 704 QQLTEKSDVYSFGVVLFEVLCARPA-LNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLS 782 (862)
Q Consensus 704 ~~~s~ksDVyS~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~ 782 (862)
...+.++|+||+||+++-+..|..+ +....... ....... .+..-........+.++.+-+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~~--------~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSRN--------LLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhhc--------ccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999844443 32221110 0111100 00000111223456778888899999
Q ss_pred cCCCCCCCHHHHHH
Q 041565 783 DQGIDRPSMGDVLW 796 (862)
Q Consensus 783 ~~p~~RPt~~evl~ 796 (862)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998777653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.6e-05 Score=82.79 Aligned_cols=139 Identities=17% Similarity=0.210 Sum_probs=86.1
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccce--eeEEEEEeecCeEEEEEEeCCCCc-
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL--VSLIGFCEEDGEMILVYDYMANGT- 608 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~E~~~~gs- 608 (862)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 23457788776533 23456889999999975444 677888877778889999998863
Q ss_pred HHHHH---------------------hcCCCCCCChhhHHH-HHH----------HHHH-HHHHhhc-CCcccEEeeCCC
Q 041565 609 LREHL---------------------YKGDKPGLPWKQRLE-ICI----------GAAR-GLHYLHT-GARYTIIHRDVK 654 (862)
Q Consensus 609 L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~ivHrDIk 654 (862)
+.+.+ |.-............ +.. .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 111001111111100 000 0000 1112211 123457999999
Q ss_pred CCCeeccCCCceEEeecccccc
Q 041565 655 TTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~ 676 (862)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.5e-06 Score=94.74 Aligned_cols=141 Identities=16% Similarity=0.223 Sum_probs=92.6
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCChhh------------------------------HH----------HHHH
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQG------------------------------VH----------EFQT 571 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 571 (862)
+-|+.++-|.||+|++++|+.||||+.++.-++. .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999877642210 01 1344
Q ss_pred HHHHHHhcc-----ccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcc
Q 041565 572 EIEMLSKLR-----HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646 (862)
Q Consensus 572 E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 646 (862)
|...+.+++ .+++.=..=|.+-.+...|+|||++|-.+.+...-.. ..++.+.+.....++.--.-+-| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~d--g-- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLRD--G-- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHhc--C--
Confidence 555555552 2332211112222456799999999988888743222 23554444443333332222222 3
Q ss_pred cEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 647 ~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+.|.|..|.||+++.++.+-+.|||+.....
T Consensus 286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999986543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.8e-05 Score=78.55 Aligned_cols=143 Identities=18% Similarity=0.179 Sum_probs=86.5
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc--eeeEEEEEe---ecCeEEEEEEeCC
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH--LVSLIGFCE---EDGEMILVYDYMA 605 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~---~~~~~~lV~E~~~ 605 (862)
.+.|+.|..+.||+...++ ..+++|..... .....+..|..+++.+.... +.+++.++. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999888 48999986644 45567888999999886443 456666543 3345789999999
Q ss_pred CCcHHH----------------HH---hcC--CCCCCChhh---------HHHH------------HHHHHH-HHHHhhc
Q 041565 606 NGTLRE----------------HL---YKG--DKPGLPWKQ---------RLEI------------CIGAAR-GLHYLHT 642 (862)
Q Consensus 606 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 642 (862)
+..+.. .+ +.. ......+.. .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887777 11 111 111111100 0000 111222 2333332
Q ss_pred ----CCcccEEeeCCCCCCeecc-CCCceEEeecccccc
Q 041565 643 ----GARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKT 676 (862)
Q Consensus 643 ----~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~ 676 (862)
.....++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2346699999999999999 556668999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.6e-05 Score=75.16 Aligned_cols=101 Identities=24% Similarity=0.299 Sum_probs=81.2
Q ss_pred HHHHHHHHhccc-cceeeEEEEEeecCeEEEEEEeCCCCcHHHH---HhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCc
Q 041565 570 QTEIEMLSKLRH-KHLVSLIGFCEEDGEMILVYDYMANGTLREH---LYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645 (862)
Q Consensus 570 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 645 (862)
..|.-+|+.+++ +++.+++|+|.+ ++|.||...+++... +.+. ..-+|..|.+||.++++.+++|++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999976 699999999954 678999987655421 1111 126899999999999999999998665
Q ss_pred ccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 646 ~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
..+.-.|++++|+.+++++++|+.|...+-.
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 6688899999999999999999999986643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.1e-05 Score=80.06 Aligned_cols=140 Identities=16% Similarity=0.118 Sum_probs=86.0
Q ss_pred eEeeeCc-EEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEeCCCCcHH
Q 041565 533 VIGVGGF-GKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDYMANGTLR 610 (862)
Q Consensus 533 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 610 (862)
.|-.|.. ..||+...++ ..+++|+..... ..+..+|+++++.+. +--+.++++++...+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 7899987654 578888876443 345678999998884 444557788777666789999999987776
Q ss_pred HHH-------------------hcCCCC--CCC--hhhHHHH-----------------------HHHHHHHHHHhh-cC
Q 041565 611 EHL-------------------YKGDKP--GLP--WKQRLEI-----------------------CIGAARGLHYLH-TG 643 (862)
Q Consensus 611 ~~l-------------------~~~~~~--~l~--~~~~~~i-----------------------~~~ia~gL~yLH-~~ 643 (862)
... +..... ++. ....+.. ..++.+.|.... ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 111100 111 0011100 111111111111 11
Q ss_pred CcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 644 ~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 235699999999999999987789999987654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.00 E-value=6e-05 Score=76.47 Aligned_cols=138 Identities=17% Similarity=0.172 Sum_probs=90.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHH---------HHHHHHHHhccc---cceeeEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEF---------QTEIEMLSKLRH---KHLVSLIGFC 591 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~~ 591 (862)
..++|...+++-......|.+-..++ ..+++|..+.......+.| .+++..+.+++. -....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 35567777777777777777766655 4789998776543333332 234444444432 2333333333
Q ss_pred e-----ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 592 E-----EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 592 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
. -....+|+|||++|-.|.+... ++. .++..+.++|.-||+.| +.|+|..|.|++++++ .+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 2 2245679999999987766532 222 35566778899999887 9999999999999865 59
Q ss_pred EEeecccccc
Q 041565 667 KVSDFGLSKT 676 (862)
Q Consensus 667 kl~DFGla~~ 676 (862)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.5e-05 Score=76.53 Aligned_cols=154 Identities=18% Similarity=0.176 Sum_probs=100.3
Q ss_pred cccCHHHHHhhccCccccee---EeeeCcEEEEEEEEcCccEEEEEecCCCChh-------------------hH-----
Q 041565 514 RHFSLAEIKHGTRNFSESHV---IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ-------------------GV----- 566 (862)
Q Consensus 514 ~~~~~~el~~at~~f~~~~~---lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~----- 566 (862)
...+++.|..--.+-..... |..|.-+.||+|...++..+|||+....... ..
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 44556666655555544444 5577888999999888889999986543111 00
Q ss_pred HHHHHHHHHHHhcc--ccceeeEEEEEeecCeEEEEEEeCCCCcHH-HHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC
Q 041565 567 HEFQTEIEMLSKLR--HKHLVSLIGFCEEDGEMILVYDYMANGTLR-EHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643 (862)
Q Consensus 567 ~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 643 (862)
.-...|+..|.++. +-.+.+.+++.. -.|||||+....+- -.|. ..++...+...+..++++.+.-|-..
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 11345777777774 445556665543 37999999653110 0010 01122335677778888888888763
Q ss_pred CcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 644 ~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
+ ++||+||+.-|||+. ++.+.|+|||-+...
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 2 499999999999999 789999999977653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=5.2e-05 Score=87.03 Aligned_cols=139 Identities=17% Similarity=0.194 Sum_probs=90.5
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCChhh-------------------------------------HHHHHHHHH
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQG-------------------------------------VHEFQTEIE 574 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 574 (862)
+-||.-+.|.||+|++++|..||||..++.-+.. .-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999876542210 112445555
Q ss_pred HHHhc----cccc------eeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC
Q 041565 575 MLSKL----RHKH------LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644 (862)
Q Consensus 575 ~l~~l----~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 644 (862)
...+. .|-+ |.+++- .-.....|+||||+|..+.+.-.-. ...++...+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf~~--- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIFKT--- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHHhc---
Confidence 44444 3444 222222 2234679999999998766543211 122555555444444333222222
Q ss_pred cccEEeeCCCCCCeeccC----CCceEEeeccccccCC
Q 041565 645 RYTIIHRDVKTTNILLDE----KWEAKVSDFGLSKTGP 678 (862)
Q Consensus 645 ~~~ivHrDIkp~NILl~~----~~~~kl~DFGla~~~~ 678 (862)
+++|+|=.|.||+++. ++.+.+.|||+.....
T Consensus 321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3999999999999984 6789999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.6e-06 Score=97.93 Aligned_cols=183 Identities=19% Similarity=0.146 Sum_probs=132.4
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc-eeeEEEEEeecCeEEEEEEeCCCC-c
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH-LVSLIGFCEEDGEMILVYDYMANG-T 608 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-s 608 (862)
-+-+++|++++++|.+-...+....+.+... ....-++++|.+++||| .++-++-+..+...+++++++..+ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3557899999999987444333445544322 34456899999999999 667777777778889999999776 2
Q ss_pred HHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccccc
Q 041565 609 LREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688 (862)
Q Consensus 609 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (862)
-..-.. .....+...+...+++.-++++++||+.. -+|+| ||+..+ ...|..||+......... ....
T Consensus 322 ~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 322 SALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred ccccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence 111110 01112445566677888899999999753 48998 887766 588999999887654322 3445
Q ss_pred ccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 041565 689 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALN 730 (862)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~ 730 (862)
..++..++|||......+..+.|+|++|+-..++.-|-+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 678999999999999999999999999998778777776654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00028 Score=71.49 Aligned_cols=129 Identities=25% Similarity=0.369 Sum_probs=90.6
Q ss_pred cceeEeeeCcEEEEEEEEcCccEEEEEecCCCC----------------hhhHHHHHHHHHHHHhcc------ccceeeE
Q 041565 530 ESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS----------------EQGVHEFQTEIEMLSKLR------HKHLVSL 587 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 587 (862)
....||+|+.-.||.- .+.....||...... ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3568999999999863 444456777665544 223566777777766665 7889999
Q ss_pred EEEEeecCeEEEEEEeCCC--C----cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 588 IGFCEEDGEMILVYDYMAN--G----TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 588 ~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
+|+...+....+|+|.+.+ | +|.+++.+.. ++. +..+.+.+..+ ||-+.+ |+.+|++|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f~~---~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEFKR---YLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHHHH---HHHHcC---CeecCCCcccEEEE
Confidence 9999999999999998753 2 5888885432 555 44555555444 454444 99999999999996
Q ss_pred CCC----ceEEee
Q 041565 662 EKW----EAKVSD 670 (862)
Q Consensus 662 ~~~----~~kl~D 670 (862)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00024 Score=88.22 Aligned_cols=147 Identities=16% Similarity=0.293 Sum_probs=92.5
Q ss_pred ceeEeeeCcEEEEEEEEcCc---cEEEEEecCCCC-hhhHHHHHHHHHHHHhcc-ccce--eeEEEEEeec---CeEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGK---TKVAIKRSNPSS-EQGVHEFQTEIEMLSKLR-HKHL--VSLIGFCEED---GEMILV 600 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 600 (862)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788999999999876654 367777754332 123457889999999995 6665 7888888764 467899
Q ss_pred EEeCCCCcHHH--------------------H---HhcCCCC---------CCCh--hhHHHHH---------------H
Q 041565 601 YDYMANGTLRE--------------------H---LYKGDKP---------GLPW--KQRLEIC---------------I 631 (862)
Q Consensus 601 ~E~~~~gsL~~--------------------~---l~~~~~~---------~l~~--~~~~~i~---------------~ 631 (862)
|||+++..+.+ . ||.-... +..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998754321 1 1111100 0011 1111111 1
Q ss_pred HHHHHHHHhhcCC--------cccEEeeCCCCCCeeccCC-Cc-eEEeeccccccC
Q 041565 632 GAARGLHYLHTGA--------RYTIIHRDVKTTNILLDEK-WE-AKVSDFGLSKTG 677 (862)
Q Consensus 632 ~ia~gL~yLH~~~--------~~~ivHrDIkp~NILl~~~-~~-~kl~DFGla~~~ 677 (862)
.+.+.+++|..+- ...+||+|+++.|||++.+ .. +-|.||+++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 1233456664321 1359999999999999853 33 579999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00039 Score=72.90 Aligned_cols=139 Identities=19% Similarity=0.213 Sum_probs=77.3
Q ss_pred eeEeeeCcE-EEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccc---ceeeEEEEEeec---CeEEEEEEeC
Q 041565 532 HVIGVGGFG-KVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK---HLVSLIGFCEED---GEMILVYDYM 604 (862)
Q Consensus 532 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~ 604 (862)
+.|+.||.. .||+. +..+++|..... ....++.+|.++|+.+... -+.+.++.+... +..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777765 58875 234677765532 2345788999999988532 344455544332 2357899999
Q ss_pred CCCcHHHH------------------HhcCCCCC--C-------------ChhhHH--HHH-------HHHHHH-HH-Hh
Q 041565 605 ANGTLREH------------------LYKGDKPG--L-------------PWKQRL--EIC-------IGAARG-LH-YL 640 (862)
Q Consensus 605 ~~gsL~~~------------------l~~~~~~~--l-------------~~~~~~--~i~-------~~ia~g-L~-yL 640 (862)
+|.++.+. |+.-.... . .|.... .+. .+.... ++ .+
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 88665321 12111000 0 011110 000 011110 11 11
Q ss_pred hc--CCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 641 HT--GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 641 H~--~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+. .....++|+|+.+.||+++++...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1245599999999999998776667999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00069 Score=73.64 Aligned_cols=78 Identities=14% Similarity=0.112 Sum_probs=57.8
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccc---cceeeEEEEEee---cCeEEEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH---KHLVSLIGFCEE---DGEMILVYD 602 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E 602 (862)
...+.||.|..+.||+....++ .+++|..+.. .....|..|.+.|+.|.- ..+.+++++|.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456899999999999876666 4667764321 123578899999999853 367888988854 366899999
Q ss_pred eCCCCcH
Q 041565 603 YMANGTL 609 (862)
Q Consensus 603 ~~~~gsL 609 (862)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00054 Score=66.59 Aligned_cols=129 Identities=19% Similarity=0.211 Sum_probs=87.6
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEEEeCCCC
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g 607 (862)
...+.|++|.+|.||+|.+.++ .+|+|.-+..+. ...+..|+++|..+.-.++. +++.|..+ .+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 3457899999999999998876 788887665443 46788999999999877765 34544333 3559999888
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCC-CCCeeccCCCceEEeecccccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK-TTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIk-p~NILl~~~~~~kl~DFGla~~ 676 (862)
.|.++.... +-+.++ .+++.---|... +|-|+.|. |...+|-.+..+.|+||.-|+.
T Consensus 98 ~L~~~~~~~-----~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-----DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-----cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765422 223333 334443334433 48898887 4444444445999999988764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0011 Score=69.26 Aligned_cols=140 Identities=18% Similarity=0.208 Sum_probs=81.0
Q ss_pred eeEeeeCcEEEEEEEEcC--ccEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEEEeCCCCc
Q 041565 532 HVIGVGGFGKVYEGYIDG--KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
+.|..|-...+|+....+ +..+++|........ .-+-.+|+.+++.+...+++ ++++.+. + .++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 567778888999988664 567888876543222 12234788888888654444 4444332 2 37999998866
Q ss_pred HHHH--------------H---hcCCCC---------CC-ChhhHHHHH-------------------------HHHHHH
Q 041565 609 LREH--------------L---YKGDKP---------GL-PWKQRLEIC-------------------------IGAARG 636 (862)
Q Consensus 609 L~~~--------------l---~~~~~~---------~l-~~~~~~~i~-------------------------~~ia~g 636 (862)
+... | ++.... .. -|..+..+. .+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5221 1 111110 01 122211111 111111
Q ss_pred HH-HhhcC-CcccEEeeCCCCCCeeccC-CCceEEeecccccc
Q 041565 637 LH-YLHTG-ARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKT 676 (862)
Q Consensus 637 L~-yLH~~-~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~ 676 (862)
|. .+... ....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11 11111 2356999999999999998 57899999987764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0011 Score=70.52 Aligned_cols=137 Identities=15% Similarity=0.123 Sum_probs=77.4
Q ss_pred EeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEEEEeCCCCcHHH-
Q 041565 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILVYDYMANGTLRE- 611 (862)
Q Consensus 534 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~- 611 (862)
+..|-.+.+|+... ++..+++|..........-...+|.++++.+....+ .++++.+. -.+||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 44567788998873 455788887554322211235778999998865444 34444432 268999998866532
Q ss_pred -------------H---HhcCCC--CCCChhhH-HHHHHH---------HHHHHHHhhc-----CCcccEEeeCCCCCCe
Q 041565 612 -------------H---LYKGDK--PGLPWKQR-LEICIG---------AARGLHYLHT-----GARYTIIHRDVKTTNI 658 (862)
Q Consensus 612 -------------~---l~~~~~--~~l~~~~~-~~i~~~---------ia~gL~yLH~-----~~~~~ivHrDIkp~NI 658 (862)
. ||.... .+++.... .....+ +.+.+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 121111 11222111 111111 1111121211 1134699999999999
Q ss_pred eccCCCceEEeecccccc
Q 041565 659 LLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 659 Ll~~~~~~kl~DFGla~~ 676 (862)
++++++ ++|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999987765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0038 Score=70.05 Aligned_cols=76 Identities=17% Similarity=0.182 Sum_probs=54.3
Q ss_pred ceeEeeeCcEEEEEEEEcCc-cEEEEEecCCC------C-hhhHHHHHHHHHHHHhcc---ccceeeEEEEEeecCeEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGK-TKVAIKRSNPS------S-EQGVHEFQTEIEMLSKLR---HKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 599 (862)
.+.||.|.+..||+....+| +.++||.-... . ....+++..|.+.|+.+. -.++.+++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 35789999999999998876 47999974321 1 224567778888888873 235667776643 45689
Q ss_pred EEEeCCCCc
Q 041565 600 VYDYMANGT 608 (862)
Q Consensus 600 V~E~~~~gs 608 (862)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.005 Score=61.96 Aligned_cols=125 Identities=26% Similarity=0.319 Sum_probs=88.6
Q ss_pred cCcccceeEeeeCc-EEEEEEEEcCccEEEEEecCC---CC--------h----------hhHHHHHHHHHHHHhcc---
Q 041565 526 RNFSESHVIGVGGF-GKVYEGYIDGKTKVAIKRSNP---SS--------E----------QGVHEFQTEIEMLSKLR--- 580 (862)
Q Consensus 526 ~~f~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~--- 580 (862)
.+++..+.||.|.- |.||+..+.+. .+|+|.... .. . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 99999998775 899998211 00 0 11234788998888875
Q ss_pred ccce--eeEEEEEeec------------------CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHh
Q 041565 581 HKHL--VSLIGFCEED------------------GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640 (862)
Q Consensus 581 H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 640 (862)
+.++ |+.+||..-. ..+.+|.||++... .+.. +-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 4566 8999986211 12467788775532 1222 2345666777889
Q ss_pred hcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 641 H~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9776 999999999987 5699999853
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0012 Score=80.25 Aligned_cols=201 Identities=18% Similarity=0.194 Sum_probs=136.9
Q ss_pred HHHHHHHHHHHHhccccceeeEEEEEeecCeEE----EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhh
Q 041565 566 VHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI----LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641 (862)
Q Consensus 566 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 641 (862)
...-.-|++.+.++.|+|++.+++|..+....- +..|++..-++...+..-.. ++....+.+..++.+||+|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHH
Confidence 334455778888899999999999876553332 33467777777777765443 788889999999999999999
Q ss_pred cCCcccEEeeCCCCC---CeeccCCCceEEe--eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCc--hhHHHH
Q 041565 642 TGARYTIIHRDVKTT---NILLDEKWEAKVS--DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE--KSDVYS 714 (862)
Q Consensus 642 ~~~~~~ivHrDIkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVyS 714 (862)
+.. ..|.-+..+ +.-.+.++...++ ||+..+........ ....-...+.++|......++. ..|+|+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 864 555555554 5555667777777 88888765543322 2223445678888776655544 479999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041565 715 FGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDV 794 (862)
Q Consensus 715 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~ev 794 (862)
+|.++..+..|..+-.... .+..+++.. ....+.+....|+..++++|++..++
T Consensus 378 lgll~~~~~~~~~i~~~~~------------------~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA------------------VPVSLLDVL--------STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCccccccc------------------chhhhhccc--------cchhhhhhhhhhcchhhhhccchhhh
Confidence 9999999998865432110 001111110 11146777889999999999999999
Q ss_pred HHHHHH
Q 041565 795 LWNLEF 800 (862)
Q Consensus 795 l~~L~~ 800 (862)
+.+.-.
T Consensus 432 l~~~f~ 437 (1351)
T KOG1035|consen 432 LTHPFL 437 (1351)
T ss_pred hhchhc
Confidence 976543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0017 Score=70.48 Aligned_cols=142 Identities=21% Similarity=0.196 Sum_probs=85.5
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc--eeeEEEE------EeecCeEEEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH--LVSLIGF------CEEDGEMILVYD 602 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 602 (862)
.+.|..|....+|+...+++ .+++|+.... ...+...|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677777789999876655 6888887642 2345677888888885443 4454432 123456789999
Q ss_pred eCCCCcHHH-----------H---HhcC----CC-----CCCChhhHH----------HHHHHHHHHHHHhhc----CCc
Q 041565 603 YMANGTLRE-----------H---LYKG----DK-----PGLPWKQRL----------EICIGAARGLHYLHT----GAR 645 (862)
Q Consensus 603 ~~~~gsL~~-----------~---l~~~----~~-----~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 645 (862)
|++|..+.. . ||.. .. ....|.... .....+..+++++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998765421 1 1110 00 011222111 011123334444443 113
Q ss_pred ccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 646 ~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
..++|+|+.|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987778999987754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0041 Score=67.82 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=83.1
Q ss_pred eeEeeeCcEEEEEEEEcC-------ccEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYIDG-------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~ 603 (862)
+.|..|-...+|+....+ +..+++|+..... ....+..+|.+++..+....+. ++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456566677899888665 4678889865433 2223457788888888644443 4555553 2 358999
Q ss_pred CCCCcHHHH-----------------HhcCCCC-------CC--ChhhHHH--------------------------HHH
Q 041565 604 MANGTLREH-----------------LYKGDKP-------GL--PWKQRLE--------------------------ICI 631 (862)
Q Consensus 604 ~~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------i~~ 631 (862)
++|..+... ||+.... .. -|..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765431 1111111 00 0111111 111
Q ss_pred HHHHHHHHhhc------CCcccEEeeCCCCCCeeccCC----CceEEeecccccc
Q 041565 632 GAARGLHYLHT------GARYTIIHRDVKTTNILLDEK----WEAKVSDFGLSKT 676 (862)
Q Consensus 632 ~ia~gL~yLH~------~~~~~ivHrDIkp~NILl~~~----~~~kl~DFGla~~ 676 (862)
.+..-++.|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234679999999999999985 7899999987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.016 Score=64.49 Aligned_cols=140 Identities=18% Similarity=0.195 Sum_probs=82.0
Q ss_pred eeEeeeCcEEEEEEEEcC-----ccEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEEEeCC
Q 041565 532 HVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 605 (862)
..|-.|-...+|+....+ +..+++|...........+ .+|..+++.+...++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345457778899887543 2578889876554333333 6789999988765554 45555533 2 5799998
Q ss_pred CCcHHHH-----------------HhcCC----CCCCChhhHHHHHHHH-----------------HHHHHH----hhc-
Q 041565 606 NGTLREH-----------------LYKGD----KPGLPWKQRLEICIGA-----------------ARGLHY----LHT- 642 (862)
Q Consensus 606 ~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~y----LH~- 642 (862)
+.+|... +|+.. .....|.++.++..++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665321 12111 0011233333332111 111111 221
Q ss_pred CCcccEEeeCCCCCCeeccC-CCceEEeecccccc
Q 041565 643 GARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKT 676 (862)
Q Consensus 643 ~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~ 676 (862)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22356999999999999986 46899999987754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.055 Score=59.46 Aligned_cols=141 Identities=15% Similarity=0.184 Sum_probs=77.5
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc--eeeEEE------EEeecCeEEEEEEe
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH--LVSLIG------FCEEDGEMILVYDY 603 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~E~ 603 (862)
+.|+.|....+|+...++| .+++|+..... .++...|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999887666 68888765222 233444566666664222 333332 12235667899999
Q ss_pred CCCCcHH-----------HHH---hcCCC---------CCCCh-hhHHHH------------HHH-HHHHHHHhhcC---
Q 041565 604 MANGTLR-----------EHL---YKGDK---------PGLPW-KQRLEI------------CIG-AARGLHYLHTG--- 643 (862)
Q Consensus 604 ~~~gsL~-----------~~l---~~~~~---------~~l~~-~~~~~i------------~~~-ia~gL~yLH~~--- 643 (862)
++|..+. +.| +.... ..+.| .....- ..+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9886431 111 11100 01112 111111 111 11122232211
Q ss_pred -CcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 644 -ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 644 -~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
-...+||+|+.+.||+++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999775568999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0029 Score=67.06 Aligned_cols=133 Identities=17% Similarity=0.095 Sum_probs=89.5
Q ss_pred CcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--C-------h-------h------hHHHHHHHHHHHHhccc--c
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--S-------E-------Q------GVHEFQTEIEMLSKLRH--K 582 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~-------~-------~------~~~~~~~E~~~l~~l~H--~ 582 (862)
-++.++.||-|.-+.||.+....|.+.++|.-+.. + + + ..-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45678999999999999999998888888842211 0 0 0 01124568888888853 2
Q ss_pred ceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC
Q 041565 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE 662 (862)
Q Consensus 583 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 662 (862)
-+.+.++++ ..++|||++.+-.|...-+- .+...+. ..+..-+--|...| +||+|..-=||++++
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHV-----EDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeeec-----CChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 345555544 55899999988776543221 2223333 33333344455455 999999999999999
Q ss_pred CCceEEeecccc
Q 041565 663 KWEAKVSDFGLS 674 (862)
Q Consensus 663 ~~~~kl~DFGla 674 (862)
+..++++||--.
T Consensus 238 d~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 DDKIVVIDFPQM 249 (465)
T ss_pred CCCEEEeechHh
Confidence 999999999644
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.028 Score=61.05 Aligned_cols=138 Identities=16% Similarity=0.263 Sum_probs=79.8
Q ss_pred EEEEEEEEcCccEEEEEecC-CCChhhHHHHHHHHHHHHhccc--cceeeEEEEEeecC--eEEEEEEeCCCCcHH----
Q 041565 540 GKVYEGYIDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRH--KHLVSLIGFCEEDG--EMILVYDYMANGTLR---- 610 (862)
Q Consensus 540 g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~---- 610 (862)
-.+|..... +++.++.+.. ...........+|+++|+.+.- .-+...++.|.++. ..+.||+|+++..+.
T Consensus 39 n~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 39 NDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred cceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 334444433 5567777331 1233445566788888888743 34456678887766 779999999873221
Q ss_pred --------------HHHh---cCC---C------------CCCChhhHHHHHH--------HHHHHHHHhhc-----CCc
Q 041565 611 --------------EHLY---KGD---K------------PGLPWKQRLEICI--------GAARGLHYLHT-----GAR 645 (862)
Q Consensus 611 --------------~~l~---~~~---~------------~~l~~~~~~~i~~--------~ia~gL~yLH~-----~~~ 645 (862)
+.|. +-. . +--.|...++.++ ....-..||++ .+.
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 1111 100 0 0011111111010 11222334433 234
Q ss_pred ccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 646 ~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
..++|+|+++.|++++++.-+-|.||+++....
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 679999999999999998889999999998743
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.032 Score=59.95 Aligned_cols=32 Identities=25% Similarity=0.433 Sum_probs=26.5
Q ss_pred cccEEeeCCCCCCeeccCCCc-eEEeecccccc
Q 041565 645 RYTIIHRDVKTTNILLDEKWE-AKVSDFGLSKT 676 (862)
Q Consensus 645 ~~~ivHrDIkp~NILl~~~~~-~kl~DFGla~~ 676 (862)
...++|+|+++.|||+++++. .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 346999999999999997555 56999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.044 Score=59.92 Aligned_cols=143 Identities=16% Similarity=0.144 Sum_probs=82.8
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc--eeeEEEEE------eecCeEEEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH--LVSLIGFC------EEDGEMILVYD 602 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 602 (862)
.+.++.|....+|+...+++ .+++|+..... ...+...|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45567777789998876655 57788765421 1234556777777774322 34444422 22456789999
Q ss_pred eCCCCcHH-----------HH---HhcCCC----C------CCChhhHHH------------HHHHHHHHHHHhhc----
Q 041565 603 YMANGTLR-----------EH---LYKGDK----P------GLPWKQRLE------------ICIGAARGLHYLHT---- 642 (862)
Q Consensus 603 ~~~~gsL~-----------~~---l~~~~~----~------~l~~~~~~~------------i~~~ia~gL~yLH~---- 642 (862)
|++|..+. +. ++.... . .-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99875421 11 121100 0 011211110 11123344555542
Q ss_pred CCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 643 ~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.....++|+|+.+.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1235699999999999999887778999987654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.026 Score=60.82 Aligned_cols=140 Identities=20% Similarity=0.284 Sum_probs=73.8
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc---ccceeeEEEEEeecCeEEEEEEeCC
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR---HKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
+..+.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678888899999987 556689999755 233456888999988884 3457788888877777799999998
Q ss_pred CCc--------HHH---HHhc-CCCCC-------------------CChhh-----HHHHHH--------------HHHH
Q 041565 606 NGT--------LRE---HLYK-GDKPG-------------------LPWKQ-----RLEICI--------------GAAR 635 (862)
Q Consensus 606 ~gs--------L~~---~l~~-~~~~~-------------------l~~~~-----~~~i~~--------------~ia~ 635 (862)
.+. |-. .||+ ..... -+|.+ |+.-.. ++.+
T Consensus 96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~ 175 (288)
T PF03881_consen 96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE 175 (288)
T ss_dssp -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence 761 111 1233 11111 12321 111111 1222
Q ss_pred HHH-Hhhc-CCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 636 GLH-YLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 636 gL~-yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
.+. .|+. .-.+.++|+||-+.|++.+.++.+.|.|=.
T Consensus 176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 221 2332 125789999999999999999889998743
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.00096 Score=82.60 Aligned_cols=161 Identities=16% Similarity=0.045 Sum_probs=113.0
Q ss_pred HHHHHHHHHHHhccccceeeEEEEEe--ecCeEEEEEEeCCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhc
Q 041565 567 HEFQTEIEMLSKLRHKHLVSLIGFCE--EDGEMILVYDYMANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHT 642 (862)
Q Consensus 567 ~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~ 642 (862)
+....|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|-+.. .+.+...-+.....+...+..-.|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33445656666778988776554332 3346688999999999999987642 2234443344444443555555554
Q ss_pred CC--cccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHH
Q 041565 643 GA--RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 720 (862)
Q Consensus 643 ~~--~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ 720 (862)
.. ....+|+++|+-|.+|..+..+|++++|+.+...+ .........+++-|+.|+....-.++.++|+|..|+.++
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 32 34589999999999999999999999999994222 111222344677789999998889999999999999999
Q ss_pred HHHhCCCCC
Q 041565 721 EVLCARPAL 729 (862)
Q Consensus 721 elltG~~p~ 729 (862)
+.-.|..++
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998887665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.068 Score=58.91 Aligned_cols=80 Identities=20% Similarity=0.282 Sum_probs=50.7
Q ss_pred eEeeeCcEEEEEEEEcCc-cEEEEEecCC-------CChhhHHHHHHHHHHHHhcc--cccee-eEEEEEeecCeEEEEE
Q 041565 533 VIGVGGFGKVYEGYIDGK-TKVAIKRSNP-------SSEQGVHEFQTEIEMLSKLR--HKHLV-SLIGFCEEDGEMILVY 601 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~niv-~l~g~~~~~~~~~lV~ 601 (862)
.||.|....||++..+++ ..|+||.-.. .-.....+..-|.+.|+... .|..+ +++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999997754 5799996321 11333455667778887663 35444 44433 344557999
Q ss_pred EeCCCC-cHHHHHh
Q 041565 602 DYMANG-TLREHLY 614 (862)
Q Consensus 602 E~~~~g-sL~~~l~ 614 (862)
|+++.. .|++.|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 999653 3445553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.12 Score=58.01 Aligned_cols=80 Identities=20% Similarity=0.207 Sum_probs=53.1
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCC----Ch---hhHHHHHHHHHHHHhcc---ccceeeEEEEEeecCeEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS----SE---QGVHEFQTEIEMLSKLR---HKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 600 (862)
.+.||.|....||+....+ ..++||+-... .. ....+-..|.+.|+.+. ..++.+++.+|.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~~-~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSS-GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcCC-ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 4678999999999987644 46889975421 11 12334455677776663 2478889998874 35788
Q ss_pred EEeCCC--CcHHHHH
Q 041565 601 YDYMAN--GTLREHL 613 (862)
Q Consensus 601 ~E~~~~--gsL~~~l 613 (862)
||++++ -.+++-|
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3455444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.06 Score=59.48 Aligned_cols=140 Identities=16% Similarity=0.270 Sum_probs=79.2
Q ss_pred eeEeeeCcEEEEEEEEcCc----cEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDGK----TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.|..|=...+|+....+. ..+++|.......... .-.+|..+++.+...++- ++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 3454466778888865442 3788887765433222 225788999998766664 5565553 32 58999976
Q ss_pred CcHHH--------------H---HhcCCCC----CCChhhHHHHHHHH----------------------HHHHH----H
Q 041565 607 GTLRE--------------H---LYKGDKP----GLPWKQRLEICIGA----------------------ARGLH----Y 639 (862)
Q Consensus 607 gsL~~--------------~---l~~~~~~----~l~~~~~~~i~~~i----------------------a~gL~----y 639 (862)
..|.. . ||..... .--|..+.++..++ .+-+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 1 1111100 11233322222211 11111 1
Q ss_pred hhc-CCcccEEeeCCCCCCeeccC-CCceEEeecccccc
Q 041565 640 LHT-GARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKT 676 (862)
Q Consensus 640 LH~-~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~ 676 (862)
+.. ......+|.|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12345899999999999975 46899999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.11 Score=56.75 Aligned_cols=32 Identities=19% Similarity=0.319 Sum_probs=28.5
Q ss_pred cccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 645 ~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
...++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44699999999999999999999999987765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.067 Score=58.07 Aligned_cols=139 Identities=17% Similarity=0.197 Sum_probs=91.0
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCC-----C--------------------hhhH-HHHHHHHHHHHhccccce
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS-----S--------------------EQGV-HEFQTEIEMLSKLRHKHL 584 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-----~--------------------~~~~-~~~~~E~~~l~~l~H~ni 584 (862)
...|..|.-+.||.++-.+|..+|||+.+.. + +... --...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4578899999999999999999999975421 0 0011 113457777777764433
Q ss_pred eeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC
Q 041565 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW 664 (862)
Q Consensus 585 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 664 (862)
.-.--... ....|||+|+....-..-.. ..-.++...+..+-.+++.-|.-|-+.| ++||.||.--|+|+.+ |
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence 21110001 13479999995321111000 1123677778888888999999888866 6999999999999964 5
Q ss_pred ceEEeecccccc
Q 041565 665 EAKVSDFGLSKT 676 (862)
Q Consensus 665 ~~kl~DFGla~~ 676 (862)
.+.|+|-+-+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 899999876543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.021 Score=64.27 Aligned_cols=50 Identities=20% Similarity=0.382 Sum_probs=38.4
Q ss_pred HHHHHHHHHHHhccccceeeEEEEEeec-CeEEEEEEeCCCCcHHHHHhcCC
Q 041565 567 HEFQTEIEMLSKLRHKHLVSLIGFCEED-GEMILVYDYMANGTLREHLYKGD 617 (862)
Q Consensus 567 ~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~ 617 (862)
.+.+....+++.+.|+|+...+.+.... ....+|+|++ +-+|.+.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 4566778889999999999988876433 4578899999 568998886543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.097 Score=58.44 Aligned_cols=81 Identities=19% Similarity=0.249 Sum_probs=52.3
Q ss_pred ceeEeeeCcEEEEEEEEcC-ccEEEEEecCC------CChhhHHHHHHHHHHHHhcc--cccee-eEEEEEeecCeEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDG-KTKVAIKRSNP------SSEQGVHEFQTEIEMLSKLR--HKHLV-SLIGFCEEDGEMILV 600 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--H~niv-~l~g~~~~~~~~~lV 600 (862)
.+.||.|.-..||++.... +..|+||.-.. .-.-..++..-|.+.|+.+. .|..| +++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999753 45799995321 11334566777888888763 45444 45543 33455789
Q ss_pred EEeCCCC-cHHHHH
Q 041565 601 YDYMANG-TLREHL 613 (862)
Q Consensus 601 ~E~~~~g-sL~~~l 613 (862)
||+++.. .|++.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998643 344444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.051 Score=55.84 Aligned_cols=31 Identities=29% Similarity=0.462 Sum_probs=21.9
Q ss_pred ccEEeeCCCCCCeec-cCCCceEEeecccccc
Q 041565 646 YTIIHRDVKTTNILL-DEKWEAKVSDFGLSKT 676 (862)
Q Consensus 646 ~~ivHrDIkp~NILl-~~~~~~kl~DFGla~~ 676 (862)
..++|+|+.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8889999999987754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.37 Score=52.55 Aligned_cols=30 Identities=33% Similarity=0.396 Sum_probs=25.8
Q ss_pred ccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 646 ~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 46999999999999987 5789999986654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.16 Score=51.44 Aligned_cols=149 Identities=11% Similarity=0.113 Sum_probs=88.8
Q ss_pred EEEEEEEEcCccEEEEEecCCCChh-hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCC
Q 041565 540 GKVYEGYIDGKTKVAIKRSNPSSEQ-GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK 618 (862)
Q Consensus 540 g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~ 618 (862)
.+.-++..+-| ...+|++....-. ...-|..+.+++++++ .|++|.. ...-.+.++.|+|-.-.
T Consensus 76 sTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~---------- 140 (308)
T PF07387_consen 76 STLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK---------- 140 (308)
T ss_pred eEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc----------
Confidence 33333333333 3556665543322 3456788899988874 4666662 23445678889883210
Q ss_pred CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCCh
Q 041565 619 PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698 (862)
Q Consensus 619 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 698 (862)
. ....++..=.++|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+..-. .+..|.--
T Consensus 141 --i---~~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~ 200 (308)
T PF07387_consen 141 --I---NFSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNI 200 (308)
T ss_pred --c---chhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEee
Confidence 0 01112222246788889653 5699999999999999999999998653211 01112221
Q ss_pred hhhhcCCCCchhHHHHHHHHHHHHHhCC
Q 041565 699 EYFRRQQLTEKSDVYSFGVVLFEVLCAR 726 (862)
Q Consensus 699 E~~~~~~~s~ksDVyS~Gvvl~elltG~ 726 (862)
.....+.++.+=+|=.-++++....
T Consensus 201 ---~Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 201 ---EYESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred ---eccccChHHHHHHHHHHHHHHHHHH
Confidence 1234567788888877778876544
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.14 E-value=1 Score=49.63 Aligned_cols=72 Identities=15% Similarity=0.129 Sum_probs=45.5
Q ss_pred eeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccc--ceeeEE---E--EEeecCeEEEEEEeCCCCc
Q 041565 536 VGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK--HLVSLI---G--FCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 536 ~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lV~E~~~~gs 608 (862)
.+.-..||+...+++..+++|..+... ....+...|++.+..|... .++... | ....++..+.++++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345578999988888789999875332 2345667788888777422 122211 1 1223466788999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 862 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-94 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-94 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 565 bits (1458), Expect = 0.0
Identities = 180/324 (55%), Positives = 228/324 (70%), Gaps = 8/324 (2%)
Query: 486 GTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEG 545
G+ ++ ++ +SS+L L +++ T NF +IG G FGKVY+G
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFE---SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 546 YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605
+ KVA+KR P S QG+ EF+TEIE LS RH HLVSLIGFC+E EMIL+Y YM
Sbjct: 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 606 NGTLREHLYKGDKPG--LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK 663
NG L+ HLY D P + W+QRLEICIGAARGLHYLHT A IIHRDVK+ NILLDE
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175
Query: 664 WEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ K++DFG+SK G L+QTH+ST+VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEVL
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 724 CARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSD 783
CAR A+ +LP+E V+LA+WA+ G +E I+DPNL I + LRKF +TA KCL+
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 784 QGIDRPSMGDVLWNLEFALQLQDN 807
DRPSMGDVLW LE+AL+LQ++
Sbjct: 296 SSEDRPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 384 bits (990), Expect = e-128
Identities = 106/300 (35%), Positives = 168/300 (56%), Gaps = 22/300 (7%)
Query: 514 RHFSLAEIKHGTRNFSE------SHVIGVGGFGKVYEGYIDGKTKVAIKR----SNPSSE 563
FS E+K+ T NF E + +G GGFG VY+GY++ T VA+K+ + ++E
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTE 71
Query: 564 QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLY-KGDKPGLP 622
+ +F EI++++K +H++LV L+GF + ++ LVY YM NG+L + L P L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
W R +I GAA G+++LH IHRD+K+ NILLDE + AK+SDFGL++ Q
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742
T +++ + G+ Y+ PE R ++T KSD+YSFGVVL E++ PA++ + + L D
Sbjct: 189 TVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLD 245
Query: 743 WA--LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800
+ + TIED ID + + + A +CL ++ RP + V L+
Sbjct: 246 IKEEIEDEE-KTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-124
Identities = 118/303 (38%), Positives = 176/303 (58%), Gaps = 6/303 (1%)
Query: 502 SSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS 561
+ + G + FSL E++ + NFS +++G GGFGKVY+G + T VA+KR
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65
Query: 562 SEQGV-HEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLY--KGDK 618
QG +FQTE+EM+S H++L+ L GFC E +LVY YMANG++ L +
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 619 PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678
P L W +R I +G+ARGL YLH IIHRDVK NILLDE++EA V DFGL+K
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ- 737
THV+T V+G+ G++ PEY + +EK+DV+ +GV+L E++ + A ++
Sbjct: 186 Y-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 738 -VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796
V L DW + +E ++D +L+GN D+ + + + A C ++RP M +V+
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 797 NLE 799
LE
Sbjct: 305 MLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 2e-83
Identities = 64/318 (20%), Positives = 122/318 (38%), Gaps = 33/318 (10%)
Query: 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEI 573
+ + V G FG V++ + + VA+K +Q + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQS-WQNEYEV 69
Query: 574 EMLSKLRHKHLVSLIGFCEED----GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
L ++H++++ IG + ++ L+ + G+L + L + W + I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHI 126
Query: 630 CIGAARGLHYLHTGARYT-------IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
ARGL YLH I HRD+K+ N+LL A ++DFGL+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 683 THVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737
+ G+ Y+ PE ++ + D+Y+ G+VL+E+ A + + +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 738 VSLADWALHCQRMGTIEDI--------IDPNLKGNIT-DQCLRKFTETAEKCLSDQGIDR 788
+ + + ++ED+ P L+ + ET E+C R
Sbjct: 247 LPFEEEI---GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 789 PSMGDVLWNLEFALQLQD 806
S G V + +L +
Sbjct: 304 LSAGCVGERITQMQRLTN 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-66
Identities = 76/272 (27%), Positives = 131/272 (48%), Gaps = 24/272 (8%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG V+ G VA+K + V+EF E+ ++ +LRH ++V +G
Sbjct: 43 EKIGAGSFGTVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 590 FCEEDGEMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
+ + +V +Y++ G+L L+K G + L ++RL + A+G++YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-VKGSFGYLDPEYFRRQQLT 707
+HR++K+ N+L+D+K+ KV DFGLS+ T +S+ G+ ++ PE R +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 708 EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767
EKSDVYSFGV+L+E+ + P ++ A + + I
Sbjct: 218 EKSDVYSFGVILWELATLQ------QPWGNLNPAQVV---------AAVGFKCKRLEIPR 262
Query: 768 QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ E C +++ RPS ++ L
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-65
Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 28/285 (9%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEML 576
SL I + + V+G G FG V + K VAIK+ SE+ F E+ L
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWRAKD-VAIKQIESESERK--AFIVELRQL 55
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK-PGLPWKQRLEICIGAAR 635
S++ H ++V L G C + LV +Y G+L L+ + P + C+ ++
Sbjct: 56 SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWE-AKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
G+ YLH+ +IHRD+K N+LL K+ DFG + + T KGS
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAA 168
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754
++ PE F +EK DV+S+G++L+EV+ R P +++ + I
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR--------IM 214
Query: 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ + + + +C S RPSM +++ +
Sbjct: 215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-63
Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 41/296 (13%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIKR-------SNPSSEQGVHEFQT 571
+ IG GGFG V++G + K+ VAIK + EFQ
Sbjct: 15 TLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 572 EIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI 631
E+ ++S L H ++V L G +V +++ G L L P + W +L + +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLML 129
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE-----AKVSDFGLSKTGPNLNQTHVS 686
A G+ Y+ I+HRD+++ NI L E AKV+DFGLS+ H
Sbjct: 130 DIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSV 183
Query: 687 TMVKGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWA 744
+ + G+F ++ PE ++ TEK+D YSF ++L+ +L P +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GP--------FD 229
Query: 745 -LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
++ I I + L+ I + C + E C S RP ++ L
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-62
Identities = 70/336 (20%), Positives = 124/336 (36%), Gaps = 47/336 (13%)
Query: 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEM 575
+ +E N +IG G +G VY+G +D + VA+K + ++ Q F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSFANRQ---NFINEKNI 58
Query: 576 --LSKLRHKHLVSLIGFCEEDG-----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLE 628
+ + H ++ I E E +LV +Y NG+L ++L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCR 115
Query: 629 ICIGAARGLHYLHT------GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT------ 676
+ RGL YLHT + I HRD+ + N+L+ +SDFGLS
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 677 GPNLNQTHVSTMVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPAL 729
+ + + G+ Y+ PE + ++ D+Y+ G++ +E+ L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 730 NVNLPKEQVSLADWALHCQRMGTIEDIID--------PNLKGNITD--QCLRKFTETAEK 779
+ +A + T ED+ P + +R ET E
Sbjct: 236 FPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 780 CLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLIS 815
C R + + +L + +K +S
Sbjct: 295 CWDQDAEARLTAQXAEERMA---ELMMIWERNKSVS 327
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-62
Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 35/280 (12%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ----GVHEFQTEIEMLSKLRHKHLVSL 587
+IG+GGFGKVY + G +VA+K + ++ + + E ++ + L+H ++++L
Sbjct: 13 EIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
G C ++ + LV ++ G L L +P + + ARG++YLH A
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 648 IIHRDVKTTNILLDEK--------WEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
IIHRD+K++NIL+ +K K++DFGL++ ++T + G++ ++ PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAPE 184
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759
R ++ SDV+S+GV+L+E+L +P + A +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVA---------YGVAMN 229
Query: 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
L I C F + E C + RPS ++L L
Sbjct: 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-61
Identities = 48/283 (16%), Positives = 112/283 (39%), Gaps = 34/283 (12%)
Query: 527 NFSE---SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRH 581
+F + + G++++G G + +K S + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 582 KHLVSLIGFCEE--DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
+++ ++G C+ L+ +M G+L L++G + Q ++ + ARG+ +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LHT I + + ++++DE A++S + + S + ++ PE
Sbjct: 127 LHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE 178
Query: 700 YFRRQQL---TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756
+++ +D++SF V+L+E++ +P +S + +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIG---------MKV 223
Query: 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
L+ I ++ + C+++ RP ++ LE
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-61
Identities = 77/275 (28%), Positives = 130/275 (47%), Gaps = 27/275 (9%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG VY+G G VA+K N + + Q + F+ E+ +L K RH +++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
+ I V + +L HL+ + K+ ++I ARG+ YLH +II
Sbjct: 88 YSTAPQLAI-VTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL--- 706
HRD+K+ NI L E K+ DFGL+ + +H + GS ++ PE R Q
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 707 TEKSDVYSFGVVLFEVLCAR-PALNVNLPKEQVSLADWALHCQ-RMGTIEDIIDPNLKGN 764
+ +SDVY+FG+VL+E++ + P N+N ++Q+ + +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQII---EMVGRGSLSPDLS---------K 249
Query: 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ C ++ +CL + +RPS +L +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 5e-60
Identities = 56/283 (19%), Positives = 112/283 (39%), Gaps = 38/283 (13%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+IG G FG+VY G G +VAI+ + +E + F+ E+ + RH+++V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
C + ++ TL + L + +I +G+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSK---TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
H+D+K+ N+ D + ++DFGL + + G +L PE R+
Sbjct: 153 HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 707 ---------TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ-RMGTIEDI 756
++ SDV++ G + +E+ P E + W + + ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII---WQMGTGMKP----NL 263
Query: 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
++ ++ C + + +RP+ ++ LE
Sbjct: 264 SQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-59
Identities = 71/311 (22%), Positives = 116/311 (37%), Gaps = 41/311 (13%)
Query: 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTK-VAIKRSNPSSEQGVHEFQTE 572
R F +++ HG V+G G FG+ + + + +K E+ F E
Sbjct: 5 RIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 573 IEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG 632
++++ L H +++ IG +D + + +Y+ GTLR + D PW QR+
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKD 116
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK------------TGPNL 680
A G+ YLH IIHRD+ + N L+ E V+DFGL++
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL 740
V G+ ++ PE + EK DV+SFG+VL E++ A + +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTMDF 232
Query: 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800
C F +C RPS + LE
Sbjct: 233 GLNVRGFLDR-------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE- 278
Query: 801 ALQLQDNPDGD 811
L+ + G
Sbjct: 279 --TLRMHLAGH 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-55
Identities = 72/304 (23%), Positives = 128/304 (42%), Gaps = 38/304 (12%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G +G+V+ G G KVA+K + E +TEI +RH++++ I
Sbjct: 43 KQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAAD 100
Query: 592 EEDG----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ ++ L+ DY NG+L ++L L K L++ + GL +LHT T
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 648 -----IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH--VSTMVKGSFGYLDPE- 699
I HRD+K+ NIL+ + ++D GL+ + G+ Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 700 -----YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754
Q +D+YSFG++L+E + R + + Q+ D + E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEEYQLPYHDLV---PSDPSYE 273
Query: 755 DIID--------PNL-KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805
D+ + P+ +D+CLR+ + +C + R + V L ++
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA---KMS 330
Query: 806 DNPD 809
++ D
Sbjct: 331 ESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-54
Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 39/303 (12%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEM--LSKLRHK 582
R+ + +G G +G+V+ G G VA+K + E+ + E E+ LRH+
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEK---SWFRETELYNTVMLRHE 62
Query: 583 HLVSLIGFC----EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
+++ I ++ L+ Y G+L ++L L L I + A GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLA 119
Query: 639 YLHTGARYT-----IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM--VKG 691
+LH T I HRD+K+ NIL+ + + ++D GL+ G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 692 SFGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL 745
+ Y+ PE ++ D+++FG+VL+EV R N + + D
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVV- 237
Query: 746 HCQRMGTIEDIID--------PNLKGNI-TDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796
+ ED+ PN+ +D L + ++C R + +
Sbjct: 238 --PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 797 NLE 799
L
Sbjct: 296 TLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 64/294 (21%), Positives = 125/294 (42%), Gaps = 35/294 (11%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG+V+ G G+ VA+K + E+ + EI LRH++++ I
Sbjct: 48 ESIGKGRFGEVWRGKWRGEE-VAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAAD 105
Query: 592 EEDG----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+D ++ LV DY +G+L ++L ++ + + +++ + A GL +LH T
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 648 -----IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH--VSTMVKGSFGYLDPE- 699
I HRD+K+ NIL+ + ++D GL+ + T G+ Y+ PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 700 -----YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754
+ + +++D+Y+ G+V +E+ R ++ Q+ + ++E
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL---PYYDLVPSDPSVE 278
Query: 755 DIID--------PNLKGNIT-DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
++ PN+ + LR + +C G R + + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-42
Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 6/192 (3%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG+V+ G +G T+VAIK P + F E +++ KLRH+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E+ I V +YM+ G+L + L L Q +++ A G+ Y+ R +HR
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D++ NIL+ E KV+DFGL++ + N+ K + PE + T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 712 VYSFGVVLFEVL 723
V+SFG++L E+
Sbjct: 364 VWSFGILLTELT 375
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-42
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLS 577
+ H + IG G FG+V+ G T VA+K +F E +L
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGL 637
+ H ++V LIG C + + +V + + G L + + L K L++ AA G+
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGM 226
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY-- 695
YL IHRD+ N L+ EK K+SDFG+S+ + + ++
Sbjct: 227 EYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAASGGLRQVPVKW 281
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
PE + + +SDV+SFG++L+E
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETF 309
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-41
Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 6/192 (3%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG+V+ G +G T+VAIK P + F E +++ KLRH+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E+ I V +YM+ G+L + L L Q +++ A G+ Y+ R +HR
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSD 711
D++ NIL+ E KV+DFGL++ + N+ K + PE + T KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 712 VYSFGVVLFEVL 723
V+SFG++L E+
Sbjct: 447 VWSFGILLTELT 458
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG+V+ GY +G TKVA+K S F E ++ +L+H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
++ I + +YM NG+L + L L + L++ A G+ ++ IHR
Sbjct: 78 TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST---MVKGSFGYLDPEYFRRQQLTE 708
D++ NIL+ + K++DFGL++ + T +K + PE T
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEAINYGTFTI 189
Query: 709 KSDVYSFGVVLFEVL 723
KSDV+SFG++L E++
Sbjct: 190 KSDVWSFGILLTEIV 204
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-40
Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 532 HVIGVGGFGKVYEGYIDGK-TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
H +G G +G+VYEG VA+K + + V EF E ++ +++H +LV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
C + ++ ++M G L ++L + ++ + L + + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKS 710
R++ N L+ E KV+DFGLS+ + K + PE + + KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 711 DVYSFGVVLFEVL 723
DV++FGV+L+E+
Sbjct: 401 DVWAFGVLLWEIA 413
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-40
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG+V+ + TKVA+K P S V F E ++ L+H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
++ I + ++MA G+L + L + P + ++ A G+ ++ + IHR
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHR 308
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY--LDPEYFRRQQLTEK 709
D++ NIL+ K++DFGL++ + + F PE T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 710 SDVYSFGVVLFEVL 723
SDV+SFG++L E++
Sbjct: 366 SDVWSFGILLMEIV 379
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG V+ GY K KVAIK R SE+ +F E E++ KL H LV L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
C E + LV ++M +G L ++L + + + L +C+ G+ YL +I
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY--LDPEYFRRQQLT 707
HRD+ N L+ E KVSDFG+++ + ++ F PE F + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 708 EKSDVYSFGVVLFEVL 723
KSDV+SFGV+++EV
Sbjct: 184 SKSDVWSFGVLMWEVF 199
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 532 HVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
+G G FG V D VA+K+ S +FQ EI++L L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 587 LIGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
G G + LV +Y+ +G LR+ L + + L + L +G+ YL +
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS-R 146
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRR 703
R +HRD+ NIL++ + K++DFGL+K + + V + + PE
Sbjct: 147 RC--VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 704 QQLTEKSDVYSFGVVLFEV--LCARP 727
+ +SDV+SFGVVL+E+ C +
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 532 HVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
+G G FG V D VA+K+ S+E+ + +F+ EIE+L L+H ++V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 587 LIGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
G C G + L+ +Y+ G+LR++L + K + + L+ +G+ YL T
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-K 133
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFGYLDPEYFRR 703
RY IHRD+ T NIL++ + K+ DFGL+K P + V + + PE
Sbjct: 134 RY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 704 QQLTEKSDVYSFGVVLFEVL 723
+ + SDV+SFGVVL+E+
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-39
Identities = 65/195 (33%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG V G G KVA+K + F E ++++LRH +LV L+G
Sbjct: 199 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 592 -EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
EE G + +V +YMA G+L ++L + L L+ + + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM--VKGSFGYLDPEYFRRQQLTE 708
RD+ N+L+ E AKVSDFGL+K + T + VK + PE R ++ +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK----WTAPEALREKKFST 365
Query: 709 KSDVYSFGVVLFEVL 723
KSDV+SFG++L+E+
Sbjct: 366 KSDVWSFGILLWEIY 380
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 532 HVIGVGGFGKVYEGY-----IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLV 585
V+G G FG VY+G K VAIK +S + E E +++ + + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L+G C + + M G L +++ + K + + L C+ A+G++YL R
Sbjct: 81 RLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLED-RR 137
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
+HRD+ N+L+ K++DFGL+K + + + K ++ E +
Sbjct: 138 L--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 706 LTEKSDVYSFGVVLFEVL 723
T +SDV+S+GV ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 43/217 (19%)
Query: 532 HVIGVGGFGKVYEGY--------IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
+G G F K+++G +T+V +K + + F M+SKL HKH
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
LV G C E ILV +++ G+L +L K +K + +LE+ A +H+L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL--- 129
Query: 644 ARYTIIHRDVKTTNILLDEKWE--------AKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
T+IH +V NILL + + K+SD G+S T V
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 696 LDP---------EYFRRQQLTEKSDVYSFGVVLFEVL 723
+ E + L +D +SFG L+E+
Sbjct: 178 QERIPWVPPECIENPKN--LNLATDKWSFGTTLWEIC 212
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G FG V G G+ VA+K + SE EF E + + KL H LV G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYG 70
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
C ++ + +V +Y++NG L +L + GL Q LE+C G+ +L + I
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY--LDPEYFRRQQLT 707
HRD+ N L+D KVSDFG+++ + + V F PE F + +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 708 EKSDVYSFGVVLFEVL 723
KSDV++FG++++EV
Sbjct: 184 SKSDVWAFGILMWEVF 199
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 14/196 (7%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G FG V G G+ VAIK + SE EF E +++ L H+ LV L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
C + + ++ +YMANG L +L + + +Q LE+C + YL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY--LDPEYFRRQQLT 707
HRD+ N L++++ KVSDFGLS+ + ++ V F PE + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 708 EKSDVYSFGVVLFEVL 723
KSD+++FGV+++E+
Sbjct: 200 SKSDIWAFGVLMWEIY 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 65/195 (33%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG V G G KVA+K + F E ++++LRH +LV L+G
Sbjct: 27 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 592 -EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
EE G + +V +YMA G+L ++L + L L+ + + YL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140
Query: 651 RDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM--VKGSFGYLDPEYFRRQQLTE 708
RD+ N+L+ E AKVSDFGL+K + T + VK + PE R ++ +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK----WTAPEALREKKFST 193
Query: 709 KSDVYSFGVVLFEVL 723
KSDV+SFG++L+E+
Sbjct: 194 KSDVWSFGILLWEIY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 533 VIGVGGFGKVYEGYIDG-----KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FG V D VA+K+ S+E+ + +F+ EIE+L L+H ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 588 IGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
G C G + L+ +Y+ G+LR++L + K + + L+ +G+ YL T R
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-KR 165
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP-NLNQTHVSTMVKGSFGYLDPEYFRRQ 704
Y IHRD+ T NIL++ + K+ DFGL+K P + V + + PE
Sbjct: 166 Y--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ + SDV+SFGVVL+E+
Sbjct: 224 KFSVASDVWSFGVVLYELF 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 533 VIGVGGFGKVYEGYIDGK---TKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G G FG V +GY K VA+K ++ + E E ++ +L + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
IG CE + M+ V + G L ++L + + K +E+ + G+ YL
Sbjct: 84 IGICEAESWML-VMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL---EESN 137
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
+HRD+ N+LL + AK+SDFGLSK + N T K + PE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 707 TEKSDVYSFGVVLFEVL 723
+ KSDV+SFGV+++E
Sbjct: 198 SSKSDVWSFGVLMWEAF 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYI----DGKTKVAIKRSNP-SSEQGVHEFQTEIE 574
I H VIG G FG VY G + + AIK + + Q V F E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 575 MLSKLRHKHLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA 633
++ L H ++++LIG +G ++ YM +G L + + + + K + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQV 133
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
ARG+ YL A +HRD+ N +LDE + KV+DFGL++ ++ ++ +
Sbjct: 134 ARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRH 187
Query: 694 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEVL 723
L E + + T KSDV+SFGV+L+E+L
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNP-SSEQGVHEFQTEI 573
+ R +G G FGKV D +VA+K P S + + + EI
Sbjct: 17 HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 574 EMLSKLRHKHLVSLIGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICI 631
E+L L H+++V G C EDG + L+ +++ +G+L+E+L +K + KQ+L+ +
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAV 133
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVK 690
+G+ YL + +Y +HRD+ N+L++ + + K+ DFGL+K + V
Sbjct: 134 QICKGMDYLGS-RQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 723
+ PE + + SDV+SFGV L E+L
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG---KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RHKHLVS 586
VIG G FG+V + I + AIKR +S+ +F E+E+L KL H ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRLEICIG 632
L+G CE G + L +Y +G L + L L +Q L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
ARG+ YL ++ IHRD+ NIL+ E + AK++DFGLS+ VK +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKT 199
Query: 693 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
G L E T SDV+S+GV+L+E+
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 532 HVIGVGGFGKVYEGYI----DGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
VIG G FG VY G + K A+K N + V +F TE ++ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 587 LIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L+G C +G ++V YM +G LR + + + K + + A+G+ YL A
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL-----DPEY 700
+HRD+ N +LDEK+ KV+DFGL++ ++ ++ + L E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 701 FRRQQLTEKSDVYSFGVVLFEVL 723
+ Q+ T KSDV+SFGV+L+E++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELM 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 533 VIGVGGFGKVYEGYIDGK----TKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G FG V G D VA+K S + + +F E+ + L H++L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L G + V + G+L + L + + + A G+ YL + R
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLES-KR 141
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
+ IHRD+ N+LL + K+ DFGL + N + + K F + PE + +
Sbjct: 142 F--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ SD + FGV L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 532 HVIGVGGFGKVYEG-YIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
H +G G +G+VYEG + VA+K + + + EF E ++ +++H +LV L+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G C + ++ ++M G L ++L + ++ + L + + + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL-----DPEYFRR 703
IHRD+ N L+ E KV+DFGLS+ T + PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 704 QQLTEKSDVYSFGVVLFEVL 723
+ + KSDV++FGV+L+E+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 22/223 (9%)
Query: 524 GTRNFSESHVIGVGGFGKVY--EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH 581
+++ +G GGF V EG DG A+KR +Q E Q E +M H
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGH-FYALKRILCHEQQDREEAQREADMHRLFNH 85
Query: 582 KHLVSLIGFCEEDG----EMILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAAR 635
+++ L+ +C + E L+ + GTL + K L Q L + +G R
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV------ 689
GL +H HRD+K TNILL ++ + + D G + +
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 690 -KGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPA 728
+ + Y PE F + E++DV+S G VL+ ++
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 52/300 (17%)
Query: 526 RNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
+F E +IG GGFG+V++ IDGKT IKR ++E + + E++ L+KL H +
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKT-YVIKRVKYNNE----KAEREVKALAKLDHVN 65
Query: 584 LVSLIGFCEEDGEMI----------------LVYDYMANGTLREHLYKGDKPGLPWKQRL 627
+V G + + ++ GTL + + K L L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
E+ +G+ Y+H +I+RD+K +NI L + + K+ DFGL + L T
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRT 179
Query: 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALH 746
KG+ Y+ PE Q ++ D+Y+ G++L E+L A + +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL-------- 231
Query: 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQD 806
R G I DI D K + + L K E DRP+ ++L L + +
Sbjct: 232 --RDGIISDIFDKKEK-TLLQKLLSKKPE-----------DRPNTSEILRTLTVWKKSPE 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 534 IGVGGFGKVYEGY---IDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG V +G + VAIK + + + E E +++ +L + ++V LI
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G C+ + M+ V + G L + L G + +P E+ + G+ YL +
Sbjct: 77 GVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL-EEKNF-- 131
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+HRD+ N+LL + AK+SDFGLSK G + + + K + PE ++ +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 708 EKSDVYSFGVVLFEVL 723
+SDV+S+GV ++E L
Sbjct: 192 SRSDVWSYGVTMWEAL 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 532 HVIGVGGFGKVYEGYIDG----KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
VIG G FG VY G + K A+K N + V +F TE ++ H +++S
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 587 LIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L+G C +G ++V YM +G LR + + + K + + A+G+ +L A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL-----DPEY 700
+HRD+ N +LDEK+ KV+DFGL++ ++ ++ + L E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 701 FRRQQLTEKSDVYSFGVVLFEVL 723
+ Q+ T KSDV+SFGV+L+E++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELM 290
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 532 HVIGVGGFGKVYEGY----IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
++G G FG+VYEG K VA+K + +F +E ++ L H H+V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
LIG EE+ I + + G L +L + +K L + + + + YL +
Sbjct: 78 LIGIIEEEPTWI-IMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLES-INC 134
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF--GYLDPEYFRRQ 704
+HRD+ NIL+ K+ DFGLS+ + ++ PE +
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ T SDV+ F V ++E+L
Sbjct: 190 RFTTASDVWMFAVCMWEIL 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 532 HVIGVGGFGKVYEGY-----IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLV 585
V+G G FG VY+G K VAIK +S + E E +++ + + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L+G C + + M G L +++ + K + + L C+ A+G++YL R
Sbjct: 81 RLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLED-RR 137
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
+HRD+ N+L+ K++DFGL+K + + + K ++ E +
Sbjct: 138 L--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 706 LTEKSDVYSFGVVLFEVL 723
T +SDV+S+GV ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G FGKV+ K VA+K + +FQ E E+L+ L+H+H+V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRLEICI 631
G C + +I+V++YM +G L + L + K L Q L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
A G+ YL A +HRD+ T N L+ K+ DFG+S+ + G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192
Query: 692 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
L PE ++ T +SDV+SFGV+L+E+ +P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 532 HVIGVGGFGKVYEGY-----IDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
V+G G FG V++G K V IK + + + L H H+
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAIGSLDHAHI 77
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
V L+G C + V Y+ G+L +H+ + + L + L + A+G++YL
Sbjct: 78 VRLLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL---E 132
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
+ ++HR++ N+LL + +V+DFG++ P ++ + + K ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ T +SDV+S+GV ++E++
Sbjct: 193 KYTHQSDVWSYGVTVWELM 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 532 HVIGVGGFGKVYEGYIDG-----KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G FGKV D VA+K + Q ++ EI++L L H+H++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 586 SLIGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
G CE+ G + LV +Y+ G+LR++L + + Q L G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHA- 152
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFR 702
Y IHRD+ N+LLD K+ DFGL+K V + PE +
Sbjct: 153 QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 703 RQQLTEKSDVYSFGVVLFEVL 723
+ SDV+SFGV L+E+L
Sbjct: 211 EYKFYYASDVWSFGVTLYELL 231
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FGKV + T VA+K +S + + +E +L ++ H H+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHL----------------------YKGDKPGLP 622
+ L G C +DG ++L+ +Y G+LR L D+ L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
+ ++G+ YL A ++HRD+ NIL+ E + K+SDFGLS+ ++ +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR---DVYE 202
Query: 683 THVSTMVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
VK S G + E T +SDV+SFGV+L+E+
Sbjct: 203 EDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 15/199 (7%)
Query: 532 HVIGVGGFGKVYEGY----IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
IG G FG V++G + VAIK +S+ +F E + + H H+V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
LIG E+ I + + G LR L + K L + + L YL
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYL---ESK 135
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF--GYLDPEYFRRQ 704
+HRD+ N+L+ K+ DFGLS+ + + KG ++ PE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 705 QLTEKSDVYSFGVVLFEVL 723
+ T SDV+ FGV ++E+L
Sbjct: 193 RFTSASDVWMFGVCMWEIL 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 532 HVIGVGGFGKVYEGYIDGK----TKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
++G G FG V E + + KVA+K +++ + + EF E + + H H+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 586 SLIGFCEEDG------EMILVYDYMANGTLREHL----YKGDKPGLPWKQRLEICIGAAR 635
L+G +++ +M +G L L + LP + + + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
G+ YL + IHRD+ N +L E V+DFGLS+ + +G
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSGDYYR--QGCASK 200
Query: 696 L-----DPEYFRRQQLTEKSDVYSFGVVLFEVL 723
L E T SDV++FGV ++E++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG--------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RH 581
+G G FG+V G VA+K ++E+ + + +E+EM+ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRL 627
K++++L+G C +DG + ++ +Y + G LRE+L + + + +K +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
ARG+ YL A IHRD+ N+L+ E K++DFGL++ ++N
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDY-- 212
Query: 688 MVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
K + G L PE + T +SDV+SFGV+++E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 26/276 (9%)
Query: 527 NFSESHVIGVGGFGKVYEGY--IDGKTKVAIKR---SNPSSEQGVHEFQTEIEMLSKLRH 581
NF IG G F +VY +DG VA+K+ + + + EI++L +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGV-PVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAARGLHY 639
+++ ED E+ +V + G L + +K K +P + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
+H ++HRD+K N+ + K+ D GL + + T ++V G+ Y+ PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLV-GTPYYMSPE 206
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759
KSD++S G +L+E+ + + SL C D
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEQCDYPPLPSDHYSE 265
Query: 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
L+ + + C+ E RP + V
Sbjct: 266 ELR-QLVNMCINPDPE-----------KRPDVTYVY 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 532 HVIGVGGFGKVYEGYIDGK----TKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
++G G FG V EG + + KVA+K + + SS++ + EF +E + H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 586 SLIGFCEEDG-----EMILVYDYMANGTLREHL----YKGDKPGLPWKQRLEICIGAARG 636
L+G C E + +++ +M G L +L + +P + L+ + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
+ YL + +HRD+ N +L + V+DFGLSK + +G +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYR--QGRIAKM 211
Query: 697 -----DPEYFRRQQLTEKSDVYSFGVVLFEVL 723
E + T KSDV++FGV ++E+
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+G G FGKV+ K VA+K +SE +FQ E E+L+ L+H+H+V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHL-------------YKGDKPGLPWKQRLEICIG 632
G C E +++V++YM +G L L L Q L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
A G+ YL A +HRD+ T N L+ + K+ DFG+S+ ++ T G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYR--VGG 218
Query: 693 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
L PE ++ T +SDV+SFGVVL+E+ +P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 527 NFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHK 582
+ IG G FGK DG+ + IK N S S + E + E+ +L+ ++H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGR-QYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
++V EE+G + +V DY G L + + Q L+ + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEY 700
I+HRD+K+ NI L + ++ DFG+++ LN T + G+ YL PE
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACI-GTPYYLSPEI 196
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760
+ KSD+++ G VL+E+ + A K V + + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSFPPVSLHYSYD 252
Query: 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
L+ ++ Q ++ DRPS+ +L
Sbjct: 253 LR-SLVSQLFKRNPR-----------DRPSVNSIL 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 532 HVIGVGGFGKVYEGY-----IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLV 585
VIG G FG+VY+G + VAIK +E+ +F E ++ + H +++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L G + M+++ +YM NG L + L + Q + + G A G+ YL A
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-----VKGSFGYLDPEY 700
+HRD+ NIL++ KVSDFGLS+ + + +T ++ + PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR----WTAPEA 221
Query: 701 FRRQQLTEKSDVYSFGVVLFEVL 723
++ T SDV+SFG+V++EV+
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVM 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKH 583
+G G FGKV E G VA+K PS +E+++LS L H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHL----------------YKGDKPGLPWKQRL 627
+V+L+G C G +++ +Y G L L + D+ L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
A+G+ +L A IHRD+ NILL K+ DFGL++ ++
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSN-- 200
Query: 688 MVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
V L PE T +SDV+S+G+ L+E+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 62/263 (23%), Positives = 115/263 (43%), Gaps = 24/263 (9%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
IG G F VY+G D +T +VA + ++ F+ E EML L+H ++V
Sbjct: 33 EIGRGSFKTVYKGL-DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 589 G----FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
+ ++LV + M +GTL+ +L + + K C +GL +LHT
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-R 148
Query: 645 RYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
IIHRD+K NI + K+ D GL+ + ++ G+ ++ PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVI-GTPEFMAPEMY-E 203
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763
++ E DVY+FG+ + E+ + + Q+ + + + + P +K
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVAIPEVK- 260
Query: 764 NITDQCLRKFTE---TAEKCLSD 783
I + C+R+ + + + L+
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNH 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 532 HVIGVGGFGKVYEGYI----DGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
+IG G G+V G + VAIK +E+ +F +E ++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L G ++V +YM NG+L L + Q + + G G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-----VKGSFGYLDPEYF 701
+HRD+ N+L+D KVSDFGLS+ + +T ++ + PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR----WTAPEAI 226
Query: 702 RRQQLTEKSDVYSFGVVLFEVL 723
+ + SDV+SFGVV++EVL
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVL 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FG+VYEG + G +VA+K SEQ +F E ++SK H+++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHL-----YKGDKPGLPWKQRLEICIGAARGLHY 639
V IG + ++ + MA G L+ L L L + A G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L IHRD+ N LL AK+ DFG+++ ++ + S KG L
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRA--SYYRKGGCAML 207
Query: 697 -----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
PE F T K+D +SFGV+L+E+ L P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG--------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RH 581
+G G FG+V G VA+K ++E+ + + +E+EM+ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRL 627
K++++L+G C +DG + ++ +Y + G LRE+L + + + +K +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
ARG+ YL A IHRD+ N+L+ E K++DFGL++ ++N
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNI--DY 258
Query: 688 MVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
K + G L PE + T +SDV+SFGV+++E+
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 532 HVIGVGGFGKVYEGYI------DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKH 583
+G G FGKV E D KVA+K + +E++++S L +H++
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHL------------YKGDKPGLPWKQRLEICI 631
+V+L+G C G ++++ +Y G L L + + L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKG 691
A+G+ +L A IHRDV N+LL AK+ DFGL++ ++ S +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMND--SNYIVK 223
Query: 692 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
L PE T +SDV+S+G++L+E+
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHL 584
+G FGKVY+G++ G VAIK + EF+ E + ++L+H ++
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRLEIC 630
V L+G +D + +++ Y ++G L E L + K L + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK 690
A G+ YL + + ++H+D+ T N+L+ +K K+SD GL + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAA--DYYKL 186
Query: 691 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
L PE + + SD++S+GVVL+EV +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FG VYEG G +T+VAIK N +S + EF E ++ + H+
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHL--------YKGDKPGLPWKQRLEICIGAARG 636
V L+G + +++ + M G L+ +L + +++ A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
+ YL +HRD+ N ++ E + K+ DFG+++ ++ +T KG G L
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYET--DYYRKGGKGLL 202
Query: 697 -----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
PE + T SDV+SFGVVL+E+ L +P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RHKH 583
+G G FG+V E G VA+K ++ +E+++L + H +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 584 LVSLIGFC-EEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRLE 628
+V+L+G C + G ++++ ++ G L +L K L + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688
A+G+ +L A IHRD+ NILL EK K+ DFGL++ ++ +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPD--Y 204
Query: 689 VKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
V+ L PE + T +SDV+SFGV+L+E+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 12/200 (6%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSL 587
++G GG G VYE D VA+K SS+ Q E +L+ H+V +
Sbjct: 41 LVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
F E DG++ + + L L + L + + I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
HRDVK NIL+ A + DFG++ + T + V G+ Y+ PE F T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHAT 213
Query: 708 EKSDVYSFGVVLFEVLCARP 727
++D+Y+ VL+E L P
Sbjct: 214 YRADIYALTCVLYECLTGSP 233
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FG+VYEG + G +VA+K SEQ +F E ++SK H+++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHL-----YKGDKPGLPWKQRLEICIGAARGLHY 639
V IG + ++ + MA G L+ L L L + A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L IHRD+ N LL AK+ DFG+++ ++ + KG L
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRA--GYYRKGGCAML 248
Query: 697 -----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
PE F T K+D +SFGV+L+E+ L P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKH 583
V+G G FGKV G +VA+K +E++M+++L H++
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHL---------------------YKGDKPGLP 622
+V+L+G C G + L+++Y G L +L + D L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
++ L A+G+ +L + +HRD+ N+L+ K+ DFGL++ ++
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMS 224
Query: 683 THVSTMVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
V L PE T KSDV+S+G++L+E+
Sbjct: 225 DSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 17/208 (8%)
Query: 533 VIGVGGFGKVY--EGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLI 588
IG G +G+ DGK + K + +E +E+ +L +L+H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGK-ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 589 G-FCEEDGEMI-LVYDYMANGTLREHLYKGDKPG--LPWKQRLEICIGAARGLHYLHT-- 642
+ + +V +Y G L + KG K L + L + L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEY 700
+T++HRD+K N+ LD K K+ DFGL++ LN T V G+ Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFV-GTPYYMSPEQ 187
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARPA 728
R EKSD++S G +L+E+ P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 15/198 (7%)
Query: 533 VIGVGGFGKVYEGY----IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVSL 587
IG G FG V++G + VAIK +S+ +F E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
IG E+ I + + G LR L + K L + + L YL
Sbjct: 457 IGVITENPVWI-IMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYL---ESKR 511
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF--GYLDPEYFRRQQ 705
+HRD+ N+L+ K+ DFGLS+ + + KG ++ PE ++
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 706 LTEKSDVYSFGVVLFEVL 723
T SDV+ FGV ++E+L
Sbjct: 569 FTSASDVWMFGVCMWEIL 586
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 532 HVIGVGGFGKVYEGYI----DGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVS 586
V+G G FG+V G + + VAIK +E+ +F E ++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L G + +++V +YM NG+L L + Q + + G A G+ YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM-----VKGSFGYLDPEYF 701
+HRD+ NIL++ KVSDFGL + + + +T ++ + PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR----WTSPEAI 222
Query: 702 RRQQLTEKSDVYSFGVVLFEVL 723
++ T SDV+S+G+VL+EV+
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVM 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-35
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 532 HVIGVGGFGKVYEGYIDG--------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RH 581
+G G FG+V G TKVA+K ++E+ + + +E+EM+ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHL--------------YKGDKPGLPWKQRL 627
K++++L+G C +DG + ++ +Y + G LRE+L + L K +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
ARG+ YL A IHRD+ N+L+ E K++DFGL++ +++
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIHHI--DY 246
Query: 688 MVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 722
K + G L PE + T +SDV+SFGV+L+E+
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 533 VIGVGGFGKVYEGY---IDGKTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG V +G + VAIK + + E E +++ +L + ++V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
G C+ + M+ V + G L + L G + +P E+ + G+ YL +
Sbjct: 403 GVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL-EEKNF-- 457
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+HR++ N+LL + AK+SDFGLSK G + + + K + PE ++ +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 708 EKSDVYSFGVVLFEVL 723
+SDV+S+GV ++E L
Sbjct: 518 SRSDVWSYGVTMWEAL 533
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/279 (22%), Positives = 103/279 (36%), Gaps = 33/279 (11%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLS 577
++F +G G +G+V++ DG+ A+KRS + E+
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL-YAVKRSMSPFRGPKDRARKLAEVGSHE 111
Query: 578 KL-RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARG 636
K+ +H V L EE G + L + +L++H LP Q
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS-LPEAQVWGYLRDTLLA 169
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L +LH+ ++H DVK NI L + K+ DFGL L + +G Y+
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYM 223
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756
PE + +DV+S G+ + EV C LP W Q++ +
Sbjct: 224 APELL-QGSYGTAADVFSLGLTILEVACNME-----LPHG---GEGW----QQL--RQGY 268
Query: 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ P ++ + LR L R + +L
Sbjct: 269 LPPEFTAGLSSE-LRSVL---VMMLEPDPKLRATAEALL 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 44/220 (20%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIK-----------------RSNPSSEQGVHEFQTEIEM 575
+ G F K+ D K A+K S + +F+ E+++
Sbjct: 38 TLNQGKFNKIILCEKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA-- 633
++ +++++ ++ G E+ ++Y+YM N ++ + + + I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 634 ----ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
Y+H I HRDVK +NIL+D+ K+SDFG S+ + +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR 211
Query: 690 KGSFGYLDPEYFRRQQLT--EKSDVYSFGVVLFEVLCARP 727
G++ ++ PE+F + K D++S G+ L+ +
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLI 588
+G GG VY D KVAIK P ++ + F+ E+ S+L H+++VS+I
Sbjct: 19 LGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTI 648
EED LV +Y+ TL E++ L + G+ + H I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
+HRD+K NIL+D K+ DFG++K + T + ++ G+ Y PE + + E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDE 191
Query: 709 KSDVYSFGVVLFEVLCARP 727
+D+YS G+VL+E+L P
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 53/225 (23%), Positives = 84/225 (37%), Gaps = 30/225 (13%)
Query: 527 NFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKH 583
+F +G GGFG V+E +D AIKR P+ E + E++ L+KL H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDC-NYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 584 LVSLIGFCEEDGEMI------------LVYDYMANGTLREHL-YKGDKPGLPWKQRLEIC 630
+V E + L++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK----------TGPNL 680
+ A + +LH ++HRD+K +NI KV DFGL +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 725
T G+ Y+ PE + K D++S G++LFE+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 44/232 (18%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHL 584
IG G FG+V++ G T VA+K +S +FQ E ++++ + ++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHL----------------------YKGDKPGLP 622
V L+G C M L+++YMA G L E L P L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
++L I A G+ YL + +HRD+ T N L+ E K++DFGLS+ N+
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR---NIYS 226
Query: 683 THVSTMVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 727
+ PE + T +SDV+++GVVL+E+ +P
Sbjct: 227 A--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHK- 582
R +S IG GG KV++ + K AIK N + Q + ++ EI L+KL+
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 583 -HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP-------WKQRLEICIGAA 634
++ L + D + +V + N L L K + WK LE
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLE------ 138
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
+H +H ++ I+H D+K N L+ + K+ DFG++ + V G+
Sbjct: 139 -AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 695 YLDPE-----------YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE + +++ KSDV+S G +L+ + +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHK- 582
R +S IG GG KV++ + K AIK N + Q + ++ EI L+KL+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 583 -HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP-------WKQRLEICIGAA 634
++ L + D + +V + N L L K K + WK LE
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLE------ 119
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
+H +H ++ I+H D+K N L+ + K+ DFG++ + V G+
Sbjct: 120 -AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 695 YLDPE-----------YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE + +++ KSDV+S G +L+ + +
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIK----RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
+G GGFG V D +VAIK +P + + EI+++ KL H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSA 77
Query: 588 IGFCEE------DGEMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYL 640
+ + +L +Y G LR++L + + GL + + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
H IIHRD+K NI+L + K+ D G +K L+Q + T G+ YL
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLA 191
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
PE +++ T D +SFG + FE +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-33
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHK- 582
R +S IG GG KV++ + K AIK N + Q + ++ EI L+KL+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 583 -HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP-------WKQRLEICIGAA 634
++ L + D + +V + N L L K K + WK LE
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLE------ 166
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
+H +H ++ I+H D+K N L+ + K+ DFG++ + V G+
Sbjct: 167 -AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 695 YLDPE-----------YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE + +++ KSDV+S G +L+ + +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 6e-33
Identities = 37/228 (16%), Positives = 72/228 (31%), Gaps = 23/228 (10%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGVHEFQTEI 573
E + G++ H++G G F +VYE K K +K P++ + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 574 EMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKP---GLPWKQRLEIC 630
E L + +LV + + GTL + +P +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA-----------KVSDFGLSKTGPN 679
+ + +H IIH D+K N +L + + D G S
Sbjct: 179 MRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ + T + G+ E + + D + ++ +L
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 527 NFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHK 582
+F +G G FG VY K +A+K ++ H+ + E+E+ S LRH
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA------ARG 636
+++ L G+ + + L+ +Y GT+ L K + + A A
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQK--------LSKFDEQRTATYITELANA 121
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L Y H +IHRD+K N+LL E K++DFG S P+ +T + G+ YL
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLC-GTLDYL 174
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
PE + EK D++S GV+ +E L +P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 63/301 (20%), Positives = 116/301 (38%), Gaps = 53/301 (17%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK 582
+F E V+G G FG+V + +D + AIK+ + E+ + +E+ +L+ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSR-YYAIKKIRHTEEK-LSTILSEVMLLASLNHQ 62
Query: 583 HLVSLIGFCEEDGEMI-------------LVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
++V E + + +Y NGTL + ++ + + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWRL 121
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN---------- 679
L Y+H IIHRD+K NI +DE K+ DFGL+K
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 680 ---LNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCA-RPALNVNLP 734
+ ++++ + G+ Y+ E EK D+YS G++ FE++ +
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 735 KEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDV 794
+++ R +IE P+ N +K + RP +
Sbjct: 238 LKKL----------RSVSIE--FPPDFDDNKMKV-EKKII---RLLIDHDPNKRPGARTL 281
Query: 795 L 795
L
Sbjct: 282 L 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 533 VIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G FG VY K +A+K +S E H+ + EIE+ S LRH +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGA------ARGLHYLHT 642
+ + + L+ ++ G L + L K R + A A LHY H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQK--------HGRFDEQRSATFMEELADALHYCH- 131
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
+IHRD+K N+L+ K E K++DFG S P+ + TM G+ YL PE
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRR--TMC-GTLDYLPPEMIE 185
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARP 727
+ EK D++ GV+ +E L P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSLIGF 590
++G G V+ G AIK N S + E E+L KL HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 591 CEEDG--EMILVYDYMANGTLREHLY-KGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
EE +L+ ++ G+L L + GLP + L + G+++L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 648 IIHRDVKTTNILL----DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
I+HR++K NI+ D + K++DFG ++ L + G+ YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189
Query: 704 QQL--------TEKSDVYSFGVVLFEVLCARP 727
L D++S GV +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 526 RNFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRH 581
R + +G GGF K +E D K A K +S + EI + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL-EICIGAAR----- 635
+H+V GF E++ + +V + +L E + ++ L E AR
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEP---EARYYLRQ 123
Query: 636 ---GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
G YLH R +IHRD+K N+ L+E E K+ DFGL+ + + G+
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KVLC-GT 178
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE ++ + + DV+S G +++ +L +P
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLI 588
+G GG +V+ D + VA+K R++ + + F+ E + + L H +V++
Sbjct: 20 LGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 589 GFCEEDGEMI----LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E + +V +Y+ TLR+ ++ + K+ +E+ A + L++ H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH--- 133
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST-MVKGSFGYLDPEYFRR 703
+ IIHRDVK NI++ KV DFG+++ + + T V G+ YL PE R
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 704 QQLTEKSDVYSFGVVLFEVLCARP 727
+ +SDVYS G VL+EVL P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 526 RNFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRH 581
R + +G GGF K +E D K A K +S + EI + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL-EICIGAAR----- 635
+H+V GF E++ + +V + +L E + ++ L E AR
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEP---EARYYLRQ 149
Query: 636 ---GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
G YLH R +IHRD+K N+ L+E E K+ DFGL+ + + G+
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KVLC-GT 204
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE ++ + + DV+S G +++ +L +P
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-32
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 25/204 (12%)
Query: 533 VIGVGGFGKVYEGY---IDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSLI 588
I GG G +Y ++G+ V +K S + E + L+++ H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 589 GFCEEDGEMI-----LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
F E +V +Y+ +L+ + LP + + + L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQK-LPVAEAIAYLLEILPALSYLH-- 199
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
+++ D+K NI+L E+ + K+ D G +N + G+ G+ PE R
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR---INSF---GYLYGTPGFQAPEIVRT 251
Query: 704 QQLTEKSDVYSFGVVLFEVLCARP 727
T +D+Y+ G L + P
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G F VY I +VAIK + V Q E+++ +L+H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQR---LEICIGAARGLHYLHTGARY 646
+ E+ + LV + NG + +L KP + R +I G+ YLH +
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLH---SH 131
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
I+HRD+ +N+LL K++DFGL+ ++ H T+ G+ Y+ PE R
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YTLC-GTPNYISPEIATRSAH 189
Query: 707 TEKSDVYSFGVVLFEVLCARP 727
+SDV+S G + + +L RP
Sbjct: 190 GLESDVWSLGCMFYTLLIGRP 210
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
++G G V+ G AIK +N S + V E E+L KL HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 591 CEEDG--EMILVYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
EE +L+ ++ G+L L + + GLP + L + G+++L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 648 IIHRDVKTTNILL----DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
I+HR++K NI+ D + K++DFG ++ L + G+ YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189
Query: 704 QQL--------TEKSDVYSFGVVLFEVLCARP 727
L D++S GV +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-31
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 524 GTRNFSESHVIGVGGFGK-VYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RH 581
G +F V+G G G VY G D + VA+KR P E+++L + H
Sbjct: 22 GKISFCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFA---DREVQLLRESDEH 77
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
+++ ++ + + A TL+E++ + D + + + GL +LH
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLH 135
Query: 642 TGARYTIIHRDVKTTNILLDEKWE-----AKVSDFGLSK-TGPNLNQTHVSTMVKGSFGY 695
I+HRD+K NIL+ A +SDFGL K + + V G+ G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 696 LDPEYFRR---QQLTEKSDVYSFGVVLFEVLC 724
+ PE + T D++S G V + V+
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 32/192 (16%), Positives = 59/192 (30%), Gaps = 33/192 (17%)
Query: 218 LQTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEI 277
+ ++ +N GG+ + + D G AS K I +
Sbjct: 4 DKVIWAVNAGGESHVDVHG----IHYRKDPLEGRV---GRASDYGMKLPILRSNP----- 51
Query: 278 APLSVYETARSMGPDPNVNRNYNLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFIN 337
+Y+T R + + I Y++ F E+ + Q+VFD+ +N
Sbjct: 52 EDQVLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVN 103
Query: 338 NQTAQEGADVIGWAGEQGVPVYKDYAIYAEDLPGDDELWVALHPSVS--------MHPEY 389
T + D+ G + I + +L V S + Y
Sbjct: 104 GHTVVKDLDIFDRVG-HSTAHDEIIPISIK----KGKLSVQGEVSTFTGKLSVEFVKGYY 158
Query: 390 YDAILNGLEIFK 401
+ + L I K
Sbjct: 159 DNPKVCALFIMK 170
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 23/165 (13%), Positives = 42/165 (25%), Gaps = 17/165 (10%)
Query: 40 CGASSDGTDSNDRKWTSDSKFLTNSGNSITATAQSQDSSLPSTIP-YMTARIFKSTSSYK 98
G D + + D S S P Y T R + + Y
Sbjct: 12 AG-GESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYD 70
Query: 99 FTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVRE 158
+ + + L L F + F V NG T++ + I +
Sbjct: 71 IPIKEEGEYVLVLKFAEVYFAQ--SQQKVFDVRVNGHTVVKDL--DIFDRVGHSTAHDEI 126
Query: 159 FSLVPAQSGDLIITFTPSSDH----------KDSYAFVNGIEVIP 193
+ + G L + S+ V + ++
Sbjct: 127 IP-ISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 28/233 (12%)
Query: 521 IKHGTRNFSESHVIGVGGFGKVY--EGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK 578
++ G V+ GGF VY + G+ + A+KR + E+ E+ + K
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGR-EYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 579 LR-HKHLVSLIGFC--------EEDGEMILVYDYMANGTLREHLYKGDKPG-LPWKQRLE 628
L H ++V E +L+ + G L E L K + G L L+
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT---GPNLNQTHV 685
I R + ++H + IIHRD+K N+LL + K+ DFG + T P+ + +
Sbjct: 141 IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 686 STMVK-------GSFGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARPA 728
+ + Y PE + + EK D+++ G +L+ + +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
V+G G +G VY G D ++AIK + EI + L+HK++V +G
Sbjct: 29 VLGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPW---------KQRLEICIGAARGLHYLH 641
E+G + + + + G+L L + L KQ LE GL YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH 139
Query: 642 TGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
I+HRD+K N+L++ K+SDFG SK +N + G+ Y+ PE
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEI 194
Query: 701 FRRQQL--TEKSDVYSFGVVLFEVLCARP 727
+ + +D++S G + E+ +P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 26/245 (10%), Positives = 52/245 (21%), Gaps = 46/245 (18%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIK---RSNPSSEQGVHEFQTEIE 574
+ G R + VG V+ D + A+K +S +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLV-RDVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 575 MLSKLRHKHLVSLIGFC-----------------------EEDGEMILVYDYM--ANGTL 609
++L + ++D + M A+ L
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 610 REHLYKGDKPG-----LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW 664
D + R L ++H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDG 231
Query: 665 EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEV 722
+ D Y E+ T + + G+ ++ V
Sbjct: 232 RLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 723 LCARP 727
C
Sbjct: 287 WCLFL 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 49/240 (20%), Positives = 93/240 (38%), Gaps = 41/240 (17%)
Query: 518 LAEIKHGTRNFSE----SHVIGVGGFGKV-YEGYIDGKTKVAIKRSNPSSEQGVHEFQTE 572
+A I + ++ ++G G G V ++G G+ VA+KR E
Sbjct: 3 IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIA---LME 58
Query: 573 IEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMANGTL-----REHLYKGDKPGLPWKQR 626
I++L++ H +++ D + + + N L +++ +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 627 LEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-------------WEAKVSDFGL 673
+ + A G+ +LH IIHRD+K NIL+ +SDFGL
Sbjct: 118 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 674 SKTGPNLNQTHVSTM--VKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLC 724
K + + + + G+ G+ PE +++LT D++S G V + +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
F +G G +G VY+ + VAIK+ E + E EI ++ + H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
+V G ++ ++ +V +Y G++ + + + L + I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEYF 701
IHRD+K NILL+ + AK++DFG++ L T +T++ G+ ++ PE
Sbjct: 145 R---KIHRDIKAGNILLNTEGHAKLADFGVAGQ---LTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 702 RRQQLTEKSDVYSFGVVLFE 721
+ +D++S G+ E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 57/242 (23%), Positives = 107/242 (44%), Gaps = 10/242 (4%)
Query: 528 FSESHVIGVGGFGKVYEG-YIDGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
F + +G G G V++ + +A K ++ E+++L + ++V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
G DGE+ + ++M G+L + + K +P + ++ I +GL YL +
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--K 150
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
+ I+HRDVK +NIL++ + E K+ DFG+S L + ++ V G+ Y+ PE +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTH 206
Query: 706 LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765
+ +SD++S G+ L E+ R + KE + + T P N
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 766 TD 767
Sbjct: 267 FG 268
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
V+G G F +V+ T A+K S + EI +L K++H+++V+L
Sbjct: 16 VLGSGAFSEVFLV-KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 591 CEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E LV ++ G L R + D + +Q L + YLH
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLS-------AVKYLHE-- 124
Query: 645 RYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I+HRD+K N+L E ++DFGLSK +ST G+ GY+ PE
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC-GTPGYVAPEVL 179
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARP 727
++ ++ D +S GV+ + +LC P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 49/231 (21%), Positives = 87/231 (37%), Gaps = 37/231 (16%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKL- 579
T F E IG G FG V++ +DG AIKRS + E+ + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCI-YAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHL--YKGDKPGLPWKQRLEICIGAARGL 637
+H H+V ED M++ +Y G+L + + + ++ + RGL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 638 HYLHTGARYTIIHRDVKTTNILLDE-------------------KWEAKVSDFGLSKTGP 678
Y+H+ + ++H D+K +NI + K K+ D G
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183
Query: 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPA 728
++ V +G +L E + K+D+++ + + A P
Sbjct: 184 -ISSPQV---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 37/254 (14%), Positives = 75/254 (29%), Gaps = 55/254 (21%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---------------------- 556
E+ R V+G E + +
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 557 ------RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA----N 606
N + F +++ + K ++ + + + + Y
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 607 GTLREHLYKGDKPG--LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW 664
T E L L RL++ + R L LH Y ++H ++ +I+LD++
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRG 243
Query: 665 EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF-----------RRQQLTEKSDVY 713
++ F + + S G+ PE RR +T D +
Sbjct: 244 GVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297
Query: 714 SFGVVLFEVLCARP 727
+ G+V++ + CA
Sbjct: 298 ALGLVIYWIWCADL 311
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 17/215 (7%)
Query: 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQTEIEML 576
E + + +G G FG+V+ D +T A+K+ + E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAVKKVRLEVFR-----VEELVAC 104
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARG 636
+ L +V L G E + + + + G+L + + + LP + L A G
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEG 162
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSK--TGPNLNQTHVSTM-VKGS 692
L YLHT I+H DVK N+LL A + DFG + L ++ ++ + G+
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 693 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
++ PE + K D++S ++ +L
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 528 FSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
+ +G G FGKVY+ + A K SE+ + ++ EIE+L+ H ++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L+G DG++ ++ ++ G + + GL Q +C L++LH+
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSKR-- 137
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPE----- 699
IIHRD+K N+L+ + + +++DFG+S +T + + G+ ++ PE
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSAK---NLKTLQKRDSFI-GTPYWMAPEVVMCE 192
Query: 700 YFRRQQLTEKSDVYSFGVVLFE 721
+ K+D++S G+ L E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 32/249 (12%), Positives = 68/249 (27%), Gaps = 46/249 (18%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIK---RSNPSSEQGVHEFQTEIE 574
E+ R V+G E D +T + + + + + E+
Sbjct: 72 ELGERPRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 575 MLSKLR----------HKHLVSLIGFCEEDG----------------EMILVYDYMANGT 608
L LR H + ++
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 609 LREHL-----YKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK 663
L+ + L RL++ + R L LH Y ++H ++ +I+LD++
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR 247
Query: 664 WEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVV 718
++ F + + Q +T D ++ G+
Sbjct: 248 GGVFLTGFEHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 719 LFEVLCARP 727
++ + CA
Sbjct: 307 IYWIWCADL 315
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 521 IKHGTRNFSE----SHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTE 572
++H T FS+ V+G G FG+V + A+K + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 573 IEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG 632
+++L +L H +++ L F E+ G LV + G L + + + I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQ 134
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMV 689
G+ Y+H I+HRD+K N+LL+ K + ++ DFGLS + +
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDK 188
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ Y+ PE EK DV+S GV+L+ +L P
Sbjct: 189 IGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
+ ++ IG G G VY + +VAI++ N + EI ++ + ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
+V+ + E+ +V +Y+A G+L + + + + Q +C + L +LH+
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN 135
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEYF 701
+IHRD+K+ NILL K++DFG + STMV G+ ++ PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 702 RRQQLTEKSDVYSFGVVLFE 721
R+ K D++S G++ E
Sbjct: 189 TRKAYGPKVDIWSLGIMAIE 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 39/214 (18%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIK-------RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
++G G +GKV E + + A+K R P+ E V + EI++L +LRHK++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV---KKEIQLLRRLRHKNV 68
Query: 585 VSL--IGFCEEDGEMILVYDYMANGT--LREHLYKGDKPGLPWKQRLEICIGAAR----- 635
+ L + + EE +M +V +Y G + + + + R +C A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RFPVC--QAHGYFCQ 117
Query: 636 ---GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
GL YLH I+H+D+K N+LL K+S G+++ +GS
Sbjct: 118 LIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 693 FGYLDPEYFRRQQLTE--KSDVYSFGVVLFEVLC 724
+ PE K D++S GV L+ +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 46/202 (22%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 533 VIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
+G G FG V+ ++ T K N + + EI ++++L H L++L
Sbjct: 58 ELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 591 CEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E+ EM+L+ ++++ G L ++ + +Q E GL ++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH--- 166
Query: 645 RYTIIHRDVKTTNILLDEKWEA--KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
++I+H D+K NI+ + K + K+ DFGL+ LN + + + + PE
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVD 223
Query: 703 RQQLTEKSDVYSFGVVLFEVLC 724
R+ + +D+++ GV+ + +L
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLS 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 528 FSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLV 585
F++ IG G FG+V++G + VAIK + +E + + Q EI +LS+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
G +D ++ ++ +Y+ G+ L + L Q I +GL YLH+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGP--LDETQIATILREILKGLDYLHSEK- 139
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEYFRR 703
IHRD+K N+LL E E K++DFG++ L T + +T V G+ ++ PE ++
Sbjct: 140 --KIHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNTFV-GTPFWMAPEVIKQ 193
Query: 704 QQLTEKSDVYSFGVVLFE 721
K+D++S G+ E
Sbjct: 194 SAYDSKADIWSLGITAIE 211
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 44/200 (22%), Positives = 86/200 (43%), Gaps = 13/200 (6%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH 583
IG G G V +VA+K + +Q E+ ++ +H +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
+V + E+ ++ +++ G L + + + L +Q +C + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVKGSFGYLDPEYF 701
+IHRD+K+ +ILL K+SDFG +++ ++V G+ ++ PE
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLV-GTPYWMAPEVI 213
Query: 702 RRQQLTEKSDVYSFGVVLFE 721
R + D++S G+++ E
Sbjct: 214 SRSLYATEVDIWSLGIMVIE 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
VIG G V Y K KVAIKR N + + E EI+ +S+ H ++VS
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLE------ICIGAARGLHYLHTGA 644
E+ LV ++ G++ + + G L+ I GL YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFG----LSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
+ IHRDVK NILL E +++DFG L+ G T V G+ ++ PE
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 701 FRRQQL-TEKSDVYSFGVVLFE 721
+ + K+D++SFG+ E
Sbjct: 198 MEQVRGYDFKADIWSFGITAIE 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 525 TRNFSE----SHVIGVGGFGKVYEGYIDGKT--KVAIK---RSNPSSEQGVHEFQTEIEM 575
+ FS+ +G G F V + T + A K S+ + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARD-FQKLEREARI 58
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEI 629
KL+H ++V L +E+ LV+D + G L RE + D +Q LE
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQILE- 116
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVS 686
+ Y H I+HR++K N+LL K + K++DFGL+ +N +
Sbjct: 117 ------SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAW 164
Query: 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ GYL PE ++ ++ D+++ GV+L+ +L P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 521 IKHGTRNFSE----SHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTE 572
I + SE +G G +G+V + AIK +++ S+ + E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEE 86
Query: 573 IEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG 632
+ +L L H +++ L F E+ LV + G L + + K I
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQ 144
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMV 689
G+ YLH + I+HRD+K N+LL+ K + K+ DFGLS
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKER 198
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ Y+ PE R+ + EK DV+S GV+LF +L P
Sbjct: 199 LGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+GVG FGKV G KVA+K R S V + + EI+ L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYLH 641
+ +V +Y++ G L +++ K R+E AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK--------HGRVEE--MEARRLFQQILSAVDYCH 128
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK---GSFGYLDP 698
R+ ++HRD+K N+LLD AK++DFGLS N ++ GS Y P
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNYAAP 179
Query: 699 EYFRRQQLT-EKSDVYSFGVVLFEVLC 724
E + + D++S GV+L+ +LC
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLC 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK-----RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
IG G F KV I +VAIK + NP+S Q + E+ ++ L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHY 639
E + + L+ +Y + G + ++L R++ AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVA--------HGRMKE--KEARSKFRQIVSAVQY 129
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS---KTGPNLNQTHVSTMVKGSFGYL 696
H + I+HRD+K N+LLD K++DFG S G L+ G+ Y
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AFC-----GAPPYA 180
Query: 697 DPEYFRRQQLT-EKSDVYSFGVVLFEVLC 724
PE F+ ++ + DV+S GV+L+ ++
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 42/197 (21%), Positives = 71/197 (36%), Gaps = 13/197 (6%)
Query: 535 GVGGFGKVYEGY-IDGKTKVAIKRSN--PSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
G V V ++R N S + V Q E+ + H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
D E+ +V +MA G+ ++ + G+ I G + L Y+H +HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHR 152
Query: 652 DVKTTNILLDEKWEAKVSDFG----LSKTGPNLNQTHVSTMVK-GSFGYLDPEYFRRQQL 706
VK ++IL+ + +S + G H +L PE ++
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 707 --TEKSDVYSFGVVLFE 721
KSD+YS G+ E
Sbjct: 213 GYDAKSDIYSVGITACE 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 53/246 (21%), Positives = 80/246 (32%), Gaps = 53/246 (21%)
Query: 532 HVIGVGGFGKVYEGY-IDGKTKVAIK-----RSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
IG G +G V + AIK + + + V +TE+ ++ KL H ++
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG------------- 632
L E++ + LV + G L + L +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 633 ------------------AAR-------GLHYLHTGARYTIIHRDVKTTNILLDEKWEA- 666
+ LHYLH I HRD+K N L
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFE 208
Query: 667 -KVSDFGLSKTGPNLNQTHVSTMVK--GSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFE 721
K+ DFGLSK LN M G+ ++ PE + K D +S GV+L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 722 VLCARP 727
+L
Sbjct: 269 LLMGAV 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 521 IKHGTRNFSE----SHVIGVGGFGKVYEGY-IDGKTKVAIK-------------RSNPSS 562
++ E +G G +G+V +G ++ AIK N +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 563 EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP 622
E+ E EI +L L H +++ L E+ LV ++ G L E + K
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPN 679
I G+ YLH + I+HRD+K NILL+ K K+ DFGLS
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---F 198
Query: 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
++ + G+ Y+ PE ++ + EK DV+S GV+++ +LC P
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 25/205 (12%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G +G+V + + A K+ + V F+ EIE++ L H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 592 EEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
E++ ++ LV + G L + + D + K L + Y H +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLS-------AVAYCH---K 124
Query: 646 YTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
+ HRD+K N L K+ DFGL+ + G+ Y+ P+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE 181
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARP 727
+ D +S GV+++ +LC P
Sbjct: 182 G-LYGPECDEWSAGVMMYVLLCGYP 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 62/205 (30%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKTK--VAIKR---SNPSSEQGVHEFQTEIEMLSKL 579
+ FS+ IG G FG VY D + VAIK+ S S + + E+ L KL
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
RH + + G + LV +Y L + K L + + GA +GL Y
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LH+ +IHRDVK NILL E K+ DFG + + + + V G+ ++ PE
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI---MAPAN--SFV-GTPYWMAPE 220
Query: 700 ---YFRRQQLTEKSDVYSFGVVLFE 721
Q K DV+S G+ E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK----RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G +G+V + VA+K + + + + EI + L H+++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFY 71
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYL 640
G E L +Y + G L + + + A+ G+ YL
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYL 121
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV-STMVKGSFGYLDPE 699
H I HRD+K N+LLDE+ K+SDFGL+ N+ + + M G+ Y+ PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 700 YFRRQQLT-EKSDVYSFGVVLFEVLC 724
+R++ E DV+S G+VL +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 43/234 (18%)
Query: 522 KHGTRNFSE----SHVIGVGGFGKVYEGYIDGKT--KVAIK---------RSNPSSEQGV 566
H T F E ++G G V I T + A+K S ++
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67
Query: 567 HEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKP 619
E+++L K+ H +++ L E + LV+D M G L + L + +
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 620 GLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679
+ + LE + LH + I+HRD+K NILLD+ K++DFG S
Sbjct: 128 KI-MRALLE-------VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--- 173
Query: 680 LNQTHVSTMVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
L+ V G+ YL PE ++ D++S GV+++ +L P
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK------RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G F V + + T + A K E + E+ +L ++ H ++
Sbjct: 19 ELGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 585 VSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLH 638
++L E +++L+ + ++ G L +E L + + KQ L+ G++
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVN 129
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEA----KVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
YLH I H D+K NI+L +K K+ DFGL+ + + G+
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPE 183
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
++ PE + L ++D++S GV+ + +L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/218 (27%), Positives = 89/218 (40%), Gaps = 36/218 (16%)
Query: 531 SHVIGVGGFGKVYEGY-IDGKTKVAIK--------RSNPSSEQGVHEFQTEIEMLSKLRH 581
S +G G G+V + KVAIK + +TEIE+L KL H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAAR 635
++ + F + + + +V + M G L + L + + Q L
Sbjct: 75 PCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY-FYQMLL------- 125
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGS 692
+ YLH IIHRD+K N+LL + E K++DFG SK L +T + + G+
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGT 179
Query: 693 FGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
YL PE D +S GV+LF L P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
S++ ++G G FG+V++ + T K+A K + E + EI ++++L H +L
Sbjct: 90 TVSKTEILGGGRFGQVHKC-EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 585 VSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLH 638
+ L E +++LV +Y+ G L + L KQ E G+
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIR 201
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEA--KVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
++H + I+H D+K NIL + K+ DFGL++ + G+ +L
Sbjct: 202 HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR---YKPREKLKVNFGTPEFL 255
Query: 697 DPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
PE ++ +D++S GV+ + +L
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQTE 572
L+ ++ F ++G G +G+VY+G KT AIK + + ++ E + E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDE-EEEIKQE 70
Query: 573 IEMLSKL-RHKHLVSLIG------FCEEDGEMILVYDYMANGTLREHLYKGDKPG-LPWK 624
I ML K H+++ + G D ++ LV ++ G++ + L K K L +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEE 129
Query: 625 QRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684
IC RGL +LH +IHRD+K N+LL E E K+ DFG+S L++T
Sbjct: 130 WIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRTV 183
Query: 685 V--STMVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFE 721
+T + G+ ++ PE + + KSD++S G+ E
Sbjct: 184 GRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK----RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLI 588
+G G +G+V + VA+K + + + + EI + L H+++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFY 71
Query: 589 GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYL 640
G E L +Y + G L + + + A+ G+ YL
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYL 121
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV-STMVKGSFGYLDPE 699
H I HRD+K N+LLDE+ K+SDFGL+ N+ + + M G+ Y+ PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 700 YFRRQQLT-EKSDVYSFGVVLFEVLC 724
+R++ E DV+S G+VL +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 503 SHLTNLAAGLCRHFSLAEIKHGTRNFSES----HVIGVGGFGKVYEGYIDGKT--KVAIK 556
H+ ++ G + + + FS++ +G G F V + T + A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAK 60
Query: 557 --RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL----- 609
+ S + + + E + KL+H ++V L +E+ LV+D + G L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 610 -REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA-- 666
RE + D +Q LE + Y H I+HR++K N+LL K +
Sbjct: 121 AREFYSEADASHC-IQQILE-------SIAYCH---SNGIVHRNLKPENLLLASKAKGAA 169
Query: 667 -KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 725
K++DFGL+ +N + G+ GYL PE ++ ++ D+++ GV+L+ +L
Sbjct: 170 VKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
Query: 726 RP 727
P
Sbjct: 227 YP 228
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G FGKV + KVA+K R + EI L LRH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYLH 641
++++V +Y A G L +++ + K+R+ R + Y H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVE--------KKRMTE--DEGRRFFQQIICAIEYCH 125
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
R+ I+HRD+K N+LLD+ K++DFGLS + N S GS Y PE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVI 179
Query: 702 RRQQLT-EKSDVYSFGVVLFEVLCAR 726
+ + DV+S G+VL+ +L R
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKV-AIK---RSNPSSEQGVHEFQTEIEMLS 577
F + V+G GGFG+V + K+ A K + +G E ++L
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----EICIGA 633
K+ + +VSL E + LV M G L+ H+Y + G P + + EIC G
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
L LH R I++RD+K NILLD+ ++SD GL+ P V G+
Sbjct: 299 ---LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTV 349
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
GY+ PE + ++ T D ++ G +L+E++ +
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 40/239 (16%)
Query: 514 RHFSLAEIKHGTRNFSE----SHVIGVGGFGKVYEGY-IDGKTKVAIK--------RSNP 560
++ + + + S +G G G+V + KVAI+ +
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 561 SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL------REHLY 614
+TEIE+L KL H ++ + F + + + +V + M G L + L
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLK 237
Query: 615 KGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDF 671
+ + Q L + YLH IIHRD+K N+LL + E K++DF
Sbjct: 238 EATCKLY-FYQMLL-------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G SK + + T+ G+ YL PE D +S GV+LF L P
Sbjct: 287 GHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 31/220 (14%)
Query: 525 TRNFSES----HVIGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQGVHEFQTEIEML 576
F+E +G G F V + + A + S + + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRC-VKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEIC 630
L+H ++V L E+G L++D + G L RE+ + D +Q LE
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-IQQILE-- 121
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVST 687
+ + H ++HR++K N+LL K + K++DFGL+ Q
Sbjct: 122 -----AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFG 172
Query: 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ GYL PE R+ + D+++ GV+L+ +L P
Sbjct: 173 FA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 55/252 (21%), Positives = 102/252 (40%), Gaps = 30/252 (11%)
Query: 491 TGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSE----SHVIGVGGFGKVYEGY 546
GK + SS+ N + + + ++ + + +G G FG V+
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV- 176
Query: 547 IDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604
+ T A K E + EI+ +S LRH LV+L E+D EM+++Y++M
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 605 ANGTL-------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTN 657
+ G L + + + +Q + GL ++H +H D+K N
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMH---ENNYVHLDLKPEN 285
Query: 658 ILLDEKWEA--KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSF 715
I+ K K+ DFGL+ L+ + G+ + PE + + +D++S
Sbjct: 286 IMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 716 GVVLFEVLCARP 727
GV+ + +L
Sbjct: 343 GVLSYILLSGLS 354
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/297 (16%), Positives = 94/297 (31%), Gaps = 49/297 (16%)
Query: 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNP-SSEQGVHEFQTEIEML 576
LA+++H + + ++ +D P SS + +I +
Sbjct: 58 LAKLEHP--GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRM 115
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP-----WKQRLEICI 631
K+ V + + + L++ + + ++I
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA- 174
Query: 632 GAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK----------TGPNLN 681
+ +LH ++HRD+K +NI KV DFGL +
Sbjct: 175 ---EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741
T G+ Y+ PE + K D++S G++LFE+L +
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----------- 277
Query: 742 DWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAE---KCLSDQGIDRPSMGDVL 795
+R+ I D+ +K+ + LS +RP D++
Sbjct: 278 ------ERVRIITDVR----NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 23/96 (23%), Positives = 34/96 (35%), Gaps = 4/96 (4%)
Query: 526 RNFSESHVIGVGGFGKVYEGY--IDGKTKVAIKRSN-PSSEQGVHEFQTEIEMLSKLRHK 582
+F +G GGFG V+E +D AIKR P+ E + E++ L+KL H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDC-NYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDK 618
+V E + E
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS 100
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/271 (21%), Positives = 103/271 (38%), Gaps = 60/271 (22%)
Query: 486 GTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTR-NFSESHVIGVGGFGKVYE 544
G+SH + SH+ + + K + ++G GGFG VY
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 545 GY-IDGKTKVAIK---RSNPSSEQGVHEFQT---EIEMLSKLRHK--HLVSLIGFCEEDG 595
G + VAIK + S + E+ +L K+ ++ L+ + E
Sbjct: 62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121
Query: 596 EMILV----------YDYMA-NGTLREHLYKGDKPGLPWKQRLEICIGAAR--------G 636
+L+ +D++ G L+E L AR
Sbjct: 122 SFVLILERPEPVQDLFDFITERGALQEEL--------------------ARSFFWQVLEA 161
Query: 637 LHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQ-THVSTMVKGSFG 694
+ + H ++HRD+K NIL+D + E K+ DFG L + T + G+
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDFD-GTRV 213
Query: 695 YLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 724
Y PE+ R + + V+S G++L++++C
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+GVG FGKV G KVA+K R S V + + EI+ L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYLH 641
++ +V +Y++ G L +++ K RL+ +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK--------NGRLDE--KESRRLFQQILSGVDYCH 133
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK---GSFGYLDP 698
R+ ++HRD+K N+LLD AK++DFGLS N ++ GS Y P
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNYAAP 184
Query: 699 EYFRRQQLT-EKSDVYSFGVVLFEVLC 724
E + + D++S GV+L+ +LC
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLC 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK------RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G F V + T + A K S+ E + E+ +L ++RH ++
Sbjct: 12 ELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 585 VSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLH 638
++L E +++L+ + ++ G L +E L + + KQ L+ G+H
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVH 122
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEA----KVSDFGLSKT-GPNLNQTHVSTMVKGSF 693
YLH I H D+K NI+L +K K+ DFG++ + G+
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIF-GTP 175
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
++ PE + L ++D++S GV+ + +L
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 520 EIKHGTRNFSE----SHVIGVGGFGKVYEGYIDGKT--KVAIK-----RSNPSSEQGVHE 568
++ F + VIG G F V I+ +T + A+K + S +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 569 FQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLP------ 622
+ E + L+H H+V L+ DG + +V+++M L + K G
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 623 ---WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKT 676
+Q LE L Y H IIHRDVK +LL K + K+ FG++
Sbjct: 133 SHYMRQILE-------ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182
Query: 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ V G+ ++ PE +R+ + DV+ GV+LF +L
Sbjct: 183 LGE-SGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK------RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G F V + + T + A K E + E+ +L ++ H ++
Sbjct: 19 ELGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 585 VSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLH 638
++L E +++L+ + ++ G L +E L + + KQ L+ G++
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVN 129
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEA----KVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
YLH I H D+K NI+L +K K+ DFGL+ + + G+
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPE 183
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
++ PE + L ++D++S GV+ + +L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 23/223 (10%)
Query: 517 SLAEIKHGTRNFSE----SHVIGVGGFGKVYEGYIDGKT--KVAIK---RSNPSSEQGVH 567
S E + F+E ++G G FG+V + D T + A+K +++ ++
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKD-TS 66
Query: 568 EFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL 627
E+E+L KL H +++ L E+ +V + G L + + K +
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAA 124
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTH 684
I G+ Y+H + I+HRD+K NILL+ K + K+ DFGLS Q
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNT 178
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ Y+ PE R EK DV+S GV+L+ +L P
Sbjct: 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 42/269 (15%)
Query: 486 GTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSE----SHVIGVGGFGK 541
+++ ++ + NL + F + VIG G
Sbjct: 50 QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSV 109
Query: 542 VYEGYIDGKT--KVAIK--------RSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGF 590
V + T + A+K S E+ + E +L ++ H H+++LI
Sbjct: 110 VRRC-VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168
Query: 591 CEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E M LV+D M G L + L + + + + LE + +LH
Sbjct: 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-MRSLLE-------AVSFLH--- 217
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
I+HRD+K NILLD+ + ++SDFG S L + G+ GYL PE +
Sbjct: 218 ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPEILKCS 274
Query: 705 QL------TEKSDVYSFGVVLFEVLCARP 727
++ D+++ GV+LF +L P
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 14/203 (6%)
Query: 532 HVIGVGGFGKVYEGY-IDGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G FG V+ + IK + S+ + + + EIE+L L H +++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 590 FCEEDGEMILVYDYMANGTLREH-LYKGDKPG-LPWKQRLEICIGAARGLHYLHTGARYT 647
E+ M +V + G L E + + L E+ L Y H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQH 144
Query: 648 IIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
++H+D+K NIL + K+ DFGL++ ST G+ Y+ PE F+R
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKR- 200
Query: 705 QLTEKSDVYSFGVVLFEVLCARP 727
+T K D++S GVV++ +L
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCL 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 28/206 (13%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
+G G VY T A+K + + +TEI +L +L H +++ L
Sbjct: 60 ELGRGATSIVYRC-KQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 591 CEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E E+ LV + + G L + + + D KQ LE + YLH
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQILE-------AVAYLHE-- 166
Query: 645 RYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I+HRD+K N+L K++DFGLSK +Q + T+ G+ GY PE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVC-GTPGYCAPEIL 222
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARP 727
R + D++S G++ + +LC
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKV-AIK---RSNPSSEQGVHEFQTEIEMLSKL 579
G F + V+G GGFG+V+ + K+ A K + +G E ++L+K+
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL------EICIGA 633
+ +VSL E ++ LV M G +R H+Y D+ +++ +I G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG- 301
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
L +LH + II+RD+K N+LLD+ ++SD GL+ G+
Sbjct: 302 ---LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTP 353
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G++ PE ++ D ++ GV L+E++ AR
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 47/213 (22%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK------RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G F V + + T + A K + + + E+ +L +++H ++
Sbjct: 18 ELGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 585 VSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLH 638
++L E ++IL+ + +A G L +E L + + KQ L G++
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVY 128
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEA----KVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
YLH I H D+K NI+L ++ K+ DFGL+ ++ + + G+
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPE 182
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
++ PE + L ++D++S GV+ + +L
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 61/223 (27%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIK--------RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+G G FG V+ + +V +K + + + EI +LS++ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 585 VSLIGFCEEDGEMILV----------YDY-MANGTLREHLYKGDKPGLPWKQRLEICIGA 633
+ ++ E G LV + + + L E L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-------------------- 131
Query: 634 AR--------GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS---KTGPNLNQ 682
A + YL IIHRD+K NI++ E + K+ DFG + + G
Sbjct: 132 ASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY- 187
Query: 683 THVSTMVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 724
T G+ Y PE + +++S GV L+ ++
Sbjct: 188 TFC-----GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 61/225 (27%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQT---EIEMLSKLR----H 581
++G GGFG V+ G+ + + +VAIK R+ + + T E+ +L K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 582 KHLVSLIGFCEEDGEMILV----------YDY-MANGTLREHLYKGDKPGLPWKQRLEIC 630
++ L+ + E +LV +DY G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP----------------- 140
Query: 631 IGAAR--------GLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLN 681
+R + + H ++HRD+K NIL+D + AK+ DFG L
Sbjct: 141 ---SRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALL 190
Query: 682 Q-THVSTMVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 724
+ G+ Y PE+ R Q + V+S G++L++++C
Sbjct: 191 HDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 523 HGTRNFSE----SHVIGVGGFGKVYEGYIDGKT--KVAIK---RSNPSSEQGVHEFQTEI 573
+ F+E ++G G FG+V + D T + A+K +++ ++ E+
Sbjct: 15 YFQGTFAERYNIVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKD-TSTILREV 72
Query: 574 EMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRL 627
E+L KL H +++ L E+ +V + G L R+ + D + KQ
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVF 131
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTH 684
G+ Y+H ++ I+HRD+K NILL+ K + K+ DFGLS Q
Sbjct: 132 S-------GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNT 178
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
G+ Y+ PE R EK DV+S GV+L+ +L P
Sbjct: 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 35/205 (17%), Positives = 82/205 (40%), Gaps = 25/205 (12%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590
+G G FG V+ ++ + K + EI +L+ RH++++ L
Sbjct: 12 DLGRGEFGIVHRC-VETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 591 CEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E E+++++++++ + + Q E L +LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLH--- 119
Query: 645 RYTIIHRDVKTTNILLDEKWEA--KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
+ I H D++ NI+ + + K+ +FG ++ L ++ + Y PE +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARP 727
++ +D++S G +++ +L
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 533 VIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
IG G FGKV + K K + + V E++++ L H LV+L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKY-MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----------EICIGAARGL 637
+++ +M +V D + G LR HL + E+ + L
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQ--------NVHFKEETVKLFICELVMA----L 128
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
YL IIHRD+K NILLDE ++DF ++ P Q TM G+ Y+
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT--TMA-GTKPYMA 182
Query: 698 PEYFRRQQLTEKS---DVYSFGVVLFEVLCARP 727
PE F ++ S D +S GV +E+L R
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 45/203 (22%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 533 VIGVGGFGKVYEG-YIDGKTKVAIKR-SNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIG 589
+G G G+V++ + +A+K+ +++ +++++ K ++V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
+ ++ + + M + L K + +P + ++ + + L+YL ++ +I
Sbjct: 92 TFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVI 147
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE- 708
HRDVK +NILLDE+ + K+ DFG+S L G Y+ PE T+
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 709 ----KSDVYSFGVVLFEVLCARP 727
++DV+S G+ L E+ +
Sbjct: 205 DYDIRADVWSLGISLVELATGQF 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 58/208 (27%), Positives = 81/208 (38%), Gaps = 35/208 (16%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG K VA+K R E Q EI LRH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR--------GLHYLH 641
+ ++ +Y + G L E + R AR G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN--------AGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 642 TGARYTIIHRDVKTTNILLDEKWEA--KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
I HRD+K N LLD K+ DFG SK+ +Q + V G+ Y+ PE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE 187
Query: 700 YFRRQQLT-EKSDVYSFGVVLFEVLCAR 726
RQ+ + +DV+S GV L+ +L
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 57/273 (20%), Positives = 113/273 (41%), Gaps = 31/273 (11%)
Query: 533 VIGVGGFGKVYEG-YIDGKTKVAIKRSNP-SSEQGVHEFQTEIEM-LSKLRHKHLVSLIG 589
+G G +G V + ++ +A+KR + Q ++++ + + V+ G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKG--DKPG-LPWKQRLEICIGAARGLHYLHTGARY 646
+G++ + + M + YK DK +P +I + + L +LH+
Sbjct: 74 ALFREGDVWICMELMDTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE----YFR 702
+IHRDVK +N+L++ + K+ DFG+S L + G Y+ PE
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762
++ + KSD++S G+ + E+ R P W Q++ + + P L
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRF------P-----YDSWGTPFQQLKQVVEEPSPQLP 235
Query: 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ FT +CL +RP+ +++
Sbjct: 236 ADKFSAEFVDFT---SQCLKKNSKERPTYPELM 265
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNP-SSEQGVHEFQTEIE-MLSKLRHKHLVSLIG 589
IG G +G V + +A+KR E+ + +++ ++ ++V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 590 FCEEDGEMILVYDYMANGTLR--EHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+G+ + + M+ + +++Y +P + +I + + L++L +
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE----YFRR 703
IIHRD+K +NILLD K+ DFG+S L + T G Y+ PE R
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 704 QQLTEKSDVYSFGVVLFEVLCARP 727
Q +SDV+S G+ L+E+ R
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRF 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 38/226 (16%)
Query: 521 IKHGTRNFSE-----SHVIGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQGVHEFQT 571
NF+ S +G G F V + I T + A K + + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQC-ISKSTGQEYAAKFLKKRRRGQDCRAEILH 77
Query: 572 EIEMLSKLRH-KHLVSLIGFCEEDGEMILVYDYMANGTL--------REHLYKGDKPGLP 622
EI +L + +++L E E+IL+ +Y A G + E + + D L
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL- 136
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSKT-GP 678
KQ LE G++YLH + I+H D+K NILL + K+ DFG+S+ G
Sbjct: 137 IKQILE-------GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
+ ++ G+ YL PE +T +D+++ G++ + +L
Sbjct: 187 A---CELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 29/207 (14%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIG 589
+G G F + + K+ A+K + E Q EI L H ++V L
Sbjct: 18 PLGEGSFSICRKC-VHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHE 73
Query: 590 FCEEDGEMILVYDYMANGTL------REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
+ LV + + G L ++H + + + ++ + + ++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-MRKLVS-------AVSHMH-- 123
Query: 644 ARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
++HRD+K N+L ++ E K+ DFG ++ P NQ + T + Y PE
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPEL 180
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ E D++S GV+L+ +L +
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 21/214 (9%), Positives = 55/214 (25%), Gaps = 42/214 (19%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIK--RSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSL 587
G + ++ D +VA+ V + + LS++ + +
Sbjct: 38 FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT 647
+ ++V +++ G+L+E + A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
+ + + + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA-------N 180
Query: 708 EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741
+ D+ G L+ +L R L + ++ A
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 520 EIKHGTRNFSE----SHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEI 573
++ + F++ IGVG + I T + A+K + S EI
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRC-IHKATNMEFAVKIIDKSKRDP----TEEI 66
Query: 574 EMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL----- 627
E+L + +H ++++L ++ + +V + M G L + + + ++
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--------QKFFSEREA 118
Query: 628 -EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA----KVSDFGLSKTGPNLNQ 682
+ + + YLH ++HRD+K +NIL ++ ++ DFG +K N
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ T + ++ PE RQ D++S GV+L+ +L
Sbjct: 176 L-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKV-AIK---RSNPSSEQGVHEFQTEIEMLSKL--- 579
+FS +IG GGFG+VY K+ A+K + +QG E MLS +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAARG 636
+V + ++ + D M G L HL + R EI +G
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILG---- 304
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696
L ++H +++RD+K NILLDE ++SD GL+ + H V G+ GY+
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYM 357
Query: 697 DPEYFRRQQLTEKS-DVYSFGVVLFEVLCARP 727
PE ++ + S D +S G +LF++L
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLS 577
K +F ++G G F V + + AIK + + E V E +++S
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---------- 627
+L H V L ++D ++ Y NG L +++ K
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--------IGSFDETCTRFYTA 137
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV-S 686
EI L YLH IIHRD+K NILL+E +++DFG +K ++ +
Sbjct: 138 EIVSA----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ V G+ Y+ PE + + SD+++ G ++++++ P
Sbjct: 191 SFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 58/234 (24%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK---------------RSNPSSEQGVHEFQT------ 571
IG G +G V Y + T A+K R P +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 572 -----EIEMLSKLRHKHLVSL---IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW 623
EI +L KL H ++V L + ED + +V++ + G + E +P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVME---------VPT 130
Query: 624 KQRLEICIGAAR--------GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
+ L AR G+ YLH IIHRD+K +N+L+ E K++DFG+S
Sbjct: 131 LKPLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCAR 726
+ +S V G+ ++ PE + + DV++ GV L+ + +
Sbjct: 186 E-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 533 VIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIG 589
V+G G +V I+ T + A+K E+EML + + H++++ LI
Sbjct: 20 VLGEGAHARVQTC-INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL------EICIGAARGLHYLHT- 642
F EE+ LV++ M G++ H++K ++ + A L +LH
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHK--------RRHFNELEASVVVQDVASALDFLHNK 130
Query: 643 GARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSK------TGPNLNQTHVSTMVKGSF 693
G I HRD+K NIL + + K+ DF L ++ + T GS
Sbjct: 131 G----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSA 185
Query: 694 GYLDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 727
Y+ PE D++S GV+L+ +L P
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/243 (23%), Positives = 101/243 (41%), Gaps = 34/243 (13%)
Query: 502 SSHLTNLAAGLCRHFSLAEIKHGTRNFSE-----SHVIGVGGFGKVYEGYIDGKT--KVA 554
+ H + ++GL F E K ++ V+G+G GKV E +T K A
Sbjct: 2 AHHHHHHSSGLEVLFQGPEPK--KYAVTDDYQLSKQVLGLGVNGKVLEC-FHRRTGQKCA 58
Query: 555 IKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMI----LVYDYMANGTL 609
+K S + + E++ + H+V ++ E ++ + M G L
Sbjct: 59 LKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKWEA-- 666
+ + ++ EI + +LH+ I HRDVK N+L K +
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAV 169
Query: 667 -KVSDFGLSK-TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724
K++DFG +K T N QT + Y+ PE ++ + D++S GV+++ +LC
Sbjct: 170 LKLTDFGFAKETTQNALQTPC-----YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 224
Query: 725 ARP 727
P
Sbjct: 225 GFP 227
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 36/228 (15%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIE 574
+++ +F VIG G FG+V + K K+ K + F+ E +
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERD 126
Query: 575 MLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL------- 627
+L K + +L ++D + LV DY G L L K + RL
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-------DRLPEEMARF 179
Query: 628 ---EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684
E+ I + +H + +HRD+K NIL+D +++DFG
Sbjct: 180 YLAEMVIA----IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 727
S V G+ Y+ PE + + + D +S GV ++E+L
Sbjct: 233 SSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 26/211 (12%)
Query: 533 VIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G F +V + G+ K+ K + F+ E ++L + + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL 126
Query: 588 IGFCEEDGEMI-LVYDYMANGTLREHLYK-GDKPGLPWKQ--RLEICIGAARGLHYLHTG 643
F +D + LV +Y G L L K G++ + EI + + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH-- 179
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
R +HRD+K NILLD +++DFG V G+ YL PE +
Sbjct: 180 -RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237
Query: 704 QQLTEKSDVY-------SFGVVLFEVLCARP 727
+ Y + GV +E+ +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 534 IGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
IG G +G V++ + T VAIK+ S + V + EI ML +L+H +LV+L+
Sbjct: 11 IGEGSYGVVFKC-RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
+ LV++Y + T+ L + G+P I + +++ H ++ I
Sbjct: 70 VFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124
Query: 650 HRDVKTTNILLDEKWEAKVSDFGL--SKTGPNLNQTH-VST 687
HRDVK NIL+ + K+ DFG TGP+ V+T
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 13/161 (8%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIG 589
+G G +G V + + T VAIK+ S + + + EI++L +LRH++LV+L+
Sbjct: 33 VGEGSYGMVMKC-RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
C++ LV++++ + T+ + L + GL ++ + G+ + H + II
Sbjct: 92 VCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTH-VST 687
HRD+K NIL+ + K+ DFG ++T P V+T
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQT---EIEMLSKLRHKHLVSLI 588
+G G + VY+G ++ T VA+K SE+G T EI ++ +L+H+++V L
Sbjct: 13 LGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLY 69
Query: 589 GFCEEDGEMILVYDYMAN---GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
+ ++ LV+++M N + GL +GL + H
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---E 126
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGL--SKTGPNLNQTH 684
I+HRD+K N+L++++ + K+ DFGL + P +
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 54/206 (26%), Positives = 81/206 (39%), Gaps = 21/206 (10%)
Query: 533 VIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL 587
VIG G FG+V K K+ K F E ++++ +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQL 134
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAARGLHYLHTGAR 645
++D + +V +YM G L + D P W + E+ + L +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARFYTAEVVLA----LDAIH---S 186
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
IHRDVK N+LLD+ K++DFG T V G+ Y+ PE + Q
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 706 LTEK----SDVYSFGVVLFEVLCARP 727
D +S GV L+E+L
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 57/277 (20%), Positives = 101/277 (36%), Gaps = 30/277 (10%)
Query: 464 VSNKKKNNDGSRCSTSSWLPLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKH 523
+SN + + + P T I
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 524 GTRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQTEIEMLSKL-R 580
+ S+ V+G+G GKV + + +T K A+K Q + + E+E+ + +
Sbjct: 62 DYKVTSQ--VLGLGINGKVLQI-FNKRTQEKFALK-----MLQDCPKARREVELHWRASQ 113
Query: 581 HKHLVSLIGFCEEDGEMI----LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARG 636
H+V ++ E +V + + G L + ++ EI
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 637 LHYLHT-GARYTIIHRDVKTTNILLDEKWEA---KVSDFGLSK--TGPNLNQTHVSTMVK 690
+ YLH+ I HRDVK N+L K K++DFG +K T N T
Sbjct: 174 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----- 224
Query: 691 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ Y+ PE ++ + D++S GV+++ +LC P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLS 577
+ F ++G G FGKV A+K + ++ V TE +L
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAA 634
RH L +L + + V +Y G L HL + + R EI
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSA-- 260
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L YLH + +++RD+K N++LD+ K++DFGL K G T + T G+
Sbjct: 261 --LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFC-GTPE 314
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
YL PE D + GVV++E++C R
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 533 VIGVGGFGKVY--EGYIDGKT------KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
V+G G FGKV+ + KV +K++ V + E ++L ++ H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKV-LKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 585 VSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAARGLHYL 640
V L + + +G++ L+ D++ G L L K + E+ + L +L
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALA----LDHL 142
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H II+RD+K NILLDE+ K++DFGLSK + + + G+ Y+ PE
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFC-GTVEYMAPEV 197
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
R+ T+ +D +SFGV++FE+L
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 7e-17
Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQ-GVHEFQT---EIEMLSKLR 580
NF + IG G +G VY+ + T VA+K+ +E GV T EI +L +L
Sbjct: 4 NFQKVEKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELN 60
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
H ++V L+ + ++ LV++++ + L++ + G+P +GL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676
H + ++HRD+K N+L++ + K++DFGL++
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 37/176 (21%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQGVHEFQT---EIEMLSKLRH 581
+ + +G G + VY+G T VA+K E+G T E+ +L L+H
Sbjct: 3 TYIKLDKLGEGTYATVYKG-KSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKG--DKPGLPW---------KQRLEIC 630
++V+L + + LV++Y+ + K D G Q L
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLL--- 110
Query: 631 IGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL--SKTGPNLNQTH 684
RGL Y H R ++HRD+K N+L++E+ E K++DFGL +K+ P +
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 533 VIGVGGFGKVY--EGYIDGKT------KVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
V+G GG+GKV+ T KV K + + + E +L +++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 585 VSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL---EICIGAARGLHYL 640
V LI + + G++ L+ +Y++ G L L + EI + L +L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-TACFYLAEISMA----LGHL 137
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H + II+RD+K NI+L+ + K++DFGL K + T G+ Y+ PE
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV-THTFC-GTIEYMAPEI 192
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARP 727
R D +S G +++++L P
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 17/213 (7%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLS 577
K +F ++G G FGKV A+K + ++ V TE +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 578 KLRHKHLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAA 634
RH L +L + + + V +Y G L HL + + EI
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA-- 117
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L YLH +++RD+K N++LD+ K++DFGL K G + T + T G+
Sbjct: 118 --LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC-GTPE 170
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
YL PE D + GVV++E++C R
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKV----AIKRSNPSSEQGVHEFQTEIEMLS 577
+ +F+ V+G G FGKV G ++ +K+ + V E +L+
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 578 K-LRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAA 634
+ L L + + V +Y+ G L H+ + + P EI IG
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-- 454
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L +L II+RD+K N++LD + K++DFG+ K T T G+
Sbjct: 455 --LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFC-GTPD 507
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE Q + D ++FGV+L+E+L +
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 7e-16
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 32/157 (20%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQ-GVHEFQT---EIEMLSKLRHKHLVSL 587
IG G +G V++ + +T VA+KR + GV + EI +L +L+HK++V L
Sbjct: 10 IGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRL 66
Query: 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW---------KQRLEICIGAARGLH 638
D ++ LV+++ + L+++ D Q L +GL
Sbjct: 67 HDVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLL-------KGLG 115
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
+ H ++HRD+K N+L++ E K+++FGL++
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 41/173 (23%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKR----SNPSSEQGVHEFQT---EIEMLSKLRHKHL 584
+G G F VY+ D T VAIK+ ++ G++ +T EI++L +L H ++
Sbjct: 18 LGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNI 74
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKG--DKPGLPW---------KQRLEICIGA 633
+ L+ + LV+D+M E + L L
Sbjct: 75 IGLLDAFGHKSNISLVFDFM------ETDLEVIIKDNSLVLTPSHIKAYMLMTL------ 122
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT--GPNLNQTH 684
+GL YLH ++ I+HRD+K N+LLDE K++DFGL+K+ PN TH
Sbjct: 123 -QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-16
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 60/215 (27%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNPSSEQGVHEFQT---------E 572
N+ H+IG G +G VY D T VAIK+ + F+ E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNTEKNVAIKKVNRM--------FEDLIDCKRILRE 75
Query: 573 IEMLSKLRHKHLVSLI-----GFCEEDGEMILVYDYM---------ANGTL-REH----L 613
I +L++L+ +++ L + E+ +V + L EH L
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL 135
Query: 614 YKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673
Y L G +++H IIHRD+K N LL++ KV DFGL
Sbjct: 136 Y----------NLL-------LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
++T + T++ ++ + ++QLT
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 32/214 (14%)
Query: 527 NFSESHVIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSKLRH 581
F +G G FG+V + G K+ K+ +Q H E +L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF 100
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR------ 635
LV L +++ + +V +Y+A G + HL + R AR
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEP--HARFYAAQI 150
Query: 636 --GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
YLH+ +I+RD+K N+L+D++ +V+DFG +K T T
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP----- 202
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
L PE + + D ++ GV+++E+ P
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLS 577
+ G NF V+G G FGKV + A+K + + V TE +LS
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 578 K-LRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAA 634
H L L + + V +++ G L H+ K + + EI
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA-- 136
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L +LH II+RD+K N+LLD + K++DFG+ K G T +T G+
Sbjct: 137 --LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFC-GTPD 189
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE + D ++ GV+L+E+LC
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 528 FSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQT----EIEMLSKLRHKH 583
++ VIG G FG V++ + +VAIK+ V + + E++++ ++H +
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKK--------VLQDKRFKNRELQIMRIVKHPN 93
Query: 584 LVSLIGFCEEDGEMI------LVYDYMANGTLREHLYKGDKPGLPWKQRLE--------- 628
+V L F +G+ LV +Y+ E +Y+ + KQ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 629 -ICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKT-GPNLNQTH- 684
+ R L Y+H+ I HRD+K N+LLD K+ DFG +K
Sbjct: 149 QLL----RSLAYIHS-IG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 685 VSTMVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ + Y PE F T D++S G V+ E++ +P
Sbjct: 202 ICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 57/240 (23%), Positives = 100/240 (41%), Gaps = 72/240 (30%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT---------EI 573
++ IG G +G V D +VAIK+ +P F+ EI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKISP--------FEHQTYCQRTLREI 76
Query: 574 EMLSKLRHKHLVSLI-----GFCEEDGEMILVYDYM---------ANGTLREH----LYK 615
++L + RH++++ + E+ ++ +V D M +H LY
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY- 135
Query: 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
Q L RGL Y+H+ ++HRD+K +N+LL+ + K+ DFGL++
Sbjct: 136 ---------QIL-------RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 676 -TGPNLNQTHVSTMVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARP 727
P+ + T T Y+ ++R + T+ D++S G +L E+L RP
Sbjct: 177 VADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSN-PSSEQGVHEF-QT---EIEMLSKLR---HKH 583
IGVG +G VY+ D + VA+K P+ G + E+ +L +L H +
Sbjct: 17 IGVGAYGTVYKA-RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 584 LVSLI-----GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
+V L+ + + ++ LV++++ LR +L K PGLP + ++ RGL
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTH 684
+LH I+HRD+K NIL+ K++DFGL++ + T
Sbjct: 135 FLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLS 577
+ +F+ V+G G FGKV A+K + + V E +L+
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 578 K-LRHKHLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGA 633
+ L L C + + V +Y+ G L H+ + + P EI IG
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG- 133
Query: 634 ARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
L +L II+RD+K N++LD + K++DFG+ K T T G+
Sbjct: 134 ---LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFC-GTP 185
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
Y+ PE Q + D ++FGV+L+E+L +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIKRSNPSS----EQGVHEFQTEIEML 576
K+ ++F +G G FG+V+ A+K +Q H E ML
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN-DERLML 60
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRL--------- 627
S + H ++ + G ++ ++ ++ DY+ G L L K QR
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYA 112
Query: 628 -EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686
E+C+ L YLH II+RD+K NILLD+ K++DFG +K P++ T
Sbjct: 113 AEVCLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG 165
Query: 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
T Y+ PE + + D +SFG++++E+L
Sbjct: 166 TP-----DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 65/234 (27%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNPSSEQGVHEFQT---------E 572
+ + +G G +G V ID ++ KVAIK+ S P FQ+ E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRP--------FQSEIFAKRAYRE 73
Query: 573 IEMLSKLRHKHLVSLI------GFCEEDGEMILVYDYMA---NGTLR-----EH----LY 614
+ +L ++H++++ L+ + LV +M + E +Y
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 615 KGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674
Q L +GL Y+H+ ++HRD+K N+ ++E E K+ DFGL+
Sbjct: 134 ----------QML-------KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 675 KTGPNLNQTHVSTMVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ +V T Y PE + D++S G ++ E+L +
Sbjct: 174 RHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 533 VIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSK-LRHKHLVS 586
VIG G + KV + KV +K+ + ++ + QTE + + H LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 587 LIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAARGLHYLHTG 643
L C + + + V +Y+ G L H+ + K + EI + L+YLH
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH-- 127
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
II+RD+K N+LLD + K++D+G+ K G T ST G+ Y+ PE R
Sbjct: 128 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC-GTPNYIAPEILRG 184
Query: 704 QQLTEKSDVYSFGVVLFEVLCARP 727
+ D ++ GV++FE++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRS 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 52/229 (22%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT----EIEMLSK 578
+++++ VIG G FG VY+ + VAIK+ V + + E++++ K
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQA-KLCDSGELVAIKK--------VLQDKRFKNRELQIMRK 103
Query: 579 LRHKHLVSLIGFCEEDGEMI------LVYDYMANGTLREHLYKGDKPGLPWKQRLE---- 628
L H ++V L F GE LV DY+ E +Y+ + KQ L
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYV 158
Query: 629 ------ICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKT--GPN 679
+ R L Y+H+ I HRD+K N+LLD + K+ DFG +K
Sbjct: 159 KLYMYQLF----RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 680 LNQTHVSTMVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 727
N +++ + Y PE F T DV+S G VL E+L +P
Sbjct: 212 PNVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 50/241 (20%), Positives = 93/241 (38%), Gaps = 67/241 (27%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT---------EI 573
+ +F ++G G +G V T VAIK+ P F EI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPTGEIVAIKKIEP--------FDKPLFALRTLREI 60
Query: 574 EMLSKLRHKHLVSLI-----GFCEEDGEMILVYDYM--------ANGTL-REH----LYK 615
++L +H++++++ E E+ ++ + M + L +H +Y
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY- 119
Query: 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
Q L R + LH +IHRD+K +N+L++ + KV DFGL++
Sbjct: 120 ---------QTL-------RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 676 TGPNLNQTHVSTMVKGSF--GYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCAR 726
+ + S ++ ++R + + DV+S G +L E+ R
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
Query: 727 P 727
P
Sbjct: 221 P 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 56/237 (23%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR--SNPSSEQGVHEFQTEIEMLS 577
+ F + G G FG V G + T VAIK+ +P E Q ++ L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLG-KEKSTGMSVAIKKVIQDPRFRN--RELQ-IMQDLA 74
Query: 578 KLRHKHLVSLIGFCEEDGE-------MILVYDYMANGTLREHLYKGDKPGLPWKQRLE-- 628
L H ++V L + GE + +V +Y+ + L++ + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPI 129
Query: 629 --------ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKT-GP 678
+ R + LH + + HRD+K N+L++E K+ DFG +K P
Sbjct: 130 LIKVFLFQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 679 NLNQTH-VST-------MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+ + + ++ G+ Y T D++S G + E++ P
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGEP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 50/237 (21%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKR--SNPSSEQGVHEFQT---------EI 573
++ I G +G V G VAIKR + S + V+ EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 574 EMLSKLRHKHLVSLI-----GFCEEDGEMILVYDYM----------ANGTL-REH----L 613
+L+ H +++ L ++ LV + M + +H +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 614 YKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673
Y L GLH LH ++HRD+ NILL + + + DF L
Sbjct: 141 Y----------HIL-------LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL 180
Query: 674 SKT-GPNLNQT-HVSTMVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 727
++ + N+T +V+ Y PE + + T+ D++S G V+ E+ +
Sbjct: 181 AREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNPSSEQGVHEFQT---------E 572
+ + IG G G V D VAIK+ S P FQ E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRP--------FQNQTHAKRAYRE 111
Query: 573 IEMLSKLRHKHLVSLI------GFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQR 626
+ ++ + HK+++SL+ EE ++ LV + M +L + + L ++
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-----NLCQVIQMELDHERM 166
Query: 627 LEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQT-H 684
+ G+ +LH+ IIHRD+K +NI++ K+ DFGL++T G + T +
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
V T Y PE E D++S G ++ E++ +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 44/165 (26%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIKRSNPSSEQ-GVHEFQT---EIEMLSKLRHKHLVSL 587
IG G FG+V++ KT VA+K+ +E+ G T EI++L L+H+++V+L
Sbjct: 25 IGQGTFGEVFKA-RHRKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLKHENVVNL 81
Query: 588 IGFCEED--------GEMILVYDYMANGTLREHLYKG--DKPGLPW---------KQRLE 628
I C G + LV+D+ EH G + + + L
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673
GL+Y+H R I+HRD+K N+L+ K++DFGL
Sbjct: 136 -------GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 52/261 (19%), Positives = 87/261 (33%), Gaps = 50/261 (19%)
Query: 477 STSSWLPLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIK-HGTRNFSESHVIG 535
S + S T +G+ + + ++ + H+IG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 536 VGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLI--- 588
G +G V E D VAIK+ E + + EI +L++L H H+V ++
Sbjct: 63 TGSYGHVCEA-YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121
Query: 589 --GFCEEDGEMILVYDYM---------ANGTL-REH----LYKGDKPGLPWKQRLEICIG 632
E+ E+ +V + L H LY L
Sbjct: 122 IPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----------NLL----- 166
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS-----KTGPNLNQTHVST 687
G+ Y+H+ I+HRD+K N L+++ KV DFGL+ N
Sbjct: 167 --VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 688 MVKGSFGYLDPEYFRRQQLTE 708
+ ++QLT
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTG 242
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 533 VIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIEMLSK-LRHKHLVS 586
VIG G + KV + +V +K+ + ++ + QTE + + H LV
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 587 LIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAARGLHYLHTG 643
L C + + + V +Y+ G L H+ + K + EI + L+YLH
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH-- 170
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
II+RD+K N+LLD + K++D+G+ K G T ST G+ Y+ PE R
Sbjct: 171 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC-GTPNYIAPEILRG 227
Query: 704 QQLTEKSDVYSFGVVLFEVLCARP 727
+ D ++ GV++FE++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 64/206 (31%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 533 VIGVGGFGKVY--EGYIDGKT---KVAIKRSNPSSEQGVHEFQTEIE---MLSKLRHKHL 584
VIG G FGKV + KV K++ ++ H E +L ++H L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH---IMSERNVLLKNVKHPFL 101
Query: 585 VSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAARGLHYLH 641
V L F + ++ V DY+ G L HL + P + EI L YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLH 156
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I++RD+K NILLD + ++DFGL K N T ST G+ YL PE
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TSTFC-GTPEYLAPEVL 211
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARP 727
+Q D + G VL+E+L P
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 527 NFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSK-LRH 581
+F ++G G FGKV+ + AIK + + V E +LS H
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 582 KHLVSLIG-FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ--RLEICIGAARGLH 638
L + F ++ + V +Y+ G L H+ K L EI +G L
Sbjct: 78 PFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQ 132
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698
+LH I++RD+K NILLD+ K++DFG+ K + +T G+ Y+ P
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFC-GTPDYIAP 187
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
E Q+ D +SFGV+L+E+L +
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 29/155 (18%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ-GVHEFQT---EIEMLSKLRHKHLVSLIG 589
+G G +G VY+ VA+KR +E G+ T EI +L +L H ++VSLI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP--STAIREISLLKELHHPNIVSLID 86
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW---------KQRLEICIGAARGLHYL 640
+ + LV+++M L++ L D+ Q L RG+ +
Sbjct: 87 VIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLL-------RGVAHC 135
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
H ++ I+HRD+K N+L++ K++DFGL++
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 13/162 (8%)
Query: 566 VHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQ 625
+ + + + + L S+ + +++ E K L +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 626 RLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685
+ A+G+ +L A IHRD+ NILL EK K+ DFGL++ +
Sbjct: 195 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246
Query: 686 STMVKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLFEV 722
V+ L PE + T +SDV+SFGV+L+E+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 30/153 (19%), Positives = 57/153 (37%), Gaps = 18/153 (11%)
Query: 532 HVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKH 583
+G G FG+V E G VA+K + +E+++L + H +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 584 LVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
+V+L+G C + G ++++ ++ G L +L +R E +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQG 138
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
I D+K + + S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 23/152 (15%)
Query: 534 IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ-GVHEFQT---EIEMLSKLRHKHLVSLIG 589
IG G +G VY+ + A+K+ E G+ T EI +L +L+H ++V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKHSNIVKLYD 67
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPW------KQRLEICIGAARGLHYLHTG 643
++LV++++ L++ L + Q L G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL-------NGIAYCH-- 117
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
++HRD+K N+L++ + E K++DFGL++
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNPSSEQGVHEFQT---------E 572
+ + IG G G V D VAIK+ S P FQ E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAILERNVAIKKLSRP--------FQNQTHAKRAYRE 74
Query: 573 IEMLSKLRHKHLVSLI------GFCEEDGEMILVYDYMA---NGTLREHLYKGDKPGLPW 623
+ ++ + HK+++ L+ EE ++ +V + M ++ L L +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 624 KQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS-KTGPNLNQ 682
Q L G+ +LH+ IIHRD+K +NI++ K+ DFGL+ G +
Sbjct: 135 -QML-------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 683 T-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
T +V T Y PE E D++S G ++ E++
Sbjct: 184 TPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 522 KHGTRNFSESHVIGVGGFGKVY--EGYIDGKT------KVAIKRSNPSSEQGVHEFQTEI 573
K G NF V+G G +GKV+ T KV K + + +TE
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 574 EMLSKLRHKH-LVSLIGFCEEDGEMI-LVYDYMANGTLREHLYKGDKPGLPWKQRL---E 628
++L +R LV+L + + + L+ DY+ G L HL + ++ ++ E
Sbjct: 110 QVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGE 167
Query: 629 ICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTM 688
I + L +LH + II+RD+K NILLD ++DFGLSK
Sbjct: 168 IVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 689 VKGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLFEVLCARP 727
G+ Y+ P+ R + D +S GV+++E+L
Sbjct: 221 C-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 32/191 (16%)
Query: 511 GLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTK---VAIKRSNPSSEQ-GV 566
GLCR + IG G +GKV++ D K VA+KR + + G+
Sbjct: 5 GLCRADQ---------QYECVAEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGM 54
Query: 567 HEFQT---EIEMLSKLR---HKHLVSLI-----GFCEEDGEMILVYDYMANGTLREHLYK 615
+ E+ +L L H ++V L + + ++ LV++++ + L +L K
Sbjct: 55 P--LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDK 111
Query: 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
+PG+P + ++ RGL +LH + ++HRD+K NIL+ + K++DFGL++
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 676 T-GPNLNQTHV 685
+ T V
Sbjct: 169 IYSFQMALTSV 179
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 38/205 (18%)
Query: 488 SHTTGKSTGTGKSTSSHLTNL---AAGLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYE 544
+H GT ++ + ++ AA + +G G +G+VY+
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSID---------RYRRITKLGEGTYGEVYK 52
Query: 545 GYIDGKTK--VAIKRSNPSSEQ-GVHEFQT---EIEMLSKLRHKHLVSLIGFCEEDGEMI 598
ID T VAIKR E+ GV T E+ +L +L+H++++ L + +
Sbjct: 53 A-IDTVTNETVAIKRIRLEHEEEGVP--GTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 599 LVYDYMANGTLREHLYKG---DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKT 655
L+++Y E+ K P + + G+++ H +HRD+K
Sbjct: 110 LIFEYA------ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKP 160
Query: 656 TNILLDEKWEA-----KVSDFGLSK 675
N+LL + K+ DFGL++
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT--EIEMLSKLR 580
+ +G G +G V D KT +VA+K+ + + +H +T E+ +L ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 581 HKHLVSLI------GFCEEDGEMILVYDYM---------ANGTLREH----LYKGDKPGL 621
H++++ L+ EE ++ LV M +H +Y
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY------- 139
Query: 622 PWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681
Q L RGL Y+H+ IIHRD+K +N+ ++E E K+ DFGL++ +
Sbjct: 140 ---QIL-------RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 682 QTHVSTMVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
+V+T Y PE + D++S G ++ E+L R
Sbjct: 187 TGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 66/235 (28%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNPSSEQGVHEFQT---------E 572
+ + +G G +G V +DG+T KVAIK+ P FQ+ E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRP--------FQSELFAKRAYRE 74
Query: 573 IEMLSKLRHKHLVSLI------GFCEEDGEMILVYDYM--------ANGTLR-EH----L 613
+ +L +RH++++ L+ ++ + LV +M + L + +
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 134
Query: 614 YKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673
Y Q L +GL Y+H IIHRD+K N+ ++E E K+ DFGL
Sbjct: 135 Y----------QML-------KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 674 SKTGPNLNQTHVSTMVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 727
++ + +V T Y PE + T+ D++S G ++ E++ +
Sbjct: 175 ARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 42/183 (22%)
Query: 534 IGVGGFGKVYEG-YIDGKT--KVAIKRSN----PSSEQGVHEFQTEIEMLSKLRHKHLVS 586
+G G +G VY+ DGK A+K+ S EI +L +L+H +++S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82
Query: 587 LIGFCEEDGEMI--LVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAA-------- 634
L + L++DY EH + + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 635 --RGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLSK--TGPNLNQTHVS 686
G+HYLH ++HRD+K NIL+ E+ K++D G ++ P +
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 687 TMV 689
+V
Sbjct: 194 PVV 196
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 39/221 (17%)
Query: 533 VIGVGGFGKVYEGYIDGKTK--VAIK--RSNPS-SEQGVHEFQTEIEMLSKLR------- 580
+G G F V+ D VA+K R + +E + EI++L ++
Sbjct: 26 KLGWGHFSTVWLAK-DMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKE 80
Query: 581 ----HKHLVSLIG---FCEEDGE-MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG 632
H++ L+ +G +++V++ + L + K + G+P +I
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDE------KWEAKVSDFGLSKTGPNLNQTHVS 686
GL Y+H IIH D+K N+L++ + K++D G + H +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYT 193
Query: 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727
++ Y PE +D++S ++FE++
Sbjct: 194 NSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 58/212 (27%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR-SNPSSEQGVHEFQT---------E 572
R + +G G +G V++ ID +T VA+K+ + FQ E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRTGEVVAVKKIFDA--------FQNSTDAQRTFRE 58
Query: 573 IEMLSKLR-HKHLVSL--IGFCEEDGEMILVYDYM---------ANGTLREH----LYKG 616
I +L++L H+++V+L + + D ++ LV+DYM AN H +Y
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY-- 116
Query: 617 DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676
Q + + + YLH+G ++HRD+K +NILL+ + KV+DFGLS++
Sbjct: 117 --------QLI-------KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158
Query: 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
N+ + + + + + + + LT+
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDD-DQPILTD 189
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 45/259 (17%), Positives = 98/259 (37%), Gaps = 80/259 (30%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKRSNPSSEQGVHEFQT----EIEMLSK 578
++ +S +G G FG V E D ++ + A+K+ V + E++++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEV-FDIESGKRFALKK--------VLQDPRYKNRELDIMKV 56
Query: 579 LRHKHLVSLIGF--------------------------------------CEEDGEMILV 600
L H +++ L+ + ++ + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 601 YDYMANGTLREHLYKGDKPGLPWKQRLE----------ICIGAARGLHYLHTGARYTIIH 650
+Y+ + L+K K + + + + R + ++H+ I H
Sbjct: 117 MEYVP-----DTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSLG---ICH 164
Query: 651 RDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE-YFRRQQLTE 708
RD+K N+L++ + K+ DFG +K ++ V+ + S Y PE + T
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIP-SEPSVAYIC--SRFYRAPELMLGATEYTP 221
Query: 709 KSDVYSFGVVLFEVLCARP 727
D++S G V E++ +P
Sbjct: 222 SIDLWSIGCVFGELILGKP 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 47/214 (21%), Positives = 93/214 (43%), Gaps = 44/214 (20%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFC 591
+G G + +V+E I KV +K P ++ + + EI++L LR ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 592 EEDGEM--ILVYDYMANGTLREHLYKGDKPGLPWKQRL----------EICIGAARGLHY 639
++ LV++++ N ++ Q L EI + L Y
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-----------QTLTDYDIRFYMYEIL----KALDY 145
Query: 640 LHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTG-PNLNQTH-VSTMVKGSFGYL 696
H+ I+HRDVK N+++D E + ++ D+GL++ P V++ +
Sbjct: 146 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 697 DPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPAL 729
PE Q+ + S D++S G +L ++ +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 27/202 (13%)
Query: 533 VIGVGGFGKVYEGYIDGKTK--VAIK--RSNPS-SEQGVHEFQTEIEMLSKLRHK----- 582
VIG G FG+V + Y D K VA+K R+ Q EI +L LR +
Sbjct: 104 VIGKGSFGQVVKAY-DHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNT 158
Query: 583 -HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
+++ ++ + + ++ ++ L E + K G + + L LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 642 TGARYTIIHRDVKTTNILLDE--KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
+ IIH D+K NILL + + KV DFG S +Q T ++ F Y PE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRV-YTYIQSRF-YRAPE 269
Query: 700 YFRRQQLTEKSDVYSFGVVLFE 721
+ D++S G +L E
Sbjct: 270 VILGARYGMPIDMWSLGCILAE 291
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 52/246 (21%), Positives = 97/246 (39%), Gaps = 75/246 (30%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKT--KVAIKR---SNPSSEQGVHEFQT--EIEMLS 577
+ + +G GG G V+ +D +VAIK+ ++P S + EI+++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIR 63
Query: 578 KLRHKHLVSLI--------------GFCEEDGEMILVYDYM---------ANGTLREH-- 612
+L H ++V + G E + +V +YM L EH
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR 123
Query: 613 --LYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVS 669
+Y Q L RGL Y+H+ ++HRD+K N+ ++ E K+
Sbjct: 124 LFMY----------QLL-------RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163
Query: 670 DFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFE 721
DFGL++ P+ + + L +++R T+ D+++ G + E
Sbjct: 164 DFGLARIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
Query: 722 VLCARP 727
+L +
Sbjct: 218 MLTGKT 223
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 533 VIGVGGFGKVYEGYIDGKTK--VAIK--RSNPS-SEQGVHEFQTEIEMLSKLRH------ 581
+IG G FG+V + Y D + VAIK ++ + Q Q E+ +L +
Sbjct: 61 LIGKGSFGQVVKAY-DRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
++V L + LV++ ++ L + L + G+ + L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 642 TGARYTIIHRDVKTTNILL--DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
T +IIH D+K NILL ++ K+ DFG S + ++ F Y PE
Sbjct: 175 T-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRF-YRSPE 228
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARP 727
D++S G +L E+ P
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 43/205 (20%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGF 590
V+G+G GKV + + + K A+K Q + + E+E+ + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 591 CEE----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GAR 645
E +++V + + G L + ++ EI + YLH+
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 137
Query: 646 YTIIHRDVKTTNILLDEKWEA---KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
I HRDVK N+L K K++DFG + E
Sbjct: 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------------KE-TT 171
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARP 727
++ + D++S GV+++ +LC P
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYP 196
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 1e-11
Identities = 81/606 (13%), Positives = 174/606 (28%), Gaps = 229/606 (37%)
Query: 305 FQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWA----GEQGVPVYK 360
F + + + ++ + +++ D I ++ A G + W E+ V
Sbjct: 29 FVDNFDCKDVQ-----DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV---- 79
Query: 361 DYAIYAEDLPGDDELWVALHPSVSMHPEYYDAILNGLEIFKQNDTMGNLAGPNPVPSAML 420
+ E++ + ++ + E + +Q D + N
Sbjct: 80 --QKFVEEVLRINYKFLM----SPIKTEQRQPSMMTRMYIEQRDRLYN------------ 121
Query: 421 LHAEATKKKFAPSS-SRSKTVVHVIGGVAGGVFGIAVATAIIFYVSNKKKNNDGSRCSTS 479
+ FA + SR + + + A+ +
Sbjct: 122 -----DNQVFAKYNVSRLQPY-------------LKLRQAL-------------LELRPA 150
Query: 480 SWLPLYGTSHTTGKSTGTGKSTSSHLTNLAAGLCRHFSLAEIKHGTRNFSESHVIGVGGF 539
+ + G G+GK+ +A +C + +
Sbjct: 151 KNVLIDGV-------LGSGKTW------VALDVCLSYKV------QCKMD---------- 181
Query: 540 GKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598
K++ +++ + +T +EML KL ++ D
Sbjct: 182 FKIF--WLNLKN---------------CNSPETVLEMLQKLLYQI----------DPNWT 214
Query: 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNI 658
D+ +N LR H + L R + + + +
Sbjct: 215 SRSDHSSNIKLRIHS---------IQAEL-----------------RRLLKSKPYENCLL 248
Query: 659 LLDEKWEAKVSD-FGLS-KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFG 716
+L AK + F LS K L ++T K +L L S
Sbjct: 249 VLLNVQNAKAWNAFNLSCKI---L----LTTRFKQVTDFLSAATTTHISLDHHSM----T 297
Query: 717 VVLFEV--LCARPALNVN---LPKEQV------------SLADWALH--------CQRMG 751
+ EV L + L+ LP+E + S+ D C ++
Sbjct: 298 LTPDEVKSLLLK-YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356
Query: 752 T-IEDIIDPNLKGNITDQCLRK---FTETA---EKCLSDQGIDRPSMGDVLWN------- 797
T IE ++ L+ + + F +A LS ++W
Sbjct: 357 TIIESSLN-VLEPAEYRKMFDRLSVFPPSAHIPTILLS-----------LIWFDVIKSDV 404
Query: 798 -------LEFALQLQDNPDGDKLI-SIQTD---KANDTYAMHKAMLN-------IDEESV 839
+++L + + I SI + K + YA+H+++++ D + +
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 840 LSDEID 845
+ +D
Sbjct: 465 IPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 61/405 (15%), Positives = 112/405 (27%), Gaps = 117/405 (28%)
Query: 83 IPYMTARIFKSTSSYKFTVSSKDR-------FWLRLHFYPASYGNLDPSNAY--F---SV 130
+ M I S + SKD FW L F +
Sbjct: 38 VQDMPKSIL-SKEEIDHIIMSKDAVSGTLRLFWTLL---------SKQEEMVQKFVEEVL 87
Query: 131 NAN-GFTLLNNFSASITAKAL-TQAYI---------VREFSLVPAQSGDLIITFTPS--S 177
N F L++ ++ T+ YI + F+ + +
Sbjct: 88 RINYKF-LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 178 DHKDSYAFVNGIEVIPMPDIFGSAPLVGFSDQSVEVNSSTLQTMYRLNVGGKFIPSTNDS 237
++G + G + S +V ++ LN+ P T
Sbjct: 147 LRPAKNVLIDG-----VLG-SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 238 GLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPN--- 294
L + Y P S++D+ + I+ + Q L ++ P N
Sbjct: 201 MLQKLLYQIDPNW-------TSRSDHSSNIKLRIHSIQA--ELRRLLKSK---PYENCLL 248
Query: 295 VNRNYNLTWIFQIDANFTYIVRFHF-CEILLTKINQRVFDIFINNQTAQEGAD--VIGWA 351
V N +A F+ C+ILLT ++V D T D +
Sbjct: 249 VLLNVQNAKA--WNA-------FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 352 GEQGVPVYKDYA-IYAEDLPGDDELWVALHP-SVSM----------HPEYY--------- 390
++ + Y +DLP + +P +S+ + +
Sbjct: 300 PDEVKSLLLKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356
Query: 391 ---DAILNGLE------------IFKQNDTMGNLAGPNPVPSAML 420
++ LN LE +F +P+ +L
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLSVF-PPSA--------HIPTILL 392
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 34/196 (17%), Positives = 55/196 (28%), Gaps = 47/196 (23%)
Query: 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIK--------RSNPSSEQGVHEFQTEIEML 576
T IG G FG+V++ I T VAIK N S ++ E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 577 SKL---------RHKHLVSLIGFCEEDG----EMILVYDYMANGTLREH----------- 612
+L R + + L G ++ +D+ + +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 613 ------------LYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660
L + I L HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLL 195
Query: 661 DEKWEAKVSDFGLSKT 676
+ K+ K+
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 49/221 (22%), Positives = 80/221 (36%), Gaps = 47/221 (21%)
Query: 533 VIGVGGFGKVYEGY--IDGKTKVAIK--RSNPS-SEQGVHEFQTEIEMLSKLRHK----- 582
+G G FGKV E GK++VA+K R+ E + EI +L K++ K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 583 -HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
V + + G M + ++ + E L + + P + L +LH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT---------------HVS 686
+ H D+K NIL + + S ++ T H +
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT 197
Query: 687 TMVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFE 721
T+V Y PE + + DV+S G +LFE
Sbjct: 198 TIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 51/225 (22%)
Query: 533 VIGVGGFGKVYEGYIDGKTK--VAIK--RSNPS-SEQGVHEFQTEIEMLSKLRH-----K 582
+G G FG+V K A+K R+ + + E ++L K+++
Sbjct: 42 KMGDGTFGRVLLCQ-HIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNN 96
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
++V G M L+++ + +L E + + + G + CI + L+YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR- 154
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV--STMVK----GSFGYL 696
+ ++ H D+K NILLD+ + K T Q + ST +K G +
Sbjct: 155 --KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 697 D--------------PE------YFRRQQLTEKSDVYSFGVVLFE 721
PE + SD++SFG VL E
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 29/165 (17%), Positives = 57/165 (34%), Gaps = 28/165 (16%)
Query: 534 IGVGGFGKVYEGY---------IDGKTKVAIK----RSNPSSEQGVHEFQTEIEMLSKLR 580
G +YE K K ++K +EQ + + ++K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 581 HKHLVSLIGF-------CEEDGEMILVYDYMANGT-LREHLYKGDKPGLPWKQRLEICIG 632
+ L+ +D LV + G L+ L K L + L++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV--SDFGLSK 675
L +LH +H +V NI +D + +++V + +G +
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 35/147 (23%), Positives = 59/147 (40%), Gaps = 12/147 (8%)
Query: 534 IGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHLVSLIGFC 591
IG G FG +Y G I +VAIK ++ E ++ ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E ++V + + G E L+ K L + + Y+H+ IHR
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHR 129
Query: 652 DVKTTNILLDEKWEAK---VSDFGLSK 675
DVK N L+ + + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 55/282 (19%), Positives = 94/282 (33%), Gaps = 80/282 (28%)
Query: 534 IGVGGFGKVYEGYIDGKTK--VAIK--RSNPSSEQGVHEFQTEIEMLSKLR--------H 581
+G G F V+ + D + K VA+K +S + + EI +L +R
Sbjct: 45 LGWGHFSTVWLSW-DIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNR 100
Query: 582 KHLVSLIGFCEEDGE----MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGL 637
+ +V L+ + G + +V++ + + L + + K + GLP +I +GL
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 638 HYLHTGARYTIIHRDVKTTNILL------------------------------------- 660
YLHT R IIH D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 661 ------------DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
EK + K++D G + + T Y E
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 709 KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750
+D++S + FE+ + +E D H +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDED---HIALI 311
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 43/226 (19%), Positives = 83/226 (36%), Gaps = 57/226 (25%)
Query: 533 VIGVGGFGKVYEGYIDGKTK---VAIK--RSNPS-SEQGVHEFQTEIEMLSKLRHK---- 582
+G G FGKV E D K VA+K ++ E ++EI++L L
Sbjct: 21 TLGEGAFGKVVECI-DHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75
Query: 583 --HLVSLIGFCEEDGEMILVYDYM-ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
V ++ + E G + +V++ + + + + + ++ + +++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVK----GSFGY 695
LH + H D+K NIL + + + + + L + +K GS Y
Sbjct: 134 LH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI----NPDIKVVDFGSATY 186
Query: 696 LD--------------PE------YFRRQQLTEKSDVYSFGVVLFE 721
D PE + ++ DV+S G +L E
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 34/151 (22%), Positives = 56/151 (37%), Gaps = 14/151 (9%)
Query: 532 HVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHLVSLIG 589
IG G FG ++EG + +VAIK S+ + + E L + ++
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
F +E +LV D + G E L K + +H +++
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 128
Query: 650 HRDVKTTNILLDEKWEAK-----VSDFGLSK 675
+RD+K N L+ V DFG+ K
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 12/147 (8%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFC 591
IG G FG++Y G I +VAIK N ++ + E ++ L+ + ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E +LV D + G E L+ L K L + + ++H + +HR
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 652 DVKTTNILLDEKWEAK---VSDFGLSK 675
D+K N L+ A + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 37/156 (23%), Positives = 53/156 (33%), Gaps = 14/156 (8%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHL 584
NF IG G FG++ G + VAIK S E +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGI 67
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
+ F +V + + G E L+ K L I I + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH--- 122
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVS-----DFGLSK 675
+I+RDVK N L+ DF L+K
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 31/165 (18%), Positives = 61/165 (36%), Gaps = 28/165 (16%)
Query: 534 IGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGVHEFQT-----EIEMLSKLRHK 582
IG GGFG +Y ++ +K + E + + E + K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 583 HLVSLIGFC----------EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG 632
+ +G ++ D G+ + +Y+ + K L++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV--SDFGLSK 675
L Y+H + +H D+K +N+LL+ K +V D+GL+
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 33/163 (20%), Positives = 61/163 (37%), Gaps = 27/163 (16%)
Query: 534 IGVGGFGKVYEGY-IDGKTKVAIK------RSNPS--SEQGVHEFQTEIEMLSKLRHKHL 584
IG GGFG +Y + + K A + N SE ++ + + + K +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 585 VSLIGF----------CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA 634
+ +G + +V + + G + + + L++ I
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT-FKKSTVLQLGIRML 161
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV--SDFGLSK 675
L Y+H +H D+K N+LL K +V +D+GLS
Sbjct: 162 DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 862 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.54 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.84 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.37 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.22 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.03 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.41 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=460.15 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=211.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...++||+|+||.||+|+++ ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999865 367899999988887888899999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCC-------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 600 VYDYMANGTLREHLYKGD-------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
|||||++|+|.++|+... ..+++|.++++|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 235999999999999999999999876 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||......+. .....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHHHH
Confidence 9999999987654443444455679999999999999999999999999999999998 8999975433221 11111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
. +. +...+..++.++.+++.+||+.+|++||||.||+++|+.+.+.
T Consensus 275 ~----g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 Q----GR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H----TC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred c----CC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 10 1112334567899999999999999999999999999998765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=455.62 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=216.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...+.||+|+||.||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCC-----------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEE
Q 041565 600 VYDYMANGTLREHLYKGD-----------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKV 668 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl 668 (862)
|||||++|+|.++|+... ...++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 345999999999999999999999877 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+|||+|+.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||......+. ......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~~- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IECITQ- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHc-
Confidence 99999986543333333344568999999999999999999999999999999998 8999976433221 111111
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+. ....+..++.++.+++.+||+.+|.+||||.||++.|+.+.+
T Consensus 246 ---~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 ---GR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ---TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 011233466789999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=453.00 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=210.9
Q ss_pred cccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
+...++||+|+||+||+|.+. .+..||||+++.. .....++|.+|+.+|++++|||||+++|+|.+++.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 455789999999999999863 3568999998754 334467899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 601 YDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
||||++|+|.++|.... ...++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 99999999999997532 235899999999999999999999877 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||......+ +.....
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i~ 261 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMIR 261 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 9999999987543333334455679999999999999999999999999999999998 899997654322 111111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+. ....+..++..+.+++.+||+.+|.+||||.||+++|+..
T Consensus 262 ----~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 ----NRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----cCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111 1122345677899999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=443.89 Aligned_cols=261 Identities=27% Similarity=0.491 Sum_probs=206.7
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCC--CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNP--SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
..+++...++||+|+||+||+|++++ .||||.++. .+.+..++|.+|+++|++++|||||+++|+|.+ +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34567788999999999999998765 489998764 345567889999999999999999999999875 4689999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.++|+.... .++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp ECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999976543 4999999999999999999999876 9999999999999999999999999998754433
Q ss_pred CccccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.........||+.|||||++.+ +.++.++|||||||+||||+||+.||......... ..... .+ ...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~----~~----~~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVG----RG----YAS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH----TT----CCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHh----cC----CCC
Confidence 3334455689999999999974 45899999999999999999999999754332211 11111 11 111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
|.+ ...+..++..+.+++.+||+.+|.+||||.||+++|+.+.
T Consensus 257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 221 1223346678999999999999999999999999998774
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=444.10 Aligned_cols=271 Identities=23% Similarity=0.365 Sum_probs=220.8
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccc-cceeeE
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRH-KHLVSL 587 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l 587 (862)
+...+.+...++|...+.||+|+||.||+|.+.+ ++.||||++.... ....++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455566677889999999999999999998654 2579999987543 4456789999999999965 899999
Q ss_pred EEEEeec-CeEEEEEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeC
Q 041565 588 IGFCEED-GEMILVYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652 (862)
Q Consensus 588 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 652 (862)
+|+|.+. +.+++|||||++|+|.++|+... ...++|.+++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 56899999999999999997532 234899999999999999999999887 99999
Q ss_pred CCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 041565 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNV 731 (862)
Q Consensus 653 Ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~ 731 (862)
|||+||||++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654333334455679999999999999999999999999999999998 9999975
Q ss_pred CCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 732 NLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
....+.. . ... ..+ .+...+..++.++.+++.+||+.+|.+|||+.||+++|+.+++.
T Consensus 291 ~~~~~~~--~---~~i-~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEEF--C---RRL-KEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHHH--H---HHH-HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHH--H---HHH-HcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 4322211 1 111 111 11122334567789999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=436.30 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=208.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|...+.||+|+||.||+|+.. +++.||||++... .....++|.+|+++|++|+|||||++++++.+++.++||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999975 5789999987543 44556789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++|+|.++|.......+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 999999999998766656899999999999999999999887 99999999999999999999999999987532 1
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
....+..+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.. .... .+.. +.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~-~~~~-----~~-- 244 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV------LKII-SGSF-----PP-- 244 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHH-HTCC-----CC--
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHH-cCCC-----CC--
Confidence 12234567999999999999999999999999999999999999999765332211 1111 1111 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+..++.++.+++.+||+.||.+|||+.|++++-+...
T Consensus 245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 12234567899999999999999999999998876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=430.43 Aligned_cols=268 Identities=23% Similarity=0.345 Sum_probs=202.3
Q ss_pred CcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC----eEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG----EMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 602 (862)
++...++||+|+||+||+|+++ |+.||||++...... ...+..|+..+.+++|||||+++|+|.+++ .++||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4667889999999999999985 678999998643322 223345666667889999999999998754 6899999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC-----cccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA-----RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
||++|+|.++|++. .++|..+++++.|+|+||+|||+++ .++||||||||+||||++++.+||+|||+++..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999764 3899999999999999999999862 346999999999999999999999999999864
Q ss_pred CCCCCc--cccccccCCCCCCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc---------cH
Q 041565 678 PNLNQT--HVSTMVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV---------SL 740 (862)
Q Consensus 678 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~---------~l 740 (862)
...... .......||+.|||||++.+. .++.++|||||||+||||+||++|+......+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 332211 122345799999999999764 4678999999999999999999887543221110 11
Q ss_pred HHHHHhhhccCccccccCCCCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGN-ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
...... . ..+.++|.+... ...+++..+.+++.+||+.+|.+||||.||++.|+.+.+.
T Consensus 239 ~~~~~~-~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKV-V----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHH-H----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHH-H----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111111 0 111122332221 1235778899999999999999999999999999988654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=421.29 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=199.2
Q ss_pred ccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee----cCeEEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE----DGEMILVY 601 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 601 (862)
...++||+|+||.||+|.... +..||+|++... .....++|.+|+++|++|+|||||++++++.. ++.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456789999999999999764 678999987532 44556789999999999999999999999865 35689999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeeccccccCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~ 680 (862)
|||++|+|.++|.+.. .+++..+..|+.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999998654 3999999999999999999999864 46999999999999984 78999999999986432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
......+||+.|||||++.+ .++.++|||||||+||||+||+.||........ + ..... .+.. +
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~---~~~i~-~~~~-----~- 248 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRRVT-SGVK-----P- 248 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHHHT-TTCC-----C-
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--H---HHHHH-cCCC-----C-
Confidence 22345679999999998865 699999999999999999999999964332211 1 11111 1100 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..++...++++.+++.+||+.||.+|||+.|+++|-+
T Consensus 249 --~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0111223456889999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=430.56 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=212.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+.|+..++||+|+||.||+|+.+ +|..||||++........+.+.+|+++|++++|||||++++++.+++.++||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999976 57899999986544445567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.+. .+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP 225 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--CC
Confidence 999999999763 3999999999999999999999887 999999999999999999999999999875432 22
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||......+... .... . ..+.+ .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~----~-----~~~~~--~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRD----N-----LPPRL--K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH----S-----SCCCC--S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHc----C-----CCCCC--C
Confidence 3345689999999999999999999999999999999999999997543322211 0100 0 01111 1
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....++.++.+++.+||+.||.+|||+.|+++|-+..
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~ 328 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence 1223456789999999999999999999999886654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=428.32 Aligned_cols=257 Identities=21% Similarity=0.226 Sum_probs=208.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.+.|...++||+|+||.||+|+.+ .|..||||+++.... +.+|+.+|++++|||||++++++.+++.++|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356788889999999999999975 478999999864322 24699999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 682 (862)
|++|+|.++|.+.. .+++.+++.++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999998654 3999999999999999999999887 99999999999999987 699999999987543211
Q ss_pred c---cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 683 T---HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 683 ~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. ......+||+.|||||++.+..++.++|||||||+||||++|++||......+... .. ......+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i--~~~~~~~------ 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KI--ASEPPPI------ 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HH--HHSCCGG------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HH--HcCCCCc------
Confidence 1 12234579999999999999999999999999999999999999997654333211 11 0111111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
...+..++..+.+++.+||+.||.+|||+.|++++|..+++-.
T Consensus 276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 1122335667899999999999999999999999999887543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=421.86 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=208.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...++||+|+||+||+|+.. +++.||||.+... .....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999975 5789999987632 2334578999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.++|.+... +++.+...++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999986543 999999999999999999999887 9999999999999999999999999998764433
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........+||+.|||||++.+..++.++||||+||+||||++|++||......+.. . .... +. ..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~--~i~~--~~------~~- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF---A--KIIK--LE------YD- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H--HHHH--TC------CC-
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H--HHHc--CC------CC-
Confidence 333445578999999999999999999999999999999999999999765332211 1 1111 11 11
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
++...+.++.+++.+||+.||.+|||+.|++.+
T Consensus 253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 122345678999999999999999999987544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=431.51 Aligned_cols=255 Identities=20% Similarity=0.333 Sum_probs=212.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.+.|+..++||+|+||.||+|+.. .|..||||++........+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999976 4789999998765555566789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|++|+|.+++... .+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..... .
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 301 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--C
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--C
Confidence 9999999999754 3999999999999999999999887 999999999999999999999999999875432 2
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......+||+.|||||++.+..|+.++|||||||++|||++|++||......+.... .. . . ..+.+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i~---~-~-----~~~~~~- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IR---D-N-----LPPRLK- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HH---H-S-----CCCCCS-
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---HH---c-C-----CCCCCc-
Confidence 233456799999999999999999999999999999999999999975433222111 10 0 0 111111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....++..+.+++.+||+.||.+|||+.|+++|-+..
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~ 405 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence 1112456789999999999999999999999876654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=408.28 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=196.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999965 5789999987543 2334567999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||| +|+|.+++.+.. .+++.+...++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 689999998754 3999999999999999999999887 999999999999999999999999999864332
Q ss_pred CccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......||+.|||||++.+..+ +.++||||+||++|||++|+.||......+. ..... .+. ..
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~------~~~i~-~~~------~~ 230 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL------FKNIS-NGV------YT 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HTC------CC
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCC------CC
Confidence 22344679999999999998876 5899999999999999999999975432211 11110 111 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+ +...+.++.+++.+||+.||.+|||+.|++++-+.-.+
T Consensus 231 ~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 231 L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 1 12245678899999999999999999999999887543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=414.43 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=199.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|+..+.||+|+||+||+|+.. .++.||||.+.... .....++.+|+++|++++|||||++++++.+++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999863 35689999876432 2233468899999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|||||++|+|.++|.+.. .+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999998654 3999999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. .......+||+.|||||++.+..++.++|||||||+||||++|+.||......+... .... +. .
T Consensus 179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-----~i~~--~~------~ 243 (304)
T 3ubd_A 179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT-----MILK--AK------L 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHH--CC------C
T ss_pred C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH-----HHHc--CC------C
Confidence 2 122345679999999999999999999999999999999999999997654322211 0000 10 1
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLE 799 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~ 799 (862)
.++..++.++.+++.+||+.||.+||| ++|+++|-+
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 112234567899999999999999998 578877654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=406.17 Aligned_cols=291 Identities=60% Similarity=1.035 Sum_probs=257.3
Q ss_pred cccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee
Q 041565 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593 (862)
Q Consensus 514 ~~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 593 (862)
..+.+.++...+++|...+.||+|+||.||+|..+++..||||+.........+++.+|++++++++||||++++++|.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45667788889999999999999999999999988888999999887766677889999999999999999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 594 DGEMILVYDYMANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
.+..++||||+++|+|.+++.... ...++|.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999987543 234899999999999999999999877 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
|+++...............||..|+|||++.+..++.++||||||+++|||++|+.||....+.+......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986543333333445568999999999999999999999999999999999999998777777777788877777777
Q ss_pred ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCCC
Q 041565 752 TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN 807 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~~ 807 (862)
.+..++++.+......+++..+.+++.+||+.+|.+|||+.|++++|+.++++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 78888888888888889999999999999999999999999999999999877543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=397.59 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=189.0
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC---------
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG--------- 595 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------- 595 (862)
+|+..+.||+|+||.||+|+.+ ++..||||++... .....+.+.+|+++|++|+|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888999999999999999975 5789999987543 3445578999999999999999999999986544
Q ss_pred ---eEEEEEEeCCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 596 ---EMILVYDYMANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 596 ---~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
.+++|||||++|+|.+++..... ...++..++.|+.||++||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 37899999999999999986543 23556778899999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCc----------cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH
Q 041565 672 GLSKTGPNLNQT----------HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA 741 (862)
Q Consensus 672 Gla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~ 741 (862)
|+|+........ ...+..+||+.|||||++.+..++.++|||||||++|||++ ||... .+....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~- 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT- 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH-
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH-
Confidence 999875432111 11234579999999999999999999999999999999996 66421 111100
Q ss_pred HHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 742 DWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 742 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. .. ..... .. ....+....+.+++.+||+.+|.+|||+.|++++-.
T Consensus 237 -~-~~-~~~~~--------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 237 -L-TD-VRNLK--------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp -H-HH-HHTTC--------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -H-HH-HhcCC--------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 0 00 00110 00 011233455678999999999999999999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=399.93 Aligned_cols=270 Identities=21% Similarity=0.277 Sum_probs=206.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee------cCe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE------DGE 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 596 (862)
++|...+.||+|+||.||+|+.. .|..||||++... .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 5789999998643 33456778999999999999999999998753 367
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
++||||||+ |+|.+++.+.. .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 78999997654 4999999999999999999999887 99999999999999999999999999986
Q ss_pred CCCCC--CccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 677 GPNLN--QTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 677 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
..... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....+.-..........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 53221 12233456899999999998875 5699999999999999999999999876544332221100000000000
Q ss_pred c--------cc---cCCCCCCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 754 E--------DI---IDPNLKGN---ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 754 ~--------~~---~d~~l~~~---~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. .. +.+..... ........+.+|+.+||+.||.+|||+.|+++|-+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 0 00 00000000 0011245688999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=388.36 Aligned_cols=288 Identities=40% Similarity=0.702 Sum_probs=248.1
Q ss_pred ccccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh-hhHHHHHHHHHHHHhccccceeeEEEEE
Q 041565 513 CRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE-QGVHEFQTEIEMLSKLRHKHLVSLIGFC 591 (862)
Q Consensus 513 ~~~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 591 (862)
...|++.++...+++|...+.||+|+||.||+|..+++..||||++..... ....++.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 457899999999999999999999999999999988888999999875432 2234689999999999999999999999
Q ss_pred eecCeEEEEEEeCCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 592 EEDGEMILVYDYMANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 592 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
...+..++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+....+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998653 3349999999999999999999999833349999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--ccccccHHHHHHhh
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNL--PKEQVSLADWALHC 747 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~ 747 (862)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+.+|....
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998654322 223344569999999999999999999999999999999999999996321 12344567787777
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+..+.+..+......+++..+.+++.+||+.+|.+|||+.||+++|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 777778888888888888889999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=385.07 Aligned_cols=268 Identities=19% Similarity=0.292 Sum_probs=200.3
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 597 (862)
.-.+.|...++||+|+||+||+|+.+ .+..||+|++.... ...++.+|+++|+.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999864 35689999886543 245688999999998 699999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeecccccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKT 676 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla~~ 676 (862)
++|||||++|+|.+++. .+++.++..++.|++.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999983 2899999999999999999999887 9999999999999877 7999999999975
Q ss_pred CCCCCC--------------------------ccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 041565 677 GPNLNQ--------------------------THVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPAL 729 (862)
Q Consensus 677 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~ 729 (862)
...... ....+..+||+.|+|||++.+. .++.++||||+||+++||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 432111 0112335699999999999875 5899999999999999999999999
Q ss_pred CCCCcc-ccccHH----------HHHHhhhcc---------Cccc---------cccCCCCCC---------CCcHHHHH
Q 041565 730 NVNLPK-EQVSLA----------DWALHCQRM---------GTIE---------DIIDPNLKG---------NITDQCLR 771 (862)
Q Consensus 730 ~~~~~~-~~~~l~----------~~~~~~~~~---------~~~~---------~~~d~~l~~---------~~~~~~~~ 771 (862)
...... ++...+ .+....... .... ....|.+.. ......+.
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 544321 111100 000000000 0000 000000000 00112345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 772 KFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 772 ~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
++.+++.+||+.||.+|||+.|+++|.++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 67899999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=409.38 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=211.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|...+.||+|+||.||+|..+ .|..||+|.+........+.+.+|+++|++|+|||||++++++.+.+.++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999975 57899999987766666788999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC--CceEEeeccccccCCCCCC
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK--WEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~~kl~DFGla~~~~~~~~ 682 (862)
++|+|.++|.... ..+++.++..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 237 ~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 237 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9999999997543 34999999999999999999999887 9999999999999854 88999999999875432
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......+||+.|||||++.+..++.++|||||||+||||++|++||......+... .. ...... +.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~---~i--~~~~~~--------~~ 376 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NV--KSCDWN--------MD 376 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HH--HTTCCC--------CC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HH--HhCCCC--------CC
Confidence 23345679999999999999999999999999999999999999997654332211 00 011111 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......+..+.+|+.+||+.||.+|||+.|+++|-+.
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 11111235678899999999999999999999988654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=400.56 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=202.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC------ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS------SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|...++||+|+||.||+++.. .|..||+|++... ......+...++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999976 4789999987532 1122223344567777889999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
||||||+||+|.++|.+... +++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999987543 999999999999999999999887 9999999999999999999999999998753
Q ss_pred CCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.. .....+||+.|||||++.+ ..|+.++|||||||+||||++|++||......+...+..... ..
T Consensus 344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~-------- 409 (689)
T 3v5w_A 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TM-------- 409 (689)
T ss_dssp SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HC--------
T ss_pred CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CC--------
Confidence 32 2234679999999999975 579999999999999999999999997543222211111110 00
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
.. .++...+.++.+++.+||+.||.+|++ +.||++|-++
T Consensus 410 ~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 410 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 01 112234567899999999999999998 7999888654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=380.48 Aligned_cols=261 Identities=25% Similarity=0.439 Sum_probs=215.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc--------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeec
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID--------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED 594 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 594 (862)
.++|...+.||+|+||.||+|... .+..||||.+... .....+++.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 457888999999999999999863 3457999998754 345567899999999999 899999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCC--------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGDK--------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
+..++||||+++|+|.+++..... ..+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986432 34899999999999999999999887 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999986544333233344557889999999999999999999999999999999 9999975433221
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..... .+ .....+..++..+.+++.+||+.+|.+||++.|++++|+.++.+
T Consensus 315 -~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 -FKLLK----EG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -HHHHH----TT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHh----cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111 11 11112233566799999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.54 Aligned_cols=281 Identities=38% Similarity=0.660 Sum_probs=231.2
Q ss_pred cccCHHHHHhhccCcccc------eeEeeeCcEEEEEEEEcCccEEEEEecCCC----ChhhHHHHHHHHHHHHhccccc
Q 041565 514 RHFSLAEIKHGTRNFSES------HVIGVGGFGKVYEGYIDGKTKVAIKRSNPS----SEQGVHEFQTEIEMLSKLRHKH 583 (862)
Q Consensus 514 ~~~~~~el~~at~~f~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~n 583 (862)
..|++.++..++++|... +.||+|+||.||+|.. ++..||+|++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 578999999999999887 8999999999999986 4668999987542 2344678999999999999999
Q ss_pred eeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcC-CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC
Q 041565 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKG-DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE 662 (862)
Q Consensus 584 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 662 (862)
|+++++++.+.+..++||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 999999999999999999999999999999743 2345999999999999999999999887 999999999999999
Q ss_pred CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 663 KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 663 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
++.+||+|||+++...............||..|+|||.+.+ .++.++||||||+++|||++|+.||......+. +..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 99999999999986544333333344568999999998865 588999999999999999999999976543322 222
Q ss_pred HHHhhh-ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 743 WALHCQ-RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 743 ~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+..... ....+.+.+++.+ ...+..++..+.+++.+||+.+|.+|||+.|++++|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222221 2233444555544 3345667889999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.34 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=212.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|...++||+|+||.||++... ++..||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356888999999999999999976 4788999988777777788999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|+|.+++..... .+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999987433 4999999999999999999999887 999999999999999999999999999864332111
Q ss_pred c------------ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 684 H------------VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 684 ~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
. ......||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 0 111456899999999999999999999999999999999999988654332211000
Q ss_pred ccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 752 TIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 752 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
......+... +..++..+.+++.+||+.+|.+|||+.|+++.|+.+..
T Consensus 235 ~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 235 NVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp CHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000011111 11234568899999999999999999999999988753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.76 Aligned_cols=276 Identities=22% Similarity=0.323 Sum_probs=211.5
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC----eEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG----EMIL 599 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 599 (862)
..++|+..++||+|+||.||+|+.. +..||||++.... .....+..|+.++++++||||+++++++.... .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467888999999999999999876 5789999987543 33455677999999999999999999998754 4799
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC-------cccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA-------RYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
||||+++|+|.+++.... +++..++.++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999997643 899999999999999999999870 1149999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||..................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99765433322233445799999999999873 4567899999999999999999999765443332222111100
Q ss_pred hccCccc-----cccCCCCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 748 QRMGTIE-----DIIDPNLKGN-ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 748 ~~~~~~~-----~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.....+. ....+.+... ....++..+.+++.+||+.+|.+|||+.|+++.|+.+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 0111111111 1224677899999999999999999999999999988653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=367.98 Aligned_cols=271 Identities=27% Similarity=0.429 Sum_probs=207.9
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 593 (862)
+...++....++|...+.||+|+||.||+|..+ +..||||++... .....+++.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 344445555678999999999999999999874 568999987654 34556789999999999999999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
.+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999999986432 23899999999999999999999764 349999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ..
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~---~~- 255 (309)
T 3p86_A 185 LSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGF---KC- 255 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHH---SC-
T ss_pred CCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---cC-
Confidence 99864321 11233456999999999999999999999999999999999999999755332211 11100 00
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
.....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+++..
T Consensus 256 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 --------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 011122234567899999999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=367.77 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=211.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...+.||+|+||.||+|.+. .+..||||++... .....++|.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888899999999999999974 3456999998754 44556789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999997653 34999999999999999999999887 99999999999999999999999999987543
Q ss_pred CCC-ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 680 LNQ-THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ... .. +
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~---~~-~------ 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI---SSV---EE-G------ 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHH---HT-T------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHH---Hc-C------
Confidence 221 112233346778999999999999999999999999999999 99999654332211 111 10 0
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
.....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+++..
T Consensus 271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111122235667899999999999999999999999999997653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=362.12 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=210.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|...+.||+|+||.||+|.. .++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45788999999999999999986 45789999987655555567889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|+|.+++.+. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999764 3899999999999999999999887 9999999999999999999999999997654322
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+. + ..
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~~------~--~~ 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT------P--EL 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHCS------C--CC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC------C--CC
Confidence 223345699999999999999999999999999999999999999975433221110 000000 0 01
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+...+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 11233556789999999999999999999999876544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=375.43 Aligned_cols=271 Identities=23% Similarity=0.354 Sum_probs=218.5
Q ss_pred ccCHHHHHhhccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceee
Q 041565 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVS 586 (862)
Q Consensus 515 ~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~ 586 (862)
.+...+.....++|...+.||+|+||.||+|.+. .+..||||++... .....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556677778889999999999999999999843 3468999998764 344567899999999999 7999999
Q ss_pred EEEEEeecC-eEEEEEEeCCCCcHHHHHhcCCC-----------------------------------------------
Q 041565 587 LIGFCEEDG-EMILVYDYMANGTLREHLYKGDK----------------------------------------------- 618 (862)
Q Consensus 587 l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 618 (862)
++++|.+.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 48999999999999999986532
Q ss_pred -----------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 619 -----------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 619 -----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12889999999999999999999887 9999999999999999999999999998654333
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..... .+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~----~~~-------- 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK----EGT-------- 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH----HTC--------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHH----cCC--------
Confidence 3333445568899999999999999999999999999999998 99999754432211 11011 110
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.|++++|+.+++
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 011122245678999999999999999999999999998874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.70 Aligned_cols=266 Identities=20% Similarity=0.291 Sum_probs=218.1
Q ss_pred cccCHHHHHhhccC----------cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcccc
Q 041565 514 RHFSLAEIKHGTRN----------FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK 582 (862)
Q Consensus 514 ~~~~~~el~~at~~----------f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 582 (862)
..++.++++.+++. |...+.||+|+||.||+|+.. ++..||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35788888888865 667789999999999999986 6889999998766666678899999999999999
Q ss_pred ceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC
Q 041565 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE 662 (862)
Q Consensus 583 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 662 (862)
||+++++++...+..++||||+++|+|.+++.+. .+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999998643 4999999999999999999999877 999999999999999
Q ss_pred CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 663 KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 663 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~ 251 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK 251 (321)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH
T ss_pred CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 9999999999998654321 122345699999999999999999999999999999999999999975432211 11
Q ss_pred HHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 743 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
... .. ..+.+. .....+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 252 ~~~---~~------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 252 RLR---DS------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HHH---HS------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred HHh---cC------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 111 00 111111 1122456789999999999999999999999876553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=378.74 Aligned_cols=261 Identities=24% Similarity=0.401 Sum_probs=211.2
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
...++|...+.||+|+||.||+|... ++..||||.+... .....++|.+|+++|++++||||++++++|...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34467888999999999999999986 5789999998754 334456789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999997543 23899999999999999999999887 999999999999999999999999999864322
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
..........++..|+|||.+.++.++.++|||||||++|||++ |+.||......+. .+... .+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~~~----~~~------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REFVE----KGG------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHHHH----TTC-------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cCC-------
Confidence 11111112234667999999999999999999999999999998 9999865432221 11111 110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 333 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 --RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 111222355678999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=375.08 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=201.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...+.||+|+||.||+|+.. .+..||||++... .....++|.+|++++++++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888999999999999999875 4667999998754 34556789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999997653 34999999999999999999999887 99999999999999999999999999987543
Q ss_pred CCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 680 LNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..... .+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i~----~~------ 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVD----EG------ 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHHH----TT------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cC------
Confidence 2111 11122345778999999999999999999999999999998 9999965432211 11111 00
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.....+..++..+.+++.+||+.+|.+||++.|+++.|+.+++.
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11111223566789999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=366.53 Aligned_cols=271 Identities=26% Similarity=0.417 Sum_probs=208.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-----CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-----GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 597 (862)
.++|+..+.||+|+||.||+++++ .+..||||++........+++.+|++++++++||||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 356888999999999999999842 4678999999877777788999999999999999999999998653 568
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999986543 4899999999999999999999877 999999999999999999999999999875
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc----cCc
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR----MGT 752 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----~~~ 752 (862)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+...... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhHHH
Confidence 432111 1222334667799999999999999999999999999999999988543111 0000000000 000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+.+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 001111111122233456789999999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=372.67 Aligned_cols=266 Identities=26% Similarity=0.432 Sum_probs=217.1
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc--------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEee
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID--------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE 593 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 593 (862)
..++|...+.||+|+||.||+|... .+..||||++... .....+++.+|+++++++ +||||++++++|..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999863 2357999998654 445567899999999999 89999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCC--------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDK--------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
.+..++||||+++|+|.+++..... ..+++.+++.|+.|+++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999986542 34899999999999999999999887 999999999999
Q ss_pred ccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 041565 660 LDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQV 738 (862)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~ 738 (862)
+++++.+||+|||+++...............+|..|+|||++.+..++.++|||||||+++||++ |+.||......+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987544333333344557889999999999999999999999999999999 9999865432221
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCCCC
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNP 808 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~~~ 808 (862)
..... . + .....+..++..+.+++.+||+.+|.+|||+.|++++|+.++......
T Consensus 303 --~~~~~---~-~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 303 --FKLLK---E-G---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp --HHHHH---T-T---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred --HHHHH---c-C---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 11111 1 1 011112234567899999999999999999999999999998654433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.65 Aligned_cols=257 Identities=29% Similarity=0.438 Sum_probs=211.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++|...+.||+|+||.||+|...++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35688889999999999999999888889999987543 23467999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ...
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 162 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc-ccc
Confidence 9999999997654 34899999999999999999999887 999999999999999999999999999864321 111
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+.. ...... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~------~~~~~~----------~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDISTG----------FRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTT----------CCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhcC----------ccC
Confidence 2233456778999999999999999999999999999999 99999754332211 111100 001
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+...+..+.+++.+||+.+|.+|||+.|++++|+.+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1112235678999999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=365.07 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=203.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-cc----EEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KT----KVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...++||+|+||.||+|++.. +. +||+|.+... .....++|.+|+.++++++||||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 468889999999999999999643 32 4688987543 3355678999999999999999999999998754 789
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|+||+++|+|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999987543 4999999999999999999999887 99999999999999999999999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.. .....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~------------ 234 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK------------ 234 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT------------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHc------------
Confidence 333333334457889999999999999999999999999999999 99999765433221 11111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
......+..++..+.+++.+||+.+|.+||++.|++++|+.+..
T Consensus 235 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 235 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111122345678999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.93 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=209.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
..++|...+.||+|+||.||+|.. ..+..||||++... .....+.+.+|+++|++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 345799999999999999999997 46789999987543 445567889999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|.+++..... +++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999976543 899999999999999999999887 999999999999999999999999999764321
Q ss_pred CCccccccccCCCCCCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.......||+.|+|||++.+..++ .++|||||||+++||++|+.||......+.. .... .+..
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~-~~~~------ 231 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR------ERVL-RGKY------ 231 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HCCC------
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCCC------
Confidence 223456799999999999988775 7999999999999999999999754322211 1111 0100
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+...+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 111123567889999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.91 Aligned_cols=264 Identities=26% Similarity=0.431 Sum_probs=215.9
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEee
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE 593 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 593 (862)
+....++|...+.||+|+||.||++... ++..||+|.+... .....+++.+|++++++++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3445677889999999999999999862 3478999998754 34556789999999999999999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCC----------------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEee
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDK----------------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 651 (862)
.+..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 9999999999999999999986432 23889999999999999999999887 9999
Q ss_pred CCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 041565 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALN 730 (862)
Q Consensus 652 DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~ 730 (862)
||||+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543332222334457788999999999999999999999999999999 999997
Q ss_pred CCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 731 VNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.....+.. ..... +. ....+..++..+.+++.+||+.+|.+||++.|++++|+.+++
T Consensus 255 ~~~~~~~~---~~~~~----~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 255 GIPPERLF---NLLKT----GH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TCCGGGHH---HHHHT----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHH---HHhhc----CC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 65432211 11111 10 111122345678999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=367.15 Aligned_cols=267 Identities=28% Similarity=0.417 Sum_probs=216.2
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEE
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 590 (862)
+.++....++|...+.||+|+||.||+|...+ +..||+|.+... .....+++.+|++++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34455667889999999999999999999753 378999998754 34456789999999999999999999999
Q ss_pred EeecCeEEEEEEeCCCCcHHHHHhcCC----------------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccE
Q 041565 591 CEEDGEMILVYDYMANGTLREHLYKGD----------------------KPGLPWKQRLEICIGAARGLHYLHTGARYTI 648 (862)
Q Consensus 591 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 648 (862)
|.+.+..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+.+ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 999999999999999999999998642 145899999999999999999999887 9
Q ss_pred EeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 041565 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARP 727 (862)
Q Consensus 649 vHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~ 727 (862)
+||||||+|||+++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999975432222222334457889999999999999999999999999999999 999
Q ss_pred CCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 728 ALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 728 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
||......+. . .. ...+.. ...+..++..+.+++.+||+.+|.+||++.|++++|+.+.+
T Consensus 276 p~~~~~~~~~---~---~~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMAHEEV---I---YY-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSCHHHH---H---HH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCChHHH---H---HH-HhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9965432211 1 11 111111 11122345678999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=385.32 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=213.2
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+...++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 44566788899999999999999999888899999987643 34688999999999999999999999987 56789999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.++|.......+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~- 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN- 337 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-
Confidence 9999999999998654335899999999999999999999887 999999999999999999999999999864321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.........++..|+|||++..+.++.++|||||||+||||++ |+.||......+.. .... ...
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~---~~~--------- 402 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE---RGY--------- 402 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHH---HTC---------
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH---cCC---------
Confidence 1111223446778999999999999999999999999999999 99999754332211 1111 110
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus 403 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 011122356789999999999999999999999999997753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=365.77 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=211.9
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEe
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCE 592 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 592 (862)
.....++|...+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999962 3467999998654 233457899999999999 8999999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCC---------------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEee
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDK---------------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 651 (862)
..+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999986532 23799999999999999999999887 9999
Q ss_pred CCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 041565 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALN 730 (862)
Q Consensus 652 DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~ 730 (862)
||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986433222223334557889999999999999999999999999999998 999997
Q ss_pred CCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 731 VNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
....... +..... .+ .....+..++..+.+++.+||+.+|.+|||+.|++++|+.++..
T Consensus 277 ~~~~~~~--~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDAN--FYKLIQ----NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHH--HHHHHH----TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHH--HHHHHh----cC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5432221 111111 11 11111223456789999999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.37 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=210.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..++|...+.||+|+||.||+|..+++..||+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 346788899999999999999999888889999987543 2346799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-Y 159 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-E
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-h
Confidence 99999999997643 24899999999999999999999887 9999999999999999999999999998654322 1
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......+|..|+|||.+.+..++.++||||||++++||++ |+.||......+.. ....... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~---~------- 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGH---R------- 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTC---C-------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCC---C-------
Confidence 22233446678999999999999999999999999999999 99999654332211 1111100 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
...+...+..+.+++.+||+.+|.+|||+.|++++|+.+.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0011123457899999999999999999999999998774
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=375.61 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=209.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC-eEEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG-EMILVYD 602 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 602 (862)
..++|...+.||+|+||.||+|..+ +..||||.++... ..++|.+|+++|++++||||++++++|.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567888899999999999999986 5689999987543 4578999999999999999999999987665 7999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++|+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999998765555899999999999999999999887 999999999999999999999999999864321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. .... .+ .
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~----~~---------~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE----KG---------Y 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHHH----TT---------C
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----cC---------C
Confidence 122357889999999999999999999999999999998 99999754332211 1111 11 1
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+...+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111233456789999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=373.55 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=210.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
.++|...+.||+|+||.||+|.+. .+..||||++... ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999853 3467999998653 455567899999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCC-----CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC---ceEEe
Q 041565 598 ILVYDYMANGTLREHLYKGD-----KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW---EAKVS 669 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~~kl~ 669 (862)
++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 234899999999999999999999887 99999999999999554 59999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhh
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. .....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~~i~--- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVT--- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHH---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---
Confidence 9999974322112222334567899999999999999999999999999999998 9999975433221 11111
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
... ....+..++..+.+++.+||+.+|.+|||+.|++++|+.+.+.
T Consensus 301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111 1111223456789999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=359.23 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=214.3
Q ss_pred hhccCcccceeEeeeCcEEEEEEEE------cCccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEeec
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYI------DGKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED 594 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 594 (862)
...++|...+.||+|+||.||+|.. ..+..||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3446788899999999999999985 245789999987543 34567899999999999 999999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCC----------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCe
Q 041565 595 GEMILVYDYMANGTLREHLYKGDK----------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNI 658 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 658 (862)
+..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999986542 24899999999999999999999887 99999999999
Q ss_pred eccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 041565 659 LLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQ 737 (862)
Q Consensus 659 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~ 737 (862)
|++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999987544332223334457788999999999999999999999999999998 9999865432221
Q ss_pred ccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 738 VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 738 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
. ...... + .....+..++..+.+++.+||+.+|.+|||+.|++++|+.+++
T Consensus 257 ~--~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 F--YKMIKE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp H--HHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHHhcc----C---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 111110 0 0111122345678999999999999999999999999998874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=385.28 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=214.7
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
...+|...++||+|+||.||+|.++. +..||||.+.... ...++|.+|+++|++++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34568888999999999999999875 6789999987543 346789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++|+|.++|.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 999999999998765566999999999999999999999887 9999999999999999999999999998754321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........++..|+|||++.+..++.++|||||||+||||++ |+.||......+. ..... ...
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~-------------~~~ 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE-------------KDY 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH-------------TTC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH-------------cCC
Confidence 122233446778999999999999999999999999999999 9999875433221 11111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+...+..++..+.+++.+||+.+|.+|||+.|+++.|+.++
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11223345678899999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.49 Aligned_cols=269 Identities=23% Similarity=0.382 Sum_probs=200.7
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcCc----cEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEE
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGK----TKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 591 (862)
++++....++|...+.||+|+||.||+|..... ..||||.+... .....+++.+|++++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 344556677899999999999999999986543 27999988654 345568899999999999999999999999
Q ss_pred eecCeE------EEEEEeCCCCcHHHHHhcCC----CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 592 EEDGEM------ILVYDYMANGTLREHLYKGD----KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 592 ~~~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
...... ++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence 876655 99999999999999996432 224899999999999999999999887 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccH
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSL 740 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l 740 (862)
+++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-- 249 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-- 249 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH--
Confidence 999999999999986543332233334456788999999999999999999999999999999 99999765432221
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
.... ... ....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+++..
T Consensus 250 -~~~~---~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 -NYLI---GGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHH---TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHh---cCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 000 01112234567899999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.90 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=207.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999976 57889999875432 23346788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|+|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999986543 3999999999999999999999887 999999999999999999999999999864332222
Q ss_pred cccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|..... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-------------~ 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT-------------Y 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCT-------------T
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccc-------------c
Confidence 33345679999999999988775 7899999999999999999999975433221 1222221100 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.......+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 0011224567889999999999999999999998877653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=353.74 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=209.5
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
...++|...+.||+|+||.||++..+++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34567888999999999999999999888999999875432 34679999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 999999999997643 24999999999999999999999887 9999999999999999999999999998643211
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..... + .
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~-~---------~ 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQ-G---------L 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHT-T---------C
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HHHhc-c---------c
Confidence 112223446778999999999999999999999999999998 99999754332211 11110 0 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+...+..+.+++.+||+.+|.+|||+.|++++|+.+++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 111112234678999999999999999999999999998864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=365.01 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=205.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCC--CChhhHHHHHHHHHHHHhccc--cceeeEEEEEeecCeEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNP--SSEQGVHEFQTEIEMLSKLRH--KHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l 599 (862)
..++|...+.||+|+||.||++...++..||||++.. ......+.+.+|+++|++++| +||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4567899999999999999999988888999998753 345556789999999999976 999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||| +.+|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 87 v~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999 45889999998754 4899999999999999999999887 99999999999997 57899999999987543
Q ss_pred CCCccccccccCCCCCCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~------ 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SK------ 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HH------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HH------
Confidence 333223345679999999999875 678999999999999999999999996432210 00
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
+..++++......+...+..+.+++.+||+.+|.+|||+.|++++.+...+.
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 230 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 1111222222222333345788999999999999999999999999886543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=353.44 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=206.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...+.||+|+||.||++... .+..||+|.+.. ......+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999965 567899998643 2345567899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997654 3899999999999999999999887 999999999999999999999999999865332
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ........ .. .
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~-----~ 231 (294)
T 4eqm_A 165 S-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VP-----N 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CC-----C
T ss_pred c-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CC-----C
Confidence 1 1222345699999999999999999999999999999999999999975433211 11111110 00 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhc
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP-SMGDVLWNLEFALQ 803 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-t~~evl~~L~~~l~ 803 (862)
.........+..+.+++.+|++.+|.+|| ++.++.+.|+.++.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011122456789999999999999999 89999998887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=350.91 Aligned_cols=273 Identities=21% Similarity=0.275 Sum_probs=213.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecC--eEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG--EMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 601 (862)
++|...++||+|+||.||+|.... +..||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 568889999999999999999764 7899999987533 334677889999999999999999999987655 789999
Q ss_pred EeCCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec----cCCCceEEeecccccc
Q 041565 602 DYMANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLSKT 676 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~~kl~DFGla~~ 676 (862)
||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986432 34899999999999999999999887 9999999999999 7888899999999987
Q ss_pred CCCCCCccccccccCCCCCCChhhhh--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHhh
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFR--------RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SLADWALHC 747 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~ 747 (862)
..... ......||..|+|||++. +..++.++|||||||++|||++|+.||......... ....-....
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 54322 223456899999999987 578899999999999999999999999644322211 111111111
Q ss_pred hccCcccccc-----------CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 748 QRMGTIEDII-----------DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 748 ~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.....+..+. +..............+.+++.+||+.||.+|||+.|++++.......
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 1111111000 01112244567888899999999999999999999999999877543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.43 Aligned_cols=253 Identities=28% Similarity=0.502 Sum_probs=197.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC----hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS----EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|+..+.||+|+||.||+|... +..||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999976 6789999876432 23357899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC--------CCceEEeecc
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE--------KWEAKVSDFG 672 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--------~~~~kl~DFG 672 (862)
|||+++++|.+++... .+++..++.++.|+++||+|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998543 4899999999999999999999876556999999999999986 6789999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
+++..... ......||..|+|||.+.+..++.++||||||++++||++|+.||......... + ....
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~--~~~~--- 228 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA----Y--GVAM--- 228 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----H--HHHT---
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----H--hhhc---
Confidence 99864322 122346899999999999999999999999999999999999999754322111 0 0000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......+..++..+.+++.+||+.+|.+|||+.|++++|+.
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111111223355679999999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=360.18 Aligned_cols=263 Identities=25% Similarity=0.442 Sum_probs=214.1
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc--------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEee
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID--------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE 593 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 593 (862)
..++|...+.||+|+||.||+|... ++..||+|++... .....+++.+|+++++++ +||||++++++|.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3567888999999999999999863 3567999998754 345567899999999999 89999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCC--------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDK--------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
.+..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999986532 24899999999999999999999887 999999999999
Q ss_pred ccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 041565 660 LDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQV 738 (862)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~ 738 (862)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999986544332223334457788999999999999999999999999999999 9999965432221
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
...... +. ....+..++..+.+++.+||+.+|.+|||+.|++++|+.++...
T Consensus 269 --~~~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 --FKLLKE----GH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp --HHHHHH----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHhc----CC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111 00 01112234567899999999999999999999999999997653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=347.58 Aligned_cols=263 Identities=16% Similarity=0.163 Sum_probs=210.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||+|.. .++..||+|.+.... ..+++.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788999999999999999996 467899999875432 234678899999999 79999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc-----eEEeeccccccC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE-----AKVSDFGLSKTG 677 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----~kl~DFGla~~~ 677 (862)
|+ +++|.+++..... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999986543 4999999999999999999999877 999999999999987766 999999999865
Q ss_pred CCCCCc-----cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 678 PNLNQT-----HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 678 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 432211 123445699999999999999999999999999999999999999976543322211111111111111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.... . ..++..+.+++.+||+.+|.+||++.+|++.|+.+++
T Consensus 242 ~~~~-----~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 242 LREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHH-----H----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 1110 0 1235678999999999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=378.48 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=207.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..++|...+.||+|+||.||+|.++++..||||.+.... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 345688889999999999999999888889999987543 335789999999999999999999999976 678999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|++|+|.+++.......+++.+++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence 99999999997543345899999999999999999999887 9999999999999999999999999998654321 1
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......++..|+|||.+.++.++.++|||||||++|||++ |+.||......+.. ..... + .+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~i~~-~---------~~ 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER-G---------YR 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHT-T---------CC
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-C---------CC
Confidence 12233456788999999999999999999999999999999 99999654332211 11111 1 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11223456788999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=354.02 Aligned_cols=267 Identities=21% Similarity=0.275 Sum_probs=204.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|+..++||+|+||.||+|...++..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35788899999999999999999888999999876432 2335678999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|++ |+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 100 FME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-- 172 (311)
T ss_dssp CCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred CCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence 997 58888887654 34999999999999999999999887 999999999999999999999999999864321
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc--cCcccc----
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR--MGTIED---- 755 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~---- 755 (862)
........||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+.... ....... ......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK--IFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH--HHHHHCCCCTTTSGGGTTS
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHHCCCChHHhhhhhcc
Confidence 122334568999999999876 5689999999999999999999999976544332211 1110000 000000
Q ss_pred ---------ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 756 ---------IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 756 ---------~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+.............++.+++.+||+.+|.+|||+.|++++.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 000000000011234578899999999999999999999987554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=361.28 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=204.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-cc----EEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KT----KVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
++|...++||+|+||.||+|.... +. +||+|.+.... ....+++.+|+.++++++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 468889999999999999999653 33 38888765432 333456788999999999999999999986 457899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999997653 34899999999999999999999887 99999999999999999999999999987654
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..... +.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~----~~------ 234 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---DLLEK----GE------ 234 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---HHHHT----TC------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---HHHHc----CC------
Confidence 433333445668889999999999999999999999999999999 99999765432221 11111 00
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+||++.|++++|+.+..
T Consensus 235 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 ---RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001111234467889999999999999999999999998864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=359.49 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=195.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..++||+|+||+||+|... ++..||||++... ......++..|+..+.++ +|+||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999986 6789999987543 334445566676666665 8999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+ +++|.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 999 679999887654 34999999999999999999999887 999999999999999999999999999765332
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.++.... .|... ..+. .
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~~--~~~~--------~ 269 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQL--RQGY--------L 269 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHHHH--TTTC--------C
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHH--hccC--------C
Confidence 22334569999999999876 78999999999999999999977664221 11111 0111 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
........+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 01111124567899999999999999999999997643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.40 Aligned_cols=257 Identities=15% Similarity=0.231 Sum_probs=209.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|...+.||+|+||.||++.... +..+|+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4678899999999999999999764 6789999887543 3456789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC--CCceEEeeccccccCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE--KWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~~ 681 (862)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999999997543 34999999999999999999999887 999999999999987 789999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ....... +.
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~--~~~~~~~----~~- 225 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIM--NAEYTFD----EE- 225 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHH--HTCCCCC----HH-
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHH--cCCCCCC----hh-
Confidence 2234456899999999999988999999999999999999999999754332211 0000 0000000 00
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.....+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 00123567899999999999999999999999988763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=354.97 Aligned_cols=263 Identities=17% Similarity=0.179 Sum_probs=209.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||+|.. .++..||||.+..... .+++.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788999999999999999996 4578899998764332 24688999999999 99999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc-----eEEeeccccccC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE-----AKVSDFGLSKTG 677 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----~kl~DFGla~~~ 677 (862)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 899999998653 35999999999999999999999887 999999999999998887 999999999864
Q ss_pred CCCCCcc-----ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 678 PNLNQTH-----VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 678 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 3322111 12356799999999999999999999999999999999999999976543332211111111110000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
... +. ..++ ++.+++.+||+.+|.+||++.++++.|+.+.+-
T Consensus 241 ~~~-----~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 IEV-----LC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHH-----HT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH-----Hh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 000 00 0133 799999999999999999999999999988653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.39 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=199.2
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
..++|...+.||+|+||.||+|.... +..||+|..... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34678889999999999999998743 356999987653 3445678999999999999999999999985 45788
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999997653 34899999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..... +.
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~----~~----- 234 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIEN----GE----- 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT----TC-----
T ss_pred cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHc----CC-----
Confidence 3211 12223346778999999999999999999999999999996 99999765433211 11110 00
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.|++++|+.+++
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011122345678999999999999999999999999998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=353.35 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=217.1
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
....++|...+.||+|+||.||+|.... +..||+|.+.... ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3456778889999999999999999875 6789999987543 3467899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999998766667999999999999999999999877 999999999999999999999999999875432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. ........+|..|+|||.+.+..++.++||||||++++||++ |+.||......+.. .....
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---~~~~~------------- 227 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEK------------- 227 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHT-------------
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhc-------------
Confidence 2 222334457888999999999999999999999999999999 99998754332211 11110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
......+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11111222345678999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=349.63 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHh--ccccceeeEEEEEeec----CeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK--LRHKHLVSLIGFCEED----GEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 598 (862)
.++|...+.||+|+||.||+|+. ++..||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788899999999999999987 4678999998643 34556677777776 7999999999987543 4689
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhh--------cCCcccEEeeCCCCCCeeccCCCceEEee
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH--------TGARYTIIHRDVKTTNILLDEKWEAKVSD 670 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDIkp~NILl~~~~~~kl~D 670 (862)
+||||+++|+|.+++... .+++..+++++.|+++||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999543 4999999999999999999999 555 99999999999999999999999
Q ss_pred ccccccCCCCCCc--cccccccCCCCCCChhhhhcC------CCCchhHHHHHHHHHHHHHhC----------CCCCCCC
Q 041565 671 FGLSKTGPNLNQT--HVSTMVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA----------RPALNVN 732 (862)
Q Consensus 671 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVyS~Gvvl~elltG----------~~p~~~~ 732 (862)
||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999754322111 112234689999999999876 455799999999999999999 7777544
Q ss_pred CccccccHHHHHHhhhccCccccccCCCCC-CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 733 LPKEQVSLADWALHCQRMGTIEDIIDPNLK-GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...... ............ ..+.+. ......++..+.+++.+||+.+|.+|||+.|+++.|+.+
T Consensus 237 ~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS-FEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC-HHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc-hhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322211 111111111111 011111 112345788999999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.65 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=211.6
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
....++|...+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 33456788899999999999999998888889999887543 345789999999999999999999999874 4689999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.......+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999997543334899999999999999999999887 9999999999999999999999999998654321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
........++..|+|||.+.+..++.++||||||++++||++ |+.||......+. . ..... +
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~~~~~-~--------- 226 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I---QNLER-G--------- 226 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H---HHHHT-T---------
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---H---HHHhc-c---------
Confidence 122233456788999999999999999999999999999999 8999865432221 1 11111 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.....+..++..+.+++.+|++.+|.+|||+.++++.|+.+...
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 00111223456789999999999999999999999999988643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.74 Aligned_cols=270 Identities=23% Similarity=0.359 Sum_probs=216.9
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeE
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSL 587 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l 587 (862)
+...+.....++|...+.||+|+||.||+|... .+..||||.+... .....+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 455566667788999999999999999999852 3578999998754 334567899999999999 79999999
Q ss_pred EEEEeecC-eEEEEEEeCCCCcHHHHHhcCCC--------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeC
Q 041565 588 IGFCEEDG-EMILVYDYMANGTLREHLYKGDK--------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRD 652 (862)
Q Consensus 588 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 652 (862)
+++|...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987754 58999999999999999986542 12789999999999999999999887 99999
Q ss_pred CCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 041565 653 VKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNV 731 (862)
Q Consensus 653 Ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~ 731 (862)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543322223334567889999999999999999999999999999998 9999965
Q ss_pred CCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 732 NLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+.. . ..... +.. . ..+..++..+.+++.+||+.+|.+|||+.|++++|+.+++
T Consensus 254 ~~~~~~~--~---~~~~~-~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKIDEEF--C---RRLKE-GTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCSHHH--H---HHHHH-TCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHH--H---HHhcc-Ccc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 4322211 1 11111 100 0 1112245678999999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.12 Aligned_cols=253 Identities=17% Similarity=0.279 Sum_probs=206.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 601 (862)
++|...+.||+|+||.||+|+.+ +..||+|.+... .....++|.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999986 668999987654 345567899999999999999999999999876 7889999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.......+++.+++.++.|+++||+|||+.+ .+++||||||+|||+++++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999998776556999999999999999999999753 4599999999999999999999999998764221
Q ss_pred CccccccccCCCCCCChhhhhcCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTE---KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
....||+.|+|||.+.+...+. ++||||||+++|||++|+.||......+.. ......
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~-------- 226 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALE-------- 226 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHS--------
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhc--------
Confidence 2245889999999998765444 899999999999999999999654322211 111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
......+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 -GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111122234567899999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=359.69 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=206.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh------hhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE------QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
.+.|...+.||+|+||.||++... ++..||+|.+..... ...+++.+|+.+|++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888999999999999999976 478899998754321 1357899999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC----ceEEeeccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW----EAKVSDFGL 673 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~~kl~DFGl 673 (862)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997543 4999999999999999999999887 99999999999998776 799999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..........
T Consensus 166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~-----~~i~~~~~~~ 237 (361)
T 2yab_A 166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANITAVSYDF 237 (361)
T ss_dssp CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----HHHHTTCCCC
T ss_pred ceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcCCCC
Confidence 9875432 1223456999999999999999999999999999999999999999754322211 0000000000
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
++. .....+..+.+++.+||..+|.+|||+.|++++.+.
T Consensus 238 ----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 238 ----DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp ----CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred ----Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 000 011234568899999999999999999999987553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.69 Aligned_cols=257 Identities=29% Similarity=0.436 Sum_probs=211.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++|...+.||+|+||.||++...++..||+|.+..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356888999999999999999998888999999875432 3468999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++..... ...
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 160 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-ccc
Confidence 9999999997653 34899999999999999999999887 999999999999999999999999999864321 111
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+. ...... + ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i~~-~---------~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDIST-G---------FRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHT-T---------CCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHHhc-C---------CcC
Confidence 1223456778999999999999999999999999999999 8999865432211 111111 0 000
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+...+..+.+++.+||+.+|.+||++.|++++|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111235678999999999999999999999999998864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=364.08 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=204.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCC--CChhhHHHHHHHHHHHHhcc--ccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNP--SSEQGVHEFQTEIEMLSKLR--HKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...+.||+|+||.||++....+..||||++.. ......+.+.+|+++|++++ |+||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 346889999999999999999988888999998753 34556788999999999996 59999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|| +.+++|.+++.... .+++.+++.++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 56889999998754 4899999999999999999999877 99999999999995 579999999999875432
Q ss_pred CCccccccccCCCCCCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~------ 276 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK------ 276 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HH------
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HH------
Confidence 22223344579999999999875 468999999999999999999999996432110 00
Q ss_pred cCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+..++++......+...+..+.+++.+||+.+|.+|||+.|++++.+....
T Consensus 277 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 277 ---LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ---HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ---HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 111122222222222234578899999999999999999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.84 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=205.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh------hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE------QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
+.|...+.||+|+||.||++... ++..||+|.+..... ...+++.+|+.+|++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888999999999999999976 478899998654321 23678999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC----ceEEeecccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW----EAKVSDFGLS 674 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~~kl~DFGla 674 (862)
+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999997543 4999999999999999999999887 99999999999999887 7999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ........
T Consensus 166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-----~~~~~~~~-- 235 (326)
T 2y0a_A 166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-----NVSAVNYE-- 235 (326)
T ss_dssp EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-----HHHHTCCC--
T ss_pred eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-----HHHhcCCC--
Confidence 8753221 2234569999999999999999999999999999999999999997543322110 00000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.........+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 236 ------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp ------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 0000011234568899999999999999999999987553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.90 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=207.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+++.+ ++..||+|.+... .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999976 4788999987643 2234567899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+.. .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999997644 3899999999999999999999887 999999999999999999999999999863321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ..... . ..
T Consensus 159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~--~i~~~--~------~~- 223 (337)
T 1o6l_A 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E--LILME--E------IR- 223 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H--HHHHC--C------CC-
T ss_pred -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---H--HHHcC--C------CC-
Confidence 12234467999999999999999999999999999999999999999754322111 0 00000 0 01
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
++...+..+.+++.+||+.+|.+|| ++.|++++..+
T Consensus 224 ---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 1222456789999999999999999 89999988554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=358.87 Aligned_cols=269 Identities=23% Similarity=0.379 Sum_probs=216.0
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEE
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLI 588 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 588 (862)
+...++....++|...+.||+|+||.||+|... .+..||+|.+... ......++.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556677788999999999999999999865 2568999998754 334556799999999999999999999
Q ss_pred EEEeecCeEEEEEEeCCCCcHHHHHhcCC--------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 589 GFCEEDGEMILVYDYMANGTLREHLYKGD--------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 589 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
+++.+.+..++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999997521 134789999999999999999999887 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-- 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--
Confidence 9999999999999986432222222233456888999999999999999999999999999999 8888865432211
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
. .... .+.. ...+..++..+.+++.+||+.+|.+|||+.|++++|+..+.
T Consensus 250 -~---~~~~-~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 -L---RFVM-EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -H---HHHH-TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -H---HHHH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 1111 1111 01122345678999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.51 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=212.5
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEcC-c-----cEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEe
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYIDG-K-----TKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCE 592 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 592 (862)
+....++|...+.||+|+||.||+|.... + ..||+|.+... .....+.+.+|+++++++ +||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999753 2 37999988754 334567899999999999 8999999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCC------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGD------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999997531 234899999999999999999999887 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
+.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999986433222222333456788999999999999999999999999999998 99998654322211
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...... + .....+..++..+.+++.+||+.+|.+|||+.|++++|+.+.+
T Consensus 277 -~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 -YKLVKD----G---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -HHHHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHhc----C---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111111 0 0011111235678999999999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=357.85 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=208.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.++|...+.||+|+||.||++..+ ++..||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999976 4788999987543 3445678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DFGla~~~~ 678 (862)
||+++|+|.+++.... .+++.+++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 108 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999997653 4899999999999999999999887 9999999999999865 459999999998754
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .......||+.|+|||++.+..++.++|||||||++|||++|++||......+ +..... .+...
T Consensus 183 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~----~~~~~---- 248 (362)
T 2bdw_A 183 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK----AGAYD---- 248 (362)
T ss_dssp TC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC----
T ss_pred CC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----hCCCC----
Confidence 32 12234579999999999999999999999999999999999999996543221 111111 01000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.........+..+.+++.+||+.+|.+||++.|++++.+..
T Consensus 249 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 249 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp --CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 00001122456789999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=361.34 Aligned_cols=256 Identities=19% Similarity=0.259 Sum_probs=209.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|...+.||+|+||.||+|... ++..+|+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357899999999999999999976 4778999998766666667899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC--CCceEEeeccccccCCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE--KWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~~ 681 (862)
+++|+|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999999987543 34899999999999999999999887 999999999999974 477999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ... ..++..
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~----~~~--~~~~~~ 273 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR----CDW--EFDEDA 273 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH----CCC--CCCSST
T ss_pred --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHh----CCC--CCCccc
Confidence 1223456999999999999999999999999999999999999999754322111 11110 000 011111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
....+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 274 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 274 ----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 12245678999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=359.00 Aligned_cols=273 Identities=15% Similarity=0.171 Sum_probs=207.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCChhhH-----------HHHHHHHHHHHhccccceee
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGV-----------HEFQTEIEMLSKLRHKHLVS 586 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~ 586 (862)
..++|...++||+|+||.||+|.+.. +..||||.+........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45679999999999999999999765 36799998765542211 12345666777888999999
Q ss_pred EEEEEeec----CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-
Q 041565 587 LIGFCEED----GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD- 661 (862)
Q Consensus 587 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~- 661 (862)
+++++... ...++||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998764 4589999999 999999998753 34999999999999999999999887 99999999999999
Q ss_pred -CCCceEEeeccccccCCCCCCc-----cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 041565 662 -EKWEAKVSDFGLSKTGPNLNQT-----HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPK 735 (862)
Q Consensus 662 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~ 735 (862)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999764321111 1123345999999999999999999999999999999999999999753222
Q ss_pred ccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCCC
Q 041565 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN 807 (862)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~~ 807 (862)
.. ...+..... ...+..++++.+.. ..++..+.+++..||+.+|.+||++.++++.|+.+++-...
T Consensus 268 ~~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 268 PK--YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HH--HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH--HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11 111111111 11223333333221 12356789999999999999999999999999998764333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=359.38 Aligned_cols=274 Identities=23% Similarity=0.346 Sum_probs=212.4
Q ss_pred cCcccceeEeeeCcEEEEEEEE-----cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEe--ecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYI-----DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE--EDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 598 (862)
++|...+.||+|+||.||++++ ..+..||||++........+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 356789999998777777788999999999999999999999886 456789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999976432 3899999999999999999999877 9999999999999999999999999998654
Q ss_pred CCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
..... .......+|..|+|||++.+..++.++||||||++++||++|+.|+......... ...+.........+.+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHHh
Confidence 32221 1223345788899999999999999999999999999999999998543211000 000000000000011111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
........+..++..+.+++.+||+.+|.+|||+.|++++|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 12222223344567899999999999999999999999999988643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.04 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=202.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh--hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE--QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...+.||+|+||.||+|....+..||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999988788999998765432 2346788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--V 154 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--c
Confidence 975 9999987643 34899999999999999999999887 999999999999999999999999999754321 1
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc--cCc---ccc--
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR--MGT---IED-- 755 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~---~~~-- 755 (862)
.......||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+... ........ ... ..+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHCCCChhhchhhhccc
Confidence 12233468999999999976 458999999999999999999999997654322211 10000000 000 000
Q ss_pred ccCCCCC-------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 756 IIDPNLK-------GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 756 ~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..++... .......+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0111111 0111224567889999999999999999999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=354.17 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=202.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-cc----EEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KT----KVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
.++|...++||+|+||.||+|.... +. +||+|.+... .....+++.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3578899999999999999999643 33 4688876543 3445678999999999999999999999998764 78
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999987543 4999999999999999999999887 9999999999999999999999999998754
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
............+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. .....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~----------- 234 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK----------- 234 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT-----------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc-----------
Confidence 3332223334456788999999999999999999999999999999 99999765433221 11111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
......+..++..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 235 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 235 --GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00111122345678999999999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.52 Aligned_cols=260 Identities=29% Similarity=0.556 Sum_probs=197.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...++||+|+||.||+|...+ .+|+|.+... .....+.|.+|++++++++||||+++++++. ....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 4678889999999999999998654 4899987543 4455678999999999999999999999764 456899999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996553 34999999999999999999999887 99999999999999999999999999986443222
Q ss_pred ccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 683 THVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
........||+.|+|||.+. +..++.++||||||++++||++|+.||......+. +...... +.. .+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~----~~~----~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR----GSL----SP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH----TSC----CC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc----ccc----Cc
Confidence 33334456999999999986 56789999999999999999999999975433221 1111111 111 11
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+ ......++..+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 1112235678999999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=349.27 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=202.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|...+.||+|+||.||++... +..||+|++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46788899999999999999876 568999998643 345789999999999999999999999874 4789999999
Q ss_pred CCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc-eEEeeccccccCCCCCCc
Q 041565 606 NGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE-AKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 606 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 683 (862)
+|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986543 24789999999999999999999843345999999999999998886 799999999754321
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.....||..|+|||++.+..++.++||||||++++||++|+.||........ ...|... . +. .+.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~--~-~~-----~~~--- 224 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH--N-GT-----RPP--- 224 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH--T-TC-----CCC---
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh--c-CC-----CCC---
Confidence 2234589999999999999999999999999999999999999965332211 1111111 1 10 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCCCC
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNP 808 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~~~ 808 (862)
....++..+.+++.+||+.+|.+|||+.|++++|+.+.+.....
T Consensus 225 -~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 225 -LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp -CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred -cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 11224567899999999999999999999999999987654433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=360.71 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=201.8
Q ss_pred ccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCCC
Q 041565 529 SESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANG 607 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 607 (862)
...+.||+|+||.||+|... ++..||+|++........+++.+|+++|++++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999975 57899999988766667788999999999999999999999999999999999999999
Q ss_pred cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec--cCCCceEEeeccccccCCCCCCccc
Q 041565 608 TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL--DEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 608 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...... .
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 9999987643 24899999999999999999999887 9999999999999 567899999999998754322 2
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ....+ ....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~---~~~~~--------~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNILA---CRWDL--------EDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHH---TCCCS--------CSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh---ccCCC--------Chhh
Confidence 23346999999999999999999999999999999999999999765432211 11110 00000 0000
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 112356789999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=384.03 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=211.8
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
...++|...++||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++|+||++++++|.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888889999987543 335789999999999999999999999976 67899999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++|+|.++|.......+++.+++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-E 417 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-H
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-c
Confidence 999999999997543345899999999999999999999887 999999999999999999999999999875321 1
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
........++..|+|||++.++.++.++|||||||+||||++ |+.||......+.. . .... + .
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~---~i~~-~---------~ 481 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---D---QVER-G---------Y 481 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---H---HHHT-T---------C
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHHc-C---------C
Confidence 111223446788999999999999999999999999999999 99999654322211 1 1111 1 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+...+..++..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111223356778999999999999999999999999997754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.76 Aligned_cols=268 Identities=26% Similarity=0.443 Sum_probs=205.2
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEE
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGF 590 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 590 (862)
.+.++....++|...+.||+|+||.||+|.... +..||+|.+... .....+++.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 445556667889999999999999999998653 347999987643 44556789999999999999999999999
Q ss_pred EeecC-----eEEEEEEeCCCCcHHHHHhcC----CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc
Q 041565 591 CEEDG-----EMILVYDYMANGTLREHLYKG----DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD 661 (862)
Q Consensus 591 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 661 (862)
+.+.. ..++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 97654 359999999999999998532 2345999999999999999999999877 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccH
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSL 740 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l 740 (862)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 258 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--- 258 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---
Confidence 999999999999986543222222334457889999999999999999999999999999999 8888865433221
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...... +. ....+..++..+.+++.+||+.+|.+|||+.+++++|+.+++
T Consensus 259 ~~~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 YDYLLH----GH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHT----TC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHc----CC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 00 011122345678999999999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=356.46 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=207.2
Q ss_pred cCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|.. ..+..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999997 457899999875321 122357889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+ +|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 689999987654 3999999999999999999999877 999999999999999999999999999865432
Q ss_pred CccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......+.. ..+...
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~- 223 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC- 223 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS-
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC-
Confidence 22334569999999999988776 78999999999999999999999654322111 000000
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
....+...+..+.+++.+||+.+|.+|||+.|++++.+.....
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 0112223456788999999999999999999999999887543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=344.27 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=208.0
Q ss_pred cCcccce-eEeeeCcEEEEEEEEc---CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESH-VIGVGGFGKVYEGYID---GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
++|...+ .||+|+||.||+|... .+..||+|.+... .....+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999854 4678999998764 345577899999999999999999999999 55678999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999997543 34999999999999999999999887 999999999999999999999999999865432
Q ss_pred CCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 681 NQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 681 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...... +.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~i~~----~~------ 230 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQ----GK------ 230 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHHT----TC------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHhc----CC------
Confidence 211 11223346788999999999999999999999999999998 9999975433221 111111 10
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+||++.|++++|+.++.
T Consensus 231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111223356689999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.12 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=198.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC----e
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG----E 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 596 (862)
.++|...+.||+|+||.||++.. .++..||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999997 45788999998654 3344567899999999999999999999987654 3
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997654 3899999999999999999999887 99999999999999999999999999986
Q ss_pred CCCCCC-ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 677 GPNLNQ-THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ...........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~~ 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIPP 239 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCCH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCCCc
Confidence 433211 11223456899999999999999999999999999999999999999754332211 11111110000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.......+..+.+++.+||+.+|.+||+..+++.+.....
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 -------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0001123567899999999999999998777776555443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=369.04 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=213.9
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEE
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 591 (862)
+.+.++...+++|...++||+|+||.||+|+.+. +..||+|++.... ....+.+.+|..++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4567778888999999999999999999999875 6789999875321 11223488999999999999999999999
Q ss_pred eecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 592 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
.+.+.+++|||||++|+|.+++.+.. ..+++..+..++.|++.||+|||+.+ ||||||||+||||+.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999998643 34999999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
|+++...... ........||+.|+|||++. .+.++.++|||||||++|||++|+.||......+.... ...
T Consensus 220 Gla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~ 295 (437)
T 4aw2_A 220 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMN 295 (437)
T ss_dssp TTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHT
T ss_pred hhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh---hhh
Confidence 9997654322 22233467999999999997 46789999999999999999999999976543222110 000
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHHH
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID--RPSMGDVLWNLEFA 801 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~--RPt~~evl~~L~~~ 801 (862)
... ...-|.... ..+..+.+++.+||..+|.+ ||++.|++++.++.
T Consensus 296 --~~~---~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 296 --HKE---RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp --HHH---HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred --ccc---cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 000 000011111 13456889999999888877 99999999987663
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=352.13 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=204.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
.++|...+.||+|+||.||+|.... +..||+|.+... ......++.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998653 235999998754 3445667999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999997653 34999999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 679 NLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .... +
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~---~~~~-~----- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MK---AIND-G----- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHT-T-----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HH---HHHC-C-----
Confidence 32111 11222346778999999999999999999999999999998 9999965432211 11 1111 1
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.....+..++..+.+++.+||+.+|.+||++.|++++|+.+++.
T Consensus 267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111223456789999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=358.64 Aligned_cols=274 Identities=22% Similarity=0.270 Sum_probs=214.5
Q ss_pred cccCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-----ccceeeE
Q 041565 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-----HKHLVSL 587 (862)
Q Consensus 514 ~~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l 587 (862)
..+++.+.....++|...++||+|+||.||+|... ++..||||++.. .....+.+..|++++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 45667777777889999999999999999999974 567899999874 3445567888999999996 9999999
Q ss_pred EEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-----
Q 041565 588 IGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE----- 662 (862)
Q Consensus 588 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~----- 662 (862)
++++...+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 99999999999999999 899999998776666999999999999999999999887 999999999999975
Q ss_pred --------------------CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHH
Q 041565 663 --------------------KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 722 (862)
Q Consensus 663 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~el 722 (862)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 788999999999864321 2345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHH---------HhhhccCccccccCC-CCC----CCC----------------cHHHHHH
Q 041565 723 LCARPALNVNLPKEQVSLADWA---------LHCQRMGTIEDIIDP-NLK----GNI----------------TDQCLRK 772 (862)
Q Consensus 723 ltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~~~~~d~-~l~----~~~----------------~~~~~~~ 772 (862)
++|+.||......+........ ....... ....++. .+. ... .......
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 9999999765433222111100 0000000 0000000 000 000 0001256
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 773 FTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 773 l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
+.+++.+||+.||.+|||+.|++++.
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 78999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.83 Aligned_cols=264 Identities=25% Similarity=0.430 Sum_probs=206.4
Q ss_pred cCcccceeEeeeCcEEEEEEEE-----cCccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYI-----DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 597 (862)
+.|+..+.||+|+||.||++++ ..+..||+|++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 35678999998743 334467899999999999999999999999876 678
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996543 24999999999999999999999887 999999999999999999999999999865
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---------cccccHHHHHHhh
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLP---------KEQVSLADWALHC 747 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~---------~~~~~l~~~~~~~ 747 (862)
...... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+..... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 254 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN-- 254 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH--
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH--
Confidence 432211 223344578889999999999999999999999999999999987632210 00000001111
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+++
T Consensus 255 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 255 --------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred --------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111111112233456779999999999999999999999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.00 Aligned_cols=269 Identities=26% Similarity=0.405 Sum_probs=208.6
Q ss_pred cccceeEeeeCcEEEEEEEEc-----CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec--CeEEE
Q 041565 528 FSESHVIGVGGFGKVYEGYID-----GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED--GEMIL 599 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 599 (862)
|...+.||+|+||.||++.++ .+..||||++... .....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999988653 4678999998754 345567899999999999999999999999874 67899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.... +++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997643 899999999999999999999887 99999999999999999999999999987543
Q ss_pred CCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.... .......+|..|+|||.+.+..++.++||||||++++||++|+.||....... .....+.........+.+.++
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence 2211 22334457788999999999999999999999999999999999985431110 000000000000001111122
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.......+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 222222333456789999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=364.64 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=205.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.++|...+.||+|+||.||++... .+..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456888999999999999999865 5788999987543 3344677899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc---CCCceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD---EKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~~kl~DFGla~~~~ 678 (862)
||+++|+|.+.+..... +++.++..++.||++||+|||+.+ |+||||||+|||++ +++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999987543 999999999999999999999887 99999999999998 45789999999998654
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.. ... ..+... ...
T Consensus 165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~---~~i----~~~~~~-~~~ 234 (444)
T 3soa_A 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY---QQI----KAGAYD-FPS 234 (444)
T ss_dssp TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHH----HHTCCC-CCT
T ss_pred CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH---HHH----HhCCCC-CCc
Confidence 322 2223457999999999999999999999999999999999999999654322211 100 011100 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+ .....+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 235 ~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 235 P-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 0 111245678999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=359.68 Aligned_cols=272 Identities=21% Similarity=0.248 Sum_probs=207.6
Q ss_pred ccCcccceeEeee--CcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVG--GFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...++||+| +||.||+++.. ++..||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578899999999 99999999986 5789999987643 34556778899999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|||||++|+|.+++.......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998765556999999999999999999999887 99999999999999999999999998864321
Q ss_pred CCC-----ccccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc---
Q 041565 680 LNQ-----THVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR--- 749 (862)
Q Consensus 680 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 749 (862)
... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... .+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCcccc
Confidence 110 111223468889999999987 6799999999999999999999999976433221100 00000000
Q ss_pred ------------------cCcccccc---CCC------CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 750 ------------------MGTIEDII---DPN------LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 750 ------------------~~~~~~~~---d~~------l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.....+.+ .+. .........+..+.+++.+||+.+|.+|||+.|++++...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 00000000 000 0001122345678999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.25 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=204.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-c-------cEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-K-------TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
.++|...+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3568889999999999999998654 2 4699999877666777889999999999999999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc--------eEE
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE--------AKV 668 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------~kl 668 (862)
.++||||+++|+|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999986542 3899999999999999999999887 999999999999998887 999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+|||+++.... .....+|..|+|||++.+ ..++.++||||||+++|||++|..|+......... ....
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----LQFY 231 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHH
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-----HHHh
Confidence 99999876422 123457899999999987 77999999999999999999965444322211110 0111
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.... .+.. ..+..+.+++.+||+.+|.+|||+.|++++|+.++.
T Consensus 232 ~~~~--------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRH--------QLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTC--------CCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccC--------CCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1110 0111 123457899999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=359.41 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=203.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 599 (862)
-++|...++||+|+||.||+++.+ ++..||+|++... .....+.+.+|.++++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999976 4788999987643 233456788999999988 69999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.+... +++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999976543 999999999999999999999887 99999999999999999999999999986332
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... .
T Consensus 177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-----~~i~~~~--------~ 241 (353)
T 3txo_A 177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-----EAILNDE--------V 241 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCC--------C
T ss_pred C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-----HHHHcCC--------C
Confidence 1 12234467999999999999999999999999999999999999999765432211 0100100 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSM------GDVLWNLEF 800 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~------~evl~~L~~ 800 (862)
.++...+..+.+++.+||+.+|.+||++ .|+++|..+
T Consensus 242 ----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 242 ----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 1112244568899999999999999998 888877544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=343.16 Aligned_cols=259 Identities=23% Similarity=0.378 Sum_probs=206.6
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
..++|...+.||+|+||.||+|...+ +..||+|.+... .....+++.+|++++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678889999999999999998653 235999998754 345567899999999999999999999998754 568
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 34899999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..... ...
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~~---~~~----- 232 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLEK---GDR----- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHHH---TCC-----
T ss_pred cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHhc---CCC-----
Confidence 3221 12233456788999999999999999999999999999998 99999654332211 11111 000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
...+..++..+.+++.+||+.+|.+||++.|++++|+.+.+.
T Consensus 233 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 -----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 011122456789999999999999999999999999988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.85 Aligned_cols=261 Identities=21% Similarity=0.239 Sum_probs=199.6
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
..++|...+.||+|+||.||+++.. .+..||+|++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3467999999999999999999976 57889999886433 223668899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc--eEEeeccccccCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE--AKVSDFGLSKTGPNL 680 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--~kl~DFGla~~~~~~ 680 (862)
|+++|+|.+++..... +++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 97 YASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred eCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 9999999999976443 999999999999999999999887 999999999999987765 99999999975322
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ........ ..
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~---------~~ 237 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRIL---------SV 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHH---------TT
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHh---------cC
Confidence 112234569999999999998887666 89999999999999999999754332221 11111110 01
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..........+..+.+++.+||+.+|.+|||+.|++++.+....+
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 000000112346788999999999999999999999998876443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=345.13 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=202.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChh-------hHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQ-------GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
.++|...+.||+|+||.||+|... ++..||+|++...... ..+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999975 5788999987643221 1267899999999999999999999987665
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc-----eEEeec
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE-----AKVSDF 671 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----~kl~DF 671 (862)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 69999999999999987654 34999999999999999999999764 34999999999999988776 999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhh--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
|+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||......... ..... ..
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~---~~ 244 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMI---RE 244 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHH---HH
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHH---hc
Confidence 99985332 233456899999999984 456789999999999999999999999754332211 11111 11
Q ss_pred cCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......+..++..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 245 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 ---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111112233356679999999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=342.44 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=207.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.++|...+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3468889999999999999999765 568999987655455577899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~~~ 680 (862)
+++++|.+++..... +++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999876543 899999999999999999999887 9999999999999 78899999999999764332
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......||+.|+|||.+.+. ++.++||||||++++||++|+.||......+.. ............
T Consensus 163 ---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~----- 228 (277)
T 3f3z_A 163 ---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-----LKIREGTFTFPE----- 228 (277)
T ss_dssp ---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCCCCCCH-----
T ss_pred ---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHhCCCCCCc-----
Confidence 122345699999999998654 899999999999999999999999754332211 000000000000
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
......+..+.+++.+||+.+|.+|||+.|++++.+..-.
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 ---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 0000235678999999999999999999999988776543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=339.02 Aligned_cols=265 Identities=19% Similarity=0.222 Sum_probs=207.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEE-eecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC-EEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||+|+. .++..||+|.+..... .+++.+|+++++.++|++++..++++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999997 4678999998754432 24688999999999998877666665 56678899999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~~ 679 (862)
|+ +++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 899999997543 34999999999999999999999887 9999999999999 4888999999999986543
Q ss_pred CCCc-----cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 680 LNQT-----HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 680 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 2211 11234579999999999999999999999999999999999999997644332222211111110000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
. +. ..++..+.+++.+||+.+|.+|||+.++++.|+.+.+-.
T Consensus 241 ~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 241 V-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp H-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0 00 123467899999999999999999999999999887543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=346.10 Aligned_cols=275 Identities=24% Similarity=0.358 Sum_probs=205.9
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhc--cccceeeEEEEEeec-
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL--RHKHLVSLIGFCEED- 594 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~- 594 (862)
...-....++|...+.||+|+||.||+|+.+ +..||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3333444568999999999999999999876 678999987533 234455666666655 899999999999877
Q ss_pred ---CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC-----cccEEeeCCCCCCeeccCCCce
Q 041565 595 ---GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA-----RYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 595 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~~ 666 (862)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7899999999999999999764 3899999999999999999999871 1249999999999999999999
Q ss_pred EEeeccccccCCCCCCcc--ccccccCCCCCCChhhhhcCCCCch------hHHHHHHHHHHHHHhC----------CCC
Q 041565 667 KVSDFGLSKTGPNLNQTH--VSTMVKGSFGYLDPEYFRRQQLTEK------SDVYSFGVVLFEVLCA----------RPA 728 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDVyS~Gvvl~elltG----------~~p 728 (862)
||+|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997643221111 1123468999999999988766654 9999999999999999 555
Q ss_pred CCCCCccccccHHHHHHhhhccCccccccCCCCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 729 LNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN-ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
|........ ....+.... .... ..+.+... ...+++..+.+++.+||+.+|.+|||+.|++++|+.+.+-+
T Consensus 262 ~~~~~~~~~-~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDP-SYEDMREIV-CIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSC-CHHHHHHHH-TTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCC-chhhhHHHH-hhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 543222111 111111111 0000 11111111 12368889999999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=365.78 Aligned_cols=265 Identities=21% Similarity=0.298 Sum_probs=211.7
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEe
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 592 (862)
.+.+++...++|...++||+|+||.||+++.+. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 355677778899999999999999999999864 6789999875321 112345789999999999999999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
+.+.+++|||||++|+|.+++.+. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999999754 3899999999999999999999887 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 673 LSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
+++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+... ....
T Consensus 214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-----~i~~ 287 (410)
T 3v8s_A 214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-----KIMN 287 (410)
T ss_dssp TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----HHHT
T ss_pred eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH-----HHHh
Confidence 998654322 11233567999999999998765 7899999999999999999999997553322110 0000
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGID--RPSMGDVLWNLEFA 801 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~--RPt~~evl~~L~~~ 801 (862)
.... ..-|. ....+..+.+++.+||+.+|.+ ||++.||++|.++.
T Consensus 288 ~~~~---~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 288 HKNS---LTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp HHHH---CCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred cccc---ccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 0000 00010 0113467889999999998988 99999999987763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.74 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=197.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEE----cCccEEEEEecCCCC----hhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI----DGKTKVAIKRSNPSS----EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
.++|...+.||+|+||.||+++. ..+..||+|.+.... ......+.+|+++|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999997 467899999886542 2345668899999999999999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997644 3899999999999999999999887 99999999999999999999999999975
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ..
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~-~~---- 237 (327)
T 3a62_A 171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKILK-CK---- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH-TC----
T ss_pred cccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CC----
Confidence 3321 12233456999999999999999999999999999999999999999754322211 11000 00
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
. ..+...+..+.+++.+||+.+|.+|| ++.|++++..+
T Consensus 238 --~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 238 --L----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp --C----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred --C----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 0 11122456789999999999999999 78899887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=378.00 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=203.8
Q ss_pred cCcccce-eEeeeCcEEEEEEEEc---CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESH-VIGVGGFGKVYEGYID---GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
+++...+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999875 45679999987643 3457889999999999999999999999976 568999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||||++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999997543 35999999999999999999999887 999999999999999999999999999875432
Q ss_pred CCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 681 NQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 681 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......+++.|+|||++.++.++.++|||||||+||||++ |+.||......+. ..... .+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~----~~------- 555 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIE----QG------- 555 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHH----TT-------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----cC-------
Confidence 211 11223346789999999999999999999999999999998 9999976543221 11111 11
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+...+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 556 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 556 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111123345678999999999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=348.76 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=203.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-----hhhHHHHHHHHHHHHhcc---ccceeeEEEEEeec
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-----EQGVHEFQTEIEMLSKLR---HKHLVSLIGFCEED 594 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 594 (862)
.+++|+..++||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999964 57889999865221 112345677887777775 99999999999775
Q ss_pred C-----eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 595 G-----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 595 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
. ..++||||++ |+|.+++.......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999996 69999998876666999999999999999999999887 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|++||......+......-......
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999986432 2223446789999999999999999999999999999999999999976543332211100000000
Q ss_pred cCcccc-------ccCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 750 MGTIED-------IIDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 750 ~~~~~~-------~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
...+.. ...+.... ....+.+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 000000 00000000 0011244678999999999999999999999976543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.52 Aligned_cols=267 Identities=20% Similarity=0.264 Sum_probs=202.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999976 4788999987543 33445788999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++ +|.+.+.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 9975 6666665533 34999999999999999999999887 999999999999999999999999999865321
Q ss_pred ccccccccCCCCCCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc--cCc---cccc
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR--MGT---IEDI 756 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~---~~~~ 756 (862)
........||..|+|||++.+.. ++.++|||||||+++||++|+.|+........ .+......... ... ....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhccc
Confidence 12233456899999999998765 79999999999999999998887543322111 11111110000 000 0000
Q ss_pred cC---------CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 757 ID---------PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 757 ~d---------~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+ ...........+..+.+++.+||+.+|.+|||+.|++++-++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 00 000011122345678899999999999999999999987554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=355.15 Aligned_cols=252 Identities=29% Similarity=0.381 Sum_probs=204.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.+.|...+.||+|+||.||+|.. .++..||||++... .....+++.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588899999999999999996 46788999987543 234457799999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+. |+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 68888886433 34999999999999999999999887 99999999999999999999999999986432
Q ss_pred CCccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.....||+.|+|||++. .+.++.++|||||||++|||++|+.||......+. ........
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~------ 269 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE------ 269 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC------
Confidence 12346899999999985 56789999999999999999999999865432211 11111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+.+. ...++..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 270 ~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 270 SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 11111 1123456889999999999999999999999888753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=348.55 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=197.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh--------------------------hhHHHHHHHHHHHH
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE--------------------------QGVHEFQTEIEMLS 577 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 577 (862)
.++|...+.||+|+||.||+|+.. ++..||||.+..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999975 467899998754321 12356899999999
Q ss_pred hccccceeeEEEEEee--cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCC
Q 041565 578 KLRHKHLVSLIGFCEE--DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKT 655 (862)
Q Consensus 578 ~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp 655 (862)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.|+++||+|||+.+ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999986 5689999999999999876532 34999999999999999999999887 99999999
Q ss_pred CCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 041565 656 TNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPALNVN 732 (862)
Q Consensus 656 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~elltG~~p~~~~ 732 (862)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999998654321 1233456999999999997765 478999999999999999999999654
Q ss_pred CccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 733 LPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.... +...... .... .+. ....+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 244 ~~~~------~~~~~~~-~~~~---~~~-----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 244 RIMC------LHSKIKS-QALE---FPD-----QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp SHHH------HHHHHHH-CCCC---CCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred cHHH------HHHHHhc-ccCC---CCC-----ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 2211 1111111 1000 000 11234678999999999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=355.45 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=204.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...++||+|+||.||+++.+. +..||+|++... .....+.+..|..++.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4578899999999999999999764 678999987542 223345688899999887 89999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|..++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999998654 3999999999999999999999887 99999999999999999999999999986322
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHhhhccCcccccc
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV--SLADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~ 757 (862)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...++.........
T Consensus 206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 1 22334567999999999999999999999999999999999999999643222110 00111111111110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSM------GDVLWNLEF 800 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~------~evl~~L~~ 800 (862)
. .++...+..+.+++.+||+.+|.+||++ .|++++..+
T Consensus 279 -~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 279 -I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred -c----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 1 1122345678999999999999999984 788877654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.01 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=205.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccE--EEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTK--VAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
++|...+.||+|+||.||+|.... +.. +|+|++... .....+++.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 568888999999999999999653 443 588987543 334556799999999999 899999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 601 YDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
|||+++|+|.+++.... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 235899999999999999999999887 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++.... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HH
Confidence 9999999975321 112233457889999999999999999999999999999998 9999965432211 11
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
.... + .....+..++..+.+++.+||+.+|.+|||+.|++++|+.+++-.
T Consensus 253 ~~~~-~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 KLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HGGG-T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred Hhhc-C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 0 011112234567899999999999999999999999999988643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=352.33 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=197.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC--------
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG-------- 595 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 595 (862)
++|+..+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+++|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999986 6789999987643 3345678999999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEEeCCCCcHHHHHhcCCC-CCCChhh
Q 041565 596 -------------------------------------------------EMILVYDYMANGTLREHLYKGDK-PGLPWKQ 625 (862)
Q Consensus 596 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~ 625 (862)
..++||||+++|+|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999987543 2356677
Q ss_pred HHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc----------cccccccCCCCC
Q 041565 626 RLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT----------HVSTMVKGSFGY 695 (862)
Q Consensus 626 ~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y 695 (862)
++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999887 999999999999999999999999999865432111 122335699999
Q ss_pred CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHH
Q 041565 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTE 775 (862)
Q Consensus 696 ~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 775 (862)
+|||++.+..++.++|||||||++|||++|..|+. +..... .. ..... ...........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~---~~-~~~~~---------~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRII---TD-VRNLK---------FPLLFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHH---HH-HHTTC---------CCHHHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHH---HH-hhccC---------CCcccccCChhHHH
Confidence 99999999999999999999999999999876541 111000 00 00000 01112234567789
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 041565 776 TAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 776 li~~Cl~~~p~~RPt~~evl~~L 798 (862)
++.+||+.+|.+|||+.|++++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHccCCCCcCCCHHHHhhch
Confidence 99999999999999999999763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=357.84 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=197.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC--c--cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEee-cCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG--K--TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 599 (862)
..|...++||+|+||.||+|...+ + ..||+|.+... .....++|.+|+.++++++||||++++++|.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346677899999999999998642 2 36899988653 34556889999999999999999999999754 467899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999997643 34899999999999999999999887 99999999999999999999999999986432
Q ss_pred CCC--ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 680 LNQ--THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 680 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
... ........+|..|+|||.+.+..++.++|||||||++|||++ |.+||......+. ...... +.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~~----~~---- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQ----GR---- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHHT----TC----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHHc----CC----
Confidence 211 112233457788999999999999999999999999999999 6777765433221 111111 10
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
....+..++..+.+++.+||+.+|.+|||+.|++++|+.++..
T Consensus 314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011223456789999999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.14 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=207.1
Q ss_pred HHhhccCcccce-eEeeeCcEEEEEEEEc---CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeec
Q 041565 521 IKHGTRNFSESH-VIGVGGFGKVYEGYID---GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 521 l~~at~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
+....++|...+ .||+|+||.||+|... .+..||||.+.... ....+++.+|++++++++||||+++++++ +.
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 334456677777 9999999999999653 35789999886542 33467899999999999999999999999 56
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
+..++||||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 77899999999999999998754 3899999999999999999999887 999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 675 KTGPNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 675 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..... .+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~~ 237 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLE----KGE 237 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHH----TTC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCC
Confidence 865432221 11223346788999999999999999999999999999999 9999975433221 11111 110
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 238 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 ---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111222356679999999999999999999999999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.77 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=204.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCc----cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEe-ecCeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGK----TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE-EDGEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~ 598 (862)
..+|...++||+|+||.||+|...+. ..+|+|.+... .....+++.+|++++++++||||++++++|. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 44678889999999999999986432 35899987653 4455678999999999999999999999865 456789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999997643 34899999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCC--ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 679 NLNQ--THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 679 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
.... ........+|+.|+|||.+.+..++.++||||||++++||++ |.+|+......+. ...... +.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~----~~--- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQ----GR--- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHT----TC---
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhc----CC---
Confidence 3221 112233457788999999999999999999999999999999 5556544322221 111110 00
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
....+..++..+.+++.+||+.+|.+|||+.|+++.|+.++..
T Consensus 250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011122456789999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.44 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=206.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999976 57899999876431 234567889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999998654 3899999999999999999999877 99999999999999999999999999986432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +....... ..
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~--------~~- 221 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAE--------LR- 221 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHCC--------CC-
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC--------CC-
Confidence 12345799999999999999999999999999999999999999965432211 11111110 01
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
++...+..+.+++.+||+.+|.+|| ++.|++++-++
T Consensus 222 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 222 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 1122345788999999999999999 89999987554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=354.81 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=193.1
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
...++|...+.||+|+||.||+|.... +..||||.+.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 345679999999999999999999874 6789999887543 3467889999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla~~~~ 678 (862)
||+++|+|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999997653 3899999999999999999999887 999999999999975 8899999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. +..... ... .
T Consensus 203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~i~~--~~~-~--- 269 (349)
T 2w4o_A 203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM----FRRILN--CEY-Y--- 269 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH----HHHHHT--TCC-C---
T ss_pred cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH----HHHHHh--CCC-c---
Confidence 21 2223456899999999999999999999999999999999999999654322111 111100 000 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.........+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 270 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 270 --FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred --cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 00111123456789999999999999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.31 Aligned_cols=268 Identities=23% Similarity=0.273 Sum_probs=202.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578889999999999999999864 788999987543 23345778899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 999999999887543 3899999999999999999999887 9999999999999999999999999998654221
Q ss_pred ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHH---------HhhhccCc
Q 041565 683 THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWA---------LHCQRMGT 752 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~ 752 (862)
.......||..|+|||++.+ ..++.++||||||++++||++|+.||......+........ ........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 12234568999999999976 67899999999999999999999999765543322111100 00000000
Q ss_pred cc--cccCCCCCCCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 753 IE--DIIDPNLKGNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~--~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.. .+.++...... ....+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 00 00111100000 01245568899999999999999999999987554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=352.07 Aligned_cols=258 Identities=18% Similarity=0.216 Sum_probs=207.8
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEE------EcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc---ccceeeEEEE
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGY------IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR---HKHLVSLIGF 590 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~ 590 (862)
++....++|...++||+|+||.||+|. ...+..||+|++.... ..++..|+++++.++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344556789999999999999999994 3456789999987654 356777888888876 9999999999
Q ss_pred EeecCeEEEEEEeCCCCcHHHHHhcC---CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-----
Q 041565 591 CEEDGEMILVYDYMANGTLREHLYKG---DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE----- 662 (862)
Q Consensus 591 ~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~----- 662 (862)
+...+..++|||||++|+|.+++... ....+++..++.|+.||++||+|||+.+ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 99999999999999999999999742 2345999999999999999999999877 999999999999998
Q ss_pred ------CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 041565 663 ------KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736 (862)
Q Consensus 663 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~ 736 (862)
++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999975432223334455679999999999999999999999999999999999999984321110
Q ss_pred cccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHhcC
Q 041565 737 QVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDR-PSMGDVLWNLEFALQL 804 (862)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~R-Pt~~evl~~L~~~l~~ 804 (862)
. .+...+.... ....+.+++..|++.+|.+| |++.++.+.|+..++.
T Consensus 293 ~------------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 C------------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp E------------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred e------------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 0111111111 24567789999999999988 5889999999888753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.23 Aligned_cols=264 Identities=19% Similarity=0.223 Sum_probs=204.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEE-eecCeEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC-EEDGEMILVY 601 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 601 (862)
..++|...+.||+|+||.||+|+. ..+..||||....... .+++.+|+++++.++|++++..+++| .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346799999999999999999996 4578899997543322 24578899999999988877777665 6677889999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~ 678 (862)
||+ +++|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 8999999975433 4999999999999999999999887 9999999999999 788999999999998654
Q ss_pred CCCCc-----cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 679 NLNQT-----HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 679 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 32211 1223456899999999999999999999999999999999999999765443322222111111111100
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.. +. ..++..+.+++.+||+.+|.+|||+.++++.|+.+++
T Consensus 240 ~~-----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 EV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh-----hh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 00 1134678999999999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.34 Aligned_cols=266 Identities=16% Similarity=0.191 Sum_probs=207.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC---------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceee---------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG---------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVS--------- 586 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 586 (862)
.++|...+.||+|+||.||+|.... +..||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999764 678999987643 35789999999999999987
Q ss_pred ------EEEEEee-cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 587 ------LIGFCEE-DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 587 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
+++++.. ++..++||||+ +++|.+++.......+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6777776 67899999999 999999998764455999999999999999999999887 999999999999
Q ss_pred ccCCC--ceEEeeccccccCCCCCC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 041565 660 LDEKW--EAKVSDFGLSKTGPNLNQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVN 732 (862)
Q Consensus 660 l~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~ 732 (862)
++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 899999999976432111 11123347999999999999999999999999999999999999999754
Q ss_pred CccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCC
Q 041565 733 LPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805 (862)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~ 805 (862)
..... .+........ .....+.+.... ....+..+.+++.+||+.+|.+||++.|+++.|+.+++-.
T Consensus 272 ~~~~~-~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPNTE-DIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTCHH-HHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcCHH-HHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 32111 1111111111 111111111110 0113467899999999999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.65 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=204.0
Q ss_pred CcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE-EEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM-ILV 600 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 600 (862)
.|...++||+|+||.||+|...+ +..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35567899999999999998643 236999987653 345567899999999999999999999999766554 999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+.+|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 34899999999999999999999887 999999999999999999999999999864332
Q ss_pred CC--ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCccccccHHHHHHhhhccCcccccc
Q 041565 681 NQ--THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPA-LNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 681 ~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.. ........++..|+|||.+.+..++.++||||||++++||++|..| +......+ +........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~--------- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGR--------- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTC---------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCC---------
Confidence 11 1122334578899999999999999999999999999999996555 43322211 111111100
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+++.
T Consensus 246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111222456789999999999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.19 Aligned_cols=270 Identities=26% Similarity=0.422 Sum_probs=209.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-----cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecC--eE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-----DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG--EM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 597 (862)
.++|...+.||+|+||.||++.. ..+..||+|++........+++.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688889999999999999984 357789999988777677788999999999999999999999986644 78
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999998754 34899999999999999999999877 999999999999999999999999999875
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc----cCc
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR----MGT 752 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----~~~ 752 (862)
...... .......++..|+|||.+.+..++.++||||||++++||++|+.|+...... .......... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHHH
Confidence 432211 1122345677899999999999999999999999999999999887532100 0000000000 000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+.+.+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111111111123345678999999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.35 Aligned_cols=257 Identities=21% Similarity=0.259 Sum_probs=204.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-----ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+.|...+.||+|+||.||++... ++..||||++... .....+++.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999975 5789999987432 12245789999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc---eEEeecccc
Q 041565 600 VYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGLS 674 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---~kl~DFGla 674 (862)
|||||++|+|.+.+... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 2334899999999999999999999887 999999999999986654 999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. .........
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~--~i~~~~~~~- 251 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE--GIIKGKYKM- 251 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH--HHHHTCCCC-
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH--HHHcCCCCC-
Confidence 8754321 123345699999999999999999999999999999999999999975321 1110 000000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+... ...+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 252 ---~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 252 ---NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp ---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 00000 12346789999999999999999999999887654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=350.44 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=205.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
++|...+.||+|+||.||+++.+ ++..||+|++... .....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999976 4678999987542 344567788999999988 899999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997654 3999999999999999999999887 999999999999999999999999999863321
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHhhhccCccccccC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV--SLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d 758 (862)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..............
T Consensus 164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 12234467999999999999999999999999999999999999999653221110 00011111000110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSM------GDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~------~evl~~L~~ 800 (862)
. .++...+..+.+++.+||+.+|.+||++ .|++++..+
T Consensus 236 ~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 236 I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred C----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 0 1122345678999999999999999984 788877554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.15 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=204.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||++.... +..||+|.+... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568889999999999999999764 678999987532 2234577899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999998654 3999999999999999999999887 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+...... .
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~------- 235 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T------- 235 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C-------
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c-------
Confidence 22345679999999999864 4589999999999999999999999975433222211111100 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-MGDVLWNLE 799 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-~~evl~~L~ 799 (862)
...++..++..+.+++.+||+.+|.+||+ +.+++++..
T Consensus 236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 01112234567899999999999999998 788776543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.95 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=200.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec-CeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-GEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 603 (862)
.++|...+.||+|+||.||++..+ +..||+|.+.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467888999999999999999875 6689999987543 457899999999999999999999997554 578999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++|+|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999997654334889999999999999999999887 999999999999999999999999998764321
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......+. .. ... .+ ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~~~-~~---------~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP---RVE-KG---------YK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH---HHT-TT---------CC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHh-cC---------CC
Confidence 122357889999999999999999999999999999998 9999965432221 11 100 00 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
...+..++..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 11222345678999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.02 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=207.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999976 4778999987532 3445678899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc---eEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---~kl~DFGla~~~~ 678 (862)
||+++++|.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887654 3899999999999999999999887 999999999999986655 9999999997643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .......||+.|+|||.+.+..++.++||||||++++||++|+.||......+.. .... .+... ...
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~----~~~~~-~~~ 228 (284)
T 3kk8_A 160 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIK----AGAYD-YPS 228 (284)
T ss_dssp SS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCCC-CCT
T ss_pred cC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---HHHH----hcccc-CCc
Confidence 32 2223456899999999999999999999999999999999999999654322211 1000 01000 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+ .....+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 229 P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 0 0112346788999999999999999999999987764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.99 Aligned_cols=269 Identities=21% Similarity=0.310 Sum_probs=192.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999865 47889999876433 2334678899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcC----CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 603 YMANGTLREHLYKG----DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 603 ~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
|++ |+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6999998643 1234899999999999999999999887 9999999999999999999999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc--cCcccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR--MGTIED 755 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~ 755 (862)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ...... ......
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI--FDIMGTPNESLWPS 235 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCSCCTTTCGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCChhHhhh
Confidence 211 12234468999999999976 46899999999999999999999999765443322111 000000 000000
Q ss_pred -----ccCCCCCC------------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 -----IIDPNLKG------------NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 -----~~d~~l~~------------~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...+.... ......+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 00000000 00112345789999999999999999999999876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=351.73 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=206.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
.++|...+.||+|+||.||+|... .+..||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467888999999999999999842 3568999998643 445567899999999999999999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCC-----CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEe
Q 041565 598 ILVYDYMANGTLREHLYKGDK-----PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVS 669 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~ 669 (862)
++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 34899999999999999999999887 999999999999984 4569999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhh
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...+...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~-- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTS-- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHHhc--
Confidence 9999874322222222334457889999999999999999999999999999998 999986543221 1111111
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.. ....+..++..+.+++.+||+.+|.+||++.|++++|+.+.+.
T Consensus 261 -~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 -GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 10 0111223456789999999999999999999999999988653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.30 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=206.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
+.++|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34678889999999999999998764 5689999875321 2235678999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++..... +++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999976543 899999999999999999999877 99999999999999999999999999865432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. ......|+..|+|||.+.+..++.++||||||++++||++|+.||......+.. ..... . ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~------~~ 224 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISR-V------EF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-T------CC
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------HHHHh-C------CC
Confidence 1 223456899999999999999999999999999999999999999754322211 00000 0 01
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+...+..+.+++.+||+.+|.+|||+.|++++.+....
T Consensus 225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 1122245678899999999999999999999999887643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=354.96 Aligned_cols=274 Identities=21% Similarity=0.279 Sum_probs=213.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecC--eEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG--EMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 600 (862)
.++|...++||+|+||.||+|.... +..||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3568889999999999999999764 7899999987533 334577889999999999999999999988755 78999
Q ss_pred EEeCCCCcHHHHHhcCCC-CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec----cCCCceEEeeccccc
Q 041565 601 YDYMANGTLREHLYKGDK-PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSDFGLSK 675 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~~kl~DFGla~ 675 (862)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976432 23899999999999999999999887 9999999999999 778889999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHh
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ-VSLADWALH 746 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~ 746 (862)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .....-...
T Consensus 165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 75432 22234569999999999875 5678899999999999999999999964332211 111110111
Q ss_pred hhccCcccccc-----------CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 747 CQRMGTIEDII-----------DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 747 ~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
......+..+- +..............+.+++.+||+.||++||++.|+++.++.+++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000000000 01112234567888899999999999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=354.14 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=195.2
Q ss_pred Ccccc-eeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHh-ccccceeeEEEEEee----cCeEEE
Q 041565 527 NFSES-HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSK-LRHKHLVSLIGFCEE----DGEMIL 599 (862)
Q Consensus 527 ~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~l 599 (862)
+|... ++||+|+||.||++... ++..||||++... ..+.+|++++.+ .+||||+++++++.. ...+++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45554 68999999999999976 4778999998632 356788888744 589999999998865 567899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeecccccc
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLSKT 676 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla~~ 676 (862)
|||||++|+|.+++.......+++.+++.|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999998765556999999999999999999999877 999999999999997 78899999999986
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHhhhccCcccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SLADWALHCQRMGTIED 755 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~ 755 (862)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... .+...
T Consensus 214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~- 285 (400)
T 1nxk_A 214 TTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYE- 285 (400)
T ss_dssp CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCC-
T ss_pred cCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCccc-
Confidence 4321 1233457899999999999999999999999999999999999999765432211 0111110 01000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+.......++..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 286 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 286 -----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp -----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 000001124567899999999999999999999999988764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=362.67 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=212.1
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEE
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 591 (862)
+.+.++....++|...++||+|+||.||+++.+ ++..||+|++.... ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456777788899999999999999999999985 57899999876421 22234588999999999999999999999
Q ss_pred eecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 592 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
.+.+.+++|||||++|+|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997643 24999999999999999999999877 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhh-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWA 744 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 744 (862)
|+++...... ........||+.|+|||++. +..++.++|||||||++|||++|+.||......+.... .
T Consensus 207 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i 282 (412)
T 2vd5_A 207 GSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK---I 282 (412)
T ss_dssp TTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---H
T ss_pred hhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH---H
Confidence 9998654322 11223457999999999997 35689999999999999999999999976543221100 0
Q ss_pred HhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHHH
Q 041565 745 LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDR---PSMGDVLWNLEF 800 (862)
Q Consensus 745 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~R---Pt~~evl~~L~~ 800 (862)
..... ...-|.. ....+..+.+++.+||+ +|.+| |++.|+++|-.+
T Consensus 283 ~~~~~-----~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 283 VHYKE-----HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp HTHHH-----HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred Hhccc-----CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 00000 0000111 11245678999999999 89887 699999988765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.60 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=206.0
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
....++|...++||+|+||.||+|+.+ ++..||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999986 47889999876431 23456788899999887 89999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999997644 3899999999999999999999887 99999999999999999999999999986
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ......
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----~~i~~~------- 233 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-----HSIRMD------- 233 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHC-------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-----HHHHhC-------
Confidence 43211 2234567999999999999999999999999999999999999999754332211 111000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMG-DVLWNLE 799 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~-evl~~L~ 799 (862)
.+. ++...+..+.+++.+||+.+|.+||++. |++++..
T Consensus 234 -~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 234 -NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp -CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred -CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 011 1122456788999999999999999998 8876644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=343.21 Aligned_cols=264 Identities=20% Similarity=0.319 Sum_probs=200.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCC---CChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNP---SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|... ++..||+|++.. ......+++.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888999999999999999974 578999998764 23455678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 602 DYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 602 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998642 2345899999999999999999999887 99999999999999999999999999976432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...... ... +
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~~-----~ 256 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-CDY-----P 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-TCS-----C
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-ccC-----C
Confidence 21 1223346899999999999999999999999999999999999998643211 1111111111 111 1
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCCC
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN 807 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~~ 807 (862)
.+ .....+..+.+++.+||+.+|.+|||+.++++.|+.+......
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11 1122456789999999999999999999999999998654333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.95 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=206.2
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 598 (862)
..++|...++||+|+||.||+++.+. +..||+|++... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999999875 678999987643 123456788999999988 7999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++|+|.+++..... +++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999986543 899999999999999999999887 9999999999999999999999999998632
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ..
T Consensus 173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~-~~------ 237 (353)
T 2i0e_A 173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIME-HN------ 237 (353)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CC------
T ss_pred cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH------HHHHh-CC------
Confidence 21 12234467999999999999999999999999999999999999999754322111 11000 00
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
. .++...+..+.+++.+||+.+|.+||+ +.|++++..+
T Consensus 238 ~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 238 V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 0 112234567899999999999999995 6888877543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.86 Aligned_cols=263 Identities=24% Similarity=0.301 Sum_probs=205.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee----cCeEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE----DGEMI 598 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 598 (862)
..++|...+.||+|+||.||++.. .++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456799999999999999999997 4678999998876666777889999999999999999999999863 34789
Q ss_pred EEEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 599 LVYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+||||+++|+|.+++... ....+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999752 2345999999999999999999999887 99999999999999999999999999875
Q ss_pred CCCCCCcc-------ccccccCCCCCCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 677 GPNLNQTH-------VSTMVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 677 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
........ ......||..|+|||.+.+.. ++.++||||||+++|||++|+.||........ ......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~-- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV-- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh--
Confidence 42111000 012345799999999987654 68999999999999999999999853111110 011000
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.. .........++..+.+++.+||+.+|.+|||+.|++++|+.+..
T Consensus 261 -~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 -QN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 00001112245678999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.31 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=206.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 57899999875421 234567899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.+... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999986543 899999999999999999999887 999999999999999999999999999865321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... +. .
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----~~i~~--~~------~-- 255 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-----EKIVS--GK------V-- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHH--CC------C--
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-----HHHHc--CC------C--
Confidence 23456899999999999999999999999999999999999999754322111 00000 11 0
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~~ 800 (862)
.++...+..+.+++.+||+.+|.+||+ +.|++++..+
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 112234567899999999999999998 9999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.07 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=206.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56888999999999999999976 5788999987533 234457889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+++++|.+++.... .+++.+++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 87 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999886543 4899999999999999999999887 999999999999999999999999999764322222
Q ss_pred cccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......|+..|+|||.+.+..+ +.++||||||++++||++|+.||........ .+..|... ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~---~~~---------- 227 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK---KTY---------- 227 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT---CTT----------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc---ccc----------
Confidence 22334568999999999987665 7899999999999999999999975433211 12222211 000
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 00112245678899999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.77 Aligned_cols=265 Identities=23% Similarity=0.237 Sum_probs=203.3
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-----ChhhHHHHHHHHHHHHhccccceeeEEEEEeec
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-----SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
+....++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445678999999999999999999975 4678999986532 334567899999999999999999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCC--------------------------------------CCCCChhhHHHHHHHHHHH
Q 041565 595 GEMILVYDYMANGTLREHLYKGD--------------------------------------KPGLPWKQRLEICIGAARG 636 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~g 636 (862)
+..++||||+++|+|.+++.... ...+++..++.++.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985210 1113567788999999999
Q ss_pred HHHhhcCCcccEEeeCCCCCCeeccCCC--ceEEeeccccccCCCCCC--ccccccccCCCCCCChhhhhc--CCCCchh
Q 041565 637 LHYLHTGARYTIIHRDVKTTNILLDEKW--EAKVSDFGLSKTGPNLNQ--THVSTMVKGSFGYLDPEYFRR--QQLTEKS 710 (862)
Q Consensus 637 L~yLH~~~~~~ivHrDIkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~ks 710 (862)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999887 99999999999998766 899999999975422111 112334568999999999975 6789999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC
Q 041565 711 DVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS 790 (862)
Q Consensus 711 DVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt 790 (862)
|||||||++|||++|+.||......+.. ........ ..........+..+.+++.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999755432211 11110000 0000011124567899999999999999999
Q ss_pred HHHHHHHHHHH
Q 041565 791 MGDVLWNLEFA 801 (862)
Q Consensus 791 ~~evl~~L~~~ 801 (862)
+.|++++.+..
T Consensus 325 ~~~~l~hp~~~ 335 (345)
T 3hko_A 325 AMRALQHPWIS 335 (345)
T ss_dssp HHHHHHSHHHH
T ss_pred HHHHhcChhhc
Confidence 99999987764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.47 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=204.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee----------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE---------- 593 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 593 (862)
.++|...+.||+|+||.||+|... ++..||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 346888999999999999999986 67899999887544 346789999999999999999998854
Q ss_pred ------cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceE
Q 041565 594 ------DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAK 667 (862)
Q Consensus 594 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~k 667 (862)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 456899999999999999998654456999999999999999999999887 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 668 VSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
|+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+... . .+....
T Consensus 163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~---~~~~~~ 231 (284)
T 2a19_B 163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S---KFFTDL 231 (284)
T ss_dssp ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---HHHHHH
T ss_pred ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---HHHHHh
Confidence 99999998654321 223446899999999999999999999999999999999999876311 0 111110
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
. +..+. ...+..+.+++.+||+.+|.+|||+.|++++|+.+.+.
T Consensus 232 -~--------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 -R--------DGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -H--------TTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -h--------ccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 11111 12345688999999999999999999999999988543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=362.87 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=208.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999976 57899999876432 123567899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 9999999999997643 4999999999999999999999887 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ . .... .+.
T Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~---~~i~-~~~-------- 232 (476)
T 2y94_A 170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---F---KKIC-DGI-------- 232 (476)
T ss_dssp --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---H---HHHH-TTC--------
T ss_pred --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---H---HHHh-cCC--------
Confidence 22334579999999999988765 7899999999999999999999975432211 1 1100 110
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
. ..+...+..+.+++.+||+.+|.+|||+.|++++.+....
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 0111234568899999999999999999999998877643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.12 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=182.9
Q ss_pred ceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 531 SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
.+.||+|+||.||++... ++..||||++.. .....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999976 478899999853 33467789999999997 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC---ceEEeeccccccCCCCCCccc
Q 041565 609 LREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW---EAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 609 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 685 (862)
|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999998754 4999999999999999999999887 99999999999997665 89999999998644321 22
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-SLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.... ...+.. .....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~------~~~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF------SFEGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC------CCCSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC------CCCcc
Confidence 23456899999999999999999999999999999999999999754332111 11111111 111110 00111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 1112456789999999999999999999999876643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=366.53 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=198.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
..++|...++||+|+||.||++... ++..||||++... .......+.+|+++++.++||||++++++|...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 4788999987632 33445678899999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
|||||++|+|.+++.... .+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999997654 38999999999999999999997 66 9999999999999999999999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ...
T Consensus 301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i~--~~~-------- 365 (446)
T 4ejn_A 301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELIL--MEE-------- 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH--HCC--------
T ss_pred CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---HHHH--hCC--------
Confidence 22 22234467999999999999999999999999999999999999999654332211 1110 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
.. ++...+..+.+++.+||+.+|.+|| ++.|++++..+
T Consensus 366 ~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 366 IR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred CC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 01 1122446789999999999999999 99999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=377.33 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=199.4
Q ss_pred eeEeeeCcEEEEEEEEc---CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYID---GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+.||+|+||.||+|.+. .+..||||+++... ....++|.+|+++|++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999764 35689999987532 3446889999999999999999999999964 568899999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC-ccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-THV 685 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~ 685 (862)
|+|.+++.... .+++.+++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 3899999999999999999999887 99999999999999999999999999986543221 122
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.. .... .+ ....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~----~~---------~~~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLE----KG---------ERMG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH----TT---------CCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----cC---------CCCC
Confidence 233456788999999999999999999999999999998 99999765432211 1111 11 1111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+..++..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22345678999999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.06 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=204.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh------hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE------QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|...+.||+|+||.||++... ++..||+|.+..... ...+++.+|++++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46888999999999999999976 478899998654321 13678999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC----ceEEeecccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW----EAKVSDFGLS 674 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~~kl~DFGla 674 (862)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999997643 4899999999999999999999887 99999999999999887 7999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+.. ..........
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~i~~~~~~~- 237 (321)
T 2a2a_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANITSVSYDF- 237 (321)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----HHHHTTCCCC-
T ss_pred eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHhccccc-
Confidence 8654321 223456899999999999999999999999999999999999999654322211 0000000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
++. .....+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 238 ---~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 238 ---DEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp ---CHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ---Chh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000 01123456899999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.45 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=193.8
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEe------
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCE------ 592 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~------ 592 (862)
+.....+|...++||+|+||.||++... .+..||+|++........+.+.+|+.+++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3444567899999999999999999975 57889999887666667788999999999996 999999999983
Q ss_pred --ecCeEEEEEEeCCCCcHHHHHhcC-CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 593 --EDGEMILVYDYMANGTLREHLYKG-DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 593 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
.....++||||++ |+|.+++... ....+++.+++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 3456899999995 7999988752 2335999999999999999999999753 359999999999999999999999
Q ss_pred eccccccCCCCCCcc----------ccccccCCCCCCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 041565 670 DFGLSKTGPNLNQTH----------VSTMVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736 (862)
Q Consensus 670 DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~ 736 (862)
|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998654321110 11134589999999998 56778999999999999999999999996432211
Q ss_pred cccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcCCC
Q 041565 737 QVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQD 806 (862)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~~~ 806 (862)
.. ...............+.+++.+||+.+|.+|||+.|++++|+.+.+...
T Consensus 261 ~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 IV-------------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hh-------------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 10 0000000111123457899999999999999999999999999876443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=368.27 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=211.5
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
...++|...++||+|+||.||++... ++..||+|++... .......+.+|+++|++++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34567999999999999999999976 5789999987542 1234567889999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999998766556999999999999999999999887 9999999999999999999999999998754
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........ .
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~~-~------- 404 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKE-V------- 404 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHHH-C-------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhhc-c-------
Confidence 321 2234579999999999999999999999999999999999999997643221111 11110000 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
...++...+..+.+++.+||+.+|.+|| ++.|+++|..+
T Consensus 405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence 0111223456789999999999999999 78999987554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=348.93 Aligned_cols=265 Identities=16% Similarity=0.169 Sum_probs=197.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCCChh-----------hHHHHHHHHHHHHhccccceeeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPSSEQ-----------GVHEFQTEIEMLSKLRHKHLVSLIG 589 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 589 (862)
.++|...+.||+|+||.||+|... .+..+|+|+....... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999976 4578999987654321 1234678889999999999999999
Q ss_pred EEee----cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-
Q 041565 590 FCEE----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW- 664 (862)
Q Consensus 590 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~- 664 (862)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9987 67899999999 999999997654 4999999999999999999999887 99999999999999887
Q ss_pred -ceEEeeccccccCCCCC-----CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 041565 665 -EAKVSDFGLSKTGPNLN-----QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738 (862)
Q Consensus 665 -~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~ 738 (862)
.+||+|||+++...... .........||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999997643211 111123457999999999999999999999999999999999999999543221111
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
........ ... +...+..... ...++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 270 -~~~~~~~~-~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 -VQTAKTNL-LDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HHHHHHHH-HHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HHHHHHhh-ccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111110 000 0000000000 002456789999999999999999999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.81 Aligned_cols=267 Identities=24% Similarity=0.375 Sum_probs=207.7
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHh--ccccceeeEEEEEeecC----
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK--LRHKHLVSLIGFCEEDG---- 595 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---- 595 (862)
....++|...+.||+|+||.||+|+.+ +..||||++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 444567999999999999999999975 678999998643 34677889999888 78999999999998775
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhh--------cCCcccEEeeCCCCCCeeccCCCceE
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH--------TGARYTIIHRDVKTTNILLDEKWEAK 667 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDIkp~NILl~~~~~~k 667 (862)
..++||||+++|+|.+++.+. .+++.+++.++.|++.||+||| +.+ |+||||||+|||++.++.+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence 899999999999999999764 3899999999999999999999 555 99999999999999999999
Q ss_pred EeeccccccCCCCCCc--cccccccCCCCCCChhhhhcCC------CCchhHHHHHHHHHHHHHhC----------CCCC
Q 041565 668 VSDFGLSKTGPNLNQT--HVSTMVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEVLCA----------RPAL 729 (862)
Q Consensus 668 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~elltG----------~~p~ 729 (862)
|+|||+++........ .......||+.|+|||++.+.. ++.++|||||||++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999754322111 1223456899999999998752 34789999999999999999 6676
Q ss_pred CCCCccccccHHHHHHhhhccCccccccCCCCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 730 NVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN-ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
......+. ....+...... ....+.+... ...+++..+.+++.+||+.+|.+|||+.||+++|+.+.+-
T Consensus 268 ~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 268 YDLVPSDP-SVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTSCSSC-CHHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcCcc-cHHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 54322111 11222221111 1111222111 1236778899999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.18 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=202.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||++..+ ++..||+|.+..... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356888999999999999999976 477899998865432 245688888888 79999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC----CceEEeeccccccCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK----WEAKVSDFGLSKTGP 678 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~~kl~DFGla~~~~ 678 (862)
|+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999997654 3999999999999999999999887 9999999999998443 359999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.. .. ..+..
T Consensus 172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i-~~~~~----- 240 (342)
T 2qr7_A 172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RI-GSGKF----- 240 (342)
T ss_dssp CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HH-HHCCC-----
T ss_pred CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HH-ccCCc-----
Confidence 321 12334568999999999998889999999999999999999999997542221111111 11 11111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+........+..+.+++.+||+.+|.+||++.|++++.+..
T Consensus 241 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 241 -SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp -CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred -ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 111111123456789999999999999999999999988874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=345.87 Aligned_cols=269 Identities=23% Similarity=0.375 Sum_probs=198.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHH--HHhccccceeeEEEEEee-----cCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEM--LSKLRHKHLVSLIGFCEE-----DGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~ 597 (862)
-++|...+.||+|+||.||+|+. ++..||||++.... ...+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 45788899999999999999976 46789999986433 3444555555 445899999999986532 3367
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC------cccEEeeCCCCCCeeccCCCceEEeec
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA------RYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
++||||+++|+|.+++.... .++..++.++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997654 589999999999999999999871 113999999999999999999999999
Q ss_pred cccccCCCCC------CccccccccCCCCCCChhhhhc-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc-
Q 041565 672 GLSKTGPNLN------QTHVSTMVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ- 737 (862)
Q Consensus 672 Gla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~- 737 (862)
|+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9997643211 1112234469999999999987 4567799999999999999999776643222111
Q ss_pred cc-----------HHHHHHhhhccCccccccCCCCCCC--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 738 VS-----------LADWALHCQRMGTIEDIIDPNLKGN--ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 738 ~~-----------l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.. ..++........ ..+.+... ....++..+.+++.+||+.+|.+|||+.|+++.|+.++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00 001111000000 01111111 1234677899999999999999999999999999999865
Q ss_pred C
Q 041565 805 Q 805 (862)
Q Consensus 805 ~ 805 (862)
.
T Consensus 320 ~ 320 (336)
T 3g2f_A 320 W 320 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=352.06 Aligned_cols=269 Identities=22% Similarity=0.338 Sum_probs=208.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457888999999999999999976 5678999987654 34556789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999997654 389999999999999999999985 5 99999999999999999999999999864311
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH-------------------
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD------------------- 742 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~------------------- 742 (862)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||......+......
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12233568999999999999999999999999999999999999997544322110000
Q ss_pred ----HHHhhhccCcc----ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 743 ----WALHCQRMGTI----EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 743 ----~~~~~~~~~~~----~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+.......... ..+.............+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 00000000000 0000000111111224557899999999999999999999999887653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.66 Aligned_cols=255 Identities=19% Similarity=0.278 Sum_probs=202.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC------hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|...+.||+|+||.||++... ++..||+|.+.... ....+++.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888999999999999999986 47889999765321 123678999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC----ceEEeecccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW----EAKVSDFGLS 674 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~~kl~DFGla 674 (862)
+||||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997643 3899999999999999999999887 99999999999998877 7999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+...... ......|++.|+|||++.+..++.++||||||++++||++|+.||......+.. .........
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~-- 229 (283)
T 3bhy_A 160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-----TNISAVNYD-- 229 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHHTTCCC--
T ss_pred eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-----HHhHhcccC--
Confidence 8643321 223346899999999999999999999999999999999999999754322111 000000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.........+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 230 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 230 ------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp ------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred ------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 00000112345789999999999999999999999876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.05 Aligned_cols=267 Identities=23% Similarity=0.342 Sum_probs=206.2
Q ss_pred ccCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCC--CChhhHHHHHHHHHHHHhcc--ccceeeEEEE
Q 041565 515 HFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNP--SSEQGVHEFQTEIEMLSKLR--HKHLVSLIGF 590 (862)
Q Consensus 515 ~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~ 590 (862)
.+.+..+....++|...+.||+|+||.||++...++..||+|.+.. ......+.+.+|++++++++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 4455555666778999999999999999999988888999998753 34456688999999999997 4999999999
Q ss_pred EeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEee
Q 041565 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSD 670 (862)
Q Consensus 591 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~D 670 (862)
+...+..++||| +.+++|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 999999999999 56889999998754 4899999999999999999999887 999999999999965 7999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 041565 671 FGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS 739 (862)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~ 739 (862)
||+++...............||..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 247 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-- 247 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--
Confidence 999986543222222334568999999999875 4788999999999999999999999964322110
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
... .++++......+...+..+.+++.+||+.+|.+||++.|++++.+...
T Consensus 248 ---~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 248 ---KLH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp ---HHH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred ---HHH---------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 011 111222221222223467899999999999999999999999887753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.22 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=204.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC----hhhHHHHHHHHHHHHhccccceeeEEEEE--eecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS----EQGVHEFQTEIEMLSKLRHKHLVSLIGFC--EEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~ 598 (862)
++|...+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57889999999999999999975 46789999876432 23457899999999999999999999998 4456889
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||++++ |.+++.......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999876 888887655556999999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCccccccccCCCCCCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
............||..|+|||++.+.. .+.++||||||++++||++|+.||......+. ..... .+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~i~-~~~---- 229 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL------FENIG-KGS---- 229 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-HCC----
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH------HHHHh-cCC----
Confidence 332233334456899999999998754 37899999999999999999999975432211 11110 010
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.. .+..++..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 230 --~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 --YA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp --CC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred --CC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 01 11224567889999999999999999999999887754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.97 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=184.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 356888999999999999999974 67889999875322 12346789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999997653 34899999999999999999999887 999999999999999999999999999864322
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.. ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+.. ..+....
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~ 228 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc
Confidence 11 122356899999999999999999999999999999999999999754322111 0000000
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. ..+...+..+.+++.+||+.+|.+|||+.|++++..
T Consensus 229 ~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 229 Y--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred c--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 0 112224567889999999999999999999997644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.11 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=199.1
Q ss_pred cCccc-ceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSE-SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+.|.. .++||+|+||.||++... ++..||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 35665 368999999999999864 5789999998766555677899999999985 79999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc---eEEeeccccccCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGLSKTGPN 679 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---~kl~DFGla~~~~~ 679 (862)
|+++|+|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998653 3899999999999999999999887 999999999999998766 99999999976432
Q ss_pred CCC-----ccccccccCCCCCCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 680 LNQ-----THVSTMVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 680 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.............
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 111223458999999999875 5688999999999999999999999976543221100000000000
Q ss_pred cCccccccCCCCCCCCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 750 MGTIEDIIDPNLKGNIT----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 750 ~~~~~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
......+..... ..+ ...+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 247 ~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 247 NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 000000000000 011 1134678999999999999999999999987553
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.79 Aligned_cols=269 Identities=22% Similarity=0.345 Sum_probs=199.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhh-HHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...+.||+|+||.||+|... ++..||+|++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999976 57889999886543221 22456799999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
++ |+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 154 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence 97 699999876543 4899999999999999999999887 999999999999999999999999999764321 1
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc-----
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII----- 757 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----- 757 (862)
.......||..|+|||++.+ ..++.++|||||||+++||++|+.||......+................+....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22233468999999999876 568999999999999999999999997654433221111000000000000000
Q ss_pred ----CCCCCCC----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 758 ----DPNLKGN----ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 758 ----d~~l~~~----~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+..... ........+.+++.+||+.+|.+|||+.|++++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 0000000 0112345688999999999999999999999987765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.65 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=208.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||++.... +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 568889999999999999999864 678999986532 3445678899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999987643 3899999999999999999999887 9999999999999999999999999998643221
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||..|+|||.+.+..++.++||||||++++||++|+.||......+. +... . ... ..
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~-~-~~~------~~- 233 (294)
T 2rku_A 170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRI-K-KNE------YS- 233 (294)
T ss_dssp --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHH-H-TTC------CC-
T ss_pred --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-h-hcc------CC-
Confidence 122345689999999999999999999999999999999999999965432211 1111 0 000 01
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+......+.+++.+||+.+|.+|||+.|++++.....
T Consensus 234 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 234 ---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ---CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 11223456889999999999999999999999877653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=342.34 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=200.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
-++|...+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367999999999999999999976 5778999987643 233457899999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998653 3899999999999999999999887 999999999999999999999999999764332
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .+ ...........
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~---~~~~~~~~~~~------ 254 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM---GAHINQAIPRP------ 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH---HHHHHSCCCCG------
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH---HHHhccCCCCc------
Confidence 11 1223346899999999999999999999999999999999999999754221 01 11111110000
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhcCC
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRP-SMGDVLWNLEFALQLQ 805 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-t~~evl~~L~~~l~~~ 805 (862)
......++..+.+++.+||+.+|.+|| ++.++++.|+.++...
T Consensus 255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 011122445788999999999999999 9999999999887543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.96 Aligned_cols=271 Identities=23% Similarity=0.265 Sum_probs=201.7
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChh-----hHHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQ-----GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
....++|...+.||+|+||.||+|... ++..||||++...... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344567999999999999999999975 4788999988643221 1246889999999999999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++ +|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999975 8998886543 34899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc--cCc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR--MGT 752 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~ 752 (862)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|++||......+... ........ ...
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHcCCCChhh
Confidence 653321 223345689999999999764 58999999999999999999999987654322211 11111000 000
Q ss_pred ccc---ccC---CCCCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 IED---IID---PNLKGNIT-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 ~~~---~~d---~~l~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+ ..+ .......+ ...+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 000 000 00000011 22346789999999999999999999999987764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=354.14 Aligned_cols=266 Identities=25% Similarity=0.373 Sum_probs=194.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeec--CeEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEED--GEMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~ 598 (862)
.++|...+.||+|+||.||+|... .+..||||++... .....+++.+|+.+++++. ||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 467999999999999999999975 5788999987543 4455677889999999997 99999999998754 3789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+|||||+ |+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 9999997 6999999763 3899999999999999999999887 9999999999999999999999999997643
Q ss_pred CCC-------------------CccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 041565 679 NLN-------------------QTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738 (862)
Q Consensus 679 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~ 738 (862)
... .....+...||+.|+|||++.+ ..++.++|||||||+++||++|++||.+....++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 210 1112234579999999999987 67899999999999999999999999765433322
Q ss_pred cHHHHHHhhhccCccc---ccc------------------CCCCCCCC------------cHHHHHHHHHHHHHccccCC
Q 041565 739 SLADWALHCQRMGTIE---DII------------------DPNLKGNI------------TDQCLRKFTETAEKCLSDQG 785 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~---~~~------------------d~~l~~~~------------~~~~~~~l~~li~~Cl~~~p 785 (862)
.... ......... .+- .......+ ...++..+.+++.+||+.+|
T Consensus 241 ~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 241 ERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 1110 000000000 000 00000000 00234578999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 041565 786 IDRPSMGDVLWNLEF 800 (862)
Q Consensus 786 ~~RPt~~evl~~L~~ 800 (862)
.+|||+.|+++|...
T Consensus 318 ~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 318 NKRISANDALKHPFV 332 (388)
T ss_dssp GGSCCHHHHTTSTTT
T ss_pred ccCCCHHHHhCCHHH
Confidence 999999999988654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=356.14 Aligned_cols=264 Identities=19% Similarity=0.230 Sum_probs=207.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCCCChhhHHHHHHHHHHHHhccc-cceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...++||+|+||.||+|.. .++..||||++..... ..++..|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36789999999999999999996 4578999998654332 2457899999999986 556666667778889999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~~ 679 (862)
|+ +++|.+++..... .+++.+++.|+.||+.||+|||+.+ ||||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 8999999975433 4999999999999999999999887 9999999999999 6889999999999986543
Q ss_pred CCCc-----cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 680 LNQT-----HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 680 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
.... .......||..|+|||++.+..++.++|||||||+||||++|+.||.......................+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 2211 11235679999999999999999999999999999999999999997654433222222111111111111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.+. ..++.++.+++.+||+.+|.+||++.+|++.|+.++..
T Consensus 239 ~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 ALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 110 12356789999999999999999999999999988654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=345.35 Aligned_cols=267 Identities=20% Similarity=0.271 Sum_probs=196.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
..++|...++||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3457999999999999999999865 57889999986543 23346788999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec-----cCCCceEEeeccccc
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL-----DEKWEAKVSDFGLSK 675 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-----~~~~~~kl~DFGla~ 675 (862)
|||++ |+|.+++..... +++..++.|+.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 599999987643 899999999999999999999887 9999999999999 455569999999997
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh--ccCc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ--RMGT 752 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~ 752 (862)
..... ........||..|+|||++.+. .++.++|||||||+++||++|+.||......+... ....... ....
T Consensus 186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGLPDDTT 261 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTT
T ss_pred ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCCCchhh
Confidence 64321 1122334689999999999874 58999999999999999999999997654332211 1111000 0000
Q ss_pred cccc--------cCCCCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 753 IEDI--------IDPNLKGN-----ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 753 ~~~~--------~d~~l~~~-----~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.... ..+..... ........+.+++.+||+.+|.+|||+.|++++.++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 0000 00001111 011134678899999999999999999999987554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.49 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=208.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
.+.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999875 57789999875432 3456789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999864 24899999999999999999999887 9999999999999999999999999997643321
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......|+..|+|||.+.+..++.++||||||++++||++|+.||......+.. .... . .. .+.+.
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~---~-~~-----~~~~~ 240 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIP---K-NN-----PPTLE 240 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH---H-SC-----CCCCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhh---c-CC-----CCCCc
Confidence 1223456899999999999999999999999999999999999999654322111 1110 0 10 11111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..++..+.+++.+||+.+|.+|||+.|++++.....
T Consensus 241 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 241 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ----cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 123456899999999999999999999999887654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=338.12 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=200.3
Q ss_pred cccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 528 FSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
+....+||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 444569999999999999975 5678999988766656678899999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCC-CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeeccccccCCCCCCcc
Q 041565 607 GTLREHLYKGD-KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 607 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++...... .
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~ 178 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--P 178 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--C
Confidence 99999998653 334678999999999999999999887 999999999999987 8999999999998643321 1
Q ss_pred ccccccCCCCCCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......|+..|+|||++.+.. ++.++||||||+++|||++|+.||......... .+..... ...+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~-------~~~~~-- 246 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMF-------KVHPE-- 246 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHH-------CCCCC--
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhccc-------ccccc--
Confidence 223456899999999997653 899999999999999999999999543221110 0110000 01111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+...+..+.+++.+||+.+|.+||++.|++++-..
T Consensus 247 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 247 --IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp --CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred --ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 222345678999999999999999999999976443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.60 Aligned_cols=258 Identities=19% Similarity=0.275 Sum_probs=191.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-h-hhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-E-QGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
..++|+..+.||+|+||.||++... ++..||+|++.... . ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3467889999999999999999974 57889999886542 2 2233445555668888999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 601 YDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
|||++ |+|.+++... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5888877641 234599999999999999999999986 6 999999999999999999999999999864
Q ss_pred CCCCCccccccccCCCCCCChhhh----hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
... .......||+.|+|||++ .+..++.++||||||++++||++|+.||........ ..... ....
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~-- 230 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----QLKQV-VEEP-- 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH----HHHHH-HHSC--
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH----HHHHH-hccC--
Confidence 332 122334689999999996 566789999999999999999999999964322111 11111 1110
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.........+..+.+++.+||+.+|.+|||+.|++++.++..
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 231 -------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011111224567899999999999999999999999877654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.28 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=199.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...+.||+|+||.||+|... ++..||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888999999999999999986 5789999987643 334567889999999999 999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC----------------
Q 041565 601 YDYMANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---------------- 662 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---------------- 662 (862)
|||+++|+|.+++.... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 244899999999999999999999887 999999999999984
Q ss_pred ---CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 041565 663 ---KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738 (862)
Q Consensus 663 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~ 738 (862)
...+||+|||+++..... ....||..|+|||.+.+. .++.++|||||||+++||++|++++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 447999999999865331 123489999999999876 66789999999999999999997764221
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+... ..+.. +. .+..++..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 236 ---~~~~~--~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 236 ---QWHEI--RQGRL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp ---HHHHH--HTTCC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred ---HHHHH--HcCCC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 11111 11111 11 12224567899999999999999999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.85 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=199.0
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee----cCeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE----DGEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 599 (862)
.|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677789999999999999975 4678999986532 34556789999999999999999999998865 356899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEEeeccccccCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~~~ 678 (862)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999997643 3899999999999999999999764 3599999999999998 78999999999997643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. ......||+.|+|||.+. +.++.++||||||++++||++|+.||........ .......... .
T Consensus 184 ~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~-~---- 248 (290)
T 1t4h_A 184 AS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVK-P---- 248 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCC-C----
T ss_pred cc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhccCC-c----
Confidence 21 223456899999999886 4589999999999999999999999965432211 1111111100 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
...+...+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 249 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 249 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 0111123356899999999999999999999997654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=339.79 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=205.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|...+.||+|+||.||++... ++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46888999999999999999976 57889999987655445567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCCCCC
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~~~~ 681 (862)
++++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 89 SGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred CCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 9999999987644 3899999999999999999999887 9999999999999 7889999999999976432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.......||+.|+|||.+.+..++.++||||||++++||++|+.||......+.. .... .+.. ..
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~----~~~~------~~ 226 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---EKIK----EGYY------EF 226 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HCCC------CC
T ss_pred --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCC------CC
Confidence 1223346899999999999999999999999999999999999999654322111 1000 0100 00
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
........+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 1111123456789999999999999999999999987765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.27 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=204.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 599 (862)
.++|...+.||+|+||.||++... ++..||+|.+... .....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999976 5788999987543 34556789999999999999999999998753 678999
Q ss_pred EEEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCC--cccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 600 VYDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGA--RYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 2344899999999999999999999754 1349999999999999999999999999997
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
..... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ +..... .+...
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~----~~~~~- 234 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIR----EGKFR- 234 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC-
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHh----hcccc-
Confidence 64321 112233568999999999999999999999999999999999999997543221 111111 11110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+..++..+.+++.+||+.+|.+||++.|++++++..
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred --------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11223456789999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=357.46 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=199.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|+..+.||+|+||.||+|... .+..||||++... .....+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999865 4778999988643 445567889999999999999999999998654 4
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++|||||++ +|.+.+.. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999975 57776643 2899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH---------HH--
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD---------WA-- 744 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~-- 744 (862)
.... ....+...||+.|+|||++.+..++.++|||||||+++||++|+.||.+....++....- +.
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 6432 222344679999999999999999999999999999999999999997654332211100 00
Q ss_pred -----Hhhh-ccC-----ccccccCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 745 -----LHCQ-RMG-----TIEDIIDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 745 -----~~~~-~~~-----~~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.... ... .+.......+.. .........+.+++.+||+.||.+|||+.|+++|.+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0000 000 000000000000 00112356789999999999999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.53 Aligned_cols=246 Identities=15% Similarity=0.189 Sum_probs=192.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEE-cCccEEEEEecCC---CChhhHHHHHHHH---HHHHhccccceeeEE-------E
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYI-DGKTKVAIKRSNP---SSEQGVHEFQTEI---EMLSKLRHKHLVSLI-------G 589 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g 589 (862)
..++|...+.||+|+||.||+|+. .++..||||++.. ......+.+.+|+ ++|++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356788899999999999999996 4578999998752 3344567899999 455556899999998 6
Q ss_pred EEeecC-----------------eEEEEEEeCCCCcHHHHHhcCCC-----CCCChhhHHHHHHHHHHHHHHhhcCCccc
Q 041565 590 FCEEDG-----------------EMILVYDYMANGTLREHLYKGDK-----PGLPWKQRLEICIGAARGLHYLHTGARYT 647 (862)
Q Consensus 590 ~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 647 (862)
++...+ ..++||||+ +|+|.+++..... ..+++..++.|+.||++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 655443 278999999 6899999975321 12446889999999999999999887
Q ss_pred EEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-----------CCCchhHHHHHH
Q 041565 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFG 716 (862)
Q Consensus 648 ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVyS~G 716 (862)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986322 2234457 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041565 717 VVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796 (862)
Q Consensus 717 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~ 796 (862)
|++|||++|+.||......+.. ..+... .. .++..+.+++.+||+.+|.+|||+.|+++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~---------------~~~~~~--~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGS---------------EWIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHSSCCC------CCS---------------GGGGSS--CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHCCCCCcccccccch---------------hhhhhh--cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999654322211 111110 01 13467899999999999999999999998
Q ss_pred HHHH
Q 041565 797 NLEF 800 (862)
Q Consensus 797 ~L~~ 800 (862)
+...
T Consensus 360 hp~f 363 (377)
T 3byv_A 360 TPEY 363 (377)
T ss_dssp SHHH
T ss_pred ChHH
Confidence 6554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.48 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=208.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...+.||+|+||.||++.... +..+|+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3568889999999999999999764 678999986532 344567889999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987643 3899999999999999999999887 999999999999999999999999999865322
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
. .......||..|+|||++.+..++.++||||||+++|||++|+.||......+. +....... ..
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~--------~~ 259 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNE--------YS 259 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHTC--------CC
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-----HHHHhcCC--------CC
Confidence 1 122345689999999999999999999999999999999999999965432211 11110000 01
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+ +..+...+.+++.+||+.+|.+|||+.|++++.....
T Consensus 260 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 260 I----PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred C----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1 1123456889999999999999999999999877654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=346.58 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=204.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|...+.||+|+||.||++.... +..||+|++... .....+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 468889999999999999999764 788999986443 33445678899999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 999999988876544 3999999999999999999999887 9999999999999999999999999997643221
Q ss_pred ccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH---------HHHhhhccCc
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD---------WALHCQRMGT 752 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~~~ 752 (862)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||......+...... +.........
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 222345689999999999875 78999999999999999999999997654332211100 0000001111
Q ss_pred cccccCCCCCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 IEDIIDPNLKGNIT-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 ~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
......+.+....+ ..++..+.+++.+||+.+|.+|||+.|++++.++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 11111111111111 12456789999999999999999999999887764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=338.35 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=197.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...+.||+|+||.||++... ++..+|+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46788899999999999999975 46789999875432 33467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCC
Q 041565 604 MANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 604 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~ 678 (862)
+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998643 2245999999999999999999999887 9999999999999 456789999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .......||..|+|||.+. +.++.++||||||++++||++|+.||......+.. .... ....
T Consensus 179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~--~~~~------- 242 (285)
T 3is5_A 179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKAT--YKEP------- 242 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH--HCCC-------
T ss_pred Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhc--cCCc-------
Confidence 32 2233456899999999886 56899999999999999999999999754322211 1000 0000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..... ....+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 243 -~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 243 -NYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp -CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred -ccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 00000 0012456889999999999999999999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.42 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=198.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC--c--cEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG--K--TKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 597 (862)
.++|...+.||+|+||.||+|.++. + ..||+|++... .....+++.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3578889999999999999998642 2 36899987643 3345678999999999999999999999998765 7
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997643 23899999999999999999999887 999999999999999999999999999875
Q ss_pred CCCCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 678 PNLNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
...... .......+|..|+|||.+.+..++.++||||||++++||++ |+.||......+. .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~--- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGE--- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCC---
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccCC---
Confidence 432221 12233457788999999999999999999999999999999 9999975432221 111111110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 011122345678999999999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=350.29 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=205.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEE----cCccEEEEEecCCCC----hhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI----DGKTKVAIKRSNPSS----EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 595 (862)
.++|...++||+|+||.||+++. ..+..||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999997 367899999876432 22345677899999999 6999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++|+|.+++.... .+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999998654 3899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 208 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~--- 281 (355)
T 1vzo_A 208 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 281 (355)
T ss_dssp ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC---
T ss_pred ecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc---
Confidence 64321 1222334579999999999986 3578999999999999999999999975432221 11111111100
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEFA 801 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~~ 801 (862)
.+ ..+.+.+..+.+++.+||+.+|.+|| ++.|+++++.+.
T Consensus 282 ----~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 282 ----EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp ----CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ----CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 01 12223456788999999999999999 999999887653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.92 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=206.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999999764 6789999875321 223467899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++|+|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999997654 3899999999999999999999877 999999999999999999999999998764321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......|+..|+|||.+.+..++.++||||||++++||++|+.||......+.. .... .. +..
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~~------~~~- 230 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIV-NV------DLK- 230 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TT------CCC-
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHh-cc------ccC-
Confidence 123356899999999999999999999999999999999999999754322111 1100 00 111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.+...+..+.+++.+||+.+|.+||++.|++++.+...
T Consensus 231 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 231 ---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 11224467889999999999999999999999877654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=348.94 Aligned_cols=245 Identities=20% Similarity=0.295 Sum_probs=202.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--------hhhHHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
.++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457888999999999999999864 57789999875432 113346788999999999999999999999999
Q ss_pred eEEEEEEeCCCC-cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 596 EMILVYDYMANG-TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 596 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
..++||||+.+| +|.+++..... +++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 99999976543 999999999999999999999887 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
+..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .
T Consensus 178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~ 237 (335)
T 3dls_A 178 AYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------V 237 (335)
T ss_dssp EECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------T
T ss_pred eECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------H
Confidence 865432 22234569999999999988776 88999999999999999999999532110 0
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..... .+...+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 238 ~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 238 EAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp TTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred hhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00000 111134578999999999999999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.96 Aligned_cols=267 Identities=26% Similarity=0.395 Sum_probs=205.9
Q ss_pred cccCHHHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEE
Q 041565 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFC 591 (862)
Q Consensus 514 ~~~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 591 (862)
..+.+.++....++|...+.||+|+||.||+|... ++..||+|.+.... ...+++.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34566667778889999999999999999999974 57889999876433 2346789999999999 799999999999
Q ss_pred ee------cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc
Q 041565 592 EE------DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE 665 (862)
Q Consensus 592 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 665 (862)
.. .+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 76 468899999999999999998765456999999999999999999999887 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccH
Q 041565 666 AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSL 740 (862)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l 740 (862)
+||+|||+++...... .......||..|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-- 243 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--
Confidence 9999999997643211 1123346899999999987 567899999999999999999999999654322111
Q ss_pred HHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 741 ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 741 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
....... .+.+. ...++..+.+++.+||+.+|.+||++.|++++....
T Consensus 244 ----~~~~~~~------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 244 ----FLIPRNP------APRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp ----HHHHHSC------CCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred ----HHhhcCc------cccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 0000000 01111 112346789999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=346.08 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=204.6
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--------hhhHHHHHHHHHHHHhc-cccceeeEEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--------EQGVHEFQTEIEMLSKL-RHKHLVSLIGFC 591 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 591 (862)
....++|...+.||+|+||.||+|.+. +|..||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567888999999999999999986 68899999875432 12245688999999999 799999999999
Q ss_pred eecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 592 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
...+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999997643 3999999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 745 (862)
|++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ....
T Consensus 245 G~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~i~ 318 (365)
T 2y7j_A 245 GFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML---RMIM 318 (365)
T ss_dssp TTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH
T ss_pred CcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHH
Confidence 999865432 122345799999999998743 5888999999999999999999999654322111 1110
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. +.... ..+. ....+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 319 ~----~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 319 E----GQYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp H----TCCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred h----CCCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 0 00000 0000 0013456899999999999999999999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=350.42 Aligned_cols=259 Identities=11% Similarity=0.067 Sum_probs=187.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhc--cccceeeEE-------EEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKL--RHKHLVSLI-------GFC 591 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 591 (862)
...|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999975 67899999877643 34456778886555555 599988755 444
Q ss_pred eec-----------------CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhH------HHHHHHHHHHHHHhhcCCcccE
Q 041565 592 EED-----------------GEMILVYDYMANGTLREHLYKGDKPGLPWKQR------LEICIGAARGLHYLHTGARYTI 648 (862)
Q Consensus 592 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 648 (862)
... ...++|||||+ |+|.+++..... .+.+..+ +.++.||++||+|||+++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 332 34899999998 899999986432 2566677 788899999999999887 9
Q ss_pred EeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCC
Q 041565 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCAR 726 (862)
Q Consensus 649 vHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~ 726 (862)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999986432 1113457799999999987 77999999999999999999999
Q ss_pred CCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 727 PALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 727 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.||.......... | ............+.......++..+.+++.+||+.+|.+|||+.|++++.++.
T Consensus 291 ~Pf~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 291 LPFGLVTPGIKGS---W-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp CSTTBCCTTCTTC---C-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CCCCCcCcccccc---h-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 9997653322110 0 00000000011111111123456789999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=356.31 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=206.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhc------cccceeeEEEEEeecCeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKL------RHKHLVSLIGFCEEDGEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 597 (862)
..+|...++||+|+||.||+|.... +..||||++... ....+++.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4568899999999999999998764 688999998753 34456788899998888 467999999999999999
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc--eEEeeccccc
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE--AKVSDFGLSK 675 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--~kl~DFGla~ 675 (862)
++||||+. ++|.+++.......+++..++.|+.||++||+|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999998776666999999999999999999999876 999999999999999887 9999999997
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh-------
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ------- 748 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------- 748 (862)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+.... ......
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~--i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC--MIELLGMPSQKLL 323 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHHHCCCCHHHH
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHcCCCCHHHH
Confidence 64321 2234689999999999999999999999999999999999999976544332111 110000
Q ss_pred -ccCccccccC--------------------------------CCCCCC----CcHHHHHHHHHHHHHccccCCCCCCCH
Q 041565 749 -RMGTIEDIID--------------------------------PNLKGN----ITDQCLRKFTETAEKCLSDQGIDRPSM 791 (862)
Q Consensus 749 -~~~~~~~~~d--------------------------------~~l~~~----~~~~~~~~l~~li~~Cl~~~p~~RPt~ 791 (862)
........++ +..... ........+.+++.+||+.||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0000000000 000000 000124568999999999999999999
Q ss_pred HHHHHHHHHH
Q 041565 792 GDVLWNLEFA 801 (862)
Q Consensus 792 ~evl~~L~~~ 801 (862)
.|++++.+..
T Consensus 404 ~e~L~Hpw~~ 413 (429)
T 3kvw_A 404 GQALRHPWLR 413 (429)
T ss_dssp HHHHTSTTTC
T ss_pred HHHhCChhhc
Confidence 9999876654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=337.78 Aligned_cols=265 Identities=19% Similarity=0.283 Sum_probs=207.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEE-c-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccc------eeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYI-D-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH------LVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 596 (862)
.++|...+.||+|+||.||++.. . ++..||||++... ....+.+.+|++++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788999999999999999986 3 5778999998753 345677899999999998775 9999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC--------------
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-------------- 662 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------------- 662 (862)
.++||||+ +++|.+++.......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999998776556899999999999999999999887 999999999999987
Q ss_pred -----CCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 041565 663 -----KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737 (862)
Q Consensus 663 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~ 737 (862)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999864321 2335689999999999999999999999999999999999999976544332
Q ss_pred ccHHHHHHh--------hhccCcc------------------ccccCCCC-CCCCcHHHHHHHHHHHHHccccCCCCCCC
Q 041565 738 VSLADWALH--------CQRMGTI------------------EDIIDPNL-KGNITDQCLRKFTETAEKCLSDQGIDRPS 790 (862)
Q Consensus 738 ~~l~~~~~~--------~~~~~~~------------------~~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~~p~~RPt 790 (862)
......... ....... .....+.. .......++..+.+++.+||+.+|.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 211110000 0000000 00000000 01123356788999999999999999999
Q ss_pred HHHHHHHHH
Q 041565 791 MGDVLWNLE 799 (862)
Q Consensus 791 ~~evl~~L~ 799 (862)
+.|++++.+
T Consensus 323 ~~ell~hp~ 331 (339)
T 1z57_A 323 LREALKHPF 331 (339)
T ss_dssp HHHHTTSGG
T ss_pred HHHHhcCHH
Confidence 999997644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=349.60 Aligned_cols=275 Identities=20% Similarity=0.220 Sum_probs=205.7
Q ss_pred cCHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC-----------hhhHHHHHHHHHHHHhccccce
Q 041565 516 FSLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS-----------EQGVHEFQTEIEMLSKLRHKHL 584 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~ni 584 (862)
..+.++....++|...+.||+|+||.||+|....+..||||++.... ....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678889999999999999999999999998888999999875321 2234789999999999999999
Q ss_pred eeEEEEEee-----cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 585 VSLIGFCEE-----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 585 v~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
+++++++.. ....++||||++ |+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999999844 346899999997 68998887543 34999999999999999999999887 999999999999
Q ss_pred ccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 041565 660 LDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738 (862)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~ 738 (862)
++.++.+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||+++||++|+.||......+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999753321 22334568899999999887 77999999999999999999999999765432221
Q ss_pred cHHHHHHhhhccCc-----------cccccCCCCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 739 SLADWALHCQRMGT-----------IEDIIDPNLKG-------NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 739 ~l~~~~~~~~~~~~-----------~~~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.. ... ...... ..+.+...+.. .........+.+++.+||+.+|.+|||+.|++++...
T Consensus 244 ~~--i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 244 NK--IVE-VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HH--HHH-HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HH--HHH-HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 10 000 000000 00000000000 0111234568999999999999999999999987665
Q ss_pred H
Q 041565 801 A 801 (862)
Q Consensus 801 ~ 801 (862)
.
T Consensus 321 ~ 321 (362)
T 3pg1_A 321 E 321 (362)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=343.75 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=205.1
Q ss_pred HhhccCcccc-eeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCe
Q 041565 522 KHGTRNFSES-HVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 522 ~~at~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 596 (862)
..-.+.|... +.||+|+||.||+|... ++..||+|++... ......++.+|+.+++++ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3334556665 88999999999999976 4789999987643 233467899999999999 46999999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeeccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGL 673 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGl 673 (862)
.++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999987665566999999999999999999999887 999999999999987 78999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ........
T Consensus 181 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~~i~~~~~-- 250 (327)
T 3lm5_A 181 SRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-----LNISQVNV-- 250 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHTCC--
T ss_pred ccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHHHhccc--
Confidence 9875332 1223456899999999999999999999999999999999999999754332211 00000000
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.........++..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 251 ------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred ------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 01111112345678999999999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=356.48 Aligned_cols=271 Identities=22% Similarity=0.272 Sum_probs=189.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee-----cCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-----DGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 596 (862)
.++|...++||+|+||.||+|... ++..||||++... .....+++.+|+++|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999866 5788999987643 34456789999999999999999999999843 357
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+++||||+ +|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 579999997653 4999999999999999999999887 99999999999999999999999999986
Q ss_pred CCCCCCc-------------------------cccccccCCCCCCChhhh-hcCCCCchhHHHHHHHHHHHHHh------
Q 041565 677 GPNLNQT-------------------------HVSTMVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLC------ 724 (862)
Q Consensus 677 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~ellt------ 724 (862)
....... ...+...||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 5321110 123345689999999986 56679999999999999999999
Q ss_pred -----CCCCCCCCCccc----c-------------ccHHHHHHhhhccCc-----------cc---cccCCCCC---CCC
Q 041565 725 -----ARPALNVNLPKE----Q-------------VSLADWALHCQRMGT-----------IE---DIIDPNLK---GNI 765 (862)
Q Consensus 725 -----G~~p~~~~~~~~----~-------------~~l~~~~~~~~~~~~-----------~~---~~~d~~l~---~~~ 765 (862)
|+++|.+..... . ............... .. ..+..... ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 566664432100 0 000000000000000 00 00000000 000
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.......+.+|+.+||+.||.+|||+.|+++|..+.
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 112356789999999999999999999999987764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.06 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=205.4
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEE--cCccEEEEEecCCCC--hhhHHHHHHHHHHHHhc---cccceeeEEEEEe--
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYI--DGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKL---RHKHLVSLIGFCE-- 592 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-- 592 (862)
..+.++|...+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34567899999999999999999997 357789999865321 11223566777777766 8999999999987
Q ss_pred ---ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEe
Q 041565 593 ---EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVS 669 (862)
Q Consensus 593 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~ 669 (862)
.....++||||++ |+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5568899999997 69999998766556999999999999999999999887 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc
Q 041565 670 DFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749 (862)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 749 (862)
|||+++.... ........||..|+|||.+.+..++.++|||||||++|||++|+.||......+... ........
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIGL 237 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHcCC
Confidence 9999986432 122334568999999999999999999999999999999999999997654322211 11100000
Q ss_pred c--Cccc-------cccCC---CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 750 M--GTIE-------DIIDP---NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 750 ~--~~~~-------~~~d~---~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. .... ..... ..........+..+.+++.+||+.+|.+|||+.|++++-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 0 0000 00000 00001122345678899999999999999999999976554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=359.97 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=199.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+.|...+.||+|+||.||+|+.. .+..+|+|++.... ......+.+|+++++.++||||++++++|.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888999999999999999976 56789999875432 3335678999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeeccccccCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDFGLSKTGPN 679 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DFGla~~~~~ 679 (862)
||++|+|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+|||++.. +.+||+|||+++....
T Consensus 117 ~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999887654 3899999999999999999999887 9999999999999764 5599999999986543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. .......||+.|+|||++. +.++.++|||||||++|||++|++||......+... ... .+... .+.
T Consensus 192 ~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~-~~~~~--~~~ 258 (494)
T 3lij_A 192 Q---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR------KVE-KGKYT--FDS 258 (494)
T ss_dssp T---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HTCCC--CCS
T ss_pred C---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hCCCC--CCc
Confidence 2 2233456999999999986 568999999999999999999999997654322211 100 01000 000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
... ...+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 259 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 259 PEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp GGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred hhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 000 12346788999999999999999999999886553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=343.84 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=205.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc--------ccceeeEEEEEe---
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR--------HKHLVSLIGFCE--- 592 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 592 (862)
.++|...++||+|+||.||+|+.. ++..||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999865 4678999998743 445678899999999996 788999999987
Q ss_pred -ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeeccCCC------
Q 041565 593 -EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLDEKW------ 664 (862)
Q Consensus 593 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~------ 664 (862)
.....++||||+ +++|.+.+.......+++..++.++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 56777777665545699999999999999999999987 6 99999999999998775
Q ss_pred -------------------------------------------ceEEeeccccccCCCCCCccccccccCCCCCCChhhh
Q 041565 665 -------------------------------------------EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701 (862)
Q Consensus 665 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 701 (862)
.+||+|||+++..... .....||..|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999864321 2334689999999999
Q ss_pred hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHH---HHhhhc-------------------cCccccccCC
Q 041565 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADW---ALHCQR-------------------MGTIEDIIDP 759 (862)
Q Consensus 702 ~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~---~~~~~~-------------------~~~~~~~~d~ 759 (862)
.+..++.++|||||||++|||++|+.||......+.....+. ...... .+.+..+.+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999976543321111000 000000 0000000000
Q ss_pred CC---------CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 760 NL---------KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 760 ~l---------~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. ....+.+....+.+++.+||+.+|.+|||+.|++++.+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 00 01234567788999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=349.32 Aligned_cols=199 Identities=27% Similarity=0.387 Sum_probs=166.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec-----Ce
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----GE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 596 (862)
.++|...+.||+|+||.||+|.... +..||||++... .....+++.+|+++|++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4579999999999999999999764 678999998653 344567899999999999999999999998766 57
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||++ |+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999996 69999997643 3999999999999999999999887 99999999999999999999999999986
Q ss_pred CCCCCCc--------------------cccccccCCCCCCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 041565 677 GPNLNQT--------------------HVSTMVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPAL 729 (862)
Q Consensus 677 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~elltG~~p~ 729 (862)
....... ...+...||+.|+|||++ ....++.++|||||||+++||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 5332111 123456799999999986 5567999999999999999999855444
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=359.25 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=207.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...++||+|+||.||+++.+ ++..||+|++.... ....+.+.+|+++|++++||||+++++++...+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888899999999999999986 57899999875432 23456789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCC--CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 601 YDYMANGTLREHLYKGD--KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 345999999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~--------- 407 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE--------- 407 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH---------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh---------
Confidence 321 122345799999999999999999999999999999999999999976532211 1111111110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSM-----GDVLWNLE 799 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~-----~evl~~L~ 799 (862)
.. ..++...+..+.+++.+||+.+|.+||++ .|++++..
T Consensus 408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 00 01122345678999999999999999965 77876643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.19 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=198.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
.++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999986 57899999875432 23356789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997654 3899999999999999999999877 999999999999999999999999999875432
Q ss_pred CCccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
.......|++.|+|||.+.+..+ +.++||||||++++||++|+.||......+. . .... .+. .
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~---~~~~-~~~------~ 228 (276)
T 2h6d_A 165 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---F---KKIR-GGV------F 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHH-HCC------C
T ss_pred ---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H---HHhh-cCc------c
Confidence 12233468999999999988765 6899999999999999999999965432111 1 1100 000 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. .+...+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 229 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 229 Y----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred c----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 0 1122345688999999999999999999999987764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.48 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=199.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|...+.||+|+||.||+|... .+..||||++... .....+++.+|+++|++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999975 5789999998543 344567889999999999999999999998765 3
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 78999999763 3899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH---------HHH
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD---------WAL 745 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~ 745 (862)
.... ..+...+|..|+|||++.+ ..++.++|||||||+++||++|+.||......++..... +..
T Consensus 177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 7432 1234568999999999987 789999999999999999999999997654332211100 000
Q ss_pred hhhcc------CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 746 HCQRM------GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 746 ~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..... ..+.......+ .......+..+.+++.+||+.||.+|||+.|++++....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 00000 00000000000 011122456789999999999999999999999986653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.33 Aligned_cols=271 Identities=23% Similarity=0.294 Sum_probs=203.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEee--------c
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--------D 594 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 594 (862)
++|...+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999974 57899999875432 2334678899999999999999999999876 4
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
+..++||||++ |+|.+.+..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 56899999997 488888866533 4999999999999999999999887 999999999999999999999999999
Q ss_pred ccCCCCC--CccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 675 KTGPNLN--QTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 675 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
+...... .........||+.|+|||++.+ ..++.++|||||||+++||++|++||......+...............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8643221 1122234568999999999876 558999999999999999999999997654433222111110000000
Q ss_pred ccccc-----cC---C--CCCCCCcHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 TIEDI-----ID---P--NLKGNITDQ-----CLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 ~~~~~-----~d---~--~l~~~~~~~-----~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..... .+ . ......... ....+.+++.+||+.||.+|||+.|++++.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 00000 00 0 000000111 134578999999999999999999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=340.03 Aligned_cols=266 Identities=25% Similarity=0.370 Sum_probs=188.7
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
...++|...+.||+|+||.||+|... ++..||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44578999999999999999999864 56789999886543 34457789999999999999999999999999999999
Q ss_pred EEeCCCCcHHHHHhc------CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 601 YDYMANGTLREHLYK------GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
|||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999874 12345899999999999999999999887 999999999999999999999999998
Q ss_pred ccCCCCC---CccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc
Q 041565 675 KTGPNLN---QTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 675 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
+...... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..... ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~-~~~ 244 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQ-NDP 244 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHT-SSC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhc-cCC
Confidence 7643221 1112234568999999999876 57899999999999999999999999765432211 00000 000
Q ss_pred Cccc-cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 751 GTIE-DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 751 ~~~~-~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.... ...++... ...+..+.+++.+||+.+|.+|||+.|++++..
T Consensus 245 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 245 PSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp CCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred Cccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 1110 11111111 223457889999999999999999999997643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=361.54 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=207.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...++||+|+||.||++... .+..||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999976 5789999987432 2345678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec---cCCCceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---DEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~~kl~DFGla~~~~ 678 (862)
||+.+|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 106 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999997654 3999999999999999999999887 9999999999999 567899999999997643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+.. .... .+...
T Consensus 181 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~~---- 245 (484)
T 3nyv_A 181 AS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---KKVE----KGKYT---- 245 (484)
T ss_dssp CC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCCC----
T ss_pred cc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCCC----
Confidence 32 12234569999999999876 6899999999999999999999999765432211 1111 11000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.........+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 000001124567899999999999999999999999887654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=350.40 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=193.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHH-HHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEM-LSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...++||+|+||.||+++.+. +..||+|++.... ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3568899999999999999999864 6789999875432 2334556777776 577899999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997644 3899999999999999999999887 99999999999999999999999999985322
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... .
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-----~~i~~~~--------~ 256 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-----DNILNKP--------L 256 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-----HHHHHSC--------C
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-----HHHHhcc--------c
Confidence 1 12234567999999999999999999999999999999999999999754322111 1111100 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSM----GDVLWNL 798 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~----~evl~~L 798 (862)
. ++...+..+.+++.+||+.+|.+||++ .|++++.
T Consensus 257 ~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 257 Q----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp C----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred C----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 1 111234578899999999999999987 4555553
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=358.63 Aligned_cols=257 Identities=25% Similarity=0.335 Sum_probs=204.2
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC-------------hhhHHHHHHHHHHHHhccccceeeEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS-------------EQGVHEFQTEIEMLSKLRHKHLVSLIG 589 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~niv~l~g 589 (862)
-.++|...++||+|+||.||+|.... +..||+|.+.... ....+++.+|+++|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35679999999999999999999764 6789999875432 133577899999999999999999999
Q ss_pred EEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC---ce
Q 041565 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW---EA 666 (862)
Q Consensus 590 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~~ 666 (862)
++.+.+..++|||||++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999987654 3999999999999999999999887 99999999999998775 69
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++|++||......+... .
T Consensus 189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK------K 258 (504)
T ss_dssp EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H
T ss_pred EEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H
Confidence 99999999875432 2233456999999999987 468999999999999999999999997654322111 1
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.. .+... .+... ....+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 259 i~-~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 259 VE-KGKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HH-HCCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HH-cCCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 00 01000 00000 0113467899999999999999999999999887653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=339.44 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=200.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
..++|+..+.||+|+||.||+|.... +..||+|.+........+++.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34678899999999999999999864 78899999877666677889999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..... .
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence 999999999987643 23999999999999999999999887 99999999999999999999999998753211 0
Q ss_pred ccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 683 THVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
........||..|+|||++. +..++.++||||||+++|||++|+.|+......+. ........ ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~~-- 241 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSD-PPT-- 241 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-CCC--
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccC-Ccc--
Confidence 11122346889999999984 56789999999999999999999999975432211 11111110 000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
...+..++..+.+++.+||+.+|.+|||+.|++++..
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 0112234567899999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.27 Aligned_cols=267 Identities=19% Similarity=0.263 Sum_probs=198.3
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee------
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE------ 593 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------ 593 (862)
+....++|...+.||+|+||.||+|... ++..||||++..... ...+|+++++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456678999999999999999999874 578999998764432 23479999999999999999999844
Q ss_pred --------------------------------cCeEEEEEEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHH
Q 041565 594 --------------------------------DGEMILVYDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHY 639 (862)
Q Consensus 594 --------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~y 639 (862)
....++||||++ |+|.+.+.. .....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999997 588877763 223459999999999999999999
Q ss_pred hhcCCcccEEeeCCCCCCeecc-CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHH
Q 041565 640 LHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGV 717 (862)
Q Consensus 640 LH~~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gv 717 (862)
||+.+ |+||||||+|||++ .++.+||+|||+++...... ......+|..|+|||.+.+. .++.++|||||||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99877 99999999999998 68899999999998653322 22345689999999998875 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHhhhc---------cCccccccCCCCCC-----CCcHHHHHHHHHHHHHcccc
Q 041565 718 VLFEVLCARPALNVNLPKEQVSLADWALHCQR---------MGTIEDIIDPNLKG-----NITDQCLRKFTETAEKCLSD 783 (862)
Q Consensus 718 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---------~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~ 783 (862)
+++||++|+.||......+... ........ .....+..-+.+.. ..+...+..+.+++.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999997654333211 11110000 00000100111111 12223456789999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 041565 784 QGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 784 ~p~~RPt~~evl~~L~~ 800 (862)
+|.+|||+.|++++-.+
T Consensus 309 dP~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFF 325 (383)
T ss_dssp SGGGSCCHHHHHTSGGG
T ss_pred ChhhCCCHHHHhcCHHH
Confidence 99999999999977544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.36 Aligned_cols=254 Identities=22% Similarity=0.274 Sum_probs=203.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---------hhhHHHHHHHHHHHHhcc-ccceeeEEEEEee
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---------EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEE 593 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 593 (862)
.++|...+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 357888999999999999999986 46889999875432 223467889999999996 9999999999999
Q ss_pred cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccc
Q 041565 594 DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGL 673 (862)
Q Consensus 594 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGl 673 (862)
.+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999997643 3899999999999999999999887 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhh------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
++..... .......|+..|+|||++. ...++.++||||||++++||++|+.||......+.. ...
T Consensus 171 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~ 241 (298)
T 1phk_A 171 SCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------RMI 241 (298)
T ss_dssp CEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH
T ss_pred hhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH------HHH
Confidence 9864332 1223456899999999985 456889999999999999999999999654322111 110
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. +.. ..........+..+.+++.+||+.+|.+|||+.|++++-.
T Consensus 242 ~~-~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 242 MS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp HH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred hc-CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 00 100 0001111234567899999999999999999999997654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.14 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=192.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--------hhhHHHHHHHHHHHHhccccceeeEEEEEeec
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
..++|...+.||+|+||.||+|.... +..||||++.... ......+.+|+++|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 35689999999999999999999754 6889999865321 122335889999999999999999999975 4
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDF 671 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DF 671 (862)
+..++|||||++|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 56899999999999999886543 4999999999999999999999887 9999999999999754 45999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
|+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +......
T Consensus 287 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~-- 359 (419)
T 3i6u_A 287 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS-- 359 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHT--
T ss_pred ccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhc--
Confidence 99987543 222344679999999999853 6788999999999999999999999975432211 1111110
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+.... .+. .....+..+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 360 --~~~~~--~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 360 --GKYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp --TCCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred --CCCCC--Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 10000 000 001235678999999999999999999999987553
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.83 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=203.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
..++|...+.||+|+||.||+|.... +..||+|.+.... ..+++.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45679999999999999999999764 7889999876543 34678999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 999999999987432 34899999999999999999999887 9999999999999999999999999997643221
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ....... .+..
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~------~~~~- 245 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTNP------PPTF- 245 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------CCCC-
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC------Cccc-
Confidence 1223456899999999999999999999999999999999999999654322111 0000000 0000
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+...+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 11222456789999999999999999999999887664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=341.61 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=197.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG------ 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 595 (862)
.++|...+.||+|+||.||+|... .+..||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367899999999999999999875 4778999987542 3455678899999999999999999999987654
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||++ |+|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 588888853 3899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc---
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT--- 752 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 752 (862)
.... ........||+.|+|||++.+..++.++|||||||+++||++|+.||......+. |.......+.
T Consensus 176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-----WNKVIEQLGTPCP 247 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHC-CCCCCH
T ss_pred cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCCCCH
Confidence 6432 1123345689999999999999999999999999999999999999976543221 1111100000
Q ss_pred ------------------------cccccCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 ------------------------IEDIIDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 ------------------------~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+.......... .........+.+++.+||+.||.+|||+.|++++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00000000000 01123467889999999999999999999999998765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=357.66 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=204.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|...++||+|+||.||++... ++..||||++... .......+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46888999999999999999976 5788999987532 12345788999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc---CCCceEEeeccccccCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD---EKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~~kl~DFGla~~~~~ 679 (862)
|+++|+|.+.+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 102 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999987654 3899999999999999999999887 99999999999995 456799999999986432
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
. .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+.. .... .+...
T Consensus 177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~~----- 240 (486)
T 3mwu_A 177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRVE----TGKYA----- 240 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCCC-----
T ss_pred C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCC-----
Confidence 2 22234568999999999876 5999999999999999999999999765332211 1010 01000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
.........+..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 241 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp -SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred -CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 000001124567899999999999999999999999987754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=337.71 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=199.1
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEe-----------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE----------- 592 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 592 (862)
.++|...+.||+|+||.||+|.... +..||+|++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578889999999999999999875 7889999987777777888999999999999999999999873
Q ss_pred ---ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEE
Q 041565 593 ---EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKV 668 (862)
Q Consensus 593 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl 668 (862)
+....++||||++ |+|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 4468899999997 6999998642 4899999999999999999999887 99999999999997 5679999
Q ss_pred eeccccccCCCCC-CccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 669 SDFGLSKTGPNLN-QTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 669 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
+|||+++...... .........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... ...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~--~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI--LES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHh
Confidence 9999998653211 1112233457899999999876 77899999999999999999999999765432211100 000
Q ss_pred hhc---------cCcccc-----ccCCCCC-CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 747 CQR---------MGTIED-----IIDPNLK-GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 747 ~~~---------~~~~~~-----~~d~~l~-~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
... ...+.. ...+... .......+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 000 000000 0000000 000112456789999999999999999999999987765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.62 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=196.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC--------hhhHHHHHHHHHHHHhccccceeeEEEEEeecCe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS--------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 596 (862)
++|...+.||+|+||.||+|.... +..||||.+.... ......+.+|++++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 568889999999999999999764 6789999876432 122345889999999999999999999987654
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc---eEEeeccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGL 673 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---~kl~DFGl 673 (862)
.++||||+++|+|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 899999999999999987543 4899999999999999999999887 999999999999987654 99999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhcc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
++.... ........||..|+|||++. ...++.++|||||||++|||++|+.||........ +......
T Consensus 164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~---- 234 (322)
T 2ycf_A 164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS---- 234 (322)
T ss_dssp CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH----
T ss_pred ceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh----
Confidence 987532 12223456999999999974 46789999999999999999999999975433221 1111111
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
+.... .+. .....+..+.+++.+||+.+|.+||++.|++++.
T Consensus 235 ~~~~~--~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 235 GKYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp TCCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred Ccccc--Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 10000 000 0012356789999999999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=343.60 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=205.8
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec-----C
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----G 595 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 595 (862)
...++|...+.||+|+||.||++... ++..||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34568999999999999999999975 5678999998753 344457899999999999999999999998654 4
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||++ |+|.+++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 6899999997 5999998754 3899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc-
Q 041565 676 TGPNLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT- 752 (862)
Q Consensus 676 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 752 (862)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...... .......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCH
Confidence 6532211 111234578999999998765 558999999999999999999999997655433221110 0000000
Q ss_pred --c------------ccccCCCCC--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 753 --I------------EDIIDPNLK--GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 753 --~------------~~~~d~~l~--~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+ .....+... .......+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 318 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 0 000000000 000012345789999999999999999999999887654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=367.78 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=207.6
Q ss_pred HHhhccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC
Q 041565 521 IKHGTRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG 595 (862)
Q Consensus 521 l~~at~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 595 (862)
.....++|...+.||+|+||.||+|.+.. +..||+|.+... .....+.|.+|+.++++++||||+++++++.+ +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 33445678889999999999999998743 357999987653 34455789999999999999999999999854 5
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 6899999999999999997653 34899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+. ...... ..
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i~~---~~--- 609 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN---GE--- 609 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHH---TC---
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc---CC---
Confidence 7543221 12233456788999999999999999999999999999997 9999975433221 111111 00
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+++
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011122345678999999999999999999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.17 Aligned_cols=260 Identities=18% Similarity=0.263 Sum_probs=201.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEee--cCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEE--DGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 601 (862)
++|+..+.||+|+||.||+|... ++..||+|.+.... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 56888999999999999999864 57899999987543 367899999999997 9999999999987 67889999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNL 680 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~ 680 (862)
||+++++|.+++.. +++.+++.++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998843 889999999999999999999887 99999999999999776 8999999999864332
Q ss_pred CCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH------------HHHHhh
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA------------DWALHC 747 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~------------~~~~~~ 747 (862)
. ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........ .+. ++....
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence 2 2233468899999999987 6789999999999999999999999954332111 011 111000
Q ss_pred hc--cCccccccC--------CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 748 QR--MGTIEDIID--------PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 748 ~~--~~~~~~~~d--------~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.. .....+.+. ...........+..+.+++.+||+.+|.+|||+.|++++.++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 00 000000000 001111122246778999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=348.04 Aligned_cols=264 Identities=25% Similarity=0.266 Sum_probs=197.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec------CeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------GEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 597 (862)
..+|...++||+|+||.||+|+.. .+..||||++..... .+.+|+++|++++||||+++++++... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346888899999999999999986 478999998764322 234799999999999999999988542 236
Q ss_pred EEEEEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-CceEEeecccc
Q 041565 598 ILVYDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLS 674 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~~kl~DFGla 674 (862)
++||||+++ +|.+.+.. .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999975 66666543 22345999999999999999999999877 9999999999999965 67899999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc----
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR---- 749 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 749 (862)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||......+.. .........
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHH
Confidence 8653321 22335689999999999764 7999999999999999999999999765433221 111111000
Q ss_pred -----cCccccccCCCCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 750 -----MGTIEDIIDPNLKGN-----ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 750 -----~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+..-+.+... +....+..+.+++.+||+.+|.+|||+.|++++..+.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 001111111111111 1122356789999999999999999999999887663
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.90 Aligned_cols=264 Identities=19% Similarity=0.302 Sum_probs=205.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChh-----------------hHHHHHHHHHHHHhccccceeeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQ-----------------GVHEFQTEIEMLSKLRHKHLVSL 587 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 587 (862)
.++|...+.||+|+||.||+|.. ++..||+|.+...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999998 7889999987532111 12789999999999999999999
Q ss_pred EEEEeecCeEEEEEEeCCCCcHHHH------HhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeec
Q 041565 588 IGFCEEDGEMILVYDYMANGTLREH------LYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILL 660 (862)
Q Consensus 588 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl 660 (862)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||+|||+ .+ |+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 655435569999999999999999999998 66 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTE-KSDVYSFGVVLFEVLCARPALNVNLPKEQV 738 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVyS~Gvvl~elltG~~p~~~~~~~~~~ 738 (862)
+.++.+||+|||+++..... ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 99999999999999864321 23345689999999999887 6666 9999999999999999999997543311
Q ss_pred cHHHHHHhhhccCccc----cccCCCCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 739 SLADWALHCQRMGTIE----DIIDPNLK---GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~----~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+...... ...... ....+... .......+..+.+++.+||+.+|.+|||+.|++++...
T Consensus 260 ~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 260 ELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp HHHHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 11111110 000000 00000000 00112345678999999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=345.57 Aligned_cols=264 Identities=22% Similarity=0.264 Sum_probs=195.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe------EEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE------MIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 599 (862)
.+|...++||+|+||.||+|+...+..+|+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999987776799998754322 12369999999999999999999865443 789
Q ss_pred EEEeCCCCcHHHHHh-cCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEEeeccccccC
Q 041565 600 VYDYMANGTLREHLY-KGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTG 677 (862)
Q Consensus 600 V~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~~ 677 (862)
||||++++.+..... ......+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998654433322 112345999999999999999999999887 99999999999999 7899999999999865
Q ss_pred CCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc-------
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR------- 749 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------- 749 (862)
.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||......+... ........
T Consensus 193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHH
T ss_pred cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHH
Confidence 3321 22345689999999998764 58999999999999999999999997654332211 11110000
Q ss_pred --cCccccccCCCCCC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 750 --MGTIEDIIDPNLKG-----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 750 --~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+..-+.... .+....+..+.+++.+||+.+|.+|||+.|++++..+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 00000000011111 11122456789999999999999999999999886653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=337.57 Aligned_cols=273 Identities=22% Similarity=0.233 Sum_probs=207.1
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-cc-----ceeeEEEEEe
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HK-----HLVSLIGFCE 592 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~ 592 (862)
+.....++|...+.||+|+||.||+|... ++..||||++... ....+++..|+++++.++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 33445678999999999999999999976 4678999998743 344677888999999885 44 4999999999
Q ss_pred ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc--CCCceEEee
Q 041565 593 EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD--EKWEAKVSD 670 (862)
Q Consensus 593 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~~kl~D 670 (862)
..+..++||||++ |+|.+++.......+++..+..++.|++.||+|||++ +.+|+||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999996 5999999877655699999999999999999999953 23599999999999995 477899999
Q ss_pred ccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh---
Q 041565 671 FGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC--- 747 (862)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--- 747 (862)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+......-....
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999875321 23356899999999999999999999999999999999999999865433221111000000
Q ss_pred ---hccCc----cccccC-----------------CC------------------C--CCCCcHHHHHHHHHHHHHcccc
Q 041565 748 ---QRMGT----IEDIID-----------------PN------------------L--KGNITDQCLRKFTETAEKCLSD 783 (862)
Q Consensus 748 ---~~~~~----~~~~~d-----------------~~------------------l--~~~~~~~~~~~l~~li~~Cl~~ 783 (862)
..... +..+.+ +. . .......+...+.+++.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 00000 000000 00 0 0011123446789999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 041565 784 QGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 784 ~p~~RPt~~evl~~L~~ 800 (862)
||.+|||+.|++++.+.
T Consensus 360 dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFF 376 (382)
T ss_dssp CTTTSCCHHHHTTSGGG
T ss_pred ChhhCCCHHHHhcCccc
Confidence 99999999999987553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=367.26 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=207.1
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC---ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS---SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 598 (862)
..++|...++||+|+||.||++.... +..||||++... .....+.+..|..+|..+ +|++|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34679999999999999999999764 678999987632 223456788899999988 7999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+||||+++|+|.+++..... +++..++.++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999986543 999999999999999999999887 9999999999999999999999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+.. .. ++.
T Consensus 494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~------~~---------i~~ 556 (674)
T 3pfq_A 494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QS---------IME 556 (674)
T ss_dssp CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH---------HHS
T ss_pred cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH------HH---------HHh
Confidence 22 12234567999999999999999999999999999999999999999764332211 11 011
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSM-----GDVLWNLEF 800 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~-----~evl~~L~~ 800 (862)
.. ..++...+.++.+++.+||+.+|.+||++ .||+++..+
T Consensus 557 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 557 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 11 11222345678999999999999999997 888876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=332.29 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=205.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC--ccEEEEEecCCCChhhHHHHHHHHHHHHhccccc------eeeEEEEEeecCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG--KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH------LVSLIGFCEEDGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 596 (862)
.++|...+.||+|+||.||++.... +..||+|++... ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3578999999999999999999753 368999998743 344677889999999998876 8999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec----------------
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL---------------- 660 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---------------- 660 (862)
.++||||+ +++|.+++.......+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 667888887665556999999999999999999999877 9999999999999
Q ss_pred ---cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 041565 661 ---DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737 (862)
Q Consensus 661 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~ 737 (862)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999986432 12335689999999999999999999999999999999999999976543322
Q ss_pred ccHHHHHHh--------hhccCcc------------------ccccCCC-CCCCCcHHHHHHHHHHHHHccccCCCCCCC
Q 041565 738 VSLADWALH--------CQRMGTI------------------EDIIDPN-LKGNITDQCLRKFTETAEKCLSDQGIDRPS 790 (862)
Q Consensus 738 ~~l~~~~~~--------~~~~~~~------------------~~~~d~~-l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt 790 (862)
......... ....... .+...+. ........+...+.+++.+||+.+|.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 111110000 0000000 0000000 000112245678999999999999999999
Q ss_pred HHHHHHHHHH
Q 041565 791 MGDVLWNLEF 800 (862)
Q Consensus 791 ~~evl~~L~~ 800 (862)
+.|++++.+.
T Consensus 328 ~~e~l~hp~f 337 (355)
T 2eu9_A 328 LAEALLHPFF 337 (355)
T ss_dssp HHHHTTSGGG
T ss_pred HHHHhcChhh
Confidence 9999976554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.01 Aligned_cols=258 Identities=20% Similarity=0.292 Sum_probs=177.9
Q ss_pred ccCcccc-eeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee----cCeEE
Q 041565 525 TRNFSES-HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE----DGEMI 598 (862)
Q Consensus 525 t~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 598 (862)
.++|... ++||+|+||.||+|... ++..||||++.... ... .+....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3567774 46999999999999987 57899999986432 212 222334566799999999999876 45589
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeeccccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLSK 675 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla~ 675 (862)
+||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998776567999999999999999999999887 999999999999976 4559999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... .... ...+.
T Consensus 180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~-~~~~~--- 249 (336)
T 3fhr_A 180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRR-IRLGQ--- 249 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHh-hhccc---
Confidence 64321 22335689999999999888999999999999999999999999965432211100 0000 00000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..........++..+.+++.+||+.+|.+|||+.|++++.+...
T Consensus 250 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 00011111234567899999999999999999999999888764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=334.30 Aligned_cols=267 Identities=18% Similarity=0.268 Sum_probs=203.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-----------ccceeeEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-----------HKHLVSLIGFCE 592 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 592 (862)
.++|...+.||+|+||.||+|... ++..||||.+... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357899999999999999999974 5788999998743 344577889999999886 899999999987
Q ss_pred ecC----eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeecc------
Q 041565 593 EDG----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLD------ 661 (862)
Q Consensus 593 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~------ 661 (862)
..+ ..++|||++ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999999876555699999999999999999999987 6 99999999999994
Q ss_pred CCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc---
Q 041565 662 EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV--- 738 (862)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--- 738 (862)
..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 445799999999986432 123346899999999999999999999999999999999999999754322110
Q ss_pred -cHHHHHHhhh------------------ccCccccccCCCC---------CCCCcHHHHHHHHHHHHHccccCCCCCCC
Q 041565 739 -SLADWALHCQ------------------RMGTIEDIIDPNL---------KGNITDQCLRKFTETAEKCLSDQGIDRPS 790 (862)
Q Consensus 739 -~l~~~~~~~~------------------~~~~~~~~~d~~l---------~~~~~~~~~~~l~~li~~Cl~~~p~~RPt 790 (862)
.+........ ..+.+..+..... ....+..++..+.+++.+||+.+|.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 0100000000 0000000000000 11244567889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 041565 791 MGDVLWNLEFA 801 (862)
Q Consensus 791 ~~evl~~L~~~ 801 (862)
+.|++++.+..
T Consensus 328 ~~ell~hp~f~ 338 (373)
T 1q8y_A 328 AGGLVNHPWLK 338 (373)
T ss_dssp HHHHHTCGGGT
T ss_pred HHHHhhChhhh
Confidence 99999877654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.65 Aligned_cols=268 Identities=20% Similarity=0.273 Sum_probs=203.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec-----CeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED-----GEM 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 597 (862)
.++|...+.||+|+||.||+|... ++..||||++... ......++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999976 5788999998653 344466788999999999999999999998654 678
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6999998763 3899999999999999999999887 999999999999999999999999999865
Q ss_pred CCCCCc--------cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 678 PNLNQT--------HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 678 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
...... .......||..|+|||++.+ ..++.++|||||||+++||++|+.||......+..... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~ 240 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI--FGIIG 240 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--HHHhC
Confidence 321111 01223468999999998765 77899999999999999999999999765432221110 00000
Q ss_pred cc---Ccc--------ccccC--CCCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 749 RM---GTI--------EDIID--PNLKG----NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 749 ~~---~~~--------~~~~d--~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.. ... .+.+. +.... ......+..+.+++.+||+.+|.+|||+.|++++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00 000 00000 00000 00112456788999999999999999999999876653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=339.49 Aligned_cols=273 Identities=21% Similarity=0.222 Sum_probs=194.1
Q ss_pred HHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe-
Q 041565 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE- 596 (862)
Q Consensus 519 ~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 596 (862)
.+.....++|...+.||+|+||.||+|... ++..||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445666789999999999999999999975 57889999875432 223456788888999999999999999866443
Q ss_pred ------EEEEEEeCCCCcHHHHHhc--CCCCCCChhhHHHHHHHHHHHHHHhh--cCCcccEEeeCCCCCCeeccC-CCc
Q 041565 597 ------MILVYDYMANGTLREHLYK--GDKPGLPWKQRLEICIGAARGLHYLH--TGARYTIIHRDVKTTNILLDE-KWE 665 (862)
Q Consensus 597 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDIkp~NILl~~-~~~ 665 (862)
.++||||+++ +|...+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 8899999976 55554442 23345899999999999999999999 766 999999999999997 899
Q ss_pred eEEeeccccccCCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 041565 666 AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWA 744 (862)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 744 (862)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... ...
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HHH
Confidence 9999999998754322 22345689999999998765 48999999999999999999999997654332211 111
Q ss_pred Hhhhcc-----------CccccccCC------CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 745 LHCQRM-----------GTIEDIIDP------NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 745 ~~~~~~-----------~~~~~~~d~------~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...... .......+. ..........+..+.+++.+||+.+|.+|||+.|++++.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence 100000 000000000 000111122467899999999999999999999999987764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=332.48 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=183.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHH-HHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIE-MLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.++|...+.||+|+||.||+|... ++..||||++... ......++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999985 5788999987654 3344456666666 677789999999999999999999999
Q ss_pred EeCCCCcHHHHHhc---CCCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 602 DYMANGTLREHLYK---GDKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 602 E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
||+++ +|.+++.. .....+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99974 88887753 2234589999999999999999999986 6 999999999999999999999999999864
Q ss_pred CCCCCccccccccCCCCCCChhhh----hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
... .......||..|+|||++ .+..++.++||||||+++|||++|+.||........ .... .
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~------~ 242 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ------V 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC------C
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH------H
Confidence 321 122334689999999998 466789999999999999999999999964321110 0000 0
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+.+.......++..+.+++.+||+.+|.+|||+.|++++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 000011111111223456789999999999999999999999887665
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.31 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=187.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec------C
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------G 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 595 (862)
.++|...+.||+|+||.||+|... ++..||||++... .....+++.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999864 5788999998643 344567889999999999999999999998653 5
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 6899998865 34999999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhc-----
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR----- 749 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 749 (862)
.... ......||..|+|||++.+ ..++.++|||||||+++||++|+.||......++.....-......
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6432 1234568999999999987 6889999999999999999999999976543332211100000000
Q ss_pred ---cCccccccC--CCCCC-CC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 750 ---MGTIEDIID--PNLKG-NI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 750 ---~~~~~~~~d--~~l~~-~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.......+. +.... .+ .......+.+++.+||+.||.+|||+.|++++....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 000000000 00000 00 011245688999999999999999999999887654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=325.45 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=194.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee----------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE---------- 593 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 593 (862)
.++|...+.||+|+||.||+|+.. ++..||+|++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356888999999999999999975 578999998854 34456789999999999999999999998865
Q ss_pred ---cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEee
Q 041565 594 ---DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSD 670 (862)
Q Consensus 594 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~D 670 (862)
.+..++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 457899999999999999998643 34788999999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCC------------ccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc
Q 041565 671 FGLSKTGPNLNQ------------THVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737 (862)
Q Consensus 671 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~ 737 (862)
||+++....... ........||..|+|||.+.+. .++.++|||||||++|||++ |+... .+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 999986432110 1122345689999999999864 78999999999999999998 33211 111
Q ss_pred ccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 738 VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 738 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. ........ . ...+........+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 235 ~---~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 235 V---NILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp H---HHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred H---HHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 1 11111110 0 111222233345567899999999999999999999997644
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=341.67 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=184.8
Q ss_pred ccc-ceeEeeeCcEEEEEEEEc---CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeEEEEE
Q 041565 528 FSE-SHVIGVGGFGKVYEGYID---GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMILVY 601 (862)
Q Consensus 528 f~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 601 (862)
|.. +++||+|+||.||+|+.. .+..||+|++..... ...+.+|+++|++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 468999999999999976 367899999875432 3568899999999999999999999954 67899999
Q ss_pred EeCCCCcHHHHHhcC-------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec----cCCCceEEee
Q 041565 602 DYMANGTLREHLYKG-------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL----DEKWEAKVSD 670 (862)
Q Consensus 602 E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~~kl~D 670 (862)
||++ |+|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5888887531 1224899999999999999999999887 9999999999999 6778999999
Q ss_pred ccccccCCCCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccc-------ccHH
Q 041565 671 FGLSKTGPNLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ-------VSLA 741 (862)
Q Consensus 671 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~-------~~l~ 741 (862)
||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||........ ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999986532211 122334578999999999987 4589999999999999999999999975433210 0000
Q ss_pred HHHHhhh--ccCccccc-------------cCCCCCCCC--------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 742 DWALHCQ--RMGTIEDI-------------IDPNLKGNI--------TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 742 ~~~~~~~--~~~~~~~~-------------~d~~l~~~~--------~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
....... ....+..+ ......... .......+.+|+.+||+.||.+|||+.|++++.
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000 00000000 000000000 000134678999999999999999999999998
Q ss_pred HHH
Q 041565 799 EFA 801 (862)
Q Consensus 799 ~~~ 801 (862)
++.
T Consensus 336 ~f~ 338 (405)
T 3rgf_A 336 YFL 338 (405)
T ss_dssp GGT
T ss_pred hhc
Confidence 875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.32 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=202.7
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
.++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 357889999999999999999976 5788999987532 2344678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC---CceEEeeccccccCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK---WEAKVSDFGLSKTGP 678 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~~kl~DFGla~~~~ 678 (862)
||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999987644 3899999999999999999999887 9999999999999754 469999999998643
Q ss_pred CCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... ......++..|+|||.+.+ .++.++||||||++++||++|+.||......+. ...... +.... +
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~--~ 242 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVET-GKYAF--D 242 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-CCCCC--C
T ss_pred CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHc-CCCCC--C
Confidence 321 1223357889999999875 489999999999999999999999975432211 111111 11000 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.. .....+..+.+++.+||+.+|.+|||+.|++++....
T Consensus 243 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 243 LP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp SG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred ch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 00 0012356789999999999999999999999876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=336.71 Aligned_cols=262 Identities=20% Similarity=0.290 Sum_probs=199.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeE----
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEM---- 597 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 597 (862)
.++|...+.||+|+||.||+|... ++..||||++... .....+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999975 5788999988653 344467889999999999999999999999876654
Q ss_pred --EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 598 --ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 598 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 689888732 3899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC---
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG--- 751 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 751 (862)
.... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+.... .........
T Consensus 193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~ 265 (371)
T 4exu_A 193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--ILKVTGVPGTEF 265 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCCCHHH
T ss_pred cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCcHHH
Confidence 6432 1234568999999999987 7899999999999999999999999976543222111 000000000
Q ss_pred -------c---cccccCCCCCCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 -------T---IEDIIDPNLKGN---ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 -------~---~~~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. ....+....... ....++..+.+++.+||+.+|.+|||+.|++++.++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 000000000000 0112356789999999999999999999999887653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.42 Aligned_cols=265 Identities=23% Similarity=0.403 Sum_probs=203.9
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeec
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
.+.+.....++|...+.||+|+||.||+|..++ .+|+|.+... .....+.+.+|+.++++++|+||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344555567789999999999999999998765 4899987643 223345678899999999999999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
+..++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999997643 34899999999999999999999887 99999999999998 679999999998
Q ss_pred ccCCCCC---CccccccccCCCCCCChhhhhc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 041565 675 KTGPNLN---QTHVSTMVKGSFGYLDPEYFRR---------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742 (862)
Q Consensus 675 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 742 (862)
+...... .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---- 252 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---- 252 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 7542211 1112233458899999999874 45789999999999999999999999754322111
Q ss_pred HHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 743 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+ ... .+. .+.+. ...++..+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 253 ~--~~~-~~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 253 W--QMG-TGM-----KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp H--HHH-TTC-----CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred H--Hhc-cCC-----CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 111 111 11111 11134568899999999999999999999999987653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.99 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=192.7
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh------hhHHHHHHHHHHHHhc----cccceeeEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE------QGVHEFQTEIEMLSKL----RHKHLVSLIGF 590 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g~ 590 (862)
..-.++|...+.||+|+||.||+|... ++..||||++..... .....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999864 577899999865432 1233466799999999 89999999999
Q ss_pred EeecCeEEEEEEe-CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEE
Q 041565 591 CEEDGEMILVYDY-MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKV 668 (862)
Q Consensus 591 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl 668 (862)
+...+..++|||+ +.+++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999998644 3899999999999999999999877 99999999999999 8899999
Q ss_pred eeccccccCCCCCCccccccccCCCCCCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh
Q 041565 669 SDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747 (862)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 747 (862)
+|||+++..... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||..... ...
T Consensus 182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~-- 247 (312)
T 2iwi_A 182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILE-- 247 (312)
T ss_dssp CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH--
T ss_pred EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------Hhh--
Confidence 999999865432 12345689999999999877764 589999999999999999999853210 000
Q ss_pred hccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 748 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
. . . ..+...+..+.+++.+||+.+|.+|||+.|++++...
T Consensus 248 -~--~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 248 -A--E------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp -T--C------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred -h--c------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0 0 0 1112245678899999999999999999999987554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.40 Aligned_cols=262 Identities=19% Similarity=0.303 Sum_probs=199.2
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe-----
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE----- 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 596 (862)
.++|...+.||+|+||.||+|... ++..||||++... .....+++.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999975 5789999987643 34446788999999999999999999999977643
Q ss_pred -EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 597 -MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 597 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
.++||||++ ++|.+++.. .+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 599999997 688877632 3899999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH---------HHHH
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA---------DWAL 745 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~ 745 (862)
.... ......+|..|+|||++.+ ..++.++|||||||+++||++|+.||......+..... +|..
T Consensus 175 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 175 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred CCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6432 1233568999999999987 67899999999999999999999999765432211100 0000
Q ss_pred hhhcc------CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 746 HCQRM------GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 746 ~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..... ..+.....+.+ .......+..+.+++.+||+.+|.+|||+.|++++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00000 00000000001 11122346678999999999999999999999987665
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=339.26 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=189.2
Q ss_pred cccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 528 FSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 528 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
|...++||+|+||+||.+...+|..||||++... ..+.+.+|+++|+++ +||||+++++++.+++..++|||||+
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456889999999998766667889999987542 245678999999987 89999999999999999999999995
Q ss_pred CcHHHHHhcCCCCC-----CChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC-------------CceEE
Q 041565 607 GTLREHLYKGDKPG-----LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK-------------WEAKV 668 (862)
Q Consensus 607 gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-------------~~~kl 668 (862)
|+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 69999998653211 244567889999999999999887 9999999999999754 48999
Q ss_pred eeccccccCCCCCCc--cccccccCCCCCCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 041565 669 SDFGLSKTGPNLNQT--HVSTMVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQV 738 (862)
Q Consensus 669 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~ 738 (862)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~- 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-
Confidence 999999875432211 11234569999999999976 678999999999999999999 9999965432211
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..... .... +.+........+.++.+++.+||+.+|.+|||+.|++++..
T Consensus 249 ---~i~~~---~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 249 ---NIIRG---IFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp ---HHHHT---CCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---HHhcC---CCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 11111 0010 11112223456788999999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=338.04 Aligned_cols=255 Identities=24% Similarity=0.284 Sum_probs=191.3
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
..+..+|...++||+|+||+||.....++..||||++..... ..+.+|+++|+++ +||||+++++++.+....++|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 344557888999999999996655556778999999865432 2356899999999 799999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-----CCceEEeeccccc
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-----KWEAKVSDFGLSK 675 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~~kl~DFGla~ 675 (862)
||||+ |+|.+++..... .+.+.+++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++
T Consensus 97 ~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 99996 699999986543 3666678899999999999999887 999999999999943 3458899999998
Q ss_pred cCCCCCC-ccccccccCCCCCCChhhhh---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhcc
Q 041565 676 TGPNLNQ-THVSTMVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRM 750 (862)
Q Consensus 676 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 750 (862)
....... ........||+.|+|||++. ...++.++|||||||+++||++ |+.||........ ......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhcc
Confidence 7543211 12234467999999999997 4677889999999999999999 8888854322111 011111
Q ss_pred CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 751 GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 751 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
.... .+ .........+.+++.+||+.+|.+|||+.|++++.
T Consensus 245 ~~~~-----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 245 CSLD-----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp CCCT-----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred CCcc-----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 1100 00 11223556688999999999999999999999654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.39 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=181.8
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhh-HHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQG-VHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
-++|...+.||+|+||.||+|... ++..||||.+.... ... .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999986 57899999876542 222 334445556788889999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-CcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG-ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||+ ++.+..++... ...+++..++.++.|+++||+|||++ + |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 45555554432 33489999999999999999999984 5 999999999999999999999999999764321
Q ss_pred CCccccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
.......||+.|+|||++. ...++.++||||||+++|||++|+.||........ .+........
T Consensus 179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~---- 247 (318)
T 2dyl_A 179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE----VLTKVLQEEP---- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHHSCC----
T ss_pred ---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH----HHHHHhccCC----
Confidence 1223456899999999994 56789999999999999999999999965322111 1111111100
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+.+.. ...++..+.+++.+||+.+|.+||++.|++++....
T Consensus 248 ---~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 248 ---PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp ---CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ---CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 11110 012346789999999999999999999999876543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.50 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=199.5
Q ss_pred HHHHhhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh------hhHHHHHHHHHHHHhcc--ccceeeEEE
Q 041565 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE------QGVHEFQTEIEMLSKLR--HKHLVSLIG 589 (862)
Q Consensus 519 ~el~~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g 589 (862)
.+.....++|...+.||+|+||.||+|... ++..||||.+..... ...+.+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344455678999999999999999999864 578899998754321 12245678999999996 599999999
Q ss_pred EEeecCeEEEEEEeCCC-CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceE
Q 041565 590 FCEEDGEMILVYDYMAN-GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAK 667 (862)
Q Consensus 590 ~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~k 667 (862)
++...+..++|||++.+ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999976 89999997643 3899999999999999999999887 99999999999999 789999
Q ss_pred EeeccccccCCCCCCccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHh
Q 041565 668 VSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALH 746 (862)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 746 (862)
|+|||+++..... ......||..|+|||++.+..+ +.++||||||+++|||++|+.||..... ...
T Consensus 191 L~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~- 257 (320)
T 3a99_A 191 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIR- 257 (320)
T ss_dssp ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-
T ss_pred EeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hhc-
Confidence 9999999875432 1233568999999999987765 6889999999999999999999853210 000
Q ss_pred hhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 747 CQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 747 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
+. ... +...+..+.+++.+||+.+|.+|||+.|++++.+
T Consensus 258 ----~~------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 258 ----GQ------VFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp ----CC------CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ----cc------ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 00 001 1123457889999999999999999999997654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=348.78 Aligned_cols=239 Identities=19% Similarity=0.291 Sum_probs=193.4
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc--CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCe-----
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID--GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGE----- 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 596 (862)
.++|...++||+|+||.||++.+. ++..||||++... .....+.+.+|++++++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999986 4788999987643 34556788999999999999999999999987665
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++||||+++++|.+++.. .+++.+++.|+.||++||+|||+++ |+||||||+|||++++ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987754 4999999999999999999999887 9999999999999986 999999999987
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.... ....||++|+|||++.++. +.++|||||||+++||++|.+|+........
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------- 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------- 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------
Confidence 5332 3456999999999998764 8999999999999999999888753211000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-MGDVLWNLEFA 801 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-~~evl~~L~~~ 801 (862)
............+.+++.+||+.+|.+||+ +.++...|...
T Consensus 285 ----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 001111224467899999999999999995 66666666554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.24 Aligned_cols=232 Identities=20% Similarity=0.340 Sum_probs=182.6
Q ss_pred cCcccc-eeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHH-HhccccceeeEEEEEee----cCeEE
Q 041565 526 RNFSES-HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEML-SKLRHKHLVSLIGFCEE----DGEMI 598 (862)
Q Consensus 526 ~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 598 (862)
++|... ++||+|+||.||++... ++..||+|++... ..+.+|++++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 78999999999999974 5789999998632 4567888887 55689999999999876 67889
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeeccccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLSK 675 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla~ 675 (862)
+||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998876556999999999999999999999887 999999999999998 7889999999987
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
... +..++.++|||||||++|||++|+.||......... ......
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~ 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence 532 134678999999999999999999999654322110 000000
Q ss_pred ccCCCCCCCCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 756 IIDPNLKGNIT----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 756 ~~d~~l~~~~~----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+..... ..+ ..++..+.+++.+||+.+|.+|||+.|++++.....
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 000000 011 124567899999999999999999999999887653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=345.58 Aligned_cols=268 Identities=24% Similarity=0.325 Sum_probs=205.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEee------cCeE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE------DGEM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 597 (862)
++|...++||+|+||.||+|... ++..||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57888999999999999999874 5788999988654 44556789999999999999999999999765 6778
Q ss_pred EEEEEeCCCCcHHHHHhcCC-CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCc---eEEeeccc
Q 041565 598 ILVYDYMANGTLREHLYKGD-KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWE---AKVSDFGL 673 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---~kl~DFGl 673 (862)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 235999999999999999999999887 999999999999997664 89999999
Q ss_pred cccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 674 SKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..|..........
T Consensus 171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 9875432 2233457999999999999999999999999999999999999999654211 1121111111000
Q ss_pred ccccC----------C--CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHhcC
Q 041565 754 EDIID----------P--NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGD-----VLWNLEFALQL 804 (862)
Q Consensus 754 ~~~~d----------~--~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~e-----vl~~L~~~l~~ 804 (862)
..... . ..........+..+.+++.+||..+|.+|||+.| ..+.++.+++.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 0 1112234457788999999999999999999988 45666666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.60 Aligned_cols=232 Identities=12% Similarity=0.110 Sum_probs=185.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCC---hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|.... +..||||.+.... ....+++.+|+.++++++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 578889999999999999999864 7899999987542 344578999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+++++|.+++.+. ....++.+|+.|+++||+|||+.+ |+||||||+|||+++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999532 355678999999999999999887 9999999999999999999997443
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
|++| ++.++|||||||++|||++|+.||......+..... ....... +..
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~--~~~ 224 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQ--PIE 224 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSC--BCC
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccC--CCC
Confidence 3333 688999999999999999999999765433211000 0000000 000
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
.......++..+.+++.+||+.||.+| |+.|+++.|+.+...
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000112245678999999999999999 999999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=330.12 Aligned_cols=244 Identities=17% Similarity=0.169 Sum_probs=182.4
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccc-cce---------e---
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRH-KHL---------V--- 585 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~ni---------v--- 585 (862)
..+..|...++||+|+||.||+|.+. ++..||||++.... ....+.|.+|+.+++.++| +|. +
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 44556788899999999999999964 57899999877432 2336789999999999977 211 1
Q ss_pred ---eE------EEEEee-----cCeEEEEEEeCCCCcHHHHHh-----cCCCCCCChhhHHHHHHHHHHHHHHhhcCCcc
Q 041565 586 ---SL------IGFCEE-----DGEMILVYDYMANGTLREHLY-----KGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646 (862)
Q Consensus 586 ---~l------~g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 646 (862)
.+ ..++.. ....+++|+++ +++|.+++. ......+++..++.|+.|+++||+|||+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11 111111 23467778776 689999885 222344889999999999999999999887
Q ss_pred cEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhh----------hcCCCCchhHHHHHH
Q 041565 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF----------RRQQLTEKSDVYSFG 716 (862)
Q Consensus 647 ~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVyS~G 716 (862)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++ .+..++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 99999999999999999999999999886432 1334567 999999999 455688899999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041565 717 VVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796 (862)
Q Consensus 717 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~ 796 (862)
|++|||++|+.||......+.. ..++... .. .+..+.+++.+||+.+|.+||++.|+++
T Consensus 305 vil~elltg~~Pf~~~~~~~~~---------------~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGS---------------EWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCS---------------GGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchhhhH---------------HHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999754322211 1111100 11 3467899999999999999999888765
Q ss_pred H
Q 041565 797 N 797 (862)
Q Consensus 797 ~ 797 (862)
+
T Consensus 364 ~ 364 (413)
T 3dzo_A 364 T 364 (413)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=315.62 Aligned_cols=244 Identities=19% Similarity=0.196 Sum_probs=184.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--------ChhhHHHHHHHHHHHHhcc---------ccceeeE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--------SEQGVHEFQTEIEMLSKLR---------HKHLVSL 587 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~---------H~niv~l 587 (862)
.++|...+.||+|+||.||+|+. .+..||||++... .....+.+.+|++++++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688899999999999999997 5689999987543 2233578899999999986 7777777
Q ss_pred EEEEe------------------------------ecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHH
Q 041565 588 IGFCE------------------------------EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGL 637 (862)
Q Consensus 588 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 637 (862)
.+.+. ..+..++|||||++|++.+.+.+ ..+++.+++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77542 26789999999999987776643 3489999999999999999
Q ss_pred HHhh-cCCcccEEeeCCCCCCeeccCCC--------------------ceEEeeccccccCCCCCCccccccccCCCCCC
Q 041565 638 HYLH-TGARYTIIHRDVKTTNILLDEKW--------------------EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYL 696 (862)
Q Consensus 638 ~yLH-~~~~~~ivHrDIkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 696 (862)
+||| +.+ |+||||||+|||++.++ .+||+|||+++.... ....||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence 9999 777 99999999999999887 899999999986432 1346999999
Q ss_pred ChhhhhcCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc-ccCCCCCCCCcHHHHHHHH
Q 041565 697 DPEYFRRQQLTEKSDVYSFGVV-LFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED-IIDPNLKGNITDQCLRKFT 774 (862)
Q Consensus 697 aPE~~~~~~~s~ksDVyS~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~ 774 (862)
|||++.+.. +.++||||+|++ .+++++|..||.. ..|....... .... ..............+.++.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh-hhhhhccCcccchhhhhhcCHHHH
Confidence 999998766 899999998777 7778889888731 1121110000 0000 0011111122345788899
Q ss_pred HHHHHccccCCCCCCCHHHHH-HHH
Q 041565 775 ETAEKCLSDQGIDRPSMGDVL-WNL 798 (862)
Q Consensus 775 ~li~~Cl~~~p~~RPt~~evl-~~L 798 (862)
+++.+||+.+ |+.|++ ++-
T Consensus 314 dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHCG
T ss_pred HHHHHHhccC-----CHHHHHhcCC
Confidence 9999999965 999998 653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-28 Score=283.83 Aligned_cols=184 Identities=20% Similarity=0.125 Sum_probs=127.9
Q ss_pred eEeeeCcEEEEEEE-EcCccEEEEEecCCC----------ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPS----------SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 533 ~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
..+.|+.|.+..++ .--|..+++|.+... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566666655544 223567899976432 123456799999999999 799999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||++|++|.+.|.+... ++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999986543 5543 58999999999999988 999999999999999999999999999875432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 727 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~ 727 (862)
........||++|||||++.+ .+..++|+||+|+++++|.++..
T Consensus 393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 122344679999999999876 46678999999999888766543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-25 Score=216.48 Aligned_cols=157 Identities=18% Similarity=0.224 Sum_probs=121.7
Q ss_pred eeeEEeecCccccCCCCCCCCcccccCCCCceecCCCccccccCCCceeecCCCCCccccchHHHHHhhhcCCCCCcccc
Q 041565 219 QTMYRLNVGGKFIPSTNDSGLTRTWYDDSPYLFGAAFGVASQADNKTKIEYPSNLSQEIAPLSVYETARSMGPDPNVNRN 298 (862)
Q Consensus 219 ~~~~R~n~G~~~v~~~~dd~~~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~ 298 (862)
|++||+||||+.++ | ..+|.|++|..|..... ... .. ..+ .....+.+|..||+|||.++.
T Consensus 5 ~~~~~INcGg~~~~---d-~~gr~w~~D~~~~~~g~--~~~-~~--~~~---~~~~~~~~~~~lY~TaR~~~~------- 65 (174)
T 2jwp_A 5 KVIWAVNAGGESHV---D-VHGIHYRKDPLEGRVGR--ASD-YG--MKL---PILRSNPEDQVLYQTERYNED------- 65 (174)
T ss_dssp HEEEEEEETSSSEE---E-TTTEEECSSCSSTTCCC--CCC-CC--TTS---CCSSSCHHHHHTTTCCCCCCS-------
T ss_pred cEEEEEECCCCCcc---C-CCCCEEcCCcCcccCCc--ccc-cc--cce---EecccCCCCchhhhhhccCCC-------
Confidence 68999999998764 3 48999999987752111 111 11 111 112236789999999998543
Q ss_pred eeeEEEEecCCCceEEEEEeeeeeeeeccCcEEEEEEEcCccccccCchhcccccCCcceEEEEEEEEcCC---------
Q 041565 299 YNLTWIFQIDANFTYIVRFHFCEILLTKINQRVFDIFINNQTAQEGADVIGWAGEQGVPVYKDYAIYAEDL--------- 369 (862)
Q Consensus 299 ~~l~~~~~~~~~~~y~v~lhFae~~~~~~~~R~F~i~ing~~~~~~~di~~~~~~~~~p~y~~~~v~v~~~--------- 369 (862)
+|+|.+|++++.+|.|||||||+.+.+.++|+|||||||+++.++|||.+++|+ +.|+++++.+.++..
T Consensus 66 -~~tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~~ 143 (174)
T 2jwp_A 66 -SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVS 143 (174)
T ss_dssp -CEEEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEEE
T ss_pred -CeEEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeeec
Confidence 599999999877999999999999888999999999999999999999999986 789999998776432
Q ss_pred CCCceeEEEeCCCCCCCchhhhhhccceeeee
Q 041565 370 PGDDELWVALHPSVSMHPEYYDAILNGLEIFK 401 (862)
Q Consensus 370 ~~~~~l~v~l~~~~~~~~s~l~~iln~l~i~~ 401 (862)
...+.|+|++.|. ..-.|++|++|+++
T Consensus 144 ~~~g~L~I~f~p~-----~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 144 TFTGKLSVEFVKG-----YYDNPKVCALFIMK 170 (174)
T ss_dssp ECCSEEEEEEECS-----SSCSSSEEEEEEES
T ss_pred ccCCeEEEEEecc-----CCCCcEEEEEEEEe
Confidence 1456799999872 23479999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=258.43 Aligned_cols=185 Identities=17% Similarity=0.202 Sum_probs=144.5
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC--------hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS--------EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 600 (862)
...++||+|+||.||+|... +..+++|+..... ....+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 33578999999999999544 4578888753321 11245689999999999999999777777777788999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
|||+++++|.+++.. ++.++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999864 5689999999999999887 999999999999999 9999999999875432
Q ss_pred CCcc-----ccccccCCCCCCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 041565 681 NQTH-----VSTMVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPAL 729 (862)
Q Consensus 681 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~elltG~~p~ 729 (862)
.... ......||+.|||||++.. ..|+.++|+|+..+-.++.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1111 1235679999999999987 66888999999999999988877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.3e-22 Score=211.65 Aligned_cols=154 Identities=14% Similarity=0.113 Sum_probs=124.3
Q ss_pred CHHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCCh------------------hhHHHHHHHHHHHHh
Q 041565 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSE------------------QGVHEFQTEIEMLSK 578 (862)
Q Consensus 517 ~~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~ 578 (862)
.+..+......|...+.||+|+||.||+|...++..||+|.+..... .....+.+|+++|++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 44556666777888899999999999999997788999998864321 135678999999999
Q ss_pred ccccceeeEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCe
Q 041565 579 LRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNI 658 (862)
Q Consensus 579 l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 658 (862)
++ | +++.+++.. +..++||||+++|+|.+ +. ......++.|+++||+|||+.+ |+||||||+||
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 99 4 666665543 45699999999999987 42 1345579999999999999877 99999999999
Q ss_pred eccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhh
Q 041565 659 LLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702 (862)
Q Consensus 659 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 702 (862)
|++ ++.+||+|||+++. +..++|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999 99999999999864 23478999874
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.2e-21 Score=187.97 Aligned_cols=154 Identities=14% Similarity=0.173 Sum_probs=115.3
Q ss_pred CcEEEecCCCCCCCCCCCCeeecCCccc-cCCCCcceeeccCCCCCCCCCCccceeeeeecCceEEEEcCCCCeEEEEEE
Q 041565 34 NSYVLACGASSDGTDSNDRKWTSDSKFL-TNSGNSITATAQSQDSSLPSTIPYMTARIFKSTSSYKFTVSSKDRFWLRLH 112 (862)
Q Consensus 34 ~~~~I~CG~~~~~~~~~~~~w~~D~~~~-~g~~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~~~~y~~~~~~~ylvR~~ 112 (862)
..|+||||++... |..||+|.+|..|. .|.................+..+|+|+|+||...+|.+++.++|+|+||||
T Consensus 6 ~~~~INcGg~~~~-d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLh 84 (174)
T 2jwp_A 6 VIWAVNAGGESHV-DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLK 84 (174)
T ss_dssp EEEEEEETSSSEE-ETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEE
T ss_pred EEEEEECCCCCcc-CCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEE
Confidence 3689999987654 45799999998886 343221110000000112234469999999999999999988899999999
Q ss_pred EecCCCCCCCCCCceeEEEeCceEEEecccchhhhhhcccccEEEEEEEcc------------CCCCcEEEEEecCCCCC
Q 041565 113 FYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVP------------AQSGDLIITFTPSSDHK 180 (862)
Q Consensus 113 F~~~~yg~~d~~~~~~~v~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~------------~~~~~~~l~f~~~~~~~ 180 (862)
|++..+.+ .+.+.|+|.+|+..++++|+....+. ...+++++|.+.. ...++|+|.|.|..
T Consensus 85 F~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag--~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~--- 157 (174)
T 2jwp_A 85 FAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVG--HSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGY--- 157 (174)
T ss_dssp EECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHS--SSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSS---
T ss_pred EeccccCC--CCCeEeEEEECCEEeecCcCHHHhhC--CCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccC---
Confidence 99888764 67789999999999999998865443 2467888887642 36789999999853
Q ss_pred CCcceeeeeEEEECC
Q 041565 181 DSYAFVNGIEVIPMP 195 (862)
Q Consensus 181 ~~~pfisaiE~~~l~ 195 (862)
...||||||||++..
T Consensus 158 ~~~a~inaIEI~~~~ 172 (174)
T 2jwp_A 158 YDNPKVCALFIMKGT 172 (174)
T ss_dssp SCSSSEEEEEEESSC
T ss_pred CCCcEEEEEEEEeCc
Confidence 568999999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=5.6e-18 Score=179.05 Aligned_cols=146 Identities=16% Similarity=0.117 Sum_probs=111.7
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEE-cCccE--EEEEecCCCCh------------------------hhHHHHH
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYI-DGKTK--VAIKRSNPSSE------------------------QGVHEFQ 570 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~ 570 (862)
+..+.....-|...+.||+|+||.||+|.. .+|.. ||||.++.... .....+.
T Consensus 39 l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 39 LYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp HHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred HHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 334444444467788999999999999998 67778 99997643211 1123688
Q ss_pred HHHHHHHhccccce--eeEEEEEeecCeEEEEEEeCCC-C----cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhh-c
Q 041565 571 TEIEMLSKLRHKHL--VSLIGFCEEDGEMILVYDYMAN-G----TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH-T 642 (862)
Q Consensus 571 ~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~ 642 (862)
+|+++|.+++|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||+||| +
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998864 444442 255899999942 4 77776532 346678899999999999999 7
Q ss_pred CCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 643 ~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
.+ |+||||||+|||+++ .++|+|||++...
T Consensus 190 ~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 AE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 77 999999999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=168.17 Aligned_cols=144 Identities=15% Similarity=0.118 Sum_probs=103.3
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC--------------hhhHHH--------HHHHHHH
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS--------------EQGVHE--------FQTEIEM 575 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~E~~~ 575 (862)
+..+.....-|+..+.||+|+||.||+|...+|..||||+++... ...... ...|...
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 445555555689999999999999999999889999999764320 000111 2346666
Q ss_pred HHhcccccee--eEEEEEeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCC
Q 041565 576 LSKLRHKHLV--SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDV 653 (862)
Q Consensus 576 l~~l~H~niv--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI 653 (862)
|.++.+.++. ..+++ . ..+|||||+++++|.++. .......++.|++.+|.+||+.+ ||||||
T Consensus 167 L~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 6666554432 22222 1 237999999998886532 22345678999999999999877 999999
Q ss_pred CCCCeeccCCC----------ceEEeecccccc
Q 041565 654 KTTNILLDEKW----------EAKVSDFGLSKT 676 (862)
Q Consensus 654 kp~NILl~~~~----------~~kl~DFGla~~ 676 (862)
||.|||+++++ .+.|+||+-+..
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999998876 388999986643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.6e-11 Score=125.94 Aligned_cols=144 Identities=15% Similarity=0.114 Sum_probs=112.3
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
-..|.....++.|+.+.||+.... +..+++|............+.+|+++++.+. |..+.++++++...+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 345777777888889999999755 5689999876421122346889999999985 67788999999988999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC----------------------------------------
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG---------------------------------------- 643 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 643 (862)
++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 92 i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 92 ADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred cCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99999987631 2234457889999999999981
Q ss_pred ----------------CcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 644 ----------------ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 644 ----------------~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998766667999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=2.1e-10 Score=120.22 Aligned_cols=131 Identities=19% Similarity=0.154 Sum_probs=98.3
Q ss_pred eEe-eeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc--eeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 533 VIG-VGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH--LVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 533 ~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
.++ .|..+.||+....+|..+++|..... ....+..|+++++.+.+.+ +.++++++..++..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 45569999998777778999987643 2245788999999996555 45688888887889999999999888
Q ss_pred HHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC---------------------------------------------
Q 041565 610 REHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA--------------------------------------------- 644 (862)
Q Consensus 610 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 644 (862)
. +.. . ....++.++++.|..||+..
T Consensus 103 ~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 103 L--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp T--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred C--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 4 211 1 12357777888888888642
Q ss_pred ----------cccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 645 ----------RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 645 ----------~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
...++|+|++|.|||++++..++|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876678999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=3.3e-09 Score=117.20 Aligned_cols=142 Identities=18% Similarity=0.305 Sum_probs=107.3
Q ss_pred cceeEeeeCcEEEEEEEEcCccEEEEEecC--CCC-hhhHHHHHHHHHHHHhcc--ccceeeEEEEEeec---CeEEEEE
Q 041565 530 ESHVIGVGGFGKVYEGYIDGKTKVAIKRSN--PSS-EQGVHEFQTEIEMLSKLR--HKHLVSLIGFCEED---GEMILVY 601 (862)
Q Consensus 530 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 601 (862)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.|. +..+.+++++|.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988765 478888765 322 123456888999999997 45678899998776 4589999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA------------------------------------- 644 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 644 (862)
||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999987764311 123778889999999999999999731
Q ss_pred ------------------cccEEeeCCCCCCeeccCCCc--eEEeecccccc
Q 041565 645 ------------------RYTIIHRDVKTTNILLDEKWE--AKVSDFGLSKT 676 (862)
Q Consensus 645 ------------------~~~ivHrDIkp~NILl~~~~~--~kl~DFGla~~ 676 (862)
...++|+|+++.|||+++++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=5.5e-09 Score=112.56 Aligned_cols=183 Identities=17% Similarity=0.184 Sum_probs=123.8
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccc--eeeEEEEEeecC---eEEEEEEeC
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKH--LVSLIGFCEEDG---EMILVYDYM 604 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~ 604 (862)
.+.++.|....||+.. ..+++|+... ......+.+|.++|+.+. +.. +.++++.+...+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4579999999999863 4688888653 244577899999999884 333 445565544333 347899999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG----------------------------------------- 643 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 643 (862)
+|.+|.+.... .++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888754332 267777888888888888888851
Q ss_pred --------------CcccEEeeCCCCCCeeccC--CCceEEeeccccccCCCCCCccccccccCCCCC---CChhhhhc-
Q 041565 644 --------------ARYTIIHRDVKTTNILLDE--KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY---LDPEYFRR- 703 (862)
Q Consensus 644 --------------~~~~ivHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~- 703 (862)
....++|+|+++.||++++ ...+.|+||+.+........ ....... ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHHH
Confidence 1245899999999999998 45678999998875322100 0011111 23332211
Q ss_pred ----CCC---------CchhHHHHHHHHHHHHHhCCCCC
Q 041565 704 ----QQL---------TEKSDVYSFGVVLFEVLCARPAL 729 (862)
Q Consensus 704 ----~~~---------s~ksDVyS~Gvvl~elltG~~p~ 729 (862)
+.. ....+.|+++.+++++.+|+.++
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4.3e-06 Score=89.90 Aligned_cols=136 Identities=19% Similarity=0.199 Sum_probs=96.2
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccc---ceeeEEEEEe-ecCeEEEEEEeCCC
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK---HLVSLIGFCE-EDGEMILVYDYMAN 606 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~ 606 (862)
.+.++.|....||+. +..+++|+.. .......+.+|.++|+.|.+. .+.+++.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888999987 4568888753 234456789999999999753 3566777764 45567899999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG------------------------------------------- 643 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 643 (862)
.+|.+.... .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763221 134455555555555555555542
Q ss_pred --------------CcccEEeeCCCCCCeeccC---CCc-eEEeecccccc
Q 041565 644 --------------ARYTIIHRDVKTTNILLDE---KWE-AKVSDFGLSKT 676 (862)
Q Consensus 644 --------------~~~~ivHrDIkp~NILl~~---~~~-~kl~DFGla~~ 676 (862)
....++|+|+++.|||+++ ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=5.8e-06 Score=86.94 Aligned_cols=136 Identities=20% Similarity=0.156 Sum_probs=97.9
Q ss_pred eeEeeeCcE-EEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 532 HVIGVGGFG-KVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 532 ~~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
+.+..|..| .||+.... ++..+++|+.... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 68987754 4567889975432 3467888999999884 3346788999999999999999999988
Q ss_pred HHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 041565 609 LREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG--------------------------------------------- 643 (862)
Q Consensus 609 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 643 (862)
+.+..... ......++.++++.|+-||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87765321 223345556666666666631
Q ss_pred ----------CcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 644 ----------ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 644 ----------~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 123489999999999999887778999987754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=3.8e-06 Score=92.26 Aligned_cols=80 Identities=8% Similarity=0.029 Sum_probs=56.1
Q ss_pred ceeE-eeeCcEEEEEEEEc-------CccEEEEEecCCCC---hhhHHHHHHHHHHHHhccc---cceeeEEEEEeec--
Q 041565 531 SHVI-GVGGFGKVYEGYID-------GKTKVAIKRSNPSS---EQGVHEFQTEIEMLSKLRH---KHLVSLIGFCEED-- 594 (862)
Q Consensus 531 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~-- 594 (862)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.|.. ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999988765 25678888765422 0012457789999998853 3567888888665
Q ss_pred -CeEEEEEEeCCCCcHH
Q 041565 595 -GEMILVYDYMANGTLR 610 (862)
Q Consensus 595 -~~~~lV~E~~~~gsL~ 610 (862)
+..++|||++++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=6.3e-05 Score=81.66 Aligned_cols=141 Identities=18% Similarity=0.192 Sum_probs=82.1
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccc--ceeeEEE------EEeecCeEEEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK--HLVSLIG------FCEEDGEMILVYD 602 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~E 602 (862)
.+.|+.|..+.||+...+++ .+++|+.... . .+...|+++++.|... .+.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987766 4889987752 2 3344566666666422 2333443 1234667899999
Q ss_pred eCCCCcHH--------------HHHhcC---C--CC-------CCChhhHH-----------------------------
Q 041565 603 YMANGTLR--------------EHLYKG---D--KP-------GLPWKQRL----------------------------- 627 (862)
Q Consensus 603 ~~~~gsL~--------------~~l~~~---~--~~-------~l~~~~~~----------------------------- 627 (862)
|++|..+. ..||.. . .. .-.|...+
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 112211 0 00 01232211
Q ss_pred --HHHHHHHHHHHHhhc----------CCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 628 --EICIGAARGLHYLHT----------GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 628 --~i~~~ia~gL~yLH~----------~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.+...+.+++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223445666763 1245699999999999998888899999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=7.4e-05 Score=83.26 Aligned_cols=75 Identities=15% Similarity=0.157 Sum_probs=49.2
Q ss_pred ceeEeeeCcEEEEEEEEc-CccEEEEEecCCCCh-------hhHHHHHHHHHHHHhccc--c-ceeeEEEEEeecCeEEE
Q 041565 531 SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSE-------QGVHEFQTEIEMLSKLRH--K-HLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~g~~~~~~~~~l 599 (862)
.+.||.|.++.||++... ++..++||....... ....++..|.++|+.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467899999999999754 456899997543211 123456789999888742 3 344566543 344589
Q ss_pred EEEeCCCC
Q 041565 600 VYDYMANG 607 (862)
Q Consensus 600 V~E~~~~g 607 (862)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00027 Score=75.84 Aligned_cols=139 Identities=14% Similarity=0.154 Sum_probs=92.4
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccc---cceeeEEEEEeecCeEEEEEEeCC
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH---KHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
...+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|.. ..+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34567899999999998754 557888876532 35678899999999852 567889999888888999999999
Q ss_pred CCcHH--------H---HHhcCCC-CC-------------------CChhhHH---HHH----------------HHHHH
Q 041565 606 NGTLR--------E---HLYKGDK-PG-------------------LPWKQRL---EIC----------------IGAAR 635 (862)
Q Consensus 606 ~gsL~--------~---~l~~~~~-~~-------------------l~~~~~~---~i~----------------~~ia~ 635 (862)
+..+. + .|+.... .. -+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87541 1 2233211 10 1343321 111 11111
Q ss_pred H-HHHhhc-CCcccEEeeCCCCCCeeccCCCceEEeecc
Q 041565 636 G-LHYLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFG 672 (862)
Q Consensus 636 g-L~yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFG 672 (862)
. ...|.. ...+.+||+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 2357799999999999999887 8888873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00059 Score=72.27 Aligned_cols=78 Identities=13% Similarity=0.092 Sum_probs=58.0
Q ss_pred CcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccc---cceeeEEEEEeecCeEEEEEEe
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH---KHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~ 603 (862)
.....+.+|.|..+.||+.++.+|+.+++|+...........|..|++.|+.|.- --+.+++++.. -++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEEEe
Confidence 4556788999999999999999999999998665443334568899999998842 23455565432 3789999
Q ss_pred CCCCc
Q 041565 604 MANGT 608 (862)
Q Consensus 604 ~~~gs 608 (862)
++.+.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00092 Score=74.98 Aligned_cols=78 Identities=14% Similarity=0.158 Sum_probs=45.6
Q ss_pred cccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccc-cCCCCCCChhhhhcC---CCCchhHHHHHHHHHH
Q 041565 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV-KGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLF 720 (862)
Q Consensus 645 ~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~ 720 (862)
...++|+|+++.|||+++++ ++|+||+.+......-. ..... .-...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45699999999999998876 99999998876321100 00000 001224444443211 1122455667777777
Q ss_pred HHHhC
Q 041565 721 EVLCA 725 (862)
Q Consensus 721 elltG 725 (862)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0023 Score=71.97 Aligned_cols=72 Identities=15% Similarity=0.158 Sum_probs=49.8
Q ss_pred ceeEeeeCcEEEEEEEEcC--------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILVY 601 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 601 (862)
.+.|+.|-...+|+....+ +..+++|+..... ....+..|..+++.|...++ .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578888889999998753 4678899874321 11455679999998865444 567776543 2899
Q ss_pred EeCCCCc
Q 041565 602 DYMANGT 608 (862)
Q Consensus 602 E~~~~gs 608 (862)
||+++.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0056 Score=65.57 Aligned_cols=158 Identities=13% Similarity=0.129 Sum_probs=86.3
Q ss_pred cCHHHHHhhccCccc-----ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccce--eeEE
Q 041565 516 FSLAEIKHGTRNFSE-----SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL--VSLI 588 (862)
Q Consensus 516 ~~~~el~~at~~f~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~ 588 (862)
++.+++...-..|.. .+.|+.|....+|+....++ .+++|...... ...++..|+++++.|...++ .+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 334444444344433 34566788899999987766 68889876521 12345668888887753332 3333
Q ss_pred EE------EeecCeEEEEEEeCCCCcHHH--------------HHhcC----CCC---CC---ChhhHHH----------
Q 041565 589 GF------CEEDGEMILVYDYMANGTLRE--------------HLYKG----DKP---GL---PWKQRLE---------- 628 (862)
Q Consensus 589 g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~---~l---~~~~~~~---------- 628 (862)
.. ....+..+++|+|++|..+.. .++.. ... .. .|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123466789999998754310 12211 000 01 1322110
Q ss_pred --HHHHHHHHHHHhhc----CCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 629 --ICIGAARGLHYLHT----GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 629 --i~~~ia~gL~yLH~----~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+...+.+.++.++. .....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01113344455542 1235699999999999999876668999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0055 Score=66.10 Aligned_cols=141 Identities=14% Similarity=0.137 Sum_probs=74.6
Q ss_pred eeEeeeCcEE-EEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccc--ceeeEEEEEeecCeEEEEEEeCCCCc
Q 041565 532 HVIGVGGFGK-VYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK--HLVSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 532 ~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
+.|+.|.... +|+....++..+++|....... .++..|+.+++.+... .+.+++.++.+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565555544 6676654355677776543321 2345577777777532 3556777655444 68999997766
Q ss_pred HHHHHhcC---------------------CCCCCC---hhhHH-------HH-------------HHHHHHHHHHhh---
Q 041565 609 LREHLYKG---------------------DKPGLP---WKQRL-------EI-------------CIGAARGLHYLH--- 641 (862)
Q Consensus 609 L~~~l~~~---------------------~~~~l~---~~~~~-------~i-------------~~~ia~gL~yLH--- 641 (862)
+.+++... ....++ ..... .+ ...+.+.++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 000111 11000 00 001111222221
Q ss_pred cCCcccEEeeCCCCCCeeccCC----CceEEeeccccccC
Q 041565 642 TGARYTIIHRDVKTTNILLDEK----WEAKVSDFGLSKTG 677 (862)
Q Consensus 642 ~~~~~~ivHrDIkp~NILl~~~----~~~kl~DFGla~~~ 677 (862)
......++|+|+.+.||+++++ ..+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124569999999999999874 67899999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0022 Score=68.24 Aligned_cols=136 Identities=13% Similarity=0.081 Sum_probs=75.9
Q ss_pred ceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEEEEeC-CCCc
Q 041565 531 SHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILVYDYM-ANGT 608 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 608 (862)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .++++++.+ .-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 578888999999998 458888766432211 123468888887754444 356655433 236899999 5544
Q ss_pred HHH------------------HHhcCCCCCCC-----hhhHHHHHH--------------HHHHHH----HHhhc-CCcc
Q 041565 609 LRE------------------HLYKGDKPGLP-----WKQRLEICI--------------GAARGL----HYLHT-GARY 646 (862)
Q Consensus 609 L~~------------------~l~~~~~~~l~-----~~~~~~i~~--------------~ia~gL----~yLH~-~~~~ 646 (862)
|.. .||.... .+. +..+..+.. .+.+.+ +.|.. ....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGA-VFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCC-CCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCC-CCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 421 1111111 011 111111100 011111 11111 2235
Q ss_pred cEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 647 ~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++|+|+.+.||+ .+++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6999999999999 5666789999988765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0084 Score=64.37 Aligned_cols=141 Identities=12% Similarity=0.159 Sum_probs=82.4
Q ss_pred eeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccc--eeeEEEE-----EeecCeEEEEEEeC
Q 041565 532 HVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKH--LVSLIGF-----CEEDGEMILVYDYM 604 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~E~~ 604 (862)
..|+ |....||+....+|..+++|...... ....++..|..+++.|.... +.+++.. ...++..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877777679999876331 12356677888888885332 3444432 12345678899999
Q ss_pred CCCcHH-----H------H---Hhc----CC---CCCCChhhH----------------------HHHHHHHHHHHHHhh
Q 041565 605 ANGTLR-----E------H---LYK----GD---KPGLPWKQR----------------------LEICIGAARGLHYLH 641 (862)
Q Consensus 605 ~~gsL~-----~------~---l~~----~~---~~~l~~~~~----------------------~~i~~~ia~gL~yLH 641 (862)
++..+. . . ++. .. ....++... ...+.+++..++-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 111 00 111222211 011112222222111
Q ss_pred c-CCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 642 T-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 642 ~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1235689999999999999 4 899999988765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0056 Score=69.17 Aligned_cols=74 Identities=15% Similarity=0.140 Sum_probs=47.7
Q ss_pred ceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEEEEeCCCCc
Q 041565 531 SHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILVYDYMANGT 608 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 608 (862)
.+.|+.|-...+|+....+ +..+++|+......... +-.+|..+++.|...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4578888889999998765 46788887643321111 12578999998865555 46777663 2 25999998744
Q ss_pred H
Q 041565 609 L 609 (862)
Q Consensus 609 L 609 (862)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.01 Score=59.15 Aligned_cols=99 Identities=15% Similarity=0.135 Sum_probs=64.8
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVS 686 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (862)
-+|.+.|...+. ++++.+++.++.|.+++|.-+-.+.. + ..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 479999976554 59999999999999999887621111 1 1233456889999999888764 1110
Q ss_pred ccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh
Q 041565 687 TMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 724 (862)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt 724 (862)
.....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356787653 355789999999999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0072 Score=66.46 Aligned_cols=140 Identities=17% Similarity=0.160 Sum_probs=82.9
Q ss_pred eeEeeeCcEEEEEEEEcC--------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEEEE
Q 041565 532 HVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 602 (862)
+.|..|-...+|+....+ +..+++|+.... ........+|.++++.|.-.++ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567677788899988642 367889986432 2234566789999998854333 466766654 28999
Q ss_pred eCCCCcHHH--------------H---HhcCCC---CCC--ChhhHHHHHHHHHH-------------------HHHHh-
Q 041565 603 YMANGTLRE--------------H---LYKGDK---PGL--PWKQRLEICIGAAR-------------------GLHYL- 640 (862)
Q Consensus 603 ~~~~gsL~~--------------~---l~~~~~---~~l--~~~~~~~i~~~ia~-------------------gL~yL- 640 (862)
|+++.+|.. . ||.... ... -|.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998755421 1 122111 111 24445555443321 12222
Q ss_pred ---hc-CCcccEEeeCCCCCCeeccCC----CceEEeecccccc
Q 041565 641 ---HT-GARYTIIHRDVKTTNILLDEK----WEAKVSDFGLSKT 676 (862)
Q Consensus 641 ---H~-~~~~~ivHrDIkp~NILl~~~----~~~kl~DFGla~~ 676 (862)
.. .....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 124569999999999999876 6899999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.004 Score=68.30 Aligned_cols=73 Identities=12% Similarity=0.188 Sum_probs=44.9
Q ss_pred ceeEeeeCcEEEEEEEEcCc---------cEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGK---------TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILV 600 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV 600 (862)
.+.|+.|....+|+....++ ..+++|+....... ..+...|.++++.|...++ .++++.. .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 35677788889999886542 57888876543222 1223678888888864444 3666544 22 689
Q ss_pred EEeCCCCc
Q 041565 601 YDYMANGT 608 (862)
Q Consensus 601 ~E~~~~gs 608 (862)
|||+++..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.021 Score=61.80 Aligned_cols=32 Identities=19% Similarity=0.401 Sum_probs=28.3
Q ss_pred cccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 645 ~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999987765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.37 E-value=0.18 Score=56.08 Aligned_cols=74 Identities=9% Similarity=0.099 Sum_probs=47.9
Q ss_pred ceeEeeeCcEEEEEEEEcC--------ccEEEEEecCCCChhhHHHHHHHHHHHHhccccce-eeEEEEEeecCeEEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL-VSLIGFCEEDGEMILVY 601 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 601 (862)
.+.|..|-...+|+....+ +..+++|+........ -+-.+|..+++.+.-.++ .++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3567777789999988763 4678888865433221 123578888888854344 4555533 22 6899
Q ss_pred EeCCCCcH
Q 041565 602 DYMANGTL 609 (862)
Q Consensus 602 E~~~~gsL 609 (862)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.22 E-value=0.75 Score=50.70 Aligned_cols=30 Identities=37% Similarity=0.462 Sum_probs=25.0
Q ss_pred cEEeeCCCCCCeec------cCCCceEEeecccccc
Q 041565 647 TIIHRDVKTTNILL------DEKWEAKVSDFGLSKT 676 (862)
Q Consensus 647 ~ivHrDIkp~NILl------~~~~~~kl~DFGla~~ 676 (862)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4456799999987754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.03 E-value=0.0083 Score=43.08 Aligned_cols=31 Identities=19% Similarity=0.311 Sum_probs=18.5
Q ss_pred EEEEeeehhhHHHHhheeeEEEEEEccccCC
Q 041565 441 VHVIGGVAGGVFGIAVATAIIFYVSNKKKNN 471 (862)
Q Consensus 441 ~~ii~~vv~~v~~l~v~~~~~~~~~~~~~~~ 471 (862)
..|++++++++++++++++++++++|||+++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3577777877776666555545545444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.41 E-value=0.011 Score=42.57 Aligned_cols=30 Identities=13% Similarity=0.169 Sum_probs=17.6
Q ss_pred EEEEeeehhhHHHHhheeeEEEEEEccccC
Q 041565 441 VHVIGGVAGGVFGIAVATAIIFYVSNKKKN 470 (862)
Q Consensus 441 ~~ii~~vv~~v~~l~v~~~~~~~~~~~~~~ 470 (862)
..|++++++++++++++++++++++|||++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 346777777776666555554444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 862 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 6e-73
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 21/283 (7%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL 579
EI G + IG G FG VY+G G V + + Q + F+ E+ +L K
Sbjct: 4 EIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
RH +++ +G+ ++ +V + +L HL+ + + ++I A+G+ Y
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDY 119
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
LH + IIHRD+K+ NI L E K+ DFGL+ + +H + GS ++ PE
Sbjct: 120 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 700 YFRRQQ---LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756
R Q + +SDVY+FG+VL+E++ + P ++ D + G +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPD 230
Query: 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ + C + +CL + +RP +L ++E
Sbjct: 231 LSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-65
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 23/280 (8%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL 579
E+ +G G FG+V+ GY +G TKVA+K S F E ++ +L
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQL 65
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
+H+ LV L ++ + ++ +YM NG+L + L L + L++ A G+ +
Sbjct: 66 QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
+ IHRD++ NIL+ + K++DFGL++ + N+ K + PE
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE 180
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759
T KSDV+SFG++L E++ + + + ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------------VIQNLER 225
Query: 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ D C + + C ++ DRP+ + LE
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 4e-65
Identities = 65/289 (22%), Positives = 125/289 (43%), Gaps = 27/289 (9%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCE 592
IG G FG+V+ G G+ +VA+K + E+ + EI LRH++++ I
Sbjct: 10 SIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 593 EDG----EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYT- 647
+D ++ LV DY +G+L ++L + + + +++ + A GL +LH T
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 648 ----IIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT--HVSTMVKGSFGYLDPEYF 701
I HRD+K+ NIL+ + ++D GL+ + T G+ Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 702 RRQ------QLTEKSDVYSFGVVLFEVLCARPALNVNL----PKEQVSLADWALHCQRMG 751
+ +++D+Y+ G+V +E+ ++ P + +D ++ R
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 752 TIEDIIDPNLKGNI-TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
E + PN+ + + LR + +C G R + + L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 8e-65
Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 23/291 (7%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEG-YIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSK 578
E++ + + H +G G +G+VYEG + VA+K + + V EF E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKE 69
Query: 579 LRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
++H +LV L+G C + ++ ++M G L ++L + ++ + L + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698
YL + IHRD+ N L+ E KV+DFGLS+ + K + P
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
E + + KSDV++FGV+L+E+ + + Q + ++++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLE 230
Query: 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPD 809
+ + + C K E C DRPS ++ E Q D
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 5e-64
Identities = 69/274 (25%), Positives = 121/274 (44%), Gaps = 21/274 (7%)
Query: 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
++ + +G G FG V G G+ VAIK S EF E +++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
L G C + + ++ +YMANG L +L + +Q LE+C + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118
Query: 646 YTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
+HRD+ N L++++ KVSDFGLS+ + ++ S K + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 706 LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765
+ KSD+++FGV+++E+ +P E+ + ++ + I L+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSE----------TAEHIAQGLRLYR 222
Query: 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
K C ++ +RP+ +L N+
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 3e-63
Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 39/311 (12%)
Query: 516 FSLAEIKHGTRNFSES---------HVIGVGGFGKVYEGY--IDGKTK--VAIKRSNPS- 561
F+ + R F++ VIG G FG+V G+ + GK + VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 562 SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGL 621
+E+ +F +E ++ + H +++ L G + ++++ ++M NG+L L + D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 622 PWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681
Q + + G A G+ YL +HRD+ NIL++ KVSDFGLS+ +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 682 QTHVSTMV---KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
T K + PE + ++ T SDV+S+G+V++EV+ P +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237
Query: 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798
+ D + + I+ + + C + C RP G ++ L
Sbjct: 238 TNQD----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 799 EFALQLQDNPD 809
+ ++ NP+
Sbjct: 288 DKMIR---NPN 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-63
Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 29/281 (10%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL 579
+ + IG G FG V G G KVA+K ++ F E ++++L
Sbjct: 3 ALNM--KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIK--NDATAQAFLAEASVMTQL 57
Query: 580 RHKHLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
RH +LV L+G EE G + +V +YMA G+L ++L + L L+ + +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 639 YLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP 698
YL +HRD+ N+L+ E AKVSDFGL+K + T K + P
Sbjct: 118 YLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAP 169
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
E R ++ + KSDV+SFG++L+E+ +P ++ L D ++
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPR----------VE 214
Query: 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
K + D C E + C RPS + LE
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-63
Identities = 78/273 (28%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVS 586
+ IG G FG V+ GY K KVAIK + +F E E++ KL H LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L G C E + LV+++M +G L ++L + L +C+ G+ YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLE---EA 120
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
+IHRD+ N L+ E KVSDFG+++ + +Q ST K + PE F +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 707 TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766
+ KSDV+SFGV+++EV N +V + + T + P L
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRL----- 226
Query: 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ C ++ DRP+ +L L
Sbjct: 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 4e-63
Identities = 63/283 (22%), Positives = 120/283 (42%), Gaps = 12/283 (4%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLS 577
E+K +F + +G G G V++ +A K + + + E+++L
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGL 637
+ ++V G DGE+ + ++M G+L + L K + +P + ++ I +GL
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
YL ++ I+HRDVK +NIL++ + E K+ DFG+S + ++ G+ Y+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
PE + + +SD++S G+ L E+ R + KE + + T
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800
P + R E P + +++LEF
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 5e-61
Identities = 74/302 (24%), Positives = 119/302 (39%), Gaps = 47/302 (15%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL 579
N IG G FG+V++ G T VA+K +S +FQ E ++++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK----------------------GD 617
+ ++V L+G C M L+++YMA G L E L
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 618 KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677
P L ++L I A G+ YL +HRD+ T N L+ E K++DFGLS+
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737
+ + ++ PE + T +SDV+++GVVL+E+ + E+
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 738 VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797
V I + D N+ + C + C S DRPS +
Sbjct: 251 V--------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 798 LE 799
L+
Sbjct: 296 LQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-61
Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 23/280 (8%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL 579
EI + +G G FG+V+ G +G T+VAIK P + F E +++ KL
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL 69
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
RH+ LV L E+ + +V +YM+ G+L + L L Q +++ A G+ Y
Sbjct: 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
+ R +HRD++ NIL+ E KV+DFGL++ + N+ K + PE
Sbjct: 129 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPE 184
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759
+ T KSDV+SFG++L E+ + + + D ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVER 229
Query: 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+ +C + +C + +RP+ + LE
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 8e-61
Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 26/288 (9%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDG-----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLR 580
+ VIG G FG+VY+G + + VAIK +E+ +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
H +++ L G + M+++ +YM NG + + Q + + G A G+ YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPE 699
+HRD+ NIL++ KVSDFGLS+ + T+ ++ K + PE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 700 YFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759
++ T SDV+SFG+V++EV+ L + + I+
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAIND 228
Query: 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN 807
+ C + +C + RP D++ L+ ++ D+
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-60
Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 26/283 (9%)
Query: 534 IGVGGFGKVYEGYI---DGKTKVAIKRSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLIG 589
+G G FG V +G + VAIK +E+ E E +++ +L + ++V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
C+ ++LV + G L + L + +P E+ + G+ YL +
Sbjct: 77 VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSK-TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTE 708
HRD+ N+LL + AK+SDFGLSK G + + + K + PE ++ +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 709 KSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQ 768
+SDV+S+GV ++E L P +++ + + I+ + +
Sbjct: 192 RSDVWSYGVTMWEALSYG-----QKPYKKMKGPE----------VMAFIEQGKRMECPPE 236
Query: 769 CLRKFTETAEKCLSDQGIDRPSMGDVLWNLE-FALQLQDNPDG 810
C + C + DRP V + L +G
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-60
Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPSSEQG-VHEFQTEIEMLSKLRH 581
+F+E VIG G FG VY G + K A+K N ++ G V +F TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 582 KHLVSLIGFC-EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
+++SL+G C +G ++V YM +G LR + + + K + + A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVSTMVKGSFGYLDP 698
+HRD+ N +LDEK+ KV+DFGL++ + H T K ++
Sbjct: 147 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 699 EYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
E + Q+ T KSDV+SFGV+L+E++ P V+ D ++ + ++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQG---RRLLQ 255
Query: 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
P + C E KC + RPS +++ +
Sbjct: 256 P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-59
Identities = 66/308 (21%), Positives = 116/308 (37%), Gaps = 43/308 (13%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYI------DGKTKVAIKRSNPSSEQG-VHEFQTE 572
E S +G G FGKV E D VA+K PS+ +E
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 573 IEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK---------------- 615
+++LS L H ++V+L+G C G +++ +Y G L L +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 616 GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
D+ L + L A+G+ +L IHRD+ NILL K+ DFGL++
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPK 735
N + V + ++ PE T +SDV+S+G+ L+E+ + +P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ +I + + + + + C + RP+ ++
Sbjct: 254 DSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 796 WNLEFALQ 803
+E +
Sbjct: 300 QLIEKQIS 307
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-59
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 27/276 (9%)
Query: 530 ESHVIGVGGFGKVYEGYIDGK---TKVAIKRSNPSSEQG--VHEFQTEIEMLSKLRHKHL 584
E +G G FG V +GY K VA+K + E E ++ +L + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
V +IG CE + +LV + G L ++L + + K +E+ + G+ YL
Sbjct: 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSK-TGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
+HRD+ N+LL + AK+SDFGLSK + N T K + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763
+ + KSDV+SFGV+++E P + ++ + +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSE----------VTAMLEKGERM 229
Query: 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
C R+ + C + +RP V L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 37/286 (12%)
Query: 514 RHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEF 569
R ++L +F +G G FG VY K +A+K ++ H+
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 570 QTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEI 629
+ E+E+ S LRH +++ L G+ + + L+ +Y GT+ L K K ++
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATY 111
Query: 630 CIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMV 689
A L Y H +IHRD+K N+LL E K++DFG S P+ T +
Sbjct: 112 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTL 164
Query: 690 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749
G+ YL PE + EK D++S GV+ +E L +P N +E + +
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRV 219
Query: 750 MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
T D + + + + L RP + +VL
Sbjct: 220 EFTFPDFVTEGAR------------DLISRLLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-58
Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDG---KTKVAIKRSNP-SSEQGVHEFQTEIEMLSKL-RH 581
+ VIG G FG+V + I + AIKR +S+ +F E+E+L KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYK--------------GDKPGLPWKQRL 627
++++L+G CE G + L +Y +G L + L K L +Q L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 628 EICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVST 687
ARG+ YL + IHRD+ NIL+ E + AK++DFGLS+ + T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 688 MVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC 747
M + ++ E T SDV+S+GV+L+E++ P ++ A+
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELY--- 236
Query: 748 QRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDN 807
+ + + C + + +C ++ +RPS +L +L L+ +
Sbjct: 237 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-58
Identities = 68/324 (20%), Positives = 126/324 (38%), Gaps = 28/324 (8%)
Query: 528 FSESHVIGVGGFGKVYEGYI-----DGKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRH 581
F + V+G G FG VY+G K VAIK + S + E E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
H+ L+G C L+ M G L +++ + K + + L C+ A+G++YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
++HRD+ N+L+ K++DFGL+K + + + K ++ E
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
+ T +SDV+S+GV ++E++ +P + I I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGE 230
Query: 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ-LQDNPDGDKLISIQTDK 820
+ C KC RP +++ + Q +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 821 ANDTYAMHKAMLNIDEESVL-SDE 843
D+ M D + V+ +DE
Sbjct: 291 PTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-58
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 30/278 (10%)
Query: 526 RNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHK 582
R IG G F VY+G + +VA ++ F+ E EML L+H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 583 HLVSLIGFCEE----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLH 638
++V E ++LV + M +GTL+ +L + + K C +GL
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQ 126
Query: 639 YLHTGARYTIIHRDVKTTNILL-DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
+LHT IIHRD+K NI + K+ D GL+ L + + V G+ ++
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMA 181
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
PE + ++ E DVY+FG+ + E+ + + Q + + + + +
Sbjct: 182 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVA 238
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
P +K E E C+ +R S+ D+L
Sbjct: 239 IPEVK------------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-57
Identities = 61/302 (20%), Positives = 116/302 (38%), Gaps = 46/302 (15%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQG-VHEFQTEIEMLSKL 579
N V+G G FGKV G +VA+K ++ +E++M+++L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 580 -RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG------------------ 620
H+++V+L+G C G + L+++Y G L +L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 621 ---LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677
L ++ L A+G+ +L + +HRD+ N+L+ K+ DFGL++
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 678 PNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737
+ + V + ++ PE T KSDV+S+G++L+E+ +P +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 738 VSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797
+I K + + + C + RPS ++
Sbjct: 275 N--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 798 LE 799
L
Sbjct: 321 LG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 4e-57
Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 26/269 (9%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FGKVY+ + A K + SE+ + ++ EI++L+ H ++V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+ + ++ ++ A G + + + ++P L Q +C L+YLH IIHR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 652 DVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF-----RRQQL 706
D+K NIL + K++DFG+S Q G+ ++ PE + +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 707 TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNIT 766
K+DV+S G+ L E+ P + P L + P
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPTLAQP------- 238
Query: 767 DQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ F + +KCL R + +L
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 9e-57
Identities = 70/278 (25%), Positives = 103/278 (37%), Gaps = 33/278 (11%)
Query: 525 TRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQG---VHEFQTEIEMLSKLR 580
+ FS+ IG G FG VY + VAIK+ + S +Q + E+ L KLR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 581 HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYL 640
H + + G + LV +Y K L + + GA +GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYL 131
Query: 641 HTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEY 700
H + +IHRDVK NILL E K+ DFG + + G+ ++ PE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEV 182
Query: 701 FR---RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
Q K DV+S G+ E+ +P L + M + I
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---------------NMNAMSALYHIA 227
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ F + CL DRP+ +L
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 27/278 (9%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKH 583
++ + IG G +G+ + + K + S E +E+ +L +L+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 584 LVSLIGFC--EEDGEMILVYDYMANGTLREHLYKGDKPG--LPWKQRLEICIGAARGLHY 639
+V + + +V +Y G L + KG K L + L + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 640 LH--TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
H + +T++HRD+K N+ LD K K+ DFGL++ + T + G+ Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
PE R EKSD++S G +L+E+ P KE G I +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------------AGKIREGK 230
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ +D+ E + L+ + RPS+ ++L
Sbjct: 231 FRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEIL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-56
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 30/290 (10%)
Query: 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTK----VAIKRSNP---SSEQGVHEFQTEIEML 576
G ++ +G G FG V G D + VA+K P S + + +F E+ +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARG 636
L H++L+ L G M +V + G+L + L K + A G
Sbjct: 66 HSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEG 123
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK-TGPNLNQTHVSTMVKGSFGY 695
+ YL IHRD+ N+LL + K+ DFGL + N + + K F +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755
PE + + + SD + FGV L+E+ + L Q+ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHK 226
Query: 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQ 805
I + + C + +C + + DRP+ + +F L+ Q
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-55
Identities = 62/272 (22%), Positives = 104/272 (38%), Gaps = 22/272 (8%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHL 584
++ +G G +G+V + VA+K + E + EI + L H+++
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
V G E L +Y + G L + + G+P G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
I HRD+K N+LLDE+ K+SDFGL+ N+ + + G+ Y+ PE +R+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 705 QL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763
+ E DV+S G+VL +L + Q D +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------------EYSDWKEKKTYL 226
Query: 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
N + K L + R ++ D+
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIK 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-55
Identities = 60/280 (21%), Positives = 113/280 (40%), Gaps = 23/280 (8%)
Query: 517 SLAEIKHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEM 575
S+ + + ++ IG G G VY + +VAI++ N + EI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
+ + ++ ++V+ + E+ +V +Y+A G+L + + + + Q +C +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
L +LH +IHRD+K+ NILL K++DFG + + + G+ +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYW 182
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755
+ PE R+ K D++S G++ E++ P P + GT E
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPEL 236
Query: 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
L R F +CL R S ++L
Sbjct: 237 QNPEKL-----SAIFRDF---LNRCLDMDVEKRGSAKELL 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-54
Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 28/289 (9%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYI----DGKTKVAIKRSNPSSEQGVHE-FQTEIE 574
EI+ IG G FG V++G + VAIK + V E F E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 575 MLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA 634
+ + H H+V LIG E+ + ++ + G LR L L + +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLS 118
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L YL +HRD+ N+L+ K+ DFGLS+ + + + ++ K
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIK 174
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754
++ PE ++ T SDV+ FGV ++E+L + V +G IE
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----------IGRIE 223
Query: 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803
+ + N KC + RP ++ L L+
Sbjct: 224 NGERLPMPPNCPPTLY----SLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 4e-53
Identities = 70/309 (22%), Positives = 134/309 (43%), Gaps = 44/309 (14%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEG--------YIDGKTKVAIKRSNP-SSEQGVHEFQ 570
E+ +G G FG+V + TKVA+K ++E+ + +
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 571 TEIEMLSKL-RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG--------- 620
+E+EM+ + +HK++++L+G C +DG + ++ +Y + G LRE+L PG
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 621 -----LPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675
L K + ARG+ YL IHRD+ N+L+ E K++DFGL++
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPK 735
+++ +T + ++ PE + T +SDV+SFGV+L+E+ + +P
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 736 EQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
E+ + ++ + + C + C RP+ ++
Sbjct: 244 EE---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 796 WNLEFALQL 804
+L+ + L
Sbjct: 289 EDLDRIVAL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (474), Expect = 4e-53
Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 25/281 (8%)
Query: 520 EIKHGTR--NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEML 576
EIKH ++ +G G FG V+ A K E + EI+ +
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 577 SKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARG 636
S LRH LV+L E+D EM+++Y++M+ G L E + + + +E +G
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKG 136
Query: 637 LHYLHTGARYTIIHRDVKTTNILLDEKW--EAKVSDFGLSKTGPNLNQTHVSTMVKGSFG 694
L ++H +H D+K NI+ K E K+ DFGL+ +L+ + G+
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAE 190
Query: 695 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754
+ PE + + +D++S GV+ + +L E + + + + +
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---------RNVKSCD 241
Query: 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+D + I++ + K L R ++ L
Sbjct: 242 WNMDDSAFSGISEDGK----DFIRKLLLADPNTRMTIHQAL 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-53
Identities = 56/284 (19%), Positives = 106/284 (37%), Gaps = 19/284 (6%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLS 577
K +F ++G G F V + + AIK + + E V E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 578 KLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGL 637
+L H V L ++D ++ Y NG L +++ K L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121
Query: 638 HYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
YLH IIHRD+K NILL+E +++DFG +K ++ + G+ Y+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
PE + + SD+++ G ++++++ P + + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKF 233
Query: 758 DPNLKGNITDQCLRKFTE---TAEKCLSDQGIDR-PSMGDVLWN 797
P + ++ ++ L E+ + P V W
Sbjct: 234 FPKAR-DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 35/299 (11%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTE 572
E+ + S +G G FG VYEG G +T+VAIK N + S + EF E
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 573 IEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPG--------LPWK 624
++ + H+V L+G + +++ + M G L+ +L
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 625 QRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684
+ +++ A G+ YL+ +HRD+ N ++ E + K+ DFG+++ +
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWA 744
++ PE + T SDV+SFGVVL+E+ L EQV
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------ 244
Query: 745 LHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803
+ +++ L + D C E C RPS +++ +++ ++
Sbjct: 245 --------LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 4e-50
Identities = 55/282 (19%), Positives = 116/282 (41%), Gaps = 25/282 (8%)
Query: 519 AEIKHGTR--NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEM 575
E+K G+ + +G G FG V+ K N + + EI +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI 79
Query: 576 LSKLRHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
+++L H L++L E+ EM+L+ ++++ G L + + D + + + A
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACE 138
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEK--WEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
GL ++H ++I+H D+K NI+ + K K+ DFGL+ LN + + +
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATA 192
Query: 694 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753
+ PE R+ + +D+++ GV+ + +L E + Q +
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---------QNVKRC 243
Query: 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ D + +++ + + + L + R ++ D L
Sbjct: 244 DWEFDEDAFSSVSPEAK----DFIKNLLQKEPRKRLTVHDAL 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 65/307 (21%), Positives = 114/307 (37%), Gaps = 42/307 (13%)
Query: 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSSEQGVH-EFQTE 572
E +G G FG+V E G VA+K + H +E
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 573 IEMLSK-LRHKHLVSLIGFCEEDGEMI-LVYDYMANGTLREHLYKGD------------- 617
+++L H ++V+L+G C + G + ++ ++ G L +L
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 618 -KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676
K L + + A+G+ +L IHRD+ NILL EK K+ DFGL++
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKE 736
+ ++ PE + T +SDV+SFGV+L+E+ P
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYP 238
Query: 737 QVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLW 796
V + + + + D + +T C + RP+ +++
Sbjct: 239 GVKIDEEFCR---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 797 NLEFALQ 803
+L LQ
Sbjct: 290 HLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-47
Identities = 42/266 (15%), Positives = 103/266 (38%), Gaps = 24/266 (9%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
+G G FG V+ K K + EI +L+ RH++++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
E E+++++++++ + E + L ++ + L +LH + I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 652 DVKTTNILLDEKWEA--KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEK 709
D++ NI+ + + K+ +FG ++ L ++ + Y PE + ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 710 SDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQC 769
+D++S G +++ +L ++ + + + E D I+ +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQII---------ENIMNAEYTFDEEAFKEISIEA 234
Query: 770 LRKFTETAEKCLSDQGIDRPSMGDVL 795
+ + ++ L + R + + L
Sbjct: 235 M----DFVDRLLVKERKSRMTASEAL 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 1e-46
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 28/277 (10%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLI 588
++G GG +V+ + VA+K F+ E + + L H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 589 GFCEEDGE----MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E + +V +Y+ TLR+ ++ + K+ +E+ A + L++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH--- 128
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRR 703
+ IIHRDVK NI++ KV DFG+++ + N + V G+ YL PE R
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763
+ +SDVYS G VL+EVL P + P H + L
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPIPPSARHEGL-- 241
Query: 764 NITDQCLRKFTETAEKCLSDQGIDRP-SMGDVLWNLE 799
L K L+ +R + ++ +L
Sbjct: 242 ---SADLDAV---VLKALAKNPENRYQTAAEMRADLV 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 3e-46
Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 26/304 (8%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHE-FQTEIEMLSKLRHKHLVSLIGF 590
V+G G F +V + VAIK + +G + EI +L K++H ++V+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
E G + L+ ++ G L + + + K + + + YLH I+H
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLH---DLGIVH 130
Query: 651 RDVKTTNILL---DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLT 707
RD+K N+L DE + +SDFGLSK + V + G+ GY+ PE ++ +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 708 EKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITD 767
+ D +S GV+ + +LC P + +++ E D +I+D
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLF---------EQILKAEYEFDSPYWDDISD 238
Query: 768 QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLISIQTDKANDTYAM 827
+ + R + L + A + + + +S Q K
Sbjct: 239 SAK----DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKW 294
Query: 828 HKAM 831
+A
Sbjct: 295 KQAF 298
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 5e-45
Identities = 61/288 (21%), Positives = 110/288 (38%), Gaps = 42/288 (14%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSS---------EQGVHEFQTEIEML 576
N+ ++G G V + A+K + + ++ E+++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 577 SKLR-HKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAAR 635
K+ H +++ L E + LV+D M G L ++L + K L K+ +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLE 121
Query: 636 GLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
+ LH + I+HRD+K NILLD+ K++DFG S L+ V G+ Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSY 175
Query: 696 LDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQR 749
L PE ++ D++S GV+++ +L P H ++
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---------------HRKQ 220
Query: 750 MGTIEDII--DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
M + I+ + D + + L Q R + + L
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-45
Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 38/307 (12%)
Query: 511 GLCRHFSLAEIKHGTRNFSESHVIGVGGFGKVYEGY--IDGKTKVAIK--RSNPSSEQGV 566
GLCR + + IG G +GKV++ +G VA+K R E
Sbjct: 1 GLCRA---------DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP 51
Query: 567 HEFQTEIEMLSKL---RHKHLVSLIGFC-----EEDGEMILVYDYMANGTLREHLYKGDK 618
E+ +L L H ++V L C + + ++ LV++++ +L K +
Sbjct: 52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPE 110
Query: 619 PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678
PG+P + ++ RGL +LH + ++HRD+K NIL+ + K++DFGL++
Sbjct: 111 PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI-- 165
Query: 679 NLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV 738
+ T V + Y PE + D++S G + E+ +P + +Q+
Sbjct: 166 -YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
Query: 739 SL----------ADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDR 788
DW + KCL+ R
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284
Query: 789 PSMGDVL 795
S L
Sbjct: 285 ISAYSAL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (409), Expect = 1e-44
Identities = 67/342 (19%), Positives = 125/342 (36%), Gaps = 44/342 (12%)
Query: 526 RNFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRH 581
++F +G G FG+V+ A+K + V E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
++ + G ++ ++ ++ DY+ G L L K + P L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLH 121
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
II+RD+K NILLD+ K++DFG +K P++ T G+ Y+ PE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
+ + D +SFG++++E+L + + + + ++
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFPPFFNEDV 228
Query: 762 KGNITDQCLRK--------FTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKL 813
K ++ + + + E + P +V+W + ++ P +
Sbjct: 229 K-DLLSRLITRDLSQRLGNLQNGTEDVKNH-----PWFKEVVWEKLLSRNIE-TPYEPPI 281
Query: 814 ISIQTDKAN-DTYAMHKAMLNIDEESVLSDEIDTSNTTDIFS 854
Q D + D Y EE + D+F
Sbjct: 282 QQGQGDTSQFDKY---------PEEDINYGVQGEDPYADLFR 314
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 2e-44
Identities = 67/333 (20%), Positives = 122/333 (36%), Gaps = 31/333 (9%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTE---IEMLSKL 579
+FS +IG GGFG+VY D A+K + +QG E + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 580 RHKHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHY 639
+V + ++ + D M G L HL + GL +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEH 122
Query: 640 LHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPE 699
+H +++RD+K NILLDE ++SD GL+ G+ GY+ PE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPE 175
Query: 700 YFRRQQ-LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
++ +D +S G +LF++L + K++ + L + D
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFS 233
Query: 759 PNLKGNITDQCLRKFTE---TAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLIS 815
P L+ ++ + L++ + + + P + W + F + P
Sbjct: 234 PELR-SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP-PPLIPPRGE 291
Query: 816 IQTDKANDTYAMHKAMLNIDEESVLSDEIDTSN 848
+ A D + DEE ++ S+
Sbjct: 292 VNAADAFDIG-------SFDEEDTKGIKLLDSD 317
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-44
Identities = 55/251 (21%), Positives = 96/251 (38%), Gaps = 18/251 (7%)
Query: 527 NFSESHVIGVGGFGKVYEG-YIDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSK-LRH 581
+F ++G G FGKV+ + AIK + + V E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 582 KHLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
L + + + V +Y+ G L H+ K + GL +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH 120
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I++RD+K NILLD+ K++DFG+ K + G+ Y+ PE
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEIL 175
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
Q+ D +SFGV+L+E+L + + +E + ++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEA 230
Query: 762 KGNITDQCLRK 772
K ++ + +
Sbjct: 231 K-DLLVKLFVR 240
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 53/286 (18%), Positives = 106/286 (37%), Gaps = 24/286 (8%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKH 583
NF + IG G +G VY+ VA+K R + +E EI +L +L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
+V L+ + ++ LV++++ + L++ + G+P +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
+ ++HRD+K N+L++ + K++DFGL++ + + V +
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV----------SLADWALHCQRMGTI 753
+ + D++S G + E++ R + +Q+ W
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 754 EDIIDPNLKGNITDQCLRKFTETA----EKCLSDQGIDRPSMGDVL 795
P + + E + L R S L
Sbjct: 238 PSF--PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-43
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 28/285 (9%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQG-VHEFQTEIEMLSKLRHKHLVSLIGF 590
IG G +G V Y K +VAIK+ +P Q EI++L + RH++++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 591 CE----EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
E + + + ++ L + L L RGL Y+H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SA 128
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKT-GPNLNQTHVSTMVKGSFGYLDPEYFRRQQ 705
++HRD+K +N+LL+ + K+ DFGL++ P+ + T T + Y PE +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 706 L-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQV----------SLADWALHCQRMGTIE 754
T+ D++S G +L E+L RP +Q+ S D
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 755 DIIDPNLKGNITDQCLRKFTETA----EKCLSDQGIDRPSMGDVL 795
+ P+ ++ A +K L+ R + L
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-43
Identities = 60/333 (18%), Positives = 127/333 (38%), Gaps = 35/333 (10%)
Query: 531 SHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLI 588
S V+G+G GKV + + + K A+K + + E+E+ + + H+V ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 589 GFCE----EDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
E +++V + + G L + ++ EI + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 645 RYTIIHRDVKTTNILLDEKWE---AKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I HRDVK N+L K K++DFG +K + N + Y+ PE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
++ + D++S GV+++ +LC P P + + + PN
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL---WNLEFALQLQDNPDGDKLISIQT 818
+ + + ++ L + R ++ + + W ++ Q +++
Sbjct: 240 EWSEVSEEVKML---IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296
Query: 819 DKANDTYAMHKAML---NIDEESVLSDEIDTSN 848
++ D + L +D E + +I+ ++
Sbjct: 297 ERWEDVKEEMTSALATMRVDYEQIKIKKIEDAS 329
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-43
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 35/286 (12%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSS-----EQGVHEFQTEIEMLSKLRHKHLVS 586
+G G F VY+ + VAIK+ + EI++L +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 587 LIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARY 646
L+ + LV+D+M L + +GL YLH ++
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 647 TIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL 706
I+HRD+K N+LLDE K++DFGL+K+ + N+ + T + Y PE ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177
Query: 707 -TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765
D+++ G +L E+L P L + +Q++ + +GT + P++
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-----RIFETLGTPTEEQWPDMCSLP 232
Query: 766 TDQCLRKFT----ETAEKCLSDQGID------------RPSMGDVL 795
+ F D +D R + L
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (391), Expect = 1e-42
Identities = 51/283 (18%), Positives = 102/283 (36%), Gaps = 20/283 (7%)
Query: 527 NFSESHVIGVGGFGKVYEGYIDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHL 584
+ IG G +G VY+ + A+K R E EI +L +L+H ++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 585 VSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
V L ++LV++++ + + GL + G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
++HRD+K N+L++ + E K++DFGL++ + + + + +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 705 QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764
+ + D++S G + E++ P +Q+ L ++ +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 765 ITDQCLRKFTETAEKCLSDQGID------------RPSMGDVL 795
E+ K L + GID R + L
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-42
Identities = 66/290 (22%), Positives = 104/290 (35%), Gaps = 30/290 (10%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV 585
+++++ VIG G FG VY+ D VAIK+ E++++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 586 SLIGFCEEDGE------MILVYDYMANGTLREHL-YKGDKPGLPWKQRLEICIGAARGLH 638
L F GE + LV DY+ R Y K LP R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 639 YLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLD 697
Y+H + I HRD+K N+LLD K+ DFG +K + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAP 191
Query: 698 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757
F T DV+S G VL E+L +P + +Q+ L I ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 758 DPNLKGNITDQCLRKFTETAEKCLSDQGID------------RPSMGDVL 795
+ +T+ + I R + +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 7e-42
Identities = 48/276 (17%), Positives = 88/276 (31%), Gaps = 24/276 (8%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFC 591
IG G FG +Y G I +VAIK ++ + E ++ ++ + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 592 EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHR 651
+G+ ++ + +L + + K L + + Y+H IHR
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIH---SKNFIHR 127
Query: 652 DVKTTNIL---LDEKWEAKVSDFGLSK-----TGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
DVK N L + + DFGL+K + + G+ Y
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763
+ + + D+ S G VL + + + IE +
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC------ 241
Query: 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799
+F C S + D+P +
Sbjct: 242 ---KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (379), Expect = 5e-41
Identities = 46/291 (15%), Positives = 84/291 (28%), Gaps = 29/291 (9%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHLVSLIGF 590
IG G FG ++EG + +VAIK + + E L + ++ F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIH 650
+E +LV D + G E L K + +H ++++
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 651 RDVKTTNILLDEKWE-----AKVSDFGLSK-----TGPNLNQTHVSTMVKGSFGYLDPEY 700
RD+K N L+ V DFG+ K + G+ Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 701 FRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760
++ + + D+ + G V L Q+ I +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---------KQKYERIGEKKQST 235
Query: 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ-LQDNPDG 810
+ +F + + P + L+ L D
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 56/274 (20%), Positives = 107/274 (39%), Gaps = 32/274 (11%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSS------EQGVHEFQTEIEMLSKLRHKHLV 585
+G G F V + + A K + + E+ +L +++H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 586 SLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGAR 645
+L E ++IL+ + +A G L + L + K L ++ E G++YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---S 131
Query: 646 YTIIHRDVKTTNILLDE----KWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYF 701
I H D+K NI+L + K K+ DFGL+ ++ + + G+ ++ PE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIV 188
Query: 702 RRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
+ L ++D++S GV+ + +L + +E A ED N
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFEDEYFSNT 243
Query: 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ F + L R ++ D L
Sbjct: 244 -----SALAKDF---IRRLLVKDPKKRMTIQDSL 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-39
Identities = 60/276 (21%), Positives = 102/276 (36%), Gaps = 28/276 (10%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHK 582
+F ++G G FGKV A+K + ++ V TE +L RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
L +L + + V +Y G L HL + + ++ L YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH- 122
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
+++RD+K N++LD+ K++DFGL K G + T G+ YL PE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762
D + GVV++E++C R + + L + P K
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAK 233
Query: 763 GNITDQCLRK--------FTETAEKCLSD---QGID 787
++ L+K A++ + I+
Sbjct: 234 -SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 52/274 (18%), Positives = 99/274 (36%), Gaps = 42/274 (15%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKR------SNPSSEQGVHEFQTEIEMLSKLRHKH-- 583
++G GGFG VY G + VAIK S+ E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 584 LVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
++ L+ + E +L+ + ++ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 644 ARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
++HRD+K NIL+D + E K+ DFG L + V T G+ Y PE+ R
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 703 RQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761
+ + V+S G++L++++C + + + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-----------FFRQRVSSEC 231
Query: 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVL 795
+ ++ CL DRP+ ++
Sbjct: 232 Q-HLIRWCLALRPS-----------DRPTFEEIQ 253
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 4e-38
Identities = 54/279 (19%), Positives = 98/279 (35%), Gaps = 22/279 (7%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIK--RSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G +G V++ + VA+K R + E EI +L +L+HK++V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 590 FCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTII 649
D ++ LV+++ + + +GL + H ++
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCH---SRNVL 123
Query: 650 HRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEK 709
HRD+K N+L++ E K+++FGL++ + S V + F + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 710 SDVYSFGVVLFEVLCA-RPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQ 768
D++S G + E+ A RP N +Q+ L +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 769 CLRKFTETAEKCLSDQGID------------RPSMGDVL 795
L+ G D R S + L
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 34/292 (11%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G FG+V++ KVA+K+ + E EI++L L+H+++V+LI
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 590 FCEE--------DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLH 641
C G + LV+D+ + K + + GL+Y+H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIH 134
Query: 642 TGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK--TGPNLNQTHVSTMVKGSFGYLDPE 699
R I+HRD+K N+L+ K++DFGL++ + +Q + T + Y PE
Sbjct: 135 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 700 YFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758
++ D++ G ++ E+ P + N + Q++L ++ +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 759 PNLKGNIT---DQCLRKFTETAEKCLSDQGID------------RPSMGDVL 795
L + Q + +D R D L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 8e-38
Identities = 57/325 (17%), Positives = 113/325 (34%), Gaps = 36/325 (11%)
Query: 527 NFSESHVIGVGGFGKVYEGY-IDGKTKVAIK---RSNPSSEQGVHEFQTEIEMLSKLRHK 582
F +G G FG+V + A+K + + + E +L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
LV L +++ + +V +Y+A G + HL + YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH- 158
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFR 702
+I+RD+K N+L+D++ +V+DFG +K T + G+ L PE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIIL 211
Query: 703 RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762
+ + D ++ GV+++E+ P + P + + +LK
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLK 266
Query: 763 GNITDQCLRK--------FTETAEKCLSDQGIDRPSMGDVLWNLEFALQLQDNPDGDKLI 814
++ L+ + W + +++ P K
Sbjct: 267 -DLLRNLLQVDLTKRFGNLKNGVNDIKNH-----KWFATTDWIAIYQRKVE-APFIPKFK 319
Query: 815 SIQTDKAN-DTYAMHKAMLNIDEES 838
D +N D Y + ++I+E+
Sbjct: 320 GP-GDTSNFDDYEEEEIRVSINEKC 343
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 7e-37
Identities = 61/312 (19%), Positives = 110/312 (35%), Gaps = 48/312 (15%)
Query: 516 FSLAEIKHGTRNFSES----HVIGVGGFGKVYEGY-IDGKTKVAIK--RSNPSSEQGVHE 568
F E+ +G G +G V KVAIK SE
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 569 FQTEIEMLSKLRHKHLVSLIGFCEEDG------EMILVYDYMANGTLREHLYKGDKPGLP 622
E+ +L +RH++++ L+ D + LV +M GT L K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLG 119
Query: 623 WKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682
+ + +GL Y+H IIHRD+K N+ ++E E K+ DFGL++ +
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--- 173
Query: 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD 742
++ V + + T+ D++S G ++ E++ + + +Q
Sbjct: 174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ----- 227
Query: 743 WALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCL-------SDQGID-------- 787
+ GT L+ + ++ E +K S ++
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287
Query: 788 ----RPSMGDVL 795
R + G+ L
Sbjct: 288 DAEQRVTAGEAL 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 64/288 (22%), Positives = 114/288 (39%), Gaps = 30/288 (10%)
Query: 522 KHGTRNFSESHVIGVGGFGKVYEGY----IDGKTKVAIKRSNPSS----EQGVHEFQTEI 573
K G NF V+G G +GKV+ D A+K ++ + +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 574 EMLSKLRHK-HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIG 632
++L +R LV+L + + ++ L+ DY+ G L HL + ++ + I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIY 134
Query: 633 AARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGS 692
+ L + II+RD+K NILLD ++DFGLSK ++T + G+
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGT 193
Query: 693 FGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRM 750
Y+ P+ R + D +S GV+++E+L V+ K + +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKSE 252
Query: 751 GTIEDIIDPNLKGNITDQCLRK--------FTETAEKCLSD---QGID 787
+ K ++ + L K A++ Q I+
Sbjct: 253 PPYPQEMSALAK-DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 4e-32
Identities = 50/304 (16%), Positives = 113/304 (37%), Gaps = 42/304 (13%)
Query: 520 EIKHGTRN-FSESHVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLS 577
++ G ++ + +G G + +V+E I KV +K P ++ + + EI++L
Sbjct: 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILE 84
Query: 578 KLR-HKHLVSLIGFCEEDGE--MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAA 634
LR ++++L ++ LV++++ N ++ L
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEIL 139
Query: 635 RGLHYLHTGARYTIIHRDVKTTNILLDEK-WEAKVSDFGLSKTGPNLNQTHVSTMVKGSF 693
+ L Y H I+HRDVK N+++D + + ++ D+GL++ + + S
Sbjct: 140 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASR 193
Query: 694 GYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPAL-----NVNLPKEQVSLADWALHC 747
+ PE Q+ D++S G +L ++ + N + +
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 748 QRMGTIEDIIDPN----LKGNITDQCLRKFTETAEKCLSDQGID------------RPSM 791
+ +DP L + + R + +S + +D R +
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 792 GDVL 795
+ +
Sbjct: 314 REAM 317
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-32
Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 20/214 (9%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
IG G G V Y VAIK+ + ++ E+ ++ + HK+++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 590 FC------EEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG 643
EE ++ LV + M + + D ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHLH-- 136
Query: 644 ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRR 703
IIHRD+K +NI++ K+ DFGL++T + + T + Y PE
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 192
Query: 704 QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQ 737
E D++S G ++ E++ + +Q
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 50/286 (17%), Positives = 107/286 (37%), Gaps = 29/286 (10%)
Query: 533 VIGVGGFGKVYEGY-IDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIG 589
+G G +G V + +VA+K+ + S E+ +L ++H++++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 590 FCEE-----DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA 644
+ + + ++ L + L + RGL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--- 138
Query: 645 RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQ 704
IIHRD+K +N+ ++E E K+ DFGL++ ++ V +
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 705 QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764
+ D++S G ++ E+L R +Q+ L + +GT + +
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-----KLILRLVGTPGAELLKKISSE 249
Query: 765 ITDQCLRKFTETAEKCLSDQGIDRPSMG-DVLWNLEFALQLQDNPD 809
++ T+ + ++ I + D+L + L + D
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM-----LVLDSD 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 2e-27
Identities = 45/248 (18%), Positives = 88/248 (35%), Gaps = 20/248 (8%)
Query: 532 HVIGVGGFGKVYEGY-IDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH--------- 581
+G G F V+ + T VA+K + + EI++L ++
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 582 --KHLVSLIGFCEE---DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARG 636
H++ L+ +G +++ + L + K + G+P +I G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 637 LHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGY 695
L Y+H R IIH D+K N+L++ + ++ G T + Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 696 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD-WALHCQRMGTIE 754
PE +D++S ++FE++ + D A + +G +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 755 DIIDPNLK 762
+ N K
Sbjct: 256 SYLLRNGK 263
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 8e-21
Identities = 31/198 (15%), Positives = 58/198 (29%), Gaps = 36/198 (18%)
Query: 533 VIGVGGFGKVYEGYIDGKTKVAIKRSNPSS----------EQGVHEFQTEIEMLSKLRHK 582
++G G V+ Y + + +K + G F ++ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 583 HLVSLIGFCEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT 642
L L G + VY + N L E + + + + E+ + +
Sbjct: 67 ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 643 GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDP---- 698
I+H D+ N+L+ E + DF S L+
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEG----------WREILERDVRN 167
Query: 699 --EYFRRQQLTEKSDVYS 714
YF R + D+ S
Sbjct: 168 IITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 862 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.96 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 94.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=425.71 Aligned_cols=262 Identities=27% Similarity=0.503 Sum_probs=206.9
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
..++|...++||+|+||+||+|+.++ .||||+++.. +....++|.+|+++|++++|||||+++|++.+ +.+++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 34678889999999999999998654 5999987643 45567889999999999999999999999865 4689999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.++|..... .+++.+++.|+.|||+||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 83 Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999976543 4999999999999999999999877 9999999999999999999999999998765433
Q ss_pred CccccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.........||+.|||||++.+ ..++.++|||||||+||||+||+.||.......... ........ .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~--------~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYL--------S 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSC--------C
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCC--------C
Confidence 3334455679999999999965 358999999999999999999999997543322211 11111111 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
|.+ ...+..+++.+.+++.+||+.+|.+|||+.||+++|+.+.+
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 11223356789999999999999999999999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=419.70 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=202.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|...+.||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688889999999999999999888889999987543 345789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++.... ..++|..++.|+.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999987654 34899999999999999999999877 99999999999999999999999999987543222 22
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....||..|+|||++.+..++.++|||||||++|||+|+ ++|+......+ +...... + .+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~----~---------~~~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST----G---------FRLY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHH----T---------CCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHh----c---------CCCC
Confidence 3345689999999999999999999999999999999995 55554322211 1111111 1 0111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.+..++.++.+++.+||+.+|.+||||+||+++|+.+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 122345678999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-49 Score=427.51 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=201.0
Q ss_pred CcccceeEeeeCcEEEEEEEEcC-c---cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYIDG-K---TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+|+..++||+|+||+||+|.++. + ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34556899999999999999753 2 35899987653 4556678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.+++..... .++|.++++|+.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 107 Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp ECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999998876543 4999999999999999999999877 9999999999999999999999999998754322
Q ss_pred Ccc---ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 682 QTH---VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 682 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
... ......||+.|||||.+.++.++.++|||||||+||||+| |++||......+. ..... .
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~i~---~-------- 248 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INAIE---Q-------- 248 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH---T--------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHHHH---c--------
Confidence 211 1223457889999999999999999999999999999998 8999965433221 11111 1
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
..+...+.+++..+.+++.+||+.+|.+||||.||++.|+.+++-
T Consensus 249 --~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 --DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111112334667899999999999999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=420.76 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=209.4
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
..++|+..+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 346788899999999999999999988899999987543 345789999999999999999999998865 467899999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|++|+|.+++.......++|.++++|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+++..... ..
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY 164 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-cc
Confidence 99999999887654445999999999999999999999877 999999999999999999999999999876432 22
Q ss_pred cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+........ +..... . + .+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~i~---~-~---------~~~ 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLE---R-G---------YRM 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH---T-T---------CCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---h-c---------CCC
Confidence 233455789999999999999999999999999999999996555433222111 111111 1 0 111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..+..++.++.+++.+||+.+|++||||.||++.|+..
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 12233556789999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-49 Score=424.24 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=215.4
Q ss_pred hhccCcccceeEeeeCcEEEEEEEEcC-ccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 523 HGTRNFSESHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 523 ~at~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
...++|...+.||+|+||+||+|+++. +..||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 344678889999999999999999864 7789999987543 34678999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.+++.......+++..++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 168 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence 9999999999998776667999999999999999999999877 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.........|++.|+|||++.++.++.++|||||||++|||++|..|+........ +.... ....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i-------------~~~~ 233 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL-------------EKDY 233 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH-------------HTTC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH-------------hcCC
Confidence 22233445688999999999999999999999999999999997766543322111 11111 1111
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
....+..++.++.+++.+||+.+|.+|||+.||++.|+.+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22223345678999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=415.21 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=206.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|+||+||+|+.+ ++..||||++.... .+..+++.+|+++|++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888999999999999999975 57899999875432 33456789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
|++|+|.++|.... .+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999986543 4999999999999999999999887 999999999999999999999999999875443333
Q ss_pred cccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 684 HVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......||+.|||||++.+..+ +.++|||||||++|||++|+.||......... +..+. ... ..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~----~~~---------~~ 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK----EKK---------TY 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHH----TTC---------TT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHh----cCC---------CC
Confidence 44455689999999999998876 57899999999999999999999754332211 11111 000 00
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......+.++.+++.+||+.+|.+|||+.|++++-+.
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 11112245678899999999999999999999876554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=414.71 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=204.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCc-----cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGK-----TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
..|+..++||+|+||.||+|.+++. ..||||++... ......+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4578889999999999999997643 36999988654 34456689999999999999999999999999999999
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|||||.+|+|.+++..... .++|.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999998876543 4999999999999999999999877 99999999999999999999999999987543
Q ss_pred CCC-ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQ-THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
... ........||+.|+|||++.++.++.++|||||||++|||++|..|+........ +.... .
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i-------------~ 227 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAI-------------N 227 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH-------------H
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHH-------------h
Confidence 222 2223345689999999999999999999999999999999997666543322211 11111 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
...+...+..++..+.+++.+||+.+|.+||||.||++.|+.+++.
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112223334567899999999999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=404.65 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=211.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|+..++||+|+||+||+|+++++..||||.++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788899999999999999999888899999887543 345789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|.+++..... .+++..+++++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 9999999876543 4899999999999999999999877 99999999999999999999999999986543322 23
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....||..|+|||.+.+..++.++|||||||++|||+| |+.||......+.. .... .+ .+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~i~-~~---------~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIA-QG---------LRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHH-TT---------CCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HHHH-hC---------CCCC
Confidence 334568999999999999999999999999999999998 89999765433221 1111 11 1111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.+..++..+.+++.+||+.+|.+|||+.|++++|.
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 22335567899999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=409.04 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=208.1
Q ss_pred ccCccccee-EeeeCcEEEEEEEEc---CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHV-IGVGGFGKVYEGYID---GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~-lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...+. ||+|+||.||+|.++ ++..||||.++.. .....++|.+|+++|++++|||||+++|+|.. +.+++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345666664 999999999999864 3457999998654 44557889999999999999999999999965 46899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|||||++|+|.+++.... ..+++.++++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 vmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999986543 34999999999999999999999877 99999999999999999999999999987543
Q ss_pred CCCc-cccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 680 LNQT-HVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 680 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+.. ... ..+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~~i----~~~~----- 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFI----EQGK----- 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHH----HTTC-----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC-----
Confidence 3222 22234568899999999999999999999999999999998 89999754332211 111 1111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+...+..++.++.+++.+||+.+|.+||||.+|++.|+...
T Consensus 230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11223345678899999999999999999999999988654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=419.26 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=209.2
Q ss_pred hccCcccceeEeeeCcEEEEEEEEcCc------cEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYIDGK------TKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG 595 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 595 (862)
..++|...++||+|+||+||+|+..+. ..||+|.+... .....+.|.+|+.+|.++ +|||||+++|+|.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 346788899999999999999997542 36899987643 334456799999999998 8999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCC---------------------CCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCC
Q 041565 596 EMILVYDYMANGTLREHLYKGDK---------------------PGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVK 654 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIk 654 (862)
..++|||||++|+|.++|..... ..+++.+++.++.||++||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999976431 24899999999999999999999877 9999999
Q ss_pred CCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 041565 655 TTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNL 733 (862)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~ 733 (862)
|+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987544333333445668999999999999999999999999999999997 899997543
Q ss_pred ccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 734 PKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
..+.. ..... ...+...+..++..+.+++.+||+.+|++|||++||+++|.-
T Consensus 272 ~~~~~--~~~~~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDANF--YKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHHH--HHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH--HHHHh-------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 32221 11111 111112233456789999999999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=406.69 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=199.8
Q ss_pred eeEeeeCcEEEEEEEEcC---ccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCCC
Q 041565 532 HVIGVGGFGKVYEGYIDG---KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMAN 606 (862)
Q Consensus 532 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 606 (862)
++||+|+||.||+|.+++ +..||||+++.. +....++|.+|+++|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 357999988643 33445789999999999999999999999965 467899999999
Q ss_pred CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC-ccc
Q 041565 607 GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-THV 685 (862)
Q Consensus 607 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~ 685 (862)
|+|.+++.+... +++.++++|+.|||+||+|||+++ ||||||||+||||+.++.+||+|||+++....... ...
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999986543 999999999999999999999877 99999999999999999999999999987543222 222
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. ..... .+ .+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~~i~----~~---------~~~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLE----KG---------ERMG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHH----TT---------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HHHHH----cC---------CCCC
Confidence 334568999999999999999999999999999999998 8999975433221 11111 11 1112
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+..++.++.+++.+||+.+|.+|||++||++.|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 2334567889999999999999999999999888764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=405.85 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=208.2
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
+|+..+.||+|+||.||+|+.+ ++..||+|++... .....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 5888999999999999999986 5788999987532 22345678999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
||++|+|.+++.+... +++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 87 y~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 87 YAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred ecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 9999999999986543 999999999999999999999887 999999999999999999999999999875432
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
......||+.|||||++.+..++.++|||||||+||||++|+.||......+.. .... ... .
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-----~~i~--~~~------~--- 221 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-----KRIS--RVE------F--- 221 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHH--TTC------C---
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-----HHHH--cCC------C---
Confidence 223457999999999999999999999999999999999999999754332211 1100 110 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.++...++++.+++.+||+.+|.+|||+.|++++.+..
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 11223456789999999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=410.05 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=210.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|+..+.||+|+||+||+|... +|..||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 57899999876555455678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.+. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 999999988754 3999999999999999999999887 9999999999999999999999999998754322 2
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGN 764 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 764 (862)
......||+.|+|||++.++.++.++|||||||++|||++|+.||......+... .. ...+. +. ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~---~~~~~------~~--~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LI---ATNGT------PE--LQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HH---HHHCS------CC--CS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH---HH---HhCCC------CC--CC
Confidence 2344579999999999999999999999999999999999999997543322211 00 01110 01 11
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 765 ITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 765 ~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.+..++..+.+++.+||+.+|.+|||+.|+++|-+.
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 223355678999999999999999999999877544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=408.37 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=208.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+.|+..+.||+|+||.||+|+.. ++..||||++........++|.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888899999999999999975 57889999987666666788999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.+++.+.. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.... ...
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence 9999999986543 24999999999999999999999887 99999999999999999999999999976322 111
Q ss_pred ccccccCCCCCCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCC
Q 041565 685 VSTMVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDP 759 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 759 (862)
......||+.|+|||++. +..++.++|||||||++|||++|+.||......+... .... +.. +
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-----~i~~--~~~-----~ 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-----KIAK--SEP-----P 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHH--SCC-----C
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-----HHHc--CCC-----C
Confidence 233467999999999984 4568999999999999999999999997654333210 0000 000 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 760 NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 760 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
. ...+..++.++.+++.+||+.+|.+|||+.|++++-+
T Consensus 234 ~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 234 T--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp C--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred C--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 1112335667899999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=407.38 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=195.5
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee--cCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--DGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 600 (862)
++|+..+.||+|+||.||+|+.+ +|..||||.+... .+...+.+.+|+++|++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56889999999999999999975 5788999987654 34556779999999999999999999999864 4568999
Q ss_pred EEeCCCCcHHHHHhcC--CCCCCChhhHHHHHHHHHHHHHHhhcCC--cccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 601 YDYMANGTLREHLYKG--DKPGLPWKQRLEICIGAARGLHYLHTGA--RYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
||||++|+|.+++.+. ....+++..++.++.|++.||+|||+++ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2345999999999999999999999854 24599999999999999999999999999987
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.... ........||+.|||||++.+..++.++|||||||++|||++|+.||......+. .. . ...+...
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~---~-i~~~~~~-- 232 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---K-IREGKFR-- 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---H-HHHTCCC--
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HH---H-HHcCCCC--
Confidence 5432 2223456799999999999999999999999999999999999999975433221 11 1 0111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWN 797 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~ 797 (862)
..+..++.++.+++.+||+.||.+|||+.|++++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122345678999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=407.66 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=204.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeCC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYMA 605 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 605 (862)
++|+..+.||+|+||.||+|+++++..||||++.... ...++|.+|+.++++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5788899999999999999999888889999987543 345789999999999999999999999965 56789999999
Q ss_pred CCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCccc
Q 041565 606 NGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHV 685 (862)
Q Consensus 606 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (862)
+|+|..++.......++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++...... ...
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence 999999987654445999999999999999999999877 9999999999999999999999999998754322 222
Q ss_pred cccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCCCC
Q 041565 686 STMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNI 765 (862)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 765 (862)
.....||+.|+|||++..+.++.++|||||||++|||++|..|+........ +..+... + .....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~----~---------~~~~~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER----G---------YRMPC 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT----T---------CCCCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHh----c---------CCCCC
Confidence 3345689999999999999999999999999999999997666543322111 1111111 0 11122
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 766 TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 766 ~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+..+++++.+++.+||+.+|++||||.+|++.|+....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 33456679999999999999999999999999887653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=401.42 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=197.7
Q ss_pred ccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee----cCeEEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE----DGEMILVY 601 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 601 (862)
...++||+|+||+||+|+.. ++..||+|.+... .....++|.+|+++|++++|||||++++++.. +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999976 4678999987542 44556789999999999999999999999865 34689999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc-CCCceEEeeccccccCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD-EKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~~kl~DFGla~~~~~~ 680 (862)
|||++|+|.+++.+.. .+++.+++.++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999997654 3899999999999999999999864 4599999999999996 578999999999986432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
.......||+.|||||++.+ .++.++|||||||++|||++|+.||......... ..... .+..
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-----~~~i~-~~~~------- 230 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVT-SGVK------- 230 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHT-TTCC-------
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH-----HHHHH-cCCC-------
Confidence 12334679999999998865 5999999999999999999999999644322211 11111 1100
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
...++...++++.+++.+||+.+|++|||+.|+++|-
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 231 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 0011122345688999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-47 Score=409.41 Aligned_cols=266 Identities=27% Similarity=0.425 Sum_probs=216.0
Q ss_pred HHHHHhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEE
Q 041565 518 LAEIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGF 590 (862)
Q Consensus 518 ~~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~ 590 (862)
+.+++...++|+..+.||+|+||+||+|+.++ +..||||++.... .+..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 44566677889999999999999999999753 4689999987543 4456789999999999999999999999
Q ss_pred EeecCeEEEEEEeCCCCcHHHHHhcCC----------------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccE
Q 041565 591 CEEDGEMILVYDYMANGTLREHLYKGD----------------------KPGLPWKQRLEICIGAARGLHYLHTGARYTI 648 (862)
Q Consensus 591 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 648 (862)
|...+..++||||+++|+|.++|.... ...+++.+++.|+.|++.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999996432 224899999999999999999999877 9
Q ss_pred EeeCCCCCCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-C
Q 041565 649 IHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-P 727 (862)
Q Consensus 649 vHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~-~ 727 (862)
|||||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998644333333344567889999999999999999999999999999999996 5
Q ss_pred CCCCCCccccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 728 ALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 728 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
|+......+.. ..+ ..+.. ...+..++.++.+++.+||+.+|++||||.||++.|+.+.
T Consensus 242 p~~~~~~~e~~---~~v----~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVI---YYV----RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHH---HHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHH---HHH----HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 66554333221 111 11111 1122335567899999999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=413.95 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=208.0
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
..++|+..++||+|+||+||+|+.. ++..||+|+++.. .....+++.+|+++|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999975 5788999987643 3344578999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.+++.+... +++..+..++.|+++||+|||+++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 99999999999986543 999999999999999999999741 399999999999999999999999999985321
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHH---------HHHhhhc---
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLAD---------WALHCQR--- 749 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~--- 749 (862)
.......||+.|+|||++.+..++.++||||+||+++||++|+.||......+...... +......
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 12334579999999999999999999999999999999999999997644321100000 0000000
Q ss_pred -----------cCc----cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 750 -----------MGT----IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 750 -----------~~~----~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
... ...+.............+.++.+++.+||+.||.+|||+.|+++|....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 000 0000000000001112345788999999999999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=405.36 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=205.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||+||+|+.. ++..||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46899999999999999999975 5789999987532 2234567999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.+++..... +++.++..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999876543 999999999999999999999887 9999999999999999999999999998765433
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-----~~i~--~~~------~-- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-----QKII--KLE------Y-- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHH--TTC------C--
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-----HHHH--cCC------C--
Confidence 333344567999999999999999999999999999999999999999754322211 0100 111 1
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.++...+.++.+++.+||+.||.+|||++|++.+.+
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 112234567899999999999999999999876544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=405.75 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=205.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-c----cEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-K----TKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.+|+..++||+|+||+||+|.+.. + .+||+|++... +.+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358999999999999999998653 3 25899987653 345578899999999999999999999999865 5678
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
++||+.+|+|.+++..... .+++..+++++.|||+||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 8999999999998876543 4999999999999999999999877 99999999999999999999999999987654
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
...........||+.|+|||++.++.++.++|||||||++|||+| |++||......+.. ..... +
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i~~----~------- 229 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK----G------- 229 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHHHH----T-------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc----C-------
Confidence 333334445568999999999999999999999999999999998 78888654333221 11111 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.+...+..++..+.+++.+||+.+|.+|||+.|++++|+.+.+
T Consensus 230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1111223356778999999999999999999999999988753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=396.15 Aligned_cols=250 Identities=29% Similarity=0.450 Sum_probs=199.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEee-cCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 604 (862)
++|+..+.||+|+||.||+|.++ |..||||+++.. ...++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45777899999999999999986 568999998754 345789999999999999999999999865 45689999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
++|+|.++|.......++|..+++|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----
Confidence 9999999997654445899999999999999999999876 99999999999999999999999999986432
Q ss_pred ccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccCCCCCC
Q 041565 685 VSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLKG 763 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 763 (862)
......+|..|+|||++.++.++.++|||||||++|||+| |++|+......+ +..+... ..+.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~-------------~~~~ 219 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK-------------GYKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT-------------TCCC
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc-------------CCCC
Confidence 1223458899999999999999999999999999999998 677776543222 2222211 1112
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 764 NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 764 ~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
..+..++..+.+++.+||+.+|.+||||.|++++|+.+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 233345567899999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-46 Score=406.96 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=211.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|+..+.||+|+||.||+|+.. +|..||||++........+.+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 37899999999999999999975 57899999988777677788999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC--CCceEEeeccccccCCCCCC
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE--KWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~~~ 682 (862)
++|+|.+++..... .+++.++..|+.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 106 SGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 99999999965433 4999999999999999999999887 999999999999964 578999999999875432
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......||+.|||||++.+..++.++|||||||++|||++|+.||......+... ........ ..
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-----~i~~~~~~--------~~ 245 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWN--------MD 245 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHTCCC--------SC
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCCC--------CC
Confidence 22344679999999999999999999999999999999999999997553322211 11111111 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......++.+.+++.+||+.||.+|||++|+++|-+.
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 11112245678999999999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=402.27 Aligned_cols=250 Identities=28% Similarity=0.353 Sum_probs=204.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
+.|+..+.||+|+||.||+|+.. ++..||||++... .....+++.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999965 5778999987543 2344577999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|..++.... .+++.+++.++.||++||+|||+++ ||||||||+||||++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999987766543 4999999999999999999999887 99999999999999999999999999986432
Q ss_pred CccccccccCCCCCCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+.. ..... +. .
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-----~~i~~--~~-----~ 231 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQ--NE-----S 231 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHH--SC-----C
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHh--CC-----C
Confidence 233569999999999864 46899999999999999999999999654322211 11111 00 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
+.+ .+..+++.+.+++.+||+.+|.+|||+.|+++|.+..
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 111 1122456789999999999999999999999886654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=396.18 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=199.9
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC----ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG----KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 599 (862)
.++|...+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+++|++++|||||+++|+|.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4578889999999999999998643 346899988654 44456789999999999999999999999964 67899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCC
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPN 679 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~ 679 (862)
|||||++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999887654 34999999999999999999999877 99999999999999999999999999987543
Q ss_pred CCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccccC
Q 041565 680 LNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDIID 758 (862)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 758 (862)
.. ........||+.|+|||.+.++.++.++|||||||++|||++ |++|+......+. ...... +.
T Consensus 161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~----~~------ 226 (273)
T d1mp8a_ 161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN----GE------ 226 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHT----TC------
T ss_pred Cc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHc----CC------
Confidence 22 223344568999999999999999999999999999999998 8999876543322 111111 11
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 759 PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 759 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
....+..++..+.+++.+||+.+|.+|||+.||+++|+.+++
T Consensus 227 ---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 227 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011223356779999999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=400.39 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=204.7
Q ss_pred HHHHhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEE
Q 041565 519 AEIKHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGF 590 (862)
Q Consensus 519 ~el~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 590 (862)
.+.+...++|...++||+|+||.||+|...+ ++.||||++... .....+++..|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3344445679999999999999999998643 357999998753 344567788898888887 68999999999
Q ss_pred Eeec-CeEEEEEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCC
Q 041565 591 CEED-GEMILVYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKT 655 (862)
Q Consensus 591 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp 655 (862)
+.+. ..+++|||||++|+|.++|.... ...+++.+++.++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8764 46899999999999999997542 234899999999999999999999877 99999999
Q ss_pred CCeeccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCc
Q 041565 656 TNILLDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PALNVNLP 734 (862)
Q Consensus 656 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~-~p~~~~~~ 734 (862)
+||||++++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++|. +||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765444333445567999999999999999999999999999999999875 56654332
Q ss_pred cccccHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 735 KEQVSLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
.+. +. .. ...+. ....+..++.++.+++.+||+.+|.+|||+.|++++|+.+++
T Consensus 243 ~~~--~~---~~-~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 DEE--FC---RR-LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SHH--HH---HH-HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--HH---HH-HhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 221 11 11 11111 111222345678999999999999999999999999998875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-46 Score=401.75 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=192.3
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC-hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS-EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
+.|...++||+|+||+||+|+.+ ++..||||.+.... ....+.+.+|+++|++++|||||++++++.+++.+++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999976 47889999876432 23345688999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc---CCCceEEeeccccccCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD---EKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~~kl~DFGla~~~~~~ 680 (862)
|++|+|.++|.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 89 VSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp CCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred cCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 99999999997654 4999999999999999999999887 99999999999994 578999999999986432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
........||+.|||||++.+..++.++|||||||++|||++|+.||......+. .. ...... ..
T Consensus 163 --~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~--~i~~~~--------~~ 227 (307)
T d1a06a_ 163 --GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FE--QILKAE--------YE 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH--HHHTTC--------CC
T ss_pred --CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HH--HHhccC--------CC
Confidence 2223345799999999999999999999999999999999999999975432221 11 111111 01
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.........++.+.+++.+||+.+|.+|||+.|++++.+.
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 1111122345678999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-45 Score=404.56 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=210.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
+.|+..+.||+|+||.||+|+.. ++..||||++........+.+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 36888999999999999999975 57899999987766666778899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc--CCCceEEeeccccccCCCCCC
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD--EKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~~kl~DFGla~~~~~~~~ 682 (862)
++|+|.+++.... ..+++.+++.|+.||+.||+|||+.+ ||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999999876543 34999999999999999999999887 99999999999998 6789999999999875432
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ... ....
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~--~~~--------~~~~ 248 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVK--RCD--------WEFD 248 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH--HCC--------CCCC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH--hCC--------CCCC
Confidence 2334467999999999999999999999999999999999999999755432211 1010 110 1111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.......+.++.+++.+||+.+|.+|||+.|+++|-+
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 1112234567899999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=395.10 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=205.3
Q ss_pred ceeEeeeCcEEEEEEEEcCc----cEEEEEecCC-CChhhHHHHHHHHHHHHhccccceeeEEEEEee-cCeEEEEEEeC
Q 041565 531 SHVIGVGGFGKVYEGYIDGK----TKVAIKRSNP-SSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-DGEMILVYDYM 604 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 604 (862)
.++||+|+||+||+|++.+. ..||||+++. .+....++|.+|+++|++++|||||+++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 3589998864 455667889999999999999999999999876 46899999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC--
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ-- 682 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 682 (862)
++|+|.+++..... .+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999876543 4889999999999999999999877 99999999999999999999999999987543221
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
........||..|+|||.+.++.++.++||||||+++|||+||+.|+....... .+..+..... .
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~g~---~---------- 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGR---R---------- 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC---C----------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC---C----------
Confidence 222334568999999999999999999999999999999999888775432211 1222221111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
...+..++..+.+++.+||+.+|.+||+|.||+++|+.+++.
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111223456789999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=396.33 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=205.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC-cc--EEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG-KT--KVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 600 (862)
++|+..++||+|+||.||+|++++ +. .||||++... .....++|.+|+++|+++ +|||||+++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567788999999999999999764 33 5788886543 444567899999999999 799999999999999999999
Q ss_pred EEeCCCCcHHHHHhcC--------------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 601 YDYMANGTLREHLYKG--------------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
|||+++|+|.++|+.. ....++|.++++++.|||+||+|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 2345999999999999999999999877 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP-ALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|.. |+......+ +...+.
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 99999999864321 12234468999999999999999999999999999999999764 564432211 111111
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhcC
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQL 804 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~~ 804 (862)
. + .+...+..++.++.+++.+||+.+|++||||.||+++|+.+++.
T Consensus 241 ~----~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 Q----G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp G----T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred h----c---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 1 11122233566899999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=393.88 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=198.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcC--c--cEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDG--K--TKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|+..+.||+|+||.||+|+++. + ..||||++... ..+..++|.+|+++|++++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 568889999999999999998643 2 36899987643 344567899999999999999999999999764 678
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+|||||++|+|.+++..... .+++..+++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999998876433 3999999999999999999999877 9999999999999999999999999998754
Q ss_pred CCCC-ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 679 NLNQ-THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 679 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
.... ........|+..|+|||.+.+..++.++|||||||++|||+| |+.||......+. ..+. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i---~~~~----- 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKI---DKEG----- 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH---HTSC-----
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHH---HhCC-----
Confidence 3322 222334567889999999999999999999999999999998 8999975433221 1111 1111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.+...+..++..+.+++.+||+.+|.+||||.||++.|+.+
T Consensus 232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112233456789999999999999999999999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=394.83 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=206.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC------ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS------SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|...+.||+|+||+||+|+.+ +|..||||++... .....++|.+|+++|++++|||||++++++.+.+.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56899999999999999999975 5789999986432 1224678999999999999999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC----ceEEeecccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW----EAKVSDFGLS 674 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~~kl~DFGla 674 (862)
+|||||++|+|.++|.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999997654 3999999999999999999999887 99999999999998776 4999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..........
T Consensus 165 ~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-----~~i~~~~~~~- 235 (293)
T d1jksa_ 165 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANVSAVNYEF- 235 (293)
T ss_dssp EECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHTTCCCC-
T ss_pred hhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-----HHHHhcCCCC-
Confidence 875432 2233456899999999999999999999999999999999999999754332211 1110110010
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
........+..+.+++.+||+.+|.+|||++|++++-+
T Consensus 236 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 236 -------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp -------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred -------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00011124567889999999999999999999997643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=396.00 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=213.3
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc------CccEEEEEecCCC-ChhhHHHHHHHHHHHHhc-cccceeeEEEEEeecC
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID------GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEEDG 595 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 595 (862)
..++|+..++||+|+||.||+|++. .+..||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3467888999999999999999863 3468999998754 344566799999999999 6999999999999999
Q ss_pred eEEEEEEeCCCCcHHHHHhcCC----------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCee
Q 041565 596 EMILVYDYMANGTLREHLYKGD----------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNIL 659 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 659 (862)
..++|||||++|+|.++|+... ...+++..+++++.||++||+|||+++ +|||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999997542 224899999999999999999999887 999999999999
Q ss_pred ccCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 041565 660 LDEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQV 738 (862)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~ 738 (862)
++.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |++|+......+.
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999997665444444556678999999999999999999999999999999999 5555544322221
Q ss_pred cHHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 739 SLADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 739 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+..... ...+...+..++..+.+|+.+||+.+|.+||||.||+++|+..+
T Consensus 257 -~~~~i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 -FYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp -HHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHh-------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111 11111222334567999999999999999999999999998765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=394.85 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=208.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEcC--------ccEEEEEecCCCC-hhhHHHHHHHHHHHHhc-cccceeeEEEEEeec
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYIDG--------KTKVAIKRSNPSS-EQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEED 594 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 594 (862)
.++|...+.||+|+||.||+|+..+ +..||||+++... .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3568888999999999999998643 2479999987543 45567899999999988 899999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCC--------------CCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeec
Q 041565 595 GEMILVYDYMANGTLREHLYKGD--------------KPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILL 660 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 660 (862)
+..++|||||++|+|.++|.... ...+++.++++++.|||.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997543 234899999999999999999999887 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 041565 661 DEKWEAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPALNVNLPKEQVS 739 (862)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~ 739 (862)
+.++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||++ |++||......+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999987544433344455678999999999999999999999999999999998 688886543321
Q ss_pred HHHHHHhhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 740 LADWALHCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 740 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
+..... .+ .....+..++..+.+++.+||+.+|.+|||+.||++.|+.++.
T Consensus 246 ~~~~i~----~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLK----EG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHH----TT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH----cC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111111 11 1111222345678999999999999999999999999998865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=394.21 Aligned_cols=267 Identities=23% Similarity=0.339 Sum_probs=200.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHH--HHHHHHhccccceeeEEEEEeecC----eEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQT--EIEMLSKLRHKHLVSLIGFCEEDG----EMIL 599 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~l 599 (862)
+.|...++||+|+||.||+|+++ |..||||++.... .+++.. |+..+.+++|||||+++|+|.+++ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 35667789999999999999975 5689999986432 234444 455556789999999999997654 6899
Q ss_pred EEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCC-----cccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 600 VYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGA-----RYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
|||||++|+|.++|++. .++|.++++++.|+|.||+|||+.. ..+||||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999864 3899999999999999999999742 356999999999999999999999999999
Q ss_pred ccCCCCCCc--cccccccCCCCCCChhhhhcCC------CCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc-------
Q 041565 675 KTGPNLNQT--HVSTMVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS------- 739 (862)
Q Consensus 675 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~------- 739 (862)
+........ .......||+.|+|||++.+.. ++.++|||||||+||||+||+.|+......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 865332211 1233467999999999987643 6779999999999999999998875433221100
Q ss_pred -HHHHHHhhhccCccccccCCCCCCCC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 740 -LADWALHCQRMGTIEDIIDPNLKGNI-TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 740 -l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+....... .+..+|.+.... ..+.+..+.+++.+||+.+|.+|||+.||+++|+.+.+
T Consensus 236 ~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011111111 111222222211 23567789999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=395.44 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=212.8
Q ss_pred HhhccCcccceeEeeeCcEEEEEEEEcC------ccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeec
Q 041565 522 KHGTRNFSESHVIGVGGFGKVYEGYIDG------KTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED 594 (862)
Q Consensus 522 ~~at~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 594 (862)
+...++|...+.||+|+||.||+|.+.+ +..||||+++.. ..+....|.+|++++++++|||||+++|+|..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3344678889999999999999998642 468999998754 445556799999999999999999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcC--------CCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCce
Q 041565 595 GEMILVYDYMANGTLREHLYKG--------DKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEA 666 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~ 666 (862)
+..++|||||++|+|.+++... ....+++..+++++.|+|+||.|||+++ |+||||||+||||++++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999998642 2234789999999999999999999876 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCccccccHHHHHH
Q 041565 667 KVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PALNVNLPKEQVSLADWAL 745 (862)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~ 745 (862)
||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||+ +|+......+. ..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~------~~ 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LR 246 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------HH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH------HH
Confidence 999999998654433333344456899999999999999999999999999999999985 66654322221 11
Q ss_pred hhhccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 746 HCQRMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 746 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
... .+. ....+..++..+.+++.+||+.+|.+||||.||+++|+..++
T Consensus 247 ~i~-~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVM-EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH-hCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 111 111222355679999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=391.84 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=208.0
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|...+.||+|+||.||+|+.+ ++..||||++... .....+++.+|+++|++++||||+++++++.+++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46889999999999999999975 5789999987632 2334677899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|.+++.+... +++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999987543 899999999999999999999887 9999999999999999999999999998654322
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.. . ... .+. ..
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~--~i~--~~~------~~- 223 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E--LIL--MEE------IR- 223 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H--HHH--HCC------CC-
T ss_pred --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH---H--HHh--cCC------CC-
Confidence 2234467999999999999999999999999999999999999999765432211 1 010 111 11
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~ 799 (862)
++...+.++.+++.+||+.||.+||+ +.|+++|-.
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 12234566889999999999999994 889988744
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-44 Score=379.00 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC----eE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG----EM 597 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 597 (862)
++|...+.||+|+||.||+|+.. +++.||||.+... +....++|.+|+++|++++||||+++++++.... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56889999999999999999974 5789999998643 3445678999999999999999999999987654 48
Q ss_pred EEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 598 ILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 598 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
++|||||++|+|.+++..... +++.+++.++.||++||+|||+.+ |+||||||+|||++.++..+|+|||.++..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999999999876543 999999999999999999999887 999999999999999999999999998754
Q ss_pred CCC-CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc
Q 041565 678 PNL-NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI 756 (862)
Q Consensus 678 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 756 (862)
... ..........||+.|+|||++.+..++.++|||||||++|||+||++||......+.. ............
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~- 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVREDPIPPS- 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCCCCCGG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH-----HHHHhcCCCCCc-
Confidence 322 1222334567999999999999999999999999999999999999999754332211 011111111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHh
Q 041565 757 IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-SMGDVLWNLEFAL 802 (862)
Q Consensus 757 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-t~~evl~~L~~~l 802 (862)
......+.++.+++.+||+.||.+|| |++++++.|..+.
T Consensus 236 -------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11112456789999999999999999 8999998887653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-44 Score=389.93 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=206.2
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||+||+|+.+ +|..||||++... .....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 45888999999999999999975 5789999987532 2234578999999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
|||++|+|..++..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999999999887654 889999999999999999999887 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+.. ....... ..
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~i~~~~--------~~- 219 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-----EKILNAE--------LR- 219 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHHHCC--------CC-
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-----HHHHcCC--------CC-
Confidence 23467999999999999999999999999999999999999999754332211 1111111 11
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
++...+..+.+++.+||+.+|.+|| |++|+++|.+
T Consensus 220 ---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 220 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 1122445688999999999999996 8999998744
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-44 Score=379.47 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=204.9
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC---------hhhHHHHHHHHHHHHhcc-ccceeeEEEEEeec
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS---------EQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEED 594 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 594 (862)
++|+..+.||+|+||+||+|+.. ++..||||++.... +...+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999974 67899999875432 122356889999999997 99999999999999
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
+..++|||||++|+|.++|..+. .+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 4999999999999999999999887 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ 748 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 748 (862)
+..... ...+...||..|+|||++.+ ..++.++||||+||+++||++|+.||......+.. ...
T Consensus 158 ~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-----~~i-- 227 (277)
T d1phka_ 158 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----RMI-- 227 (277)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHH--
T ss_pred eEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-----HHH--
Confidence 875432 22344679999999999864 34688999999999999999999999765432211 000
Q ss_pred ccCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 749 RMGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 749 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
..+.. ..........++++.+++.+||+.+|.+|||+.|++++-
T Consensus 228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 11111 011111223556789999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=386.38 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=201.5
Q ss_pred cCcccc-eeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhc-cccceeeEEEEEee----cCeEE
Q 041565 526 RNFSES-HVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKL-RHKHLVSLIGFCEE----DGEMI 598 (862)
Q Consensus 526 ~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 598 (862)
++|... ++||+|+||.||+|+.. ++..||||+++.. ..+.+|++++.++ +|||||++++++.+ +..++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467765 46999999999999974 5789999998642 4567899987655 89999999999865 46789
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC---CCceEEeeccccc
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE---KWEAKVSDFGLSK 675 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~~kl~DFGla~ 675 (862)
+|||||++|+|.++|.+.....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 9999999999999998765556999999999999999999999887 999999999999985 4679999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||......+.... .......+
T Consensus 163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~---- 232 (335)
T d2ozaa1 163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMG---- 232 (335)
T ss_dssp ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC----
T ss_pred eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcC----
Confidence 754322 23445799999999999999999999999999999999999999965433221100 00000000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
...+........++++.+++.+||+.+|.+|||+.|++++-+..
T Consensus 233 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 233 --QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp --SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred --CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 00111111234567899999999999999999999999986654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-43 Score=388.73 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=200.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHH---HHHHHHHhccccceeeEEEEEeecCeEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQ---TEIEMLSKLRHKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 598 (862)
++|...++||+|+||.||+|+.. +|..||||++... .......+. .|+++++.++|||||++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47899999999999999999976 5789999987532 112223344 4467777788999999999999999999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
+|||||++|+|.++|.+... +++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999986543 899999999999999999999887 9999999999999999999999999998654
Q ss_pred CCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc
Q 041565 679 NLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII 757 (862)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 757 (862)
.. ......||+.|+|||++.. ..++.++|||||||+||||++|+.||......+...+. ......
T Consensus 159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~------ 224 (364)
T d1omwa3 159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------ 224 (364)
T ss_dssp SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSC------
T ss_pred CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccC------
Confidence 32 2234579999999999975 56899999999999999999999999765433221111 000000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 041565 758 DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPS-----MGDVLWNLE 799 (862)
Q Consensus 758 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt-----~~evl~~L~ 799 (862)
....+...+.++.+++.+||+.||.+||| +.|+++|-+
T Consensus 225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 225 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp ----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 01112224567899999999999999999 689988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=383.08 Aligned_cols=255 Identities=15% Similarity=0.231 Sum_probs=207.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
++|...+.||+|+||+||+|... ++..||||.+..... ....+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 56888999999999999999976 577899999876543 3456889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCC--CceEEeeccccccCCCCCC
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEK--WEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~~kl~DFGla~~~~~~~~ 682 (862)
++|+|.+++.... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999999997653 24999999999999999999999887 9999999999999854 57999999999875332
Q ss_pred ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNLK 762 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 762 (862)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .........+...
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~-----~~i~~~~~~~~~~------ 225 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-----ENIMNAEYTFDEE------ 225 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHHHTCCCCCHH------
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhCCCCCChh------
Confidence 2233456899999999999999999999999999999999999999765432211 1111111111100
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 763 GNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 763 ~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
.....+.++.+++.+||..||.+|||+.|+++|-+..
T Consensus 226 --~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 226 --AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred --hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 0012345688999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=379.69 Aligned_cols=263 Identities=23% Similarity=0.236 Sum_probs=196.9
Q ss_pred ceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChh-----hHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEeC
Q 041565 531 SHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQ-----GVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDYM 604 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 604 (862)
.++||+|+||+||+|+.. +++.||||++...... ..+.+.+|+++|++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 4789999988643221 1346889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCcc
Q 041565 605 ANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQTH 684 (862)
Q Consensus 605 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (862)
.++++..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence 887776655433 34899999999999999999999887 9999999999999999999999999998654322 2
Q ss_pred ccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccc------c
Q 041565 685 VSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDI------I 757 (862)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~ 757 (862)
......||+.|+|||++.+. .++.++|||||||++|||++|++||......+......-............. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 22345699999999998754 6799999999999999999999999765443322111000000000000000 0
Q ss_pred CCCCCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 758 DPNLKGNIT-----DQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 758 d~~l~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.-......+ ....+.+.+++.+||+.||++|||+.|+++|-.+
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 000000011 1234678999999999999999999999987553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=385.33 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=203.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHH-hccccceeeEEEEEeecCeEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLS-KLRHKHLVSLIGFCEEDGEMILV 600 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 600 (862)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999976 5788999988532 1233556777777765 68999999999999999999999
Q ss_pred EEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCC
Q 041565 601 YDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 601 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (862)
||||++|+|.+++..... +++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999986543 899999999999999999999887 999999999999999999999999999865432
Q ss_pred CCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCC
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPN 760 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 760 (862)
....+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .... .+ .+.
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-----~~i~--~~------~~~ 221 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-----HSIR--MD------NPF 221 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHH--HC------CCC
T ss_pred --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-----HHHH--cC------CCC
Confidence 22334467999999999999999999999999999999999999999765432211 1111 11 111
Q ss_pred CCCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHH
Q 041565 761 LKGNITDQCLRKFTETAEKCLSDQGIDRPSMG-DVLWNL 798 (862)
Q Consensus 761 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~-evl~~L 798 (862)
+ +..++.++.+++.+||+.+|.+||++. |+++|-
T Consensus 222 ~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 222 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred C----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence 1 222456789999999999999999995 787653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-43 Score=388.89 Aligned_cols=248 Identities=20% Similarity=0.295 Sum_probs=206.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC---ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS---SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 601 (862)
++|+..+.||+|+||.||+|+.+ +|..||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46889999999999999999975 5789999987532 2234567899999999999999999999999999999999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLN 681 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (862)
||+.+|+|.+++.+... +++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999976543 999999999999999999999887 999999999999999999999999999875432
Q ss_pred CccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccccccCCCC
Q 041565 682 QTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDIIDPNL 761 (862)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 761 (862)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......... . .... +. +.
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~--~i~~--~~------~~- 256 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---E--KIVS--GK------VR- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H--HHHH--CC------CC-
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---H--HHhc--CC------CC-
Confidence 23457999999999999999999999999999999999999999754322211 1 1111 10 11
Q ss_pred CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 041565 762 KGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLEF 800 (862)
Q Consensus 762 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~~ 800 (862)
.+...+.++.+++.+||+.||.+|+ |+.|+++|-++
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 1122456789999999999999994 89999987543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=374.19 Aligned_cols=268 Identities=21% Similarity=0.286 Sum_probs=202.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..++||+|+||+||+|+.. .++.||||++.... ....+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47889999999999999999974 57899999886432 2335789999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
|+.+ ++.+++.......+++.++..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence 9965 5555665555556999999999999999999999887 999999999999999999999999999864332
Q ss_pred ccccccccCCCCCCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccccc-CCC
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIEDII-DPN 760 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~ 760 (862)
........||+.|+|||.+.... ++.++|||||||++|||++|+.||......+......-.............. .+.
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 22233457999999999987755 5889999999999999999999997654332211100000000000000000 000
Q ss_pred CC--------CCC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 761 LK--------GNI---TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 761 l~--------~~~---~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. ... ....+.++.+++.+||+.+|.+|||+.|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 00 000 0123467889999999999999999999998744
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-42 Score=372.52 Aligned_cols=266 Identities=19% Similarity=0.234 Sum_probs=201.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC--hhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS--EQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 603 (862)
++|...++||+|+||+||+|+.+++..||||++.... ....+++.+|+.+|++++|||||++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4788899999999999999999988999999986543 33357899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCCc
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQT 683 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (862)
+.++.+..+.... ..+++.++..++.||++||+|||+.+ ||||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 9876666655433 34999999999999999999999877 9999999999999999999999999997643221
Q ss_pred cccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc---ccc---
Q 041565 684 HVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI---EDI--- 756 (862)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~--- 756 (862)
.......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||......+................. ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 12233458899999999876 45699999999999999999999999765433322111110000000000 000
Q ss_pred ------cCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041565 757 ------IDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNL 798 (862)
Q Consensus 757 ------~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L 798 (862)
..+..........+..+.+++.+||+.||++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 000000111222456789999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=374.97 Aligned_cols=269 Identities=21% Similarity=0.279 Sum_probs=200.1
Q ss_pred hccCcccceeEeeeCcEEEEEEEEc-C-ccEEEEEecCCC--ChhhHHHHHHHHHHHHhc---cccceeeEEEEEee---
Q 041565 524 GTRNFSESHVIGVGGFGKVYEGYID-G-KTKVAIKRSNPS--SEQGVHEFQTEIEMLSKL---RHKHLVSLIGFCEE--- 593 (862)
Q Consensus 524 at~~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~--- 593 (862)
..++|+..++||+|+||+||+|+.. . ++.||||++... .......+.+|+++|+.| +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4578999999999999999999974 3 567999986432 122233466777777766 79999999999853
Q ss_pred --cCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeec
Q 041565 594 --DGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDF 671 (862)
Q Consensus 594 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DF 671 (862)
....+++|||++++.+...... ....+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3578999999988776655443 3445999999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 672 GLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
|+++.... ........||+.|+|||++.+..++.++||||+||++|||++|++||......+.....-.........
T Consensus 161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 99986432 233455679999999999999999999999999999999999999997654433221111100000000
Q ss_pred cc------c-ccc---CCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 752 TI------E-DII---DPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 752 ~~------~-~~~---d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
.. . ... .+..........++.+.+++.+||+.||.+|||+.|+++|.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 00 0 000 000001112224456889999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=372.93 Aligned_cols=242 Identities=21% Similarity=0.375 Sum_probs=196.1
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCC------hhhHHHHHHHHHHHHhcc--ccceeeEEEEEeecCe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSS------EQGVHEFQTEIEMLSKLR--HKHLVSLIGFCEEDGE 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 596 (862)
++|+..++||+|+||.||+|+.. ++..||||++.... .....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57899999999999999999975 57899999865321 112234678999999996 8999999999999999
Q ss_pred EEEEEEeCCC-CcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-CCceEEeecccc
Q 041565 597 MILVYDYMAN-GTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-KWEAKVSDFGLS 674 (862)
Q Consensus 597 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~~kl~DFGla 674 (862)
.++||||+.+ +++.+++.... .+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999975 67888876544 3999999999999999999999887 999999999999985 479999999999
Q ss_pred ccCCCCCCccccccccCCCCCCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcc
Q 041565 675 KTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTI 753 (862)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (862)
+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . . . +.
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i----~--~--~~- 220 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I----I--R--GQ- 220 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H----H--H--CC-
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H----h--h--cc-
Confidence 864321 2334679999999999988765 5779999999999999999999964210 0 0 0 00
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 754 EDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 754 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
..+.. ..+.++.+++.+||+.||.+|||++|++++.+
T Consensus 221 -----~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 221 -----VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp -----CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -----cCCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 01111 23457899999999999999999999997644
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-40 Score=354.55 Aligned_cols=263 Identities=16% Similarity=0.164 Sum_probs=206.5
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccc-cceeeEEEEEeecCeEEEEEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRH-KHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 602 (862)
.++|...++||+|+||.||+|+.. ++..||||.+..... ..++.+|++.++.|+| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357999999999999999999975 578899998754322 2457788999999965 899999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccC-----CCceEEeeccccccC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDE-----KWEAKVSDFGLSKTG 677 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~~kl~DFGla~~~ 677 (862)
|+ +++|.+++..... .+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 82 ~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 6899999876543 4999999999999999999999887 999999999999974 567999999999864
Q ss_pred CCCCC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc
Q 041565 678 PNLNQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT 752 (862)
Q Consensus 678 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 752 (862)
..... ........||+.|||||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 32211 1123345799999999999999999999999999999999999999976543332211111111111111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhc
Q 041565 753 IEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFALQ 803 (862)
Q Consensus 753 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l~ 803 (862)
..+ +.. .+++++.+++..|++.+|++||+++.+.+.|+.+++
T Consensus 237 ~~~-----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 LRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hHH-----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 111 111 134578999999999999999999999988887754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=362.08 Aligned_cols=271 Identities=21% Similarity=0.265 Sum_probs=198.6
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee--------c
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE--------D 594 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 594 (862)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++.+.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999975 6789999987543 33345778999999999999999999998854 3
Q ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccc
Q 041565 595 GEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLS 674 (862)
Q Consensus 595 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla 674 (862)
+..++||||++++.+...... ...++...+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 468999999987766654433 334899999999999999999999877 999999999999999999999999999
Q ss_pred ccCCCCCCc--cccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccC
Q 041565 675 KTGPNLNQT--HVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMG 751 (862)
Q Consensus 675 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 751 (862)
+........ .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||......+...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 765432211 122334699999999998765 68999999999999999999999997654333222111111000000
Q ss_pred ccccc--------cC-CCCCCCCcH------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 752 TIEDI--------ID-PNLKGNITD------QCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 752 ~~~~~--------~d-~~l~~~~~~------~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
..... +. ......... .....+.+++.+||+.||++|||+.|+++|-.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 00000 00 000000001 1134567899999999999999999999987653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-40 Score=355.58 Aligned_cols=261 Identities=18% Similarity=0.181 Sum_probs=196.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeE-EEEEeecCeEEEEEEe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSL-IGFCEEDGEMILVYDY 603 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~E~ 603 (862)
++|+..+.||+|+||.||+|+.. ++..||||.+..... .+++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46899999999999999999974 578999998664432 2457889999999987765555 4555777888999999
Q ss_pred CCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeecc---CCCceEEeeccccccCCCC
Q 041565 604 MANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLD---EKWEAKVSDFGLSKTGPNL 680 (862)
Q Consensus 604 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~~kl~DFGla~~~~~~ 680 (862)
+ +++|...+.... ..+++..++.++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+++.....
T Consensus 85 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 457777665543 34999999999999999999999887 99999999999875 4567999999999865432
Q ss_pred CC-----ccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCcccc
Q 041565 681 NQ-----THVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIED 755 (862)
Q Consensus 681 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 755 (862)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 1123456799999999999999999999999999999999999999976543332211111111000000111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 041565 756 IIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFAL 802 (862)
Q Consensus 756 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~l 802 (862)
+.. .++.++.+++.+|++.+|.+||++.++.+.|+.+.
T Consensus 240 -----~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 240 -----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----HTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111 24567899999999999999999999988887764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=365.40 Aligned_cols=264 Identities=24% Similarity=0.233 Sum_probs=194.8
Q ss_pred CcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhccccceeeEEEEEeec------CeEEE
Q 041565 527 NFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEED------GEMIL 599 (862)
Q Consensus 527 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 599 (862)
+|...++||+|+||+||+|+.. .++.||||++..... .+.+|+++|++++|+||+++++++... ..+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 578999998865432 234799999999999999999998543 35799
Q ss_pred EEEeCCCCcHHHHHhc-CCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccC
Q 041565 600 VYDYMANGTLREHLYK-GDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTG 677 (862)
Q Consensus 600 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~ 677 (862)
|||||+++.+...... .....+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986644433321 23345999999999999999999999877 99999999999999775 8999999999875
Q ss_pred CCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH----------HHHHh
Q 041565 678 PNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA----------DWALH 746 (862)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~ 746 (862)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|++||......+..... .|...
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 4322 2233569999999998875 57899999999999999999999999765433322111 01000
Q ss_pred hhc--cCccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 747 CQR--MGTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 747 ~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
... ....................+.++.+++.+||+.||.+|||+.|+++|-.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 000 000000000000011112345678999999999999999999999987554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=366.40 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=196.0
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC------
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG------ 595 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 595 (862)
.++|+..+.||+|+||+||+|... +|..||||++... +....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 457999999999999999999975 5789999998643 4445678999999999999999999999997654
Q ss_pred eEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccc
Q 041565 596 EMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSK 675 (862)
Q Consensus 596 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~ 675 (862)
.+++||||+ +.+|..++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 579999999 56787777543 3999999999999999999999887 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhh-------
Q 041565 676 TGPNLNQTHVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHC------- 747 (862)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------- 747 (862)
.... ..+...||+.|+|||.+.+ ..++.++||||+||+++||++|++||......+...........
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 7432 2234568999999999876 45789999999999999999999999765433221111000000
Q ss_pred -hcc-------CccccccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 748 -QRM-------GTIEDIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 748 -~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
... ..+.+.....+ ..........+.+++.+||..||.+|||+.|+++|-+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 000 00000000000 01111234567899999999999999999999998543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=366.08 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=197.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC-ChhhHHHHHHHHHHHHhccccceeeEEEEEeecC----eEE
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS-SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDG----EMI 598 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 598 (862)
+.+|+..+.||+|+||+||+|+.+ +++.||||++... .....+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 346889999999999999999864 6789999998654 3445678999999999999999999999986543 234
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCC
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGP 678 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~ 678 (862)
++++++.+|+|.+++... .+++..+..++.|+++||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 445566689999999754 3999999999999999999999887 9999999999999999999999999998643
Q ss_pred CCCC-ccccccccCCCCCCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCc----
Q 041565 679 NLNQ-THVSTMVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGT---- 752 (862)
Q Consensus 679 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---- 752 (862)
.... ........||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 2211 122344568999999999854 5678999999999999999999999976543322211111000000000
Q ss_pred ----ccc-c-cCCCCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 041565 753 ----IED-I-IDPNLKGNI----TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLE 799 (862)
Q Consensus 753 ----~~~-~-~d~~l~~~~----~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~ 799 (862)
... . ..+...+.. ......++.+++.+||+.||.+|||+.|++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 000 0 000000000 0112346889999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=349.16 Aligned_cols=268 Identities=20% Similarity=0.246 Sum_probs=204.4
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEeecCeEEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEEDGEMILVYD 602 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 602 (862)
++|+..++||+|+||+||+|+.. ++..||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999975 5788999987432 34456889999999999999999999999999999999999
Q ss_pred eCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeeccccccCCCCCC
Q 041565 603 YMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKTGPNLNQ 682 (862)
Q Consensus 603 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (862)
++.+++|..++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999888876543 3899999999999999999999877 99999999999999999999999999987543221
Q ss_pred ccccccccCCCCCCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccc-cccHHHHHHhhhccCc---ccccc
Q 041565 683 THVSTMVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPALNVNLPKE-QVSLADWALHCQRMGT---IEDII 757 (862)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~---~~~~~ 757 (862)
......++..|+|||.+.... ++.++|||||||+++||++|+.||....... ................ .....
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 223345778899999987765 6999999999999999999999874332211 1111100000000000 00000
Q ss_pred C---------CCCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 758 D---------PNLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 758 d---------~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
+ ..............+.+++.+||+.||.+|||++|++++-++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 0 000111222345678899999999999999999999987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=356.20 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=202.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc----CccEEEEEecCCC----ChhhHHHHHHHHHHHHhccc-cceeeEEEEEeecCe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID----GKTKVAIKRSNPS----SEQGVHEFQTEIEMLSKLRH-KHLVSLIGFCEEDGE 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 596 (862)
++|+..+.||+|+||+||+|+.. .|+.||||.+... .....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 45899999999999999999852 3678999987542 22334668899999999976 899999999999999
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++|||||.+|+|.+++..... ++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999986554 788999999999999999999877 99999999999999999999999999986
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhhccCccc
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQRMGTIE 754 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (862)
..... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+..... ...... .
T Consensus 179 ~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~-~--- 251 (322)
T d1vzoa_ 179 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK-S--- 251 (322)
T ss_dssp CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH-C---
T ss_pred hcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhccc-C---
Confidence 54322 2223445799999999999764 4788999999999999999999999766443322111 110000 0
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 041565 755 DIIDPNLKGNITDQCLRKFTETAEKCLSDQGIDRP-----SMGDVLWNLE 799 (862)
Q Consensus 755 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----t~~evl~~L~ 799 (862)
.+ ..+..++.++.+++.+||+.+|.+|| |++|+++|.+
T Consensus 252 ---~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 252 ---EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp ---CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ---CC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 01 11223567789999999999999999 4889987644
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-39 Score=352.64 Aligned_cols=261 Identities=18% Similarity=0.252 Sum_probs=198.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEee--cCeEEEEE
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEE--DGEMILVY 601 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 601 (862)
++|+..++||+|+||+||+|+.. +++.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 47999999999999999999974 57889999987543 467889999999995 9999999999874 45689999
Q ss_pred EeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCC-ceEEeeccccccCCCC
Q 041565 602 DYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKW-EAKVSDFGLSKTGPNL 680 (862)
Q Consensus 602 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~ 680 (862)
|||++++|..+. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999987653 23899999999999999999999887 99999999999998654 6999999999865432
Q ss_pred CCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccc-c----------HHHHHHhhh
Q 041565 681 NQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQV-S----------LADWALHCQ 748 (862)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~----------l~~~~~~~~ 748 (862)
.......+|..|+|||.+.+. .++.++||||+||+++||++|+.||......... . ..+|.....
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 223445689999999998775 4799999999999999999999999654432110 0 001111100
Q ss_pred cc--CccccccCC--------CCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 749 RM--GTIEDIIDP--------NLKGNITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 749 ~~--~~~~~~~d~--------~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.. ......... ..........+.++.+++.+||+.||.+|||++|+++|-++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 00 000111100 01111122345678999999999999999999999987654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=353.34 Aligned_cols=265 Identities=20% Similarity=0.238 Sum_probs=193.8
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee------cCe
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE------DGE 596 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 596 (862)
++|+..++||+|+||+||+|+.. +|..||||++... +....+++.+|+.+|++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 5789999987543 34556778999999999999999999999853 368
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
+++|||||.++ |.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999765 4455432 3899999999999999999999887 99999999999999999999999999886
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHH----------HHH--
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLA----------DWA-- 744 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~-- 744 (862)
... ....+...+|+.|+|||.+.+..++.++||||+||+++||++|+.||............ .|.
T Consensus 169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 432 22334557899999999999999999999999999999999999999765432211100 000
Q ss_pred ----H-hhhccCc-----cccccCCCCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 041565 745 ----L-HCQRMGT-----IEDIIDPNLKG---NITDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEFA 801 (862)
Q Consensus 745 ----~-~~~~~~~-----~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~~ 801 (862)
. ....... ........... ......+..+.+++.+||+.||++|||+.|+++|-+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 0 0000000 00001001111 11234567889999999999999999999999886553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=354.01 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=196.6
Q ss_pred ccCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCC--ChhhHHHHHHHHHHHHhccccceeeEEEEEee-----cCe
Q 041565 525 TRNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPS--SEQGVHEFQTEIEMLSKLRHKHLVSLIGFCEE-----DGE 596 (862)
Q Consensus 525 t~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 596 (862)
.++|+..++||+|+||+||+|+.. +++.||||++... +....+++.+|+++|++++|||+|++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999964 5889999998643 34455678999999999999999999999853 334
Q ss_pred EEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 597 MILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 597 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
.++++||+.+|+|.+++..+ .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 46667788899999998543 3999999999999999999999887 99999999999999999999999999976
Q ss_pred CCCCCCccccccccCCCCCCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccccccHHHHHHhhh-------
Q 041565 677 GPNLNQTHVSTMVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVSLADWALHCQ------- 748 (862)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------- 748 (862)
... ......|+..|+|||.+.+. .++.++|||||||+++||++|+.||...................
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 422 22345688899999987765 56899999999999999999999997654322211110000000
Q ss_pred -ccCccccccC--CCCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 041565 749 -RMGTIEDIID--PNLKGNI----TDQCLRKFTETAEKCLSDQGIDRPSMGDVLWNLEF 800 (862)
Q Consensus 749 -~~~~~~~~~d--~~l~~~~----~~~~~~~l~~li~~Cl~~~p~~RPt~~evl~~L~~ 800 (862)
.......... +...... .......+.+++.+||+.||.+|||+.|+++|-++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 0000000000 0000000 01134568899999999999999999999998654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-34 Score=314.71 Aligned_cols=267 Identities=18% Similarity=0.228 Sum_probs=192.7
Q ss_pred cCcccceeEeeeCcEEEEEEEEc-CccEEEEEecCCCChhhHHHHHHHHHHHHhcc-----------ccceeeEEEEEee
Q 041565 526 RNFSESHVIGVGGFGKVYEGYID-GKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-----------HKHLVSLIGFCEE 593 (862)
Q Consensus 526 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 593 (862)
++|...++||+|+||+||+|+.. +|..||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35888999999999999999974 68899999987543 33467888999998885 5789999988754
Q ss_pred c--CeEEEEEEeCCCC-cHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCCC-----
Q 041565 594 D--GEMILVYDYMANG-TLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKW----- 664 (862)
Q Consensus 594 ~--~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~----- 664 (862)
. ...+++|+++..+ .............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4566777766544 34444444455568999999999999999999997 44 99999999999998654
Q ss_pred -ceEEeeccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcccccc----
Q 041565 665 -EAKVSDFGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNVNLPKEQVS---- 739 (862)
Q Consensus 665 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~---- 739 (862)
.+|++|||.++.... ......||+.|+|||++.+..++.++||||+||+++||++|+.||..........
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 389999999976432 1234569999999999999999999999999999999999999996543221111
Q ss_pred HHHHHHhhhc------------------cCccccccCCC---------CCCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 041565 740 LADWALHCQR------------------MGTIEDIIDPN---------LKGNITDQCLRKFTETAEKCLSDQGIDRPSMG 792 (862)
Q Consensus 740 l~~~~~~~~~------------------~~~~~~~~d~~---------l~~~~~~~~~~~l~~li~~Cl~~~p~~RPt~~ 792 (862)
+......... ......+.... ............+.+++.+||..||.+|||+.
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111110000 00000000000 01123456778899999999999999999999
Q ss_pred HHHHHHHHH
Q 041565 793 DVLWNLEFA 801 (862)
Q Consensus 793 evl~~L~~~ 801 (862)
|+++|-++.
T Consensus 324 e~L~Hp~f~ 332 (362)
T d1q8ya_ 324 GLVNHPWLK 332 (362)
T ss_dssp HHHTCGGGT
T ss_pred HHhcCcccC
Confidence 999876543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.2e-22 Score=197.19 Aligned_cols=170 Identities=14% Similarity=0.129 Sum_probs=121.9
Q ss_pred ccceeEeeeCcEEEEEEEEcCccEEEEEecCCCC------------------hhhHHHHHHHHHHHHhccccceeeEEEE
Q 041565 529 SESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSS------------------EQGVHEFQTEIEMLSKLRHKHLVSLIGF 590 (862)
Q Consensus 529 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~g~ 590 (862)
..+++||+|+||.||+|+..+|..||||.++... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999998888999999754311 0112345678899999999999988865
Q ss_pred EeecCeEEEEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcCCcccEEeeCCCCCCeeccCCCceEEee
Q 041565 591 CEEDGEMILVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTGARYTIIHRDVKTTNILLDEKWEAKVSD 670 (862)
Q Consensus 591 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~~kl~D 670 (862)
.. .+++|||++++.+.+ ++.....+++.|++++|+|||+.+ |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 42 279999998765432 556677889999999999999887 9999999999999965 589999
Q ss_pred ccccccCCCCCCccccccccCCCCCCChhhhhcCCCCchhHHHHHHHHHH
Q 041565 671 FGLSKTGPNLNQTHVSTMVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 720 (862)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ 720 (862)
||+|+............. .... -.|. ..+.++.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 999976432111000000 0000 0011 2356788899999875544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=8.7e-07 Score=90.28 Aligned_cols=149 Identities=16% Similarity=0.125 Sum_probs=98.3
Q ss_pred HHHhhccCcccceeEeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcc-ccceeeEEEEEeecCeEE
Q 041565 520 EIKHGTRNFSESHVIGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLR-HKHLVSLIGFCEEDGEMI 598 (862)
Q Consensus 520 el~~at~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 598 (862)
|+..--+.|+..+..+.++.+.||+...++ ..+++|+...........+.+|...++.+. +--+.+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~-~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCC-CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 444444555544443333346899886444 467888766444333445778888888774 444667888888889999
Q ss_pred EEEEeCCCCcHHHHHhcCCCCCCChhhHHHHHHHHHHHHHHhhcC-----------------------------------
Q 041565 599 LVYDYMANGTLREHLYKGDKPGLPWKQRLEICIGAARGLHYLHTG----------------------------------- 643 (862)
Q Consensus 599 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------- 643 (862)
+||+++++.++.+.... ......++.++++.|+.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999887654321 112233445555555555531
Q ss_pred ---------------------CcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 644 ---------------------ARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 644 ---------------------~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
....++|+|+.|.|||++++...-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 123489999999999999876677999987654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.77 E-value=3.9e-05 Score=77.12 Aligned_cols=74 Identities=19% Similarity=0.213 Sum_probs=53.8
Q ss_pred eEeeeCc-EEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccc--ceeeEEEEEeecCeEEEEEEeCCCCcH
Q 041565 533 VIGVGGF-GKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHK--HLVSLIGFCEEDGEMILVYDYMANGTL 609 (862)
Q Consensus 533 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL 609 (862)
.+..|.. +.||+...+++..+++|....... ..+..|.+.++.+... .+.++++++.+++..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444443 679999888888889998664432 3466788888877533 356778888888899999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00031 Score=75.44 Aligned_cols=76 Identities=16% Similarity=0.160 Sum_probs=48.0
Q ss_pred ceeEeeeCcEEEEEEEEcC-ccEEEEEecCCC-------ChhhHHHHHHHHHHHHhcc-c--cceeeEEEEEeecCeEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDG-KTKVAIKRSNPS-------SEQGVHEFQTEIEMLSKLR-H--KHLVSLIGFCEEDGEMIL 599 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l 599 (862)
.+.||.|....||+....+ +..++||..... -.....+...|.+.|+.+. + ..+.+++.++. ...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 3578999999999998654 567888853321 1112334556888887663 2 34566666543 34578
Q ss_pred EEEeCCCCc
Q 041565 600 VYDYMANGT 608 (862)
Q Consensus 600 V~E~~~~gs 608 (862)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.16 E-value=0.0066 Score=64.64 Aligned_cols=73 Identities=18% Similarity=0.178 Sum_probs=49.2
Q ss_pred ceeEeeeCcEEEEEEEEcCc--------cEEEEEecCCCChhhHHHHHHHHHHHHhcccccee-eEEEEEeecCeEEEEE
Q 041565 531 SHVIGVGGFGKVYEGYIDGK--------TKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV-SLIGFCEEDGEMILVY 601 (862)
Q Consensus 531 ~~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~ 601 (862)
.+.|+.|-.-.+|+....++ ..|++++... .. ......+|..+++.+.-.++. ++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35788888899999987543 3466665542 22 233456899999988644554 77777753 5889
Q ss_pred EeCCCCcH
Q 041565 602 DYMANGTL 609 (862)
Q Consensus 602 E~~~~gsL 609 (862)
||+++.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.96 E-value=0.01 Score=61.38 Aligned_cols=136 Identities=13% Similarity=0.184 Sum_probs=79.5
Q ss_pred cEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhccccce--eeEEE-----EEeecCeEEEEEEeCCCCcHH-
Q 041565 539 FGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHL--VSLIG-----FCEEDGEMILVYDYMANGTLR- 610 (862)
Q Consensus 539 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~- 610 (862)
--.||+...++|..+++|..+.. ....+++..|.+.+..|...++ +..+. ....++..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 46899999999999999987654 2234677889998888854332 11111 224566788999998763321
Q ss_pred ----H------H---Hhc----C---CCCCCChh-------------------h---HHHHHHHHHHHHHHh-hcCCccc
Q 041565 611 ----E------H---LYK----G---DKPGLPWK-------------------Q---RLEICIGAARGLHYL-HTGARYT 647 (862)
Q Consensus 611 ----~------~---l~~----~---~~~~l~~~-------------------~---~~~i~~~ia~gL~yL-H~~~~~~ 647 (862)
. . ++. . .+..+++. . ....+.++...+.-+ .+.....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 1 111 1 01112211 1 112222222222211 2223456
Q ss_pred EEeeCCCCCCeeccCCCceEEeeccccccC
Q 041565 648 IIHRDVKTTNILLDEKWEAKVSDFGLSKTG 677 (862)
Q Consensus 648 ivHrDIkp~NILl~~~~~~kl~DFGla~~~ 677 (862)
+||+|+.+.|||++++ ..++||+-+...
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred eecCCCCcccEEEeCC--ceEEechhcccC
Confidence 9999999999999754 458999987653
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=94.92 E-value=0.07 Score=47.61 Aligned_cols=80 Identities=15% Similarity=0.260 Sum_probs=55.4
Q ss_pred ceEEEEcCCCCeEEEEEEEecCCCCCCCCCCceeEEEeCceEEEecccchhhhhhcccccEEEEEEEccCCCCcEEEEEe
Q 041565 95 SSYKFTVSSKDRFWLRLHFYPASYGNLDPSNAYFSVNANGFTLLNNFSASITAKALTQAYIVREFSLVPAQSGDLIITFT 174 (862)
Q Consensus 95 ~~~~y~~~~~~~ylvR~~F~~~~yg~~d~~~~~~~v~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~l~f~ 174 (862)
..|.+.| |+|.|.|+++|-- ..-..+.+.+-..+..+.. ...-+.| .+.+.+++|.|.|+
T Consensus 65 ~~f~v~v-PnG~Y~Vtv~~Gd---------~~~~~~~~eg~~~~~~~~g---------~~~~~~~-~V~VtDG~L~l~ft 124 (146)
T d2o14a1 65 NTFNVDL-PNGLYEVKVTLGN---------TARASVAAEGVFQVINMTG---------DGAEDTF-QIPVTDGQLNLLVT 124 (146)
T ss_dssp CCEEEEC-CSEEEEEEEEESS---------CSEEEEEETTEEEEEEEES---------TTCEEEE-EEEECSSEEEEEEE
T ss_pred ceEEEEC-CCCeEEEEEEEec---------CCCccEEEeeEEeccccCC---------ccEEEEE-EEEEECCeEEEEEe
Confidence 3566666 6899999999871 2234677888777776633 2223344 36678899999998
Q ss_pred cCCCCCCCcceeeeeEEEECCC
Q 041565 175 PSSDHKDSYAFVNGIEVIPMPD 196 (862)
Q Consensus 175 ~~~~~~~~~pfisaiE~~~l~~ 196 (862)
... ....|-||+|||.+..|
T Consensus 125 ~~~--~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 125 EGK--AGTAFTLSALKIKKLSD 144 (146)
T ss_dssp ESS--TTSCCEEEEEEEEEEES
T ss_pred cCC--CCCccEEEEEEEEeccc
Confidence 543 14589999999998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.14 E-value=0.095 Score=53.14 Aligned_cols=158 Identities=13% Similarity=0.058 Sum_probs=83.6
Q ss_pred cCHHHHHhhccCccccee-----EeeeCcEEEEEEEEcCccEEEEEecCCCChhhHHHHHHHHHHHHhcccccee--eEE
Q 041565 516 FSLAEIKHGTRNFSESHV-----IGVGGFGKVYEGYIDGKTKVAIKRSNPSSEQGVHEFQTEIEMLSKLRHKHLV--SLI 588 (862)
Q Consensus 516 ~~~~el~~at~~f~~~~~-----lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~ 588 (862)
.+.+|+..--.+|..++. |..|---+.|+...++| .+++|+..... ..++...|++++..|...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 455667666677765443 33555578899887776 58888875432 223455677778777543321 111
Q ss_pred E------EEeecCeEEEEEEeCCCCcHH--------------HHHhc--C--CCC-C--C------------------Ch
Q 041565 589 G------FCEEDGEMILVYDYMANGTLR--------------EHLYK--G--DKP-G--L------------------PW 623 (862)
Q Consensus 589 g------~~~~~~~~~lV~E~~~~gsL~--------------~~l~~--~--~~~-~--l------------------~~ 623 (862)
- +....+....++.+..+.... ..++. . ... . . ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 122345566777776653211 01110 0 000 0 0 01
Q ss_pred hhHHHHHHHHHHHHHHhhc-CCcccEEeeCCCCCCeeccCCCceEEeecccccc
Q 041565 624 KQRLEICIGAARGLHYLHT-GARYTIIHRDVKTTNILLDEKWEAKVSDFGLSKT 676 (862)
Q Consensus 624 ~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~~kl~DFGla~~ 676 (862)
......+..+...+.-.+. .-..++||+|+.+.||+++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1112222222233333222 1235699999999999999887778999997754
|